data_2jys_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jys _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 C--O 1.215 -0.645 0 CA-C-O 121.248 0.437 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 23' ' ' TRP . 4.1 mp -88.8 167.46 13.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.261 -0.9 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -104.35 139.6 39.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.27 152.81 33.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 17' ' ' THR . 59.8 tt0 -123.8 120.38 32.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.456 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.51 HG23 HD13 ' A' ' 14' ' ' ILE . 29.8 mt -111.69 128.47 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HG3' HG22 ' A' ' 14' ' ' ILE . 48.3 mttm 50.77 29.58 4.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.564 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.36 -12.08 67.78 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 28.7 m -80.59 129.95 34.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -1.1 . . . . 0.0 109.455 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.463 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 62.4 tttm -96.61 125.38 41.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.609 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.524 HD12 ' CZ ' ' A' ' 36' ' ' PHE . 37.9 mt -147.19 169.85 18.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.284 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -87.28 153.93 21.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.9 . . . . 0.0 109.487 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.36 168.84 18.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.323 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.519 ' O ' ' CD2' ' A' ' 85' ' ' LEU . 70.3 m-70 -131.06 131.37 44.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.615 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.462 ' CH2' ' HB2' ' A' ' 25' ' ' SER . 53.1 t90 -86.25 126.95 34.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.368 -0.833 . . . . 0.0 109.336 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 23' ' ' TRP . 97.1 m-20 -137.67 103.9 5.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.462 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 22.9 t -59.56 -29.23 67.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.51 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.32 -27.36 65.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -84.05 131.2 34.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -1.144 . . . . 0.0 109.576 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.8 p -96.66 -11.62 24.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 109.487 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.512 ' CG2' HD12 ' A' ' 76' ' ' LEU . 10.1 tt -134.23 145.51 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.89 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.518 ' CG2' HG11 ' A' ' 75' ' ' VAL . 86.6 m -63.55 140.97 58.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.442 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.529 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -121.47 128.43 52.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.521 HG11 ' CB ' ' A' ' 75' ' ' VAL . 4.2 m -127.77 163.34 43.82 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.408 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 78' ' ' SER . 55.7 Cg_endo -79.1 138.97 14.75 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.519 2.146 . . . . 0.0 111.943 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.428 ' HG2' ' CB ' ' A' ' 77' ' ' ALA . 74.7 mt-10 -46.88 -24.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.463 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.48 -24.54 3.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.492 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CZ ' HD12 ' A' ' 19' ' ' LEU . 22.8 m-85 -97.85 -8.92 27.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 109.629 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 37' ' ' LEU . 2.7 mm? . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 0.0 109.694 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 8.1 m-85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.32 0.581 . . . . 0.0 110.002 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.492 ' CE1' ' HB3' ' A' ' 72' ' ' GLU . 47.0 t80 -95.88 108.98 21.4 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.472 HD13 ' CD1' ' A' ' 37' ' ' LEU . 50.5 mt -120.6 168.35 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.054 -1.029 . . . . 0.0 110.517 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.534 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 88.9 m -118.05 125.94 51.31 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.488 ' CE2' HG22 ' A' ' 66' ' ' VAL . 37.5 p90 -145.16 155.2 43.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 0.0 109.685 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 31.7 mttt -89.03 129.18 35.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.488 HG22 ' CE2' ' A' ' 64' ' ' PHE . 2.0 t -103.33 97.78 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 76.5 mt-30 65.02 41.11 4.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.214 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.22 32.88 41.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -137.63 108.63 6.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -1.146 . . . . 0.0 109.34 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -58.12 122.51 13.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.539 HG23 ' CH2' ' A' ' 92' ' ' TRP . 93.6 t -147.7 134.22 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.285 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.534 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 88.5 mt-10 -110.61 140.46 44.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.667 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.15 162.84 34.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.351 -0.843 . . . . 0.0 109.569 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 96.7 mt-10 -80.9 136.28 36.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.846 . . . . 0.0 109.175 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.521 ' CB ' HG11 ' A' ' 32' ' ' VAL . 12.4 m -129.54 150.91 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.225 -0.922 . . . . 0.0 109.683 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.512 HD12 ' CG2' ' A' ' 29' ' ' ILE . 5.4 mp -100.41 150.17 22.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.277 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' CB ' ' HG2' ' A' ' 34' ' ' GLU . . . -80.04 135.6 36.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.47 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 2.8 t -142.9 150.19 52.29 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.47 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.0 Cg_endo -70.78 2.27 4.27 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.664 2.243 . . . . 0.0 112.088 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.459 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 67.1 m-85 -66.04 171.17 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.568 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -110.98 20.45 17.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.788 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.593 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 12.3 p90 -145.46 -159.91 1.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 109.441 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.513 ' O ' ' CD2' ' A' ' 82' ' ' TYR . 4.3 mt -125.16 154.44 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.62 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.593 ' HG ' ' CE2' ' A' ' 82' ' ' TYR . 1.8 mt -120.03 126.48 50.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.263 -0.898 . . . . 0.0 109.063 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -105.61 142.02 36.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.536 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.518 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -102.26 161.82 22.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.366 -0.834 . . . . 0.0 109.431 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 51.9 Cg_endo -71.64 -21.6 25.27 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.618 2.212 . . . . 0.0 111.677 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.2 m -77.81 -34.1 52.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 0.0 109.403 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 90' ' ' VAL . 1.6 p30 -80.02 -40.67 27.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.457 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 86' ' ' ASN . 2.6 m -109.31 70.0 0.44 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.573 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.6 Cg_endo -70.53 -22.18 28.91 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.659 2.239 . . . . 0.0 111.843 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.573 ' CZ3' ' HD2' ' A' ' 91' ' ' PRO . 47.5 p90 -77.27 -31.71 55.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.439 HD21 ' O ' ' A' ' 93' ' ' LEU . 10.0 tt . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.575 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.6 Cg_endo . . . . . 0 C--O 1.215 -0.642 0 CA-C-O 121.129 0.387 . . . . 0.0 111.766 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.449 HD13 ' HB2' ' A' ' 23' ' ' TRP . 4.3 mp -80.51 168.29 19.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 109.336 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -102.03 145.77 28.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.81 152.98 36.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.257 -0.902 . . . . 0.0 109.471 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 65' ' ' LYS . 82.0 tt0 -126.72 119.73 27.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 64' ' ' PHE . 50.2 mt -115.93 129.61 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 109.374 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 82.8 mttt 58.35 24.03 11.18 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 109.572 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.44 -0.85 85.62 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.0 m -98.83 128.21 44.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -1.223 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -83.78 138.89 33.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 109.443 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.456 ' HB3' HD13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -150.01 167.21 27.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.555 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -83.53 155.0 23.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.516 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.485 ' CB ' HD23 ' A' ' 85' ' ' LEU . . . -147.88 167.14 25.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 109.379 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.575 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 67.1 m-70 -132.45 131.89 42.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.649 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.605 ' CZ2' ' CD1' ' A' ' 93' ' ' LEU . 71.6 t90 -84.7 128.15 34.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.327 -0.858 . . . . 0.0 109.386 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -138.33 104.97 5.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 109.526 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.54 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 6.5 p -60.45 -26.91 67.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.951 . . . . 0.0 109.438 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.05 -28.13 73.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -85.44 122.15 29.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -1.14 . . . . 0.0 109.232 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.1 p -91.89 -12.76 32.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.39 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 74' ' ' GLU . 11.1 tp -127.04 142.33 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -0.936 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 44.4 m -63.39 139.56 58.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.526 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -120.78 123.23 42.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.21 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.586 ' CG2' ' CD1' ' A' ' 37' ' ' LEU . 17.3 m -121.83 162.87 34.59 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 109.727 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 82' ' ' TYR . 54.7 Cg_endo -79.35 133.16 10.58 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.593 2.196 . . . . 0.0 111.554 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -46.72 -24.88 0.63 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.422 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.58 -32.95 53.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.646 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.436 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 5.3 m-85 -93.55 -3.95 51.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 109.67 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.637 ' CD2' ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.176 -0.952 . . . . 0.0 109.737 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.637 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 38.3 m-85 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.235 0.541 . . . . 0.0 109.838 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.457 ' O ' HD22 ' A' ' 62' ' ' LEU . 36.2 t80 -94.74 111.8 23.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 108.874 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.457 HD22 ' O ' ' A' ' 61' ' ' TYR . 43.9 mt -121.3 167.09 13.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 110.122 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.538 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 52.2 m -124.01 113.99 19.16 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.486 ' CE2' ' CG2' ' A' ' 66' ' ' VAL . 12.7 p90 -134.29 159.27 41.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.815 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 74.5 mttt -90.84 123.74 34.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.307 -0.871 . . . . 0.0 109.291 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.486 ' CG2' ' CE2' ' A' ' 64' ' ' PHE . 51.9 t -100.85 106.52 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.762 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 98.0 mt-30 62.3 36.54 14.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.313 -0.867 . . . . 0.0 109.484 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.69 26.25 54.4 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 71' ' ' VAL . 55.0 mtt180 -131.35 115.06 15.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.248 -1.148 . . . . 0.0 109.277 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.53 120.31 9.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 69' ' ' ARG . 36.4 t -141.2 133.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.538 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 45.6 mt-10 -113.94 136.38 52.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.602 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.36 166.42 29.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.831 . . . . 0.0 109.631 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 98.1 mt-10 -80.87 133.69 35.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.513 ' CG2' HG21 ' A' ' 32' ' ' VAL . 3.4 m -127.21 161.9 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.536 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mt -116.25 151.52 35.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.362 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.0 134.56 36.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.339 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.462 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.5 t -140.08 150.84 63.36 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.361 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.462 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.4 Cg_endo -70.55 -0.18 7.17 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.652 2.234 . . . . 0.0 111.78 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -64.95 168.52 6.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.493 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -110.99 22.35 15.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.612 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.572 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 15.3 p90 -144.04 -160.78 1.16 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 109.281 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.507 ' CG2' HG13 ' A' ' 32' ' ' VAL . 5.0 mt -126.64 143.56 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 109.737 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.572 HD11 ' CZ ' ' A' ' 82' ' ' TYR . 6.4 mp -107.57 123.15 48.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.814 . . . . 0.0 109.066 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -102.13 137.48 40.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.548 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.517 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -99.63 160.16 28.1 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.86 . . . . 0.0 109.687 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 51.7 Cg_endo -71.21 -27.92 19.28 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.735 2.29 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.0 m -69.19 -38.9 78.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.1 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 90' ' ' VAL . 1.7 p30 -74.43 -40.15 62.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.87 . . . . 0.0 108.993 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 86' ' ' ASN . 3.4 m -111.79 79.99 2.77 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.575 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 48.7 Cg_endo -69.18 -31.39 23.19 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.69 2.26 . . . . 0.0 112.085 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.575 ' CZ3' ' HD2' ' A' ' 91' ' ' PRO . 30.6 p90 -63.89 -21.58 66.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.096 -1.003 . . . . 0.0 109.419 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.605 ' CD1' ' CZ2' ' A' ' 23' ' ' TRP . 2.2 mm? . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 109.606 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.539 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 48.9 Cg_endo . . . . . 0 C--O 1.215 -0.652 0 CA-C-O 121.213 0.422 . . . . 0.0 111.804 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.528 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 18.3 mt -99.49 178.64 4.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.131 -0.981 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.68 139.85 42.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.354 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.86 149.66 31.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 109.707 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 65' ' ' LYS . 96.2 mt-10 -123.74 116.1 22.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.27 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.519 HG23 ' CD1' ' A' ' 36' ' ' PHE . 49.9 mt -108.95 129.53 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HG3' HG23 ' A' ' 14' ' ' ILE . 85.6 mttt 54.91 24.47 5.86 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.253 -0.904 . . . . 0.0 109.62 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.29 -2.61 83.55 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.5 m -89.88 117.37 28.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -1.202 . . . . 0.0 109.491 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.45 ' O ' HD21 ' A' ' 19' ' ' LEU . 84.2 tttt -81.8 125.75 31.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.557 HD12 ' CZ ' ' A' ' 36' ' ' PHE . 92.5 mt -145.77 161.77 39.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.28 148.6 30.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.529 ' HB3' ' CD1' ' A' ' 85' ' ' LEU . . . -129.92 173.14 10.98 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.172 -0.955 . . . . 0.0 109.532 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.539 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 41.0 m-70 -127.24 127.99 45.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 0.0 109.657 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.559 ' CH2' ' HB3' ' A' ' 25' ' ' SER . 60.8 t90 -91.94 128.12 37.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.581 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.458 ' CB ' HD22 ' A' ' 84' ' ' LEU . 61.1 t0 -137.82 104.36 5.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.559 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 59.6 p -56.64 -28.0 59.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.895 . . . . 0.0 109.514 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.07 -29.67 74.84 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.77 142.2 58.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -1.176 . . . . 0.0 109.506 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 28' ' ' THR . 86.7 m -108.61 -5.24 16.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.512 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 18.4 tt -152.0 144.54 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.521 ' N ' ' HB2' ' A' ' 86' ' ' ASN . 44.8 m -53.94 150.64 7.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.679 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.42 ' O ' HG22 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -122.36 129.59 52.27 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.269 -0.894 . . . . 0.0 109.116 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.535 ' CG1' ' HD2' ' A' ' 33' ' ' PRO . 77.3 t -134.57 145.83 56.67 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.297 -0.877 . . . . 0.0 109.455 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.535 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 55.3 Cg_endo -77.95 133.55 12.55 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.291 1.994 . . . . 0.0 111.651 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 40.7 tp10 -42.06 -27.4 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.44 -0.788 . . . . 0.0 109.792 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -47.81 -39.15 17.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.645 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.557 ' CZ ' HD12 ' A' ' 19' ' ' LEU . 32.7 m-85 -92.12 -5.48 52.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 109.847 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.648 ' CD2' ' CD2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.93 . . . . 0.0 109.857 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.648 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 34.6 m-85 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.323 0.582 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.458 ' O ' HD23 ' A' ' 62' ' ' LEU . 42.9 t80 -94.47 107.74 19.7 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 61' ' ' TYR . 39.3 mt -118.1 171.29 8.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -0.99 . . . . 0.0 110.334 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.533 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 82.8 m -125.93 119.02 26.66 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.1 p90 -140.6 157.73 45.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.791 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 13' ' ' GLU . 20.3 mttm -87.36 132.02 34.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.835 . . . . 0.0 109.383 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 98.8 t -112.1 107.08 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.461 ' OE1' HD22 ' A' ' 93' ' ' LEU . 83.4 mt-30 63.37 35.46 12.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 109.4 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.74 33.81 32.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -141.24 115.09 9.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -1.116 . . . . 0.0 109.411 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.427 ' C ' HG21 ' A' ' 71' ' ' VAL . 3.5 ttpm? -61.68 123.11 17.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.535 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.429 HG23 ' CH2' ' A' ' 92' ' ' TRP . 92.0 t -144.41 132.58 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.462 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.533 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 50.4 mt-10 -109.02 138.01 46.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.622 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.509 ' CB ' ' OD2' ' A' ' 89' ' ' ASP . . . -160.27 165.76 30.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.668 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 96.1 mt-10 -81.42 129.87 34.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.515 HG13 ' CG2' ' A' ' 30' ' ' THR . 3.2 m -124.92 160.88 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.119 -0.988 . . . . 0.0 109.61 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.476 HD11 ' CG2' ' A' ' 29' ' ' ILE . 29.0 mt -109.35 145.11 36.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.95 134.76 36.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.438 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.528 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 3.5 t -142.25 149.64 52.43 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.395 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.7 Cg_endo -70.16 0.26 6.21 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.635 2.223 . . . . 0.0 111.873 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.528 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 66.6 m-85 -65.82 177.52 1.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.333 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -119.85 22.27 11.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.414 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.461 ' OH ' HD12 ' A' ' 84' ' ' LEU . 15.1 p90 -135.78 -173.72 3.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.863 . . . . 0.0 109.183 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.467 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 1.4 mt -131.54 112.33 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.461 HD12 ' OH ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -79.56 135.25 36.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.208 -0.933 . . . . 0.0 109.176 179.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -98.65 134.62 41.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.669 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.521 ' HB2' ' N ' ' A' ' 30' ' ' THR . 29.8 t30 -86.21 140.77 34.58 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.441 -0.787 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.477 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 46.5 Cg_endo -67.91 -34.54 23.35 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.69 2.26 . . . . 0.0 111.756 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.7 m -66.37 -36.05 81.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.182 -0.949 . . . . 0.0 109.283 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.509 ' OD2' ' CB ' ' A' ' 73' ' ' ALA . 91.8 m-20 -72.42 -32.1 66.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.493 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.63 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -113.93 72.85 2.22 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.535 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.4 Cg_endo -71.04 -21.98 26.87 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.667 2.245 . . . . 0.0 112.0 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.63 ' CZ2' ' CG1' ' A' ' 90' ' ' VAL . 47.0 p90 -74.72 -30.43 61.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.461 HD22 ' OE1' ' A' ' 67' ' ' GLN . 66.9 mt . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.576 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.1 Cg_endo . . . . . 0 C--O 1.216 -0.621 0 CA-C-O 121.271 0.446 . . . . 0.0 111.811 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.463 HD13 ' HB2' ' A' ' 23' ' ' TRP . 4.5 mp -81.27 166.47 20.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.46 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -104.65 144.37 31.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.503 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.2 152.78 30.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 109.463 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.45 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 78.3 tt0 -123.14 120.34 32.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.321 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.573 HG23 ' CD1' ' A' ' 36' ' ' PHE . 57.7 mt -114.92 128.03 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.446 ' HG2' HG22 ' A' ' 14' ' ' ILE . 31.7 mmtp 59.43 23.26 11.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.45 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 86.54 10.51 73.32 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 33.8 m -108.52 125.8 52.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -1.13 . . . . 0.0 109.451 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.522 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 28.7 mttm -80.28 125.32 29.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.453 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.522 ' CD2' ' O ' ' A' ' 18' ' ' LYS . 1.3 mm? -141.06 158.26 44.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -80.23 155.44 27.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 109.402 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.73 164.29 33.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.563 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.576 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 73.4 m-70 -124.9 133.19 53.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.616 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 20.0 t90 -83.95 126.25 32.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -132.91 97.71 4.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.311 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.513 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 52.1 p -58.53 -26.83 63.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.578 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.05 -31.31 76.19 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -77.78 138.32 38.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.173 . . . . 0.0 109.693 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.8 p -98.64 -4.71 33.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.592 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.431 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 21.1 tt -142.65 156.64 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.0 109.327 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 33.5 m -71.71 140.48 49.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.952 . . . . 0.0 109.63 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.522 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -124.31 122.08 36.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.423 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.526 ' CG2' HG23 ' A' ' 75' ' ' VAL . 3.4 m -119.62 164.61 20.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.922 . . . . 0.0 109.368 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.2 Cg_endo -79.04 137.85 14.02 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.475 2.117 . . . . 0.0 111.65 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -47.57 -23.59 0.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 0.0 109.592 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.03 -36.66 18.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.55 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.573 ' CD1' HG23 ' A' ' 14' ' ' ILE . 31.1 m-85 -89.61 -10.52 45.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.581 ' CD2' ' CG ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.581 ' CG ' ' CD2' ' A' ' 37' ' ' LEU . 9.1 m-85 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.374 0.607 . . . . 0.0 109.968 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.512 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 48.1 t80 -100.02 112.96 25.24 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.6 mt -123.19 170.5 10.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 110.417 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.516 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 89.4 m -118.84 126.68 52.39 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.534 ' CE2' HG23 ' A' ' 66' ' ' VAL . 35.7 p90 -142.99 154.78 44.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.093 -1.004 . . . . 0.0 109.748 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -88.07 128.4 35.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 109.383 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.534 HG23 ' CE2' ' A' ' 64' ' ' PHE . 2.2 t -105.78 103.78 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 90.0 mt-30 62.01 31.57 17.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.926 . . . . 0.0 109.285 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.99 28.66 25.21 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -132.91 126.53 32.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -1.172 . . . . 0.0 109.508 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -68.28 123.52 20.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.563 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.445 ' CG2' HG22 ' A' ' 66' ' ' VAL . 41.4 t -145.29 129.05 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.448 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.516 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 67.2 mt-10 -112.45 135.17 53.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.04 166.07 30.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.739 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 91.9 mt-10 -80.24 133.26 35.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.283 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.526 HG23 ' CG2' ' A' ' 32' ' ' VAL . 3.8 m -129.04 159.47 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.558 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 4.1 mp -110.83 151.28 28.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -0.885 . . . . 0.0 109.406 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.01 142.08 35.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.416 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.515 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 8.3 t -145.05 148.63 39.21 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 109.361 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.469 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.1 Cg_endo -70.34 0.24 6.37 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.649 2.233 . . . . 0.0 111.873 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.515 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 31.3 m-85 -63.63 171.88 2.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 109.458 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -111.74 17.59 19.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.59 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.589 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 21.6 p90 -141.03 -156.17 0.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.136 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.6 mt -130.46 147.04 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.019 -1.051 . . . . 0.0 109.988 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' HG ' ' CE2' ' A' ' 82' ' ' TYR . 1.1 mt -108.99 130.39 55.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 108.98 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -99.73 144.29 28.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 109.853 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.524 ' OD1' ' CD ' ' A' ' 87' ' ' PRO . 4.2 t30 -97.02 136.91 21.32 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.453 -0.78 . . . . 0.0 109.034 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.571 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.1 Cg_endo -63.88 -33.56 63.65 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.85 2.367 . . . . 0.0 112.028 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.2 m -75.47 -29.43 59.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.302 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.445 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 90.4 m-20 -73.35 -31.13 63.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.273 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.491 ' CG1' HG12 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -121.49 77.54 36.07 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.888 . . . . 0.0 109.363 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.82 -23.83 30.1 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.802 2.335 . . . . 0.0 111.874 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -80.91 -22.42 39.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.418 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.616 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 25.0 tp . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.403 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.574 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 47.9 Cg_endo . . . . . 0 C--O 1.215 -0.634 0 CA-C-O 121.194 0.414 . . . . 0.0 111.763 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.516 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 26.4 mt -80.91 -177.58 6.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.486 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -118.02 139.9 50.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.368 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.75 154.01 38.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 17' ' ' THR . 87.1 tt0 -128.5 120.47 26.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.944 . . . . 0.0 109.357 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.459 ' CG2' ' HG3' ' A' ' 15' ' ' LYS . 59.2 mt -115.63 127.83 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.393 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.459 ' HG3' ' CG2' ' A' ' 14' ' ' ILE . 45.6 mttt 60.77 23.76 13.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 109.449 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.427 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.29 -5.22 84.29 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.512 HG22 ' CD2' ' A' ' 19' ' ' LEU . 35.4 m -93.14 127.59 38.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -1.158 . . . . 0.0 109.459 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.446 ' O ' HD21 ' A' ' 19' ' ' LEU . 18.2 tttm -87.24 120.45 28.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.568 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.512 ' CD2' HG22 ' A' ' 17' ' ' THR . 3.5 mm? -129.59 164.6 23.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 109.313 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -83.0 155.96 23.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.938 . . . . 0.0 109.395 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.85 163.24 34.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 73.6 m-70 -125.92 127.8 46.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.527 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.58 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 51.9 t90 -78.67 118.5 20.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.907 . . . . 0.0 109.507 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -128.2 102.93 6.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.953 . . . . 0.0 109.336 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.58 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 60.6 p -60.8 -29.2 69.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.609 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.98 -34.36 78.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.08 136.74 54.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.491 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.448 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 36.9 m -95.51 -14.73 23.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 tt -142.36 155.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.467 ' HB ' HG12 ' A' ' 75' ' ' VAL . 47.5 m -61.1 136.93 58.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.522 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -119.22 126.6 51.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.382 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.569 ' CG2' ' CG2' ' A' ' 75' ' ' VAL . 15.7 m -124.96 161.37 49.55 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 109.66 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 82' ' ' TYR . 54.8 Cg_endo -79.38 132.05 9.92 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.751 2.301 . . . . 0.0 111.834 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.1 tt0 -45.36 -26.81 0.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.63 -36.1 33.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.509 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.07 -2.56 57.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.621 ' CD2' ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 0.0 109.916 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.621 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 17.5 m-85 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.303 0.573 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.469 ' O ' HD21 ' A' ' 62' ' ' LEU . 48.6 t80 -95.86 112.0 23.84 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.469 HD21 ' O ' ' A' ' 61' ' ' TYR . 37.6 mt -121.79 170.22 9.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.052 -1.03 . . . . 0.0 110.489 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.525 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 87.1 m -121.97 119.77 32.47 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.407 ' CE2' HG22 ' A' ' 66' ' ' VAL . 44.6 p90 -140.68 154.46 46.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.026 -1.046 . . . . 0.0 109.739 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.428 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 20.1 mttm -85.87 132.33 34.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.833 . . . . 0.0 109.318 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 1.9 t -109.0 100.86 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.703 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 81.2 mt-30 65.09 35.45 7.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.458 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.33 35.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -134.08 116.73 15.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -1.072 . . . . 0.0 109.424 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -66.8 119.7 12.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.44 ' HB ' HG21 ' A' ' 66' ' ' VAL . 98.6 t -141.24 134.39 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.867 . . . . 0.0 109.429 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.525 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 61.1 mt-10 -110.5 136.13 50.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 109.593 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.26 166.34 29.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.672 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 96.3 mt-10 -80.02 136.24 36.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.27 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.569 ' CG2' ' CG2' ' A' ' 32' ' ' VAL . 4.1 m -127.96 158.19 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.22 -0.925 . . . . 0.0 109.65 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.4 tp -109.32 146.09 34.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.8 124.5 28.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 109.227 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.467 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 2.0 t -128.09 150.21 73.18 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.8 Cg_endo -70.58 -0.3 7.39 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.683 2.255 . . . . 0.0 111.628 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.443 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 56.0 m-85 -64.13 172.14 2.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 109.444 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -112.14 17.09 19.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.607 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.557 ' CZ ' ' CD1' ' A' ' 84' ' ' LEU . 19.3 p90 -139.35 -156.82 0.71 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.245 -0.909 . . . . 0.0 109.087 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.555 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.0 mt -130.04 140.9 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.557 ' CD1' ' CZ ' ' A' ' 82' ' ' TYR . 6.5 mp -105.5 131.77 52.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 108.987 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -98.94 146.55 25.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.139 -0.976 . . . . 0.0 109.666 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.524 ' OD1' ' CD ' ' A' ' 87' ' ' PRO . 4.7 t30 -99.74 136.86 20.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 109.189 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.524 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.6 Cg_endo -64.13 -33.26 61.93 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.805 2.336 . . . . 0.0 111.81 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.8 t -76.56 -25.95 54.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.18 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.421 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 89.6 m-20 -80.26 -32.69 38.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.376 -0.827 . . . . 0.0 109.306 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -120.03 76.23 22.45 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.872 . . . . 0.0 109.54 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.27 -24.85 26.87 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.682 2.255 . . . . 0.0 111.796 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.457 ' CZ2' HG11 ' A' ' 90' ' ' VAL . 39.8 p90 -75.27 -27.59 59.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -0.89 . . . . 0.0 109.585 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.497 HD13 ' CD1' ' A' ' 23' ' ' TRP . 9.4 tt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.571 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 48.9 Cg_endo . . . . . 0 C--O 1.215 -0.646 0 CA-C-O 121.239 0.433 . . . . 0.0 111.793 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.485 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 20.9 mt -83.79 -177.36 6.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.92 . . . . 0.0 109.559 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -117.93 136.97 53.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 109.389 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.98 150.13 32.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.207 -0.933 . . . . 0.0 109.653 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.422 ' HG2' ' HA ' ' A' ' 18' ' ' LYS . 95.5 mt-10 -118.58 123.04 44.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.28 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.2 mt -117.37 124.11 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.582 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.7 tptt 64.11 22.13 12.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.524 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.13 -1.03 82.39 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.518 HG22 ' CD2' ' A' ' 19' ' ' LEU . 10.6 m -96.16 129.66 43.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.136 . . . . 0.0 109.384 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.46 ' O ' HD22 ' A' ' 19' ' ' LEU . 71.4 tttt -86.9 117.02 25.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.44 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.529 ' CB ' HD13 ' A' ' 83' ' ' ILE . 3.8 mm? -132.17 161.37 33.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.386 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -84.45 153.57 23.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.419 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 10' ' ' LEU . . . -141.58 163.01 34.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 109.56 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 74.2 m-70 -121.01 127.72 52.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 109.627 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.485 ' HB2' ' CD1' ' A' ' 10' ' ' LEU . 34.1 t90 -80.39 118.89 22.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.587 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -127.67 102.97 7.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.265 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.457 ' HA ' ' HG3' ' A' ' 87' ' ' PRO . 23.4 t -59.12 -29.43 67.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 109.625 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.51 -40.16 94.06 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.425 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -65.19 128.27 35.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -1.151 . . . . 0.0 109.487 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.509 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 45.6 p -94.09 -8.07 40.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.217 -0.927 . . . . 0.0 109.447 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.521 HG23 ' CD1' ' A' ' 76' ' ' LEU . 11.1 tp -139.09 151.23 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.245 -0.909 . . . . 0.0 109.293 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 34.7 m -68.59 140.06 55.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 9.2 t -129.51 139.24 51.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.256 -0.903 . . . . 0.0 109.14 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.513 ' HB ' ' HD2' ' A' ' 33' ' ' PRO . 4.0 m -136.85 167.05 22.85 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.225 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.5 Cg_endo -78.93 134.32 11.77 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.202 1.935 . . . . 0.0 111.704 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' LEU . 81.3 tt0 -45.05 -24.58 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.363 -0.836 . . . . 0.0 109.874 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -47.71 -36.18 10.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 109.723 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -92.38 -7.41 47.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.182 -0.949 . . . . 0.0 109.588 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.574 ' HG ' ' CD2' ' A' ' 60' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 109.527 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.574 ' CD2' ' HG ' ' A' ' 37' ' ' LEU . 26.6 m-85 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.441 0.639 . . . . 0.0 110.316 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.571 ' CE2' ' HG2' ' A' ' 72' ' ' GLU . 4.8 t80 -98.19 110.13 22.77 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 61' ' ' TYR . 3.6 mm? -124.03 156.35 36.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.481 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.509 ' CA ' ' HG3' ' A' ' 72' ' ' GLU . 5.0 m -110.97 126.09 54.4 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.443 -0.786 . . . . 0.0 108.931 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.522 ' CE2' HG23 ' A' ' 66' ' ' VAL . 28.1 p90 -141.48 153.39 44.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.107 -0.995 . . . . 0.0 109.694 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -83.85 127.95 34.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.28 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.522 HG23 ' CE2' ' A' ' 64' ' ' PHE . 25.1 t -105.75 98.99 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 82.1 mt-30 64.68 36.5 8.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.51 30.01 31.3 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -136.7 125.17 23.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -1.134 . . . . 0.0 109.449 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' C ' HG21 ' A' ' 71' ' ' VAL . 71.5 tttt -67.33 128.41 36.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.473 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.437 ' HB ' HG22 ' A' ' 66' ' ' VAL . 43.3 t -150.0 128.18 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.571 ' HG2' ' CE2' ' A' ' 61' ' ' TYR . 55.2 tt0 -118.31 134.59 54.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.0 175.23 13.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.268 -0.895 . . . . 0.0 109.434 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 95.6 mt-10 -79.71 139.65 37.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 109.261 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 30' ' ' THR . 10.8 m -133.82 151.86 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.269 -0.894 . . . . 0.0 109.583 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 4.3 mp -102.61 145.77 29.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.33 -0.856 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.0 137.94 36.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.298 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 1.3 t -144.02 151.17 51.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.461 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.0 Cg_endo -71.79 2.53 4.62 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.69 2.26 . . . . 0.0 111.83 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -63.55 167.11 5.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.162 -0.962 . . . . 0.0 109.338 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -109.71 17.71 20.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.625 ' CZ ' ' CD1' ' A' ' 84' ' ' LEU . 14.5 p90 -139.49 -157.71 0.79 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.136 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.541 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.0 mt -128.98 145.82 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 109.575 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.625 ' CD1' ' CZ ' ' A' ' 82' ' ' TYR . 5.9 mp -110.76 135.0 52.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -0.882 . . . . 0.0 108.872 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -105.64 142.49 35.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 28' ' ' THR . 6.5 t30 -100.13 134.86 20.56 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 108.949 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.492 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 41.5 Cg_endo -63.86 -22.85 68.88 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.769 2.313 . . . . 0.0 112.234 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.2 m -77.05 -31.62 56.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 0.0 109.298 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 90' ' ' VAL . 1.9 p30 -80.37 -35.63 35.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 109.378 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.514 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 2.4 m -112.1 69.28 0.92 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.391 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.87 -21.94 32.26 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.679 2.252 . . . . 0.0 111.813 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.489 ' CZ2' ' CG1' ' A' ' 90' ' ' VAL . 38.7 p90 -72.76 -28.8 62.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.2 tp . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.929 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.575 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.4 Cg_endo . . . . . 0 C--O 1.215 -0.669 0 CA-C-O 121.205 0.419 . . . . 0.0 111.707 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.524 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 17.2 mt -81.45 179.92 7.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.33 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -110.48 139.13 46.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.89 148.65 32.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.488 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.435 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 79.3 tt0 -129.23 116.08 18.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -0.86 . . . . 0.0 109.37 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 14' ' ' ILE . 59.4 mt -111.72 127.31 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.14 -0.975 . . . . 0.0 109.592 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HG3' HG23 ' A' ' 14' ' ' ILE . 54.4 mttp 57.88 24.76 11.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.288 -0.882 . . . . 0.0 109.599 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.435 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.52 -10.69 72.54 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 50.0 m -79.72 125.51 29.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -1.105 . . . . 0.0 109.312 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' O ' HD21 ' A' ' 19' ' ' LEU . 3.3 ttmt -88.81 117.34 27.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.527 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.635 ' CD1' ' CE1' ' A' ' 36' ' ' PHE . 73.3 mt -136.54 156.52 48.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.868 . . . . 0.0 109.363 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -84.72 151.75 24.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.461 ' HB3' ' CD2' ' A' ' 85' ' ' LEU . . . -133.69 -179.76 5.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.936 . . . . 0.0 109.578 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.575 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 67.5 m-70 -134.24 131.16 38.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.901 . . . . 0.0 109.599 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.524 ' HB2' ' CD1' ' A' ' 10' ' ' LEU . 64.4 t90 -88.33 119.04 28.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.264 -0.898 . . . . 0.0 109.352 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -128.21 103.02 6.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.297 -0.877 . . . . 0.0 109.427 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.516 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 21.4 t -55.83 -31.84 63.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.646 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.27 -37.51 91.96 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.463 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -68.03 144.94 54.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -1.192 . . . . 0.0 109.517 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.517 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 39.7 p -113.13 -5.6 13.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.459 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.8 tt -141.8 146.28 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 0.0 109.423 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.466 ' HB ' HG22 ' A' ' 75' ' ' VAL . 51.7 m -66.73 141.17 57.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 0.0 109.633 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.525 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -126.66 136.41 52.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.531 ' CG2' HD12 ' A' ' 37' ' ' LEU . 25.0 m -132.38 165.02 39.31 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.831 . . . . 0.0 108.899 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.4 Cg_endo -78.23 129.84 9.81 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.115 1.876 . . . . 0.0 111.419 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 33' ' ' PRO . 81.3 tt0 -40.87 -27.82 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.53 -0.731 . . . . 0.0 109.891 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -50.79 -28.33 9.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.538 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.635 ' CE1' ' CD1' ' A' ' 19' ' ' LEU . 15.0 m-85 -96.36 -7.76 34.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 109.528 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.64 ' CD2' ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.797 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.64 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 25.5 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.253 0.549 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -87.14 114.12 23.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.887 . . . . 0.0 108.776 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.4 mt -120.89 163.45 18.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.133 -0.979 . . . . 0.0 110.235 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.539 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 41.5 m -124.24 121.12 34.17 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.526 ' CE2' HG23 ' A' ' 66' ' ' VAL . 22.0 p90 -145.4 164.17 32.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.951 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -90.87 132.95 35.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.414 -0.804 . . . . 0.0 109.339 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.526 HG23 ' CE2' ' A' ' 64' ' ' PHE . 38.3 t -111.4 98.3 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.552 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 88.0 mt-30 63.35 36.28 11.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.325 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.45 35.08 18.13 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -141.98 124.59 15.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -1.1 . . . . 0.0 109.39 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -69.68 122.44 19.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.448 ' HB ' HG22 ' A' ' 66' ' ' VAL . 39.6 t -141.14 134.79 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.887 . . . . 0.0 109.556 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.539 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 52.1 mt-10 -125.77 132.59 52.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.557 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.29 -176.99 5.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.474 ' O ' HG22 ' A' ' 75' ' ' VAL . 93.9 mt-10 -79.82 154.03 28.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.273 -0.892 . . . . 0.0 109.091 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.53 HG13 ' CG2' ' A' ' 32' ' ' VAL . 56.0 t -144.83 157.64 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.188 -0.945 . . . . 0.0 109.748 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.446 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 16.4 tp -117.58 144.4 45.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 109.041 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.97 137.46 36.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 109.529 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.468 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 3.2 t -142.31 150.23 54.35 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.332 -0.855 . . . . 0.0 109.471 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.462 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 52.8 Cg_endo -72.68 5.71 2.76 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.602 2.202 . . . . 0.0 111.905 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.468 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 54.5 m-85 -64.73 -178.94 0.45 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -118.87 14.68 13.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.471 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.571 ' CZ ' ' HG ' ' A' ' 84' ' ' LEU . 20.5 p90 -142.28 -156.99 0.73 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 108.972 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.56 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 2.8 mt -128.84 128.28 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.25 -0.906 . . . . 0.0 109.812 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.571 ' HG ' ' CZ ' ' A' ' 82' ' ' TYR . 1.7 mt -83.86 136.91 33.93 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.2 -0.937 . . . . 0.0 108.713 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.522 ' CD1' HD13 ' A' ' 10' ' ' LEU . 5.2 mt -102.13 143.57 31.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 0.0 110.049 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 28' ' ' THR . 10.3 t-20 -102.54 133.12 20.68 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.472 -0.768 . . . . 0.0 109.133 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.483 ' HD2' ' OD1' ' A' ' 86' ' ' ASN . 44.2 Cg_endo -66.05 -30.27 47.67 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.759 2.306 . . . . 0.0 111.929 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.7 m -76.21 -31.75 58.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.162 -0.961 . . . . 0.0 109.238 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -73.21 -28.3 62.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.382 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.534 HG13 ' CZ2' ' A' ' 92' ' ' TRP . 2.2 m -124.1 77.83 59.45 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.552 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.5 Cg_endo -70.14 -20.45 33.03 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.731 2.287 . . . . 0.0 111.972 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.552 ' CZ3' ' HD2' ' A' ' 91' ' ' PRO . 48.8 p90 -80.99 -27.45 35.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.487 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 109.391 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.56 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.9 Cg_endo . . . . . 0 C--O 1.216 -0.608 0 CA-C-O 121.233 0.431 . . . . 0.0 111.747 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mp -81.8 176.36 9.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.428 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -104.76 140.31 38.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.65 152.7 33.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.873 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 17' ' ' THR . 91.9 mt-10 -129.35 116.35 18.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 109.531 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.45 HG22 ' CD2' ' A' ' 36' ' ' PHE . 33.5 mt -109.88 128.76 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 109.401 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HG3' HG21 ' A' ' 14' ' ' ILE . 2.8 mtmt 58.71 22.32 9.84 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.178 -0.951 . . . . 0.0 109.55 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.72 -0.88 83.15 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 31.2 m -93.46 132.7 37.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -1.218 . . . . 0.0 109.479 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.501 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 25.7 tttt -83.05 121.15 26.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.51 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.501 ' CD2' ' O ' ' A' ' 18' ' ' LYS . 1.6 mm? -138.34 158.82 43.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.945 . . . . 0.0 109.545 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.495 ' HD3' ' CG ' ' A' ' 9' ' ' PRO . 46.2 mttt -82.48 147.01 28.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 85' ' ' LEU . . . -134.86 159.78 40.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.373 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.56 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 53.1 m-70 -123.06 133.97 54.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.42 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.577 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 63.5 t90 -95.29 121.81 37.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.598 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.448 ' CB ' HD21 ' A' ' 84' ' ' LEU . 61.1 t0 -131.07 103.79 6.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -0.881 . . . . 0.0 109.306 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.556 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 56.1 p -56.69 -16.84 7.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.58 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.92 -35.51 58.07 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.457 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -69.6 140.79 53.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -1.152 . . . . 0.0 109.594 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.8 p -107.02 -0.89 22.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 0.0 109.495 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.52 HG22 ' CD1' ' A' ' 76' ' ' LEU . 20.0 tt -144.26 152.52 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.232 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.525 ' CG2' HG11 ' A' ' 75' ' ' VAL . 34.5 m -65.99 149.9 49.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.501 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.436 ' HB3' ' CB ' ' A' ' 84' ' ' LEU . 13.1 t -123.06 141.66 51.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.173 -0.955 . . . . 0.0 109.121 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.533 ' CG1' ' HD2' ' A' ' 33' ' ' PRO . 74.3 t -143.43 145.9 33.72 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.412 -0.805 . . . . 0.0 109.308 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.533 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 55.4 Cg_endo -77.76 132.11 11.73 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.245 1.964 . . . . 0.0 111.447 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 33' ' ' PRO . 82.6 tt0 -41.59 -28.1 0.12 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.429 -0.794 . . . . 0.0 109.71 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -51.46 -30.21 18.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.145 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.45 ' CD2' HG22 ' A' ' 14' ' ' ILE . 7.2 m-85 -97.63 0.39 47.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 109.712 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.642 ' CD2' ' CG ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.013 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.642 ' CG ' ' CD2' ' A' ' 37' ' ' LEU . 13.8 m-85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.36 0.6 . . . . 0.0 109.99 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.517 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 46.5 t80 -99.83 113.65 26.31 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 61' ' ' TYR . 40.2 mt -122.46 169.35 11.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.524 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 97.8 m -120.7 116.48 25.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.483 ' CE2' HG23 ' A' ' 66' ' ' VAL . 22.6 p90 -136.41 158.19 45.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.057 -1.027 . . . . 0.0 109.773 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -89.98 129.12 36.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.322 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.483 HG23 ' CE2' ' A' ' 64' ' ' PHE . 11.7 t -105.99 101.88 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.917 . . . . 0.0 109.515 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 80.4 mt-30 64.32 38.98 7.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.895 . . . . 0.0 109.412 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.62 32.43 41.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.0 mtt-85 -138.33 114.51 10.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.442 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.422 ' C ' HG21 ' A' ' 71' ' ' VAL . 72.6 tttt -61.49 122.75 15.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.616 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.45 ' HB ' HG22 ' A' ' 66' ' ' VAL . 58.8 t -145.32 130.13 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.224 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.524 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 82.1 mt-10 -108.3 137.36 46.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 0.0 109.617 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.3 166.56 29.26 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.603 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.473 ' O ' ' HB ' ' A' ' 30' ' ' THR . 93.6 mt-10 -79.86 140.57 36.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.525 HG11 ' CG2' ' A' ' 30' ' ' THR . 10.2 m -131.16 153.19 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.635 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.537 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 5.2 mp -107.48 148.42 29.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.385 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.78 140.09 37.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 109.425 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.484 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -151.56 152.86 31.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.296 -0.877 . . . . 0.0 109.239 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.484 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.0 Cg_endo -70.57 2.49 3.94 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.528 2.152 . . . . 0.0 112.034 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.41 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 34.0 m-85 -65.88 170.38 5.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 109.438 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -114.43 21.19 14.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.365 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.449 ' C ' HG13 ' A' ' 83' ' ' ILE . 33.3 p90 -142.01 -166.5 2.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 109.143 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.449 HG13 ' C ' ' A' ' 82' ' ' TYR . 1.5 mt -132.02 118.62 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.923 . . . . 0.0 109.64 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.448 HD21 ' CB ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -82.61 134.45 35.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 108.987 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.502 ' CD2' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -97.31 142.26 29.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.065 -1.022 . . . . 0.0 109.763 -179.71 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.513 ' OD1' ' CD ' ' A' ' 87' ' ' PRO . 6.5 t-20 -90.11 135.57 29.84 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.033 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.565 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 41.5 Cg_endo -64.1 -33.14 62.71 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.805 2.337 . . . . 0.0 111.972 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.4 m -71.88 -28.02 63.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.118 -0.989 . . . . 0.0 109.107 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -79.17 -30.79 43.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 109.344 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.584 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -119.67 74.25 17.72 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.917 . . . . 0.0 109.328 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.565 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.9 Cg_endo -69.6 -18.92 37.49 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.749 2.299 . . . . 0.0 111.926 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.584 ' CZ2' ' CG1' ' A' ' 90' ' ' VAL . 48.9 p90 -81.21 -26.24 36.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.479 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.577 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 24.1 tp . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.442 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.466 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 48.8 Cg_endo . . . . . 0 C--O 1.215 -0.627 0 CA-C-O 121.203 0.418 . . . . 0.0 111.694 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.515 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 25.2 mt -90.6 -177.32 5.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.582 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -112.19 134.44 53.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.353 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.0 146.24 28.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -0.948 . . . . 0.0 109.5 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 17' ' ' THR . 65.4 tt0 -121.97 122.21 38.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.883 . . . . 0.0 109.224 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.497 HG23 HD13 ' A' ' 14' ' ' ILE . 43.2 mt -114.74 127.12 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.694 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 58.07 25.59 12.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.531 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 90.66 -13.69 65.0 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 52.8 m -79.78 131.85 36.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -1.21 . . . . 0.0 109.385 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.5 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 29.7 tttm -96.4 123.9 40.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 109.62 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.545 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 57.2 mt -143.32 162.67 35.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -89.43 146.93 24.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.928 . . . . 0.0 109.527 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.01 176.58 7.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.488 ' C ' ' CD2' ' A' ' 85' ' ' LEU . 59.5 m-70 -127.47 129.97 48.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.455 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.549 ' CZ2' ' HB3' ' A' ' 87' ' ' PRO . 20.6 t90 -83.17 122.54 28.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.683 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -127.52 96.28 4.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.341 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.467 ' HA ' ' HG3' ' A' ' 87' ' ' PRO . 17.3 t -53.68 -33.9 56.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.645 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.62 -35.65 86.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.32 137.22 57.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -1.166 . . . . 0.0 109.631 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.518 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 89.2 m -102.07 -9.43 20.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 109.381 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.418 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 20.1 tt -139.61 160.12 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.335 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.5 m -71.51 150.19 45.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.315 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.542 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -126.83 127.17 44.57 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -0.916 . . . . 0.0 108.998 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.546 ' CG1' ' HD2' ' A' ' 33' ' ' PRO . 53.8 t -126.92 147.37 61.11 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 109.176 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.546 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 55.5 Cg_endo -77.26 132.99 12.95 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.176 1.917 . . . . 0.0 111.914 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 33' ' ' PRO . 80.5 tt0 -43.01 -26.67 0.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.741 . . . . 0.0 109.701 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.48 -23.09 1.41 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.516 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.545 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 14.1 m-85 -102.44 -6.41 22.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.518 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.512 HD23 ' N ' ' A' ' 37' ' ' LEU . 2.7 mm? . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.198 -0.939 . . . . 0.0 109.558 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.261 0.553 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.54 ' CE1' ' HB3' ' A' ' 72' ' ' GLU . 41.3 t80 -91.36 119.4 31.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 108.844 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.487 ' CD1' HD11 ' A' ' 37' ' ' LEU . 64.4 mt -131.16 170.18 14.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.387 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.524 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 87.9 m -119.56 122.92 42.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.517 -0.739 . . . . 0.0 109.084 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.498 ' CE2' HG22 ' A' ' 66' ' ' VAL . 33.2 p90 -141.82 157.2 45.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 0.0 109.781 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 83.7 mttt -87.83 129.69 35.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.23 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.498 HG22 ' CE2' ' A' ' 64' ' ' PHE . 4.3 t -104.24 98.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 90.0 mt-30 62.93 35.34 13.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.898 . . . . 0.0 109.193 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.77 31.81 20.08 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 -136.84 111.62 8.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -1.125 . . . . 0.0 109.432 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -61.84 117.72 6.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.458 HG23 ' CH2' ' A' ' 92' ' ' TRP . 44.4 t -142.31 136.91 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 0.0 109.412 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.54 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 64.0 mt-10 -112.61 137.93 50.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.974 . . . . 0.0 109.388 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.21 166.31 29.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.83 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 96.3 mt-10 -81.43 136.15 35.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.228 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.483 ' HB ' ' CG2' ' A' ' 32' ' ' VAL . 17.5 m -125.55 148.03 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.181 -0.949 . . . . 0.0 109.731 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 32' ' ' VAL . 28.1 tp -94.05 143.05 26.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.853 . . . . 0.0 109.13 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.27 133.66 36.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.571 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 21.8 t -144.4 148.84 42.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.626 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.469 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.3 Cg_endo -70.36 1.79 4.49 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.728 2.285 . . . . 0.0 112.058 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.571 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 39.6 m-85 -63.34 172.72 1.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 109.432 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -113.36 21.29 15.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 109.579 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.577 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 13.1 p90 -144.87 -161.02 1.21 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.16 -0.963 . . . . 0.0 109.356 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.444 HG13 ' C ' ' A' ' 82' ' ' TYR . 2.2 mt -132.62 149.1 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.881 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.577 ' HG ' ' CE2' ' A' ' 82' ' ' TYR . 1.4 mt -109.21 131.82 54.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.865 . . . . 0.0 108.757 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -99.95 133.17 44.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.109 -0.994 . . . . 0.0 109.723 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 28' ' ' THR . 6.2 t-20 -88.18 136.23 32.21 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 0.0 109.146 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.549 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 41.8 Cg_endo -64.34 -32.16 61.6 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.744 2.296 . . . . 0.0 111.881 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.2 m -72.32 -33.94 67.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 109.222 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -71.9 -34.11 68.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.313 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.475 HG13 ' CG1' ' A' ' 66' ' ' VAL . 33.5 m -115.84 76.56 6.07 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 109.55 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.431 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 48.6 Cg_endo -69.15 -21.63 36.04 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.698 2.265 . . . . 0.0 111.678 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.458 ' CH2' HG23 ' A' ' 71' ' ' VAL . 36.4 p90 -70.66 -26.32 63.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.314 -0.866 . . . . 0.0 109.469 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.6 tp . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.474 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.574 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.3 Cg_endo . . . . . 0 C--O 1.215 -0.625 0 CA-C-O 121.233 0.43 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.459 HD12 HD12 ' A' ' 85' ' ' LEU . 15.3 mt -79.83 -174.63 4.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.445 ' OE2' ' HE3' ' A' ' 18' ' ' LYS . 75.9 tt0 -113.65 137.2 51.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 109.501 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.3 142.25 25.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -120.65 118.02 29.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.508 HG21 ' CD1' ' A' ' 36' ' ' PHE . 36.6 mt -109.49 129.46 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.507 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.0 mttt 54.52 24.83 5.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.9 . . . . 0.0 109.5 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.06 -10.81 72.79 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.5 ' CG2' HD13 ' A' ' 19' ' ' LEU . 4.3 m -80.31 126.94 31.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -1.183 . . . . 0.0 109.422 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.445 ' HE3' ' OE2' ' A' ' 11' ' ' GLU . 39.1 tttt -85.93 125.16 33.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.347 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.5 HD13 ' CG2' ' A' ' 17' ' ' THR . 1.9 mp -146.21 156.03 43.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 109.587 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -80.16 152.13 29.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 0.0 109.507 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.46 ' CB ' HD23 ' A' ' 85' ' ' LEU . . . -136.92 169.56 17.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 85.1 m-70 -127.41 138.84 53.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 109.463 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.629 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 40.0 t90 -91.08 114.1 26.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.206 -0.934 . . . . 0.0 109.408 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -121.57 100.1 6.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 109.382 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.563 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 59.8 p -60.8 -25.66 66.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.758 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.64 -41.59 95.76 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -67.77 140.97 56.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.194 -1.18 . . . . 0.0 109.538 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.435 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 68.6 p -99.59 -10.27 22.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.893 . . . . 0.0 109.384 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.434 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 19.7 tt -139.06 159.79 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.272 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.509 ' CG2' HG13 ' A' ' 75' ' ' VAL . 85.4 m -67.53 153.26 44.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 109.671 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -131.21 116.81 18.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.072 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.553 ' CG1' ' HD2' ' A' ' 33' ' ' PRO . 54.0 t -114.07 147.71 38.41 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.553 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 55.4 Cg_endo -77.4 132.04 12.07 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.094 1.862 . . . . 0.0 111.664 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 33' ' ' PRO . 82.1 tt0 -41.77 -27.67 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.467 -0.77 . . . . 0.0 109.801 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -50.56 -31.64 16.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.525 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.508 ' CD1' HG21 ' A' ' 14' ' ' ILE . 14.3 m-85 -98.47 -3.24 37.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.665 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.622 ' CD2' ' CG ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.797 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.622 ' CG ' ' CD2' ' A' ' 37' ' ' LEU . 12.4 m-85 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.271 0.558 . . . . 0.0 109.902 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.467 ' O ' HD21 ' A' ' 62' ' ' LEU . 44.3 t80 -100.67 113.11 25.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.849 . . . . 0.0 108.771 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.467 HD21 ' O ' ' A' ' 61' ' ' TYR . 44.6 mt -122.46 173.02 7.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.105 -0.997 . . . . 0.0 110.276 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.518 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 86.6 m -124.01 125.48 44.63 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 9.4 p90 -144.68 157.81 44.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.888 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -88.38 130.52 35.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.418 -0.801 . . . . 0.0 109.292 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.46 ' CG2' ' CE2' ' A' ' 64' ' ' PHE . 74.4 t -110.77 104.47 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 86.7 mt-30 63.13 35.17 13.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.331 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.77 31.95 34.59 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -137.54 116.53 12.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -1.139 . . . . 0.0 109.477 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -62.13 121.0 11.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.461 HG21 ' CH2' ' A' ' 92' ' ' TRP . 87.3 t -142.69 129.05 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.88 . . . . 0.0 109.498 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.518 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 35.8 mt-10 -108.59 136.47 48.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.19 169.98 22.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 109.619 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 95.4 mt-10 -80.41 135.89 36.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.509 HG13 ' CG2' ' A' ' 30' ' ' THR . 5.0 m -126.76 152.22 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 109.631 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 32' ' ' VAL . 20.7 tp -105.42 149.13 26.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.109 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.58 137.3 37.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 109.196 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.581 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 23.3 t -148.7 149.57 31.14 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.926 . . . . 0.0 109.669 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.479 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 54.5 Cg_endo -72.88 6.88 2.23 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.661 2.241 . . . . 0.0 111.985 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.581 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 30.7 m-85 -60.52 -178.99 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.613 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -119.93 20.73 12.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.927 . . . . 0.0 109.325 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.559 ' CZ ' ' HG ' ' A' ' 84' ' ' LEU . 13.3 p90 -153.61 -152.35 0.41 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.275 -0.89 . . . . 0.0 108.894 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.533 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 1.7 mt -132.35 125.58 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.785 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.559 ' HG ' ' CZ ' ' A' ' 82' ' ' TYR . 1.2 mt -82.94 143.27 30.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.218 -0.926 . . . . 0.0 108.93 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.46 HD23 ' CB ' ' A' ' 21' ' ' ALA . 3.9 mt -109.73 135.3 50.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -0.978 . . . . 0.0 109.929 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.522 ' OD1' ' CD ' ' A' ' 87' ' ' PRO . 4.4 t30 -91.16 136.65 26.99 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 109.125 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.522 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 43.5 Cg_endo -64.6 -36.96 39.75 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.781 2.32 . . . . 0.0 112.034 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.418 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 3.1 m -70.38 -32.47 70.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.121 -0.987 . . . . 0.0 109.303 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.455 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 81.8 m-20 -71.84 -29.2 64.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.352 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.623 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -118.81 74.92 12.98 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.314 -0.866 . . . . 0.0 109.531 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.59 -21.99 28.89 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.747 2.298 . . . . 0.0 111.801 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.623 ' CZ2' ' CG1' ' A' ' 90' ' ' VAL . 40.8 p90 -76.28 -28.31 56.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 0.0 109.49 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.629 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 38.6 tp . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.461 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 C--O 1.216 -0.616 0 CA-C-O 121.15 0.396 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 23' ' ' TRP . 4.3 mp -85.0 165.84 17.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.514 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -103.46 144.13 31.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 109.428 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.7 148.11 22.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 64' ' ' PHE . 78.1 tt0 -121.02 121.08 37.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.581 ' HB ' ' CE1' ' A' ' 36' ' ' PHE . 42.4 mt -111.93 127.71 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HG3' HG23 ' A' ' 14' ' ' ILE . 3.6 mtmt 54.5 25.82 6.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 93.29 -15.81 62.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.53 ' CG2' HD13 ' A' ' 19' ' ' LEU . 2.3 m -79.85 126.07 30.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -1.181 . . . . 0.0 109.312 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.451 ' C ' ' CD1' ' A' ' 19' ' ' LEU . 31.4 tttt -94.26 116.9 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.0 109.63 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.53 HD13 ' CG2' ' A' ' 17' ' ' THR . 9.4 mp -135.09 166.09 23.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.306 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -80.32 155.03 27.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.449 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 83' ' ' ILE . . . -141.27 163.03 34.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 109.482 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.497 ' C ' ' CD2' ' A' ' 85' ' ' LEU . 70.0 m-70 -125.38 136.84 53.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.559 ' CZ2' ' HB3' ' A' ' 87' ' ' PRO . 26.2 t90 -85.58 126.67 34.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.422 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -133.58 100.63 4.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.507 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 60.4 p -62.39 -29.21 70.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.495 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.2 -33.25 64.61 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.414 ' O ' ' OD1' ' A' ' 86' ' ' ASN . . . -73.81 140.34 45.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -1.129 . . . . 0.0 109.418 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 28' ' ' THR . 87.4 m -100.36 -5.27 27.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.633 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.486 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 21.2 tt -146.67 149.3 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.507 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.477 ' N ' ' HB2' ' A' ' 86' ' ' ASN . 86.4 m -52.47 150.79 4.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.634 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -128.03 136.98 51.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.193 -0.942 . . . . 0.0 109.212 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.548 ' CG1' ' HD2' ' A' ' 33' ' ' PRO . 56.9 t -138.61 147.43 54.75 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 109.172 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.548 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 54.8 Cg_endo -77.66 132.21 11.91 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.123 1.882 . . . . 0.0 111.308 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 37' ' ' LEU . 79.9 tt0 -41.87 -27.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.759 . . . . 0.0 109.833 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -48.41 -24.53 1.28 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.14 -0.975 . . . . 0.0 109.308 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.581 ' CE1' ' HB ' ' A' ' 14' ' ' ILE . 7.6 m-85 -97.03 -9.38 28.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.646 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.512 HD11 ' CD2' ' A' ' 60' ' ' TYR . 2.8 mm? . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 109.628 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.512 ' CD2' HD11 ' A' ' 37' ' ' LEU . 11.1 m-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.147 0.499 . . . . 0.0 109.731 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 39.7 t80 -85.26 110.06 18.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 108.885 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 61' ' ' TYR . 53.1 mt -125.1 171.01 10.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 110.36 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.531 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 89.7 m -116.08 119.35 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 13' ' ' GLU . 17.3 p90 -136.07 154.22 51.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.037 . . . . 0.0 109.782 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.462 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 45.3 mttm -90.69 127.04 36.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.341 -0.849 . . . . 0.0 109.411 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 18.9 t -101.5 101.55 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 109.614 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 92.9 mt-30 62.87 33.13 15.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.297 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.82 24.8 34.21 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 65' ' ' LYS . 67.3 mtt180 -126.72 120.09 28.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -1.165 . . . . 0.0 109.362 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.419 ' C ' HG22 ' A' ' 71' ' ' VAL . 58.2 tttt -67.0 117.05 8.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.403 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.419 HG22 ' C ' ' A' ' 70' ' ' LYS . 86.0 t -141.15 130.85 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.531 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 58.4 mt-10 -111.78 135.44 52.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.589 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.41 166.27 29.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.835 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 95.4 mt-10 -80.69 136.06 36.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.372 -0.83 . . . . 0.0 109.193 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.535 ' HB ' ' CG2' ' A' ' 32' ' ' VAL . 34.6 m -123.26 145.55 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.227 -0.921 . . . . 0.0 109.696 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 32' ' ' VAL . 89.0 mt -90.53 143.9 26.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.091 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.34 135.64 36.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.0 . . . . 0.0 109.445 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.531 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 3.8 t -143.89 150.46 49.81 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 109.519 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.476 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 52.0 Cg_endo -72.46 5.99 2.52 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.665 2.244 . . . . 0.0 112.301 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.531 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 84.4 m-85 -71.37 167.51 19.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.056 -1.028 . . . . 0.0 109.527 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -107.79 17.05 22.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.66 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.576 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 15.6 p90 -137.19 -163.51 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 109.52 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 31' ' ' CYS . 4.0 mt -127.44 154.92 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -0.981 . . . . 0.0 109.744 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.576 ' HG ' ' CE2' ' A' ' 82' ' ' TYR . 1.3 mt -117.21 132.8 56.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.011 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.555 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -97.91 122.48 41.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.084 -1.01 . . . . 0.0 109.628 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.508 ' N ' ' OD2' ' A' ' 89' ' ' ASP . 26.2 t30 -79.54 142.36 57.67 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.435 -0.791 . . . . 0.0 109.098 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.559 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 47.0 Cg_endo -67.31 -23.47 44.66 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.512 2.141 . . . . 0.0 111.677 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.418 ' OG ' ' ND2' ' A' ' 86' ' ' ASN . 51.8 p -80.41 -33.85 36.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.373 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.522 ' OD1' ' CG1' ' A' ' 90' ' ' VAL . 2.2 p30 -74.78 -28.87 60.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.493 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.522 ' CG1' ' OD1' ' A' ' 89' ' ' ASP . 4.1 m -122.3 78.62 44.54 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.656 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.558 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.8 Cg_endo -71.68 -23.56 22.73 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.615 2.21 . . . . 0.0 111.822 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.558 ' CZ3' ' HD2' ' A' ' 91' ' ' PRO . 47.1 p90 -77.32 -33.09 55.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.593 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.547 HD21 ' CD1' ' A' ' 23' ' ' TRP . 21.9 tp . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.511 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.6 Cg_endo . . . . . 0 C--O 1.215 -0.657 0 CA-C-O 121.186 0.411 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.46 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 25.2 mt -88.27 -175.11 4.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.505 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.58 141.58 50.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 109.403 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.34 149.29 26.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 51.9 tt0 -118.35 118.14 30.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.534 HG22 HD12 ' A' ' 14' ' ' ILE . 41.5 mt -111.11 128.7 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HG3' HG21 ' A' ' 14' ' ' ILE . 44.3 mttm 56.71 22.85 7.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.63 0.87 71.9 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.425 HG21 HD21 ' A' ' 19' ' ' LEU . 24.8 m -102.4 122.25 43.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -1.194 . . . . 0.0 109.457 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' O ' HD23 ' A' ' 19' ' ' LEU . 26.8 tttt -82.56 123.57 29.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.473 ' CB ' HD13 ' A' ' 83' ' ' ILE . 1.5 mm? -132.89 167.08 20.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -85.88 139.65 31.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.447 ' HB3' ' CD1' ' A' ' 85' ' ' LEU . . . -128.28 168.66 15.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.628 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.484 ' C ' ' CD2' ' A' ' 85' ' ' LEU . 47.6 m-70 -129.4 126.85 39.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.403 -0.811 . . . . 0.0 109.648 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.52 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 33.3 t90 -79.4 125.86 30.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.456 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -131.39 102.77 6.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.52 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 58.2 p -61.63 -31.68 71.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.629 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.08 -31.53 73.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.49 139.66 49.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -1.166 . . . . 0.0 109.615 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.434 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 35.0 p -106.02 -4.9 19.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.85 . . . . 0.0 109.554 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.511 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 19.7 tt -143.82 141.14 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.405 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.522 ' N ' ' HB2' ' A' ' 86' ' ' ASN . 23.4 m -54.92 137.42 45.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.731 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . 0.9 OUTLIER -125.94 128.63 47.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.524 HG21 ' CG2' ' A' ' 75' ' ' VAL . 25.2 m -127.83 163.44 43.26 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.584 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.8 Cg_endo -78.91 134.1 11.65 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.57 2.18 . . . . 0.0 111.688 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.472 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 81.1 tt0 -49.03 -22.89 0.98 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.616 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.6 -40.36 52.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.41 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.422 ' CD1' HG21 ' A' ' 14' ' ' ILE . 14.2 m-85 -86.85 -4.23 59.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.275 -0.89 . . . . 0.0 109.605 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.499 HD23 ' N ' ' A' ' 37' ' ' LEU . 3.8 mm? . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.234 -0.916 . . . . 0.0 109.844 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 3.1 m-85 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.393 0.616 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.559 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 46.4 t80 -107.14 113.66 27.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 0.0 108.715 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.432 ' CD1' HG21 ' A' ' 75' ' ' VAL . 39.2 mt -116.28 162.21 17.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.115 -0.991 . . . . 0.0 110.343 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.533 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 20.4 m -120.12 118.24 30.04 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 14.3 p90 -144.07 154.98 43.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.022 -1.049 . . . . 0.0 109.937 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.462 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 47.9 mtmt -92.62 126.99 37.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.364 -0.835 . . . . 0.0 109.167 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 21.3 t -106.37 111.84 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.146 -0.971 . . . . 0.0 109.711 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 87.2 mt-30 62.98 37.22 11.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.54 25.28 63.44 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.1 mtt-85 -129.59 107.5 9.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 109.511 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 79.0 tttt -58.91 125.33 23.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.558 HG21 ' CH2' ' A' ' 92' ' ' TRP . 97.7 t -146.26 133.09 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 109.231 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.559 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 80.6 mt-10 -115.27 135.57 54.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 109.633 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.461 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . . . -160.36 173.38 15.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.389 -0.82 . . . . 0.0 109.674 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 94.4 mt-10 -79.79 143.97 33.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.85 . . . . 0.0 109.172 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.524 ' CG2' HG21 ' A' ' 32' ' ' VAL . 3.2 m -138.97 162.45 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.78 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.5 tp -113.23 145.73 40.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -0.827 . . . . 0.0 109.258 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.99 136.23 36.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.447 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.46 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 5.4 t -141.47 148.43 50.44 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 109.521 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.46 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 48.6 Cg_endo -69.87 -0.8 7.52 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.744 2.296 . . . . 0.0 111.774 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.511 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 31.5 m-85 -59.75 166.63 2.47 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.179 -0.951 . . . . 0.0 109.323 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -107.6 19.35 20.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.952 . . . . 0.0 109.86 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.59 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 25.7 p90 -142.48 -154.83 0.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.473 HD13 ' CB ' ' A' ' 19' ' ' LEU . 4.7 mt -130.15 144.51 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.997 -1.064 . . . . 0.0 109.777 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.59 ' HG ' ' CE2' ' A' ' 82' ' ' TYR . 1.3 mp -110.36 123.92 50.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.343 -0.848 . . . . 0.0 109.116 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.518 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -95.44 134.64 38.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.522 ' HB2' ' N ' ' A' ' 30' ' ' THR . 26.5 t30 -89.19 142.31 29.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.288 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.513 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 47.1 Cg_endo -67.41 -26.12 41.27 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.537 2.158 . . . . 0.0 111.79 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.2 m -78.08 -31.2 50.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.312 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 90' ' ' VAL . 2.1 p30 -77.01 -32.97 57.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.618 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -110.9 73.7 0.89 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.897 . . . . 0.0 109.394 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.573 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.0 Cg_endo -70.29 -24.36 27.34 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.743 2.295 . . . . 0.0 112.016 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.618 ' CZ2' ' CG1' ' A' ' 90' ' ' VAL . 44.4 p90 -71.43 -36.89 71.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.092 -1.005 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 92' ' ' TRP . 72.6 mt . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.349 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.572 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.5 Cg_endo . . . . . 0 C--O 1.215 -0.662 0 CA-C-O 121.233 0.43 . . . . 0.0 111.824 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 29.0 mt -81.06 -173.44 4.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.516 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.475 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 75.1 mm-40 -117.89 137.9 52.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 109.476 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.09 146.12 30.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.541 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -123.96 116.92 23.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.325 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.45 HG23 ' HG3' ' A' ' 15' ' ' LYS . 56.0 mt -112.83 130.41 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.933 . . . . 0.0 109.674 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HG3' HG23 ' A' ' 14' ' ' ILE . 95.9 mttt 52.22 23.47 2.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.318 -0.864 . . . . 0.0 109.621 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.31 -13.97 66.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.444 ' CG2' HD12 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -80.39 114.13 19.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -1.181 . . . . 0.0 109.427 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.46 ' O ' HD11 ' A' ' 19' ' ' LEU . 69.5 tttt -87.64 118.79 27.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 109.558 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.46 HD11 ' O ' ' A' ' 18' ' ' LYS . 9.3 mp -133.64 172.98 12.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.353 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.475 ' NZ ' ' OE2' ' A' ' 11' ' ' GLU . 16.0 mmtt -91.24 147.39 23.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.375 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 10' ' ' LEU . . . -133.15 174.3 10.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 109.698 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.572 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 79.7 m-70 -131.07 127.76 38.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.86 . . . . 0.0 109.379 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.555 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 35.5 t90 -76.39 117.4 18.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -124.58 100.72 6.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.317 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.555 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 28.5 p -62.81 -30.38 71.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.07 -39.46 80.04 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.15 140.6 58.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.141 . . . . 0.0 109.52 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.6 m -96.11 -13.0 23.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.498 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 74' ' ' GLU . 7.4 tp -143.94 162.85 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.265 -0.897 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 26.4 m -66.27 132.64 48.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.681 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.446 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 0.9 OUTLIER -119.22 126.79 52.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.382 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.527 ' CG2' ' CG1' ' A' ' 75' ' ' VAL . 3.6 m -127.91 167.21 19.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.406 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.1 Cg_endo -79.58 133.32 10.43 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.459 2.106 . . . . 0.0 111.639 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.463 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.5 tt0 -43.05 -27.23 0.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.34 -0.85 . . . . 0.0 109.571 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.3 -38.54 27.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.844 . . . . 0.0 109.576 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -87.91 -7.19 57.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 109.649 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 34' ' ' GLU . 12.0 mt . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.139 -0.976 . . . . 0.0 109.757 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 3.7 m-85 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.256 0.551 . . . . 0.0 109.619 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -102.52 114.96 29.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.27 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.0 mt -119.32 160.93 21.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 110.029 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.526 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 11.4 m -121.78 116.88 25.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.478 -0.763 . . . . 0.0 109.137 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 8.2 p90 -142.98 161.72 37.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 109.668 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.473 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 12.5 mtmm -96.68 129.09 44.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.295 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 60.4 t -107.09 112.64 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.557 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 90.6 mt-30 63.48 33.53 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 109.403 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.37 23.63 58.29 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -127.98 111.45 13.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.319 -1.106 . . . . 0.0 109.408 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 80.5 tttt -61.04 121.23 11.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.612 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 70' ' ' LYS . 65.6 t -141.66 133.55 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 109.164 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.526 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 53.8 mt-10 -116.28 137.25 52.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 109.837 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.59 -169.7 2.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.439 -0.788 . . . . 0.0 109.379 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.534 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 98.2 mt-10 -79.96 171.36 15.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.094 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 74' ' ' GLU . 72.9 t -159.4 151.03 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.143 -0.973 . . . . 0.0 109.808 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.9 tp -121.32 143.62 49.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.43 -0.794 . . . . 0.0 109.282 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.77 133.41 36.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 109.602 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 1.4 t -138.68 150.91 67.53 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.859 . . . . 0.0 109.355 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.6 Cg_endo -72.28 1.97 5.51 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.624 2.216 . . . . 0.0 111.885 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.432 ' CE2' ' OG ' ' A' ' 78' ' ' SER . 47.9 m-85 -65.14 168.0 7.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.532 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.8 p30 -108.9 14.07 24.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.233 -0.917 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.58 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 17.7 p90 -136.34 -157.8 0.82 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 109.008 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.548 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.0 mt -129.09 144.7 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.056 -1.027 . . . . 0.0 109.707 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.58 ' HG ' ' CE2' ' A' ' 82' ' ' TYR . 6.2 mp -109.95 136.33 49.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.259 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.537 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -103.92 145.36 30.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.768 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.526 ' OD1' ' CD ' ' A' ' 87' ' ' PRO . 4.9 t30 -96.87 136.59 21.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.255 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.526 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.0 Cg_endo -63.45 -31.98 71.53 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.847 2.365 . . . . 0.0 111.94 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -75.24 -30.17 60.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.227 -0.921 . . . . 0.0 109.176 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -77.49 -30.83 53.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.326 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.525 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.6 OUTLIER -122.25 75.95 42.18 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 109.468 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.21 -24.95 27.03 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.637 2.225 . . . . 0.0 111.932 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.525 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 32.7 p90 -74.19 -28.47 61.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.137 -0.977 . . . . 0.0 109.481 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.495 HD11 ' CD1' ' A' ' 23' ' ' TRP . 9.6 tt . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.485 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.573 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.3 Cg_endo . . . . . 0 C--O 1.214 -0.702 0 CA-C-O 121.287 0.453 . . . . 0.0 111.637 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.457 HD13 HD13 ' A' ' 85' ' ' LEU . 4.6 mp -80.23 166.35 21.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.96 . . . . 0.0 109.525 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -103.63 148.74 25.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.558 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.38 151.22 20.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 64' ' ' PHE . 65.7 tt0 -119.62 121.71 39.91 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.409 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.539 ' HB ' ' CE2' ' A' ' 36' ' ' PHE . 44.6 mt -113.54 124.21 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 60.8 mttm 61.28 20.38 10.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 109.474 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.65 -12.89 68.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.0 m -88.52 131.11 35.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -1.145 . . . . 0.0 109.446 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.498 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 18.0 mttp -82.98 133.37 35.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.879 . . . . 0.0 109.492 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.498 ' CD2' ' O ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -144.64 159.82 42.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.87 . . . . 0.0 109.459 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -81.41 150.93 28.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.352 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.14 169.69 17.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 60.9 m-70 -130.5 136.89 49.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 109.644 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.575 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 64.3 t90 -95.17 118.91 32.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 109.431 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -130.17 104.24 7.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.528 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.575 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 60.4 p -56.22 -27.59 55.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.531 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.37 -36.5 93.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.415 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -64.55 143.58 57.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.458 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.511 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 59.4 m -108.36 -12.08 15.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.501 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.2 tt -142.64 155.35 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 34.4 m -71.38 136.45 47.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.608 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.525 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -120.84 131.9 54.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.423 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.515 ' CG2' HG23 ' A' ' 75' ' ' VAL . 15.4 m -121.72 161.17 43.33 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 82' ' ' TYR . 55.8 Cg_endo -79.27 129.57 8.73 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.583 2.189 . . . . 0.0 111.717 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.466 ' HG2' ' CB ' ' A' ' 77' ' ' ALA . 79.2 mt-10 -43.77 -26.93 0.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 109.362 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.77 -39.45 77.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.285 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.539 ' CE2' ' HB ' ' A' ' 14' ' ' ILE . 1.7 m-85 -83.7 -2.15 55.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.428 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 mt . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.154 -0.966 . . . . 0.0 109.741 -179.767 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 4.0 m-85 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.467 0.651 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.518 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 42.4 t80 -108.17 112.4 24.89 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 61' ' ' TYR . 34.2 mt -115.98 163.31 16.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.121 -0.987 . . . . 0.0 110.305 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.515 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 28.6 m -120.47 116.94 26.42 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 13.6 p90 -138.54 156.94 47.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 109.815 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -93.3 127.24 38.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.332 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 24.1 t -103.64 106.69 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.927 . . . . 0.0 109.564 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 91.2 mt-30 63.24 36.4 11.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.329 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.46 51.4 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -130.72 109.68 10.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -1.119 . . . . 0.0 109.325 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -59.65 123.34 16.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 109.697 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.6 t -143.49 129.37 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.312 -0.868 . . . . 0.0 109.329 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 49.3 mt-10 -111.5 135.36 52.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.96 . . . . 0.0 109.629 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . . . -160.26 170.48 21.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.345 -0.847 . . . . 0.0 109.589 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 95.0 mt-10 -79.76 146.17 32.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.234 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.515 HG23 ' CG2' ' A' ' 32' ' ' VAL . 3.7 m -138.77 164.36 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.161 -0.962 . . . . 0.0 109.85 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.436 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 21.2 tp -118.04 149.41 41.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.432 -0.793 . . . . 0.0 109.196 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.466 ' CB ' ' HG2' ' A' ' 34' ' ' GLU . . . -79.81 132.27 36.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 0.0 109.5 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.454 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.8 t -135.32 149.97 71.24 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.386 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.454 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.1 Cg_endo -70.73 0.59 6.15 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.808 2.338 . . . . 0.0 111.837 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -64.47 176.75 1.02 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.485 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -114.61 17.55 17.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.429 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.59 ' CZ ' ' HG ' ' A' ' 84' ' ' LEU . 23.6 p90 -142.27 -156.27 0.67 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.066 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.559 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.1 mt -128.1 124.21 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.612 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.59 ' HG ' ' CZ ' ' A' ' 82' ' ' TYR . 1.5 mt -80.18 133.14 36.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 108.981 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 22' ' ' HIS . 6.8 mt -101.41 144.2 30.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 109.934 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 28' ' ' THR . 9.5 t-20 -101.88 134.26 20.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.398 -0.814 . . . . 0.0 109.118 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.498 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 43.1 Cg_endo -64.48 -31.12 61.6 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.7 2.267 . . . . 0.0 111.903 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 m -75.67 -28.26 58.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.339 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 83.8 m-20 -77.81 -29.16 50.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 109.361 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.48 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -121.85 76.69 38.89 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.481 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.5 Cg_endo -69.82 -24.88 28.91 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.676 2.251 . . . . 0.0 111.766 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.48 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.2 p90 -75.98 -24.84 55.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.563 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.523 ' CD1' ' CD1' ' A' ' 23' ' ' TRP . 9.6 tt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 109.451 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.564 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.0 Cg_endo . . . . . 0 C--O 1.215 -0.64 0 CA-C-O 121.273 0.447 . . . . 0.0 111.811 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.466 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 28.7 mt -89.22 -171.17 3.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.408 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.08 137.37 54.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.364 -0.835 . . . . 0.0 109.455 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 65' ' ' LYS . . . -148.7 154.02 39.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.905 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 17' ' ' THR . 70.4 tt0 -123.2 115.5 21.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.873 . . . . 0.0 109.269 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 74.6 mt -109.6 127.41 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 69.9 mttt 60.22 21.82 11.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.52 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.66 -15.32 62.82 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 68.0 m -80.02 130.47 35.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -1.136 . . . . 0.0 109.316 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.459 ' O ' HD23 ' A' ' 19' ' ' LEU . 41.4 tttp -91.78 125.27 36.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.17 -0.956 . . . . 0.0 109.491 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.58 HD12 ' CZ ' ' A' ' 36' ' ' PHE . 97.8 mt -143.47 168.55 19.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.371 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -92.31 154.03 18.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.453 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.42 172.32 13.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.244 -0.91 . . . . 0.0 109.402 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 76.4 m-70 -125.63 123.97 40.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 109.458 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.583 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 55.4 t90 -76.92 122.06 24.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.552 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -130.06 103.62 6.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.583 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 52.2 p -61.23 -25.6 67.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.943 . . . . 0.0 109.524 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.1 89.05 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -72.9 141.17 47.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -1.194 . . . . 0.0 109.552 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.438 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 28.5 p -105.52 -3.17 22.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 0.0 109.559 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 74' ' ' GLU . 19.9 tt -145.51 147.94 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.323 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 38.2 m -61.56 133.13 55.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.905 . . . . 0.0 109.67 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.447 ' HB3' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -116.56 129.19 56.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 109.53 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.525 HG22 ' CG1' ' A' ' 75' ' ' VAL . 4.7 m -131.38 164.52 41.94 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.953 . . . . 0.0 109.358 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.8 Cg_endo -78.55 131.62 10.55 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.422 2.082 . . . . 0.0 111.483 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.3 tt0 -43.14 -26.7 0.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.945 . . . . 0.0 109.718 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.05 -36.44 18.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.58 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.58 ' CZ ' HD12 ' A' ' 19' ' ' LEU . 13.9 m-85 -88.82 -7.19 56.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 109.663 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.486 ' CD1' ' HB2' ' A' ' 77' ' ' ALA . 4.3 mt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 110.027 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 3.9 m-85 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.408 0.623 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -105.55 112.09 25.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.41 ' HB2' HG22 ' A' ' 75' ' ' VAL . 6.9 mp -116.38 161.28 19.3 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 110.155 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.525 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 18.1 m -121.39 117.33 26.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.513 -0.742 . . . . 0.0 109.057 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 6.1 p90 -140.08 156.83 46.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.085 -1.009 . . . . 0.0 109.939 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 80.6 mttt -91.91 127.86 37.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.385 -0.822 . . . . 0.0 109.239 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 58.1 t -108.27 109.44 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.606 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 85.3 mt-30 62.88 37.98 11.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.321 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.76 29.08 58.02 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -133.26 113.55 12.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -1.14 . . . . 0.0 109.332 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.461 ' HE2' HG21 ' A' ' 63' ' ' THR . 27.0 tttt -63.52 121.21 13.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.715 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 94.2 t -140.57 132.06 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.268 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.525 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 49.7 mt-10 -115.77 136.92 52.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.131 -0.981 . . . . 0.0 109.745 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.37 -169.65 2.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.432 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 95.9 mt-10 -80.02 165.66 22.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 0.0 109.153 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.525 ' CG1' HG22 ' A' ' 32' ' ' VAL . 94.7 t -152.58 156.77 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.92 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.43 141.31 52.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.53 -0.731 . . . . 0.0 109.213 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 37' ' ' LEU . . . -80.42 136.01 36.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -0.97 . . . . 0.0 109.43 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.466 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -143.91 151.67 53.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.466 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.2 Cg_endo -72.75 4.14 3.81 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.689 2.259 . . . . 0.0 111.864 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -65.6 171.72 3.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.157 -0.965 . . . . 0.0 109.392 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -113.72 17.63 18.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.409 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.589 ' CZ ' ' CD1' ' A' ' 84' ' ' LEU . 12.4 p90 -139.81 -159.38 0.95 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.261 -0.899 . . . . 0.0 109.032 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.51 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 2.5 mt -129.17 147.17 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.183 -0.948 . . . . 0.0 109.633 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' CD1' ' CZ ' ' A' ' 82' ' ' TYR . 6.6 mp -111.69 135.95 51.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.344 -0.847 . . . . 0.0 108.952 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -102.55 140.73 36.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.984 . . . . 0.0 109.867 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.508 ' OD1' ' CD ' ' A' ' 87' ' ' PRO . 8.9 t-20 -92.32 134.58 28.05 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.487 -0.758 . . . . 0.0 109.096 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.518 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.5 Cg_endo -64.03 -30.74 66.37 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.766 2.311 . . . . 0.0 111.946 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 m -74.68 -29.61 61.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.262 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -79.44 -29.32 41.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.43 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.621 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -122.88 74.82 47.63 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.379 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.7 -24.47 29.89 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.727 2.284 . . . . 0.0 111.812 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.621 ' CZ2' ' CG1' ' A' ' 90' ' ' VAL . 42.3 p90 -72.78 -29.87 63.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.5 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.477 ' CD1' ' HB ' ' A' ' 90' ' ' VAL . 73.4 mt . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.569 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 47.9 Cg_endo . . . . . 0 C--O 1.214 -0.688 0 CA-C-O 121.287 0.453 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.516 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 29.4 mt -83.13 -176.24 6.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.467 ' OE2' ' CE ' ' A' ' 18' ' ' LYS . 72.3 tt0 -113.2 137.32 51.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.496 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.12 142.74 27.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 109.609 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -116.16 120.25 38.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.264 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.536 HD13 HG23 ' A' ' 14' ' ' ILE . 36.9 mt -111.53 129.14 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.601 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.459 ' HG3' HG22 ' A' ' 14' ' ' ILE . 32.5 mttm 51.84 24.39 2.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -0.878 . . . . 0.0 109.665 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.64 -4.72 79.63 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.485 HG23 ' CD1' ' A' ' 19' ' ' LEU . 13.1 m -87.98 128.85 35.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -1.196 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' CE ' ' OE2' ' A' ' 11' ' ' GLU . 19.3 tttt -86.8 121.75 29.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.492 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.586 ' CD2' ' CE1' ' A' ' 36' ' ' PHE . 5.2 mp -140.54 161.89 36.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.89 . . . . 0.0 109.458 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -88.37 155.36 19.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -0.922 . . . . 0.0 109.428 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HB3' ' CD2' ' A' ' 85' ' ' LEU . . . -139.23 176.87 8.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.569 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 64.9 m-70 -134.56 122.49 22.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.566 ' CG ' HD21 ' A' ' 93' ' ' LEU . 71.4 t90 -79.59 128.08 32.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.303 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -141.58 109.75 5.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.555 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.462 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 20.7 t -60.88 -27.18 67.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.77 -27.14 70.68 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -79.84 127.63 32.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -1.195 . . . . 0.0 109.48 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 m -95.33 -16.84 22.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 0.0 109.438 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 29' ' ' ILE . 21.1 tt -135.56 130.84 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 90.5 m -50.92 139.19 17.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.595 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -119.82 128.95 54.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.27 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.525 ' CG2' HD23 ' A' ' 37' ' ' LEU . 16.6 m -122.4 162.57 37.23 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 78' ' ' SER . 55.4 Cg_endo -78.67 131.35 10.27 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.466 2.111 . . . . 0.0 111.623 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.53 ' HG2' ' CB ' ' A' ' 77' ' ' ALA . 96.8 mt-10 -42.9 -27.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 109.548 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -47.46 -43.02 23.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.77 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.586 ' CE1' ' CD2' ' A' ' 19' ' ' LEU . 21.4 m-85 -84.98 -6.32 59.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.102 -0.999 . . . . 0.0 109.756 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.525 HD23 ' CG2' ' A' ' 32' ' ' VAL . 4.3 mm? . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.168 -0.958 . . . . 0.0 109.678 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.56 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 3.4 m-85 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.289 0.566 . . . . 0.0 109.61 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 32.9 t80 -104.88 115.5 30.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 108.961 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 61' ' ' TYR . 18.9 mt -121.47 156.52 32.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 110.08 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.522 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 67.9 m -115.31 125.68 53.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 18.1 p90 -149.02 151.23 34.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.082 -1.011 . . . . 0.0 109.681 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -85.28 133.32 34.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.323 -0.861 . . . . 0.0 109.198 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 40.1 t -109.58 112.64 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 93.7 mt-30 61.33 20.96 11.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.86 . . . . 0.0 109.468 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.64 21.77 18.19 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.529 ' HG2' ' CG2' ' A' ' 71' ' ' VAL . 6.6 ttt85 -126.86 116.82 21.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -1.057 . . . . 0.0 109.068 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -64.55 116.07 5.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 109.367 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.529 ' CG2' ' HG2' ' A' ' 69' ' ' ARG . 55.4 t -138.12 134.97 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 109.481 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.551 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 80.6 mt-10 -111.05 140.35 45.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.3 168.99 24.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.624 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 95.8 mt-10 -79.84 141.06 36.55 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.393 -0.817 . . . . 0.0 109.079 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.8 m -138.18 163.46 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.186 -0.946 . . . . 0.0 109.775 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.1 tp -117.39 146.85 43.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.53 ' CB ' ' HG2' ' A' ' 34' ' ' GLU . . . -79.75 126.01 30.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.386 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.474 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.1 t -133.06 152.18 79.23 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.474 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.474 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 48.9 Cg_endo -69.6 -0.82 7.33 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.605 2.203 . . . . 0.0 111.779 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -58.78 169.86 0.91 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.384 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -111.97 22.32 15.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.58 ' CE2' HD12 ' A' ' 84' ' ' LEU . 19.2 p90 -148.14 -159.32 1.01 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.417 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.477 HG23 ' CG1' ' A' ' 32' ' ' VAL . 4.0 mt -125.22 140.64 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.735 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.58 HD12 ' CE2' ' A' ' 82' ' ' TYR . 6.9 mp -106.35 130.59 54.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.32 -0.863 . . . . 0.0 109.039 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -111.48 135.18 52.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.624 -179.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.531 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 6.8 p-10 -97.55 158.17 33.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.243 -0.91 . . . . 0.0 109.737 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 48.8 Cg_endo -69.19 -20.0 38.11 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.663 2.242 . . . . 0.0 111.403 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.5 p -76.36 -36.39 58.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.317 -0.864 . . . . 0.0 109.116 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.469 ' HB2' ' OD1' ' A' ' 86' ' ' ASN . 88.0 m-20 -79.38 -32.07 43.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -0.826 . . . . 0.0 108.905 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -119.25 71.68 12.45 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.835 . . . . 0.0 109.515 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.559 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.4 Cg_endo -70.31 -20.15 32.59 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.735 2.29 . . . . 0.0 111.784 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.559 ' CZ3' ' HD2' ' A' ' 91' ' ' PRO . 47.2 p90 -79.85 -32.88 40.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.923 . . . . 0.0 109.562 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.566 HD21 ' CG ' ' A' ' 23' ' ' TRP . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.431 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.555 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 51.1 Cg_endo . . . . . 0 C--O 1.214 -0.68 0 CA-C-O 121.29 0.454 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.526 HD12 ' CD1' ' A' ' 85' ' ' LEU . 4.1 mp -82.59 161.15 22.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.473 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.55 142.64 29.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.502 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.07 151.84 28.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.54 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.46 ' OE2' ' HE2' ' A' ' 18' ' ' LYS . 92.2 mt-10 -130.88 121.53 25.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 109.432 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 75.9 mt -114.7 128.14 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.936 . . . . 0.0 109.43 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 65.5 mttt 61.11 20.26 10.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.44 -12.42 69.76 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.446 HG22 ' CD1' ' A' ' 19' ' ' LEU . 41.9 m -81.8 134.63 35.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -1.169 . . . . 0.0 109.409 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.46 ' HE2' ' OE2' ' A' ' 13' ' ' GLU . 89.0 mttt -89.75 139.04 30.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.446 ' CD1' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -158.8 165.61 33.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.411 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 9' ' ' PRO . 11.8 mmtt -86.5 150.67 24.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 10' ' ' LEU . . . -133.49 171.11 14.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.555 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 68.2 m-70 -131.52 133.83 45.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 109.836 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.605 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 58.5 t90 -90.31 115.13 27.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 109.448 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -127.08 102.53 7.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.386 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.474 ' HA ' ' HG3' ' A' ' 87' ' ' PRO . 32.2 t -57.83 -34.03 69.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.613 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.95 -35.59 48.72 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.18 136.11 51.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 28' ' ' THR . 54.2 m -95.29 -16.4 22.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.45 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.5 tt -141.65 149.41 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.316 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 27.9 m -57.69 135.49 56.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.508 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -119.24 119.53 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.9 . . . . 0.0 109.214 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.463 ' HB ' ' HD2' ' A' ' 33' ' ' PRO . 29.1 m -113.44 162.2 23.5 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.281 -0.887 . . . . 0.0 109.515 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 78' ' ' SER . 55.6 Cg_endo -79.2 130.6 9.32 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.547 2.164 . . . . 0.0 111.575 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 81.0 tt0 -43.27 -26.87 0.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 0.0 109.51 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -53.08 -41.81 65.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.402 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -83.15 -3.04 56.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.226 -0.921 . . . . 0.0 109.445 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 34' ' ' GLU . 6.1 mt . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.946 . . . . 0.0 109.779 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 4.0 m-85 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.319 0.581 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.552 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 43.3 t80 -107.0 112.49 25.47 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 mp -115.66 158.88 22.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.155 -0.965 . . . . 0.0 110.445 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.536 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 51.0 m -117.74 116.76 27.67 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.542 ' CE2' HG22 ' A' ' 66' ' ' VAL . 39.9 p90 -137.21 160.02 40.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 109.955 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -93.11 129.08 39.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 109.356 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.542 HG22 ' CE2' ' A' ' 64' ' ' PHE . 1.7 t -105.53 103.55 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 109.656 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 84.1 mt-30 63.61 36.73 10.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.895 . . . . 0.0 109.33 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.72 26.01 51.54 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -129.55 120.88 26.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.333 -1.098 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -66.33 122.82 18.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.582 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.558 HG21 ' CH2' ' A' ' 92' ' ' TRP . 90.2 t -144.17 133.44 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.451 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 76.4 mt-10 -117.16 137.18 52.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.641 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.07 172.49 17.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.6 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 96.1 mt-10 -79.9 141.35 36.17 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -0.922 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.9 m -135.14 162.3 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.943 . . . . 0.0 109.752 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.8 mt -119.34 154.71 33.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.847 . . . . 0.0 109.287 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.422 ' HB3' HD13 ' A' ' 37' ' ' LEU . . . -80.17 138.83 36.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.478 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.572 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 4.6 t -143.11 149.0 47.26 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.461 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.2 Cg_endo -72.65 3.37 4.36 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.701 2.267 . . . . 0.0 112.065 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.572 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 74.3 m-85 -66.81 174.93 2.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 109.587 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -114.06 15.65 18.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 0.0 109.341 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' N ' ' A' ' 83' ' ' ILE . 33.0 p90 -139.22 -157.89 0.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.208 -0.933 . . . . 0.0 109.08 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.563 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 4.5 mt -123.66 126.21 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.669 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.508 ' HB2' ' CB ' ' A' ' 31' ' ' CYS . 5.7 mp -84.27 142.59 30.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 108.941 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.526 ' CD1' HD12 ' A' ' 10' ' ' LEU . 6.6 mt -112.92 143.26 44.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 110.083 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.528 ' OD1' ' CD ' ' A' ' 87' ' ' PRO . 3.3 t30 -103.61 137.41 19.24 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.529 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.5 Cg_endo -64.0 -35.65 53.33 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.703 2.269 . . . . 0.0 111.998 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 m -72.54 -27.01 61.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.141 -0.974 . . . . 0.0 109.411 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -79.55 -28.92 41.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.34 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.549 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -120.26 71.85 18.03 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.841 . . . . 0.0 109.464 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.34 -16.3 35.09 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.632 2.221 . . . . 0.0 111.762 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.558 ' CH2' HG21 ' A' ' 71' ' ' VAL . 41.6 p90 -82.6 -28.51 30.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.894 . . . . 0.0 109.414 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.605 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 22.0 tp . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.4 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.526 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.2 Cg_endo . . . . . 0 C--O 1.215 -0.644 0 CA-C-O 121.181 0.409 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.493 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 3.7 mp -84.38 164.47 18.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.439 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -101.79 147.21 26.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.475 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.25 146.31 25.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.521 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.45 ' OE1' ' NZ ' ' A' ' 65' ' ' LYS . 89.9 mt-10 -123.8 118.68 27.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.44 HD13 HG22 ' A' ' 14' ' ' ILE . 61.6 mt -114.15 129.65 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.503 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.438 ' HG3' HG21 ' A' ' 14' ' ' ILE . 93.2 mttt 54.35 22.39 3.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.94 -8.55 76.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 32.7 m -82.58 128.45 34.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -1.13 . . . . 0.0 109.493 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.463 ' O ' HD23 ' A' ' 19' ' ' LEU . 29.6 tttt -92.47 122.79 35.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.403 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.592 ' CD1' ' CE1' ' A' ' 36' ' ' PHE . 63.7 mt -140.88 168.08 20.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.498 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -87.67 155.54 19.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.496 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.522 ' HB3' ' CD2' ' A' ' 85' ' ' LEU . . . -139.85 167.73 21.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -0.859 . . . . 0.0 109.337 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.526 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 80.4 m-70 -130.98 132.47 45.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.498 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.576 ' CZ2' ' HB3' ' A' ' 87' ' ' PRO . 38.9 t90 -85.76 122.98 30.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.587 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -130.15 99.31 5.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.875 . . . . 0.0 109.463 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.499 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 53.4 p -57.16 -26.76 61.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -0.861 . . . . 0.0 109.509 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.22 -36.17 92.0 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -72.17 137.37 46.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -1.15 . . . . 0.0 109.425 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.5 m -99.1 -10.45 22.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 109.385 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.433 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 21.2 tt -139.4 152.77 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.5 HG22 ' N ' ' A' ' 31' ' ' CYS . 32.4 m -61.24 152.11 29.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.477 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.536 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -127.93 113.72 16.23 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.111 179.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.543 ' CG1' ' HD2' ' A' ' 33' ' ' PRO . 60.3 t -113.55 146.91 36.4 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.312 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.543 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 55.3 Cg_endo -76.75 131.22 12.14 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.125 1.883 . . . . 0.0 111.625 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 33' ' ' PRO . 81.3 tt0 -40.7 -27.48 0.05 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.533 -0.729 . . . . 0.0 110.234 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.14 -27.75 3.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.096 -1.003 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.592 ' CE1' ' CD1' ' A' ' 19' ' ' LEU . 21.4 m-85 -101.77 -3.04 28.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 0.0 109.77 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.569 ' CD2' ' CG ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.698 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.569 ' CG ' ' CD2' ' A' ' 37' ' ' LEU . 11.4 m-85 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.29 0.567 . . . . 0.0 109.889 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.465 ' O ' HD21 ' A' ' 62' ' ' LEU . 43.5 t80 -102.15 114.4 28.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.257 -0.902 . . . . 0.0 108.956 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.484 ' CD1' HG22 ' A' ' 75' ' ' VAL . 44.1 mt -121.01 169.05 10.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.061 -1.024 . . . . 0.0 110.288 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.529 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 25.4 m -121.22 118.05 28.62 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 9.5 p90 -140.34 163.22 33.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.988 -1.07 . . . . 0.0 109.801 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.45 ' NZ ' ' OE1' ' A' ' 13' ' ' GLU . 15.2 mtmt -99.38 126.01 45.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.388 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 78.0 t -104.42 116.19 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.481 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 94.7 mt-30 62.29 30.96 17.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.386 -0.821 . . . . 0.0 109.393 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.65 22.45 59.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -125.64 117.61 23.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -1.164 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.435 ' O ' HG22 ' A' ' 71' ' ' VAL . 26.7 ttpt -58.91 123.9 18.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.439 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.521 HG21 ' CH2' ' A' ' 92' ' ' TRP . 53.7 t -148.55 127.03 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.335 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.529 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 79.5 mt-10 -107.66 138.82 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.525 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.32 168.34 25.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.338 -0.851 . . . . 0.0 109.695 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 95.5 mt-10 -80.04 137.29 36.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.328 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.484 HG22 ' CD1' ' A' ' 62' ' ' LEU . 5.0 m -127.92 151.39 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 32' ' ' VAL . 24.6 tp -103.75 143.63 32.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.355 -0.84 . . . . 0.0 109.082 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.17 125.9 30.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.243 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 35.2 t -137.14 150.13 68.3 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.296 -0.878 . . . . 0.0 109.534 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.484 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.8 Cg_endo -71.01 5.07 2.34 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.669 2.246 . . . . 0.0 112.176 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.575 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 31.3 m-85 -62.57 178.22 0.45 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 109.362 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -118.22 18.3 13.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.568 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 13.9 p90 -145.08 -153.97 0.51 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.349 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.549 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 2.4 mt -133.22 148.01 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 0.0 109.563 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.568 HD11 ' CZ ' ' A' ' 82' ' ' TYR . 6.0 mp -112.27 133.73 54.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 108.886 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.522 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -100.63 133.09 45.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.067 -1.021 . . . . 0.0 109.851 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.503 ' OD1' ' HD2' ' A' ' 87' ' ' PRO . 3.3 t30 -85.67 136.57 36.84 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.576 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 40.5 Cg_endo -63.06 -25.76 73.45 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.696 2.264 . . . . 0.0 111.849 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.497 ' OG ' ' ND2' ' A' ' 86' ' ' ASN . 1.0 OUTLIER -80.42 -28.92 37.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.27 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -78.06 -28.6 48.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.864 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.625 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -116.06 73.95 5.17 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.202 -0.936 . . . . 0.0 109.505 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.405 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.8 Cg_endo -70.3 -23.73 28.0 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.757 2.305 . . . . 0.0 111.791 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.625 ' CZ2' ' CG1' ' A' ' 90' ' ' VAL . 43.9 p90 -73.06 -29.63 63.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.475 ' CD1' ' HB ' ' A' ' 90' ' ' VAL . 76.3 mt . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.241 -0.912 . . . . 0.0 109.467 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.515 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 48.3 Cg_endo . . . . . 0 C--O 1.215 -0.637 0 CA-C-O 121.204 0.418 . . . . 0.0 111.77 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.434 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 86.3 mt -93.81 154.17 17.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.475 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -88.49 140.24 29.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.548 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.48 155.35 41.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -128.65 109.56 11.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -0.953 . . . . 0.0 109.412 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.578 ' HB ' ' CE2' ' A' ' 36' ' ' PHE . 90.0 mt -104.92 128.81 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.51 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 52.7 mttp 61.31 18.17 8.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.632 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.08 -10.93 73.39 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.45 HG23 ' N ' ' A' ' 18' ' ' LYS . 81.8 m -85.5 140.43 30.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -1.136 . . . . 0.0 109.171 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.45 ' N ' HG23 ' A' ' 17' ' ' THR . 27.2 tttt -79.26 117.45 20.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.295 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.576 ' CD2' ' CE1' ' A' ' 36' ' ' PHE . 11.7 tp -130.14 147.81 51.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.476 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.459 ' O ' HD12 ' A' ' 83' ' ' ILE . 40.6 mttt -81.93 157.82 24.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.6 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.515 ' HB2' ' CD2' ' A' ' 85' ' ' LEU . . . -144.98 160.08 41.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.554 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.515 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 65.4 m-70 -128.72 129.32 45.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.265 -0.897 . . . . 0.0 109.471 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.581 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 21.9 t90 -75.28 125.45 29.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.641 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -132.85 95.9 3.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.394 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.581 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 54.6 p -56.45 -31.8 64.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.657 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.57 -27.58 68.31 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -79.98 139.29 37.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -1.167 . . . . 0.0 109.472 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.503 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 41.8 p -103.57 -4.36 24.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.584 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.476 HG21 ' CD1' ' A' ' 76' ' ' LEU . 21.2 tt -143.98 149.41 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.932 . . . . 0.0 109.472 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.455 HG23 HG21 ' A' ' 75' ' ' VAL . 27.8 m -61.12 139.67 58.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.647 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.527 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -123.48 140.07 53.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.546 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.548 ' CG2' ' CG1' ' A' ' 75' ' ' VAL . 34.9 m -141.13 165.8 26.73 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.915 . . . . 0.0 109.411 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.526 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.4 Cg_endo -78.29 128.15 8.73 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.29 1.993 . . . . 0.0 111.451 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' PRO . 83.9 tt0 -41.78 -28.19 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.749 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -53.27 -31.48 43.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.557 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CE2' ' HB ' ' A' ' 14' ' ' ILE . 2.2 m-85 -88.75 -10.92 46.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 0.0 109.673 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.634 ' CD2' ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.858 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.634 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 25.6 m-85 . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.335 0.588 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.45 ' OH ' ' HB2' ' A' ' 72' ' ' GLU . 45.2 t80 -85.91 110.19 19.25 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.1 mt -115.81 161.62 18.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.032 -1.043 . . . . 0.0 110.624 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.53 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 29.5 m -121.23 124.24 44.17 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.518 ' CE2' ' CG2' ' A' ' 66' ' ' VAL . 43.2 p90 -145.92 160.38 41.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.044 -1.035 . . . . 0.0 109.97 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 70' ' ' LYS . 6.8 mmtt -90.1 126.75 35.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.406 -0.809 . . . . 0.0 109.229 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.518 ' CG2' ' CE2' ' A' ' 64' ' ' PHE . 1.7 t -104.54 103.09 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.688 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 82.9 mt-30 62.61 35.06 14.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.317 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.46 30.93 28.88 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -136.28 120.56 17.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -1.169 . . . . 0.0 109.39 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.474 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 15.0 tttp -67.35 120.44 13.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.443 ' HB ' HG22 ' A' ' 66' ' ' VAL . 64.0 t -141.94 131.84 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.475 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.53 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 27.3 mt-10 -116.01 136.48 52.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.31 -178.11 6.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.845 . . . . 0.0 109.667 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.432 ' C ' HG23 ' A' ' 75' ' ' VAL . 94.1 mt-10 -79.64 152.81 29.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.02 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.548 ' CG1' ' CG2' ' A' ' 32' ' ' VAL . 91.6 t -143.51 156.97 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.123 -0.985 . . . . 0.0 109.744 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.476 ' CD1' HG21 ' A' ' 29' ' ' ILE . 17.2 mt -121.89 147.37 46.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.37 -0.831 . . . . 0.0 109.313 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.94 139.66 36.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.483 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 1.5 t -143.98 150.81 50.74 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 109.345 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.454 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.9 Cg_endo -71.37 1.75 5.17 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.677 2.251 . . . . 0.0 111.772 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.498 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 70.6 m-85 -69.15 162.53 26.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.278 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -104.32 19.79 19.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.604 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.616 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 22.4 p90 -140.57 -162.35 1.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.979 . . . . 0.0 109.552 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 19' ' ' LEU . 7.5 mt -125.44 152.16 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.1 -1.0 . . . . 0.0 110.248 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.616 ' HG ' ' CE2' ' A' ' 82' ' ' TYR . 2.2 mt -118.55 124.59 47.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.298 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.569 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -92.47 140.68 29.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 109.82 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 28' ' ' THR . 8.2 t-20 -90.87 134.79 29.71 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.491 -0.755 . . . . 0.0 109.25 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.5 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.1 Cg_endo -63.95 -30.3 67.07 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.796 2.33 . . . . 0.0 111.78 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.4 t -75.73 -29.09 58.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 109.269 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -79.89 -33.21 40.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.897 . . . . 0.0 109.44 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.608 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.8 OUTLIER -119.52 76.39 18.71 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.882 . . . . 0.0 109.424 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.433 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.3 Cg_endo -69.99 -22.05 31.58 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.697 2.264 . . . . 0.0 111.785 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.608 ' CZ2' ' CG1' ' A' ' 90' ' ' VAL . 44.2 p90 -76.23 -25.72 55.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.171 -0.955 . . . . 0.0 109.401 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.489 HD11 ' CB ' ' A' ' 90' ' ' VAL . 59.9 mt . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.478 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.411 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.7 Cg_endo . . . . . 0 C--O 1.214 -0.678 0 CA-C-O 121.218 0.424 . . . . 0.0 111.668 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 21' ' ' ALA . 65.8 mt -93.63 142.03 27.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.493 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -83.43 134.1 34.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.14 150.75 37.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.527 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.456 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 45.0 tt0 -115.93 121.0 41.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.405 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.541 ' HB ' ' CE1' ' A' ' 36' ' ' PHE . 27.1 mt -111.06 125.4 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.439 ' HG3' HG21 ' A' ' 14' ' ' ILE . 42.5 mttt 55.02 24.79 6.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.321 -0.862 . . . . 0.0 109.55 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 90.31 4.52 71.01 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 42.7 m -103.64 126.45 50.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -1.203 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -82.12 129.15 34.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.453 ' HB3' HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -141.27 167.76 21.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -87.55 148.61 24.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 0.0 109.569 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 10' ' ' LEU . . . -135.92 163.79 29.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 109.475 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.476 ' O ' ' CD2' ' A' ' 85' ' ' LEU . 52.8 m-70 -130.37 129.42 43.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.563 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.489 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 48.4 t90 -77.0 127.74 33.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -137.59 107.41 6.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.489 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 18.2 p -65.69 -33.11 75.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.82 -15.76 55.49 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.12 130.43 34.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -1.155 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.7 m -94.98 -24.02 17.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 74' ' ' GLU . 11.3 tp -132.72 143.12 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -0.926 . . . . 0.0 109.6 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 39.1 m -58.46 136.46 57.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.655 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 9.9 t -124.76 140.04 53.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.533 ' HB ' ' HD2' ' A' ' 33' ' ' PRO . 2.6 m -137.72 172.14 7.29 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.32 -0.862 . . . . 0.0 109.14 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.5 Cg_endo -79.82 132.26 9.58 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.22 1.946 . . . . 0.0 111.833 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 33' ' ' PRO . 22.4 pt-20 -44.22 -25.92 0.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.642 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -48.52 -34.34 11.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 109.526 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.541 ' CE1' ' HB ' ' A' ' 14' ' ' ILE . 12.8 m-85 -89.42 -9.75 49.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 109.646 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.783 -179.678 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 4.6 m-85 . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 121.283 0.563 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 35.9 t80 -108.24 113.12 25.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -0.826 . . . . 0.0 108.957 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.4 mt -117.25 158.84 23.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.071 -1.018 . . . . 0.0 110.128 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.531 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 22.0 m -119.88 115.7 24.36 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 9.4 p90 -138.89 162.02 35.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.067 -1.02 . . . . 0.0 109.945 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.2 mttm -92.39 127.37 37.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.395 -0.816 . . . . 0.0 109.278 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 49.8 t -106.98 105.86 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 109.537 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 85.5 mt-30 63.85 36.26 10.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.291 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.09 33.86 39.36 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.453 ' O ' HG21 ' A' ' 71' ' ' VAL . 74.3 mtt180 -139.19 108.81 6.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.225 -1.162 . . . . 0.0 109.405 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -55.72 121.71 9.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.91 . . . . 0.0 109.628 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 69' ' ' ARG . 80.3 t -141.16 129.98 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 109.429 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.531 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 54.5 mt-10 -113.7 136.36 52.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.621 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.37 -173.49 4.03 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.368 -0.832 . . . . 0.0 109.353 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.526 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 97.2 mt-10 -80.0 164.79 23.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.002 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 60' ' ' TYR . 89.8 t -152.76 145.42 15.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.134 -0.979 . . . . 0.0 109.914 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.9 tp -114.95 143.03 45.79 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.14 143.12 32.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.1 -1.0 . . . . 0.0 109.649 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.471 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -152.25 152.11 28.78 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 0.0 109.304 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.471 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.2 Cg_endo -71.19 2.53 4.25 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.613 2.209 . . . . 0.0 112.019 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.408 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 41.1 m-85 -63.34 169.23 3.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.047 -1.033 . . . . 0.0 109.301 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -113.71 23.26 13.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.519 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.583 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 16.3 p90 -147.86 -166.81 2.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 109.528 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.474 ' O ' ' CD2' ' A' ' 82' ' ' TYR . 4.9 mt -114.95 151.67 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.94 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.583 ' HG ' ' CE2' ' A' ' 82' ' ' TYR . 1.1 mt -119.14 124.97 48.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 108.949 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -107.45 138.38 43.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.968 . . . . 0.0 109.647 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.521 ' N ' ' OD2' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -100.76 159.3 29.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 109.518 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 47.6 Cg_endo -69.41 -24.24 31.48 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.71 2.274 . . . . 0.0 111.505 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.9 m -74.27 -34.07 63.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.334 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 86' ' ' ASN . 1.7 p30 -80.16 -38.34 31.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 0.0 109.263 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 86' ' ' ASN . 2.3 m -108.18 69.64 0.33 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.584 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.558 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 52.8 Cg_endo -70.72 -25.85 23.72 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.798 2.332 . . . . 0.0 112.045 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.558 ' CZ3' ' HD2' ' A' ' 91' ' ' PRO . 44.9 p90 -71.26 -37.65 71.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.955 . . . . 0.0 109.497 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 92' ' ' TRP . 29.8 tp . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.18 147.62 60.57 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.69 2.26 . . . . 0.0 111.708 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 23' ' ' TRP . 4.1 mp -88.8 167.46 13.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.261 -0.9 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -104.35 139.6 39.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.27 152.81 33.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 17' ' ' THR . 59.8 tt0 -123.8 120.38 32.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.456 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.51 HG23 HD13 ' A' ' 14' ' ' ILE . 29.8 mt -111.69 128.47 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HG3' HG22 ' A' ' 14' ' ' ILE . 48.3 mttm 50.77 29.58 4.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.564 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.36 -12.08 67.78 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 28.7 m -80.59 129.95 34.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -1.1 . . . . 0.0 109.455 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.463 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 62.4 tttm -96.61 125.38 41.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.609 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.524 HD12 ' CZ ' ' A' ' 36' ' ' PHE . 37.9 mt -147.19 169.85 18.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.284 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -87.28 153.93 21.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.9 . . . . 0.0 109.487 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.36 168.84 18.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.323 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.519 ' O ' ' CD2' ' A' ' 85' ' ' LEU . 70.3 m-70 -131.06 131.37 44.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.615 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.462 ' CH2' ' HB2' ' A' ' 25' ' ' SER . 53.1 t90 -86.25 126.95 34.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.368 -0.833 . . . . 0.0 109.336 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 23' ' ' TRP . 97.1 m-20 -137.67 103.9 5.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.462 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 22.9 t -59.56 -29.23 67.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.51 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.32 -27.36 65.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -84.05 131.2 34.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -1.144 . . . . 0.0 109.576 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.8 p -96.66 -11.62 24.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 109.487 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.512 ' CG2' HD12 ' A' ' 76' ' ' LEU . 10.1 tt -134.23 145.51 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.89 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.518 ' CG2' HG11 ' A' ' 75' ' ' VAL . 86.6 m -63.55 140.97 58.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.442 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.529 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -121.47 128.43 52.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.521 HG11 ' CB ' ' A' ' 75' ' ' VAL . 4.2 m -127.77 163.34 43.82 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.408 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 78' ' ' SER . 55.7 Cg_endo -79.1 138.97 14.75 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.519 2.146 . . . . 0.0 111.943 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.428 ' HG2' ' CB ' ' A' ' 77' ' ' ALA . 74.7 mt-10 -46.88 -24.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.463 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.48 -24.54 3.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.492 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CZ ' HD12 ' A' ' 19' ' ' LEU . 22.8 m-85 -97.85 -8.92 27.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 109.629 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 37' ' ' LEU . 2.7 mm? -116.55 2.75 13.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 0.0 109.694 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -53.85 -42.95 69.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 109.295 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -110.81 25.43 11.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.331 -0.855 . . . . 0.0 109.291 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.479 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 70.7 mm-40 -108.78 -169.23 1.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.627 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 ptt85 -149.63 129.29 6.49 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.455 -0.778 . . . . 0.0 109.25 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.574 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 51.0 Cg_endo -70.82 124.4 10.61 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.589 2.193 . . . . 0.0 111.975 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.504 HG13 ' N ' ' A' ' 44' ' ' GLN . 31.9 pt -72.59 -36.11 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.245 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.504 ' N ' HG13 ' A' ' 43' ' ' ILE . 94.8 mt-30 -139.37 164.95 28.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.403 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.5 p -128.77 162.46 27.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.418 ' HE1' HG21 ' A' ' 59' ' ' VAL . 63.8 mtt -128.83 145.06 51.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.425 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.47 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 4.8 mp -100.58 128.75 46.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.532 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.522 ' CD1' ' HG3' ' A' ' 57' ' ' GLN . 25.5 mt -125.05 133.28 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.49 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -100.42 130.99 46.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.455 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 53' ' ' GLY . 9.8 p -125.12 163.26 22.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.905 . . . . 0.0 109.517 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.482 HG13 ' N ' ' A' ' 52' ' ' HIS . 20.2 pt -61.61 -38.99 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.51 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.482 ' N ' HG13 ' A' ' 51' ' ' ILE . 86.5 t60 -69.62 -34.26 73.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 0.0 109.458 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.45 ' O ' ' OG1' ' A' ' 50' ' ' THR . . . 172.92 -172.06 44.83 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -97.05 129.14 44.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -1.174 . . . . 0.0 109.424 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -121.99 147.0 46.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 109.526 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -113.08 135.89 53.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.915 . . . . 0.0 109.511 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.522 ' HG3' ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -106.72 128.87 54.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.378 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 42' ' ' PRO . 88.8 m-20 -81.04 152.39 27.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.63 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.513 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 22.0 t -115.35 132.0 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.846 . . . . 0.0 109.269 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.574 ' CE1' ' HB3' ' A' ' 42' ' ' PRO . 8.1 m-85 -121.39 131.72 54.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.002 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.492 ' CE1' ' HB3' ' A' ' 72' ' ' GLU . 47.0 t80 -95.88 108.98 21.4 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.472 HD13 ' CD1' ' A' ' 37' ' ' LEU . 50.5 mt -120.6 168.35 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.054 -1.029 . . . . 0.0 110.517 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.534 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 88.9 m -118.05 125.94 51.31 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.488 ' CE2' HG22 ' A' ' 66' ' ' VAL . 37.5 p90 -145.16 155.2 43.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 0.0 109.685 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 31.7 mttt -89.03 129.18 35.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.488 HG22 ' CE2' ' A' ' 64' ' ' PHE . 2.0 t -103.33 97.78 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 76.5 mt-30 65.02 41.11 4.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.214 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.22 32.88 41.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -137.63 108.63 6.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -1.146 . . . . 0.0 109.34 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -58.12 122.51 13.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.539 HG23 ' CH2' ' A' ' 92' ' ' TRP . 93.6 t -147.7 134.22 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.285 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.534 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 88.5 mt-10 -110.61 140.46 44.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.667 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.15 162.84 34.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.351 -0.843 . . . . 0.0 109.569 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.513 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 96.7 mt-10 -80.9 136.28 36.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.846 . . . . 0.0 109.175 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.521 ' CB ' HG11 ' A' ' 32' ' ' VAL . 12.4 m -129.54 150.91 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.225 -0.922 . . . . 0.0 109.683 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.512 HD12 ' CG2' ' A' ' 29' ' ' ILE . 5.4 mp -100.41 150.17 22.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.277 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' CB ' ' HG2' ' A' ' 34' ' ' GLU . . . -80.04 135.6 36.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.47 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 2.8 t -142.9 150.19 52.29 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.47 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.0 Cg_endo -70.78 2.27 4.27 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.664 2.243 . . . . 0.0 112.088 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.459 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 67.1 m-85 -66.04 171.17 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.568 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -110.98 20.45 17.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.788 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.593 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 12.3 p90 -145.46 -159.91 1.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 109.441 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.513 ' O ' ' CD2' ' A' ' 82' ' ' TYR . 4.3 mt -125.16 154.44 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.62 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.593 ' HG ' ' CE2' ' A' ' 82' ' ' TYR . 1.8 mt -120.03 126.48 50.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.263 -0.898 . . . . 0.0 109.063 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -105.61 142.02 36.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.536 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.518 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -102.26 161.82 22.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.366 -0.834 . . . . 0.0 109.431 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 51.9 Cg_endo -71.64 -21.6 25.27 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.618 2.212 . . . . 0.0 111.677 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.2 m -77.81 -34.1 52.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 0.0 109.403 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 90' ' ' VAL . 1.6 p30 -80.02 -40.67 27.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.457 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 86' ' ' ASN . 2.6 m -109.31 70.0 0.44 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.573 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.6 Cg_endo -70.53 -22.18 28.91 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.659 2.239 . . . . 0.0 111.843 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.573 ' CZ3' ' HD2' ' A' ' 91' ' ' PRO . 47.5 p90 -77.27 -31.71 55.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.439 HD21 ' O ' ' A' ' 93' ' ' LEU . 10.0 tt -54.2 -40.98 68.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.505 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 90.2 mtp -60.06 -36.57 77.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.242 -0.911 . . . . 0.0 109.505 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -86.9 145.11 26.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.41 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -68.88 144.9 96.35 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.11 145.14 54.28 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.766 2.31 . . . . 0.0 111.775 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 tt . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.95 . . . . 0.0 109.466 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.575 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.6 Cg_endo -70.02 144.59 53.1 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.794 2.329 . . . . 0.0 111.766 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.451 HD21 ' CE ' ' A' ' 94' ' ' MET . 4.3 mp -80.51 168.29 19.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 109.336 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -102.03 145.77 28.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.81 152.98 36.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.257 -0.902 . . . . 0.0 109.471 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 65' ' ' LYS . 82.0 tt0 -126.72 119.73 27.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 64' ' ' PHE . 50.2 mt -115.93 129.61 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 109.374 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 82.8 mttt 58.35 24.03 11.18 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 109.572 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.44 -0.85 85.62 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.0 m -98.83 128.21 44.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -1.223 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -83.78 138.89 33.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 109.443 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.456 ' HB3' HD13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -150.01 167.21 27.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.555 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -83.53 155.0 23.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.516 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.485 ' CB ' HD23 ' A' ' 85' ' ' LEU . . . -147.88 167.14 25.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 109.379 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.575 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 67.1 m-70 -132.45 131.89 42.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.649 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.605 ' CZ2' ' CD1' ' A' ' 93' ' ' LEU . 71.6 t90 -84.7 128.15 34.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.327 -0.858 . . . . 0.0 109.386 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -138.33 104.97 5.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 109.526 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.54 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 6.5 p -60.45 -26.91 67.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.951 . . . . 0.0 109.438 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.05 -28.13 73.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -85.44 122.15 29.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -1.14 . . . . 0.0 109.232 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.1 p -91.89 -12.76 32.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.39 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 74' ' ' GLU . 11.1 tp -127.04 142.33 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -0.936 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 44.4 m -63.39 139.56 58.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.526 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -120.78 123.23 42.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.21 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.586 ' CG2' ' CD1' ' A' ' 37' ' ' LEU . 17.3 m -121.83 162.87 34.59 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 109.727 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 82' ' ' TYR . 54.7 Cg_endo -79.35 133.16 10.58 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.593 2.196 . . . . 0.0 111.554 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -46.72 -24.88 0.63 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.422 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.58 -32.95 53.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.646 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.436 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 5.3 m-85 -93.55 -3.95 51.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 109.67 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.637 ' CD2' ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -112.75 4.72 17.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.176 -0.952 . . . . 0.0 109.737 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -52.49 -25.61 10.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.123 -0.986 . . . . 0.0 109.53 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -123.91 28.09 6.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.268 -0.895 . . . . 0.0 108.956 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.437 ' CD ' HD21 ' A' ' 62' ' ' LEU . 41.7 mm-40 -102.23 152.81 20.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.417 -0.802 . . . . 0.0 109.736 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.1 mtm180 -116.95 127.67 26.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.216 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.573 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 52.6 Cg_endo -72.1 116.09 4.57 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.577 2.185 . . . . 0.0 111.824 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.504 HG13 ' N ' ' A' ' 44' ' ' GLN . 27.9 pt -67.37 -36.5 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 109.325 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.504 ' N ' HG13 ' A' ' 43' ' ' ILE . 91.1 mt-30 -137.1 160.96 37.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.257 -0.902 . . . . 0.0 109.291 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 56.9 p -125.9 151.55 46.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.626 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 69.2 mtm -142.69 147.04 35.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.363 -0.836 . . . . 0.0 109.351 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 56' ' ' GLN . 0.5 OUTLIER -102.09 124.8 48.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.538 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.431 HD13 ' HG3' ' A' ' 57' ' ' GLN . 66.9 mt -118.02 134.42 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.398 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 33.2 mttp -106.3 139.89 40.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.523 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.407 HG23 ' C ' ' A' ' 49' ' ' LYS . 16.5 p -128.91 162.48 27.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 109.386 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 52' ' ' HIS . 12.9 tt -52.9 -39.47 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.429 ' N ' ' CG2' ' A' ' 51' ' ' ILE . 70.6 m80 -63.3 -37.64 88.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.563 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.93 -175.94 43.24 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 93.8 mt-10 -90.74 135.11 33.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.213 -1.169 . . . . 0.0 109.545 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -134.33 139.67 45.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.364 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 47' ' ' LEU . 51.4 tt0 -97.65 119.95 37.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.643 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.431 ' HG3' HD13 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -107.22 146.34 31.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.281 -0.887 . . . . 0.0 109.407 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 88.1 m-20 -110.97 152.03 27.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 109.461 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 25.9 t -95.81 145.27 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.835 . . . . 0.0 109.117 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.637 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 38.3 m-85 -132.59 126.97 34.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.457 ' O ' HD22 ' A' ' 62' ' ' LEU . 36.2 t80 -94.74 111.8 23.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 108.874 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.457 HD22 ' O ' ' A' ' 61' ' ' TYR . 43.9 mt -121.3 167.09 13.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 110.122 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.538 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 52.2 m -124.01 113.99 19.16 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.486 ' CE2' ' CG2' ' A' ' 66' ' ' VAL . 12.7 p90 -134.29 159.27 41.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.815 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 74.5 mttt -90.84 123.74 34.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.307 -0.871 . . . . 0.0 109.291 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.486 ' CG2' ' CE2' ' A' ' 64' ' ' PHE . 51.9 t -100.85 106.52 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.762 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 98.0 mt-30 62.3 36.54 14.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.313 -0.867 . . . . 0.0 109.484 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.69 26.25 54.4 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 71' ' ' VAL . 55.0 mtt180 -131.35 115.06 15.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.248 -1.148 . . . . 0.0 109.277 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.53 120.31 9.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 69' ' ' ARG . 36.4 t -141.2 133.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.538 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 45.6 mt-10 -113.94 136.38 52.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.602 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.36 166.42 29.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.831 . . . . 0.0 109.631 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.516 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 98.1 mt-10 -80.87 133.69 35.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.513 ' CG2' HG21 ' A' ' 32' ' ' VAL . 3.4 m -127.21 161.9 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.536 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.403 HD21 ' O ' ' A' ' 58' ' ' ASP . 5.0 mt -116.25 151.52 35.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.362 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.0 134.56 36.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.339 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.462 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.5 t -140.08 150.84 63.36 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.361 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.462 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.4 Cg_endo -70.55 -0.18 7.17 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.652 2.234 . . . . 0.0 111.78 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -64.95 168.52 6.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.493 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -110.99 22.35 15.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.612 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.572 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 15.3 p90 -144.04 -160.78 1.16 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 109.281 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.507 ' CG2' HG13 ' A' ' 32' ' ' VAL . 5.0 mt -126.64 143.56 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 109.737 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.572 HD11 ' CZ ' ' A' ' 82' ' ' TYR . 6.4 mp -107.57 123.15 48.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.814 . . . . 0.0 109.066 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -102.13 137.48 40.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.548 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.517 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -99.63 160.16 28.1 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.86 . . . . 0.0 109.687 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 51.7 Cg_endo -71.21 -27.92 19.28 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.735 2.29 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.0 m -69.19 -38.9 78.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.1 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 90' ' ' VAL . 1.7 p30 -74.43 -40.15 62.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.87 . . . . 0.0 108.993 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 86' ' ' ASN . 3.4 m -111.79 79.99 2.77 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.575 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 48.7 Cg_endo -69.18 -31.39 23.19 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.69 2.26 . . . . 0.0 112.085 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.575 ' CZ3' ' HD2' ' A' ' 91' ' ' PRO . 30.6 p90 -63.89 -21.58 66.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.096 -1.003 . . . . 0.0 109.419 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.605 ' CD1' ' CZ2' ' A' ' 23' ' ' TRP . 2.2 mm? 58.08 63.14 1.84 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 109.606 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.454 ' HA ' ' OE1' ' A' ' 67' ' ' GLN . 36.7 mtt 67.75 169.93 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 109.645 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 18.4 tttt -75.58 136.54 40.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.508 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 2.1 tttp 169.76 -56.2 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.472 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 96' ' ' LYS . 49.1 Cg_endo -68.85 143.51 55.6 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.443 2.095 . . . . 0.0 111.723 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.3 mt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.486 179.987 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.539 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 48.9 Cg_endo -70.16 161.06 47.37 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.7 2.267 . . . . 0.0 111.804 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.528 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 18.3 mt -99.49 178.64 4.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.131 -0.981 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.68 139.85 42.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.354 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.86 149.66 31.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 109.707 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 65' ' ' LYS . 96.2 mt-10 -123.74 116.1 22.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.27 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.519 HG23 ' CD1' ' A' ' 36' ' ' PHE . 49.9 mt -108.95 129.53 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HG3' HG23 ' A' ' 14' ' ' ILE . 85.6 mttt 54.91 24.47 5.86 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.253 -0.904 . . . . 0.0 109.62 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.29 -2.61 83.55 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.5 m -89.88 117.37 28.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -1.202 . . . . 0.0 109.491 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.45 ' O ' HD21 ' A' ' 19' ' ' LEU . 84.2 tttt -81.8 125.75 31.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.557 HD12 ' CZ ' ' A' ' 36' ' ' PHE . 92.5 mt -145.77 161.77 39.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.28 148.6 30.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.529 ' HB3' ' CD1' ' A' ' 85' ' ' LEU . . . -129.92 173.14 10.98 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.172 -0.955 . . . . 0.0 109.532 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.539 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 41.0 m-70 -127.24 127.99 45.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 0.0 109.657 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.559 ' CH2' ' HB3' ' A' ' 25' ' ' SER . 60.8 t90 -91.94 128.12 37.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.581 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.458 ' CB ' HD22 ' A' ' 84' ' ' LEU . 61.1 t0 -137.82 104.36 5.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.559 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 59.6 p -56.64 -28.0 59.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.895 . . . . 0.0 109.514 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.07 -29.67 74.84 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.77 142.2 58.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -1.176 . . . . 0.0 109.506 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 28' ' ' THR . 86.7 m -108.61 -5.24 16.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.512 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 18.4 tt -152.0 144.54 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.521 ' N ' ' HB2' ' A' ' 86' ' ' ASN . 44.8 m -53.94 150.64 7.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.679 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.42 ' O ' HG22 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -122.36 129.59 52.27 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.269 -0.894 . . . . 0.0 109.116 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.535 ' CG1' ' HD2' ' A' ' 33' ' ' PRO . 77.3 t -134.57 145.83 56.67 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.297 -0.877 . . . . 0.0 109.455 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.535 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 55.3 Cg_endo -77.95 133.55 12.55 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.291 1.994 . . . . 0.0 111.651 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 40.7 tp10 -42.06 -27.4 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.44 -0.788 . . . . 0.0 109.792 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -47.81 -39.15 17.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.645 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.557 ' CZ ' HD12 ' A' ' 19' ' ' LEU . 32.7 m-85 -92.12 -5.48 52.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 109.847 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.648 ' CD2' ' CD2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -107.66 1.71 23.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.93 . . . . 0.0 109.857 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -50.63 -24.71 3.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.975 . . . . 0.0 109.391 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -125.39 30.1 5.88 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 108.955 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.472 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 47.8 mm-40 -105.23 154.78 19.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.849 . . . . 0.0 109.836 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -117.7 128.74 25.81 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.823 . . . . 0.0 109.154 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 60' ' ' TYR . 51.3 Cg_endo -71.19 119.53 6.35 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.65 2.233 . . . . 0.0 112.05 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.8 pt -75.49 -26.36 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.307 -0.871 . . . . 0.0 109.16 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -145.55 151.15 37.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.352 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.5 p -121.06 156.09 32.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.918 . . . . 0.0 109.485 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.2 mtp -147.48 141.5 25.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 0.0 109.47 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.1 tp -98.79 130.13 45.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.472 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.463 HD12 ' CB ' ' A' ' 57' ' ' GLN . 66.3 mt -123.33 127.06 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.147 -0.971 . . . . 0.0 109.527 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.438 ' HG3' ' HG2' ' A' ' 54' ' ' GLU . 36.7 tttt -102.29 126.28 49.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.352 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.31 -169.76 1.52 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.932 . . . . 0.0 109.52 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.434 HD11 HG21 ' A' ' 51' ' ' ILE . 15.6 mm -78.62 -47.31 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.331 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -57.4 -41.28 80.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.12 -169.28 41.52 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HG2' ' HG3' ' A' ' 49' ' ' LYS . 98.6 mt-10 -84.06 140.16 32.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -1.168 . . . . 0.0 109.449 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -125.99 141.01 52.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -100.66 117.06 34.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.463 ' CB ' HD12 ' A' ' 48' ' ' ILE . 3.2 mm-40 -112.67 125.15 53.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.469 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -109.48 156.0 20.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.875 . . . . 0.0 109.476 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.532 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 39.9 t -101.85 142.9 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.377 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.648 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 34.6 m-85 -131.31 129.38 41.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.146 -0.971 . . . . 0.0 110.037 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.458 ' O ' HD23 ' A' ' 62' ' ' LEU . 42.9 t80 -94.47 107.74 19.7 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 61' ' ' TYR . 39.3 mt -118.1 171.29 8.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -0.99 . . . . 0.0 110.334 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.533 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 82.8 m -125.93 119.02 26.66 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.1 p90 -140.6 157.73 45.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.791 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 13' ' ' GLU . 20.3 mttm -87.36 132.02 34.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.835 . . . . 0.0 109.383 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 98.8 t -112.1 107.08 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.461 ' OE1' HD22 ' A' ' 93' ' ' LEU . 83.4 mt-30 63.37 35.46 12.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 109.4 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.74 33.81 32.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -141.24 115.09 9.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -1.116 . . . . 0.0 109.411 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.427 ' C ' HG21 ' A' ' 71' ' ' VAL . 3.5 ttpm? -61.68 123.11 17.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.535 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.429 HG23 ' CH2' ' A' ' 92' ' ' TRP . 92.0 t -144.41 132.58 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.462 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.533 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 50.4 mt-10 -109.02 138.01 46.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.622 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.509 ' CB ' ' OD2' ' A' ' 89' ' ' ASP . . . -160.27 165.76 30.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.668 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.532 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 96.1 mt-10 -81.42 129.87 34.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.515 HG13 ' CG2' ' A' ' 30' ' ' THR . 3.2 m -124.92 160.88 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.119 -0.988 . . . . 0.0 109.61 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.476 HD11 ' CG2' ' A' ' 29' ' ' ILE . 29.0 mt -109.35 145.11 36.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.95 134.76 36.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.438 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.528 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 3.5 t -142.25 149.64 52.43 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.395 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.7 Cg_endo -70.16 0.26 6.21 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.635 2.223 . . . . 0.0 111.873 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.528 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 66.6 m-85 -65.82 177.52 1.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.333 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -119.85 22.27 11.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.414 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.461 ' OH ' HD12 ' A' ' 84' ' ' LEU . 15.1 p90 -135.78 -173.72 3.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.863 . . . . 0.0 109.183 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.467 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 1.4 mt -131.54 112.33 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.461 HD12 ' OH ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -79.56 135.25 36.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.208 -0.933 . . . . 0.0 109.176 179.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -98.65 134.62 41.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.669 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.521 ' HB2' ' N ' ' A' ' 30' ' ' THR . 29.8 t30 -86.21 140.77 34.58 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.441 -0.787 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.477 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 46.5 Cg_endo -67.91 -34.54 23.35 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.69 2.26 . . . . 0.0 111.756 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.7 m -66.37 -36.05 81.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.182 -0.949 . . . . 0.0 109.283 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.509 ' OD2' ' CB ' ' A' ' 73' ' ' ALA . 91.8 m-20 -72.42 -32.1 66.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.493 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.63 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -113.93 72.85 2.22 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.535 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.4 Cg_endo -71.04 -21.98 26.87 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.667 2.245 . . . . 0.0 112.0 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.63 ' CZ2' ' CG1' ' A' ' 90' ' ' VAL . 47.0 p90 -74.72 -30.43 61.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.461 HD22 ' OE1' ' A' ' 67' ' ' GLN . 66.9 mt -59.21 -35.34 73.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 66.1 mtt -58.63 -39.16 79.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 109.614 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -80.19 150.61 30.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 109.573 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 6.2 ttpt 52.33 73.42 0.95 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.563 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.92 145.31 55.86 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.759 2.306 . . . . 0.0 111.7 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.2 mt . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.436 179.922 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.576 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.1 Cg_endo -69.85 160.15 50.73 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.72 2.28 . . . . 0.0 111.811 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.463 HD13 ' HB2' ' A' ' 23' ' ' TRP . 4.5 mp -81.27 166.47 20.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.46 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -104.65 144.37 31.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.503 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.2 152.78 30.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 109.463 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.45 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 78.3 tt0 -123.14 120.34 32.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.321 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.573 HG23 ' CD1' ' A' ' 36' ' ' PHE . 57.7 mt -114.92 128.03 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.446 ' HG2' HG22 ' A' ' 14' ' ' ILE . 31.7 mmtp 59.43 23.26 11.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.45 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 86.54 10.51 73.32 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 33.8 m -108.52 125.8 52.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -1.13 . . . . 0.0 109.451 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.522 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 28.7 mttm -80.28 125.32 29.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.453 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.522 ' CD2' ' O ' ' A' ' 18' ' ' LYS . 1.3 mm? -141.06 158.26 44.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -80.23 155.44 27.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 109.402 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.73 164.29 33.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.563 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.576 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 73.4 m-70 -124.9 133.19 53.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.616 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 20.0 t90 -83.95 126.25 32.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -132.91 97.71 4.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.311 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.513 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 52.1 p -58.53 -26.83 63.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.578 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.05 -31.31 76.19 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -77.78 138.32 38.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.173 . . . . 0.0 109.693 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.8 p -98.64 -4.71 33.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.592 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.431 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 21.1 tt -142.65 156.64 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.0 109.327 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 33.5 m -71.71 140.48 49.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.952 . . . . 0.0 109.63 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.522 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -124.31 122.08 36.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.423 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.526 ' CG2' HG23 ' A' ' 75' ' ' VAL . 3.4 m -119.62 164.61 20.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.922 . . . . 0.0 109.368 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.2 Cg_endo -79.04 137.85 14.02 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.475 2.117 . . . . 0.0 111.65 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -47.57 -23.59 0.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 0.0 109.592 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.03 -36.66 18.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.55 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.573 ' CD1' HG23 ' A' ' 14' ' ' ILE . 31.1 m-85 -89.61 -10.52 45.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.581 ' CD2' ' CG ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -107.87 38.2 2.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 39' ' ' ASP . 42.7 tp10 -56.83 92.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 109.709 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 38' ' ' GLU . 55.8 m-20 61.93 28.59 17.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.326 -0.859 . . . . 0.0 109.657 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.526 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 17.9 mm-40 -59.28 -178.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.94 114.28 43.93 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.55 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 53.9 Cg_endo -72.9 128.37 13.15 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.586 2.19 . . . . 0.0 111.753 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 61' ' ' TYR . 28.4 pt -84.97 -29.61 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.5 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.512 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 93.9 mt-30 -147.34 165.78 29.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 18.4 p -115.45 154.12 29.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 109.723 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.431 ' O ' ' HG3' ' A' ' 56' ' ' GLN . 24.8 mmm -138.8 161.78 36.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.294 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.503 ' CD2' ' HG3' ' A' ' 56' ' ' GLN . 49.3 mt -108.17 135.95 48.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 109.643 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.21 131.38 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -100.96 134.65 43.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.565 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 m -126.4 159.61 32.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.375 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.499 HG13 ' N ' ' A' ' 52' ' ' HIS . 19.1 pt -61.19 -39.59 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.176 -0.953 . . . . 0.0 109.457 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.499 ' N ' HG13 ' A' ' 51' ' ' ILE . 79.1 m80 -69.49 -35.75 75.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.912 . . . . 0.0 109.565 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.24 -171.62 44.02 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -102.28 128.76 48.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -1.128 . . . . 0.0 109.53 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -123.28 132.22 53.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 109.5 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.503 ' HG3' ' CD2' ' A' ' 47' ' ' LEU . 56.7 tt0 -103.77 134.03 47.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.499 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -130.36 155.98 45.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 109.542 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 33.1 m-20 -87.27 142.13 28.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.428 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 74' ' ' GLU . 9.6 p -92.29 160.25 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.433 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.581 ' CG ' ' CD2' ' A' ' 37' ' ' LEU . 9.1 m-85 -135.51 142.18 45.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.187 -0.945 . . . . 0.0 109.968 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.512 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 48.1 t80 -100.02 112.96 25.24 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.6 mt -123.19 170.5 10.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 110.417 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.516 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 89.4 m -118.84 126.68 52.39 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.534 ' CE2' HG23 ' A' ' 66' ' ' VAL . 35.7 p90 -142.99 154.78 44.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.093 -1.004 . . . . 0.0 109.748 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -88.07 128.4 35.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 109.383 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.534 HG23 ' CE2' ' A' ' 64' ' ' PHE . 2.2 t -105.78 103.78 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 90.0 mt-30 62.01 31.57 17.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.926 . . . . 0.0 109.285 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.99 28.66 25.21 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -132.91 126.53 32.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -1.172 . . . . 0.0 109.508 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -68.28 123.52 20.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.563 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.445 ' CG2' HG22 ' A' ' 66' ' ' VAL . 41.4 t -145.29 129.05 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.448 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.516 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 67.2 mt-10 -112.45 135.17 53.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.04 166.07 30.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.739 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.528 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 91.9 mt-10 -80.24 133.26 35.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.283 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.526 HG23 ' CG2' ' A' ' 32' ' ' VAL . 3.8 m -129.04 159.47 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.558 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 4.1 mp -110.83 151.28 28.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -0.885 . . . . 0.0 109.406 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.01 142.08 35.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.416 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.515 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 8.3 t -145.05 148.63 39.21 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 109.361 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.469 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.1 Cg_endo -70.34 0.24 6.37 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.649 2.233 . . . . 0.0 111.873 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.515 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 31.3 m-85 -63.63 171.88 2.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 109.458 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -111.74 17.59 19.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.59 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.589 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 21.6 p90 -141.03 -156.17 0.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.136 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.6 mt -130.46 147.04 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.019 -1.051 . . . . 0.0 109.988 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' HG ' ' CE2' ' A' ' 82' ' ' TYR . 1.1 mt -108.99 130.39 55.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 108.98 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -99.73 144.29 28.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 109.853 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.524 ' OD1' ' CD ' ' A' ' 87' ' ' PRO . 4.2 t30 -97.02 136.91 21.32 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.453 -0.78 . . . . 0.0 109.034 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.571 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.1 Cg_endo -63.88 -33.56 63.65 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.85 2.367 . . . . 0.0 112.028 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.2 m -75.47 -29.43 59.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.302 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.445 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 90.4 m-20 -73.35 -31.13 63.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.273 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.491 ' CG1' HG12 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -121.49 77.54 36.07 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.888 . . . . 0.0 109.363 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.82 -23.83 30.1 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.802 2.335 . . . . 0.0 111.874 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -80.91 -22.42 39.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.418 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.616 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 25.0 tp -56.67 -41.16 76.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.403 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 84.5 mtp -85.02 134.13 34.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.306 -0.871 . . . . 0.0 109.5 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -110.0 147.8 32.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 109.42 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -125.6 76.53 69.74 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.518 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.26 -21.16 31.57 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.633 2.222 . . . . 0.0 111.738 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.8 mt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.45 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.574 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 47.9 Cg_endo -68.86 149.73 72.8 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.759 2.306 . . . . 0.0 111.763 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.516 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 26.4 mt -80.91 -177.58 6.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.486 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -118.02 139.9 50.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.368 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.75 154.01 38.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 17' ' ' THR . 87.1 tt0 -128.5 120.47 26.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.944 . . . . 0.0 109.357 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.459 ' CG2' ' HG3' ' A' ' 15' ' ' LYS . 59.2 mt -115.63 127.83 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.393 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.459 ' HG3' ' CG2' ' A' ' 14' ' ' ILE . 45.6 mttt 60.77 23.76 13.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 109.449 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.427 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.29 -5.22 84.29 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.512 HG22 ' CD2' ' A' ' 19' ' ' LEU . 35.4 m -93.14 127.59 38.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -1.158 . . . . 0.0 109.459 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.446 ' O ' HD21 ' A' ' 19' ' ' LEU . 18.2 tttm -87.24 120.45 28.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.568 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.512 ' CD2' HG22 ' A' ' 17' ' ' THR . 3.5 mm? -129.59 164.6 23.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 109.313 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -83.0 155.96 23.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.938 . . . . 0.0 109.395 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.85 163.24 34.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 73.6 m-70 -125.92 127.8 46.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.527 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.58 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 51.9 t90 -78.67 118.5 20.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.907 . . . . 0.0 109.507 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -128.2 102.93 6.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.953 . . . . 0.0 109.336 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.58 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 60.6 p -60.8 -29.2 69.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.609 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.98 -34.36 78.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.08 136.74 54.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.491 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.448 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 36.9 m -95.51 -14.73 23.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 tt -142.36 155.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.467 ' HB ' HG12 ' A' ' 75' ' ' VAL . 47.5 m -61.1 136.93 58.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.522 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -119.22 126.6 51.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.382 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.569 ' CG2' ' CG2' ' A' ' 75' ' ' VAL . 15.7 m -124.96 161.37 49.55 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 109.66 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 82' ' ' TYR . 54.8 Cg_endo -79.38 132.05 9.92 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.751 2.301 . . . . 0.0 111.834 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.1 tt0 -45.36 -26.81 0.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.63 -36.1 33.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.509 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.07 -2.56 57.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.621 ' CD2' ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -109.35 0.35 19.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 0.0 109.916 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -51.46 -25.76 6.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.0 109.484 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -122.18 25.41 9.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 109.177 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.514 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 55.5 mm-40 -100.55 160.93 13.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.734 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.33 128.99 25.07 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.37 -0.831 . . . . 0.0 109.233 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.583 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 52.8 Cg_endo -72.89 121.07 7.03 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.54 2.16 . . . . 0.0 112.048 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.449 HG13 ' HG3' ' A' ' 44' ' ' GLN . 36.4 pt -89.91 -23.5 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.245 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.449 ' HG3' HG13 ' A' ' 43' ' ' ILE . 94.6 mt-30 -141.81 175.3 9.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.26 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 40.2 p -126.67 150.35 49.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.164 -0.96 . . . . 0.0 109.811 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 29.1 tpp -132.37 145.74 51.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.324 -0.86 . . . . 0.0 109.462 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.49 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 5.1 mp -102.18 132.6 48.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.9 . . . . 0.0 109.446 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 55' ' ' LYS . 66.2 mt -122.4 135.15 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.493 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -111.39 135.95 51.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.166 -0.958 . . . . 0.0 109.57 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.1 p -127.12 157.94 38.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 109.363 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.401 ' CG2' ' N ' ' A' ' 52' ' ' HIS . 11.1 tp -56.92 -38.02 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.503 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.401 ' N ' ' CG2' ' A' ' 51' ' ' ILE . 67.2 m80 -67.09 -39.42 86.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.495 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.82 -170.14 41.06 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.32 132.2 44.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -1.193 . . . . 0.0 109.557 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 48' ' ' ILE . 54.2 tptt -129.17 131.22 47.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.425 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.455 ' OE1' HD22 ' A' ' 47' ' ' LEU . 25.9 mt-30 -111.54 141.6 44.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.682 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.494 ' NE2' ' CD2' ' A' ' 76' ' ' LEU . 25.5 mt-30 -132.27 157.54 44.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.267 -0.896 . . . . 0.0 109.296 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 58.2 m-20 -90.88 142.16 28.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.756 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.522 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 20.5 t -83.42 154.83 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 108.985 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.621 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 17.5 m-85 -135.51 130.21 34.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 110.011 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.469 ' O ' HD21 ' A' ' 62' ' ' LEU . 48.6 t80 -95.86 112.0 23.84 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.499 ' CD2' ' CD ' ' A' ' 40' ' ' GLU . 37.6 mt -121.79 170.22 9.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.052 -1.03 . . . . 0.0 110.489 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.525 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 87.1 m -121.97 119.77 32.47 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.407 ' CE2' HG22 ' A' ' 66' ' ' VAL . 44.6 p90 -140.68 154.46 46.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.026 -1.046 . . . . 0.0 109.739 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.428 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 20.1 mttm -85.87 132.33 34.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.833 . . . . 0.0 109.318 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 1.9 t -109.0 100.86 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.703 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 81.2 mt-30 65.09 35.45 7.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.458 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.33 35.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -134.08 116.73 15.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -1.072 . . . . 0.0 109.424 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -66.8 119.7 12.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.44 ' HB ' HG21 ' A' ' 66' ' ' VAL . 98.6 t -141.24 134.39 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.867 . . . . 0.0 109.429 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.525 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 61.1 mt-10 -110.5 136.13 50.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 109.593 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.26 166.34 29.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.672 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.522 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 96.3 mt-10 -80.02 136.24 36.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.27 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.569 ' CG2' ' CG2' ' A' ' 32' ' ' VAL . 4.1 m -127.96 158.19 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.22 -0.925 . . . . 0.0 109.65 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.494 ' CD2' ' NE2' ' A' ' 57' ' ' GLN . 32.4 tp -109.32 146.09 34.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.8 124.5 28.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 109.227 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.467 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 2.0 t -128.09 150.21 73.18 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.8 Cg_endo -70.58 -0.3 7.39 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.683 2.255 . . . . 0.0 111.628 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.443 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 56.0 m-85 -64.13 172.14 2.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 109.444 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -112.14 17.09 19.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.607 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.557 ' CZ ' ' CD1' ' A' ' 84' ' ' LEU . 19.3 p90 -139.35 -156.82 0.71 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.245 -0.909 . . . . 0.0 109.087 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.555 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.0 mt -130.04 140.9 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.557 ' CD1' ' CZ ' ' A' ' 82' ' ' TYR . 6.5 mp -105.5 131.77 52.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 108.987 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -98.94 146.55 25.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.139 -0.976 . . . . 0.0 109.666 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.524 ' OD1' ' CD ' ' A' ' 87' ' ' PRO . 4.7 t30 -99.74 136.86 20.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 109.189 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.524 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.6 Cg_endo -64.13 -33.26 61.93 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.805 2.336 . . . . 0.0 111.81 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.8 t -76.56 -25.95 54.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.18 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.421 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 89.6 m-20 -80.26 -32.69 38.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.376 -0.827 . . . . 0.0 109.306 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -120.03 76.23 22.45 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.872 . . . . 0.0 109.54 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.27 -24.85 26.87 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.682 2.255 . . . . 0.0 111.796 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.457 ' CZ2' HG11 ' A' ' 90' ' ' VAL . 39.8 p90 -75.27 -27.59 59.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -0.89 . . . . 0.0 109.585 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.497 HD13 ' CD1' ' A' ' 23' ' ' TRP . 9.4 tt -56.75 -39.4 73.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.3 mmm -100.03 143.09 30.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.425 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -91.41 139.88 30.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.93 . . . . 0.0 109.48 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -73.47 132.66 81.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.541 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.08 145.6 55.75 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.769 2.313 . . . . 0.0 111.839 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.569 ' CD1' ' N ' ' A' ' 98' ' ' LEU . 4.0 mp . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 109.417 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.571 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 48.9 Cg_endo -69.79 146.85 61.25 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.687 2.258 . . . . 0.0 111.793 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.485 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 20.9 mt -83.79 -177.36 6.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.92 . . . . 0.0 109.559 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -117.93 136.97 53.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 109.389 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.98 150.13 32.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.207 -0.933 . . . . 0.0 109.653 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.422 ' HG2' ' HA ' ' A' ' 18' ' ' LYS . 95.5 mt-10 -118.58 123.04 44.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.28 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.2 mt -117.37 124.11 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.582 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.7 tptt 64.11 22.13 12.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.524 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.13 -1.03 82.39 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.518 HG22 ' CD2' ' A' ' 19' ' ' LEU . 10.6 m -96.16 129.66 43.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.136 . . . . 0.0 109.384 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.46 ' O ' HD22 ' A' ' 19' ' ' LEU . 71.4 tttt -86.9 117.02 25.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.44 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.529 ' CB ' HD13 ' A' ' 83' ' ' ILE . 3.8 mm? -132.17 161.37 33.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.386 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -84.45 153.57 23.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.419 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 10' ' ' LEU . . . -141.58 163.01 34.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 109.56 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 74.2 m-70 -121.01 127.72 52.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 109.627 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.485 ' HB2' ' CD1' ' A' ' 10' ' ' LEU . 34.1 t90 -80.39 118.89 22.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.587 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -127.67 102.97 7.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.265 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.457 ' HA ' ' HG3' ' A' ' 87' ' ' PRO . 23.4 t -59.12 -29.43 67.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 109.625 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.51 -40.16 94.06 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.425 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -65.19 128.27 35.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -1.151 . . . . 0.0 109.487 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.509 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 45.6 p -94.09 -8.07 40.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.217 -0.927 . . . . 0.0 109.447 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.521 HG23 ' CD1' ' A' ' 76' ' ' LEU . 11.1 tp -139.09 151.23 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.245 -0.909 . . . . 0.0 109.293 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 34.7 m -68.59 140.06 55.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 9.2 t -129.51 139.24 51.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.256 -0.903 . . . . 0.0 109.14 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.513 ' HB ' ' HD2' ' A' ' 33' ' ' PRO . 4.0 m -136.85 167.05 22.85 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.225 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.5 Cg_endo -78.93 134.32 11.77 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.202 1.935 . . . . 0.0 111.704 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' LEU . 81.3 tt0 -45.05 -24.58 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.363 -0.836 . . . . 0.0 109.874 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -47.71 -36.18 10.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 109.723 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.458 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 38.4 m-85 -92.38 -7.41 47.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.182 -0.949 . . . . 0.0 109.588 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.574 ' HG ' ' CD2' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -106.0 -12.89 15.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 109.527 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 34' ' ' GLU . 81.2 tt0 -49.81 -22.83 1.58 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.107 -0.995 . . . . 0.0 109.398 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -122.61 14.64 10.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.309 -0.869 . . . . 0.0 109.124 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.47 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 61.4 mm-40 -98.69 155.85 17.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.154 -0.966 . . . . 0.0 109.673 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -111.37 129.27 24.24 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.374 -0.829 . . . . 0.0 109.052 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.568 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 50.0 Cg_endo -70.34 120.29 7.02 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.522 2.148 . . . . 0.0 111.939 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 61' ' ' TYR . 21.2 pt -88.21 -27.82 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.245 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.463 ' O ' ' N ' ' A' ' 59' ' ' VAL . 63.9 tt0 -142.67 164.13 30.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.264 -0.898 . . . . 0.0 109.259 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.424 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 69.9 p -115.59 158.92 21.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.51 ' HE3' ' CD1' ' A' ' 48' ' ' ILE . 4.0 ttp -147.14 145.29 29.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.528 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.458 HD23 ' HB2' ' A' ' 56' ' ' GLN . 42.1 mt -83.67 129.67 34.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 109.615 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.51 ' CD1' ' HE3' ' A' ' 46' ' ' MET . 30.1 mm -115.78 131.78 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 109.301 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -103.94 127.69 51.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 0.0 109.55 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -115.76 -178.31 3.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 109.672 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 55.8 mt -70.77 -50.3 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -56.51 -42.06 77.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -177.41 -159.1 21.91 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -105.42 129.07 53.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -1.111 . . . . 0.0 109.507 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 48' ' ' ILE . 83.2 tttt -129.14 136.48 50.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.458 ' HB2' HD23 ' A' ' 47' ' ' LEU . 62.7 tt0 -94.39 129.85 40.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.699 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.418 ' NE2' HG13 ' A' ' 48' ' ' ILE . 24.8 mt-30 -115.99 159.37 21.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.905 . . . . 0.0 109.388 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' HB3' ' CB ' ' A' ' 42' ' ' PRO . 62.7 m-20 -86.54 142.27 28.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.0 109.611 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.521 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 14.4 t -89.04 151.12 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 109.269 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.574 ' CD2' ' HG ' ' A' ' 37' ' ' LEU . 26.6 m-85 -132.4 137.51 47.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.138 -0.977 . . . . 0.0 110.316 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.571 ' CE2' ' HG2' ' A' ' 72' ' ' GLU . 4.8 t80 -98.19 110.13 22.77 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 61' ' ' TYR . 3.6 mm? -124.03 156.35 36.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.481 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.509 ' CA ' ' HG3' ' A' ' 72' ' ' GLU . 5.0 m -110.97 126.09 54.4 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.443 -0.786 . . . . 0.0 108.931 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.522 ' CE2' HG23 ' A' ' 66' ' ' VAL . 28.1 p90 -141.48 153.39 44.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.107 -0.995 . . . . 0.0 109.694 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -83.85 127.95 34.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.28 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.522 HG23 ' CE2' ' A' ' 64' ' ' PHE . 25.1 t -105.75 98.99 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 82.1 mt-30 64.68 36.5 8.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.51 30.01 31.3 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -136.7 125.17 23.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -1.134 . . . . 0.0 109.449 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' C ' HG21 ' A' ' 71' ' ' VAL . 71.5 tttt -67.33 128.41 36.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.473 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.437 ' HB ' HG22 ' A' ' 66' ' ' VAL . 43.3 t -150.0 128.18 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.571 ' HG2' ' CE2' ' A' ' 61' ' ' TYR . 55.2 tt0 -118.31 134.59 54.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.0 175.23 13.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.268 -0.895 . . . . 0.0 109.434 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.521 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 95.6 mt-10 -79.71 139.65 37.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 109.261 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 30' ' ' THR . 10.8 m -133.82 151.86 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.269 -0.894 . . . . 0.0 109.583 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 4.3 mp -102.61 145.77 29.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.33 -0.856 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.0 137.94 36.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.298 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 1.3 t -144.02 151.17 51.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.461 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.0 Cg_endo -71.79 2.53 4.62 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.69 2.26 . . . . 0.0 111.83 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -63.55 167.11 5.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.162 -0.962 . . . . 0.0 109.338 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -109.71 17.71 20.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.625 ' CZ ' ' CD1' ' A' ' 84' ' ' LEU . 14.5 p90 -139.49 -157.71 0.79 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.136 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.541 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.0 mt -128.98 145.82 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 109.575 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.625 ' CD1' ' CZ ' ' A' ' 82' ' ' TYR . 5.9 mp -110.76 135.0 52.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -0.882 . . . . 0.0 108.872 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -105.64 142.49 35.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 28' ' ' THR . 6.5 t30 -100.13 134.86 20.56 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 108.949 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.492 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 41.5 Cg_endo -63.86 -22.85 68.88 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.769 2.313 . . . . 0.0 112.234 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.2 m -77.05 -31.62 56.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 0.0 109.298 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 90' ' ' VAL . 1.9 p30 -80.37 -35.63 35.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 109.378 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.514 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 2.4 m -112.1 69.28 0.92 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.391 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.87 -21.94 32.26 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.679 2.252 . . . . 0.0 111.813 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.489 ' CZ2' ' CG1' ' A' ' 90' ' ' VAL . 38.7 p90 -72.76 -28.8 62.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.2 tp -66.68 -36.27 82.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 90.6 mtp -66.85 -33.07 74.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 109.55 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -94.79 141.15 28.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 109.454 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.8 79.52 68.21 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.14 -0.975 . . . . 0.0 109.612 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.96 143.58 50.31 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.656 2.238 . . . . 0.0 111.782 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.6 tp . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.483 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.575 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.4 Cg_endo -70.15 154.91 65.76 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.745 2.296 . . . . 0.0 111.707 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.524 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 17.2 mt -81.45 179.92 7.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.33 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -110.48 139.13 46.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.89 148.65 32.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.488 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.435 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 79.3 tt0 -129.23 116.08 18.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -0.86 . . . . 0.0 109.37 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 14' ' ' ILE . 59.4 mt -111.72 127.31 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.14 -0.975 . . . . 0.0 109.592 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HG3' HG23 ' A' ' 14' ' ' ILE . 54.4 mttp 57.88 24.76 11.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.288 -0.882 . . . . 0.0 109.599 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.435 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.52 -10.69 72.54 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 50.0 m -79.72 125.51 29.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -1.105 . . . . 0.0 109.312 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' O ' HD21 ' A' ' 19' ' ' LEU . 3.3 ttmt -88.81 117.34 27.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.527 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.635 ' CD1' ' CE1' ' A' ' 36' ' ' PHE . 73.3 mt -136.54 156.52 48.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.868 . . . . 0.0 109.363 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -84.72 151.75 24.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.461 ' HB3' ' CD2' ' A' ' 85' ' ' LEU . . . -133.69 -179.76 5.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.936 . . . . 0.0 109.578 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.575 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 67.5 m-70 -134.24 131.16 38.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.901 . . . . 0.0 109.599 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.524 ' HB2' ' CD1' ' A' ' 10' ' ' LEU . 64.4 t90 -88.33 119.04 28.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.264 -0.898 . . . . 0.0 109.352 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -128.21 103.02 6.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.297 -0.877 . . . . 0.0 109.427 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.516 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 21.4 t -55.83 -31.84 63.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.646 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.27 -37.51 91.96 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.463 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -68.03 144.94 54.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -1.192 . . . . 0.0 109.517 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.517 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 39.7 p -113.13 -5.6 13.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.459 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.8 tt -141.8 146.28 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 0.0 109.423 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.466 ' HB ' HG22 ' A' ' 75' ' ' VAL . 51.7 m -66.73 141.17 57.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 0.0 109.633 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.525 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -126.66 136.41 52.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.531 ' CG2' HD12 ' A' ' 37' ' ' LEU . 25.0 m -132.38 165.02 39.31 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.831 . . . . 0.0 108.899 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.4 Cg_endo -78.23 129.84 9.81 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.115 1.876 . . . . 0.0 111.419 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 81.3 tt0 -40.87 -27.82 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.53 -0.731 . . . . 0.0 109.891 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -50.79 -28.33 9.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.538 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.635 ' CE1' ' CD1' ' A' ' 19' ' ' LEU . 15.0 m-85 -96.36 -7.76 34.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 109.528 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.64 ' CD2' ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -108.11 -5.43 16.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.797 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 93.7 mt-10 -48.66 -26.9 2.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.103 -0.998 . . . . 0.0 109.291 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -121.96 26.13 8.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.943 . . . . 0.0 109.189 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.48 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 40.9 mm-40 -101.62 158.94 15.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.594 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.57 130.47 24.84 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.355 -0.84 . . . . 0.0 109.246 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 52.3 Cg_endo -71.3 119.73 6.48 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 122.626 2.218 . . . . 0.0 111.822 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.495 HG13 ' N ' ' A' ' 44' ' ' GLN . 37.9 pt -73.77 -34.36 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.89 . . . . 0.0 109.117 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.495 ' N ' HG13 ' A' ' 43' ' ' ILE . 89.7 mt-30 -140.05 157.26 45.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.356 -0.84 . . . . 0.0 109.033 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 33.0 p -125.99 157.36 38.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 109.757 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.3 mtp -132.94 146.7 52.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 0.0 109.328 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 tp -102.93 127.66 50.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.932 . . . . 0.0 109.531 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 48' ' ' ILE . 70.3 mt -116.63 137.42 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.352 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.1 tttt -126.29 130.24 50.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.548 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.6 p -128.8 158.12 39.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.44 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.1 tt -56.06 -34.46 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.913 . . . . 0.0 109.458 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -68.43 -40.73 81.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.521 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.52 -170.01 41.84 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -99.15 134.2 42.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -1.141 . . . . 0.0 109.553 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -115.67 145.92 42.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.283 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -114.04 123.09 48.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.73 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.507 ' CG ' HD12 ' A' ' 76' ' ' LEU . 2.2 tp60 -126.56 132.62 51.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.341 -0.849 . . . . 0.0 109.393 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 45.0 m-20 -121.07 153.99 36.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.249 -0.907 . . . . 0.0 109.304 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' ' 44' ' ' GLN . 5.9 m -98.61 150.58 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.444 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.64 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 25.5 m-85 -128.6 127.06 41.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.87 . . . . 0.0 109.794 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -87.14 114.12 23.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.887 . . . . 0.0 108.776 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.452 HD21 ' HG3' ' A' ' 40' ' ' GLU . 32.4 mt -120.89 163.45 18.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.133 -0.979 . . . . 0.0 110.235 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.539 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 41.5 m -124.24 121.12 34.17 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.526 ' CE2' HG23 ' A' ' 66' ' ' VAL . 22.0 p90 -145.4 164.17 32.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.951 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -90.87 132.95 35.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.414 -0.804 . . . . 0.0 109.339 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.526 HG23 ' CE2' ' A' ' 64' ' ' PHE . 38.3 t -111.4 98.3 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.552 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 88.0 mt-30 63.35 36.28 11.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.325 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.45 35.08 18.13 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -141.98 124.59 15.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -1.1 . . . . 0.0 109.39 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -69.68 122.44 19.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.448 ' HB ' HG22 ' A' ' 66' ' ' VAL . 39.6 t -141.14 134.79 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.887 . . . . 0.0 109.556 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.539 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 52.1 mt-10 -125.77 132.59 52.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.557 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.29 -176.99 5.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.474 ' O ' HG22 ' A' ' 75' ' ' VAL . 93.9 mt-10 -79.82 154.03 28.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.273 -0.892 . . . . 0.0 109.091 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.53 HG13 ' CG2' ' A' ' 32' ' ' VAL . 56.0 t -144.83 157.64 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.188 -0.945 . . . . 0.0 109.748 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.507 HD12 ' CG ' ' A' ' 57' ' ' GLN . 16.4 tp -117.58 144.4 45.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 109.041 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.97 137.46 36.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 109.529 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.468 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 3.2 t -142.31 150.23 54.35 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.332 -0.855 . . . . 0.0 109.471 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.462 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 52.8 Cg_endo -72.68 5.71 2.76 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.602 2.202 . . . . 0.0 111.905 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.468 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 54.5 m-85 -64.73 -178.94 0.45 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -118.87 14.68 13.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.471 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.571 ' CZ ' ' HG ' ' A' ' 84' ' ' LEU . 20.5 p90 -142.28 -156.99 0.73 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 108.972 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.56 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 2.8 mt -128.84 128.28 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.25 -0.906 . . . . 0.0 109.812 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.571 ' HG ' ' CZ ' ' A' ' 82' ' ' TYR . 1.7 mt -83.86 136.91 33.93 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.2 -0.937 . . . . 0.0 108.713 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.522 ' CD1' HD13 ' A' ' 10' ' ' LEU . 5.2 mt -102.13 143.57 31.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 0.0 110.049 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 28' ' ' THR . 10.3 t-20 -102.54 133.12 20.68 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.472 -0.768 . . . . 0.0 109.133 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.483 ' HD2' ' OD1' ' A' ' 86' ' ' ASN . 44.2 Cg_endo -66.05 -30.27 47.67 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.759 2.306 . . . . 0.0 111.929 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.7 m -76.21 -31.75 58.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.162 -0.961 . . . . 0.0 109.238 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -73.21 -28.3 62.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.382 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.534 HG13 ' CZ2' ' A' ' 92' ' ' TRP . 2.2 m -124.1 77.83 59.45 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.552 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.5 Cg_endo -70.14 -20.45 33.03 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.731 2.287 . . . . 0.0 111.972 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.552 ' CZ3' ' HD2' ' A' ' 91' ' ' PRO . 48.8 p90 -80.99 -27.45 35.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.487 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 3.4 tm? -57.95 -37.91 75.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 109.391 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 71.5 mtm -81.62 131.68 35.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.395 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -58.49 -33.11 69.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.462 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt 55.93 67.78 2.72 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.52 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.48 145.02 51.8 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.713 2.275 . . . . 0.0 111.776 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 24.0 tp . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.159 -0.963 . . . . 0.0 109.484 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.56 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.9 Cg_endo -70.45 160.71 48.57 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.732 2.288 . . . . 0.0 111.747 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mp -81.8 176.36 9.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.428 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -104.76 140.31 38.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.65 152.7 33.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.873 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 17' ' ' THR . 91.9 mt-10 -129.35 116.35 18.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 109.531 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.45 HG22 ' CD2' ' A' ' 36' ' ' PHE . 33.5 mt -109.88 128.76 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 109.401 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HG3' HG21 ' A' ' 14' ' ' ILE . 2.8 mtmt 58.71 22.32 9.84 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.178 -0.951 . . . . 0.0 109.55 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.72 -0.88 83.15 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 31.2 m -93.46 132.7 37.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -1.218 . . . . 0.0 109.479 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.501 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 25.7 tttt -83.05 121.15 26.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.51 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.501 ' CD2' ' O ' ' A' ' 18' ' ' LYS . 1.6 mm? -138.34 158.82 43.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.945 . . . . 0.0 109.545 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.495 ' HD3' ' CG ' ' A' ' 9' ' ' PRO . 46.2 mttt -82.48 147.01 28.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 85' ' ' LEU . . . -134.86 159.78 40.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.373 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.56 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 53.1 m-70 -123.06 133.97 54.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.42 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.577 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 63.5 t90 -95.29 121.81 37.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.598 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.448 ' CB ' HD21 ' A' ' 84' ' ' LEU . 61.1 t0 -131.07 103.79 6.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -0.881 . . . . 0.0 109.306 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.556 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 56.1 p -56.69 -16.84 7.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.58 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.92 -35.51 58.07 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.457 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -69.6 140.79 53.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -1.152 . . . . 0.0 109.594 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.8 p -107.02 -0.89 22.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 0.0 109.495 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.52 HG22 ' CD1' ' A' ' 76' ' ' LEU . 20.0 tt -144.26 152.52 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.232 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.525 ' CG2' HG11 ' A' ' 75' ' ' VAL . 34.5 m -65.99 149.9 49.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.501 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.436 ' HB3' ' CB ' ' A' ' 84' ' ' LEU . 13.1 t -123.06 141.66 51.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.173 -0.955 . . . . 0.0 109.121 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.533 ' CG1' ' HD2' ' A' ' 33' ' ' PRO . 74.3 t -143.43 145.9 33.72 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.412 -0.805 . . . . 0.0 109.308 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.533 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 55.4 Cg_endo -77.76 132.11 11.73 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.245 1.964 . . . . 0.0 111.447 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 33' ' ' PRO . 82.6 tt0 -41.59 -28.1 0.12 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.429 -0.794 . . . . 0.0 109.71 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -51.46 -30.21 18.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.145 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.45 ' CD2' HG22 ' A' ' 14' ' ' ILE . 7.2 m-85 -97.63 0.39 47.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 109.712 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.642 ' CD2' ' CG ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -113.01 -3.61 14.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.013 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -52.1 -24.12 6.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.127 -0.983 . . . . 0.0 109.433 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -126.14 27.7 6.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 108.96 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.452 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 52.0 mm-40 -103.23 173.05 6.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 109.945 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -132.76 128.22 20.73 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 109.207 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.578 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 53.7 Cg_endo -73.74 123.82 8.8 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.631 2.221 . . . . 0.0 111.917 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 44' ' ' GLN . 33.5 pt -85.31 -28.31 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.171 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.402 ' N ' HG13 ' A' ' 43' ' ' ILE . 93.6 mt-30 -143.89 166.57 24.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.879 . . . . 0.0 109.202 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 61.3 p -124.75 151.09 45.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.808 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.457 ' O ' ' HG3' ' A' ' 56' ' ' GLN . 64.9 mtt -138.68 142.31 38.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.337 -0.852 . . . . 0.0 109.324 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.2 tt -96.36 131.91 42.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.602 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.464 HD12 HG23 ' A' ' 48' ' ' ILE . 69.0 mt -118.59 133.54 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.365 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -113.98 136.22 53.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.56 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.8 p -129.15 158.27 39.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 109.512 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.437 HG21 ' N ' ' A' ' 52' ' ' HIS . 10.8 tp -56.52 -37.04 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.515 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.437 ' N ' HG21 ' A' ' 51' ' ' ILE . 58.8 t-80 -67.41 -37.9 83.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.521 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.67 -175.41 47.35 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -106.46 128.46 54.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -1.1 . . . . 0.0 109.545 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -131.27 137.55 48.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.91 . . . . 0.0 109.387 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 46' ' ' MET . 38.9 tt0 -114.34 130.44 56.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.194 -0.941 . . . . 0.0 109.673 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -120.64 159.62 24.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 109.213 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 52.6 m-20 -98.73 141.12 31.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.135 -0.978 . . . . 0.0 109.628 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.528 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 15.9 t -82.64 150.44 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.082 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.642 ' CG ' ' CD2' ' A' ' 37' ' ' LEU . 13.8 m-85 -131.43 135.49 47.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.121 -0.987 . . . . 0.0 109.99 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.517 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 46.5 t80 -99.83 113.65 26.31 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 61' ' ' TYR . 40.2 mt -122.46 169.35 11.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.524 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 97.8 m -120.7 116.48 25.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.483 ' CE2' HG23 ' A' ' 66' ' ' VAL . 22.6 p90 -136.41 158.19 45.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.057 -1.027 . . . . 0.0 109.773 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -89.98 129.12 36.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.322 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.483 HG23 ' CE2' ' A' ' 64' ' ' PHE . 11.7 t -105.99 101.88 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.917 . . . . 0.0 109.515 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 80.4 mt-30 64.32 38.98 7.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.895 . . . . 0.0 109.412 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.62 32.43 41.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.0 mtt-85 -138.33 114.51 10.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.442 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' C ' HG21 ' A' ' 71' ' ' VAL . 72.6 tttt -61.49 122.75 15.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.616 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.45 ' HB ' HG22 ' A' ' 66' ' ' VAL . 58.8 t -145.32 130.13 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.224 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.524 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 82.1 mt-10 -108.3 137.36 46.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 0.0 109.617 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.3 166.56 29.26 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.603 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.528 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 93.6 mt-10 -79.86 140.57 36.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.525 HG11 ' CG2' ' A' ' 30' ' ' THR . 10.2 m -131.16 153.19 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.635 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.537 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 5.2 mp -107.48 148.42 29.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.385 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.78 140.09 37.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 109.425 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.484 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -151.56 152.86 31.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.296 -0.877 . . . . 0.0 109.239 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.484 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.0 Cg_endo -70.57 2.49 3.94 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.528 2.152 . . . . 0.0 112.034 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 34.0 m-85 -65.88 170.38 5.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 109.438 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -114.43 21.19 14.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.365 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.449 ' C ' HG13 ' A' ' 83' ' ' ILE . 33.3 p90 -142.01 -166.5 2.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 109.143 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.449 HG13 ' C ' ' A' ' 82' ' ' TYR . 1.5 mt -132.02 118.62 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.923 . . . . 0.0 109.64 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.448 HD21 ' CB ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -82.61 134.45 35.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 108.987 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.502 ' CD2' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -97.31 142.26 29.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.065 -1.022 . . . . 0.0 109.763 -179.71 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.513 ' OD1' ' CD ' ' A' ' 87' ' ' PRO . 6.5 t-20 -90.11 135.57 29.84 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.033 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.565 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 41.5 Cg_endo -64.1 -33.14 62.71 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.805 2.337 . . . . 0.0 111.972 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.4 m -71.88 -28.02 63.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.118 -0.989 . . . . 0.0 109.107 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -79.17 -30.79 43.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 109.344 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.584 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -119.67 74.25 17.72 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.917 . . . . 0.0 109.328 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.565 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.9 Cg_endo -69.6 -18.92 37.49 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.749 2.299 . . . . 0.0 111.926 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.584 ' CZ2' ' CG1' ' A' ' 90' ' ' VAL . 48.9 p90 -81.21 -26.24 36.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.479 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.577 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 24.1 tp -60.47 -32.04 71.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.442 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 87.6 mtp -81.29 130.41 35.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.192 -0.943 . . . . 0.0 109.486 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -71.06 138.52 49.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.24 140.63 93.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.287 -0.883 . . . . 0.0 109.453 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.25 -20.73 32.17 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.696 2.264 . . . . 0.0 111.83 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.8 mt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.466 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 48.8 Cg_endo -69.89 158.48 56.64 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.568 2.179 . . . . 0.0 111.694 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.515 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 25.2 mt -90.6 -177.32 5.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.582 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -112.19 134.44 53.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.353 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.0 146.24 28.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -0.948 . . . . 0.0 109.5 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 17' ' ' THR . 65.4 tt0 -121.97 122.21 38.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.883 . . . . 0.0 109.224 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.497 HG23 HD13 ' A' ' 14' ' ' ILE . 43.2 mt -114.74 127.12 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.694 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 58.07 25.59 12.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.531 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 90.66 -13.69 65.0 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 52.8 m -79.78 131.85 36.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -1.21 . . . . 0.0 109.385 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.5 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 29.7 tttm -96.4 123.9 40.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 109.62 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.545 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 57.2 mt -143.32 162.67 35.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -89.43 146.93 24.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.928 . . . . 0.0 109.527 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.01 176.58 7.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.488 ' C ' ' CD2' ' A' ' 85' ' ' LEU . 59.5 m-70 -127.47 129.97 48.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.455 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.549 ' CZ2' ' HB3' ' A' ' 87' ' ' PRO . 20.6 t90 -83.17 122.54 28.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.683 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -127.52 96.28 4.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.341 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.467 ' HA ' ' HG3' ' A' ' 87' ' ' PRO . 17.3 t -53.68 -33.9 56.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.645 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.62 -35.65 86.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.32 137.22 57.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -1.166 . . . . 0.0 109.631 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.518 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 89.2 m -102.07 -9.43 20.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 109.381 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.418 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 20.1 tt -139.61 160.12 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.335 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.5 m -71.51 150.19 45.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.315 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.542 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -126.83 127.17 44.57 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -0.916 . . . . 0.0 108.998 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.546 ' CG1' ' HD2' ' A' ' 33' ' ' PRO . 53.8 t -126.92 147.37 61.11 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 109.176 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.546 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 55.5 Cg_endo -77.26 132.99 12.95 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.176 1.917 . . . . 0.0 111.914 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 33' ' ' PRO . 80.5 tt0 -43.01 -26.67 0.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.741 . . . . 0.0 109.701 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.48 -23.09 1.41 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.516 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.545 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 14.1 m-85 -102.44 -6.41 22.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.518 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.537 ' HA ' ' CG ' ' A' ' 40' ' ' GLU . 2.7 mm? -109.98 -5.36 15.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.198 -0.939 . . . . 0.0 109.558 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -45.27 -44.38 11.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.381 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -107.26 24.51 12.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.381 -0.824 . . . . 0.0 109.472 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.537 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 72.2 mm-40 -108.74 -171.35 1.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.796 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -146.54 129.47 8.03 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.455 -0.778 . . . . 0.0 109.144 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.579 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 49.6 Cg_endo -69.38 123.34 10.13 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 122.733 2.289 . . . . 0.0 111.87 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.0 pt -78.46 -27.3 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -0.842 . . . . 0.0 109.57 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.434 ' HB2' HG12 ' A' ' 59' ' ' VAL . 81.7 mt-30 -146.62 163.45 35.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 109.612 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 34.0 p -112.03 158.4 19.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.299 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 46.0 ttm -142.1 137.19 30.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 109.507 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.527 ' CD2' ' OE2' ' A' ' 54' ' ' GLU . 27.1 tp -94.47 129.13 41.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.575 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 71.5 mt -117.83 131.3 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.86 . . . . 0.0 109.44 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 15.6 tttp -125.58 119.89 29.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 0.0 109.428 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.49 -170.34 1.65 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 109.556 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.429 HG23 HD13 ' A' ' 51' ' ' ILE . 19.4 mm -78.22 -46.85 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -58.69 -38.87 79.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.0 -173.06 43.98 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.527 ' OE2' ' CD2' ' A' ' 47' ' ' LEU . 80.4 tt0 -113.28 131.02 56.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -1.078 . . . . 0.0 109.394 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.43 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 23.4 mttm -129.46 131.26 46.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 109.471 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.423 ' HB2' HD11 ' A' ' 47' ' ' LEU . 48.8 tt0 -102.49 128.47 49.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -128.28 154.27 46.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.483 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' HB3' ' CB ' ' A' ' 42' ' ' PRO . 67.4 m-20 -90.54 152.56 20.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.73 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.525 ' CG2' ' HB3' ' A' ' 74' ' ' GLU . 9.3 p -95.52 158.49 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.299 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.579 ' CE2' ' HD3' ' A' ' 42' ' ' PRO . 20.5 m-85 -136.83 126.35 25.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.852 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.54 ' CE1' ' HB3' ' A' ' 72' ' ' GLU . 41.3 t80 -91.36 119.4 31.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 108.844 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.487 ' CD1' HD11 ' A' ' 37' ' ' LEU . 64.4 mt -131.16 170.18 14.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.387 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.524 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 87.9 m -119.56 122.92 42.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.517 -0.739 . . . . 0.0 109.084 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.498 ' CE2' HG22 ' A' ' 66' ' ' VAL . 33.2 p90 -141.82 157.2 45.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 0.0 109.781 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 83.7 mttt -87.83 129.69 35.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.23 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.498 HG22 ' CE2' ' A' ' 64' ' ' PHE . 4.3 t -104.24 98.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 90.0 mt-30 62.93 35.34 13.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.898 . . . . 0.0 109.193 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.77 31.81 20.08 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 -136.84 111.62 8.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -1.125 . . . . 0.0 109.432 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -61.84 117.72 6.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.458 HG23 ' CH2' ' A' ' 92' ' ' TRP . 44.4 t -142.31 136.91 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 0.0 109.412 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.54 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 64.0 mt-10 -112.61 137.93 50.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.974 . . . . 0.0 109.388 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.21 166.31 29.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.83 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.525 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 96.3 mt-10 -81.43 136.15 35.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.228 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.483 ' HB ' ' CG2' ' A' ' 32' ' ' VAL . 17.5 m -125.55 148.03 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.181 -0.949 . . . . 0.0 109.731 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 32' ' ' VAL . 28.1 tp -94.05 143.05 26.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.853 . . . . 0.0 109.13 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.27 133.66 36.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.571 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 21.8 t -144.4 148.84 42.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.626 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.469 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.3 Cg_endo -70.36 1.79 4.49 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.728 2.285 . . . . 0.0 112.058 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.571 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 39.6 m-85 -63.34 172.72 1.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 109.432 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -113.36 21.29 15.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 109.579 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.577 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 13.1 p90 -144.87 -161.02 1.21 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.16 -0.963 . . . . 0.0 109.356 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.444 HG13 ' C ' ' A' ' 82' ' ' TYR . 2.2 mt -132.62 149.1 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.881 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.577 ' HG ' ' CE2' ' A' ' 82' ' ' TYR . 1.4 mt -109.21 131.82 54.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.865 . . . . 0.0 108.757 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -99.95 133.17 44.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.109 -0.994 . . . . 0.0 109.723 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 28' ' ' THR . 6.2 t-20 -88.18 136.23 32.21 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 0.0 109.146 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.549 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 41.8 Cg_endo -64.34 -32.16 61.6 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.744 2.296 . . . . 0.0 111.881 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.2 m -72.32 -33.94 67.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 109.222 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -71.9 -34.11 68.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.313 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.475 HG13 ' CG1' ' A' ' 66' ' ' VAL . 33.5 m -115.84 76.56 6.07 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 109.55 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.431 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 48.6 Cg_endo -69.15 -21.63 36.04 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.698 2.265 . . . . 0.0 111.678 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.458 ' CH2' HG23 ' A' ' 71' ' ' VAL . 36.4 p90 -70.66 -26.32 63.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.314 -0.866 . . . . 0.0 109.469 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.6 tp -78.05 -34.16 50.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.474 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 95.2 mtp -67.24 -29.46 69.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.508 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -75.67 139.54 42.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.24 -0.913 . . . . 0.0 109.4 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.484 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -128.61 80.89 71.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.748 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.12 -18.18 35.5 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.613 2.208 . . . . 0.0 111.68 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.5 tp . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 109.469 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.574 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.3 Cg_endo -70.25 153.09 66.99 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.674 2.249 . . . . 0.0 111.736 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.459 HD12 HD12 ' A' ' 85' ' ' LEU . 15.3 mt -79.83 -174.63 4.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.445 ' OE2' ' HE3' ' A' ' 18' ' ' LYS . 75.9 tt0 -113.65 137.2 51.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 109.501 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.3 142.25 25.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -120.65 118.02 29.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.508 HG21 ' CD1' ' A' ' 36' ' ' PHE . 36.6 mt -109.49 129.46 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.507 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.0 mttt 54.52 24.83 5.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.9 . . . . 0.0 109.5 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.06 -10.81 72.79 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.5 ' CG2' HD13 ' A' ' 19' ' ' LEU . 4.3 m -80.31 126.94 31.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -1.183 . . . . 0.0 109.422 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.445 ' HE3' ' OE2' ' A' ' 11' ' ' GLU . 39.1 tttt -85.93 125.16 33.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.347 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.5 HD13 ' CG2' ' A' ' 17' ' ' THR . 1.9 mp -146.21 156.03 43.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 109.587 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -80.16 152.13 29.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 0.0 109.507 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.46 ' CB ' HD23 ' A' ' 85' ' ' LEU . . . -136.92 169.56 17.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 85.1 m-70 -127.41 138.84 53.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 109.463 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.629 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 40.0 t90 -91.08 114.1 26.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.206 -0.934 . . . . 0.0 109.408 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -121.57 100.1 6.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 109.382 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.563 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 59.8 p -60.8 -25.66 66.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.758 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.64 -41.59 95.76 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -67.77 140.97 56.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.194 -1.18 . . . . 0.0 109.538 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.435 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 68.6 p -99.59 -10.27 22.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.893 . . . . 0.0 109.384 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.434 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 19.7 tt -139.06 159.79 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.272 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.509 ' CG2' HG13 ' A' ' 75' ' ' VAL . 85.4 m -67.53 153.26 44.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 109.671 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -131.21 116.81 18.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.072 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.553 ' CG1' ' HD2' ' A' ' 33' ' ' PRO . 54.0 t -114.07 147.71 38.41 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.553 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 55.4 Cg_endo -77.4 132.04 12.07 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.094 1.862 . . . . 0.0 111.664 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 33' ' ' PRO . 82.1 tt0 -41.77 -27.67 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.467 -0.77 . . . . 0.0 109.801 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -50.56 -31.64 16.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.525 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.508 ' CD1' HG21 ' A' ' 14' ' ' ILE . 14.3 m-85 -98.47 -3.24 37.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.665 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.622 ' CD2' ' CG ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -110.95 13.25 22.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.797 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -60.94 -22.52 64.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.069 -1.019 . . . . 0.0 109.255 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -128.5 27.36 5.56 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.314 -0.866 . . . . 0.0 108.724 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.487 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 57.3 mm-40 -99.43 162.3 13.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.407 -0.808 . . . . 0.0 109.815 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.88 129.4 24.59 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.458 -0.776 . . . . 0.0 109.216 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.58 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 54.2 Cg_endo -73.42 123.92 9.02 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.556 2.171 . . . . 0.0 112.008 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.424 HG13 ' N ' ' A' ' 44' ' ' GLN . 24.3 pt -83.51 -31.27 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 109.246 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.492 ' NE2' ' HE3' ' A' ' 46' ' ' MET . 13.3 pt20 -143.07 175.64 9.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.831 . . . . 0.0 109.255 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 77.3 p -128.45 155.48 44.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.703 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.517 ' HG3' ' CG2' ' A' ' 59' ' ' VAL . 63.5 mtt -142.15 147.37 36.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.345 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.52 ' CD1' ' HB2' ' A' ' 56' ' ' GLN . 21.5 tp -98.64 126.9 44.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.15 -0.969 . . . . 0.0 109.541 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.447 HG21 HD13 ' A' ' 48' ' ' ILE . 29.0 mm -116.27 135.26 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.915 . . . . 0.0 109.423 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -109.08 135.42 50.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.2 p -128.53 158.14 39.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.528 HG22 ' CD2' ' A' ' 52' ' ' HIS . 15.3 tt -53.18 -41.01 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.928 . . . . 0.0 109.497 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.528 ' CD2' HG22 ' A' ' 51' ' ' ILE . 48.2 m170 -63.23 -35.55 80.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.554 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.13 -176.42 43.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -93.36 133.65 36.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.132 . . . . 0.0 109.405 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -131.94 133.97 45.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.52 ' HB2' ' CD1' ' A' ' 47' ' ' LEU . 48.9 tt0 -107.8 128.22 54.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 109.663 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -125.35 161.24 27.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.173 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' HB3' ' CB ' ' A' ' 42' ' ' PRO . 59.8 m-20 -96.71 142.06 29.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.933 . . . . 0.0 109.716 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.521 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 12.9 t -83.85 151.11 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.046 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.622 ' CG ' ' CD2' ' A' ' 37' ' ' LEU . 12.4 m-85 -131.72 137.7 48.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.087 -1.008 . . . . 0.0 109.902 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.467 ' O ' HD21 ' A' ' 62' ' ' LEU . 44.3 t80 -100.67 113.11 25.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.849 . . . . 0.0 108.771 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.467 HD21 ' O ' ' A' ' 61' ' ' TYR . 44.6 mt -122.46 173.02 7.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.105 -0.997 . . . . 0.0 110.276 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.518 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 86.6 m -124.01 125.48 44.63 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 9.4 p90 -144.68 157.81 44.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.888 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -88.38 130.52 35.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.418 -0.801 . . . . 0.0 109.292 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.46 ' CG2' ' CE2' ' A' ' 64' ' ' PHE . 74.4 t -110.77 104.47 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 86.7 mt-30 63.13 35.17 13.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.331 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.77 31.95 34.59 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -137.54 116.53 12.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -1.139 . . . . 0.0 109.477 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -62.13 121.0 11.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.461 HG21 ' CH2' ' A' ' 92' ' ' TRP . 87.3 t -142.69 129.05 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.88 . . . . 0.0 109.498 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.518 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 35.8 mt-10 -108.59 136.47 48.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.19 169.98 22.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 109.619 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.521 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 95.4 mt-10 -80.41 135.89 36.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.509 HG13 ' CG2' ' A' ' 30' ' ' THR . 5.0 m -126.76 152.22 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 109.631 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 32' ' ' VAL . 20.7 tp -105.42 149.13 26.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.109 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.58 137.3 37.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 109.196 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.581 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 23.3 t -148.7 149.57 31.14 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.926 . . . . 0.0 109.669 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.479 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 54.5 Cg_endo -72.88 6.88 2.23 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.661 2.241 . . . . 0.0 111.985 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.581 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 30.7 m-85 -60.52 -178.99 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.613 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -119.93 20.73 12.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.927 . . . . 0.0 109.325 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.559 ' CZ ' ' HG ' ' A' ' 84' ' ' LEU . 13.3 p90 -153.61 -152.35 0.41 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.275 -0.89 . . . . 0.0 108.894 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.533 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 1.7 mt -132.35 125.58 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.785 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.559 ' HG ' ' CZ ' ' A' ' 82' ' ' TYR . 1.2 mt -82.94 143.27 30.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.218 -0.926 . . . . 0.0 108.93 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.46 HD23 ' CB ' ' A' ' 21' ' ' ALA . 3.9 mt -109.73 135.3 50.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -0.978 . . . . 0.0 109.929 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.522 ' OD1' ' CD ' ' A' ' 87' ' ' PRO . 4.4 t30 -91.16 136.65 26.99 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 109.125 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.522 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 43.5 Cg_endo -64.6 -36.96 39.75 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.781 2.32 . . . . 0.0 112.034 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.418 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 3.1 m -70.38 -32.47 70.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.121 -0.987 . . . . 0.0 109.303 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.455 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 81.8 m-20 -71.84 -29.2 64.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.352 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.623 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -118.81 74.92 12.98 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.314 -0.866 . . . . 0.0 109.531 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.59 -21.99 28.89 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.747 2.298 . . . . 0.0 111.801 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.623 ' CZ2' ' CG1' ' A' ' 90' ' ' VAL . 40.8 p90 -76.28 -28.31 56.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 0.0 109.49 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.629 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 38.6 tp -56.36 -40.45 74.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.461 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 69.8 mtm -93.3 135.2 34.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 109.48 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -106.46 146.85 30.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.428 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -64.38 153.85 85.25 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.4 143.84 48.9 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.695 2.263 . . . . 0.0 111.735 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.5 tp . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.414 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.09 151.55 67.23 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.668 2.246 . . . . 0.0 111.722 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 23' ' ' TRP . 4.3 mp -85.0 165.84 17.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.514 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -103.46 144.13 31.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 109.428 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.7 148.11 22.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 64' ' ' PHE . 78.1 tt0 -121.02 121.08 37.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.581 ' HB ' ' CE1' ' A' ' 36' ' ' PHE . 42.4 mt -111.93 127.71 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HG3' HG23 ' A' ' 14' ' ' ILE . 3.6 mtmt 54.5 25.82 6.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 93.29 -15.81 62.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.53 ' CG2' HD13 ' A' ' 19' ' ' LEU . 2.3 m -79.85 126.07 30.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -1.181 . . . . 0.0 109.312 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.451 ' C ' ' CD1' ' A' ' 19' ' ' LEU . 31.4 tttt -94.26 116.9 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.0 109.63 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.53 HD13 ' CG2' ' A' ' 17' ' ' THR . 9.4 mp -135.09 166.09 23.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.306 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -80.32 155.03 27.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.449 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 83' ' ' ILE . . . -141.27 163.03 34.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 109.482 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.497 ' C ' ' CD2' ' A' ' 85' ' ' LEU . 70.0 m-70 -125.38 136.84 53.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.559 ' CZ2' ' HB3' ' A' ' 87' ' ' PRO . 26.2 t90 -85.58 126.67 34.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.422 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -133.58 100.63 4.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.507 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 60.4 p -62.39 -29.21 70.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.495 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.2 -33.25 64.61 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.414 ' O ' ' OD1' ' A' ' 86' ' ' ASN . . . -73.81 140.34 45.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -1.129 . . . . 0.0 109.418 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 28' ' ' THR . 87.4 m -100.36 -5.27 27.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.633 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.486 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 21.2 tt -146.67 149.3 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.507 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.477 ' N ' ' HB2' ' A' ' 86' ' ' ASN . 86.4 m -52.47 150.79 4.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.634 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -128.03 136.98 51.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.193 -0.942 . . . . 0.0 109.212 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.548 ' CG1' ' HD2' ' A' ' 33' ' ' PRO . 56.9 t -138.61 147.43 54.75 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 109.172 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.548 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 54.8 Cg_endo -77.66 132.21 11.91 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.123 1.882 . . . . 0.0 111.308 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 37' ' ' LEU . 79.9 tt0 -41.87 -27.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.759 . . . . 0.0 109.833 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -48.41 -24.53 1.28 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.14 -0.975 . . . . 0.0 109.308 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.581 ' CE1' ' HB ' ' A' ' 14' ' ' ILE . 7.6 m-85 -97.03 -9.38 28.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.646 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.512 HD11 ' CD2' ' A' ' 60' ' ' TYR . 2.8 mm? -107.83 9.26 28.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 109.628 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -59.23 -37.75 78.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 109.265 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -113.84 27.28 9.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.895 . . . . 0.0 109.249 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.481 ' HB2' HD11 ' A' ' 37' ' ' LEU . 73.3 mm-40 -117.17 -170.1 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.378 -0.826 . . . . 0.0 109.634 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 -148.01 132.02 8.55 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.177 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 50.0 Cg_endo -70.87 124.8 10.95 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.654 2.236 . . . . 0.0 111.908 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 44' ' ' GLN . 41.2 pt -76.61 -32.86 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.274 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.488 ' N ' HG13 ' A' ' 43' ' ' ILE . 97.5 mt-30 -146.16 174.01 11.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 0.0 109.381 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 36.6 p -119.9 159.78 23.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.603 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.3 ttm -134.86 141.76 46.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.908 . . . . 0.0 109.409 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.0 mp -92.04 132.63 36.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.544 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.5 mt -120.38 132.87 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 109.304 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -118.28 129.76 55.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.56 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.12 179.72 4.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.531 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.7 mt -69.92 -49.25 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.362 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -56.92 -42.03 79.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.467 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.53 -169.51 39.37 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -109.32 133.65 52.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.216 -1.167 . . . . 0.0 109.527 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -127.57 150.65 49.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.87 . . . . 0.0 109.337 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -114.17 142.1 46.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.153 -0.967 . . . . 0.0 109.507 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -133.95 168.11 19.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -0.863 . . . . 0.0 109.345 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.482 ' HB3' ' CB ' ' A' ' 42' ' ' PRO . 63.4 m-20 -107.14 150.67 26.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.762 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.483 HG12 ' CD2' ' A' ' 76' ' ' LEU . 13.7 m -101.03 152.05 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.272 -0.892 . . . . 0.0 109.193 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.575 ' CE1' ' HB3' ' A' ' 42' ' ' PRO . 11.1 m-85 -130.93 122.63 27.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -0.994 . . . . 0.0 109.731 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 39.7 t80 -85.26 110.06 18.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 108.885 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 61' ' ' TYR . 53.1 mt -125.1 171.01 10.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 110.36 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.531 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 89.7 m -116.08 119.35 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 13' ' ' GLU . 17.3 p90 -136.07 154.22 51.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.037 . . . . 0.0 109.782 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.462 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 45.3 mttm -90.69 127.04 36.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.341 -0.849 . . . . 0.0 109.411 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 18.9 t -101.5 101.55 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 109.614 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 92.9 mt-30 62.87 33.13 15.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.297 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.82 24.8 34.21 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 65' ' ' LYS . 67.3 mtt180 -126.72 120.09 28.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -1.165 . . . . 0.0 109.362 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.419 ' C ' HG22 ' A' ' 71' ' ' VAL . 58.2 tttt -67.0 117.05 8.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.403 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.419 HG22 ' C ' ' A' ' 70' ' ' LYS . 86.0 t -141.15 130.85 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.531 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 58.4 mt-10 -111.78 135.44 52.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.589 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.41 166.27 29.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.835 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 95.4 mt-10 -80.69 136.06 36.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.372 -0.83 . . . . 0.0 109.193 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.535 ' HB ' ' CG2' ' A' ' 32' ' ' VAL . 34.6 m -123.26 145.55 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.227 -0.921 . . . . 0.0 109.696 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.483 ' CD2' HG12 ' A' ' 59' ' ' VAL . 89.0 mt -90.53 143.9 26.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.091 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.34 135.64 36.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.0 . . . . 0.0 109.445 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.531 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 3.8 t -143.89 150.46 49.81 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 109.519 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.476 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 52.0 Cg_endo -72.46 5.99 2.52 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.665 2.244 . . . . 0.0 112.301 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.531 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 84.4 m-85 -71.37 167.51 19.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.056 -1.028 . . . . 0.0 109.527 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -107.79 17.05 22.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.66 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.576 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 15.6 p90 -137.19 -163.51 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 109.52 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 31' ' ' CYS . 4.0 mt -127.44 154.92 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -0.981 . . . . 0.0 109.744 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.576 ' HG ' ' CE2' ' A' ' 82' ' ' TYR . 1.3 mt -117.21 132.8 56.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.011 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.555 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -97.91 122.48 41.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.084 -1.01 . . . . 0.0 109.628 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.508 ' N ' ' OD2' ' A' ' 89' ' ' ASP . 26.2 t30 -79.54 142.36 57.67 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.435 -0.791 . . . . 0.0 109.098 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.559 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 47.0 Cg_endo -67.31 -23.47 44.66 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.512 2.141 . . . . 0.0 111.677 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.418 ' OG ' ' ND2' ' A' ' 86' ' ' ASN . 51.8 p -80.41 -33.85 36.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.373 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.522 ' OD1' ' CG1' ' A' ' 90' ' ' VAL . 2.2 p30 -74.78 -28.87 60.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.493 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.522 ' CG1' ' OD1' ' A' ' 89' ' ' ASP . 4.1 m -122.3 78.62 44.54 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.656 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.558 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.8 Cg_endo -71.68 -23.56 22.73 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.615 2.21 . . . . 0.0 111.822 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.558 ' CZ3' ' HD2' ' A' ' 91' ' ' PRO . 47.1 p90 -77.32 -33.09 55.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.593 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.547 HD21 ' CD1' ' A' ' 23' ' ' TRP . 21.9 tp -55.16 -31.95 61.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.511 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 71.1 mtm -84.58 122.58 29.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -57.75 -36.91 72.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.478 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 ptpt -66.01 128.56 93.91 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.535 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.66 147.06 62.7 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.769 2.313 . . . . 0.0 111.789 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.462 HD12 ' CB ' ' A' ' 91' ' ' PRO . 46.7 mt . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.505 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.6 Cg_endo -70.09 157.36 59.99 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.729 2.286 . . . . 0.0 111.709 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.46 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 25.2 mt -88.27 -175.11 4.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.505 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.58 141.58 50.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 109.403 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.34 149.29 26.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 51.9 tt0 -118.35 118.14 30.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.534 HG22 HD12 ' A' ' 14' ' ' ILE . 41.5 mt -111.11 128.7 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HG3' HG21 ' A' ' 14' ' ' ILE . 44.3 mttm 56.71 22.85 7.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.63 0.87 71.9 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.425 HG21 HD21 ' A' ' 19' ' ' LEU . 24.8 m -102.4 122.25 43.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -1.194 . . . . 0.0 109.457 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' O ' HD23 ' A' ' 19' ' ' LEU . 26.8 tttt -82.56 123.57 29.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.473 ' CB ' HD13 ' A' ' 83' ' ' ILE . 1.5 mm? -132.89 167.08 20.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -85.88 139.65 31.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.447 ' HB3' ' CD1' ' A' ' 85' ' ' LEU . . . -128.28 168.66 15.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.628 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.484 ' C ' ' CD2' ' A' ' 85' ' ' LEU . 47.6 m-70 -129.4 126.85 39.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.403 -0.811 . . . . 0.0 109.648 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.52 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 33.3 t90 -79.4 125.86 30.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.456 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -131.39 102.77 6.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.52 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 58.2 p -61.63 -31.68 71.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.629 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.08 -31.53 73.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.49 139.66 49.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -1.166 . . . . 0.0 109.615 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.434 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 35.0 p -106.02 -4.9 19.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.85 . . . . 0.0 109.554 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.511 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 19.7 tt -143.82 141.14 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.405 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.522 ' N ' ' HB2' ' A' ' 86' ' ' ASN . 23.4 m -54.92 137.42 45.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.731 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . 0.9 OUTLIER -125.94 128.63 47.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.524 HG21 ' CG2' ' A' ' 75' ' ' VAL . 25.2 m -127.83 163.44 43.26 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.584 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.8 Cg_endo -78.91 134.1 11.65 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.57 2.18 . . . . 0.0 111.688 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.472 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 81.1 tt0 -49.03 -22.89 0.98 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.616 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.6 -40.36 52.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.41 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.422 ' CD1' HG21 ' A' ' 14' ' ' ILE . 14.2 m-85 -86.85 -4.23 59.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.275 -0.89 . . . . 0.0 109.605 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.499 HD23 ' N ' ' A' ' 37' ' ' LEU . 3.8 mm? -89.4 18.7 5.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.234 -0.916 . . . . 0.0 109.844 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 37' ' ' LEU . 76.6 mt-10 -41.58 -57.58 2.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.343 -0.848 . . . . 0.0 108.905 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 p30 -96.22 38.99 1.16 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.605 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 21.2 pt-20 -41.29 132.71 2.55 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.536 0.684 . . . . 0.0 110.624 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.02 89.94 43.99 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 50.8 Cg_endo -70.01 125.95 12.6 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.703 2.269 . . . . 0.0 112.317 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.441 HD12 ' HB2' ' A' ' 61' ' ' TYR . 38.6 pt -109.74 -16.55 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.303 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 45' ' ' THR . 43.4 tt0 -143.12 166.55 24.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.212 -0.93 . . . . 0.0 109.457 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.516 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 61.2 p -116.74 151.27 36.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.402 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 46.5 ttm -145.49 144.03 30.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.563 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.402 HD11 ' OE2' ' A' ' 54' ' ' GLU . 8.9 tt -100.19 131.59 46.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.287 -0.883 . . . . 0.0 109.51 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 55' ' ' LYS . 30.6 mm -115.24 134.9 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.4 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -128.23 119.75 25.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.8 -177.32 3.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.453 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.7 mt -71.23 -50.51 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.347 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -49.88 -39.41 39.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.57 -175.62 47.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' OE2' HD11 ' A' ' 47' ' ' LEU . 61.7 tt0 -103.72 129.19 51.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -1.127 . . . . 0.0 109.431 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 48' ' ' ILE . 22.9 mttm -130.31 137.9 50.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.187 -0.945 . . . . 0.0 109.365 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -108.46 128.62 54.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.89 . . . . 0.0 109.674 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -125.35 159.9 30.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.262 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -92.5 163.79 13.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.524 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 29.4 t -101.48 139.29 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 108.896 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.605 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 3.1 m-85 -121.4 150.01 42.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.033 -1.042 . . . . 0.0 110.159 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.559 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 46.4 t80 -107.14 113.66 27.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 0.0 108.715 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.432 ' CD1' HG21 ' A' ' 75' ' ' VAL . 39.2 mt -116.28 162.21 17.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.115 -0.991 . . . . 0.0 110.343 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.533 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 20.4 m -120.12 118.24 30.04 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 14.3 p90 -144.07 154.98 43.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.022 -1.049 . . . . 0.0 109.937 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.462 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 47.9 mtmt -92.62 126.99 37.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.364 -0.835 . . . . 0.0 109.167 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 21.3 t -106.37 111.84 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.146 -0.971 . . . . 0.0 109.711 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 87.2 mt-30 62.98 37.22 11.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.54 25.28 63.44 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.1 mtt-85 -129.59 107.5 9.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 109.511 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 79.0 tttt -58.91 125.33 23.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.558 HG21 ' CH2' ' A' ' 92' ' ' TRP . 97.7 t -146.26 133.09 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 109.231 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.559 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 80.6 mt-10 -115.27 135.57 54.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 109.633 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.461 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . . . -160.36 173.38 15.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.389 -0.82 . . . . 0.0 109.674 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.524 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 94.4 mt-10 -79.79 143.97 33.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.85 . . . . 0.0 109.172 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.524 ' CG2' HG21 ' A' ' 32' ' ' VAL . 3.2 m -138.97 162.45 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.78 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.5 tp -113.23 145.73 40.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -0.827 . . . . 0.0 109.258 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.99 136.23 36.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.447 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.46 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 5.4 t -141.47 148.43 50.44 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 109.521 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.46 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 48.6 Cg_endo -69.87 -0.8 7.52 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.744 2.296 . . . . 0.0 111.774 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.511 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 31.5 m-85 -59.75 166.63 2.47 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.179 -0.951 . . . . 0.0 109.323 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -107.6 19.35 20.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.952 . . . . 0.0 109.86 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.59 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 25.7 p90 -142.48 -154.83 0.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.473 HD13 ' CB ' ' A' ' 19' ' ' LEU . 4.7 mt -130.15 144.51 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.997 -1.064 . . . . 0.0 109.777 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.59 ' HG ' ' CE2' ' A' ' 82' ' ' TYR . 1.3 mp -110.36 123.92 50.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.343 -0.848 . . . . 0.0 109.116 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.518 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -95.44 134.64 38.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.522 ' HB2' ' N ' ' A' ' 30' ' ' THR . 26.5 t30 -89.19 142.31 29.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.288 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.513 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 47.1 Cg_endo -67.41 -26.12 41.27 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.537 2.158 . . . . 0.0 111.79 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.2 m -78.08 -31.2 50.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.312 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 90' ' ' VAL . 2.1 p30 -77.01 -32.97 57.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.618 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -110.9 73.7 0.89 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.897 . . . . 0.0 109.394 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.573 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.0 Cg_endo -70.29 -24.36 27.34 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.743 2.295 . . . . 0.0 112.016 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.618 ' CZ2' ' CG1' ' A' ' 90' ' ' VAL . 44.4 p90 -71.43 -36.89 71.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.092 -1.005 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 92' ' ' TRP . 72.6 mt -50.23 -42.7 52.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.349 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 88.3 mtp -68.17 134.39 50.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.444 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -103.44 143.31 32.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.476 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -120.93 86.17 41.35 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.1 146.29 57.65 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.668 2.245 . . . . 0.0 111.8 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.5 tp . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 0.0 109.49 179.993 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.572 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.5 Cg_endo -70.05 148.42 63.17 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.748 2.299 . . . . 0.0 111.824 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 29.0 mt -81.06 -173.44 4.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.516 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.475 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 75.1 mm-40 -117.89 137.9 52.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 109.476 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.09 146.12 30.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.541 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -123.96 116.92 23.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.325 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.45 HG23 ' HG3' ' A' ' 15' ' ' LYS . 56.0 mt -112.83 130.41 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.933 . . . . 0.0 109.674 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HG3' HG23 ' A' ' 14' ' ' ILE . 95.9 mttt 52.22 23.47 2.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.318 -0.864 . . . . 0.0 109.621 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.31 -13.97 66.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.444 ' CG2' HD12 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -80.39 114.13 19.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -1.181 . . . . 0.0 109.427 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.46 ' O ' HD11 ' A' ' 19' ' ' LEU . 69.5 tttt -87.64 118.79 27.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 109.558 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.46 HD11 ' O ' ' A' ' 18' ' ' LYS . 9.3 mp -133.64 172.98 12.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.353 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.475 ' NZ ' ' OE2' ' A' ' 11' ' ' GLU . 16.0 mmtt -91.24 147.39 23.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.375 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 10' ' ' LEU . . . -133.15 174.3 10.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 109.698 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.572 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 79.7 m-70 -131.07 127.76 38.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.86 . . . . 0.0 109.379 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.555 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 35.5 t90 -76.39 117.4 18.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -124.58 100.72 6.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.317 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.555 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 28.5 p -62.81 -30.38 71.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.07 -39.46 80.04 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.15 140.6 58.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.141 . . . . 0.0 109.52 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.6 m -96.11 -13.0 23.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.498 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 74' ' ' GLU . 7.4 tp -143.94 162.85 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.265 -0.897 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 26.4 m -66.27 132.64 48.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.681 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.446 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 0.9 OUTLIER -119.22 126.79 52.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.382 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.527 ' CG2' ' CG1' ' A' ' 75' ' ' VAL . 3.6 m -127.91 167.21 19.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.406 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.1 Cg_endo -79.58 133.32 10.43 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.459 2.106 . . . . 0.0 111.639 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.463 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.5 tt0 -43.05 -27.23 0.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.34 -0.85 . . . . 0.0 109.571 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.3 -38.54 27.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.844 . . . . 0.0 109.576 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -87.91 -7.19 57.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 109.649 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 34' ' ' GLU . 12.0 mt -100.46 20.79 14.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.139 -0.976 . . . . 0.0 109.757 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 37' ' ' LEU . 72.0 mt-10 -43.74 -56.87 3.53 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 40' ' ' GLU . 45.1 m-20 -94.61 40.06 1.09 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.608 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 20.2 pt-20 -39.0 135.21 0.93 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.532 0.682 . . . . 0.0 110.394 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.83 81.66 70.33 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.516 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 48.7 Cg_endo -69.46 116.31 4.47 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.727 2.285 . . . . 0.0 112.186 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.8 pt -78.05 -31.64 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.091 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.463 ' O ' HG11 ' A' ' 59' ' ' VAL . 37.4 mt-30 -143.51 163.2 33.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.239 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 82.7 p -119.68 157.56 28.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.931 . . . . 0.0 109.522 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' GLN . 88.0 mtp -144.75 143.76 30.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.331 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -93.46 122.89 36.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.386 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.7 mm -118.09 127.68 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.608 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.446 ' HG2' ' HG2' ' A' ' 54' ' ' GLU . 21.8 mttp -107.01 137.44 45.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.415 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -124.65 179.36 5.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.94 . . . . 0.0 109.379 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.4 mt -64.34 -50.05 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 0.0 109.365 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -51.87 -46.84 64.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.464 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.81 -172.17 45.11 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 49' ' ' LYS . 96.1 mt-10 -84.94 135.55 34.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -1.139 . . . . 0.0 109.387 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -128.5 148.97 50.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -98.81 121.11 40.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.571 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.55 ' CG ' ' CD1' ' A' ' 76' ' ' LEU . 1.2 tp60 -118.58 132.86 56.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 69.5 m-20 -109.66 156.41 20.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 0.0 109.596 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 42' ' ' PRO . 12.5 p -98.51 136.36 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.289 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.608 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 3.7 m-85 -121.72 141.53 51.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.619 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -102.52 114.96 29.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.27 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.0 mt -119.32 160.93 21.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 110.029 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.526 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 11.4 m -121.78 116.88 25.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.478 -0.763 . . . . 0.0 109.137 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 8.2 p90 -142.98 161.72 37.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 109.668 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.473 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 12.5 mtmm -96.68 129.09 44.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.295 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 60.4 t -107.09 112.64 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.557 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 90.6 mt-30 63.48 33.53 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 109.403 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.37 23.63 58.29 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -127.98 111.45 13.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.319 -1.106 . . . . 0.0 109.408 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 80.5 tttt -61.04 121.23 11.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.612 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 70' ' ' LYS . 65.6 t -141.66 133.55 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 109.164 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.526 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 53.8 mt-10 -116.28 137.25 52.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 109.837 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.59 -169.7 2.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.439 -0.788 . . . . 0.0 109.379 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.534 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 98.2 mt-10 -79.96 171.36 15.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.094 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 74' ' ' GLU . 72.9 t -159.4 151.03 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.143 -0.973 . . . . 0.0 109.808 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.55 ' CD1' ' CG ' ' A' ' 57' ' ' GLN . 25.9 tp -121.32 143.62 49.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.43 -0.794 . . . . 0.0 109.282 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.77 133.41 36.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 109.602 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 1.4 t -138.68 150.91 67.53 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.859 . . . . 0.0 109.355 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.6 Cg_endo -72.28 1.97 5.51 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.624 2.216 . . . . 0.0 111.885 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.432 ' CE2' ' OG ' ' A' ' 78' ' ' SER . 47.9 m-85 -65.14 168.0 7.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.532 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.8 p30 -108.9 14.07 24.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.233 -0.917 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.58 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 17.7 p90 -136.34 -157.8 0.82 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 109.008 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.548 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.0 mt -129.09 144.7 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.056 -1.027 . . . . 0.0 109.707 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.58 ' HG ' ' CE2' ' A' ' 82' ' ' TYR . 6.2 mp -109.95 136.33 49.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.259 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.537 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -103.92 145.36 30.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.768 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.526 ' OD1' ' CD ' ' A' ' 87' ' ' PRO . 4.9 t30 -96.87 136.59 21.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.255 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.526 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.0 Cg_endo -63.45 -31.98 71.53 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.847 2.365 . . . . 0.0 111.94 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -75.24 -30.17 60.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.227 -0.921 . . . . 0.0 109.176 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -77.49 -30.83 53.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.326 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.525 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.6 OUTLIER -122.25 75.95 42.18 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 109.468 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.21 -24.95 27.03 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.637 2.225 . . . . 0.0 111.932 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.525 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 32.7 p90 -74.19 -28.47 61.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.137 -0.977 . . . . 0.0 109.481 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.495 HD11 ' CD1' ' A' ' 23' ' ' TRP . 9.6 tt -58.89 -36.91 75.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.485 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 87.5 mtp -78.65 149.56 32.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.496 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.01 154.21 19.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.407 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 97' ' ' PRO . 6.3 mtmt -115.04 159.31 38.22 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.168 -0.957 . . . . 0.0 109.511 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 96' ' ' LYS . 50.6 Cg_endo -70.49 -15.28 34.36 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.631 2.22 . . . . 0.0 111.768 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.4 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.444 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.573 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.3 Cg_endo -70.3 159.98 51.13 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.683 2.255 . . . . 0.0 111.637 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.457 HD13 HD13 ' A' ' 85' ' ' LEU . 4.6 mp -80.23 166.35 21.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.96 . . . . 0.0 109.525 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -103.63 148.74 25.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.558 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.38 151.22 20.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 64' ' ' PHE . 65.7 tt0 -119.62 121.71 39.91 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.409 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.539 ' HB ' ' CE2' ' A' ' 36' ' ' PHE . 44.6 mt -113.54 124.21 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 60.8 mttm 61.28 20.38 10.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 109.474 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.65 -12.89 68.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.0 m -88.52 131.11 35.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -1.145 . . . . 0.0 109.446 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.498 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 18.0 mttp -82.98 133.37 35.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.879 . . . . 0.0 109.492 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.498 ' CD2' ' O ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -144.64 159.82 42.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.87 . . . . 0.0 109.459 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -81.41 150.93 28.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.352 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.14 169.69 17.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 60.9 m-70 -130.5 136.89 49.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 109.644 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.611 ' CZ2' ' CG ' ' A' ' 94' ' ' MET . 64.3 t90 -95.17 118.91 32.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 109.431 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -130.17 104.24 7.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.528 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.575 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 60.4 p -56.22 -27.59 55.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.531 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.37 -36.5 93.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.415 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -64.55 143.58 57.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.458 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.511 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 59.4 m -108.36 -12.08 15.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.501 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.2 tt -142.64 155.35 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 34.4 m -71.38 136.45 47.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.608 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.525 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -120.84 131.9 54.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.423 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.515 ' CG2' HG23 ' A' ' 75' ' ' VAL . 15.4 m -121.72 161.17 43.33 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 82' ' ' TYR . 55.8 Cg_endo -79.27 129.57 8.73 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.583 2.189 . . . . 0.0 111.717 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.466 ' HG2' ' CB ' ' A' ' 77' ' ' ALA . 79.2 mt-10 -43.77 -26.93 0.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 109.362 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.77 -39.45 77.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.285 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.539 ' CE2' ' HB ' ' A' ' 14' ' ' ILE . 1.7 m-85 -83.7 -2.15 55.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.428 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 7.2 mt -99.43 23.43 9.36 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.154 -0.966 . . . . 0.0 109.741 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 37' ' ' LEU . 55.2 tt0 -44.27 -55.96 4.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.07 -1.019 . . . . 0.0 108.918 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -97.08 40.21 1.15 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.616 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 21.5 pt-20 -43.12 133.68 3.81 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.465 0.65 . . . . 0.0 110.361 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -127.29 87.03 57.34 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 48.3 Cg_endo -69.6 121.38 8.11 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.642 2.228 . . . . 0.0 112.235 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.3 pt -94.1 -31.44 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.522 -0.736 . . . . 0.0 109.058 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -135.18 176.95 8.2 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.371 -0.831 . . . . 0.0 109.136 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 69.1 p -127.51 156.54 42.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.21 -0.931 . . . . 0.0 109.595 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.512 ' HG3' ' CG2' ' A' ' 59' ' ' VAL . 84.1 mtp -143.65 144.83 32.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 109.345 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.439 HD23 ' HG2' ' A' ' 56' ' ' GLN . 12.1 mt -98.34 138.43 35.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.178 -0.951 . . . . 0.0 109.476 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 55' ' ' LYS . 74.5 mt -126.64 136.0 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.872 . . . . 0.0 109.43 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 78.6 tttt -124.41 135.37 53.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.541 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.0 p -129.92 158.26 40.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.457 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 52' ' ' HIS . 13.6 tt -53.99 -41.87 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 109.548 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.471 ' N ' ' CG2' ' A' ' 51' ' ' ILE . 97.1 m-70 -62.36 -37.19 84.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 109.578 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.28 -176.65 48.14 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 73.8 tt0 -107.61 128.81 54.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -1.107 . . . . 0.0 109.484 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 48' ' ' ILE . 76.2 mttt -130.23 143.34 50.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.852 . . . . 0.0 109.221 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.439 ' HG2' HD23 ' A' ' 47' ' ' LEU . 28.0 mt-30 -115.77 141.96 47.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.885 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -137.56 165.25 26.76 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.374 -0.828 . . . . 0.0 108.803 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 76.2 m-20 -103.76 162.1 13.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.029 . . . . 0.0 109.831 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.512 ' CG2' ' HG3' ' A' ' 46' ' ' MET . 12.0 t -100.46 139.35 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.616 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 4.0 m-85 -118.37 149.58 40.97 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.103 -0.998 . . . . 0.0 110.08 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.518 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 42.4 t80 -108.17 112.4 24.89 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 61' ' ' TYR . 34.2 mt -115.98 163.31 16.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.121 -0.987 . . . . 0.0 110.305 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.515 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 28.6 m -120.47 116.94 26.42 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 13.6 p90 -138.54 156.94 47.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 109.815 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -93.3 127.24 38.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.332 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 24.1 t -103.64 106.69 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.927 . . . . 0.0 109.564 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 91.2 mt-30 63.24 36.4 11.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.329 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.46 51.4 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -130.72 109.68 10.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -1.119 . . . . 0.0 109.325 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -59.65 123.34 16.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 109.697 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.6 t -143.49 129.37 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.312 -0.868 . . . . 0.0 109.329 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 49.3 mt-10 -111.5 135.36 52.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.96 . . . . 0.0 109.629 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . . . -160.26 170.48 21.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.345 -0.847 . . . . 0.0 109.589 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.491 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 95.0 mt-10 -79.76 146.17 32.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.234 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.515 HG23 ' CG2' ' A' ' 32' ' ' VAL . 3.7 m -138.77 164.36 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.161 -0.962 . . . . 0.0 109.85 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.436 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 21.2 tp -118.04 149.41 41.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.432 -0.793 . . . . 0.0 109.196 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.466 ' CB ' ' HG2' ' A' ' 34' ' ' GLU . . . -79.81 132.27 36.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 0.0 109.5 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.454 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.8 t -135.32 149.97 71.24 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.386 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.454 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.1 Cg_endo -70.73 0.59 6.15 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.808 2.338 . . . . 0.0 111.837 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -64.47 176.75 1.02 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.485 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -114.61 17.55 17.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.429 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.59 ' CZ ' ' HG ' ' A' ' 84' ' ' LEU . 23.6 p90 -142.27 -156.27 0.67 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.066 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.559 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.1 mt -128.1 124.21 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.612 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.59 ' HG ' ' CZ ' ' A' ' 82' ' ' TYR . 1.5 mt -80.18 133.14 36.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 108.981 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 22' ' ' HIS . 6.8 mt -101.41 144.2 30.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 109.934 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 28' ' ' THR . 9.5 t-20 -101.88 134.26 20.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.398 -0.814 . . . . 0.0 109.118 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.498 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 43.1 Cg_endo -64.48 -31.12 61.6 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.7 2.267 . . . . 0.0 111.903 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 m -75.67 -28.26 58.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.339 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 83.8 m-20 -77.81 -29.16 50.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 109.361 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.48 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -121.85 76.69 38.89 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.481 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.5 Cg_endo -69.82 -24.88 28.91 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.676 2.251 . . . . 0.0 111.766 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.48 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.2 p90 -75.98 -24.84 55.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.563 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.523 ' CD1' ' CD1' ' A' ' 23' ' ' TRP . 9.6 tt -62.46 -34.95 77.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 109.451 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.611 ' CG ' ' CZ2' ' A' ' 23' ' ' TRP . 93.8 mmm -103.67 136.11 43.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -80.34 141.94 34.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.596 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 49.47 62.41 12.09 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.678 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.74 149.71 61.06 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.682 2.255 . . . . 0.0 111.751 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 35.7 tp . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 109.486 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.564 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.0 Cg_endo -70.21 154.51 65.88 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.712 2.275 . . . . 0.0 111.811 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.466 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 28.7 mt -89.22 -171.17 3.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.408 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.08 137.37 54.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.364 -0.835 . . . . 0.0 109.455 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 65' ' ' LYS . . . -148.7 154.02 39.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.905 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 17' ' ' THR . 70.4 tt0 -123.2 115.5 21.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.873 . . . . 0.0 109.269 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 74.6 mt -109.6 127.41 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 69.9 mttt 60.22 21.82 11.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.52 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.66 -15.32 62.82 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 68.0 m -80.02 130.47 35.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -1.136 . . . . 0.0 109.316 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.459 ' O ' HD23 ' A' ' 19' ' ' LEU . 41.4 tttp -91.78 125.27 36.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.17 -0.956 . . . . 0.0 109.491 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.58 HD12 ' CZ ' ' A' ' 36' ' ' PHE . 97.8 mt -143.47 168.55 19.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.371 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -92.31 154.03 18.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.453 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.42 172.32 13.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.244 -0.91 . . . . 0.0 109.402 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 76.4 m-70 -125.63 123.97 40.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 109.458 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.583 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 55.4 t90 -76.92 122.06 24.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.552 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -130.06 103.62 6.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.583 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 52.2 p -61.23 -25.6 67.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.943 . . . . 0.0 109.524 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.1 89.05 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -72.9 141.17 47.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -1.194 . . . . 0.0 109.552 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.438 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 28.5 p -105.52 -3.17 22.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 0.0 109.559 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 74' ' ' GLU . 19.9 tt -145.51 147.94 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.323 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 38.2 m -61.56 133.13 55.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.905 . . . . 0.0 109.67 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.447 ' HB3' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -116.56 129.19 56.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 109.53 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.525 HG22 ' CG1' ' A' ' 75' ' ' VAL . 4.7 m -131.38 164.52 41.94 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.953 . . . . 0.0 109.358 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.8 Cg_endo -78.55 131.62 10.55 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.422 2.082 . . . . 0.0 111.483 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.3 tt0 -43.14 -26.7 0.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.945 . . . . 0.0 109.718 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.05 -36.44 18.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.58 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.58 ' CZ ' HD12 ' A' ' 19' ' ' LEU . 13.9 m-85 -88.82 -7.19 56.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 109.663 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.515 HD23 ' CB ' ' A' ' 40' ' ' GLU . 4.3 mt -94.93 23.35 5.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 110.027 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 37' ' ' LEU . 23.2 tp10 -44.99 -56.43 4.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.0 109.032 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 40' ' ' GLU . 13.8 p30 -97.45 36.89 1.42 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.594 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 21.4 pt-20 -39.38 131.07 1.66 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.536 0.684 . . . . 0.0 110.503 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -124.61 87.54 54.43 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.463 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 49.1 Cg_endo -69.87 117.73 5.26 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.653 2.236 . . . . 0.0 112.213 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.3 pt -91.37 -24.86 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.29 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -143.24 178.53 7.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.897 . . . . 0.0 109.495 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 71.6 p -120.91 149.72 42.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 109.595 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.445 ' HE2' ' CD1' ' A' ' 48' ' ' ILE . 61.3 ttp -137.75 145.19 42.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.89 . . . . 0.0 109.398 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 tt -110.39 130.92 55.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.455 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 32.4 mm -116.31 139.68 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.449 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -130.7 124.01 30.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.433 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.0 p -121.83 168.69 11.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.513 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.49 HG13 ' N ' ' A' ' 52' ' ' HIS . 24.1 pt -65.24 -39.38 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.598 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.49 ' N ' HG13 ' A' ' 51' ' ' ILE . 76.1 m80 -63.46 -33.3 75.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.607 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.66 -179.13 46.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -103.14 131.94 49.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -1.139 . . . . 0.0 109.437 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 8.0 mtmt -128.41 130.16 47.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.211 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -114.48 130.28 56.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.684 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -136.51 156.53 48.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.384 -0.822 . . . . 0.0 109.127 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 59.1 m-20 -86.77 165.24 16.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.995 . . . . 0.0 109.777 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 42' ' ' PRO . 41.3 t -99.5 139.59 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.367 -0.833 . . . . 0.0 108.945 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.594 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 3.9 m-85 -122.52 147.73 46.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.046 -1.034 . . . . 0.0 110.119 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -105.55 112.09 25.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.41 ' HB2' HG22 ' A' ' 75' ' ' VAL . 6.9 mp -116.38 161.28 19.3 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 110.155 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.525 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 18.1 m -121.39 117.33 26.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.513 -0.742 . . . . 0.0 109.057 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 6.1 p90 -140.08 156.83 46.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.085 -1.009 . . . . 0.0 109.939 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 80.6 mttt -91.91 127.86 37.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.385 -0.822 . . . . 0.0 109.239 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 58.1 t -108.27 109.44 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.606 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 85.3 mt-30 62.88 37.98 11.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.321 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.76 29.08 58.02 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -133.26 113.55 12.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -1.14 . . . . 0.0 109.332 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.461 ' HE2' HG21 ' A' ' 63' ' ' THR . 27.0 tttt -63.52 121.21 13.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.715 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 94.2 t -140.57 132.06 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.268 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.525 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 49.7 mt-10 -115.77 136.92 52.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.131 -0.981 . . . . 0.0 109.745 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.37 -169.65 2.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.432 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 95.9 mt-10 -80.02 165.66 22.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 0.0 109.153 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.525 ' CG1' HG22 ' A' ' 32' ' ' VAL . 94.7 t -152.58 156.77 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.92 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.43 141.31 52.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.53 -0.731 . . . . 0.0 109.213 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 37' ' ' LEU . . . -80.42 136.01 36.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -0.97 . . . . 0.0 109.43 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.466 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -143.91 151.67 53.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.466 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.2 Cg_endo -72.75 4.14 3.81 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.689 2.259 . . . . 0.0 111.864 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -65.6 171.72 3.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.157 -0.965 . . . . 0.0 109.392 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -113.72 17.63 18.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.409 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.589 ' CZ ' ' CD1' ' A' ' 84' ' ' LEU . 12.4 p90 -139.81 -159.38 0.95 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.261 -0.899 . . . . 0.0 109.032 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.51 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 2.5 mt -129.17 147.17 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.183 -0.948 . . . . 0.0 109.633 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' CD1' ' CZ ' ' A' ' 82' ' ' TYR . 6.6 mp -111.69 135.95 51.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.344 -0.847 . . . . 0.0 108.952 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -102.55 140.73 36.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.984 . . . . 0.0 109.867 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.508 ' OD1' ' CD ' ' A' ' 87' ' ' PRO . 8.9 t-20 -92.32 134.58 28.05 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.487 -0.758 . . . . 0.0 109.096 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.518 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.5 Cg_endo -64.03 -30.74 66.37 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.766 2.311 . . . . 0.0 111.946 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 m -74.68 -29.61 61.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.262 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -79.44 -29.32 41.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.43 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.621 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -122.88 74.82 47.63 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.379 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.7 -24.47 29.89 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.727 2.284 . . . . 0.0 111.812 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.621 ' CZ2' ' CG1' ' A' ' 90' ' ' VAL . 42.3 p90 -72.78 -29.87 63.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.5 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.477 ' CD1' ' HB ' ' A' ' 90' ' ' VAL . 73.4 mt -59.77 -38.01 80.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.51 ' O ' ' N ' ' A' ' 96' ' ' LYS . 65.0 mtt -51.95 -40.21 60.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.843 . . . . 0.0 109.605 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.6 mttm 45.12 -94.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.234 -0.916 . . . . 0.0 109.598 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 94' ' ' MET . 10.2 ttpt 64.69 60.89 1.39 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.114 -0.991 . . . . 0.0 109.485 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.6 147.44 57.47 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.667 2.245 . . . . 0.0 111.735 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.6 tp . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.412 179.933 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.569 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 47.9 Cg_endo -69.77 149.46 66.85 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.778 2.319 . . . . 0.0 111.912 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.516 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 29.4 mt -83.13 -176.24 6.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.467 ' OE2' ' CE ' ' A' ' 18' ' ' LYS . 72.3 tt0 -113.2 137.32 51.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.496 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.12 142.74 27.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 109.609 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -116.16 120.25 38.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.264 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.536 HD13 HG23 ' A' ' 14' ' ' ILE . 36.9 mt -111.53 129.14 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.601 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.459 ' HG3' HG22 ' A' ' 14' ' ' ILE . 32.5 mttm 51.84 24.39 2.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -0.878 . . . . 0.0 109.665 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.64 -4.72 79.63 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.485 HG23 ' CD1' ' A' ' 19' ' ' LEU . 13.1 m -87.98 128.85 35.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -1.196 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' CE ' ' OE2' ' A' ' 11' ' ' GLU . 19.3 tttt -86.8 121.75 29.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.492 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.586 ' CD2' ' CE1' ' A' ' 36' ' ' PHE . 5.2 mp -140.54 161.89 36.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.89 . . . . 0.0 109.458 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -88.37 155.36 19.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -0.922 . . . . 0.0 109.428 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HB3' ' CD2' ' A' ' 85' ' ' LEU . . . -139.23 176.87 8.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.569 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 64.9 m-70 -134.56 122.49 22.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.566 ' CG ' HD21 ' A' ' 93' ' ' LEU . 71.4 t90 -79.59 128.08 32.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.303 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -141.58 109.75 5.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.555 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.462 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 20.7 t -60.88 -27.18 67.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.77 -27.14 70.68 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -79.84 127.63 32.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -1.195 . . . . 0.0 109.48 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 m -95.33 -16.84 22.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 0.0 109.438 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 29' ' ' ILE . 21.1 tt -135.56 130.84 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 90.5 m -50.92 139.19 17.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.595 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -119.82 128.95 54.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.27 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.525 ' CG2' HD23 ' A' ' 37' ' ' LEU . 16.6 m -122.4 162.57 37.23 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 78' ' ' SER . 55.4 Cg_endo -78.67 131.35 10.27 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.466 2.111 . . . . 0.0 111.623 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.53 ' HG2' ' CB ' ' A' ' 77' ' ' ALA . 96.8 mt-10 -42.9 -27.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 109.548 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -47.46 -43.02 23.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.77 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.586 ' CE1' ' CD2' ' A' ' 19' ' ' LEU . 21.4 m-85 -84.98 -6.32 59.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.102 -0.999 . . . . 0.0 109.756 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.528 HD12 ' CB ' ' A' ' 40' ' ' GLU . 4.3 mm? -92.48 18.09 9.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.168 -0.958 . . . . 0.0 109.678 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 37' ' ' LEU . 68.7 mt-10 -44.25 -54.17 5.97 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 40' ' ' GLU . 18.7 p30 -99.41 37.16 1.62 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.607 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 19.0 pt-20 -38.69 134.11 0.98 Allowed 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.53 0.681 . . . . 0.0 110.513 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.5 mtp85 -128.42 83.37 66.35 Favored Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 48.5 Cg_endo -68.59 117.25 4.86 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.842 2.361 . . . . 0.0 112.341 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.1 pt -91.17 -28.95 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.391 -0.818 . . . . 0.0 109.04 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -141.36 157.05 45.7 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.483 -0.76 . . . . 0.0 109.183 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.0 p -120.44 154.58 35.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.124 -0.985 . . . . 0.0 109.674 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 63.0 mtt -140.85 142.65 34.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.408 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.4 tp -96.59 127.45 42.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 55' ' ' LYS . 29.4 mm -113.9 132.51 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.555 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -110.57 133.11 53.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.74 179.38 4.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.44 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 54.2 mt -68.75 -49.92 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -54.11 -47.74 71.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.458 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.69 -162.41 25.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -100.51 132.4 45.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -1.119 . . . . 0.0 109.436 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 48' ' ' ILE . 22.8 tptm -120.58 136.92 54.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.357 -0.839 . . . . 0.0 109.452 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -104.42 122.84 46.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.608 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.02 145.24 46.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.256 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.536 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 78.9 m-20 -101.21 155.92 17.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.486 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 44.6 t -99.09 134.19 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.146 -0.971 . . . . 0.0 109.125 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.607 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 3.4 m-85 -122.61 147.41 46.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.161 -0.962 . . . . 0.0 109.61 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 32.9 t80 -104.88 115.5 30.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 108.961 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 61' ' ' TYR . 18.9 mt -121.47 156.52 32.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 110.08 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.522 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 67.9 m -115.31 125.68 53.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 18.1 p90 -149.02 151.23 34.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.082 -1.011 . . . . 0.0 109.681 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -85.28 133.32 34.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.323 -0.861 . . . . 0.0 109.198 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 40.1 t -109.58 112.64 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 93.7 mt-30 61.33 20.96 11.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.86 . . . . 0.0 109.468 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.64 21.77 18.19 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.529 ' HG2' ' CG2' ' A' ' 71' ' ' VAL . 6.6 ttt85 -126.86 116.82 21.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -1.057 . . . . 0.0 109.068 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -64.55 116.07 5.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 109.367 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.529 ' CG2' ' HG2' ' A' ' 69' ' ' ARG . 55.4 t -138.12 134.97 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 109.481 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.551 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 80.6 mt-10 -111.05 140.35 45.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.3 168.99 24.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.624 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.486 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 95.8 mt-10 -79.84 141.06 36.55 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.393 -0.817 . . . . 0.0 109.079 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.8 m -138.18 163.46 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.186 -0.946 . . . . 0.0 109.775 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.1 tp -117.39 146.85 43.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.53 ' CB ' ' HG2' ' A' ' 34' ' ' GLU . . . -79.75 126.01 30.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.386 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.474 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.1 t -133.06 152.18 79.23 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.474 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.474 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 48.9 Cg_endo -69.6 -0.82 7.33 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.605 2.203 . . . . 0.0 111.779 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -58.78 169.86 0.91 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.384 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -111.97 22.32 15.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.58 ' CE2' HD12 ' A' ' 84' ' ' LEU . 19.2 p90 -148.14 -159.32 1.01 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.417 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.477 HG23 ' CG1' ' A' ' 32' ' ' VAL . 4.0 mt -125.22 140.64 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.735 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.58 HD12 ' CE2' ' A' ' 82' ' ' TYR . 6.9 mp -106.35 130.59 54.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.32 -0.863 . . . . 0.0 109.039 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -111.48 135.18 52.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.624 -179.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.531 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 6.8 p-10 -97.55 158.17 33.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.243 -0.91 . . . . 0.0 109.737 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 48.8 Cg_endo -69.19 -20.0 38.11 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.663 2.242 . . . . 0.0 111.403 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.5 p -76.36 -36.39 58.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.317 -0.864 . . . . 0.0 109.116 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.469 ' HB2' ' OD1' ' A' ' 86' ' ' ASN . 88.0 m-20 -79.38 -32.07 43.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -0.826 . . . . 0.0 108.905 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -119.25 71.68 12.45 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.835 . . . . 0.0 109.515 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.559 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.4 Cg_endo -70.31 -20.15 32.59 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.735 2.29 . . . . 0.0 111.784 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.559 ' CZ3' ' HD2' ' A' ' 91' ' ' PRO . 47.2 p90 -79.85 -32.88 40.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.923 . . . . 0.0 109.562 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.566 HD21 ' CG ' ' A' ' 23' ' ' TRP . 0.7 OUTLIER -43.53 -42.2 4.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.431 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 71.9 mtm -82.16 127.9 33.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.0 109.474 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -61.17 -37.18 81.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.504 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.13 153.76 76.93 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.524 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.75 168.67 20.87 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.727 2.285 . . . . 0.0 111.819 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 98' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.555 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 51.1 Cg_endo -69.8 149.3 66.46 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.677 2.251 . . . . 0.0 111.854 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.526 HD12 ' CD1' ' A' ' 85' ' ' LEU . 4.1 mp -82.59 161.15 22.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.473 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.55 142.64 29.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.502 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.07 151.84 28.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.54 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.46 ' OE2' ' HE2' ' A' ' 18' ' ' LYS . 92.2 mt-10 -130.88 121.53 25.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 109.432 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 75.9 mt -114.7 128.14 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.936 . . . . 0.0 109.43 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 65.5 mttt 61.11 20.26 10.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.44 -12.42 69.76 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.446 HG22 ' CD1' ' A' ' 19' ' ' LEU . 41.9 m -81.8 134.63 35.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -1.169 . . . . 0.0 109.409 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.46 ' HE2' ' OE2' ' A' ' 13' ' ' GLU . 89.0 mttt -89.75 139.04 30.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.446 ' CD1' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -158.8 165.61 33.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.411 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 9' ' ' PRO . 11.8 mmtt -86.5 150.67 24.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 10' ' ' LEU . . . -133.49 171.11 14.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.555 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 68.2 m-70 -131.52 133.83 45.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 109.836 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.605 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 58.5 t90 -90.31 115.13 27.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 109.448 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -127.08 102.53 7.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.386 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.474 ' HA ' ' HG3' ' A' ' 87' ' ' PRO . 32.2 t -57.83 -34.03 69.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.613 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.95 -35.59 48.72 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.18 136.11 51.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 28' ' ' THR . 54.2 m -95.29 -16.4 22.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.45 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.5 tt -141.65 149.41 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.316 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 27.9 m -57.69 135.49 56.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.508 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -119.24 119.53 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.9 . . . . 0.0 109.214 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.463 ' HB ' ' HD2' ' A' ' 33' ' ' PRO . 29.1 m -113.44 162.2 23.5 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.281 -0.887 . . . . 0.0 109.515 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 78' ' ' SER . 55.6 Cg_endo -79.2 130.6 9.32 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.547 2.164 . . . . 0.0 111.575 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 81.0 tt0 -43.27 -26.87 0.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 0.0 109.51 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -53.08 -41.81 65.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.402 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -83.15 -3.04 56.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.226 -0.921 . . . . 0.0 109.445 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.464 HD21 ' HA ' ' A' ' 40' ' ' GLU . 6.1 mt -95.93 20.72 9.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.946 . . . . 0.0 109.779 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 37' ' ' LEU . 71.5 mt-10 -43.9 -56.51 3.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 0.0 108.942 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 49.2 m-20 -97.05 40.15 1.15 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.599 ' HB2' ' CD2' ' A' ' 60' ' ' TYR . 21.0 pt-20 -42.94 134.2 3.44 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.522 0.677 . . . . 0.0 110.551 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -127.83 85.97 59.41 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.32 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 49.9 Cg_endo -70.28 118.85 5.92 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.717 2.278 . . . . 0.0 112.242 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 44' ' ' GLN . 36.1 pt -90.5 -35.86 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.023 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.455 ' N ' HG13 ' A' ' 43' ' ' ILE . 94.7 mt-30 -137.99 175.66 9.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.405 -0.809 . . . . 0.0 109.106 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 76.6 p -129.85 151.83 50.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.086 -1.009 . . . . 0.0 109.829 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.49 ' HG3' ' CG2' ' A' ' 59' ' ' VAL . 81.2 mtp -138.38 147.12 43.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.422 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.529 ' CD1' ' HB2' ' A' ' 56' ' ' GLN . 20.8 tp -98.63 129.43 45.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.506 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.448 HD12 HG22 ' A' ' 48' ' ' ILE . 66.8 mt -113.47 134.2 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.43 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -104.21 140.7 37.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 53' ' ' GLY . 91.4 m -131.81 144.42 50.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.92 . . . . 0.0 109.385 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.485 HG21 ' N ' ' A' ' 52' ' ' HIS . 16.4 tt -48.82 -41.71 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.901 . . . . 0.0 109.478 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.485 ' N ' HG21 ' A' ' 51' ' ' ILE . 56.1 t-80 -67.28 -36.52 81.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 109.452 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 50' ' ' THR . . . -179.25 -173.94 44.91 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -103.79 129.04 51.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -1.193 . . . . 0.0 109.528 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -122.68 134.14 54.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 0.0 109.35 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.529 ' HB2' ' CD1' ' A' ' 47' ' ' LEU . 62.8 tt0 -109.46 125.37 52.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.596 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.418 ' OE1' ' HB3' ' A' ' 76' ' ' LEU . 7.4 tt0 -123.02 147.16 46.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.258 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 83.4 m-20 -83.81 159.04 21.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.195 -0.941 . . . . 0.0 109.661 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.518 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 43.4 t -98.94 134.69 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.262 -0.898 . . . . 0.0 109.043 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.599 ' CD2' ' HB2' ' A' ' 40' ' ' GLU . 4.0 m-85 -119.06 148.46 43.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.047 -1.033 . . . . 0.0 109.913 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.552 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 43.3 t80 -107.0 112.49 25.47 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 mp -115.66 158.88 22.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.155 -0.965 . . . . 0.0 110.445 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.536 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 51.0 m -117.74 116.76 27.67 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.542 ' CE2' HG22 ' A' ' 66' ' ' VAL . 39.9 p90 -137.21 160.02 40.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 109.955 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -93.11 129.08 39.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 109.356 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.542 HG22 ' CE2' ' A' ' 64' ' ' PHE . 1.7 t -105.53 103.55 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 109.656 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 84.1 mt-30 63.61 36.73 10.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.895 . . . . 0.0 109.33 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.72 26.01 51.54 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -129.55 120.88 26.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.333 -1.098 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -66.33 122.82 18.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.582 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.558 HG21 ' CH2' ' A' ' 92' ' ' TRP . 90.2 t -144.17 133.44 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.451 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 76.4 mt-10 -117.16 137.18 52.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.641 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.07 172.49 17.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.6 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.518 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 96.1 mt-10 -79.9 141.35 36.17 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -0.922 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.9 m -135.14 162.3 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.943 . . . . 0.0 109.752 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.418 ' HB3' ' OE1' ' A' ' 57' ' ' GLN . 72.8 mt -119.34 154.71 33.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.847 . . . . 0.0 109.287 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.422 ' HB3' HD13 ' A' ' 37' ' ' LEU . . . -80.17 138.83 36.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.478 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.572 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 4.6 t -143.11 149.0 47.26 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.461 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.2 Cg_endo -72.65 3.37 4.36 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.701 2.267 . . . . 0.0 112.065 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.572 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 74.3 m-85 -66.81 174.93 2.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 109.587 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -114.06 15.65 18.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 0.0 109.341 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' N ' ' A' ' 83' ' ' ILE . 33.0 p90 -139.22 -157.89 0.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.208 -0.933 . . . . 0.0 109.08 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.563 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 4.5 mt -123.66 126.21 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.669 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.508 ' HB2' ' CB ' ' A' ' 31' ' ' CYS . 5.7 mp -84.27 142.59 30.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 108.941 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.526 ' CD1' HD12 ' A' ' 10' ' ' LEU . 6.6 mt -112.92 143.26 44.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 110.083 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.528 ' OD1' ' CD ' ' A' ' 87' ' ' PRO . 3.3 t30 -103.61 137.41 19.24 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.529 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.5 Cg_endo -64.0 -35.65 53.33 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.703 2.269 . . . . 0.0 111.998 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 m -72.54 -27.01 61.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.141 -0.974 . . . . 0.0 109.411 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -79.55 -28.92 41.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.34 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.549 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -120.26 71.85 18.03 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.841 . . . . 0.0 109.464 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.34 -16.3 35.09 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.632 2.221 . . . . 0.0 111.762 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.558 ' CH2' HG21 ' A' ' 71' ' ' VAL . 41.6 p90 -82.6 -28.51 30.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.894 . . . . 0.0 109.414 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.605 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 22.0 tp -60.58 -26.28 66.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.4 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 88.0 mtp -67.52 -35.54 79.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.36 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 92' ' ' TRP . 63.7 mttm -117.36 137.66 52.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.402 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -71.66 148.09 92.5 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.902 . . . . 0.0 109.62 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 49.3 Cg_endo -69.5 -16.77 38.84 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.804 2.336 . . . . 0.0 111.833 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 97' ' ' PRO . 44.3 mt . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.215 0.531 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.526 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.2 Cg_endo -69.74 152.05 69.31 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.655 2.237 . . . . 0.0 111.709 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.493 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 3.7 mp -84.38 164.47 18.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.439 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -101.79 147.21 26.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.475 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.25 146.31 25.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.521 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.45 ' OE1' ' NZ ' ' A' ' 65' ' ' LYS . 89.9 mt-10 -123.8 118.68 27.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.44 HD13 HG22 ' A' ' 14' ' ' ILE . 61.6 mt -114.15 129.65 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.503 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.438 ' HG3' HG21 ' A' ' 14' ' ' ILE . 93.2 mttt 54.35 22.39 3.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.94 -8.55 76.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 32.7 m -82.58 128.45 34.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -1.13 . . . . 0.0 109.493 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.463 ' O ' HD23 ' A' ' 19' ' ' LEU . 29.6 tttt -92.47 122.79 35.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.403 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.592 ' CD1' ' CE1' ' A' ' 36' ' ' PHE . 63.7 mt -140.88 168.08 20.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.498 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -87.67 155.54 19.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.496 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.522 ' HB3' ' CD2' ' A' ' 85' ' ' LEU . . . -139.85 167.73 21.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -0.859 . . . . 0.0 109.337 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.526 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 80.4 m-70 -130.98 132.47 45.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.498 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.576 ' CZ2' ' HB3' ' A' ' 87' ' ' PRO . 38.9 t90 -85.76 122.98 30.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.587 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -130.15 99.31 5.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.875 . . . . 0.0 109.463 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.499 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 53.4 p -57.16 -26.76 61.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -0.861 . . . . 0.0 109.509 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.22 -36.17 92.0 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -72.17 137.37 46.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -1.15 . . . . 0.0 109.425 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.5 m -99.1 -10.45 22.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 109.385 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.433 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 21.2 tt -139.4 152.77 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.5 HG22 ' N ' ' A' ' 31' ' ' CYS . 32.4 m -61.24 152.11 29.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.477 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.536 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -127.93 113.72 16.23 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.111 179.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.543 ' CG1' ' HD2' ' A' ' 33' ' ' PRO . 60.3 t -113.55 146.91 36.4 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.312 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.543 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 55.3 Cg_endo -76.75 131.22 12.14 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.125 1.883 . . . . 0.0 111.625 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 33' ' ' PRO . 81.3 tt0 -40.7 -27.48 0.05 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.533 -0.729 . . . . 0.0 110.234 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.14 -27.75 3.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.096 -1.003 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.592 ' CE1' ' CD1' ' A' ' 19' ' ' LEU . 21.4 m-85 -101.77 -3.04 28.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 0.0 109.77 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.569 ' CD2' ' CG ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -115.25 15.01 17.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.698 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 70.7 mm-40 -61.48 -24.13 66.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.099 -1.001 . . . . 0.0 109.325 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -128.44 27.07 5.61 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.531 ' CB ' HD21 ' A' ' 37' ' ' LEU . 53.7 mm-40 -96.15 174.4 6.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.506 -0.747 . . . . 0.0 109.805 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.03 128.83 20.78 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 109.223 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.576 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 52.1 Cg_endo -72.27 121.44 7.5 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.578 2.185 . . . . 0.0 111.923 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 61' ' ' TYR . 3.2 pt -84.96 -29.7 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 109.173 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 59' ' ' VAL . 63.2 tt0 -143.68 163.85 32.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.189 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 71.5 p -122.94 149.07 44.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 109.761 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.418 ' HG3' HG22 ' A' ' 59' ' ' VAL . 63.0 mtt -141.92 144.21 33.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.317 -0.864 . . . . 0.0 109.359 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.7 tt -93.16 131.72 37.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.385 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.2 mt -119.24 129.21 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.868 . . . . 0.0 109.568 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -108.28 134.73 50.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.399 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.18 -168.72 1.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.7 mm -80.08 -47.01 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.371 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -58.01 -38.83 76.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.508 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.41 -169.41 41.05 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.2 mp0 -104.98 136.99 43.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -1.105 . . . . 0.0 109.507 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -137.23 134.01 35.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.363 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -107.18 127.91 53.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.545 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.434 ' NE2' ' CD2' ' A' ' 76' ' ' LEU . 26.1 mt-30 -123.82 160.73 26.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.306 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 79.6 m-20 -93.23 144.41 25.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 109.689 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.526 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 21.7 t -86.39 153.78 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 109.293 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.576 ' CE2' ' HD3' ' A' ' 42' ' ' PRO . 11.4 m-85 -133.16 139.3 46.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.138 -0.976 . . . . 0.0 109.889 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.465 ' O ' HD21 ' A' ' 62' ' ' LEU . 43.5 t80 -102.15 114.4 28.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.257 -0.902 . . . . 0.0 108.956 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.507 ' CD2' ' OE1' ' A' ' 40' ' ' GLU . 44.1 mt -121.01 169.05 10.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.061 -1.024 . . . . 0.0 110.288 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.529 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 25.4 m -121.22 118.05 28.62 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 9.5 p90 -140.34 163.22 33.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.988 -1.07 . . . . 0.0 109.801 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.45 ' NZ ' ' OE1' ' A' ' 13' ' ' GLU . 15.2 mtmt -99.38 126.01 45.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.388 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 78.0 t -104.42 116.19 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.481 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 94.7 mt-30 62.29 30.96 17.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.386 -0.821 . . . . 0.0 109.393 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.65 22.45 59.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -125.64 117.61 23.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -1.164 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' O ' HG22 ' A' ' 71' ' ' VAL . 26.7 ttpt -58.91 123.9 18.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.439 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.521 HG21 ' CH2' ' A' ' 92' ' ' TRP . 53.7 t -148.55 127.03 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.335 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.529 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 79.5 mt-10 -107.66 138.82 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.525 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.32 168.34 25.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.338 -0.851 . . . . 0.0 109.695 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.526 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 95.5 mt-10 -80.04 137.29 36.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.328 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.484 HG22 ' CD1' ' A' ' 62' ' ' LEU . 5.0 m -127.92 151.39 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 32' ' ' VAL . 24.6 tp -103.75 143.63 32.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.355 -0.84 . . . . 0.0 109.082 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.17 125.9 30.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.243 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 35.2 t -137.14 150.13 68.3 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.296 -0.878 . . . . 0.0 109.534 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.484 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.8 Cg_endo -71.01 5.07 2.34 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.669 2.246 . . . . 0.0 112.176 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.575 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 31.3 m-85 -62.57 178.22 0.45 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 109.362 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -118.22 18.3 13.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.568 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 13.9 p90 -145.08 -153.97 0.51 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.349 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.549 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 2.4 mt -133.22 148.01 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 0.0 109.563 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.568 HD11 ' CZ ' ' A' ' 82' ' ' TYR . 6.0 mp -112.27 133.73 54.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 108.886 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.522 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -100.63 133.09 45.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.067 -1.021 . . . . 0.0 109.851 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.503 ' OD1' ' HD2' ' A' ' 87' ' ' PRO . 3.3 t30 -85.67 136.57 36.84 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.576 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 40.5 Cg_endo -63.06 -25.76 73.45 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.696 2.264 . . . . 0.0 111.849 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.497 ' OG ' ' ND2' ' A' ' 86' ' ' ASN . 1.0 OUTLIER -80.42 -28.92 37.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.27 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -78.06 -28.6 48.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.864 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.625 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -116.06 73.95 5.17 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.202 -0.936 . . . . 0.0 109.505 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.405 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.8 Cg_endo -70.3 -23.73 28.0 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.757 2.305 . . . . 0.0 111.791 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.625 ' CZ2' ' CG1' ' A' ' 90' ' ' VAL . 43.9 p90 -73.06 -29.63 63.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.475 ' CD1' ' HB ' ' A' ' 90' ' ' VAL . 76.3 mt -61.3 -33.76 74.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.241 -0.912 . . . . 0.0 109.467 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.48 ' SD ' ' CH2' ' A' ' 23' ' ' TRP . 89.9 mtp -107.44 154.22 21.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.51 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -88.2 139.81 30.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.476 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -125.43 79.55 66.74 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.495 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 98' ' ' LEU . 49.7 Cg_endo -70.04 145.36 55.3 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.656 2.237 . . . . 0.0 111.735 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.412 ' HB3' ' O ' ' A' ' 97' ' ' PRO . 26.1 tp . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.172 -0.955 . . . . 0.0 109.493 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.508 ' CB ' ' CD ' ' A' ' 9' ' ' PRO . 11.5 mm100 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.515 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 48.3 Cg_endo -69.92 152.48 68.52 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.66 2.24 . . . . 0.0 111.77 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.434 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 86.3 mt -93.81 154.17 17.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.475 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -88.49 140.24 29.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.548 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.48 155.35 41.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -128.65 109.56 11.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -0.953 . . . . 0.0 109.412 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.578 ' HB ' ' CE2' ' A' ' 36' ' ' PHE . 90.0 mt -104.92 128.81 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.51 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 52.7 mttp 61.31 18.17 8.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.632 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.08 -10.93 73.39 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.45 HG23 ' N ' ' A' ' 18' ' ' LYS . 81.8 m -85.5 140.43 30.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -1.136 . . . . 0.0 109.171 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.45 ' N ' HG23 ' A' ' 17' ' ' THR . 27.2 tttt -79.26 117.45 20.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.295 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.576 ' CD2' ' CE1' ' A' ' 36' ' ' PHE . 11.7 tp -130.14 147.81 51.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.476 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.459 ' O ' HD12 ' A' ' 83' ' ' ILE . 40.6 mttt -81.93 157.82 24.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.6 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.515 ' HB2' ' CD2' ' A' ' 85' ' ' LEU . . . -144.98 160.08 41.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.554 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.515 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 65.4 m-70 -128.72 129.32 45.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.265 -0.897 . . . . 0.0 109.471 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.581 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 21.9 t90 -75.28 125.45 29.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.641 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -132.85 95.9 3.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.394 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.581 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 54.6 p -56.45 -31.8 64.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.657 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.57 -27.58 68.31 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -79.98 139.29 37.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -1.167 . . . . 0.0 109.472 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.503 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 41.8 p -103.57 -4.36 24.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.584 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.476 HG21 ' CD1' ' A' ' 76' ' ' LEU . 21.2 tt -143.98 149.41 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.932 . . . . 0.0 109.472 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.455 HG23 HG21 ' A' ' 75' ' ' VAL . 27.8 m -61.12 139.67 58.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.647 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.527 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -123.48 140.07 53.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.546 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.548 ' CG2' ' CG1' ' A' ' 75' ' ' VAL . 34.9 m -141.13 165.8 26.73 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.915 . . . . 0.0 109.411 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.526 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.4 Cg_endo -78.29 128.15 8.73 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.29 1.993 . . . . 0.0 111.451 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' PRO . 83.9 tt0 -41.78 -28.19 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.749 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -53.27 -31.48 43.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.557 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CE2' ' HB ' ' A' ' 14' ' ' ILE . 2.2 m-85 -88.75 -10.92 46.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 0.0 109.673 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.634 ' CD2' ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -106.56 0.88 24.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.858 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -51.83 -25.78 8.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 109.321 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -120.99 23.57 10.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.39 -0.819 . . . . 0.0 109.234 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.462 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 41.7 mm-40 -98.02 157.03 16.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.724 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.24 129.3 25.46 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.08 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.546 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 52.9 Cg_endo -72.93 124.53 9.71 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.53 2.153 . . . . 0.0 111.745 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.409 HG13 ' N ' ' A' ' 44' ' ' GLN . 26.9 pt -81.8 -28.99 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.26 -0.9 . . . . 0.0 109.356 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.444 ' HB2' HG13 ' A' ' 59' ' ' VAL . 94.7 mt-30 -147.51 177.97 8.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.289 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 60.4 p -118.53 148.58 42.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.145 -0.972 . . . . 0.0 109.71 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.414 ' O ' ' HG3' ' A' ' 56' ' ' GLN . 86.2 mtp -129.34 149.28 51.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.511 ' CD2' ' HB2' ' A' ' 56' ' ' GLN . 1.8 tm? -101.86 128.82 48.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.299 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.501 ' N ' HD13 ' A' ' 47' ' ' LEU . 25.2 mm -111.83 138.16 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 109.49 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.9 tttm -121.38 132.29 54.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.531 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.8 p -126.81 156.15 41.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.352 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.9 tt -58.26 -36.7 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -68.6 -46.24 69.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.871 . . . . 0.0 109.352 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.86 -167.65 27.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.3 mp0 -113.04 129.88 56.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.187 -1.184 . . . . 0.0 109.552 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.463 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 59.2 mttm -124.82 147.54 48.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.348 -0.845 . . . . 0.0 109.121 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.511 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 57.0 tt0 -120.34 132.86 55.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.655 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -128.85 161.23 30.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.289 -0.882 . . . . 0.0 109.293 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 41.4 m-20 -98.22 141.36 31.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.181 -0.949 . . . . 0.0 109.714 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.496 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 14.4 p -79.99 158.47 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.245 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.634 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 25.6 m-85 -139.64 123.66 17.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.185 -0.947 . . . . 0.0 110.053 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.45 ' OH ' ' HB2' ' A' ' 72' ' ' GLU . 45.2 t80 -85.91 110.19 19.25 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.453 HD23 ' HG3' ' A' ' 40' ' ' GLU . 60.1 mt -115.81 161.62 18.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.032 -1.043 . . . . 0.0 110.624 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.53 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 29.5 m -121.23 124.24 44.17 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.518 ' CE2' ' CG2' ' A' ' 66' ' ' VAL . 43.2 p90 -145.92 160.38 41.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.044 -1.035 . . . . 0.0 109.97 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 70' ' ' LYS . 6.8 mmtt -90.1 126.75 35.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.406 -0.809 . . . . 0.0 109.229 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.518 ' CG2' ' CE2' ' A' ' 64' ' ' PHE . 1.7 t -104.54 103.09 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.688 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 82.9 mt-30 62.61 35.06 14.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.317 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.46 30.93 28.88 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -136.28 120.56 17.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -1.169 . . . . 0.0 109.39 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.474 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 15.0 tttp -67.35 120.44 13.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.443 ' HB ' HG22 ' A' ' 66' ' ' VAL . 64.0 t -141.94 131.84 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.475 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.53 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 27.3 mt-10 -116.01 136.48 52.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.31 -178.11 6.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.845 . . . . 0.0 109.667 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.432 ' C ' HG23 ' A' ' 75' ' ' VAL . 94.1 mt-10 -79.64 152.81 29.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.02 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.548 ' CG1' ' CG2' ' A' ' 32' ' ' VAL . 91.6 t -143.51 156.97 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.123 -0.985 . . . . 0.0 109.744 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.476 ' CD1' HG21 ' A' ' 29' ' ' ILE . 17.2 mt -121.89 147.37 46.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.37 -0.831 . . . . 0.0 109.313 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.94 139.66 36.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.483 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 1.5 t -143.98 150.81 50.74 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 109.345 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.454 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.9 Cg_endo -71.37 1.75 5.17 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.677 2.251 . . . . 0.0 111.772 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.498 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 70.6 m-85 -69.15 162.53 26.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.278 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -104.32 19.79 19.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.604 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.616 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 22.4 p90 -140.57 -162.35 1.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.979 . . . . 0.0 109.552 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 19' ' ' LEU . 7.5 mt -125.44 152.16 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.1 -1.0 . . . . 0.0 110.248 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.616 ' HG ' ' CE2' ' A' ' 82' ' ' TYR . 2.2 mt -118.55 124.59 47.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.298 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.569 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -92.47 140.68 29.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 109.82 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 28' ' ' THR . 8.2 t-20 -90.87 134.79 29.71 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.491 -0.755 . . . . 0.0 109.25 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.5 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.1 Cg_endo -63.95 -30.3 67.07 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.796 2.33 . . . . 0.0 111.78 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.4 t -75.73 -29.09 58.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 109.269 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -79.89 -33.21 40.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.897 . . . . 0.0 109.44 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.608 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.8 OUTLIER -119.52 76.39 18.71 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.882 . . . . 0.0 109.424 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.433 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.3 Cg_endo -69.99 -22.05 31.58 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.697 2.264 . . . . 0.0 111.785 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.608 ' CZ2' ' CG1' ' A' ' 90' ' ' VAL . 44.2 p90 -76.23 -25.72 55.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.171 -0.955 . . . . 0.0 109.401 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.489 HD11 ' CB ' ' A' ' 90' ' ' VAL . 59.9 mt -68.37 -30.17 69.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.478 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 90.0 mtp -53.25 -36.57 61.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.84 . . . . 0.0 109.558 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.92 138.37 48.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.127 -0.983 . . . . 0.0 109.554 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.3 160.49 45.47 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.355 -0.84 . . . . 0.0 109.473 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.424 ' O ' ' HB3' ' A' ' 98' ' ' LEU . 50.1 Cg_endo -69.57 156.03 64.95 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.727 2.285 . . . . 0.0 111.81 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 97' ' ' PRO . 21.6 tp . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.484 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.492 ' CB ' ' CD ' ' A' ' 9' ' ' PRO . 1.3 mm-40 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 8' ' ' GLN . 50.7 Cg_endo -70.14 163.08 39.89 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.729 2.286 . . . . 0.0 111.668 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 21' ' ' ALA . 65.8 mt -93.63 142.03 27.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.493 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -83.43 134.1 34.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.14 150.75 37.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.527 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.456 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 45.0 tt0 -115.93 121.0 41.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.405 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.541 ' HB ' ' CE1' ' A' ' 36' ' ' PHE . 27.1 mt -111.06 125.4 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.439 ' HG3' HG21 ' A' ' 14' ' ' ILE . 42.5 mttt 55.02 24.79 6.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.321 -0.862 . . . . 0.0 109.55 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 90.31 4.52 71.01 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 42.7 m -103.64 126.45 50.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -1.203 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -82.12 129.15 34.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.453 ' HB3' HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -141.27 167.76 21.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -87.55 148.61 24.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 0.0 109.569 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 10' ' ' LEU . . . -135.92 163.79 29.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 109.475 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.476 ' O ' ' CD2' ' A' ' 85' ' ' LEU . 52.8 m-70 -130.37 129.42 43.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.563 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.489 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 48.4 t90 -77.0 127.74 33.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -137.59 107.41 6.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.489 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 18.2 p -65.69 -33.11 75.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.82 -15.76 55.49 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.12 130.43 34.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -1.155 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.7 m -94.98 -24.02 17.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 74' ' ' GLU . 11.3 tp -132.72 143.12 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -0.926 . . . . 0.0 109.6 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 39.1 m -58.46 136.46 57.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.655 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 9.9 t -124.76 140.04 53.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.533 ' HB ' ' HD2' ' A' ' 33' ' ' PRO . 2.6 m -137.72 172.14 7.29 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.32 -0.862 . . . . 0.0 109.14 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.5 Cg_endo -79.82 132.26 9.58 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.22 1.946 . . . . 0.0 111.833 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 33' ' ' PRO . 22.4 pt-20 -44.22 -25.92 0.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.642 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -48.52 -34.34 11.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 109.526 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.541 ' CE1' ' HB ' ' A' ' 14' ' ' ILE . 12.8 m-85 -89.42 -9.75 49.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 109.646 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.519 HD13 ' CB ' ' A' ' 40' ' ' GLU . 3.6 mm? -90.45 21.19 4.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.783 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 37' ' ' LEU . 52.9 tt0 -44.15 -57.37 3.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 108.919 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 40' ' ' GLU . 24.4 m-20 -98.52 37.67 1.45 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.607 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 20.5 pt-20 -38.7 132.7 1.16 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.519 0.676 . . . . 0.0 110.368 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.04 85.01 61.64 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.517 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 50.2 Cg_endo -68.76 116.24 4.34 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.655 2.237 . . . . 0.0 112.171 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.4 pt -79.28 -27.51 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.294 -0.879 . . . . 0.0 109.148 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.42 ' HB2' ' CG1' ' A' ' 59' ' ' VAL . 94.4 mt-30 -146.91 172.65 13.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 109.322 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.7 p -123.74 150.33 44.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.509 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 87.6 mtp -130.33 148.77 52.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.878 . . . . 0.0 109.355 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.1 mt -103.83 125.75 50.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.424 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 55' ' ' LYS . 23.4 mm -114.53 130.17 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 109.453 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -106.94 136.7 46.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 53' ' ' GLY . 52.0 m -126.95 139.97 52.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 109.463 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.1 tt -47.95 -36.22 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.443 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -74.25 -31.77 62.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.952 . . . . 0.0 109.439 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 50' ' ' THR . . . -179.6 -177.52 47.89 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -102.8 128.54 49.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 109.455 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 48' ' ' ILE . 15.6 tptp -121.47 135.7 55.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.285 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -103.61 123.67 47.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.193 -0.942 . . . . 0.0 109.644 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.94 136.51 52.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.168 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -96.01 154.64 17.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 109.431 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 42' ' ' PRO . 7.2 p -97.81 138.64 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.153 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.607 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 4.6 m-85 -121.91 147.83 45.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.272 -0.892 . . . . 0.0 109.636 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 35.9 t80 -108.24 113.12 25.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -0.826 . . . . 0.0 108.957 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.4 mt -117.25 158.84 23.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.071 -1.018 . . . . 0.0 110.128 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.531 ' CG2' ' HG2' ' A' ' 72' ' ' GLU . 22.0 m -119.88 115.7 24.36 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 9.4 p90 -138.89 162.02 35.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.067 -1.02 . . . . 0.0 109.945 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.2 mttm -92.39 127.37 37.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.395 -0.816 . . . . 0.0 109.278 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 49.8 t -106.98 105.86 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 109.537 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 85.5 mt-30 63.85 36.26 10.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.291 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.09 33.86 39.36 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.453 ' O ' HG21 ' A' ' 71' ' ' VAL . 74.3 mtt180 -139.19 108.81 6.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.225 -1.162 . . . . 0.0 109.405 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -55.72 121.71 9.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.91 . . . . 0.0 109.628 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 69' ' ' ARG . 80.3 t -141.16 129.98 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 109.429 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.531 ' HG2' ' CG2' ' A' ' 63' ' ' THR . 54.5 mt-10 -113.7 136.36 52.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.621 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.37 -173.49 4.03 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.368 -0.832 . . . . 0.0 109.353 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.526 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 97.2 mt-10 -80.0 164.79 23.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.002 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 60' ' ' TYR . 89.8 t -152.76 145.42 15.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.134 -0.979 . . . . 0.0 109.914 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.9 tp -114.95 143.03 45.79 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.14 143.12 32.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.1 -1.0 . . . . 0.0 109.649 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.471 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -152.25 152.11 28.78 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 0.0 109.304 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.471 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.2 Cg_endo -71.19 2.53 4.25 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.613 2.209 . . . . 0.0 112.019 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.408 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 41.1 m-85 -63.34 169.23 3.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.047 -1.033 . . . . 0.0 109.301 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -113.71 23.26 13.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.519 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.583 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 16.3 p90 -147.86 -166.81 2.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 109.528 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.474 ' O ' ' CD2' ' A' ' 82' ' ' TYR . 4.9 mt -114.95 151.67 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.94 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.583 ' HG ' ' CE2' ' A' ' 82' ' ' TYR . 1.1 mt -119.14 124.97 48.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 108.949 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -107.45 138.38 43.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.968 . . . . 0.0 109.647 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.521 ' N ' ' OD2' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -100.76 159.3 29.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 109.518 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 47.6 Cg_endo -69.41 -24.24 31.48 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.71 2.274 . . . . 0.0 111.505 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.9 m -74.27 -34.07 63.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.334 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 86' ' ' ASN . 1.7 p30 -80.16 -38.34 31.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 0.0 109.263 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 86' ' ' ASN . 2.3 m -108.18 69.64 0.33 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.584 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.558 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 52.8 Cg_endo -70.72 -25.85 23.72 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.798 2.332 . . . . 0.0 112.045 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.558 ' CZ3' ' HD2' ' A' ' 91' ' ' PRO . 44.9 p90 -71.26 -37.65 71.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.955 . . . . 0.0 109.497 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 92' ' ' TRP . 29.8 tp -51.47 -38.62 54.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 95.4 mmm -59.01 -32.99 70.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.936 . . . . 0.0 109.589 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -62.22 140.95 58.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.497 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.84 79.32 49.59 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.69 -19.35 36.55 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.74 2.293 . . . . 0.0 111.682 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.3 tp . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.88 . . . . 0.0 109.454 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 49.6 Cg_endo . . . . . 0 C--O 1.215 -0.645 0 CA-C-O 121.248 0.437 . . . . 0.0 111.708 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 10' ' ' LEU . 4.1 mp -88.8 167.46 13.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.261 -0.9 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -104.35 139.6 39.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.27 152.81 33.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 17' ' ' THR . 59.8 tt0 -123.8 120.38 32.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.456 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.668 HG22 ' HG3' ' A' ' 15' ' ' LYS . 29.8 mt -111.69 128.47 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.668 ' HG3' HG22 ' A' ' 14' ' ' ILE . 48.3 mttm 50.77 29.58 4.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.564 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.416 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.36 -12.08 67.78 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 28.7 m -80.59 129.95 34.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -1.1 . . . . 0.0 109.455 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.734 ' O ' HD23 ' A' ' 19' ' ' LEU . 62.4 tttm -96.61 125.38 41.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.609 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.734 HD23 ' O ' ' A' ' 18' ' ' LYS . 37.9 mt -147.19 169.85 18.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.284 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 9' ' ' PRO . 44.1 mttt -87.28 153.93 21.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.9 . . . . 0.0 109.487 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.872 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -136.36 168.84 18.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.323 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.793 ' O ' HD22 ' A' ' 85' ' ' LEU . 44.9 m80 -131.06 131.37 44.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.615 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.463 ' HE1' HG23 ' A' ' 90' ' ' VAL . 53.1 t90 -86.25 126.95 34.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.368 -0.833 . . . . 0.0 109.336 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 23' ' ' TRP . 97.1 m-20 -137.67 103.9 5.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.46 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 22.9 t -59.56 -29.23 67.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.51 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.32 -27.36 65.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.48 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -84.05 131.2 34.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -1.144 . . . . 0.0 109.576 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.8 p -96.66 -11.62 24.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 109.487 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.563 HD13 HD11 ' A' ' 76' ' ' LEU . 10.1 tt -134.23 145.51 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.89 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.645 ' HB ' HG12 ' A' ' 75' ' ' VAL . 86.6 m -63.55 140.97 58.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.442 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.682 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -121.47 128.43 52.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.915 HG13 ' HB ' ' A' ' 75' ' ' VAL . 4.2 m -127.77 163.34 43.82 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.408 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.7 Cg_endo -79.1 138.97 14.75 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.519 2.146 . . . . 0.0 111.943 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.864 ' HG2' ' HB1' ' A' ' 77' ' ' ALA . 74.7 mt-10 -46.88 -24.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.463 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.48 -24.54 3.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.492 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.51 ' C ' HD22 ' A' ' 37' ' ' LEU . 22.8 m-85 -97.85 -8.92 27.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 109.629 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.993 HD11 HD11 ' A' ' 62' ' ' LEU . 2.7 mm? . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 0.0 109.694 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.597 ' CD2' HD12 ' A' ' 37' ' ' LEU . 8.1 m-85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.32 0.581 . . . . 0.0 110.002 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.514 ' CE1' ' HB3' ' A' ' 72' ' ' GLU . 47.0 t80 -95.88 108.98 21.4 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.993 HD11 HD11 ' A' ' 37' ' ' LEU . 50.5 mt -120.6 168.35 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.054 -1.029 . . . . 0.0 110.517 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.724 HG23 ' HG2' ' A' ' 72' ' ' GLU . 88.9 m -118.05 125.94 51.31 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.626 ' CE2' HG22 ' A' ' 66' ' ' VAL . 37.5 p90 -145.16 155.2 43.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 0.0 109.685 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 31.7 mttt -89.03 129.18 35.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.718 HG11 ' CG1' ' A' ' 90' ' ' VAL . 2.0 t -103.33 97.78 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 76.5 mt-30 65.02 41.11 4.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.214 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.22 32.88 41.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.405 ' O ' HG23 ' A' ' 71' ' ' VAL . 89.4 mtt180 -137.63 108.63 6.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -1.146 . . . . 0.0 109.34 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -58.12 122.51 13.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.516 HG21 ' CH2' ' A' ' 92' ' ' TRP . 93.6 t -147.7 134.22 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.285 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.724 ' HG2' HG23 ' A' ' 63' ' ' THR . 88.5 mt-10 -110.61 140.46 44.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.667 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.15 162.84 34.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.351 -0.843 . . . . 0.0 109.569 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 96.7 mt-10 -80.9 136.28 36.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.846 . . . . 0.0 109.175 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.915 ' HB ' HG13 ' A' ' 32' ' ' VAL . 12.4 m -129.54 150.91 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.225 -0.922 . . . . 0.0 109.683 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.761 ' N ' HD12 ' A' ' 76' ' ' LEU . 5.4 mp -100.41 150.17 22.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.277 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.864 ' HB1' ' HG2' ' A' ' 34' ' ' GLU . . . -80.04 135.6 36.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.484 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 2.8 t -142.9 150.19 52.29 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.484 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.0 Cg_endo -70.78 2.27 4.27 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.664 2.243 . . . . 0.0 112.088 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.41 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 67.1 m-85 -66.04 171.17 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.568 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -110.98 20.45 17.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.788 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.827 ' OH ' HD21 ' A' ' 84' ' ' LEU . 12.3 p90 -145.46 -159.91 1.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 109.441 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.703 HG23 HG12 ' A' ' 32' ' ' VAL . 4.3 mt -125.16 154.44 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.62 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.879 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.8 mt -120.03 126.48 50.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.263 -0.898 . . . . 0.0 109.063 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.879 HD13 ' C ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -105.61 142.02 36.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.536 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.723 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -102.26 161.82 22.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.366 -0.834 . . . . 0.0 109.431 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 51.9 Cg_endo -71.64 -21.6 25.27 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.618 2.212 . . . . 0.0 111.677 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.2 m -77.81 -34.1 52.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 0.0 109.403 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.951 ' OD1' HG13 ' A' ' 90' ' ' VAL . 1.6 p30 -80.02 -40.67 27.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.457 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.951 HG13 ' OD1' ' A' ' 89' ' ' ASP . 2.6 m -109.31 70.0 0.44 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.58 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.6 Cg_endo -70.53 -22.18 28.91 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.659 2.239 . . . . 0.0 111.843 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.803 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 47.5 p90 -77.27 -31.71 55.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 93' ' ' LEU . 10.0 tt . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.404 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.6 Cg_endo . . . . . 0 C--O 1.215 -0.642 0 CA-C-O 121.129 0.387 . . . . 0.0 111.766 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.433 ' H ' HD12 ' A' ' 10' ' ' LEU . 4.3 mp -80.51 168.29 19.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 109.336 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -102.03 145.77 28.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.81 152.98 36.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.257 -0.902 . . . . 0.0 109.471 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 65' ' ' LYS . 82.0 tt0 -126.72 119.73 27.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.825 HG22 ' HG3' ' A' ' 15' ' ' LYS . 50.2 mt -115.93 129.61 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 109.374 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.825 ' HG3' HG22 ' A' ' 14' ' ' ILE . 82.8 mttt 58.35 24.03 11.18 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 109.572 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.44 -0.85 85.62 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.0 m -98.83 128.21 44.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -1.223 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.671 ' O ' HD12 ' A' ' 19' ' ' LEU . 34.1 mttp -83.78 138.89 33.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 109.443 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.692 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -150.01 167.21 27.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.555 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -83.53 155.0 23.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.516 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.045 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -147.88 167.14 25.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 109.379 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.515 ' O ' HD22 ' A' ' 85' ' ' LEU . 28.2 m80 -132.45 131.89 42.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.649 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 1.064 ' CZ2' HD11 ' A' ' 93' ' ' LEU . 71.6 t90 -84.7 128.15 34.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.327 -0.858 . . . . 0.0 109.386 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -138.33 104.97 5.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 109.526 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.56 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 6.5 p -60.45 -26.91 67.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.951 . . . . 0.0 109.438 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.05 -28.13 73.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.487 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -85.44 122.15 29.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -1.14 . . . . 0.0 109.232 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.1 p -91.89 -12.76 32.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.39 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.442 HG21 ' CD1' ' A' ' 76' ' ' LEU . 11.1 tp -127.04 142.33 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -0.936 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.718 ' HB ' HG12 ' A' ' 75' ' ' VAL . 44.4 m -63.39 139.56 58.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.893 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -120.78 123.23 42.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.21 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.983 HG12 HG23 ' A' ' 83' ' ' ILE . 17.3 m -121.83 162.87 34.59 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 109.727 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.7 Cg_endo -79.35 133.16 10.58 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.593 2.196 . . . . 0.0 111.554 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -46.72 -24.88 0.63 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.422 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.58 -32.95 53.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.646 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.692 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 5.3 m-85 -93.55 -3.95 51.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 109.67 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.691 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.176 -0.952 . . . . 0.0 109.737 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.691 ' CD2' HD23 ' A' ' 37' ' ' LEU . 38.3 m-85 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.235 0.541 . . . . 0.0 109.838 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.53 ' O ' HD23 ' A' ' 62' ' ' LEU . 36.2 t80 -94.74 111.8 23.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 108.874 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 61' ' ' TYR . 43.9 mt -121.3 167.09 13.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 110.122 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.723 HG23 ' HG2' ' A' ' 72' ' ' GLU . 52.2 m -124.01 113.99 19.16 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.508 ' CE2' HG22 ' A' ' 66' ' ' VAL . 12.7 p90 -134.29 159.27 41.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.815 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 74.5 mttt -90.84 123.74 34.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.307 -0.871 . . . . 0.0 109.291 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.73 HG11 HG11 ' A' ' 90' ' ' VAL . 51.9 t -100.85 106.52 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.762 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 98.0 mt-30 62.3 36.54 14.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.313 -0.867 . . . . 0.0 109.484 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.69 26.25 54.4 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.556 ' O ' HG23 ' A' ' 71' ' ' VAL . 55.0 mtt180 -131.35 115.06 15.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.248 -1.148 . . . . 0.0 109.277 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.53 120.31 9.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 69' ' ' ARG . 36.4 t -141.2 133.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.723 ' HG2' HG23 ' A' ' 63' ' ' THR . 45.6 mt-10 -113.94 136.38 52.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.602 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.36 166.42 29.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.831 . . . . 0.0 109.631 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 98.1 mt-10 -80.87 133.69 35.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.718 HG12 ' HB ' ' A' ' 30' ' ' THR . 3.4 m -127.21 161.9 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.536 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.442 ' CD1' HG21 ' A' ' 29' ' ' ILE . 5.0 mt -116.25 151.52 35.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.362 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.0 134.56 36.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.339 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.479 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.5 t -140.08 150.84 63.36 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.361 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.479 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.4 Cg_endo -70.55 -0.18 7.17 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.652 2.234 . . . . 0.0 111.78 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -64.95 168.52 6.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.493 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -110.99 22.35 15.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.612 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.563 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 15.3 p90 -144.04 -160.78 1.16 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 109.281 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.983 HG23 HG12 ' A' ' 32' ' ' VAL . 5.0 mt -126.64 143.56 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 109.737 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.893 HD13 ' HB3' ' A' ' 31' ' ' CYS . 6.4 mp -107.57 123.15 48.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.814 . . . . 0.0 109.066 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.045 HD21 ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -102.13 137.48 40.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.548 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.786 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -99.63 160.16 28.1 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.86 . . . . 0.0 109.687 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 51.7 Cg_endo -71.21 -27.92 19.28 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.735 2.29 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.0 m -69.19 -38.9 78.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.1 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.98 ' OD1' HG13 ' A' ' 90' ' ' VAL . 1.7 p30 -74.43 -40.15 62.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.87 . . . . 0.0 108.993 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.98 HG13 ' OD1' ' A' ' 89' ' ' ASP . 3.4 m -111.79 79.99 2.77 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.579 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 48.7 Cg_endo -69.18 -31.39 23.19 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.69 2.26 . . . . 0.0 112.085 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.877 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 30.6 p90 -63.89 -21.58 66.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.096 -1.003 . . . . 0.0 109.419 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.064 HD11 ' CZ2' ' A' ' 23' ' ' TRP . 2.2 mm? . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 109.606 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.488 ' CB ' ' O ' ' A' ' 21' ' ' ALA . 48.9 Cg_endo . . . . . 0 C--O 1.215 -0.652 0 CA-C-O 121.213 0.422 . . . . 0.0 111.804 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.536 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 18.3 mt -99.49 178.64 4.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.131 -0.981 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.68 139.85 42.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.354 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.86 149.66 31.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 109.707 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 18' ' ' LYS . 96.2 mt-10 -123.74 116.1 22.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.27 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.843 HG22 ' HG3' ' A' ' 15' ' ' LYS . 49.9 mt -108.95 129.53 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.843 ' HG3' HG22 ' A' ' 14' ' ' ILE . 85.6 mttt 54.91 24.47 5.86 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.253 -0.904 . . . . 0.0 109.62 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.29 -2.61 83.55 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.5 m -89.88 117.37 28.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -1.202 . . . . 0.0 109.491 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.644 ' O ' HD23 ' A' ' 19' ' ' LEU . 84.2 tttt -81.8 125.75 31.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 18' ' ' LYS . 92.5 mt -145.77 161.77 39.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.28 148.6 30.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.785 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -129.92 173.14 10.98 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.172 -0.955 . . . . 0.0 109.532 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.807 ' O ' HD22 ' A' ' 85' ' ' LEU . 15.7 m80 -127.24 127.99 45.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 0.0 109.657 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.574 ' CH2' ' HB3' ' A' ' 25' ' ' SER . 60.8 t90 -91.94 128.12 37.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.581 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.636 ' CB ' HD21 ' A' ' 84' ' ' LEU . 61.1 t0 -137.82 104.36 5.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.574 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 59.6 p -56.64 -28.0 59.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.895 . . . . 0.0 109.514 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.07 -29.67 74.84 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.77 142.2 58.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -1.176 . . . . 0.0 109.506 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.494 ' O ' HG22 ' A' ' 28' ' ' THR . 86.7 m -108.61 -5.24 16.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.512 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 18.4 tt -152.0 144.54 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.942 ' HB ' HG12 ' A' ' 75' ' ' VAL . 44.8 m -53.94 150.64 7.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.679 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.36 129.59 52.27 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.269 -0.894 . . . . 0.0 109.116 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.764 HG13 ' HD2' ' A' ' 33' ' ' PRO . 77.3 t -134.57 145.83 56.67 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.297 -0.877 . . . . 0.0 109.455 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.764 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.3 Cg_endo -77.95 133.55 12.55 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.291 1.994 . . . . 0.0 111.651 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 40.7 tp10 -42.06 -27.4 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.44 -0.788 . . . . 0.0 109.792 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -47.81 -39.15 17.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.645 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.517 ' CZ ' ' CD1' ' A' ' 19' ' ' LEU . 32.7 m-85 -92.12 -5.48 52.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 109.847 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.7 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.93 . . . . 0.0 109.857 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.7 ' CD2' HD23 ' A' ' 37' ' ' LEU . 34.6 m-85 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.323 0.582 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.47 ' O ' HD23 ' A' ' 62' ' ' LEU . 42.9 t80 -94.47 107.74 19.7 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 61' ' ' TYR . 39.3 mt -118.1 171.29 8.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -0.99 . . . . 0.0 110.334 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.717 HG23 ' HG2' ' A' ' 72' ' ' GLU . 82.8 m -125.93 119.02 26.66 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.575 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 4.1 p90 -140.6 157.73 45.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.791 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 13' ' ' GLU . 20.3 mttm -87.36 132.02 34.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.835 . . . . 0.0 109.383 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.634 HG11 HG11 ' A' ' 90' ' ' VAL . 98.8 t -112.1 107.08 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 83.4 mt-30 63.37 35.46 12.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 109.4 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.74 33.81 32.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -141.24 115.09 9.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -1.116 . . . . 0.0 109.411 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -61.68 123.11 17.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.535 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.654 HG21 ' CH2' ' A' ' 92' ' ' TRP . 92.0 t -144.41 132.58 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.462 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.717 ' HG2' HG23 ' A' ' 63' ' ' THR . 50.4 mt-10 -109.02 138.01 46.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.622 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HB1' ' OD2' ' A' ' 89' ' ' ASP . . . -160.27 165.76 30.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.668 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 96.1 mt-10 -81.42 129.87 34.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.942 HG12 ' HB ' ' A' ' 30' ' ' THR . 3.2 m -124.92 160.88 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.119 -0.988 . . . . 0.0 109.61 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.428 ' CD1' HG21 ' A' ' 29' ' ' ILE . 29.0 mt -109.35 145.11 36.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.95 134.76 36.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.438 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.491 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 3.5 t -142.25 149.64 52.43 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.395 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.474 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.7 Cg_endo -70.16 0.26 6.21 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.635 2.223 . . . . 0.0 111.873 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.491 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 66.6 m-85 -65.82 177.52 1.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.333 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -119.85 22.27 11.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.414 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.951 ' OH ' HD12 ' A' ' 84' ' ' LEU . 15.1 p90 -135.78 -173.72 3.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.863 . . . . 0.0 109.183 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.558 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 1.4 mt -131.54 112.33 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.951 HD12 ' OH ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -79.56 135.25 36.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.208 -0.933 . . . . 0.0 109.176 179.734 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.807 HD22 ' O ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -98.65 134.62 41.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.669 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.745 ' O ' HG22 ' A' ' 90' ' ' VAL . 29.8 t30 -86.21 140.77 34.58 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.441 -0.787 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HD2' ' OD1' ' A' ' 86' ' ' ASN . 46.5 Cg_endo -67.91 -34.54 23.35 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.69 2.26 . . . . 0.0 111.756 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.7 m -66.37 -36.05 81.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.182 -0.949 . . . . 0.0 109.283 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.583 ' OD2' ' HB1' ' A' ' 73' ' ' ALA . 91.8 m-20 -72.42 -32.1 66.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.493 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.184 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -113.93 72.85 2.22 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.546 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.4 Cg_endo -71.04 -21.98 26.87 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.667 2.245 . . . . 0.0 112.0 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.184 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 47.0 p90 -74.72 -30.43 61.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.462 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 66.9 mt . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 C--O 1.216 -0.621 0 CA-C-O 121.271 0.446 . . . . 0.0 111.811 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.476 ' H ' HD12 ' A' ' 10' ' ' LEU . 4.5 mp -81.27 166.47 20.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.46 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -104.65 144.37 31.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.503 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.2 152.78 30.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 109.463 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.451 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 78.3 tt0 -123.14 120.34 32.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.321 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.86 HG22 ' HG2' ' A' ' 15' ' ' LYS . 57.7 mt -114.92 128.03 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.86 ' HG2' HG22 ' A' ' 14' ' ' ILE . 31.7 mmtp 59.43 23.26 11.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.451 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 86.54 10.51 73.32 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.502 HG22 HD23 ' A' ' 19' ' ' LEU . 33.8 m -108.52 125.8 52.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -1.13 . . . . 0.0 109.451 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 1.031 ' O ' HD22 ' A' ' 19' ' ' LEU . 28.7 mttm -80.28 125.32 29.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.453 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.031 HD22 ' O ' ' A' ' 18' ' ' LYS . 1.3 mm? -141.06 158.26 44.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -80.23 155.44 27.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 109.402 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.538 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -146.73 164.29 33.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.563 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.695 ' O ' HD22 ' A' ' 85' ' ' LEU . 30.9 m80 -124.9 133.19 53.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.616 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 20.0 t90 -83.95 126.25 32.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -132.91 97.71 4.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.311 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.523 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 52.1 p -58.53 -26.83 63.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.578 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.05 -31.31 76.19 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -77.78 138.32 38.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.173 . . . . 0.0 109.693 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.8 p -98.64 -4.71 33.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.592 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.961 HD13 HD11 ' A' ' 76' ' ' LEU . 21.1 tt -142.65 156.64 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.0 109.327 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.79 ' HB ' HG12 ' A' ' 75' ' ' VAL . 33.5 m -71.71 140.48 49.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.952 . . . . 0.0 109.63 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.545 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -124.31 122.08 36.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.423 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.579 HG13 ' HB ' ' A' ' 75' ' ' VAL . 3.4 m -119.62 164.61 20.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.922 . . . . 0.0 109.368 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.2 Cg_endo -79.04 137.85 14.02 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.475 2.117 . . . . 0.0 111.65 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -47.57 -23.59 0.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 0.0 109.592 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.03 -36.66 18.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.55 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.409 ' CE1' ' HB ' ' A' ' 14' ' ' ILE . 31.1 m-85 -89.61 -10.52 45.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.581 ' CD2' ' CG ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.581 ' CG ' ' CD2' ' A' ' 37' ' ' LEU . 9.1 m-85 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.374 0.607 . . . . 0.0 109.968 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.533 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 48.1 t80 -100.02 112.96 25.24 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 61' ' ' TYR . 57.6 mt -123.19 170.5 10.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 110.417 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.692 HG23 ' HG2' ' A' ' 72' ' ' GLU . 89.4 m -118.84 126.68 52.39 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.751 ' CE2' HG22 ' A' ' 66' ' ' VAL . 35.7 p90 -142.99 154.78 44.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.093 -1.004 . . . . 0.0 109.748 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -88.07 128.4 35.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 109.383 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.751 HG22 ' CE2' ' A' ' 64' ' ' PHE . 2.2 t -105.78 103.78 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 25.8 mt-30 62.01 31.57 17.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.926 . . . . 0.0 109.285 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.99 28.66 25.21 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -132.91 126.53 32.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -1.172 . . . . 0.0 109.508 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -68.28 123.52 20.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.563 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.4 t -145.29 129.05 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.448 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.692 ' HG2' HG23 ' A' ' 63' ' ' THR . 67.2 mt-10 -112.45 135.17 53.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.04 166.07 30.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.739 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 91.9 mt-10 -80.24 133.26 35.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.283 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.79 HG12 ' HB ' ' A' ' 30' ' ' THR . 3.8 m -129.04 159.47 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.961 HD11 HD13 ' A' ' 29' ' ' ILE . 4.1 mp -110.83 151.28 28.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -0.885 . . . . 0.0 109.406 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.01 142.08 35.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.416 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.476 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 8.3 t -145.05 148.63 39.21 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 109.361 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.476 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.1 Cg_endo -70.34 0.24 6.37 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.649 2.233 . . . . 0.0 111.873 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -63.63 171.88 2.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 109.458 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -111.74 17.59 19.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.59 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.732 ' OH ' HD21 ' A' ' 84' ' ' LEU . 21.6 p90 -141.03 -156.17 0.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.136 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.6 mt -130.46 147.04 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.019 -1.051 . . . . 0.0 109.988 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.732 HD21 ' OH ' ' A' ' 82' ' ' TYR . 1.1 mt -108.99 130.39 55.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 108.98 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.777 ' H ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -99.73 144.29 28.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 109.853 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.587 ' O ' HG22 ' A' ' 90' ' ' VAL . 4.2 t30 -97.02 136.91 21.32 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.453 -0.78 . . . . 0.0 109.034 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.566 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.1 Cg_endo -63.88 -33.56 63.65 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.85 2.367 . . . . 0.0 112.028 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.407 ' HB2' HD21 ' A' ' 86' ' ' ASN . 6.2 m -75.47 -29.43 59.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.302 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 90.4 m-20 -73.35 -31.13 63.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.273 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.75 HG11 HG11 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -121.49 77.54 36.07 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.888 . . . . 0.0 109.363 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.82 -23.83 30.1 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.802 2.335 . . . . 0.0 111.874 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.686 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 32.8 p90 -80.91 -22.42 39.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.418 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.616 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 25.0 tp . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.403 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 C--O 1.215 -0.634 0 CA-C-O 121.194 0.414 . . . . 0.0 111.763 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.731 ' CD1' HD11 ' A' ' 93' ' ' LEU . 26.4 mt -80.91 -177.58 6.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.486 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -118.02 139.9 50.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.368 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.75 154.01 38.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 17' ' ' THR . 87.1 tt0 -128.5 120.47 26.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.944 . . . . 0.0 109.357 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 1.01 HG22 ' HG3' ' A' ' 15' ' ' LYS . 59.2 mt -115.63 127.83 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.393 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 1.01 ' HG3' HG22 ' A' ' 14' ' ' ILE . 45.6 mttt 60.77 23.76 13.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 109.449 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.427 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.29 -5.22 84.29 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.685 HG22 ' CD2' ' A' ' 19' ' ' LEU . 35.4 m -93.14 127.59 38.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -1.158 . . . . 0.0 109.459 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.871 ' O ' HD22 ' A' ' 19' ' ' LEU . 18.2 tttm -87.24 120.45 28.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.568 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 18' ' ' LYS . 3.5 mm? -129.59 164.6 23.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 109.313 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -83.0 155.96 23.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.938 . . . . 0.0 109.395 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.792 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -144.85 163.24 34.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.467 ' HB2' ' CE2' ' A' ' 82' ' ' TYR . 35.4 m80 -125.92 127.8 46.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.527 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.723 ' CD1' HD13 ' A' ' 93' ' ' LEU . 51.9 t90 -78.67 118.5 20.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.907 . . . . 0.0 109.507 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -128.2 102.93 6.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.953 . . . . 0.0 109.336 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.584 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 60.6 p -60.8 -29.2 69.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.609 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.98 -34.36 78.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.08 136.74 54.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.491 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.448 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 36.9 m -95.51 -14.73 23.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 tt -142.36 155.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.564 ' HB ' HG12 ' A' ' 75' ' ' VAL . 47.5 m -61.1 136.93 58.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -119.22 126.6 51.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.382 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.911 HG12 HG23 ' A' ' 83' ' ' ILE . 15.7 m -124.96 161.37 49.55 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 109.66 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 78' ' ' SER . 54.8 Cg_endo -79.38 132.05 9.92 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.751 2.301 . . . . 0.0 111.834 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.1 tt0 -45.36 -26.81 0.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.63 -36.1 33.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.509 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.07 -2.56 57.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.692 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 0.0 109.916 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.692 ' CD2' HD23 ' A' ' 37' ' ' LEU . 17.5 m-85 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.303 0.573 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 48.6 t80 -95.86 112.0 23.84 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.504 HD12 HG21 ' A' ' 75' ' ' VAL . 37.6 mt -121.79 170.22 9.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.052 -1.03 . . . . 0.0 110.489 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.717 HG23 ' HG2' ' A' ' 72' ' ' GLU . 87.1 m -121.97 119.77 32.47 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.763 ' CE2' HG22 ' A' ' 66' ' ' VAL . 44.6 p90 -140.68 154.46 46.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.026 -1.046 . . . . 0.0 109.739 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.431 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 20.1 mttm -85.87 132.33 34.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.833 . . . . 0.0 109.318 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.763 HG22 ' CE2' ' A' ' 64' ' ' PHE . 1.9 t -109.0 100.86 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.703 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 81.2 mt-30 65.09 35.45 7.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.458 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.33 35.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -134.08 116.73 15.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -1.072 . . . . 0.0 109.424 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.555 ' HE3' HG21 ' A' ' 63' ' ' THR . 15.3 tttp -66.8 119.7 12.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.534 HG21 ' CH2' ' A' ' 92' ' ' TRP . 98.6 t -141.24 134.39 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.867 . . . . 0.0 109.429 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.717 ' HG2' HG23 ' A' ' 63' ' ' THR . 61.1 mt-10 -110.5 136.13 50.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 109.593 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.26 166.34 29.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.672 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 96.3 mt-10 -80.02 136.24 36.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.27 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.718 HG21 HG21 ' A' ' 32' ' ' VAL . 4.1 m -127.96 158.19 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.22 -0.925 . . . . 0.0 109.65 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.4 tp -109.32 146.09 34.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.8 124.5 28.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 109.227 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.483 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 2.0 t -128.09 150.21 73.18 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.483 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.8 Cg_endo -70.58 -0.3 7.39 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.683 2.255 . . . . 0.0 111.628 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 56.0 m-85 -64.13 172.14 2.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 109.444 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -112.14 17.09 19.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.607 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.68 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 19.3 p90 -139.35 -156.82 0.71 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.245 -0.909 . . . . 0.0 109.087 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.911 HG23 HG12 ' A' ' 32' ' ' VAL . 3.0 mt -130.04 140.9 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.72 ' N ' HD12 ' A' ' 84' ' ' LEU . 6.5 mp -105.5 131.77 52.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 108.987 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.792 HD21 ' HB1' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -98.94 146.55 25.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.139 -0.976 . . . . 0.0 109.666 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.676 ' O ' HG22 ' A' ' 90' ' ' VAL . 4.7 t30 -99.74 136.86 20.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 109.189 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.524 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.6 Cg_endo -64.13 -33.26 61.93 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.805 2.336 . . . . 0.0 111.81 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.408 ' HB3' HD21 ' A' ' 86' ' ' ASN . 4.8 t -76.56 -25.95 54.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.18 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.432 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 89.6 m-20 -80.26 -32.69 38.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.376 -0.827 . . . . 0.0 109.306 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.964 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -120.03 76.23 22.45 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.872 . . . . 0.0 109.54 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.27 -24.85 26.87 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.682 2.255 . . . . 0.0 111.796 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.964 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 39.8 p90 -75.27 -27.59 59.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -0.89 . . . . 0.0 109.585 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.731 HD11 ' CD1' ' A' ' 10' ' ' LEU . 9.4 tt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 C--O 1.215 -0.646 0 CA-C-O 121.239 0.433 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.494 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 20.9 mt -83.79 -177.36 6.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.92 . . . . 0.0 109.559 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -117.93 136.97 53.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 109.389 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.98 150.13 32.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.207 -0.933 . . . . 0.0 109.653 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.445 ' HG2' ' HA ' ' A' ' 18' ' ' LYS . 95.5 mt-10 -118.58 123.04 44.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.28 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' A' ' 64' ' ' PHE . 56.2 mt -117.37 124.11 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.582 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.7 tptt 64.11 22.13 12.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.524 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.13 -1.03 82.39 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.734 HG22 ' CD2' ' A' ' 19' ' ' LEU . 10.6 m -96.16 129.66 43.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.136 . . . . 0.0 109.384 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.88 ' O ' HD22 ' A' ' 19' ' ' LEU . 71.4 tttt -86.9 117.02 25.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.44 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.88 HD22 ' O ' ' A' ' 18' ' ' LYS . 3.8 mm? -132.17 161.37 33.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.386 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -84.45 153.57 23.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.419 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.789 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -141.58 163.01 34.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 109.56 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 82' ' ' TYR . 36.7 m80 -121.01 127.72 52.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 109.627 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.494 ' HB2' ' CD1' ' A' ' 10' ' ' LEU . 34.1 t90 -80.39 118.89 22.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.587 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -127.67 102.97 7.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.265 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' A' ' 87' ' ' PRO . 23.4 t -59.12 -29.43 67.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 109.625 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.51 -40.16 94.06 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.434 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -65.19 128.27 35.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -1.151 . . . . 0.0 109.487 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.509 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 45.6 p -94.09 -8.07 40.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.217 -0.927 . . . . 0.0 109.447 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 29' ' ' ILE . 11.1 tp -139.09 151.23 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.245 -0.909 . . . . 0.0 109.293 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 34.7 m -68.59 140.06 55.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 9.2 t -129.51 139.24 51.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.256 -0.903 . . . . 0.0 109.14 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.546 ' HB ' ' HD2' ' A' ' 33' ' ' PRO . 4.0 m -136.85 167.05 22.85 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.225 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.546 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.5 Cg_endo -78.93 134.32 11.77 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.202 1.935 . . . . 0.0 111.704 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -45.05 -24.58 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.363 -0.836 . . . . 0.0 109.874 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -47.71 -36.18 10.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 109.723 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -92.38 -7.41 47.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.182 -0.949 . . . . 0.0 109.588 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.58 ' HG ' ' CD2' ' A' ' 60' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 109.527 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.58 ' CD2' ' HG ' ' A' ' 37' ' ' LEU . 26.6 m-85 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.441 0.639 . . . . 0.0 110.316 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.82 ' O ' HD22 ' A' ' 62' ' ' LEU . 4.8 t80 -98.19 110.13 22.77 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.82 HD22 ' O ' ' A' ' 61' ' ' TYR . 3.6 mm? -124.03 156.35 36.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.481 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.548 HG23 ' HB2' ' A' ' 72' ' ' GLU . 5.0 m -110.97 126.09 54.4 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.443 -0.786 . . . . 0.0 108.931 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.624 ' CE2' HG22 ' A' ' 66' ' ' VAL . 28.1 p90 -141.48 153.39 44.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.107 -0.995 . . . . 0.0 109.694 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 6.0 mmtp -83.85 127.95 34.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.28 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.891 HG11 HG11 ' A' ' 90' ' ' VAL . 25.1 t -105.75 98.99 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 82.1 mt-30 64.68 36.5 8.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.51 30.01 31.3 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 65' ' ' LYS . 56.6 mtt180 -136.7 125.17 23.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -1.134 . . . . 0.0 109.449 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -67.33 128.41 36.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.473 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.437 HG21 ' CH2' ' A' ' 92' ' ' TRP . 43.3 t -150.0 128.18 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.56 ' HG2' ' CE2' ' A' ' 61' ' ' TYR . 55.2 tt0 -118.31 134.59 54.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.0 175.23 13.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.268 -0.895 . . . . 0.0 109.434 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.426 ' HG3' ' CD1' ' A' ' 61' ' ' TYR . 95.6 mt-10 -79.71 139.65 37.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 109.261 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' ' 32' ' ' VAL . 10.8 m -133.82 151.86 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.269 -0.894 . . . . 0.0 109.583 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.852 ' N ' HD12 ' A' ' 76' ' ' LEU . 4.3 mp -102.61 145.77 29.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.33 -0.856 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.0 137.94 36.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.298 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.478 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.3 t -144.02 151.17 51.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.0 Cg_endo -71.79 2.53 4.62 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.69 2.26 . . . . 0.0 111.83 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -63.55 167.11 5.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.162 -0.962 . . . . 0.0 109.338 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -109.71 17.71 20.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.762 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 14.5 p90 -139.49 -157.71 0.79 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.136 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.541 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.0 mt -128.98 145.82 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 109.575 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.762 HD11 ' CZ ' ' A' ' 82' ' ' TYR . 5.9 mp -110.76 135.0 52.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -0.882 . . . . 0.0 108.872 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.835 ' N ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -105.64 142.49 35.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.606 ' O ' HG22 ' A' ' 90' ' ' VAL . 6.5 t30 -100.13 134.86 20.56 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 108.949 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.492 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 41.5 Cg_endo -63.86 -22.85 68.88 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.769 2.313 . . . . 0.0 112.234 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.431 ' HB2' HD21 ' A' ' 86' ' ' ASN . 14.2 m -77.05 -31.62 56.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 0.0 109.298 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.914 ' OD1' HG13 ' A' ' 90' ' ' VAL . 1.9 p30 -80.37 -35.63 35.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 109.378 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.035 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 2.4 m -112.1 69.28 0.92 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.391 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.87 -21.94 32.26 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.679 2.252 . . . . 0.0 111.813 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.035 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 38.7 p90 -72.76 -28.8 62.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.431 HD13 HE22 ' A' ' 67' ' ' GLN . 24.2 tp . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 C--O 1.215 -0.669 0 CA-C-O 121.205 0.419 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.71 HD12 HD13 ' A' ' 85' ' ' LEU . 17.2 mt -81.45 179.92 7.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.33 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -110.48 139.13 46.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.89 148.65 32.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.488 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.436 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 79.3 tt0 -129.23 116.08 18.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -0.86 . . . . 0.0 109.37 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.642 HG22 ' HG3' ' A' ' 15' ' ' LYS . 59.4 mt -111.72 127.31 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.14 -0.975 . . . . 0.0 109.592 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.642 ' HG3' HG22 ' A' ' 14' ' ' ILE . 54.4 mttp 57.88 24.76 11.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.288 -0.882 . . . . 0.0 109.599 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.436 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.52 -10.69 72.54 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.426 HG21 ' HZ ' ' A' ' 36' ' ' PHE . 50.0 m -79.72 125.51 29.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -1.105 . . . . 0.0 109.312 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.755 ' O ' HD23 ' A' ' 19' ' ' LEU . 3.3 ttmt -88.81 117.34 27.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.527 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.775 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 73.3 mt -136.54 156.52 48.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.868 . . . . 0.0 109.363 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -84.72 151.75 24.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.865 ' CB ' HD21 ' A' ' 85' ' ' LEU . . . -133.69 -179.76 5.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.936 . . . . 0.0 109.578 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.47 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 27.8 m80 -134.24 131.16 38.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.901 . . . . 0.0 109.599 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.596 ' N ' HD12 ' A' ' 85' ' ' LEU . 64.4 t90 -88.33 119.04 28.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.264 -0.898 . . . . 0.0 109.352 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -128.21 103.02 6.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.297 -0.877 . . . . 0.0 109.427 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.511 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 21.4 t -55.83 -31.84 63.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.646 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.27 -37.51 91.96 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.467 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -68.03 144.94 54.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -1.192 . . . . 0.0 109.517 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.517 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 39.7 p -113.13 -5.6 13.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.459 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.8 tt -141.8 146.28 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 0.0 109.423 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.641 ' HB ' HG22 ' A' ' 75' ' ' VAL . 51.7 m -66.73 141.17 57.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 0.0 109.633 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -126.66 136.41 52.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.995 HG12 HG23 ' A' ' 83' ' ' ILE . 25.0 m -132.38 165.02 39.31 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.831 . . . . 0.0 108.899 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.4 Cg_endo -78.23 129.84 9.81 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.115 1.876 . . . . 0.0 111.419 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 33' ' ' PRO . 81.3 tt0 -40.87 -27.82 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.53 -0.731 . . . . 0.0 109.891 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -50.79 -28.33 9.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.538 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.775 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 15.0 m-85 -96.36 -7.76 34.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 109.528 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.64 ' CD2' ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.797 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.64 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 25.5 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.253 0.549 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.603 ' O ' HD23 ' A' ' 62' ' ' LEU . 34.5 t80 -87.14 114.12 23.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.887 . . . . 0.0 108.776 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 61' ' ' TYR . 32.4 mt -120.89 163.45 18.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.133 -0.979 . . . . 0.0 110.235 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.733 HG23 ' HG2' ' A' ' 72' ' ' GLU . 41.5 m -124.24 121.12 34.17 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.709 ' CE2' HG22 ' A' ' 66' ' ' VAL . 22.0 p90 -145.4 164.17 32.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.951 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -90.87 132.95 35.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.414 -0.804 . . . . 0.0 109.339 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.823 HG11 HG11 ' A' ' 90' ' ' VAL . 38.3 t -111.4 98.3 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.552 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 88.0 mt-30 63.35 36.28 11.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.325 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.45 35.08 18.13 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -141.98 124.59 15.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -1.1 . . . . 0.0 109.39 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -69.68 122.44 19.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.14 134.79 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.887 . . . . 0.0 109.556 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.733 ' HG2' HG23 ' A' ' 63' ' ' THR . 52.1 mt-10 -125.77 132.59 52.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.557 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.29 -176.99 5.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.82 154.03 28.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.273 -0.892 . . . . 0.0 109.091 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.786 ' CG1' HG22 ' A' ' 32' ' ' VAL . 56.0 t -144.83 157.64 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.188 -0.945 . . . . 0.0 109.748 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.468 ' N ' HG12 ' A' ' 75' ' ' VAL . 16.4 tp -117.58 144.4 45.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 109.041 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.97 137.46 36.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 109.529 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.475 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 3.2 t -142.31 150.23 54.35 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.332 -0.855 . . . . 0.0 109.471 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.475 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 52.8 Cg_endo -72.68 5.71 2.76 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.602 2.202 . . . . 0.0 111.905 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -64.73 -178.94 0.45 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -118.87 14.68 13.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.471 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.578 ' CZ ' ' HG ' ' A' ' 84' ' ' LEU . 20.5 p90 -142.28 -156.99 0.73 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 108.972 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.995 HG23 HG12 ' A' ' 32' ' ' VAL . 2.8 mt -128.84 128.28 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.25 -0.906 . . . . 0.0 109.812 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.578 ' HG ' ' CZ ' ' A' ' 82' ' ' TYR . 1.7 mt -83.86 136.91 33.93 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.2 -0.937 . . . . 0.0 108.713 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.865 HD21 ' CB ' ' A' ' 21' ' ' ALA . 5.2 mt -102.13 143.57 31.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 0.0 110.049 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.665 ' O ' HG22 ' A' ' 90' ' ' VAL . 10.3 t-20 -102.54 133.12 20.68 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.472 -0.768 . . . . 0.0 109.133 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 44.2 Cg_endo -66.05 -30.27 47.67 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.759 2.306 . . . . 0.0 111.929 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.409 ' HB2' HD21 ' A' ' 86' ' ' ASN . 14.7 m -76.21 -31.75 58.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.162 -0.961 . . . . 0.0 109.238 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -73.21 -28.3 62.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.382 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.938 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 2.2 m -124.1 77.83 59.45 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.559 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.5 Cg_endo -70.14 -20.45 33.03 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.731 2.287 . . . . 0.0 111.972 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.938 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 48.8 p90 -80.99 -27.45 35.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.812 ' O ' HD13 ' A' ' 93' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 109.391 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.502 ' CG ' ' HD3' ' A' ' 20' ' ' LYS . 49.9 Cg_endo . . . . . 0 C--O 1.216 -0.608 0 CA-C-O 121.233 0.431 . . . . 0.0 111.747 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.471 ' H ' HD12 ' A' ' 10' ' ' LEU . 4.5 mp -81.8 176.36 9.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.428 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -104.76 140.31 38.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.65 152.7 33.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.873 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 17' ' ' THR . 91.9 mt-10 -129.35 116.35 18.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 109.531 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.926 HG22 ' HG3' ' A' ' 15' ' ' LYS . 33.5 mt -109.88 128.76 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 109.401 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.926 ' HG3' HG22 ' A' ' 14' ' ' ILE . 2.8 mtmt 58.71 22.32 9.84 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.178 -0.951 . . . . 0.0 109.55 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.72 -0.88 83.15 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.471 HG22 HD23 ' A' ' 19' ' ' LEU . 31.2 m -93.46 132.7 37.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -1.218 . . . . 0.0 109.479 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.981 ' O ' HD22 ' A' ' 19' ' ' LEU . 25.7 tttt -83.05 121.15 26.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.51 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.981 HD22 ' O ' ' A' ' 18' ' ' LYS . 1.6 mm? -138.34 158.82 43.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.945 . . . . 0.0 109.545 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HD3' ' CG ' ' A' ' 9' ' ' PRO . 46.2 mttt -82.48 147.01 28.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.75 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -134.86 159.78 40.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.373 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.855 ' O ' HD22 ' A' ' 85' ' ' LEU . 19.9 m80 -123.06 133.97 54.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.42 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.948 ' CD1' HD23 ' A' ' 93' ' ' LEU . 63.5 t90 -95.29 121.81 37.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.598 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.744 ' CB ' HD21 ' A' ' 84' ' ' LEU . 61.1 t0 -131.07 103.79 6.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -0.881 . . . . 0.0 109.306 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.564 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 56.1 p -56.69 -16.84 7.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.58 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.92 -35.51 58.07 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.465 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -69.6 140.79 53.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -1.152 . . . . 0.0 109.594 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.8 p -107.02 -0.89 22.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 0.0 109.495 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.858 HD13 HD11 ' A' ' 76' ' ' LEU . 20.0 tt -144.26 152.52 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.232 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.661 ' HB ' HG12 ' A' ' 75' ' ' VAL . 34.5 m -65.99 149.9 49.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.501 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 84' ' ' LEU . 13.1 t -123.06 141.66 51.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.173 -0.955 . . . . 0.0 109.121 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.771 HG23 ' HB ' ' A' ' 75' ' ' VAL . 74.3 t -143.43 145.9 33.72 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.412 -0.805 . . . . 0.0 109.308 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.738 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.4 Cg_endo -77.76 132.11 11.73 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.245 1.964 . . . . 0.0 111.447 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 33' ' ' PRO . 82.6 tt0 -41.59 -28.1 0.12 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.429 -0.794 . . . . 0.0 109.71 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -51.46 -30.21 18.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.145 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -97.63 0.39 47.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 109.712 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.642 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.013 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.642 ' CD2' HD23 ' A' ' 37' ' ' LEU . 13.8 m-85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.36 0.6 . . . . 0.0 109.99 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.556 ' O ' HD23 ' A' ' 62' ' ' LEU . 46.5 t80 -99.83 113.65 26.31 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 61' ' ' TYR . 40.2 mt -122.46 169.35 11.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.705 HG23 ' HG2' ' A' ' 72' ' ' GLU . 97.8 m -120.7 116.48 25.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.586 ' CE2' HG22 ' A' ' 66' ' ' VAL . 22.6 p90 -136.41 158.19 45.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.057 -1.027 . . . . 0.0 109.773 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 13' ' ' GLU . 40.8 mttm -89.98 129.12 36.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.322 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.796 HG11 HG11 ' A' ' 90' ' ' VAL . 11.7 t -105.99 101.88 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.917 . . . . 0.0 109.515 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 19.3 mt-30 64.32 38.98 7.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.895 . . . . 0.0 109.412 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.62 32.43 41.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.0 mtt-85 -138.33 114.51 10.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.442 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HE2' HG21 ' A' ' 63' ' ' THR . 72.6 tttt -61.49 122.75 15.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.616 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.511 HG21 ' CH2' ' A' ' 92' ' ' TRP . 58.8 t -145.32 130.13 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.224 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.705 ' HG2' HG23 ' A' ' 63' ' ' THR . 82.1 mt-10 -108.3 137.36 46.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 0.0 109.617 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.3 166.56 29.26 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.603 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.484 ' O ' ' HB ' ' A' ' 30' ' ' THR . 93.6 mt-10 -79.86 140.57 36.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.771 ' HB ' HG23 ' A' ' 32' ' ' VAL . 10.2 m -131.16 153.19 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.635 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.858 HD11 HD13 ' A' ' 29' ' ' ILE . 5.2 mp -107.48 148.42 29.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.385 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.78 140.09 37.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 109.425 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.501 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -151.56 152.86 31.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.296 -0.877 . . . . 0.0 109.239 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.501 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.0 Cg_endo -70.57 2.49 3.94 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.528 2.152 . . . . 0.0 112.034 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 34.0 m-85 -65.88 170.38 5.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 109.438 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -114.43 21.19 14.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.365 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.582 ' OH ' HD12 ' A' ' 84' ' ' LEU . 33.3 p90 -142.01 -166.5 2.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 109.143 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 19' ' ' LEU . 1.5 mt -132.02 118.62 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.923 . . . . 0.0 109.64 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.744 HD21 ' CB ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -82.61 134.45 35.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 108.987 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.855 HD22 ' O ' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -97.31 142.26 29.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.065 -1.022 . . . . 0.0 109.763 -179.71 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.645 ' O ' HG22 ' A' ' 90' ' ' VAL . 6.5 t-20 -90.11 135.57 29.84 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.033 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.56 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 41.5 Cg_endo -64.1 -33.14 62.71 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.805 2.337 . . . . 0.0 111.972 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.409 ' HB2' HD21 ' A' ' 86' ' ' ASN . 13.4 m -71.88 -28.02 63.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.118 -0.989 . . . . 0.0 109.107 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -79.17 -30.79 43.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 109.344 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.127 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -119.67 74.25 17.72 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.917 . . . . 0.0 109.328 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.575 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.9 Cg_endo -69.6 -18.92 37.49 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.749 2.299 . . . . 0.0 111.926 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.127 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 48.9 p90 -81.21 -26.24 36.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.479 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.948 HD23 ' CD1' ' A' ' 23' ' ' TRP . 24.1 tp . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.442 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 C--O 1.215 -0.627 0 CA-C-O 121.203 0.418 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 23' ' ' TRP . 25.2 mt -90.6 -177.32 5.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.582 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -112.19 134.44 53.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.353 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.0 146.24 28.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -0.948 . . . . 0.0 109.5 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 17' ' ' THR . 65.4 tt0 -121.97 122.21 38.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.883 . . . . 0.0 109.224 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.456 HG12 ' HB3' ' A' ' 64' ' ' PHE . 43.2 mt -114.74 127.12 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.694 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 58.07 25.59 12.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.531 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.44 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 90.66 -13.69 65.0 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 52.8 m -79.78 131.85 36.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -1.21 . . . . 0.0 109.385 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.865 ' O ' HD23 ' A' ' 19' ' ' LEU . 29.7 tttm -96.4 123.9 40.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 109.62 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.865 HD23 ' O ' ' A' ' 18' ' ' LYS . 57.2 mt -143.32 162.67 35.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -89.43 146.93 24.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.928 . . . . 0.0 109.527 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.621 ' CB ' HD11 ' A' ' 85' ' ' LEU . . . -130.01 176.58 7.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.749 ' O ' HD22 ' A' ' 85' ' ' LEU . 25.9 m80 -127.47 129.97 48.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.455 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.605 ' HB2' HD11 ' A' ' 10' ' ' LEU . 20.6 t90 -83.17 122.54 28.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.683 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -127.52 96.28 4.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.341 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.46 ' HA ' ' HG3' ' A' ' 87' ' ' PRO . 17.3 t -53.68 -33.9 56.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.645 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.62 -35.65 86.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.32 137.22 57.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -1.166 . . . . 0.0 109.631 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.518 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 89.2 m -102.07 -9.43 20.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 109.381 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.435 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 20.1 tt -139.61 160.12 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.335 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.513 ' CG2' HG12 ' A' ' 75' ' ' VAL . 38.5 m -71.51 150.19 45.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.315 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.556 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -126.83 127.17 44.57 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -0.916 . . . . 0.0 108.998 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.78 HG13 ' HD2' ' A' ' 33' ' ' PRO . 53.8 t -126.92 147.37 61.11 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 109.176 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.78 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.5 Cg_endo -77.26 132.99 12.95 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.176 1.917 . . . . 0.0 111.914 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 33' ' ' PRO . 80.5 tt0 -43.01 -26.67 0.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.741 . . . . 0.0 109.701 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.48 -23.09 1.41 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.516 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.611 ' HZ ' HD11 ' A' ' 19' ' ' LEU . 14.1 m-85 -102.44 -6.41 22.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.518 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.031 HD11 HD11 ' A' ' 62' ' ' LEU . 2.7 mm? . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.198 -0.939 . . . . 0.0 109.558 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.261 0.553 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.685 ' O ' HD23 ' A' ' 62' ' ' LEU . 41.3 t80 -91.36 119.4 31.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 108.844 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.031 HD11 HD11 ' A' ' 37' ' ' LEU . 64.4 mt -131.16 170.18 14.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.387 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.705 HG23 ' HG2' ' A' ' 72' ' ' GLU . 87.9 m -119.56 122.92 42.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.517 -0.739 . . . . 0.0 109.084 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.812 ' CE2' HG22 ' A' ' 66' ' ' VAL . 33.2 p90 -141.82 157.2 45.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 0.0 109.781 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 83.7 mttt -87.83 129.69 35.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.23 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.812 HG22 ' CE2' ' A' ' 64' ' ' PHE . 4.3 t -104.24 98.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 90.0 mt-30 62.93 35.34 13.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.898 . . . . 0.0 109.193 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.77 31.81 20.08 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.446 ' O ' HG23 ' A' ' 71' ' ' VAL . 51.6 mtt180 -136.84 111.62 8.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -1.125 . . . . 0.0 109.432 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -61.84 117.72 6.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.575 HG21 ' CH2' ' A' ' 92' ' ' TRP . 44.4 t -142.31 136.91 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 0.0 109.412 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.705 ' HG2' HG23 ' A' ' 63' ' ' THR . 64.0 mt-10 -112.61 137.93 50.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.974 . . . . 0.0 109.388 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.21 166.31 29.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.83 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 96.3 mt-10 -81.43 136.15 35.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.228 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.683 ' HB ' HG23 ' A' ' 32' ' ' VAL . 17.5 m -125.55 148.03 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.181 -0.949 . . . . 0.0 109.731 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 32' ' ' VAL . 28.1 tp -94.05 143.05 26.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.853 . . . . 0.0 109.13 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.27 133.66 36.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.556 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 21.8 t -144.4 148.84 42.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.626 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.48 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.3 Cg_endo -70.36 1.79 4.49 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.728 2.285 . . . . 0.0 112.058 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.556 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 39.6 m-85 -63.34 172.72 1.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 109.432 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -113.36 21.29 15.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 109.579 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.586 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 13.1 p90 -144.87 -161.02 1.21 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.16 -0.963 . . . . 0.0 109.356 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.453 HG13 ' C ' ' A' ' 82' ' ' TYR . 2.2 mt -132.62 149.1 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.881 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.741 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.4 mt -109.21 131.82 54.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.865 . . . . 0.0 108.757 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.807 ' H ' HD22 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -99.95 133.17 44.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.109 -0.994 . . . . 0.0 109.723 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.574 ' O ' HG22 ' A' ' 90' ' ' VAL . 6.2 t-20 -88.18 136.23 32.21 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 0.0 109.146 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.547 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 41.8 Cg_endo -64.34 -32.16 61.6 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.744 2.296 . . . . 0.0 111.881 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.439 ' HB2' HD21 ' A' ' 86' ' ' ASN . 14.2 m -72.32 -33.94 67.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 109.222 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -71.9 -34.11 68.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.313 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.781 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 33.5 m -115.84 76.56 6.07 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 109.55 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.44 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 48.6 Cg_endo -69.15 -21.63 36.04 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.698 2.265 . . . . 0.0 111.678 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.781 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 36.4 p90 -70.66 -26.32 63.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.314 -0.866 . . . . 0.0 109.469 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.441 HD23 ' CD1' ' A' ' 23' ' ' TRP . 28.6 tp . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.474 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 C--O 1.215 -0.625 0 CA-C-O 121.233 0.43 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 23' ' ' TRP . 15.3 mt -79.83 -174.63 4.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.443 ' OE2' ' HE3' ' A' ' 18' ' ' LYS . 75.9 tt0 -113.65 137.2 51.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 109.501 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.3 142.25 25.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -120.65 118.02 29.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.888 HG22 ' HG3' ' A' ' 15' ' ' LYS . 36.6 mt -109.49 129.46 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.507 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.888 ' HG3' HG22 ' A' ' 14' ' ' ILE . 72.0 mttt 54.52 24.83 5.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.9 . . . . 0.0 109.5 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.06 -10.81 72.79 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.593 HG22 HD11 ' A' ' 19' ' ' LEU . 4.3 m -80.31 126.94 31.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -1.183 . . . . 0.0 109.422 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HE3' ' OE2' ' A' ' 11' ' ' GLU . 39.1 tttt -85.93 125.16 33.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.347 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.593 HD11 HG22 ' A' ' 17' ' ' THR . 1.9 mp -146.21 156.03 43.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 109.587 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -80.16 152.13 29.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 0.0 109.507 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.702 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -136.92 169.56 17.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.461 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 47.2 m80 -127.41 138.84 53.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 109.463 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.629 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 40.0 t90 -91.08 114.1 26.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.206 -0.934 . . . . 0.0 109.408 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -121.57 100.1 6.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 109.382 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.573 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 59.8 p -60.8 -25.66 66.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.758 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.64 -41.59 95.76 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.442 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -67.77 140.97 56.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.194 -1.18 . . . . 0.0 109.538 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.435 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 68.6 p -99.59 -10.27 22.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.893 . . . . 0.0 109.384 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.453 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 19.7 tt -139.06 159.79 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.272 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.4 m -67.53 153.26 44.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 109.671 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.578 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -131.21 116.81 18.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.072 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.785 HG13 ' HD2' ' A' ' 33' ' ' PRO . 54.0 t -114.07 147.71 38.41 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.785 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.4 Cg_endo -77.4 132.04 12.07 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.094 1.862 . . . . 0.0 111.664 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.1 tt0 -41.77 -27.67 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.467 -0.77 . . . . 0.0 109.801 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -50.56 -31.64 16.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.525 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.43 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 14.3 m-85 -98.47 -3.24 37.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.665 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.675 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.797 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.675 ' CD2' HD23 ' A' ' 37' ' ' LEU . 12.4 m-85 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.271 0.558 . . . . 0.0 109.902 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.501 ' O ' HD23 ' A' ' 62' ' ' LEU . 44.3 t80 -100.67 113.11 25.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.849 . . . . 0.0 108.771 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.666 HD12 HG21 ' A' ' 75' ' ' VAL . 44.6 mt -122.46 173.02 7.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.105 -0.997 . . . . 0.0 110.276 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.673 HG23 ' HG2' ' A' ' 72' ' ' GLU . 86.6 m -124.01 125.48 44.63 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 9.4 p90 -144.68 157.81 44.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.888 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -88.38 130.52 35.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.418 -0.801 . . . . 0.0 109.292 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.469 HG11 HG11 ' A' ' 90' ' ' VAL . 74.4 t -110.77 104.47 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 86.7 mt-30 63.13 35.17 13.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.331 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.77 31.95 34.59 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -137.54 116.53 12.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -1.139 . . . . 0.0 109.477 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -62.13 121.0 11.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.504 HG21 ' CH2' ' A' ' 92' ' ' TRP . 87.3 t -142.69 129.05 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.88 . . . . 0.0 109.498 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.673 ' HG2' HG23 ' A' ' 63' ' ' THR . 35.8 mt-10 -108.59 136.47 48.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.19 169.98 22.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 109.619 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 95.4 mt-10 -80.41 135.89 36.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.74 ' HB ' HG23 ' A' ' 32' ' ' VAL . 5.0 m -126.76 152.22 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 109.631 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 32' ' ' VAL . 20.7 tp -105.42 149.13 26.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.109 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.58 137.3 37.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 109.196 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.571 ' OG ' ' CE2' ' A' ' 80' ' ' TYR . 23.3 t -148.7 149.57 31.14 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.926 . . . . 0.0 109.669 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.488 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 54.5 Cg_endo -72.88 6.88 2.23 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.661 2.241 . . . . 0.0 111.985 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.571 ' CE2' ' OG ' ' A' ' 78' ' ' SER . 30.7 m-85 -60.52 -178.99 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.613 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -119.93 20.73 12.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.927 . . . . 0.0 109.325 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.602 ' OH ' HD21 ' A' ' 84' ' ' LEU . 13.3 p90 -153.61 -152.35 0.41 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.275 -0.89 . . . . 0.0 108.894 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.533 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 1.7 mt -132.35 125.58 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.785 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.602 HD21 ' OH ' ' A' ' 82' ' ' TYR . 1.2 mt -82.94 143.27 30.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.218 -0.926 . . . . 0.0 108.93 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.702 HD21 ' HB1' ' A' ' 21' ' ' ALA . 3.9 mt -109.73 135.3 50.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -0.978 . . . . 0.0 109.929 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.697 ' O ' HG22 ' A' ' 90' ' ' VAL . 4.4 t30 -91.16 136.65 26.99 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 109.125 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.522 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 43.5 Cg_endo -64.6 -36.96 39.75 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.781 2.32 . . . . 0.0 112.034 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.422 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 3.1 m -70.38 -32.47 70.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.121 -0.987 . . . . 0.0 109.303 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.464 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 81.8 m-20 -71.84 -29.2 64.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.352 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.155 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -118.81 74.92 12.98 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.314 -0.866 . . . . 0.0 109.531 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.59 -21.99 28.89 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.747 2.298 . . . . 0.0 111.801 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.155 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 40.8 p90 -76.28 -28.31 56.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 0.0 109.49 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.629 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 38.6 tp . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.461 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 C--O 1.216 -0.616 0 CA-C-O 121.15 0.396 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.595 HD13 HD23 ' A' ' 85' ' ' LEU . 4.3 mp -85.0 165.84 17.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.514 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -103.46 144.13 31.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 109.428 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.7 148.11 22.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 64' ' ' PHE . 78.1 tt0 -121.02 121.08 37.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.868 HG22 ' HG3' ' A' ' 15' ' ' LYS . 42.4 mt -111.93 127.71 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.868 ' HG3' HG22 ' A' ' 14' ' ' ILE . 3.6 mtmt 54.5 25.82 6.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.443 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 93.29 -15.81 62.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.886 HG22 HD11 ' A' ' 19' ' ' LEU . 2.3 m -79.85 126.07 30.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -1.181 . . . . 0.0 109.312 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.967 ' C ' HD12 ' A' ' 19' ' ' LEU . 31.4 tttt -94.26 116.9 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.0 109.63 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.967 HD12 ' C ' ' A' ' 18' ' ' LYS . 9.4 mp -135.09 166.09 23.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.306 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -80.32 155.03 27.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.449 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.888 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -141.27 163.03 34.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 109.482 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.835 ' O ' HD22 ' A' ' 85' ' ' LEU . 36.0 m80 -125.38 136.84 53.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.749 ' CD1' HD23 ' A' ' 93' ' ' LEU . 26.2 t90 -85.58 126.67 34.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.422 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -133.58 100.63 4.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.519 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 60.4 p -62.39 -29.21 70.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.495 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.2 -33.25 64.61 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.414 ' O ' ' OD1' ' A' ' 86' ' ' ASN . . . -73.81 140.34 45.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -1.129 . . . . 0.0 109.418 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 28' ' ' THR . 87.4 m -100.36 -5.27 27.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.633 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.486 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 21.2 tt -146.67 149.3 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.507 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.849 ' CG2' HG12 ' A' ' 75' ' ' VAL . 86.4 m -52.47 150.79 4.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.634 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.622 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -128.03 136.98 51.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.193 -0.942 . . . . 0.0 109.212 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.776 HG13 ' HD2' ' A' ' 33' ' ' PRO . 56.9 t -138.61 147.43 54.75 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 109.172 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.776 ' HD2' HG13 ' A' ' 32' ' ' VAL . 54.8 Cg_endo -77.66 132.21 11.91 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.123 1.882 . . . . 0.0 111.308 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 37' ' ' LEU . 79.9 tt0 -41.87 -27.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.759 . . . . 0.0 109.833 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -48.41 -24.53 1.28 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.14 -0.975 . . . . 0.0 109.308 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.638 ' CE2' HD22 ' A' ' 19' ' ' LEU . 7.6 m-85 -97.03 -9.38 28.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.646 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.95 HD11 HD11 ' A' ' 62' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 109.628 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.711 ' CD2' HD12 ' A' ' 37' ' ' LEU . 11.1 m-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.147 0.499 . . . . 0.0 109.731 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 39.7 t80 -85.26 110.06 18.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 108.885 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.95 HD11 HD11 ' A' ' 37' ' ' LEU . 53.1 mt -125.1 171.01 10.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 110.36 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.702 HG23 ' HG2' ' A' ' 72' ' ' GLU . 89.7 m -116.08 119.35 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CE2' HG22 ' A' ' 66' ' ' VAL . 17.3 p90 -136.07 154.22 51.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.037 . . . . 0.0 109.782 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.46 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 45.3 mttm -90.69 127.04 36.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.341 -0.849 . . . . 0.0 109.411 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.735 HG11 HG11 ' A' ' 90' ' ' VAL . 18.9 t -101.5 101.55 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 109.614 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 92.9 mt-30 62.87 33.13 15.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.297 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.82 24.8 34.21 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 65' ' ' LYS . 67.3 mtt180 -126.72 120.09 28.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -1.165 . . . . 0.0 109.362 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -67.0 117.05 8.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.403 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.75 HG21 ' HH2' ' A' ' 92' ' ' TRP . 86.0 t -141.15 130.85 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.702 ' HG2' HG23 ' A' ' 63' ' ' THR . 58.4 mt-10 -111.78 135.44 52.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.589 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.41 166.27 29.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.835 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 95.4 mt-10 -80.69 136.06 36.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.372 -0.83 . . . . 0.0 109.193 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.849 HG12 ' CG2' ' A' ' 30' ' ' THR . 34.6 m -123.26 145.55 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.227 -0.921 . . . . 0.0 109.696 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 32' ' ' VAL . 89.0 mt -90.53 143.9 26.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.091 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.34 135.64 36.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.0 . . . . 0.0 109.445 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.522 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 3.8 t -143.89 150.46 49.81 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 109.519 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.49 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 52.0 Cg_endo -72.46 5.99 2.52 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.665 2.244 . . . . 0.0 112.301 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.522 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 84.4 m-85 -71.37 167.51 19.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.056 -1.028 . . . . 0.0 109.527 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -107.79 17.05 22.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.66 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.657 ' OH ' HD21 ' A' ' 84' ' ' LEU . 15.6 p90 -137.19 -163.51 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 109.52 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.441 ' O ' ' CD2' ' A' ' 82' ' ' TYR . 4.0 mt -127.44 154.92 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -0.981 . . . . 0.0 109.744 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.753 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.3 mt -117.21 132.8 56.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.011 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.888 HD11 ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -97.91 122.48 41.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.084 -1.01 . . . . 0.0 109.628 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.731 ' O ' HG22 ' A' ' 90' ' ' VAL . 26.2 t30 -79.54 142.36 57.67 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.435 -0.791 . . . . 0.0 109.098 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.562 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 47.0 Cg_endo -67.31 -23.47 44.66 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.512 2.141 . . . . 0.0 111.677 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.418 ' OG ' ' ND2' ' A' ' 86' ' ' ASN . 51.8 p -80.41 -33.85 36.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.373 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.955 ' OD1' HG13 ' A' ' 90' ' ' VAL . 2.2 p30 -74.78 -28.87 60.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.493 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.955 HG13 ' OD1' ' A' ' 89' ' ' ASP . 4.1 m -122.3 78.62 44.54 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.656 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.565 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.8 Cg_endo -71.68 -23.56 22.73 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.615 2.21 . . . . 0.0 111.822 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.775 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 47.1 p90 -77.32 -33.09 55.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.593 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.749 HD23 ' CD1' ' A' ' 23' ' ' TRP . 21.9 tp . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.511 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 C--O 1.215 -0.657 0 CA-C-O 121.186 0.411 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.606 HD11 ' HB2' ' A' ' 23' ' ' TRP . 25.2 mt -88.27 -175.11 4.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.505 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.58 141.58 50.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 109.403 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.34 149.29 26.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 51.9 tt0 -118.35 118.14 30.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.858 HG22 ' HG3' ' A' ' 15' ' ' LYS . 41.5 mt -111.11 128.7 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.858 ' HG3' HG22 ' A' ' 14' ' ' ILE . 44.3 mttm 56.71 22.85 7.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 91.63 0.87 71.9 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.496 HG22 ' CD2' ' A' ' 19' ' ' LEU . 24.8 m -102.4 122.25 43.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -1.194 . . . . 0.0 109.457 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.834 ' O ' HD22 ' A' ' 19' ' ' LEU . 26.8 tttt -82.56 123.57 29.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.834 HD22 ' O ' ' A' ' 18' ' ' LYS . 1.5 mm? -132.89 167.08 20.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -85.88 139.65 31.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.801 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -128.28 168.66 15.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.628 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.688 ' O ' HD22 ' A' ' 85' ' ' LEU . 18.4 m80 -129.4 126.85 39.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.403 -0.811 . . . . 0.0 109.648 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.606 ' HB2' HD11 ' A' ' 10' ' ' LEU . 33.3 t90 -79.4 125.86 30.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.456 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -131.39 102.77 6.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.528 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 58.2 p -61.63 -31.68 71.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.629 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.08 -31.53 73.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.49 139.66 49.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -1.166 . . . . 0.0 109.615 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.434 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 35.0 p -106.02 -4.9 19.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.85 . . . . 0.0 109.554 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.511 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 19.7 tt -143.82 141.14 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.405 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.537 ' N ' ' HB2' ' A' ' 86' ' ' ASN . 23.4 m -54.92 137.42 45.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.731 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.715 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.9 OUTLIER -125.94 128.63 47.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.724 HG12 HG23 ' A' ' 83' ' ' ILE . 25.2 m -127.83 163.44 43.26 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.584 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.8 Cg_endo -78.91 134.1 11.65 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.57 2.18 . . . . 0.0 111.688 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 81.1 tt0 -49.03 -22.89 0.98 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.616 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.6 -40.36 52.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.41 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -86.85 -4.23 59.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.275 -0.89 . . . . 0.0 109.605 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.501 ' HA ' HD13 ' A' ' 37' ' ' LEU . 3.8 mm? . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.234 -0.916 . . . . 0.0 109.844 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 3.1 m-85 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.393 0.616 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.58 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 46.4 t80 -107.14 113.66 27.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 0.0 108.715 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.654 HD12 HG21 ' A' ' 75' ' ' VAL . 39.2 mt -116.28 162.21 17.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.115 -0.991 . . . . 0.0 110.343 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.701 HG23 ' HG2' ' A' ' 72' ' ' GLU . 20.4 m -120.12 118.24 30.04 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.479 ' HB3' HG12 ' A' ' 14' ' ' ILE . 14.3 p90 -144.07 154.98 43.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.022 -1.049 . . . . 0.0 109.937 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.471 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 47.9 mtmt -92.62 126.99 37.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.364 -0.835 . . . . 0.0 109.167 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 21.3 t -106.37 111.84 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.146 -0.971 . . . . 0.0 109.711 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.476 HE22 HD22 ' A' ' 93' ' ' LEU . 87.2 mt-30 62.98 37.22 11.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.54 25.28 63.44 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.417 ' O ' HG23 ' A' ' 71' ' ' VAL . 78.1 mtt-85 -129.59 107.5 9.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 109.511 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 79.0 tttt -58.91 125.33 23.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.679 HG21 ' CH2' ' A' ' 92' ' ' TRP . 97.7 t -146.26 133.09 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 109.231 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.701 ' HG2' HG23 ' A' ' 63' ' ' THR . 80.6 mt-10 -115.27 135.57 54.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 109.633 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.467 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . . . -160.36 173.38 15.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.389 -0.82 . . . . 0.0 109.674 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 94.4 mt-10 -79.79 143.97 33.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.85 . . . . 0.0 109.172 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.654 HG21 HG21 ' A' ' 32' ' ' VAL . 3.2 m -138.97 162.45 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.78 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.5 tp -113.23 145.73 40.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -0.827 . . . . 0.0 109.258 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.99 136.23 36.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.447 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.47 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 5.4 t -141.47 148.43 50.44 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 109.521 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.47 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 48.6 Cg_endo -69.87 -0.8 7.52 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.744 2.296 . . . . 0.0 111.774 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.521 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 31.5 m-85 -59.75 166.63 2.47 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.179 -0.951 . . . . 0.0 109.323 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -107.6 19.35 20.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.952 . . . . 0.0 109.86 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.809 ' OH ' HD21 ' A' ' 84' ' ' LEU . 25.7 p90 -142.48 -154.83 0.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.724 HG23 HG12 ' A' ' 32' ' ' VAL . 4.7 mt -130.15 144.51 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.997 -1.064 . . . . 0.0 109.777 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.809 HD21 ' OH ' ' A' ' 82' ' ' TYR . 1.3 mp -110.36 123.92 50.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.343 -0.848 . . . . 0.0 109.116 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.801 HD11 ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -95.44 134.64 38.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.786 ' O ' HG22 ' A' ' 90' ' ' VAL . 26.5 t30 -89.19 142.31 29.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.288 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.51 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 47.1 Cg_endo -67.41 -26.12 41.27 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.537 2.158 . . . . 0.0 111.79 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.2 m -78.08 -31.2 50.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.312 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.769 ' OD1' HG13 ' A' ' 90' ' ' VAL . 2.1 p30 -77.01 -32.97 57.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.162 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -110.9 73.7 0.89 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.897 . . . . 0.0 109.394 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.583 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.0 Cg_endo -70.29 -24.36 27.34 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.743 2.295 . . . . 0.0 112.016 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.162 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.4 p90 -71.43 -36.89 71.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.092 -1.005 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.497 HD12 ' CG2' ' A' ' 90' ' ' VAL . 72.6 mt . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.349 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 C--O 1.215 -0.662 0 CA-C-O 121.233 0.43 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.761 ' CD1' HD11 ' A' ' 93' ' ' LEU . 29.0 mt -81.06 -173.44 4.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.516 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.465 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 75.1 mm-40 -117.89 137.9 52.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 109.476 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.09 146.12 30.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.541 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -123.96 116.92 23.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.325 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.56 HG22 ' HG3' ' A' ' 15' ' ' LYS . 56.0 mt -112.83 130.41 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.933 . . . . 0.0 109.674 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.56 ' HG3' HG22 ' A' ' 14' ' ' ILE . 95.9 mttt 52.22 23.47 2.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.318 -0.864 . . . . 0.0 109.621 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.31 -13.97 66.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.83 HG22 HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -80.39 114.13 19.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -1.181 . . . . 0.0 109.427 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.884 ' C ' HD12 ' A' ' 19' ' ' LEU . 69.5 tttt -87.64 118.79 27.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 109.558 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.884 HD12 ' C ' ' A' ' 18' ' ' LYS . 9.3 mp -133.64 172.98 12.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.353 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.465 ' NZ ' ' OE2' ' A' ' 11' ' ' GLU . 16.0 mmtt -91.24 147.39 23.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.375 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.622 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -133.15 174.3 10.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 109.698 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.506 ' O ' HD22 ' A' ' 85' ' ' LEU . 40.8 m80 -131.07 127.76 38.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.86 . . . . 0.0 109.379 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.813 ' CD1' HD13 ' A' ' 93' ' ' LEU . 35.5 t90 -76.39 117.4 18.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -124.58 100.72 6.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.317 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.564 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 28.5 p -62.81 -30.38 71.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.07 -39.46 80.04 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.15 140.6 58.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.141 . . . . 0.0 109.52 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.6 m -96.11 -13.0 23.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.498 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 29' ' ' ILE . 7.4 tp -143.94 162.85 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.265 -0.897 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 26.4 m -66.27 132.64 48.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.681 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 0.9 OUTLIER -119.22 126.79 52.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.382 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.805 HG13 HG13 ' A' ' 75' ' ' VAL . 3.6 m -127.91 167.21 19.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.406 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.1 Cg_endo -79.58 133.32 10.43 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.459 2.106 . . . . 0.0 111.639 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.5 tt0 -43.05 -27.23 0.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.34 -0.85 . . . . 0.0 109.571 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.3 -38.54 27.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.844 . . . . 0.0 109.576 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.601 ' HE2' HD22 ' A' ' 19' ' ' LEU . 15.5 m-85 -87.91 -7.19 57.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 109.649 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' A' ' 77' ' ' ALA . 12.0 mt . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.139 -0.976 . . . . 0.0 109.757 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 3.7 m-85 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.256 0.551 . . . . 0.0 109.619 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.628 ' O ' HD23 ' A' ' 62' ' ' LEU . 33.4 t80 -102.52 114.96 29.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.27 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.628 HD23 ' O ' ' A' ' 61' ' ' TYR . 21.0 mt -119.32 160.93 21.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 110.029 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.719 HG23 ' HG2' ' A' ' 72' ' ' GLU . 11.4 m -121.78 116.88 25.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.478 -0.763 . . . . 0.0 109.137 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 8.2 p90 -142.98 161.72 37.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 109.668 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.485 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 12.5 mtmm -96.68 129.09 44.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.295 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.452 HG11 HG11 ' A' ' 90' ' ' VAL . 60.4 t -107.09 112.64 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.557 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 90.6 mt-30 63.48 33.53 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 109.403 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.37 23.63 58.29 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -127.98 111.45 13.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.319 -1.106 . . . . 0.0 109.408 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 80.5 tttt -61.04 121.23 11.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.612 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.578 HG21 ' HH2' ' A' ' 92' ' ' TRP . 65.6 t -141.66 133.55 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 109.164 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.719 ' HG2' HG23 ' A' ' 63' ' ' THR . 53.8 mt-10 -116.28 137.25 52.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 109.837 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.59 -169.7 2.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.439 -0.788 . . . . 0.0 109.379 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 75' ' ' VAL . 98.2 mt-10 -79.96 171.36 15.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.094 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.805 HG13 HG13 ' A' ' 32' ' ' VAL . 72.9 t -159.4 151.03 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.143 -0.973 . . . . 0.0 109.808 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.9 tp -121.32 143.62 49.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.43 -0.794 . . . . 0.0 109.282 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.649 ' HB2' HD13 ' A' ' 37' ' ' LEU . . . -79.77 133.41 36.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 109.602 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 1.4 t -138.68 150.91 67.53 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.859 . . . . 0.0 109.355 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.6 Cg_endo -72.28 1.97 5.51 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.624 2.216 . . . . 0.0 111.885 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -65.14 168.0 7.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.532 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.8 p30 -108.9 14.07 24.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.233 -0.917 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.585 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 17.7 p90 -136.34 -157.8 0.82 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 109.008 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.548 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.0 mt -129.09 144.7 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.056 -1.027 . . . . 0.0 109.707 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 84' ' ' LEU . 6.2 mp -109.95 136.33 49.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.259 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.802 ' N ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -103.92 145.36 30.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.768 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.684 ' O ' HG22 ' A' ' 90' ' ' VAL . 4.9 t30 -96.87 136.59 21.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.255 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.526 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.0 Cg_endo -63.45 -31.98 71.53 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.847 2.365 . . . . 0.0 111.94 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -75.24 -30.17 60.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.227 -0.921 . . . . 0.0 109.176 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -77.49 -30.83 53.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.326 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.909 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.6 OUTLIER -122.25 75.95 42.18 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 109.468 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.21 -24.95 27.03 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.637 2.225 . . . . 0.0 111.932 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.909 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 32.7 p90 -74.19 -28.47 61.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.137 -0.977 . . . . 0.0 109.481 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.813 HD13 ' CD1' ' A' ' 23' ' ' TRP . 9.6 tt . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.485 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 C--O 1.214 -0.702 0 CA-C-O 121.287 0.453 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.553 ' CD2' HD11 ' A' ' 93' ' ' LEU . 4.6 mp -80.23 166.35 21.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.96 . . . . 0.0 109.525 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -103.63 148.74 25.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.558 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.38 151.22 20.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 64' ' ' PHE . 65.7 tt0 -119.62 121.71 39.91 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.409 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.548 ' HB ' ' CE2' ' A' ' 36' ' ' PHE . 44.6 mt -113.54 124.21 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 60.8 mttm 61.28 20.38 10.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 109.474 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.65 -12.89 68.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.0 m -88.52 131.11 35.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -1.145 . . . . 0.0 109.446 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.999 ' O ' HD22 ' A' ' 19' ' ' LEU . 18.0 mttp -82.98 133.37 35.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.879 . . . . 0.0 109.492 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.999 HD22 ' O ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -144.64 159.82 42.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.87 . . . . 0.0 109.459 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -81.41 150.93 28.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.352 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.883 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -139.14 169.69 17.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.492 ' HB2' ' CE2' ' A' ' 82' ' ' TYR . 23.7 m80 -130.5 136.89 49.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 109.644 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.957 ' CD1' HD13 ' A' ' 93' ' ' LEU . 64.3 t90 -95.17 118.91 32.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 109.431 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -130.17 104.24 7.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.528 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.582 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 60.4 p -56.22 -27.59 55.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.531 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.37 -36.5 93.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.424 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -64.55 143.58 57.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.458 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.511 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 59.4 m -108.36 -12.08 15.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.501 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.403 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 20.2 tt -142.64 155.35 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.495 ' HB ' HG12 ' A' ' 75' ' ' VAL . 34.4 m -71.38 136.45 47.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.608 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.539 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -120.84 131.9 54.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.423 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.904 HG12 HG23 ' A' ' 83' ' ' ILE . 15.4 m -121.72 161.17 43.33 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 82' ' ' TYR . 55.8 Cg_endo -79.27 129.57 8.73 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.583 2.189 . . . . 0.0 111.717 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.864 ' CG ' ' HB1' ' A' ' 77' ' ' ALA . 79.2 mt-10 -43.77 -26.93 0.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 109.362 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.77 -39.45 77.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.285 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.569 ' HZ ' HD23 ' A' ' 19' ' ' LEU . 1.7 m-85 -83.7 -2.15 55.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.428 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.715 ' CD1' ' HB2' ' A' ' 77' ' ' ALA . 7.2 mt . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.154 -0.966 . . . . 0.0 109.741 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 4.0 m-85 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.467 0.651 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 42.4 t80 -108.17 112.4 24.89 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.499 HD12 HG21 ' A' ' 75' ' ' VAL . 34.2 mt -115.98 163.31 16.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.121 -0.987 . . . . 0.0 110.305 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.702 HG23 ' HG2' ' A' ' 72' ' ' GLU . 28.6 m -120.47 116.94 26.42 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 13.6 p90 -138.54 156.94 47.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 109.815 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -93.3 127.24 38.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.332 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.641 HG11 HG11 ' A' ' 90' ' ' VAL . 24.1 t -103.64 106.69 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.927 . . . . 0.0 109.564 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 91.2 mt-30 63.24 36.4 11.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.329 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.46 51.4 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -130.72 109.68 10.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -1.119 . . . . 0.0 109.325 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.464 ' HE2' HG21 ' A' ' 63' ' ' THR . 18.9 tttm -59.65 123.34 16.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 109.697 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.535 HG21 ' CH2' ' A' ' 92' ' ' TRP . 87.6 t -143.49 129.37 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.312 -0.868 . . . . 0.0 109.329 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.702 ' HG2' HG23 ' A' ' 63' ' ' THR . 49.3 mt-10 -111.5 135.36 52.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.96 . . . . 0.0 109.629 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . . . -160.26 170.48 21.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.345 -0.847 . . . . 0.0 109.589 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 95.0 mt-10 -79.76 146.17 32.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.234 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.542 HG21 HG21 ' A' ' 32' ' ' VAL . 3.7 m -138.77 164.36 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.161 -0.962 . . . . 0.0 109.85 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.442 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 21.2 tp -118.04 149.41 41.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.432 -0.793 . . . . 0.0 109.196 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.864 ' HB1' ' CG ' ' A' ' 34' ' ' GLU . . . -79.81 132.27 36.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 0.0 109.5 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.463 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.8 t -135.32 149.97 71.24 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.386 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.463 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.1 Cg_endo -70.73 0.59 6.15 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.808 2.338 . . . . 0.0 111.837 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -64.47 176.75 1.02 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.485 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -114.61 17.55 17.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.429 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.598 ' CZ ' ' HG ' ' A' ' 84' ' ' LEU . 23.6 p90 -142.27 -156.27 0.67 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.066 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.904 HG23 HG12 ' A' ' 32' ' ' VAL . 3.1 mt -128.1 124.21 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.612 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.598 ' HG ' ' CZ ' ' A' ' 82' ' ' TYR . 1.5 mt -80.18 133.14 36.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 108.981 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.883 HD21 ' HB1' ' A' ' 21' ' ' ALA . 6.8 mt -101.41 144.2 30.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 109.934 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.635 ' O ' HG22 ' A' ' 90' ' ' VAL . 9.5 t-20 -101.88 134.26 20.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.398 -0.814 . . . . 0.0 109.118 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.498 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 43.1 Cg_endo -64.48 -31.12 61.6 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.7 2.267 . . . . 0.0 111.903 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 m -75.67 -28.26 58.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.339 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.416 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 83.8 m-20 -77.81 -29.16 50.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 109.361 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.965 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -121.85 76.69 38.89 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.481 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.5 Cg_endo -69.82 -24.88 28.91 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.676 2.251 . . . . 0.0 111.766 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.965 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.2 p90 -75.98 -24.84 55.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.563 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.957 HD13 ' CD1' ' A' ' 23' ' ' TRP . 9.6 tt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 109.451 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 C--O 1.215 -0.64 0 CA-C-O 121.273 0.447 . . . . 0.0 111.811 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 23' ' ' TRP . 28.7 mt -89.22 -171.17 3.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.408 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.08 137.37 54.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.364 -0.835 . . . . 0.0 109.455 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 65' ' ' LYS . . . -148.7 154.02 39.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.905 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 17' ' ' THR . 70.4 tt0 -123.2 115.5 21.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.873 . . . . 0.0 109.269 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 64' ' ' PHE . 74.6 mt -109.6 127.41 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 69.9 mttt 60.22 21.82 11.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.52 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.66 -15.32 62.82 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 68.0 m -80.02 130.47 35.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -1.136 . . . . 0.0 109.316 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.478 ' O ' HD23 ' A' ' 19' ' ' LEU . 41.4 tttp -91.78 125.27 36.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.17 -0.956 . . . . 0.0 109.491 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.532 ' CD1' ' CZ ' ' A' ' 36' ' ' PHE . 97.8 mt -143.47 168.55 19.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.371 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -92.31 154.03 18.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.453 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.64 ' CB ' HD21 ' A' ' 85' ' ' LEU . . . -138.42 172.32 13.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.244 -0.91 . . . . 0.0 109.402 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.42 ' O ' HD22 ' A' ' 85' ' ' LEU . 39.2 m80 -125.63 123.97 40.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 109.458 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.59 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 55.4 t90 -76.92 122.06 24.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.552 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -130.06 103.62 6.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.59 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 52.2 p -61.23 -25.6 67.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.943 . . . . 0.0 109.524 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.1 89.05 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.468 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -72.9 141.17 47.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -1.194 . . . . 0.0 109.552 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.438 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 28.5 p -105.52 -3.17 22.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 0.0 109.559 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' ' 74' ' ' GLU . 19.9 tt -145.51 147.94 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.323 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 38.2 m -61.56 133.13 55.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.905 . . . . 0.0 109.67 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.654 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -116.56 129.19 56.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 109.53 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.757 HG22 ' CG1' ' A' ' 75' ' ' VAL . 4.7 m -131.38 164.52 41.94 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.953 . . . . 0.0 109.358 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.507 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.8 Cg_endo -78.55 131.62 10.55 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.422 2.082 . . . . 0.0 111.483 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.3 tt0 -43.14 -26.7 0.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.945 . . . . 0.0 109.718 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.05 -36.44 18.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.58 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.532 ' CZ ' ' CD1' ' A' ' 19' ' ' LEU . 13.9 m-85 -88.82 -7.19 56.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 109.663 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.915 HD13 ' HB2' ' A' ' 77' ' ' ALA . 4.3 mt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 110.027 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 3.9 m-85 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.408 0.623 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.598 ' O ' HD12 ' A' ' 62' ' ' LEU . 39.8 t80 -105.55 112.09 25.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.613 ' HB2' HG21 ' A' ' 75' ' ' VAL . 6.9 mp -116.38 161.28 19.3 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 110.155 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.696 HG23 ' HG2' ' A' ' 72' ' ' GLU . 18.1 m -121.39 117.33 26.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.513 -0.742 . . . . 0.0 109.057 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 6.1 p90 -140.08 156.83 46.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.085 -1.009 . . . . 0.0 109.939 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 80.6 mttt -91.91 127.86 37.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.385 -0.822 . . . . 0.0 109.239 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.574 HG11 HG11 ' A' ' 90' ' ' VAL . 58.1 t -108.27 109.44 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.606 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 85.3 mt-30 62.88 37.98 11.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.321 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.76 29.08 58.02 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -133.26 113.55 12.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -1.14 . . . . 0.0 109.332 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -63.52 121.21 13.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.715 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 ' CH2' ' A' ' 92' ' ' TRP . 94.2 t -140.57 132.06 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.268 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.696 ' HG2' HG23 ' A' ' 63' ' ' THR . 49.7 mt-10 -115.77 136.92 52.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.131 -0.981 . . . . 0.0 109.745 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.37 -169.65 2.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.432 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.514 ' HB3' HD11 ' A' ' 29' ' ' ILE . 95.9 mt-10 -80.02 165.66 22.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 0.0 109.153 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.757 ' CG1' HG22 ' A' ' 32' ' ' VAL . 94.7 t -152.58 156.77 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.92 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.465 ' N ' HG12 ' A' ' 75' ' ' VAL . 14.8 tp -125.43 141.31 52.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.53 -0.731 . . . . 0.0 109.213 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.915 ' HB2' HD13 ' A' ' 37' ' ' LEU . . . -80.42 136.01 36.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -0.97 . . . . 0.0 109.43 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.48 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -143.91 151.67 53.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.48 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.2 Cg_endo -72.75 4.14 3.81 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.689 2.259 . . . . 0.0 111.864 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -65.6 171.72 3.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.157 -0.965 . . . . 0.0 109.392 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -113.72 17.63 18.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.409 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.74 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 12.4 p90 -139.81 -159.38 0.95 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.261 -0.899 . . . . 0.0 109.032 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.674 HG23 HG12 ' A' ' 32' ' ' VAL . 2.5 mt -129.17 147.17 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.183 -0.948 . . . . 0.0 109.633 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.74 HD11 ' CZ ' ' A' ' 82' ' ' TYR . 6.6 mp -111.69 135.95 51.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.344 -0.847 . . . . 0.0 108.952 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.758 ' N ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -102.55 140.73 36.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.984 . . . . 0.0 109.867 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.642 ' O ' HG22 ' A' ' 90' ' ' VAL . 8.9 t-20 -92.32 134.58 28.05 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.487 -0.758 . . . . 0.0 109.096 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.519 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.5 Cg_endo -64.03 -30.74 66.37 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.766 2.311 . . . . 0.0 111.946 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 m -74.68 -29.61 61.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.262 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -79.44 -29.32 41.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.43 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.177 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -122.88 74.82 47.63 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.379 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.7 -24.47 29.89 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.727 2.284 . . . . 0.0 111.812 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.177 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 42.3 p90 -72.78 -29.87 63.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.5 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.591 HD12 ' CG2' ' A' ' 90' ' ' VAL . 73.4 mt . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 C--O 1.214 -0.688 0 CA-C-O 121.287 0.453 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.53 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 29.4 mt -83.13 -176.24 6.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.467 ' OE2' ' CE ' ' A' ' 18' ' ' LYS . 72.3 tt0 -113.2 137.32 51.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.496 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.12 142.74 27.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 109.609 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -116.16 120.25 38.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.264 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.635 HG22 ' HG3' ' A' ' 15' ' ' LYS . 36.9 mt -111.53 129.14 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.601 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.635 ' HG3' HG22 ' A' ' 14' ' ' ILE . 32.5 mttm 51.84 24.39 2.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -0.878 . . . . 0.0 109.665 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.64 -4.72 79.63 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.873 HG22 HD11 ' A' ' 19' ' ' LEU . 13.1 m -87.98 128.85 35.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -1.196 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.889 ' C ' HD12 ' A' ' 19' ' ' LEU . 19.3 tttt -86.8 121.75 29.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.492 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.889 HD12 ' C ' ' A' ' 18' ' ' LYS . 5.2 mp -140.54 161.89 36.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.89 . . . . 0.0 109.458 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -88.37 155.36 19.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -0.922 . . . . 0.0 109.428 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.071 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -139.23 176.87 8.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -134.56 122.49 22.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.817 ' CE2' HD22 ' A' ' 93' ' ' LEU . 71.4 t90 -79.59 128.08 32.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.303 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -141.58 109.75 5.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.555 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 20.7 t -60.88 -27.18 67.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.77 -27.14 70.68 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.482 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -79.84 127.63 32.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -1.195 . . . . 0.0 109.48 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 m -95.33 -16.84 22.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 0.0 109.438 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 29' ' ' ILE . 21.1 tt -135.56 130.84 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 84' ' ' LEU . 90.5 m -50.92 139.19 17.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.595 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.593 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -119.82 128.95 54.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.27 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.924 HG12 HG23 ' A' ' 83' ' ' ILE . 16.6 m -122.4 162.57 37.23 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 78' ' ' SER . 55.4 Cg_endo -78.67 131.35 10.27 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.466 2.111 . . . . 0.0 111.623 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.964 ' HG2' ' HB1' ' A' ' 77' ' ' ALA . 96.8 mt-10 -42.9 -27.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 109.548 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -47.46 -43.02 23.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.77 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.586 ' CE1' ' CD2' ' A' ' 19' ' ' LEU . 21.4 m-85 -84.98 -6.32 59.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.102 -0.999 . . . . 0.0 109.756 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.522 HD21 ' CG2' ' A' ' 32' ' ' VAL . 4.3 mm? . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.168 -0.958 . . . . 0.0 109.678 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.56 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 3.4 m-85 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.289 0.566 . . . . 0.0 109.61 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.675 ' O ' HD23 ' A' ' 62' ' ' LEU . 32.9 t80 -104.88 115.5 30.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 108.961 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 61' ' ' TYR . 18.9 mt -121.47 156.52 32.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 110.08 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.718 HG23 ' HG2' ' A' ' 72' ' ' GLU . 67.9 m -115.31 125.68 53.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.449 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 18.1 p90 -149.02 151.23 34.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.082 -1.011 . . . . 0.0 109.681 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -85.28 133.32 34.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.323 -0.861 . . . . 0.0 109.198 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.549 HG11 HG11 ' A' ' 90' ' ' VAL . 40.1 t -109.58 112.64 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 93.7 mt-30 61.33 20.96 11.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.86 . . . . 0.0 109.468 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.64 21.77 18.19 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.93 ' HG2' HG23 ' A' ' 71' ' ' VAL . 6.6 ttt85 -126.86 116.82 21.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -1.057 . . . . 0.0 109.068 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -64.55 116.07 5.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 109.367 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.93 HG23 ' HG2' ' A' ' 69' ' ' ARG . 55.4 t -138.12 134.97 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 109.481 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.718 ' HG2' HG23 ' A' ' 63' ' ' THR . 80.6 mt-10 -111.05 140.35 45.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.3 168.99 24.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.624 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 95.8 mt-10 -79.84 141.06 36.55 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.393 -0.817 . . . . 0.0 109.079 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.624 HG21 HD12 ' A' ' 62' ' ' LEU . 2.8 m -138.18 163.46 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.186 -0.946 . . . . 0.0 109.775 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.1 tp -117.39 146.85 43.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.964 ' HB1' ' HG2' ' A' ' 34' ' ' GLU . . . -79.75 126.01 30.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.386 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 1.1 t -133.06 152.18 79.23 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.474 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.487 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 48.9 Cg_endo -69.6 -0.82 7.33 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.605 2.203 . . . . 0.0 111.779 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -58.78 169.86 0.91 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.384 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -111.97 22.32 15.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.695 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 19.2 p90 -148.14 -159.32 1.01 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.417 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.924 HG23 HG12 ' A' ' 32' ' ' VAL . 4.0 mt -125.22 140.64 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.735 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.786 ' O ' HG23 ' A' ' 30' ' ' THR . 6.9 mp -106.35 130.59 54.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.32 -0.863 . . . . 0.0 109.039 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.071 HD21 ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -111.48 135.18 52.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.624 -179.677 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.531 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 6.8 p-10 -97.55 158.17 33.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.243 -0.91 . . . . 0.0 109.737 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 48.8 Cg_endo -69.19 -20.0 38.11 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.663 2.242 . . . . 0.0 111.403 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.5 p -76.36 -36.39 58.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.317 -0.864 . . . . 0.0 109.116 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.459 ' HB2' ' OD1' ' A' ' 86' ' ' ASN . 88.0 m-20 -79.38 -32.07 43.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -0.826 . . . . 0.0 108.905 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.062 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -119.25 71.68 12.45 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.835 . . . . 0.0 109.515 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.565 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.4 Cg_endo -70.31 -20.15 32.59 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.735 2.29 . . . . 0.0 111.784 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.062 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 47.2 p90 -79.85 -32.88 40.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.923 . . . . 0.0 109.562 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.817 HD22 ' CE2' ' A' ' 23' ' ' TRP . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.431 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 51.1 Cg_endo . . . . . 0 C--O 1.214 -0.68 0 CA-C-O 121.29 0.454 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.526 HD13 HD12 ' A' ' 85' ' ' LEU . 4.1 mp -82.59 161.15 22.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.473 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.55 142.64 29.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.502 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.07 151.84 28.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.54 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 18' ' ' LYS . 92.2 mt-10 -130.88 121.53 25.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 109.432 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 75.9 mt -114.7 128.14 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.936 . . . . 0.0 109.43 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 65.5 mttt 61.11 20.26 10.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.44 -12.42 69.76 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.45 HG22 HD12 ' A' ' 19' ' ' LEU . 41.9 m -81.8 134.63 35.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -1.169 . . . . 0.0 109.409 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.747 ' O ' HD12 ' A' ' 19' ' ' LEU . 89.0 mttt -89.75 139.04 30.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -158.8 165.61 33.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.411 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 9' ' ' PRO . 11.8 mmtt -86.5 150.67 24.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.764 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -133.49 171.11 14.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.539 ' HB2' ' CE2' ' A' ' 82' ' ' TYR . 26.2 m80 -131.52 133.83 45.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 109.836 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.605 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 58.5 t90 -90.31 115.13 27.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 109.448 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -127.08 102.53 7.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.386 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.473 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 32.2 t -57.83 -34.03 69.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.613 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.95 -35.59 48.72 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.18 136.11 51.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.2 m -95.29 -16.4 22.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.45 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.5 tt -141.65 149.41 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.316 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 27.9 m -57.69 135.49 56.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.732 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -119.24 119.53 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.9 . . . . 0.0 109.214 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.637 HG12 HG23 ' A' ' 83' ' ' ILE . 29.1 m -113.44 162.2 23.5 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.281 -0.887 . . . . 0.0 109.515 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.6 Cg_endo -79.2 130.6 9.32 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.547 2.164 . . . . 0.0 111.575 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 81.0 tt0 -43.27 -26.87 0.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 0.0 109.51 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -53.08 -41.81 65.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.402 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.636 ' HZ ' HD13 ' A' ' 19' ' ' LEU . 5.9 m-85 -83.15 -3.04 56.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.226 -0.921 . . . . 0.0 109.445 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 77' ' ' ALA . 6.1 mt . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.946 . . . . 0.0 109.779 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 4.0 m-85 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.319 0.581 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.588 ' O ' HD12 ' A' ' 62' ' ' LEU . 43.3 t80 -107.0 112.49 25.47 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.826 HD22 HG21 ' A' ' 75' ' ' VAL . 6.8 mp -115.66 158.88 22.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.155 -0.965 . . . . 0.0 110.445 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.716 HG23 ' HG2' ' A' ' 72' ' ' GLU . 51.0 m -117.74 116.76 27.67 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.801 ' CE2' HG22 ' A' ' 66' ' ' VAL . 39.9 p90 -137.21 160.02 40.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 109.955 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -93.11 129.08 39.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 109.356 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.801 HG22 ' CE2' ' A' ' 64' ' ' PHE . 1.7 t -105.53 103.55 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 109.656 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 22.0 mt-30 63.61 36.73 10.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.895 . . . . 0.0 109.33 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.72 26.01 51.54 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -129.55 120.88 26.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.333 -1.098 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -66.33 122.82 18.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.582 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.693 HG21 ' CH2' ' A' ' 92' ' ' TRP . 90.2 t -144.17 133.44 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.451 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.716 ' HG2' HG23 ' A' ' 63' ' ' THR . 76.4 mt-10 -117.16 137.18 52.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.641 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.07 172.49 17.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.6 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 96.1 mt-10 -79.9 141.35 36.17 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -0.922 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.826 HG21 HD22 ' A' ' 62' ' ' LEU . 2.9 m -135.14 162.3 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.943 . . . . 0.0 109.752 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.8 mt -119.34 154.71 33.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.847 . . . . 0.0 109.287 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB2' HD13 ' A' ' 37' ' ' LEU . . . -80.17 138.83 36.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.478 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.572 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 4.6 t -143.11 149.0 47.26 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.475 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.2 Cg_endo -72.65 3.37 4.36 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.701 2.267 . . . . 0.0 112.065 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.572 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 74.3 m-85 -66.81 174.93 2.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 109.587 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -114.06 15.65 18.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 0.0 109.341 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' N ' ' A' ' 83' ' ' ILE . 33.0 p90 -139.22 -157.89 0.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.208 -0.933 . . . . 0.0 109.08 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.637 HG23 HG12 ' A' ' 32' ' ' VAL . 4.5 mt -123.66 126.21 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.669 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.732 HD13 ' HB3' ' A' ' 31' ' ' CYS . 5.7 mp -84.27 142.59 30.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 108.941 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.764 HD21 ' HB1' ' A' ' 21' ' ' ALA . 6.6 mt -112.92 143.26 44.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 110.083 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.74 ' O ' HG22 ' A' ' 90' ' ' VAL . 3.3 t30 -103.61 137.41 19.24 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.53 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.5 Cg_endo -64.0 -35.65 53.33 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.703 2.269 . . . . 0.0 111.998 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.447 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 2.5 m -72.54 -27.01 61.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.141 -0.974 . . . . 0.0 109.411 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -79.55 -28.92 41.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.34 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.094 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -120.26 71.85 18.03 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.841 . . . . 0.0 109.464 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.34 -16.3 35.09 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.632 2.221 . . . . 0.0 111.762 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.094 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 41.6 p90 -82.6 -28.51 30.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.894 . . . . 0.0 109.414 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.605 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 22.0 tp . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.4 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 C--O 1.215 -0.644 0 CA-C-O 121.181 0.409 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 3.7 mp -84.38 164.47 18.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.439 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -101.79 147.21 26.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.475 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.25 146.31 25.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.521 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 17' ' ' THR . 89.9 mt-10 -123.8 118.68 27.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.71 HG22 ' HG3' ' A' ' 15' ' ' LYS . 61.6 mt -114.15 129.65 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.503 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.71 ' HG3' HG22 ' A' ' 14' ' ' ILE . 93.2 mttt 54.35 22.39 3.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.94 -8.55 76.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 32.7 m -82.58 128.45 34.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -1.13 . . . . 0.0 109.493 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.812 ' O ' HD23 ' A' ' 19' ' ' LEU . 29.6 tttt -92.47 122.79 35.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.403 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.812 HD23 ' O ' ' A' ' 18' ' ' LYS . 63.7 mt -140.88 168.08 20.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.498 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -87.67 155.54 19.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.496 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.696 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -139.85 167.73 21.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -0.859 . . . . 0.0 109.337 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.622 ' O ' HD22 ' A' ' 85' ' ' LEU . 46.1 m80 -130.98 132.47 45.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.498 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.573 ' CZ2' ' HB3' ' A' ' 87' ' ' PRO . 38.9 t90 -85.76 122.98 30.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.587 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -130.15 99.31 5.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.875 . . . . 0.0 109.463 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.516 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 53.4 p -57.16 -26.76 61.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -0.861 . . . . 0.0 109.509 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.22 -36.17 92.0 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -72.17 137.37 46.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -1.15 . . . . 0.0 109.425 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.451 ' O ' HG22 ' A' ' 28' ' ' THR . 93.5 m -99.1 -10.45 22.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 109.385 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.452 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 21.2 tt -139.4 152.77 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 84' ' ' LEU . 32.4 m -61.24 152.11 29.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.477 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.975 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -127.93 113.72 16.23 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.111 179.829 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.782 HG13 ' HD2' ' A' ' 33' ' ' PRO . 60.3 t -113.55 146.91 36.4 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.312 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.782 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.3 Cg_endo -76.75 131.22 12.14 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.125 1.883 . . . . 0.0 111.625 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 33' ' ' PRO . 81.3 tt0 -40.7 -27.48 0.05 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.533 -0.729 . . . . 0.0 110.234 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.14 -27.75 3.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.096 -1.003 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.751 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 21.4 m-85 -101.77 -3.04 28.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 0.0 109.77 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.569 ' CD2' ' CG ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.698 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.569 ' CG ' ' CD2' ' A' ' 37' ' ' LEU . 11.4 m-85 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.29 0.567 . . . . 0.0 109.889 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.493 ' O ' HD23 ' A' ' 62' ' ' LEU . 43.5 t80 -102.15 114.4 28.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.257 -0.902 . . . . 0.0 108.956 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.576 HD12 HG21 ' A' ' 75' ' ' VAL . 44.1 mt -121.01 169.05 10.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.061 -1.024 . . . . 0.0 110.288 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.711 HG23 ' HG2' ' A' ' 72' ' ' GLU . 25.4 m -121.22 118.05 28.62 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.502 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 9.5 p90 -140.34 163.22 33.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.988 -1.07 . . . . 0.0 109.801 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.45 ' NZ ' ' OE1' ' A' ' 13' ' ' GLU . 15.2 mtmt -99.38 126.01 45.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.388 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 78.0 t -104.42 116.19 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.481 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 94.7 mt-30 62.29 30.96 17.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.386 -0.821 . . . . 0.0 109.393 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.65 22.45 59.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -125.64 117.61 23.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -1.164 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -58.91 123.9 18.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.439 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.689 HG21 ' CH2' ' A' ' 92' ' ' TRP . 53.7 t -148.55 127.03 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.335 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.711 ' HG2' HG23 ' A' ' 63' ' ' THR . 79.5 mt-10 -107.66 138.82 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.525 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.32 168.34 25.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.338 -0.851 . . . . 0.0 109.695 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 95.5 mt-10 -80.04 137.29 36.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.328 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.694 ' HB ' HG23 ' A' ' 32' ' ' VAL . 5.0 m -127.92 151.39 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 32' ' ' VAL . 24.6 tp -103.75 143.63 32.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.355 -0.84 . . . . 0.0 109.082 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.17 125.9 30.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.243 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.495 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 35.2 t -137.14 150.13 68.3 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.296 -0.878 . . . . 0.0 109.534 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.495 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.8 Cg_endo -71.01 5.07 2.34 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.669 2.246 . . . . 0.0 112.176 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 31.3 m-85 -62.57 178.22 0.45 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 109.362 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -118.22 18.3 13.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.549 ' CD2' ' N ' ' A' ' 83' ' ' ILE . 13.9 p90 -145.08 -153.97 0.51 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.349 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.549 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 2.4 mt -133.22 148.01 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 0.0 109.563 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.975 HD13 ' HB3' ' A' ' 31' ' ' CYS . 6.0 mp -112.27 133.73 54.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 108.886 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.76 ' H ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -100.63 133.09 45.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.067 -1.021 . . . . 0.0 109.851 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.677 ' O ' HG22 ' A' ' 90' ' ' VAL . 3.3 t30 -85.67 136.57 36.84 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.573 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 40.5 Cg_endo -63.06 -25.76 73.45 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.696 2.264 . . . . 0.0 111.849 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.497 ' OG ' ' ND2' ' A' ' 86' ' ' ASN . 1.0 OUTLIER -80.42 -28.92 37.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.27 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -78.06 -28.6 48.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.864 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.179 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -116.06 73.95 5.17 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.202 -0.936 . . . . 0.0 109.505 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.414 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.8 Cg_endo -70.3 -23.73 28.0 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.757 2.305 . . . . 0.0 111.791 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.179 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 43.9 p90 -73.06 -29.63 63.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.492 HD12 ' CG2' ' A' ' 90' ' ' VAL . 76.3 mt . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.241 -0.912 . . . . 0.0 109.467 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.595 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 48.3 Cg_endo . . . . . 0 C--O 1.215 -0.637 0 CA-C-O 121.204 0.418 . . . . 0.0 111.77 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 23' ' ' TRP . 86.3 mt -93.81 154.17 17.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.475 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -88.49 140.24 29.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.548 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.48 155.35 41.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 17' ' ' THR . 67.5 tt0 -128.65 109.56 11.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -0.953 . . . . 0.0 109.412 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.585 ' HB ' ' CE2' ' A' ' 36' ' ' PHE . 90.0 mt -104.92 128.81 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.51 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 52.7 mttp 61.31 18.17 8.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.632 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.08 -10.93 73.39 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 81.8 m -85.5 140.43 30.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -1.136 . . . . 0.0 109.171 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -79.26 117.45 20.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.295 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.907 HD22 ' CE1' ' A' ' 36' ' ' PHE . 11.7 tp -130.14 147.81 51.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.476 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.746 ' O ' HD12 ' A' ' 83' ' ' ILE . 40.6 mttt -81.93 157.82 24.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.6 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.075 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -144.98 160.08 41.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.554 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.727 ' O ' HD22 ' A' ' 85' ' ' LEU . 61.2 m80 -128.72 129.32 45.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.265 -0.897 . . . . 0.0 109.471 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.59 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 21.9 t90 -75.28 125.45 29.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.641 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -132.85 95.9 3.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.394 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.59 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 54.6 p -56.45 -31.8 64.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.657 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.57 -27.58 68.31 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -79.98 139.29 37.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -1.167 . . . . 0.0 109.472 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.503 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 41.8 p -103.57 -4.36 24.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.584 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.791 HG21 HD11 ' A' ' 76' ' ' LEU . 21.2 tt -143.98 149.41 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.932 . . . . 0.0 109.472 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.692 ' HB ' HG22 ' A' ' 75' ' ' VAL . 27.8 m -61.12 139.67 58.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.647 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.803 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -123.48 140.07 53.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.546 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.041 HG12 HG23 ' A' ' 83' ' ' ILE . 34.9 m -141.13 165.8 26.73 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.915 . . . . 0.0 109.411 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.4 Cg_endo -78.29 128.15 8.73 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.29 1.993 . . . . 0.0 111.451 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' PRO . 83.9 tt0 -41.78 -28.19 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.749 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -53.27 -31.48 43.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.557 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.907 ' CE1' HD22 ' A' ' 19' ' ' LEU . 2.2 m-85 -88.75 -10.92 46.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 0.0 109.673 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.659 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.858 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.659 ' CD2' HD23 ' A' ' 37' ' ' LEU . 25.6 m-85 . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.335 0.588 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.473 ' OH ' ' HB2' ' A' ' 72' ' ' GLU . 45.2 t80 -85.91 110.19 19.25 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.1 mt -115.81 161.62 18.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.032 -1.043 . . . . 0.0 110.624 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.7 HG23 ' HG2' ' A' ' 72' ' ' GLU . 29.5 m -121.23 124.24 44.17 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.981 ' CE2' HG22 ' A' ' 66' ' ' VAL . 43.2 p90 -145.92 160.38 41.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.044 -1.035 . . . . 0.0 109.97 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.504 ' HD3' ' HA ' ' A' ' 70' ' ' LYS . 6.8 mmtt -90.1 126.75 35.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.406 -0.809 . . . . 0.0 109.229 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.981 HG22 ' CE2' ' A' ' 64' ' ' PHE . 1.7 t -104.54 103.09 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.688 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.586 ' NE2' ' CD2' ' A' ' 93' ' ' LEU . 24.9 mt-30 62.61 35.06 14.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.317 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.46 30.93 28.88 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -136.28 120.56 17.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -1.169 . . . . 0.0 109.39 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.504 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 15.0 tttp -67.35 120.44 13.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.471 HG21 ' CH2' ' A' ' 92' ' ' TRP . 64.0 t -141.94 131.84 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.475 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.7 ' HG2' HG23 ' A' ' 63' ' ' THR . 27.3 mt-10 -116.01 136.48 52.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.31 -178.11 6.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.845 . . . . 0.0 109.667 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -79.64 152.81 29.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.02 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.897 ' CG1' HG22 ' A' ' 32' ' ' VAL . 91.6 t -143.51 156.97 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.123 -0.985 . . . . 0.0 109.744 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.791 HD11 HG21 ' A' ' 29' ' ' ILE . 17.2 mt -121.89 147.37 46.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.37 -0.831 . . . . 0.0 109.313 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.94 139.66 36.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.468 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.5 t -143.98 150.81 50.74 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 109.345 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.468 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.9 Cg_endo -71.37 1.75 5.17 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.677 2.251 . . . . 0.0 111.772 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.51 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 70.6 m-85 -69.15 162.53 26.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.278 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -104.32 19.79 19.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.604 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.84 ' OH ' HD21 ' A' ' 84' ' ' LEU . 22.4 p90 -140.57 -162.35 1.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.979 . . . . 0.0 109.552 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.041 HG23 HG12 ' A' ' 32' ' ' VAL . 7.5 mt -125.44 152.16 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.1 -1.0 . . . . 0.0 110.248 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.84 HD21 ' OH ' ' A' ' 82' ' ' TYR . 2.2 mt -118.55 124.59 47.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.298 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.075 HD11 ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -92.47 140.68 29.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 109.82 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.656 ' O ' HG22 ' A' ' 90' ' ' VAL . 8.2 t-20 -90.87 134.79 29.71 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.491 -0.755 . . . . 0.0 109.25 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.5 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.1 Cg_endo -63.95 -30.3 67.07 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.796 2.33 . . . . 0.0 111.78 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.407 ' HB3' HD21 ' A' ' 86' ' ' ASN . 6.4 t -75.73 -29.09 58.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 109.269 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -79.89 -33.21 40.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.897 . . . . 0.0 109.44 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.157 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.8 OUTLIER -119.52 76.39 18.71 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.882 . . . . 0.0 109.424 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.439 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.3 Cg_endo -69.99 -22.05 31.58 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.697 2.264 . . . . 0.0 111.785 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.157 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.2 p90 -76.23 -25.72 55.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.171 -0.955 . . . . 0.0 109.401 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.586 ' CD2' ' NE2' ' A' ' 67' ' ' GLN . 59.9 mt . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.478 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 C--O 1.214 -0.678 0 CA-C-O 121.218 0.424 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.779 HD11 ' HB2' ' A' ' 23' ' ' TRP . 65.8 mt -93.63 142.03 27.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.493 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -83.43 134.1 34.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 65' ' ' LYS . . . -145.14 150.75 37.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.527 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.458 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 45.0 tt0 -115.93 121.0 41.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.405 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.633 HG22 ' HG3' ' A' ' 15' ' ' LYS . 27.1 mt -111.06 125.4 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.633 ' HG3' HG22 ' A' ' 14' ' ' ILE . 42.5 mttt 55.02 24.79 6.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.321 -0.862 . . . . 0.0 109.55 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.458 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 90.31 4.52 71.01 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 42.7 m -103.64 126.45 50.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -1.203 . . . . 0.0 109.467 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -82.12 129.15 34.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.73 HD13 ' HZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -141.27 167.76 21.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -87.55 148.61 24.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 0.0 109.569 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.846 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -135.92 163.79 29.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 109.475 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.741 ' O ' HD22 ' A' ' 85' ' ' LEU . 20.6 m80 -130.37 129.42 43.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.563 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.779 ' HB2' HD11 ' A' ' 10' ' ' LEU . 48.4 t90 -77.0 127.74 33.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -137.59 107.41 6.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.499 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 18.2 p -65.69 -33.11 75.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.82 -15.76 55.49 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.12 130.43 34.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -1.155 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.7 m -94.98 -24.02 17.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.986 HD11 ' HB2' ' A' ' 74' ' ' GLU . 11.3 tp -132.72 143.12 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -0.926 . . . . 0.0 109.6 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 84' ' ' LEU . 39.1 m -58.46 136.46 57.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.655 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 9.9 t -124.76 140.04 53.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.834 HG13 HG13 ' A' ' 75' ' ' VAL . 2.6 m -137.72 172.14 7.29 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.32 -0.862 . . . . 0.0 109.14 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.5 Cg_endo -79.82 132.26 9.58 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.22 1.946 . . . . 0.0 111.833 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 33' ' ' PRO . 22.4 pt-20 -44.22 -25.92 0.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.642 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -48.52 -34.34 11.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 109.526 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.73 ' HZ ' HD13 ' A' ' 19' ' ' LEU . 12.8 m-85 -89.42 -9.75 49.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 109.646 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.486 ' HA ' HD13 ' A' ' 37' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.783 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 4.6 m-85 . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 121.283 0.563 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.534 ' O ' HD23 ' A' ' 62' ' ' LEU . 35.9 t80 -108.24 113.12 25.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -0.826 . . . . 0.0 108.957 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 61' ' ' TYR . 28.4 mt -117.25 158.84 23.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.071 -1.018 . . . . 0.0 110.128 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.712 HG23 ' HG2' ' A' ' 72' ' ' GLU . 22.0 m -119.88 115.7 24.36 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 9.4 p90 -138.89 162.02 35.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.067 -1.02 . . . . 0.0 109.945 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 32.2 mttm -92.39 127.37 37.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.395 -0.816 . . . . 0.0 109.278 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 49.8 t -106.98 105.86 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 109.537 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 21.2 mt-30 63.85 36.26 10.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.291 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.09 33.86 39.36 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 71' ' ' VAL . 74.3 mtt180 -139.19 108.81 6.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.225 -1.162 . . . . 0.0 109.405 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -55.72 121.71 9.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.91 . . . . 0.0 109.628 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.614 HG21 ' CH2' ' A' ' 92' ' ' TRP . 80.3 t -141.16 129.98 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 109.429 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.712 ' HG2' HG23 ' A' ' 63' ' ' THR . 54.5 mt-10 -113.7 136.36 52.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.621 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.37 -173.49 4.03 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.368 -0.832 . . . . 0.0 109.353 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.986 ' HB2' HD11 ' A' ' 29' ' ' ILE . 97.2 mt-10 -80.0 164.79 23.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.002 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.834 HG13 HG13 ' A' ' 32' ' ' VAL . 89.8 t -152.76 145.42 15.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.134 -0.979 . . . . 0.0 109.914 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.9 tp -114.95 143.03 45.79 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.14 143.12 32.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.1 -1.0 . . . . 0.0 109.649 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.488 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -152.25 152.11 28.78 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 0.0 109.304 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.488 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.2 Cg_endo -71.19 2.53 4.25 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.613 2.209 . . . . 0.0 112.019 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 41.1 m-85 -63.34 169.23 3.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.047 -1.033 . . . . 0.0 109.301 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -113.71 23.26 13.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.519 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.887 ' OH ' HD21 ' A' ' 84' ' ' LEU . 16.3 p90 -147.86 -166.81 2.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 109.528 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.625 HG23 HG12 ' A' ' 32' ' ' VAL . 4.9 mt -114.95 151.67 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.94 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.908 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.1 mt -119.14 124.97 48.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 108.949 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.908 HD13 ' C ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -107.45 138.38 43.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.968 . . . . 0.0 109.647 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.769 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -100.76 159.3 29.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 109.518 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 47.6 Cg_endo -69.41 -24.24 31.48 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.71 2.274 . . . . 0.0 111.505 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.9 m -74.27 -34.07 63.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.334 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.92 ' OD1' HG13 ' A' ' 90' ' ' VAL . 1.7 p30 -80.16 -38.34 31.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 0.0 109.263 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.92 HG13 ' OD1' ' A' ' 89' ' ' ASP . 2.3 m -108.18 69.64 0.33 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.584 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.563 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 52.8 Cg_endo -70.72 -25.85 23.72 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.798 2.332 . . . . 0.0 112.045 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.847 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.9 p90 -71.26 -37.65 71.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.955 . . . . 0.0 109.497 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.558 HD23 ' CD1' ' A' ' 23' ' ' TRP . 29.8 tp . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 49.6 Cg_endo -70.18 147.62 60.57 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.69 2.26 . . . . 0.0 111.708 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 10' ' ' LEU . 4.1 mp -88.8 167.46 13.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.261 -0.9 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -104.35 139.6 39.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.27 152.81 33.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 17' ' ' THR . 59.8 tt0 -123.8 120.38 32.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.456 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.668 HG22 ' HG3' ' A' ' 15' ' ' LYS . 29.8 mt -111.69 128.47 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.668 ' HG3' HG22 ' A' ' 14' ' ' ILE . 48.3 mttm 50.77 29.58 4.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.564 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.416 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.36 -12.08 67.78 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 28.7 m -80.59 129.95 34.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -1.1 . . . . 0.0 109.455 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.734 ' O ' HD23 ' A' ' 19' ' ' LEU . 62.4 tttm -96.61 125.38 41.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.609 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.734 HD23 ' O ' ' A' ' 18' ' ' LYS . 37.9 mt -147.19 169.85 18.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.284 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 9' ' ' PRO . 44.1 mttt -87.28 153.93 21.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.9 . . . . 0.0 109.487 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.872 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -136.36 168.84 18.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.323 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.793 ' O ' HD22 ' A' ' 85' ' ' LEU . 44.9 m80 -131.06 131.37 44.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.615 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.463 ' HE1' HG23 ' A' ' 90' ' ' VAL . 53.1 t90 -86.25 126.95 34.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.368 -0.833 . . . . 0.0 109.336 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 23' ' ' TRP . 97.1 m-20 -137.67 103.9 5.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.46 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 22.9 t -59.56 -29.23 67.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.51 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.32 -27.36 65.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.48 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -84.05 131.2 34.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -1.144 . . . . 0.0 109.576 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.8 p -96.66 -11.62 24.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 109.487 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.563 HD13 HD11 ' A' ' 76' ' ' LEU . 10.1 tt -134.23 145.51 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.89 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.645 ' HB ' HG12 ' A' ' 75' ' ' VAL . 86.6 m -63.55 140.97 58.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.442 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.682 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -121.47 128.43 52.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.915 HG13 ' HB ' ' A' ' 75' ' ' VAL . 4.2 m -127.77 163.34 43.82 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.408 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.7 Cg_endo -79.1 138.97 14.75 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.519 2.146 . . . . 0.0 111.943 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.864 ' HG2' ' HB1' ' A' ' 77' ' ' ALA . 74.7 mt-10 -46.88 -24.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.463 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.48 -24.54 3.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.492 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.51 ' C ' HD22 ' A' ' 37' ' ' LEU . 22.8 m-85 -97.85 -8.92 27.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 109.629 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.993 HD11 HD11 ' A' ' 62' ' ' LEU . 2.7 mm? -116.55 2.75 13.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 0.0 109.694 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -53.85 -42.95 69.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 109.295 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -110.81 25.43 11.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.331 -0.855 . . . . 0.0 109.291 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.489 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 70.7 mm-40 -108.78 -169.23 1.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.627 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 ptt85 -149.63 129.29 6.49 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.455 -0.778 . . . . 0.0 109.25 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.579 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 51.0 Cg_endo -70.82 124.4 10.61 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.589 2.193 . . . . 0.0 111.975 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.517 HG13 ' N ' ' A' ' 44' ' ' GLN . 31.9 pt -72.59 -36.11 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.245 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.517 ' N ' HG13 ' A' ' 43' ' ' ILE . 94.8 mt-30 -139.37 164.95 28.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.403 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.5 p -128.77 162.46 27.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 63.8 mtt -128.83 145.06 51.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.425 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.733 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.8 mp -100.58 128.75 46.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.532 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.549 HD12 ' HG3' ' A' ' 57' ' ' GLN . 25.5 mt -125.05 133.28 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.49 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -100.42 130.99 46.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.455 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 p -125.12 163.26 22.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.905 . . . . 0.0 109.517 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.499 HG13 ' N ' ' A' ' 52' ' ' HIS . 20.2 pt -61.61 -38.99 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.51 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.499 ' N ' HG13 ' A' ' 51' ' ' ILE . 86.5 t60 -69.62 -34.26 73.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 0.0 109.458 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.92 -172.06 44.83 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -97.05 129.14 44.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -1.174 . . . . 0.0 109.424 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -121.99 147.0 46.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 109.526 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -113.08 135.89 53.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.915 . . . . 0.0 109.511 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.549 ' HG3' HD12 ' A' ' 48' ' ' ILE . 21.3 mm-40 -106.72 128.87 54.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.378 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 42' ' ' PRO . 88.8 m-20 -81.04 152.39 27.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.63 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 22.0 t -115.35 132.0 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.846 . . . . 0.0 109.269 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.597 ' CD2' HD12 ' A' ' 37' ' ' LEU . 8.1 m-85 -121.39 131.72 54.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.002 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.514 ' CE1' ' HB3' ' A' ' 72' ' ' GLU . 47.0 t80 -95.88 108.98 21.4 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.993 HD11 HD11 ' A' ' 37' ' ' LEU . 50.5 mt -120.6 168.35 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.054 -1.029 . . . . 0.0 110.517 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.724 HG23 ' HG2' ' A' ' 72' ' ' GLU . 88.9 m -118.05 125.94 51.31 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.626 ' CE2' HG22 ' A' ' 66' ' ' VAL . 37.5 p90 -145.16 155.2 43.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 0.0 109.685 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 31.7 mttt -89.03 129.18 35.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.718 HG11 ' CG1' ' A' ' 90' ' ' VAL . 2.0 t -103.33 97.78 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 76.5 mt-30 65.02 41.11 4.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.214 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.22 32.88 41.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.405 ' O ' HG23 ' A' ' 71' ' ' VAL . 89.4 mtt180 -137.63 108.63 6.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -1.146 . . . . 0.0 109.34 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -58.12 122.51 13.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.516 HG21 ' CH2' ' A' ' 92' ' ' TRP . 93.6 t -147.7 134.22 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.285 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.724 ' HG2' HG23 ' A' ' 63' ' ' THR . 88.5 mt-10 -110.61 140.46 44.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.667 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.15 162.84 34.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.351 -0.843 . . . . 0.0 109.569 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.525 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 96.7 mt-10 -80.9 136.28 36.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.846 . . . . 0.0 109.175 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.915 ' HB ' HG13 ' A' ' 32' ' ' VAL . 12.4 m -129.54 150.91 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.225 -0.922 . . . . 0.0 109.683 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.761 ' N ' HD12 ' A' ' 76' ' ' LEU . 5.4 mp -100.41 150.17 22.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.277 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.864 ' HB1' ' HG2' ' A' ' 34' ' ' GLU . . . -80.04 135.6 36.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.484 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 2.8 t -142.9 150.19 52.29 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.484 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.0 Cg_endo -70.78 2.27 4.27 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.664 2.243 . . . . 0.0 112.088 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 67.1 m-85 -66.04 171.17 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.568 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -110.98 20.45 17.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.788 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.827 ' OH ' HD21 ' A' ' 84' ' ' LEU . 12.3 p90 -145.46 -159.91 1.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 109.441 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.703 HG23 HG12 ' A' ' 32' ' ' VAL . 4.3 mt -125.16 154.44 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.62 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.879 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.8 mt -120.03 126.48 50.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.263 -0.898 . . . . 0.0 109.063 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.879 HD13 ' C ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -105.61 142.02 36.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.536 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.723 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -102.26 161.82 22.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.366 -0.834 . . . . 0.0 109.431 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 51.9 Cg_endo -71.64 -21.6 25.27 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.618 2.212 . . . . 0.0 111.677 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.2 m -77.81 -34.1 52.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 0.0 109.403 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.951 ' OD1' HG13 ' A' ' 90' ' ' VAL . 1.6 p30 -80.02 -40.67 27.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.457 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.951 HG13 ' OD1' ' A' ' 89' ' ' ASP . 2.6 m -109.31 70.0 0.44 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.58 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.6 Cg_endo -70.53 -22.18 28.91 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.659 2.239 . . . . 0.0 111.843 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.803 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 47.5 p90 -77.27 -31.71 55.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 93' ' ' LEU . 10.0 tt -54.2 -40.98 68.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.505 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 90.2 mtp -60.06 -36.57 77.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.242 -0.911 . . . . 0.0 109.505 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -86.9 145.11 26.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.41 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -68.88 144.9 96.35 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.11 145.14 54.28 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.766 2.31 . . . . 0.0 111.775 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 98' ' ' LEU . 7.2 tt . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.95 . . . . 0.0 109.466 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.404 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.6 Cg_endo -70.02 144.59 53.1 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.794 2.329 . . . . 0.0 111.766 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.86 HD21 ' CE ' ' A' ' 94' ' ' MET . 4.3 mp -80.51 168.29 19.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 109.336 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -102.03 145.77 28.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.81 152.98 36.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.257 -0.902 . . . . 0.0 109.471 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 65' ' ' LYS . 82.0 tt0 -126.72 119.73 27.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.825 HG22 ' HG3' ' A' ' 15' ' ' LYS . 50.2 mt -115.93 129.61 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 109.374 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.825 ' HG3' HG22 ' A' ' 14' ' ' ILE . 82.8 mttt 58.35 24.03 11.18 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 109.572 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.44 -0.85 85.62 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.0 m -98.83 128.21 44.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -1.223 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.671 ' O ' HD12 ' A' ' 19' ' ' LEU . 34.1 mttp -83.78 138.89 33.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 109.443 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.692 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -150.01 167.21 27.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.555 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -83.53 155.0 23.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.516 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.045 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -147.88 167.14 25.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 109.379 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.515 ' O ' HD22 ' A' ' 85' ' ' LEU . 28.2 m80 -132.45 131.89 42.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.649 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 1.064 ' CZ2' HD11 ' A' ' 93' ' ' LEU . 71.6 t90 -84.7 128.15 34.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.327 -0.858 . . . . 0.0 109.386 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -138.33 104.97 5.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 109.526 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.56 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 6.5 p -60.45 -26.91 67.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.951 . . . . 0.0 109.438 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.05 -28.13 73.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.487 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -85.44 122.15 29.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -1.14 . . . . 0.0 109.232 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.1 p -91.89 -12.76 32.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.39 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.442 HG21 ' CD1' ' A' ' 76' ' ' LEU . 11.1 tp -127.04 142.33 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -0.936 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.718 ' HB ' HG12 ' A' ' 75' ' ' VAL . 44.4 m -63.39 139.56 58.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.893 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -120.78 123.23 42.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.21 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.983 HG12 HG23 ' A' ' 83' ' ' ILE . 17.3 m -121.83 162.87 34.59 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 109.727 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.7 Cg_endo -79.35 133.16 10.58 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.593 2.196 . . . . 0.0 111.554 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -46.72 -24.88 0.63 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.422 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.58 -32.95 53.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.646 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.692 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 5.3 m-85 -93.55 -3.95 51.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 109.67 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.691 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -112.75 4.72 17.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.176 -0.952 . . . . 0.0 109.737 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -52.49 -25.61 10.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.123 -0.986 . . . . 0.0 109.53 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -123.91 28.09 6.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.268 -0.895 . . . . 0.0 108.956 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 41.7 mm-40 -102.23 152.81 20.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.417 -0.802 . . . . 0.0 109.736 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.1 mtm180 -116.95 127.67 26.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.216 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.568 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 52.6 Cg_endo -72.1 116.09 4.57 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.577 2.185 . . . . 0.0 111.824 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.521 HG13 ' N ' ' A' ' 44' ' ' GLN . 27.9 pt -67.37 -36.5 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 109.325 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.521 ' N ' HG13 ' A' ' 43' ' ' ILE . 91.1 mt-30 -137.1 160.96 37.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.257 -0.902 . . . . 0.0 109.291 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 56.9 p -125.9 151.55 46.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.626 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 69.2 mtm -142.69 147.04 35.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.363 -0.836 . . . . 0.0 109.351 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 56' ' ' GLN . 0.5 OUTLIER -102.09 124.8 48.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.538 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.94 HD12 ' HG3' ' A' ' 57' ' ' GLN . 66.9 mt -118.02 134.42 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.398 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 33.2 mttp -106.3 139.89 40.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.523 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.5 p -128.91 162.48 27.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 109.386 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 52' ' ' HIS . 12.9 tt -52.9 -39.47 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.489 ' N ' HG23 ' A' ' 51' ' ' ILE . 70.6 m80 -63.3 -37.64 88.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.563 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.93 -175.94 43.24 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 93.8 mt-10 -90.74 135.11 33.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.213 -1.169 . . . . 0.0 109.545 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -134.33 139.67 45.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.364 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 47' ' ' LEU . 51.4 tt0 -97.65 119.95 37.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.643 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.94 ' HG3' HD12 ' A' ' 48' ' ' ILE . 16.6 mm-40 -107.22 146.34 31.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.281 -0.887 . . . . 0.0 109.407 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 88.1 m-20 -110.97 152.03 27.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 109.461 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.528 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 25.9 t -95.81 145.27 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.835 . . . . 0.0 109.117 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.691 ' CD2' HD23 ' A' ' 37' ' ' LEU . 38.3 m-85 -132.59 126.97 34.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.53 ' O ' HD23 ' A' ' 62' ' ' LEU . 36.2 t80 -94.74 111.8 23.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 108.874 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 61' ' ' TYR . 43.9 mt -121.3 167.09 13.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 110.122 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.723 HG23 ' HG2' ' A' ' 72' ' ' GLU . 52.2 m -124.01 113.99 19.16 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.508 ' CE2' HG22 ' A' ' 66' ' ' VAL . 12.7 p90 -134.29 159.27 41.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.815 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 74.5 mttt -90.84 123.74 34.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.307 -0.871 . . . . 0.0 109.291 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.73 HG11 HG11 ' A' ' 90' ' ' VAL . 51.9 t -100.85 106.52 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.762 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 98.0 mt-30 62.3 36.54 14.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.313 -0.867 . . . . 0.0 109.484 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.69 26.25 54.4 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.556 ' O ' HG23 ' A' ' 71' ' ' VAL . 55.0 mtt180 -131.35 115.06 15.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.248 -1.148 . . . . 0.0 109.277 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.53 120.31 9.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 69' ' ' ARG . 36.4 t -141.2 133.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.723 ' HG2' HG23 ' A' ' 63' ' ' THR . 45.6 mt-10 -113.94 136.38 52.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.602 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.36 166.42 29.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.831 . . . . 0.0 109.631 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.528 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 98.1 mt-10 -80.87 133.69 35.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.718 HG12 ' HB ' ' A' ' 30' ' ' THR . 3.4 m -127.21 161.9 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.536 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.442 ' CD1' HG21 ' A' ' 29' ' ' ILE . 5.0 mt -116.25 151.52 35.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.362 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.0 134.56 36.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.339 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.479 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.5 t -140.08 150.84 63.36 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.361 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.479 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.4 Cg_endo -70.55 -0.18 7.17 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.652 2.234 . . . . 0.0 111.78 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -64.95 168.52 6.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.493 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -110.99 22.35 15.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.612 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.563 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 15.3 p90 -144.04 -160.78 1.16 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 109.281 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.983 HG23 HG12 ' A' ' 32' ' ' VAL . 5.0 mt -126.64 143.56 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 109.737 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.893 HD13 ' HB3' ' A' ' 31' ' ' CYS . 6.4 mp -107.57 123.15 48.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.814 . . . . 0.0 109.066 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.045 HD21 ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -102.13 137.48 40.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.548 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.786 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -99.63 160.16 28.1 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.86 . . . . 0.0 109.687 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 51.7 Cg_endo -71.21 -27.92 19.28 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.735 2.29 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.0 m -69.19 -38.9 78.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.1 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.98 ' OD1' HG13 ' A' ' 90' ' ' VAL . 1.7 p30 -74.43 -40.15 62.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.87 . . . . 0.0 108.993 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.98 HG13 ' OD1' ' A' ' 89' ' ' ASP . 3.4 m -111.79 79.99 2.77 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.579 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 48.7 Cg_endo -69.18 -31.39 23.19 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.69 2.26 . . . . 0.0 112.085 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.877 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 30.6 p90 -63.89 -21.58 66.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.096 -1.003 . . . . 0.0 109.419 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.064 HD11 ' CZ2' ' A' ' 23' ' ' TRP . 2.2 mm? 58.08 63.14 1.84 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 109.606 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.86 ' CE ' HD21 ' A' ' 10' ' ' LEU . 36.7 mtt 67.75 169.93 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 109.645 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 18.4 tttt -75.58 136.54 40.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.508 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 2.1 tttp 169.76 -56.2 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.472 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 96' ' ' LYS . 49.1 Cg_endo -68.85 143.51 55.6 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.443 2.095 . . . . 0.0 111.723 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.3 mt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.486 179.987 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.488 ' CB ' ' O ' ' A' ' 21' ' ' ALA . 48.9 Cg_endo -70.16 161.06 47.37 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.7 2.267 . . . . 0.0 111.804 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.536 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 18.3 mt -99.49 178.64 4.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.131 -0.981 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.68 139.85 42.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.354 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.86 149.66 31.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 109.707 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 18' ' ' LYS . 96.2 mt-10 -123.74 116.1 22.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.27 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.843 HG22 ' HG3' ' A' ' 15' ' ' LYS . 49.9 mt -108.95 129.53 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.843 ' HG3' HG22 ' A' ' 14' ' ' ILE . 85.6 mttt 54.91 24.47 5.86 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.253 -0.904 . . . . 0.0 109.62 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.29 -2.61 83.55 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.5 m -89.88 117.37 28.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -1.202 . . . . 0.0 109.491 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.644 ' O ' HD23 ' A' ' 19' ' ' LEU . 84.2 tttt -81.8 125.75 31.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 18' ' ' LYS . 92.5 mt -145.77 161.77 39.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.28 148.6 30.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.785 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -129.92 173.14 10.98 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.172 -0.955 . . . . 0.0 109.532 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.807 ' O ' HD22 ' A' ' 85' ' ' LEU . 15.7 m80 -127.24 127.99 45.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 0.0 109.657 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.574 ' CH2' ' HB3' ' A' ' 25' ' ' SER . 60.8 t90 -91.94 128.12 37.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.581 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.636 ' CB ' HD21 ' A' ' 84' ' ' LEU . 61.1 t0 -137.82 104.36 5.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.574 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 59.6 p -56.64 -28.0 59.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.895 . . . . 0.0 109.514 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.07 -29.67 74.84 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.77 142.2 58.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -1.176 . . . . 0.0 109.506 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.494 ' O ' HG22 ' A' ' 28' ' ' THR . 86.7 m -108.61 -5.24 16.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.512 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 18.4 tt -152.0 144.54 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.942 ' HB ' HG12 ' A' ' 75' ' ' VAL . 44.8 m -53.94 150.64 7.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.679 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.36 129.59 52.27 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.269 -0.894 . . . . 0.0 109.116 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.764 HG13 ' HD2' ' A' ' 33' ' ' PRO . 77.3 t -134.57 145.83 56.67 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.297 -0.877 . . . . 0.0 109.455 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.764 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.3 Cg_endo -77.95 133.55 12.55 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.291 1.994 . . . . 0.0 111.651 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 40.7 tp10 -42.06 -27.4 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.44 -0.788 . . . . 0.0 109.792 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -47.81 -39.15 17.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.645 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.517 ' CZ ' ' CD1' ' A' ' 19' ' ' LEU . 32.7 m-85 -92.12 -5.48 52.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 109.847 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.7 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -107.66 1.71 23.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.93 . . . . 0.0 109.857 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -50.63 -24.71 3.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.975 . . . . 0.0 109.391 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -125.39 30.1 5.88 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 108.955 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.498 ' CD ' HD22 ' A' ' 62' ' ' LEU . 47.8 mm-40 -105.23 154.78 19.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.849 . . . . 0.0 109.836 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -117.7 128.74 25.81 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.823 . . . . 0.0 109.154 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 51.3 Cg_endo -71.19 119.53 6.35 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.65 2.233 . . . . 0.0 112.05 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.8 pt -75.49 -26.36 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.307 -0.871 . . . . 0.0 109.16 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -145.55 151.15 37.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.352 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 51.5 p -121.06 156.09 32.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.918 . . . . 0.0 109.485 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.2 mtp -147.48 141.5 25.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 0.0 109.47 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.1 tp -98.79 130.13 45.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.472 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.837 HD12 ' HG3' ' A' ' 57' ' ' GLN . 66.3 mt -123.33 127.06 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.147 -0.971 . . . . 0.0 109.527 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.449 ' HG3' ' HG2' ' A' ' 54' ' ' GLU . 36.7 tttt -102.29 126.28 49.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.352 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.31 -169.76 1.52 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.932 . . . . 0.0 109.52 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.484 ' HA ' HD13 ' A' ' 51' ' ' ILE . 15.6 mm -78.62 -47.31 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.331 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -57.4 -41.28 80.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.12 -169.28 41.52 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HG2' ' HG3' ' A' ' 49' ' ' LYS . 98.6 mt-10 -84.06 140.16 32.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -1.168 . . . . 0.0 109.449 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -125.99 141.01 52.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -100.66 117.06 34.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.837 ' HG3' HD12 ' A' ' 48' ' ' ILE . 3.2 mm-40 -112.67 125.15 53.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.469 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.559 ' O ' HD23 ' A' ' 76' ' ' LEU . 91.8 m-20 -109.48 156.0 20.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.875 . . . . 0.0 109.476 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.553 HG11 ' OE1' ' A' ' 74' ' ' GLU . 39.9 t -101.85 142.9 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.377 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.7 ' CD2' HD23 ' A' ' 37' ' ' LEU . 34.6 m-85 -131.31 129.38 41.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.146 -0.971 . . . . 0.0 110.037 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.47 ' O ' HD23 ' A' ' 62' ' ' LEU . 42.9 t80 -94.47 107.74 19.7 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.498 HD22 ' CD ' ' A' ' 40' ' ' GLU . 39.3 mt -118.1 171.29 8.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -0.99 . . . . 0.0 110.334 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.717 HG23 ' HG2' ' A' ' 72' ' ' GLU . 82.8 m -125.93 119.02 26.66 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.575 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 4.1 p90 -140.6 157.73 45.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.791 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 13' ' ' GLU . 20.3 mttm -87.36 132.02 34.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.835 . . . . 0.0 109.383 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.634 HG11 HG11 ' A' ' 90' ' ' VAL . 98.8 t -112.1 107.08 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 83.4 mt-30 63.37 35.46 12.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 109.4 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.74 33.81 32.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -141.24 115.09 9.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -1.116 . . . . 0.0 109.411 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -61.68 123.11 17.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.535 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.654 HG21 ' CH2' ' A' ' 92' ' ' TRP . 92.0 t -144.41 132.58 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.462 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.717 ' HG2' HG23 ' A' ' 63' ' ' THR . 50.4 mt-10 -109.02 138.01 46.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.622 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HB1' ' OD2' ' A' ' 89' ' ' ASP . . . -160.27 165.76 30.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.668 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.553 ' OE1' HG11 ' A' ' 59' ' ' VAL . 96.1 mt-10 -81.42 129.87 34.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.942 HG12 ' HB ' ' A' ' 30' ' ' THR . 3.2 m -124.92 160.88 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.119 -0.988 . . . . 0.0 109.61 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 58' ' ' ASP . 29.0 mt -109.35 145.11 36.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.95 134.76 36.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.438 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.491 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 3.5 t -142.25 149.64 52.43 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.395 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.474 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.7 Cg_endo -70.16 0.26 6.21 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.635 2.223 . . . . 0.0 111.873 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.491 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 66.6 m-85 -65.82 177.52 1.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.333 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -119.85 22.27 11.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.414 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.951 ' OH ' HD12 ' A' ' 84' ' ' LEU . 15.1 p90 -135.78 -173.72 3.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.863 . . . . 0.0 109.183 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.558 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 1.4 mt -131.54 112.33 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.951 HD12 ' OH ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -79.56 135.25 36.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.208 -0.933 . . . . 0.0 109.176 179.734 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.807 HD22 ' O ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -98.65 134.62 41.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.669 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.745 ' O ' HG22 ' A' ' 90' ' ' VAL . 29.8 t30 -86.21 140.77 34.58 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.441 -0.787 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HD2' ' OD1' ' A' ' 86' ' ' ASN . 46.5 Cg_endo -67.91 -34.54 23.35 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.69 2.26 . . . . 0.0 111.756 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.7 m -66.37 -36.05 81.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.182 -0.949 . . . . 0.0 109.283 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.583 ' OD2' ' HB1' ' A' ' 73' ' ' ALA . 91.8 m-20 -72.42 -32.1 66.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.493 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.184 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -113.93 72.85 2.22 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.4 Cg_endo -71.04 -21.98 26.87 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.667 2.245 . . . . 0.0 112.0 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.184 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 47.0 p90 -74.72 -30.43 61.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.462 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 66.9 mt -59.21 -35.34 73.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 66.1 mtt -58.63 -39.16 79.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 109.614 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -80.19 150.61 30.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 109.573 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 6.2 ttpt 52.33 73.42 0.95 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.563 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.92 145.31 55.86 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.759 2.306 . . . . 0.0 111.7 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.2 mt . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.436 179.922 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.85 160.15 50.73 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.72 2.28 . . . . 0.0 111.811 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.476 ' H ' HD12 ' A' ' 10' ' ' LEU . 4.5 mp -81.27 166.47 20.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.46 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -104.65 144.37 31.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.503 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.2 152.78 30.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 109.463 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.451 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 78.3 tt0 -123.14 120.34 32.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.321 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.86 HG22 ' HG2' ' A' ' 15' ' ' LYS . 57.7 mt -114.92 128.03 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.86 ' HG2' HG22 ' A' ' 14' ' ' ILE . 31.7 mmtp 59.43 23.26 11.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.451 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 86.54 10.51 73.32 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.502 HG22 HD23 ' A' ' 19' ' ' LEU . 33.8 m -108.52 125.8 52.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -1.13 . . . . 0.0 109.451 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 1.031 ' O ' HD22 ' A' ' 19' ' ' LEU . 28.7 mttm -80.28 125.32 29.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.453 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.031 HD22 ' O ' ' A' ' 18' ' ' LYS . 1.3 mm? -141.06 158.26 44.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -80.23 155.44 27.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 109.402 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.538 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -146.73 164.29 33.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.563 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.695 ' O ' HD22 ' A' ' 85' ' ' LEU . 30.9 m80 -124.9 133.19 53.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.616 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 20.0 t90 -83.95 126.25 32.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -132.91 97.71 4.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.311 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.523 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 52.1 p -58.53 -26.83 63.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.578 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.05 -31.31 76.19 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -77.78 138.32 38.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.173 . . . . 0.0 109.693 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.8 p -98.64 -4.71 33.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.592 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.961 HD13 HD11 ' A' ' 76' ' ' LEU . 21.1 tt -142.65 156.64 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.0 109.327 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.79 ' HB ' HG12 ' A' ' 75' ' ' VAL . 33.5 m -71.71 140.48 49.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.952 . . . . 0.0 109.63 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.545 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -124.31 122.08 36.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.423 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.579 HG13 ' HB ' ' A' ' 75' ' ' VAL . 3.4 m -119.62 164.61 20.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.922 . . . . 0.0 109.368 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.2 Cg_endo -79.04 137.85 14.02 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.475 2.117 . . . . 0.0 111.65 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -47.57 -23.59 0.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 0.0 109.592 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.03 -36.66 18.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.55 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.409 ' CE1' ' HB ' ' A' ' 14' ' ' ILE . 31.1 m-85 -89.61 -10.52 45.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.581 ' CD2' ' CG ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -107.87 38.2 2.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 39' ' ' ASP . 42.7 tp10 -56.83 92.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 109.709 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 37' ' ' LEU . 55.8 m-20 61.93 28.59 17.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.326 -0.859 . . . . 0.0 109.657 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 17.9 mm-40 -59.28 -178.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.94 114.28 43.93 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.539 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 53.9 Cg_endo -72.9 128.37 13.15 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.586 2.19 . . . . 0.0 111.753 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.84 HD13 ' HB2' ' A' ' 61' ' ' TYR . 28.4 pt -84.97 -29.61 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.5 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 1.012 ' O ' HG12 ' A' ' 59' ' ' VAL . 93.9 mt-30 -147.34 165.78 29.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.498 HG22 ' OD1' ' A' ' 58' ' ' ASP . 18.4 p -115.45 154.12 29.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 109.723 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.454 ' O ' ' HG3' ' A' ' 56' ' ' GLN . 24.8 mmm -138.8 161.78 36.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.294 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.965 HD23 ' HG3' ' A' ' 56' ' ' GLN . 49.3 mt -108.17 135.95 48.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 109.643 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.21 131.38 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -100.96 134.65 43.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.565 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 m -126.4 159.61 32.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.375 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.517 HG13 ' N ' ' A' ' 52' ' ' HIS . 19.1 pt -61.19 -39.59 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.176 -0.953 . . . . 0.0 109.457 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.517 ' N ' HG13 ' A' ' 51' ' ' ILE . 79.1 m80 -69.49 -35.75 75.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.912 . . . . 0.0 109.565 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.24 -171.62 44.02 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -102.28 128.76 48.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -1.128 . . . . 0.0 109.53 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -123.28 132.22 53.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 109.5 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.965 ' HG3' HD23 ' A' ' 47' ' ' LEU . 56.7 tt0 -103.77 134.03 47.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.499 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -130.36 155.98 45.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 109.542 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.498 ' OD1' HG22 ' A' ' 45' ' ' THR . 33.1 m-20 -87.27 142.13 28.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.428 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.012 HG12 ' O ' ' A' ' 44' ' ' GLN . 9.6 p -92.29 160.25 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.433 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.581 ' CG ' ' CD2' ' A' ' 37' ' ' LEU . 9.1 m-85 -135.51 142.18 45.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.187 -0.945 . . . . 0.0 109.968 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.84 ' HB2' HD13 ' A' ' 43' ' ' ILE . 48.1 t80 -100.02 112.96 25.24 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 61' ' ' TYR . 57.6 mt -123.19 170.5 10.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 110.417 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.692 HG23 ' HG2' ' A' ' 72' ' ' GLU . 89.4 m -118.84 126.68 52.39 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.751 ' CE2' HG22 ' A' ' 66' ' ' VAL . 35.7 p90 -142.99 154.78 44.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.093 -1.004 . . . . 0.0 109.748 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -88.07 128.4 35.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 109.383 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.751 HG22 ' CE2' ' A' ' 64' ' ' PHE . 2.2 t -105.78 103.78 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 25.8 mt-30 62.01 31.57 17.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.926 . . . . 0.0 109.285 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.99 28.66 25.21 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -132.91 126.53 32.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -1.172 . . . . 0.0 109.508 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -68.28 123.52 20.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.563 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.4 t -145.29 129.05 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.448 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.692 ' HG2' HG23 ' A' ' 63' ' ' THR . 67.2 mt-10 -112.45 135.17 53.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.04 166.07 30.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.739 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.548 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 91.9 mt-10 -80.24 133.26 35.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.283 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.79 HG12 ' HB ' ' A' ' 30' ' ' THR . 3.8 m -129.04 159.47 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.961 HD11 HD13 ' A' ' 29' ' ' ILE . 4.1 mp -110.83 151.28 28.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -0.885 . . . . 0.0 109.406 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.01 142.08 35.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.416 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.476 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 8.3 t -145.05 148.63 39.21 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 109.361 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.476 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.1 Cg_endo -70.34 0.24 6.37 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.649 2.233 . . . . 0.0 111.873 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -63.63 171.88 2.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 109.458 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -111.74 17.59 19.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.59 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.732 ' OH ' HD21 ' A' ' 84' ' ' LEU . 21.6 p90 -141.03 -156.17 0.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.136 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.6 mt -130.46 147.04 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.019 -1.051 . . . . 0.0 109.988 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.732 HD21 ' OH ' ' A' ' 82' ' ' TYR . 1.1 mt -108.99 130.39 55.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 108.98 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.777 ' H ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -99.73 144.29 28.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 109.853 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.587 ' O ' HG22 ' A' ' 90' ' ' VAL . 4.2 t30 -97.02 136.91 21.32 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.453 -0.78 . . . . 0.0 109.034 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.566 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.1 Cg_endo -63.88 -33.56 63.65 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.85 2.367 . . . . 0.0 112.028 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.407 ' HB2' HD21 ' A' ' 86' ' ' ASN . 6.2 m -75.47 -29.43 59.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.302 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 90.4 m-20 -73.35 -31.13 63.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.273 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.75 HG11 HG11 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -121.49 77.54 36.07 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.888 . . . . 0.0 109.363 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.82 -23.83 30.1 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.802 2.335 . . . . 0.0 111.874 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.686 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 32.8 p90 -80.91 -22.42 39.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.418 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.616 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 25.0 tp -56.67 -41.16 76.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.403 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 84.5 mtp -85.02 134.13 34.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.306 -0.871 . . . . 0.0 109.5 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -110.0 147.8 32.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 109.42 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -125.6 76.53 69.74 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.518 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.684 ' O ' HD23 ' A' ' 98' ' ' LEU . 50.0 Cg_endo -70.26 -21.16 31.57 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.633 2.222 . . . . 0.0 111.738 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 97' ' ' PRO . 56.8 mt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.45 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.86 149.73 72.8 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.759 2.306 . . . . 0.0 111.763 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.731 ' CD1' HD11 ' A' ' 93' ' ' LEU . 26.4 mt -80.91 -177.58 6.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.486 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -118.02 139.9 50.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.368 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.75 154.01 38.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 17' ' ' THR . 87.1 tt0 -128.5 120.47 26.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.944 . . . . 0.0 109.357 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 1.01 HG22 ' HG3' ' A' ' 15' ' ' LYS . 59.2 mt -115.63 127.83 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.393 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 1.01 ' HG3' HG22 ' A' ' 14' ' ' ILE . 45.6 mttt 60.77 23.76 13.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 109.449 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.427 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.29 -5.22 84.29 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.685 HG22 ' CD2' ' A' ' 19' ' ' LEU . 35.4 m -93.14 127.59 38.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -1.158 . . . . 0.0 109.459 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.871 ' O ' HD22 ' A' ' 19' ' ' LEU . 18.2 tttm -87.24 120.45 28.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.568 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 18' ' ' LYS . 3.5 mm? -129.59 164.6 23.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 109.313 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -83.0 155.96 23.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.938 . . . . 0.0 109.395 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.792 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -144.85 163.24 34.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.467 ' HB2' ' CE2' ' A' ' 82' ' ' TYR . 35.4 m80 -125.92 127.8 46.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.527 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.723 ' CD1' HD13 ' A' ' 93' ' ' LEU . 51.9 t90 -78.67 118.5 20.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.907 . . . . 0.0 109.507 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -128.2 102.93 6.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.953 . . . . 0.0 109.336 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.584 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 60.6 p -60.8 -29.2 69.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.609 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.98 -34.36 78.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.08 136.74 54.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.491 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.448 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 36.9 m -95.51 -14.73 23.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 tt -142.36 155.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.564 ' HB ' HG12 ' A' ' 75' ' ' VAL . 47.5 m -61.1 136.93 58.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -119.22 126.6 51.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.382 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.911 HG12 HG23 ' A' ' 83' ' ' ILE . 15.7 m -124.96 161.37 49.55 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 109.66 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 78' ' ' SER . 54.8 Cg_endo -79.38 132.05 9.92 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.751 2.301 . . . . 0.0 111.834 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.1 tt0 -45.36 -26.81 0.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.63 -36.1 33.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.509 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.07 -2.56 57.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.692 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -109.35 0.35 19.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 0.0 109.916 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -51.46 -25.76 6.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.0 109.484 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -122.18 25.41 9.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 109.177 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.663 ' CD ' HD22 ' A' ' 62' ' ' LEU . 55.5 mm-40 -100.55 160.93 13.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.734 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.33 128.99 25.07 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.37 -0.831 . . . . 0.0 109.233 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 52.8 Cg_endo -72.89 121.07 7.03 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.54 2.16 . . . . 0.0 112.048 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.541 HD13 ' HB2' ' A' ' 61' ' ' TYR . 36.4 pt -89.91 -23.5 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.245 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.437 ' HG3' HG13 ' A' ' 43' ' ' ILE . 94.6 mt-30 -141.81 175.3 9.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.26 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 40.2 p -126.67 150.35 49.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.164 -0.96 . . . . 0.0 109.811 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 29.1 tpp -132.37 145.74 51.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.324 -0.86 . . . . 0.0 109.462 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.748 ' N ' HD12 ' A' ' 47' ' ' LEU . 5.1 mp -102.18 132.6 48.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.9 . . . . 0.0 109.446 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 66.2 mt -122.4 135.15 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.493 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -111.39 135.95 51.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.166 -0.958 . . . . 0.0 109.57 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.1 p -127.12 157.94 38.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 109.363 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 52' ' ' HIS . 11.1 tp -56.92 -38.02 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.503 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.456 ' N ' HG23 ' A' ' 51' ' ' ILE . 67.2 m80 -67.09 -39.42 86.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.495 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.82 -170.14 41.06 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.32 132.2 44.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -1.193 . . . . 0.0 109.557 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.465 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 54.2 tptt -129.17 131.22 47.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.425 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.421 ' OE1' HD23 ' A' ' 47' ' ' LEU . 25.9 mt-30 -111.54 141.6 44.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.682 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.735 ' OE1' HD21 ' A' ' 76' ' ' LEU . 87.1 mt-30 -132.27 157.54 44.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.267 -0.896 . . . . 0.0 109.296 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 58.2 m-20 -90.88 142.16 28.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.756 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 20.5 t -83.42 154.83 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 108.985 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.692 ' CD2' HD23 ' A' ' 37' ' ' LEU . 17.5 m-85 -135.51 130.21 34.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 110.011 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.541 ' HB2' HD13 ' A' ' 43' ' ' ILE . 48.6 t80 -95.86 112.0 23.84 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.663 HD22 ' CD ' ' A' ' 40' ' ' GLU . 37.6 mt -121.79 170.22 9.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.052 -1.03 . . . . 0.0 110.489 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.717 HG23 ' HG2' ' A' ' 72' ' ' GLU . 87.1 m -121.97 119.77 32.47 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.763 ' CE2' HG22 ' A' ' 66' ' ' VAL . 44.6 p90 -140.68 154.46 46.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.026 -1.046 . . . . 0.0 109.739 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.431 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 20.1 mttm -85.87 132.33 34.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.833 . . . . 0.0 109.318 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.763 HG22 ' CE2' ' A' ' 64' ' ' PHE . 1.9 t -109.0 100.86 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.703 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 81.2 mt-30 65.09 35.45 7.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.458 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.33 35.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -134.08 116.73 15.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -1.072 . . . . 0.0 109.424 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.555 ' HE3' HG21 ' A' ' 63' ' ' THR . 15.3 tttp -66.8 119.7 12.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.534 HG21 ' CH2' ' A' ' 92' ' ' TRP . 98.6 t -141.24 134.39 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.867 . . . . 0.0 109.429 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.717 ' HG2' HG23 ' A' ' 63' ' ' THR . 61.1 mt-10 -110.5 136.13 50.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 109.593 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.26 166.34 29.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.672 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.533 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 96.3 mt-10 -80.02 136.24 36.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.27 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.718 HG21 HG21 ' A' ' 32' ' ' VAL . 4.1 m -127.96 158.19 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.22 -0.925 . . . . 0.0 109.65 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.735 HD21 ' OE1' ' A' ' 57' ' ' GLN . 32.4 tp -109.32 146.09 34.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.8 124.5 28.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 109.227 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.483 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 2.0 t -128.09 150.21 73.18 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.483 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.8 Cg_endo -70.58 -0.3 7.39 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.683 2.255 . . . . 0.0 111.628 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 56.0 m-85 -64.13 172.14 2.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 109.444 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -112.14 17.09 19.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.607 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.68 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 19.3 p90 -139.35 -156.82 0.71 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.245 -0.909 . . . . 0.0 109.087 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.911 HG23 HG12 ' A' ' 32' ' ' VAL . 3.0 mt -130.04 140.9 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.72 ' N ' HD12 ' A' ' 84' ' ' LEU . 6.5 mp -105.5 131.77 52.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 108.987 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.792 HD21 ' HB1' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -98.94 146.55 25.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.139 -0.976 . . . . 0.0 109.666 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.676 ' O ' HG22 ' A' ' 90' ' ' VAL . 4.7 t30 -99.74 136.86 20.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 109.189 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.524 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.6 Cg_endo -64.13 -33.26 61.93 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.805 2.336 . . . . 0.0 111.81 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.408 ' HB3' HD21 ' A' ' 86' ' ' ASN . 4.8 t -76.56 -25.95 54.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.18 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.432 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 89.6 m-20 -80.26 -32.69 38.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.376 -0.827 . . . . 0.0 109.306 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.964 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -120.03 76.23 22.45 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.872 . . . . 0.0 109.54 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.27 -24.85 26.87 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.682 2.255 . . . . 0.0 111.796 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.964 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 39.8 p90 -75.27 -27.59 59.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -0.89 . . . . 0.0 109.585 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.731 HD11 ' CD1' ' A' ' 10' ' ' LEU . 9.4 tt -56.75 -39.4 73.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.3 mmm -100.03 143.09 30.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.425 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -91.41 139.88 30.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.93 . . . . 0.0 109.48 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -73.47 132.66 81.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.541 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.08 145.6 55.75 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.769 2.313 . . . . 0.0 111.839 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.844 ' N ' HD12 ' A' ' 98' ' ' LEU . 4.0 mp . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 109.417 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.79 146.85 61.25 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.687 2.258 . . . . 0.0 111.793 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.494 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 20.9 mt -83.79 -177.36 6.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.92 . . . . 0.0 109.559 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -117.93 136.97 53.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 109.389 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.98 150.13 32.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.207 -0.933 . . . . 0.0 109.653 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.445 ' HG2' ' HA ' ' A' ' 18' ' ' LYS . 95.5 mt-10 -118.58 123.04 44.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.28 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' A' ' 64' ' ' PHE . 56.2 mt -117.37 124.11 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.582 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.7 tptt 64.11 22.13 12.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.524 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.13 -1.03 82.39 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.734 HG22 ' CD2' ' A' ' 19' ' ' LEU . 10.6 m -96.16 129.66 43.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.136 . . . . 0.0 109.384 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.88 ' O ' HD22 ' A' ' 19' ' ' LEU . 71.4 tttt -86.9 117.02 25.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.44 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.88 HD22 ' O ' ' A' ' 18' ' ' LYS . 3.8 mm? -132.17 161.37 33.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.386 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -84.45 153.57 23.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.419 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.789 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -141.58 163.01 34.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 109.56 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 82' ' ' TYR . 36.7 m80 -121.01 127.72 52.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 109.627 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.494 ' HB2' ' CD1' ' A' ' 10' ' ' LEU . 34.1 t90 -80.39 118.89 22.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.587 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -127.67 102.97 7.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.265 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' A' ' 87' ' ' PRO . 23.4 t -59.12 -29.43 67.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 109.625 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.51 -40.16 94.06 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.434 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -65.19 128.27 35.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -1.151 . . . . 0.0 109.487 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.509 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 45.6 p -94.09 -8.07 40.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.217 -0.927 . . . . 0.0 109.447 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 29' ' ' ILE . 11.1 tp -139.09 151.23 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.245 -0.909 . . . . 0.0 109.293 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 34.7 m -68.59 140.06 55.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 9.2 t -129.51 139.24 51.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.256 -0.903 . . . . 0.0 109.14 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.546 ' HB ' ' HD2' ' A' ' 33' ' ' PRO . 4.0 m -136.85 167.05 22.85 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.225 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.546 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.5 Cg_endo -78.93 134.32 11.77 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.202 1.935 . . . . 0.0 111.704 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 38' ' ' GLU . 81.3 tt0 -45.05 -24.58 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.363 -0.836 . . . . 0.0 109.874 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -47.71 -36.18 10.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 109.723 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.483 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 38.4 m-85 -92.38 -7.41 47.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.182 -0.949 . . . . 0.0 109.588 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.652 HD12 ' HG3' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -106.0 -12.89 15.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 109.527 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 34' ' ' GLU . 81.2 tt0 -49.81 -22.83 1.58 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.107 -0.995 . . . . 0.0 109.398 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -122.61 14.64 10.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.309 -0.869 . . . . 0.0 109.124 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.724 ' CD ' HD11 ' A' ' 62' ' ' LEU . 61.4 mm-40 -98.69 155.85 17.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.154 -0.966 . . . . 0.0 109.673 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -111.37 129.27 24.24 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.374 -0.829 . . . . 0.0 109.052 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.568 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 50.0 Cg_endo -70.34 120.29 7.02 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.522 2.148 . . . . 0.0 111.939 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.735 HD13 ' HB2' ' A' ' 61' ' ' TYR . 21.2 pt -88.21 -27.82 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.245 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.463 ' O ' ' N ' ' A' ' 59' ' ' VAL . 63.9 tt0 -142.67 164.13 30.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.264 -0.898 . . . . 0.0 109.259 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.436 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 69.9 p -115.59 158.92 21.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.405 ' HE1' ' CD1' ' A' ' 48' ' ' ILE . 4.0 ttp -147.14 145.29 29.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.528 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.833 HD23 ' HG3' ' A' ' 56' ' ' GLN . 42.1 mt -83.67 129.67 34.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 109.615 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 55' ' ' LYS . 30.1 mm -115.78 131.78 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 109.301 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 54.4 tttt -103.94 127.69 51.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 0.0 109.55 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -115.76 -178.31 3.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 109.672 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 55.8 mt -70.77 -50.3 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -56.51 -42.06 77.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -177.41 -159.1 21.91 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 81.8 tt0 -105.42 129.07 53.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -1.111 . . . . 0.0 109.507 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 48' ' ' ILE . 83.2 tttt -129.14 136.48 50.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.833 ' HG3' HD23 ' A' ' 47' ' ' LEU . 62.7 tt0 -94.39 129.85 40.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.699 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -115.99 159.37 21.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.905 . . . . 0.0 109.388 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.451 ' HB3' ' CB ' ' A' ' 42' ' ' PRO . 62.7 m-20 -86.54 142.27 28.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.0 109.611 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 14.4 t -89.04 151.12 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 109.269 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.58 ' CD2' ' HG ' ' A' ' 37' ' ' LEU . 26.6 m-85 -132.4 137.51 47.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.138 -0.977 . . . . 0.0 110.316 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.82 ' O ' HD22 ' A' ' 62' ' ' LEU . 4.8 t80 -98.19 110.13 22.77 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.82 HD22 ' O ' ' A' ' 61' ' ' TYR . 3.6 mm? -124.03 156.35 36.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.481 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.548 HG23 ' HB2' ' A' ' 72' ' ' GLU . 5.0 m -110.97 126.09 54.4 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.443 -0.786 . . . . 0.0 108.931 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.624 ' CE2' HG22 ' A' ' 66' ' ' VAL . 28.1 p90 -141.48 153.39 44.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.107 -0.995 . . . . 0.0 109.694 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 6.0 mmtp -83.85 127.95 34.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.28 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.891 HG11 HG11 ' A' ' 90' ' ' VAL . 25.1 t -105.75 98.99 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 82.1 mt-30 64.68 36.5 8.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.51 30.01 31.3 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 65' ' ' LYS . 56.6 mtt180 -136.7 125.17 23.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -1.134 . . . . 0.0 109.449 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -67.33 128.41 36.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.473 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.437 HG21 ' CH2' ' A' ' 92' ' ' TRP . 43.3 t -150.0 128.18 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.56 ' HG2' ' CE2' ' A' ' 61' ' ' TYR . 55.2 tt0 -118.31 134.59 54.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.0 175.23 13.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.268 -0.895 . . . . 0.0 109.434 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 95.6 mt-10 -79.71 139.65 37.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 109.261 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' ' 32' ' ' VAL . 10.8 m -133.82 151.86 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.269 -0.894 . . . . 0.0 109.583 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.852 ' N ' HD12 ' A' ' 76' ' ' LEU . 4.3 mp -102.61 145.77 29.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.33 -0.856 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.0 137.94 36.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.298 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.478 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.3 t -144.02 151.17 51.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.0 Cg_endo -71.79 2.53 4.62 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.69 2.26 . . . . 0.0 111.83 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -63.55 167.11 5.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.162 -0.962 . . . . 0.0 109.338 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -109.71 17.71 20.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.762 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 14.5 p90 -139.49 -157.71 0.79 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.136 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.541 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.0 mt -128.98 145.82 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 109.575 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.762 HD11 ' CZ ' ' A' ' 82' ' ' TYR . 5.9 mp -110.76 135.0 52.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -0.882 . . . . 0.0 108.872 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.835 ' N ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -105.64 142.49 35.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.606 ' O ' HG22 ' A' ' 90' ' ' VAL . 6.5 t30 -100.13 134.86 20.56 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 108.949 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.492 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 41.5 Cg_endo -63.86 -22.85 68.88 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.769 2.313 . . . . 0.0 112.234 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.431 ' HB2' HD21 ' A' ' 86' ' ' ASN . 14.2 m -77.05 -31.62 56.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 0.0 109.298 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.914 ' OD1' HG13 ' A' ' 90' ' ' VAL . 1.9 p30 -80.37 -35.63 35.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 109.378 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.035 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 2.4 m -112.1 69.28 0.92 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.391 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.87 -21.94 32.26 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.679 2.252 . . . . 0.0 111.813 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.035 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 38.7 p90 -72.76 -28.8 62.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.431 HD13 HE22 ' A' ' 67' ' ' GLN . 24.2 tp -66.68 -36.27 82.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 90.6 mtp -66.85 -33.07 74.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 109.55 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -94.79 141.15 28.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 109.454 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.8 79.52 68.21 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.14 -0.975 . . . . 0.0 109.612 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.96 143.58 50.31 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.656 2.238 . . . . 0.0 111.782 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.6 tp . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.483 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.15 154.91 65.76 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.745 2.296 . . . . 0.0 111.707 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.71 HD12 HD13 ' A' ' 85' ' ' LEU . 17.2 mt -81.45 179.92 7.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.33 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -110.48 139.13 46.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.89 148.65 32.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.488 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.436 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 79.3 tt0 -129.23 116.08 18.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -0.86 . . . . 0.0 109.37 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.642 HG22 ' HG3' ' A' ' 15' ' ' LYS . 59.4 mt -111.72 127.31 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.14 -0.975 . . . . 0.0 109.592 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.642 ' HG3' HG22 ' A' ' 14' ' ' ILE . 54.4 mttp 57.88 24.76 11.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.288 -0.882 . . . . 0.0 109.599 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.436 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.52 -10.69 72.54 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.426 HG21 ' HZ ' ' A' ' 36' ' ' PHE . 50.0 m -79.72 125.51 29.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -1.105 . . . . 0.0 109.312 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.755 ' O ' HD23 ' A' ' 19' ' ' LEU . 3.3 ttmt -88.81 117.34 27.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.527 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.775 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 73.3 mt -136.54 156.52 48.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.868 . . . . 0.0 109.363 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -84.72 151.75 24.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.865 ' CB ' HD21 ' A' ' 85' ' ' LEU . . . -133.69 -179.76 5.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.936 . . . . 0.0 109.578 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.47 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 27.8 m80 -134.24 131.16 38.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.901 . . . . 0.0 109.599 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.596 ' N ' HD12 ' A' ' 85' ' ' LEU . 64.4 t90 -88.33 119.04 28.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.264 -0.898 . . . . 0.0 109.352 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -128.21 103.02 6.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.297 -0.877 . . . . 0.0 109.427 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.511 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 21.4 t -55.83 -31.84 63.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.646 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.27 -37.51 91.96 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.467 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -68.03 144.94 54.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -1.192 . . . . 0.0 109.517 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.517 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 39.7 p -113.13 -5.6 13.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.459 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.8 tt -141.8 146.28 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 0.0 109.423 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.641 ' HB ' HG22 ' A' ' 75' ' ' VAL . 51.7 m -66.73 141.17 57.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 0.0 109.633 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -126.66 136.41 52.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.995 HG12 HG23 ' A' ' 83' ' ' ILE . 25.0 m -132.38 165.02 39.31 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.831 . . . . 0.0 108.899 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.4 Cg_endo -78.23 129.84 9.81 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.115 1.876 . . . . 0.0 111.419 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 81.3 tt0 -40.87 -27.82 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.53 -0.731 . . . . 0.0 109.891 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -50.79 -28.33 9.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.538 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.775 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 15.0 m-85 -96.36 -7.76 34.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 109.528 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.64 ' CD2' ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -108.11 -5.43 16.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.797 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 93.7 mt-10 -48.66 -26.9 2.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.103 -0.998 . . . . 0.0 109.291 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -121.96 26.13 8.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.943 . . . . 0.0 109.189 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.489 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 40.9 mm-40 -101.62 158.94 15.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.594 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.57 130.47 24.84 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.355 -0.84 . . . . 0.0 109.246 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.574 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 52.3 Cg_endo -71.3 119.73 6.48 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 122.626 2.218 . . . . 0.0 111.822 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.658 HD13 ' HB2' ' A' ' 61' ' ' TYR . 37.9 pt -73.77 -34.36 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.89 . . . . 0.0 109.117 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.507 ' N ' HG13 ' A' ' 43' ' ' ILE . 89.7 mt-30 -140.05 157.26 45.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.356 -0.84 . . . . 0.0 109.033 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 33.0 p -125.99 157.36 38.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 109.757 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.3 mtp -132.94 146.7 52.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 0.0 109.328 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 tp -102.93 127.66 50.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.932 . . . . 0.0 109.531 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.3 mt -116.63 137.42 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.352 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.1 tttt -126.29 130.24 50.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.548 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.6 p -128.8 158.12 39.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.44 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.1 tt -56.06 -34.46 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.913 . . . . 0.0 109.458 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -68.43 -40.73 81.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.521 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.52 -170.01 41.84 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -99.15 134.2 42.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -1.141 . . . . 0.0 109.553 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -115.67 145.92 42.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.283 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -114.04 123.09 48.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.73 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.658 ' CD ' HD11 ' A' ' 76' ' ' LEU . 2.2 tp60 -126.56 132.62 51.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.341 -0.849 . . . . 0.0 109.393 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 45.0 m-20 -121.07 153.99 36.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.249 -0.907 . . . . 0.0 109.304 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.9 m -98.61 150.58 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.444 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.64 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 25.5 m-85 -128.6 127.06 41.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.87 . . . . 0.0 109.794 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.658 ' HB2' HD13 ' A' ' 43' ' ' ILE . 34.5 t80 -87.14 114.12 23.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.887 . . . . 0.0 108.776 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 61' ' ' TYR . 32.4 mt -120.89 163.45 18.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.133 -0.979 . . . . 0.0 110.235 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.733 HG23 ' HG2' ' A' ' 72' ' ' GLU . 41.5 m -124.24 121.12 34.17 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.709 ' CE2' HG22 ' A' ' 66' ' ' VAL . 22.0 p90 -145.4 164.17 32.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.951 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -90.87 132.95 35.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.414 -0.804 . . . . 0.0 109.339 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.823 HG11 HG11 ' A' ' 90' ' ' VAL . 38.3 t -111.4 98.3 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.552 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 88.0 mt-30 63.35 36.28 11.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.325 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.45 35.08 18.13 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -141.98 124.59 15.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -1.1 . . . . 0.0 109.39 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -69.68 122.44 19.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.14 134.79 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.887 . . . . 0.0 109.556 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.733 ' HG2' HG23 ' A' ' 63' ' ' THR . 52.1 mt-10 -125.77 132.59 52.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.557 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.29 -176.99 5.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.82 154.03 28.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.273 -0.892 . . . . 0.0 109.091 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.786 ' CG1' HG22 ' A' ' 32' ' ' VAL . 56.0 t -144.83 157.64 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.188 -0.945 . . . . 0.0 109.748 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.658 HD11 ' CD ' ' A' ' 57' ' ' GLN . 16.4 tp -117.58 144.4 45.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 109.041 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.97 137.46 36.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 109.529 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.475 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 3.2 t -142.31 150.23 54.35 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.332 -0.855 . . . . 0.0 109.471 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.475 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 52.8 Cg_endo -72.68 5.71 2.76 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.602 2.202 . . . . 0.0 111.905 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -64.73 -178.94 0.45 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -118.87 14.68 13.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.471 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.578 ' CZ ' ' HG ' ' A' ' 84' ' ' LEU . 20.5 p90 -142.28 -156.99 0.73 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 108.972 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.995 HG23 HG12 ' A' ' 32' ' ' VAL . 2.8 mt -128.84 128.28 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.25 -0.906 . . . . 0.0 109.812 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.578 ' HG ' ' CZ ' ' A' ' 82' ' ' TYR . 1.7 mt -83.86 136.91 33.93 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.2 -0.937 . . . . 0.0 108.713 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.865 HD21 ' CB ' ' A' ' 21' ' ' ALA . 5.2 mt -102.13 143.57 31.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 0.0 110.049 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.665 ' O ' HG22 ' A' ' 90' ' ' VAL . 10.3 t-20 -102.54 133.12 20.68 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.472 -0.768 . . . . 0.0 109.133 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 44.2 Cg_endo -66.05 -30.27 47.67 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.759 2.306 . . . . 0.0 111.929 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.409 ' HB2' HD21 ' A' ' 86' ' ' ASN . 14.7 m -76.21 -31.75 58.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.162 -0.961 . . . . 0.0 109.238 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -73.21 -28.3 62.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.382 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.938 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 2.2 m -124.1 77.83 59.45 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.559 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.5 Cg_endo -70.14 -20.45 33.03 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.731 2.287 . . . . 0.0 111.972 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.938 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 48.8 p90 -80.99 -27.45 35.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.812 ' O ' HD13 ' A' ' 93' ' ' LEU . 3.4 tm? -57.95 -37.91 75.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 109.391 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 71.5 mtm -81.62 131.68 35.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.395 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -58.49 -33.11 69.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.462 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt 55.93 67.78 2.72 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.52 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.48 145.02 51.8 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.713 2.275 . . . . 0.0 111.776 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 24.0 tp . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.159 -0.963 . . . . 0.0 109.484 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.502 ' CG ' ' HD3' ' A' ' 20' ' ' LYS . 49.9 Cg_endo -70.45 160.71 48.57 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.732 2.288 . . . . 0.0 111.747 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.471 ' H ' HD12 ' A' ' 10' ' ' LEU . 4.5 mp -81.8 176.36 9.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.428 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -104.76 140.31 38.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.65 152.7 33.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.873 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 17' ' ' THR . 91.9 mt-10 -129.35 116.35 18.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 109.531 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.926 HG22 ' HG3' ' A' ' 15' ' ' LYS . 33.5 mt -109.88 128.76 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 109.401 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.926 ' HG3' HG22 ' A' ' 14' ' ' ILE . 2.8 mtmt 58.71 22.32 9.84 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.178 -0.951 . . . . 0.0 109.55 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.72 -0.88 83.15 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.471 HG22 HD23 ' A' ' 19' ' ' LEU . 31.2 m -93.46 132.7 37.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -1.218 . . . . 0.0 109.479 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.981 ' O ' HD22 ' A' ' 19' ' ' LEU . 25.7 tttt -83.05 121.15 26.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.51 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.981 HD22 ' O ' ' A' ' 18' ' ' LYS . 1.6 mm? -138.34 158.82 43.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.945 . . . . 0.0 109.545 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HD3' ' CG ' ' A' ' 9' ' ' PRO . 46.2 mttt -82.48 147.01 28.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.75 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -134.86 159.78 40.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.373 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.855 ' O ' HD22 ' A' ' 85' ' ' LEU . 19.9 m80 -123.06 133.97 54.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.42 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.948 ' CD1' HD23 ' A' ' 93' ' ' LEU . 63.5 t90 -95.29 121.81 37.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.598 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.744 ' CB ' HD21 ' A' ' 84' ' ' LEU . 61.1 t0 -131.07 103.79 6.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -0.881 . . . . 0.0 109.306 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.564 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 56.1 p -56.69 -16.84 7.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.58 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.92 -35.51 58.07 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.465 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -69.6 140.79 53.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -1.152 . . . . 0.0 109.594 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.8 p -107.02 -0.89 22.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 0.0 109.495 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.858 HD13 HD11 ' A' ' 76' ' ' LEU . 20.0 tt -144.26 152.52 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.232 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.661 ' HB ' HG12 ' A' ' 75' ' ' VAL . 34.5 m -65.99 149.9 49.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.501 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 84' ' ' LEU . 13.1 t -123.06 141.66 51.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.173 -0.955 . . . . 0.0 109.121 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.771 HG23 ' HB ' ' A' ' 75' ' ' VAL . 74.3 t -143.43 145.9 33.72 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.412 -0.805 . . . . 0.0 109.308 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.738 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.4 Cg_endo -77.76 132.11 11.73 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.245 1.964 . . . . 0.0 111.447 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 33' ' ' PRO . 82.6 tt0 -41.59 -28.1 0.12 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.429 -0.794 . . . . 0.0 109.71 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -51.46 -30.21 18.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.145 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -97.63 0.39 47.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 109.712 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.642 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -113.01 -3.61 14.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.013 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -52.1 -24.12 6.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.127 -0.983 . . . . 0.0 109.433 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -126.14 27.7 6.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 108.96 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.462 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 52.0 mm-40 -103.23 173.05 6.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 109.945 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -132.76 128.22 20.73 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 109.207 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.571 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 53.7 Cg_endo -73.74 123.82 8.8 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.631 2.221 . . . . 0.0 111.917 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.604 HD13 ' HB2' ' A' ' 61' ' ' TYR . 33.5 pt -85.31 -28.31 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.171 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.416 ' N ' HG13 ' A' ' 43' ' ' ILE . 93.6 mt-30 -143.89 166.57 24.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.879 . . . . 0.0 109.202 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 61.3 p -124.75 151.09 45.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.808 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.504 ' CE ' HG21 ' A' ' 59' ' ' VAL . 64.9 mtt -138.68 142.31 38.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.337 -0.852 . . . . 0.0 109.324 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.552 HD23 ' C ' ' A' ' 47' ' ' LEU . 9.2 tt -96.36 131.91 42.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.602 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.51 ' N ' HD23 ' A' ' 47' ' ' LEU . 69.0 mt -118.59 133.54 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.365 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -113.98 136.22 53.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.56 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.8 p -129.15 158.27 39.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 109.512 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.443 HG23 ' N ' ' A' ' 52' ' ' HIS . 10.8 tp -56.52 -37.04 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.515 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.443 ' N ' HG23 ' A' ' 51' ' ' ILE . 58.8 t-80 -67.41 -37.9 83.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.521 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.67 -175.41 47.35 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -106.46 128.46 54.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -1.1 . . . . 0.0 109.545 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -131.27 137.55 48.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.91 . . . . 0.0 109.387 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 46' ' ' MET . 38.9 tt0 -114.34 130.44 56.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.194 -0.941 . . . . 0.0 109.673 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -120.64 159.62 24.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 109.213 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 52.6 m-20 -98.73 141.12 31.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.135 -0.978 . . . . 0.0 109.628 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.541 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 15.9 t -82.64 150.44 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.082 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.642 ' CD2' HD23 ' A' ' 37' ' ' LEU . 13.8 m-85 -131.43 135.49 47.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.121 -0.987 . . . . 0.0 109.99 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.604 ' HB2' HD13 ' A' ' 43' ' ' ILE . 46.5 t80 -99.83 113.65 26.31 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 61' ' ' TYR . 40.2 mt -122.46 169.35 11.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.705 HG23 ' HG2' ' A' ' 72' ' ' GLU . 97.8 m -120.7 116.48 25.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.586 ' CE2' HG22 ' A' ' 66' ' ' VAL . 22.6 p90 -136.41 158.19 45.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.057 -1.027 . . . . 0.0 109.773 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 13' ' ' GLU . 40.8 mttm -89.98 129.12 36.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.322 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.796 HG11 HG11 ' A' ' 90' ' ' VAL . 11.7 t -105.99 101.88 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.917 . . . . 0.0 109.515 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 19.3 mt-30 64.32 38.98 7.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.895 . . . . 0.0 109.412 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.62 32.43 41.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.0 mtt-85 -138.33 114.51 10.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.442 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HE2' HG21 ' A' ' 63' ' ' THR . 72.6 tttt -61.49 122.75 15.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.616 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.511 HG21 ' CH2' ' A' ' 92' ' ' TRP . 58.8 t -145.32 130.13 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.224 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.705 ' HG2' HG23 ' A' ' 63' ' ' THR . 82.1 mt-10 -108.3 137.36 46.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 0.0 109.617 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.3 166.56 29.26 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.603 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.541 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 93.6 mt-10 -79.86 140.57 36.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.771 ' HB ' HG23 ' A' ' 32' ' ' VAL . 10.2 m -131.16 153.19 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.635 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.858 HD11 HD13 ' A' ' 29' ' ' ILE . 5.2 mp -107.48 148.42 29.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.385 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.78 140.09 37.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 109.425 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.501 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -151.56 152.86 31.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.296 -0.877 . . . . 0.0 109.239 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.501 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.0 Cg_endo -70.57 2.49 3.94 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.528 2.152 . . . . 0.0 112.034 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 34.0 m-85 -65.88 170.38 5.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 109.438 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -114.43 21.19 14.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.365 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.582 ' OH ' HD12 ' A' ' 84' ' ' LEU . 33.3 p90 -142.01 -166.5 2.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 109.143 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 19' ' ' LEU . 1.5 mt -132.02 118.62 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.923 . . . . 0.0 109.64 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.744 HD21 ' CB ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -82.61 134.45 35.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 108.987 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.855 HD22 ' O ' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -97.31 142.26 29.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.065 -1.022 . . . . 0.0 109.763 -179.71 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.645 ' O ' HG22 ' A' ' 90' ' ' VAL . 6.5 t-20 -90.11 135.57 29.84 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.033 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.56 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 41.5 Cg_endo -64.1 -33.14 62.71 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.805 2.337 . . . . 0.0 111.972 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.409 ' HB2' HD21 ' A' ' 86' ' ' ASN . 13.4 m -71.88 -28.02 63.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.118 -0.989 . . . . 0.0 109.107 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -79.17 -30.79 43.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 109.344 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.127 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -119.67 74.25 17.72 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.917 . . . . 0.0 109.328 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.575 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.9 Cg_endo -69.6 -18.92 37.49 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.749 2.299 . . . . 0.0 111.926 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.127 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 48.9 p90 -81.21 -26.24 36.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.479 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.948 HD23 ' CD1' ' A' ' 23' ' ' TRP . 24.1 tp -60.47 -32.04 71.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.442 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 87.6 mtp -81.29 130.41 35.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.192 -0.943 . . . . 0.0 109.486 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -71.06 138.52 49.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.24 140.63 93.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.287 -0.883 . . . . 0.0 109.453 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.25 -20.73 32.17 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.696 2.264 . . . . 0.0 111.83 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.8 mt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.89 158.48 56.64 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.568 2.179 . . . . 0.0 111.694 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 23' ' ' TRP . 25.2 mt -90.6 -177.32 5.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.582 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -112.19 134.44 53.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.353 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.0 146.24 28.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -0.948 . . . . 0.0 109.5 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 17' ' ' THR . 65.4 tt0 -121.97 122.21 38.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.883 . . . . 0.0 109.224 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.456 HG12 ' HB3' ' A' ' 64' ' ' PHE . 43.2 mt -114.74 127.12 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.694 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 58.07 25.59 12.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.531 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.44 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 90.66 -13.69 65.0 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 52.8 m -79.78 131.85 36.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -1.21 . . . . 0.0 109.385 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.865 ' O ' HD23 ' A' ' 19' ' ' LEU . 29.7 tttm -96.4 123.9 40.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 109.62 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.865 HD23 ' O ' ' A' ' 18' ' ' LYS . 57.2 mt -143.32 162.67 35.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -89.43 146.93 24.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.928 . . . . 0.0 109.527 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.621 ' CB ' HD11 ' A' ' 85' ' ' LEU . . . -130.01 176.58 7.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.749 ' O ' HD22 ' A' ' 85' ' ' LEU . 25.9 m80 -127.47 129.97 48.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.455 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.605 ' HB2' HD11 ' A' ' 10' ' ' LEU . 20.6 t90 -83.17 122.54 28.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.683 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -127.52 96.28 4.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.341 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.46 ' HA ' ' HG3' ' A' ' 87' ' ' PRO . 17.3 t -53.68 -33.9 56.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.645 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.62 -35.65 86.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.32 137.22 57.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -1.166 . . . . 0.0 109.631 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.518 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 89.2 m -102.07 -9.43 20.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 109.381 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.435 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 20.1 tt -139.61 160.12 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.335 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.513 ' CG2' HG12 ' A' ' 75' ' ' VAL . 38.5 m -71.51 150.19 45.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.315 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.556 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -126.83 127.17 44.57 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -0.916 . . . . 0.0 108.998 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.78 HG13 ' HD2' ' A' ' 33' ' ' PRO . 53.8 t -126.92 147.37 61.11 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 109.176 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.78 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.5 Cg_endo -77.26 132.99 12.95 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.176 1.917 . . . . 0.0 111.914 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 33' ' ' PRO . 80.5 tt0 -43.01 -26.67 0.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.741 . . . . 0.0 109.701 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.48 -23.09 1.41 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.516 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.611 ' HZ ' HD11 ' A' ' 19' ' ' LEU . 14.1 m-85 -102.44 -6.41 22.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.518 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.031 HD11 HD11 ' A' ' 62' ' ' LEU . 2.7 mm? -109.98 -5.36 15.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.198 -0.939 . . . . 0.0 109.558 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 94.2 mt-10 -45.27 -44.38 11.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.381 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -107.26 24.51 12.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.381 -0.824 . . . . 0.0 109.472 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.546 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 72.2 mm-40 -108.74 -171.35 1.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.796 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -146.54 129.47 8.03 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.455 -0.778 . . . . 0.0 109.144 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.576 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 49.6 Cg_endo -69.38 123.34 10.13 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 122.733 2.289 . . . . 0.0 111.87 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.559 HD13 ' HB2' ' A' ' 61' ' ' TYR . 37.0 pt -78.46 -27.3 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -0.842 . . . . 0.0 109.57 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.931 ' O ' HG12 ' A' ' 59' ' ' VAL . 81.7 mt-30 -146.62 163.45 35.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 109.612 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 34.0 p -112.03 158.4 19.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.299 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 46.0 ttm -142.1 137.19 30.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 109.507 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.922 HD21 ' OE2' ' A' ' 54' ' ' GLU . 27.1 tp -94.47 129.13 41.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.575 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 71.5 mt -117.83 131.3 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.86 . . . . 0.0 109.44 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 15.6 tttp -125.58 119.89 29.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 0.0 109.428 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.49 -170.34 1.65 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 109.556 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 51' ' ' ILE . 19.4 mm -78.22 -46.85 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -58.69 -38.87 79.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.0 -173.06 43.98 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.922 ' OE2' HD21 ' A' ' 47' ' ' LEU . 80.4 tt0 -113.28 131.02 56.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -1.078 . . . . 0.0 109.394 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 23.4 mttm -129.46 131.26 46.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 109.471 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.545 ' HB2' HD12 ' A' ' 47' ' ' LEU . 48.8 tt0 -102.49 128.47 49.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.695 ' OE1' HD21 ' A' ' 76' ' ' LEU . 90.3 mt-30 -128.28 154.27 46.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.483 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.49 ' HB3' ' CB ' ' A' ' 42' ' ' PRO . 67.4 m-20 -90.54 152.56 20.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.73 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.931 HG12 ' O ' ' A' ' 44' ' ' GLN . 9.3 p -95.52 158.49 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.299 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.576 ' CE2' ' HD3' ' A' ' 42' ' ' PRO . 20.5 m-85 -136.83 126.35 25.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.852 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.685 ' O ' HD23 ' A' ' 62' ' ' LEU . 41.3 t80 -91.36 119.4 31.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 108.844 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.031 HD11 HD11 ' A' ' 37' ' ' LEU . 64.4 mt -131.16 170.18 14.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.387 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.705 HG23 ' HG2' ' A' ' 72' ' ' GLU . 87.9 m -119.56 122.92 42.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.517 -0.739 . . . . 0.0 109.084 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.812 ' CE2' HG22 ' A' ' 66' ' ' VAL . 33.2 p90 -141.82 157.2 45.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 0.0 109.781 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 83.7 mttt -87.83 129.69 35.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.23 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.812 HG22 ' CE2' ' A' ' 64' ' ' PHE . 4.3 t -104.24 98.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 90.0 mt-30 62.93 35.34 13.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.898 . . . . 0.0 109.193 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.77 31.81 20.08 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.446 ' O ' HG23 ' A' ' 71' ' ' VAL . 51.6 mtt180 -136.84 111.62 8.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -1.125 . . . . 0.0 109.432 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -61.84 117.72 6.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.575 HG21 ' CH2' ' A' ' 92' ' ' TRP . 44.4 t -142.31 136.91 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 0.0 109.412 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.705 ' HG2' HG23 ' A' ' 63' ' ' THR . 64.0 mt-10 -112.61 137.93 50.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.974 . . . . 0.0 109.388 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.21 166.31 29.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.83 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 96.3 mt-10 -81.43 136.15 35.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.228 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.683 ' HB ' HG23 ' A' ' 32' ' ' VAL . 17.5 m -125.55 148.03 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.181 -0.949 . . . . 0.0 109.731 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.695 HD21 ' OE1' ' A' ' 57' ' ' GLN . 28.1 tp -94.05 143.05 26.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.853 . . . . 0.0 109.13 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.27 133.66 36.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.556 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 21.8 t -144.4 148.84 42.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.626 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.48 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.3 Cg_endo -70.36 1.79 4.49 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.728 2.285 . . . . 0.0 112.058 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.556 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 39.6 m-85 -63.34 172.72 1.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 109.432 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -113.36 21.29 15.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 109.579 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.586 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 13.1 p90 -144.87 -161.02 1.21 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.16 -0.963 . . . . 0.0 109.356 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.453 HG13 ' C ' ' A' ' 82' ' ' TYR . 2.2 mt -132.62 149.1 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.881 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.741 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.4 mt -109.21 131.82 54.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.865 . . . . 0.0 108.757 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.807 ' H ' HD22 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -99.95 133.17 44.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.109 -0.994 . . . . 0.0 109.723 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.574 ' O ' HG22 ' A' ' 90' ' ' VAL . 6.2 t-20 -88.18 136.23 32.21 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 0.0 109.146 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.547 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 41.8 Cg_endo -64.34 -32.16 61.6 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.744 2.296 . . . . 0.0 111.881 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.439 ' HB2' HD21 ' A' ' 86' ' ' ASN . 14.2 m -72.32 -33.94 67.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 109.222 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -71.9 -34.11 68.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.313 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.781 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 33.5 m -115.84 76.56 6.07 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 109.55 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.44 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 48.6 Cg_endo -69.15 -21.63 36.04 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.698 2.265 . . . . 0.0 111.678 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.781 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 36.4 p90 -70.66 -26.32 63.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.314 -0.866 . . . . 0.0 109.469 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.441 HD23 ' CD1' ' A' ' 23' ' ' TRP . 28.6 tp -78.05 -34.16 50.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.474 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 95.2 mtp -67.24 -29.46 69.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.508 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -75.67 139.54 42.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.24 -0.913 . . . . 0.0 109.4 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.484 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -128.61 80.89 71.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.748 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.12 -18.18 35.5 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.613 2.208 . . . . 0.0 111.68 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.5 tp . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 109.469 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.25 153.09 66.99 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.674 2.249 . . . . 0.0 111.736 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 23' ' ' TRP . 15.3 mt -79.83 -174.63 4.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.443 ' OE2' ' HE3' ' A' ' 18' ' ' LYS . 75.9 tt0 -113.65 137.2 51.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 109.501 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.3 142.25 25.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -120.65 118.02 29.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.888 HG22 ' HG3' ' A' ' 15' ' ' LYS . 36.6 mt -109.49 129.46 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.507 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.888 ' HG3' HG22 ' A' ' 14' ' ' ILE . 72.0 mttt 54.52 24.83 5.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.9 . . . . 0.0 109.5 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.06 -10.81 72.79 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.593 HG22 HD11 ' A' ' 19' ' ' LEU . 4.3 m -80.31 126.94 31.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -1.183 . . . . 0.0 109.422 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HE3' ' OE2' ' A' ' 11' ' ' GLU . 39.1 tttt -85.93 125.16 33.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.347 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.593 HD11 HG22 ' A' ' 17' ' ' THR . 1.9 mp -146.21 156.03 43.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 109.587 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -80.16 152.13 29.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 0.0 109.507 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.702 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -136.92 169.56 17.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.461 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 47.2 m80 -127.41 138.84 53.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 109.463 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.629 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 40.0 t90 -91.08 114.1 26.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.206 -0.934 . . . . 0.0 109.408 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -121.57 100.1 6.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 109.382 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.573 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 59.8 p -60.8 -25.66 66.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.758 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.64 -41.59 95.76 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.442 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -67.77 140.97 56.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.194 -1.18 . . . . 0.0 109.538 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.435 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 68.6 p -99.59 -10.27 22.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.893 . . . . 0.0 109.384 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.453 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 19.7 tt -139.06 159.79 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.272 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.4 m -67.53 153.26 44.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 109.671 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.578 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -131.21 116.81 18.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.072 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.785 HG13 ' HD2' ' A' ' 33' ' ' PRO . 54.0 t -114.07 147.71 38.41 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.785 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.4 Cg_endo -77.4 132.04 12.07 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.094 1.862 . . . . 0.0 111.664 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.1 tt0 -41.77 -27.67 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.467 -0.77 . . . . 0.0 109.801 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -50.56 -31.64 16.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.525 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.43 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 14.3 m-85 -98.47 -3.24 37.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.665 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.675 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -110.95 13.25 22.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.797 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -60.94 -22.52 64.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.069 -1.019 . . . . 0.0 109.255 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -128.5 27.36 5.56 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.314 -0.866 . . . . 0.0 108.724 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.496 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 57.3 mm-40 -99.43 162.3 13.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.407 -0.808 . . . . 0.0 109.815 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.88 129.4 24.59 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.458 -0.776 . . . . 0.0 109.216 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.578 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 54.2 Cg_endo -73.42 123.92 9.02 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.556 2.171 . . . . 0.0 112.008 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.441 HG13 ' N ' ' A' ' 44' ' ' GLN . 24.3 pt -83.51 -31.27 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 109.246 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.496 ' NE2' ' OE2' ' A' ' 74' ' ' GLU . 21.2 pt20 -143.07 175.64 9.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.831 . . . . 0.0 109.255 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 77.3 p -128.45 155.48 44.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.703 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.539 ' HE3' HG21 ' A' ' 59' ' ' VAL . 63.5 mtt -142.15 147.37 36.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.345 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.638 HD12 ' HB2' ' A' ' 56' ' ' GLN . 21.5 tp -98.64 126.9 44.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.15 -0.969 . . . . 0.0 109.541 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.41 HD13 ' O ' ' A' ' 47' ' ' LEU . 29.0 mm -116.27 135.26 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.915 . . . . 0.0 109.423 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -109.08 135.42 50.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.2 p -128.53 158.14 39.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 52' ' ' HIS . 15.3 tt -53.18 -41.01 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.928 . . . . 0.0 109.497 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.527 ' N ' HG23 ' A' ' 51' ' ' ILE . 5.8 m-70 -63.23 -35.55 80.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.554 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.13 -176.42 43.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -93.36 133.65 36.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.132 . . . . 0.0 109.405 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -131.94 133.97 45.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.638 ' HB2' HD12 ' A' ' 47' ' ' LEU . 48.9 tt0 -107.8 128.22 54.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 109.663 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.585 ' OE1' HD21 ' A' ' 76' ' ' LEU . 88.7 mt-30 -125.35 161.24 27.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.173 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.49 ' HB3' ' CB ' ' A' ' 42' ' ' PRO . 59.8 m-20 -96.71 142.06 29.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.933 . . . . 0.0 109.716 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.539 HG21 ' HE3' ' A' ' 46' ' ' MET . 12.9 t -83.85 151.11 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.046 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.675 ' CD2' HD23 ' A' ' 37' ' ' LEU . 12.4 m-85 -131.72 137.7 48.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.087 -1.008 . . . . 0.0 109.902 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.501 ' O ' HD23 ' A' ' 62' ' ' LEU . 44.3 t80 -100.67 113.11 25.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.849 . . . . 0.0 108.771 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.666 HD12 HG21 ' A' ' 75' ' ' VAL . 44.6 mt -122.46 173.02 7.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.105 -0.997 . . . . 0.0 110.276 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.673 HG23 ' HG2' ' A' ' 72' ' ' GLU . 86.6 m -124.01 125.48 44.63 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 9.4 p90 -144.68 157.81 44.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.888 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -88.38 130.52 35.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.418 -0.801 . . . . 0.0 109.292 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.469 HG11 HG11 ' A' ' 90' ' ' VAL . 74.4 t -110.77 104.47 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 86.7 mt-30 63.13 35.17 13.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.331 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.77 31.95 34.59 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -137.54 116.53 12.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -1.139 . . . . 0.0 109.477 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -62.13 121.0 11.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.504 HG21 ' CH2' ' A' ' 92' ' ' TRP . 87.3 t -142.69 129.05 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.88 . . . . 0.0 109.498 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.673 ' HG2' HG23 ' A' ' 63' ' ' THR . 35.8 mt-10 -108.59 136.47 48.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.19 169.98 22.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 109.619 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.534 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 95.4 mt-10 -80.41 135.89 36.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.74 ' HB ' HG23 ' A' ' 32' ' ' VAL . 5.0 m -126.76 152.22 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 109.631 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.585 HD21 ' OE1' ' A' ' 57' ' ' GLN . 20.7 tp -105.42 149.13 26.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.109 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.58 137.3 37.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 109.196 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.571 ' OG ' ' CE2' ' A' ' 80' ' ' TYR . 23.3 t -148.7 149.57 31.14 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.926 . . . . 0.0 109.669 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.488 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 54.5 Cg_endo -72.88 6.88 2.23 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.661 2.241 . . . . 0.0 111.985 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.571 ' CE2' ' OG ' ' A' ' 78' ' ' SER . 30.7 m-85 -60.52 -178.99 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.613 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -119.93 20.73 12.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.927 . . . . 0.0 109.325 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.602 ' OH ' HD21 ' A' ' 84' ' ' LEU . 13.3 p90 -153.61 -152.35 0.41 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.275 -0.89 . . . . 0.0 108.894 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.533 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 1.7 mt -132.35 125.58 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.785 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.602 HD21 ' OH ' ' A' ' 82' ' ' TYR . 1.2 mt -82.94 143.27 30.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.218 -0.926 . . . . 0.0 108.93 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.702 HD21 ' HB1' ' A' ' 21' ' ' ALA . 3.9 mt -109.73 135.3 50.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -0.978 . . . . 0.0 109.929 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.697 ' O ' HG22 ' A' ' 90' ' ' VAL . 4.4 t30 -91.16 136.65 26.99 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 109.125 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.522 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 43.5 Cg_endo -64.6 -36.96 39.75 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.781 2.32 . . . . 0.0 112.034 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.422 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 3.1 m -70.38 -32.47 70.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.121 -0.987 . . . . 0.0 109.303 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.464 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 81.8 m-20 -71.84 -29.2 64.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.352 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.155 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -118.81 74.92 12.98 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.314 -0.866 . . . . 0.0 109.531 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.59 -21.99 28.89 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.747 2.298 . . . . 0.0 111.801 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.155 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 40.8 p90 -76.28 -28.31 56.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 0.0 109.49 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.629 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 38.6 tp -56.36 -40.45 74.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.461 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 69.8 mtm -93.3 135.2 34.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 109.48 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -106.46 146.85 30.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.428 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -64.38 153.85 85.25 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.4 143.84 48.9 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.695 2.263 . . . . 0.0 111.735 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.5 tp . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.414 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.09 151.55 67.23 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.668 2.246 . . . . 0.0 111.722 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.595 HD13 HD23 ' A' ' 85' ' ' LEU . 4.3 mp -85.0 165.84 17.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.514 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -103.46 144.13 31.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 109.428 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.7 148.11 22.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 64' ' ' PHE . 78.1 tt0 -121.02 121.08 37.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.868 HG22 ' HG3' ' A' ' 15' ' ' LYS . 42.4 mt -111.93 127.71 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.868 ' HG3' HG22 ' A' ' 14' ' ' ILE . 3.6 mtmt 54.5 25.82 6.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.443 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 93.29 -15.81 62.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.886 HG22 HD11 ' A' ' 19' ' ' LEU . 2.3 m -79.85 126.07 30.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -1.181 . . . . 0.0 109.312 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.967 ' C ' HD12 ' A' ' 19' ' ' LEU . 31.4 tttt -94.26 116.9 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.0 109.63 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.967 HD12 ' C ' ' A' ' 18' ' ' LYS . 9.4 mp -135.09 166.09 23.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.306 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -80.32 155.03 27.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.449 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.888 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -141.27 163.03 34.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 109.482 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.835 ' O ' HD22 ' A' ' 85' ' ' LEU . 36.0 m80 -125.38 136.84 53.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.749 ' CD1' HD23 ' A' ' 93' ' ' LEU . 26.2 t90 -85.58 126.67 34.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.422 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -133.58 100.63 4.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.519 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 60.4 p -62.39 -29.21 70.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.495 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.2 -33.25 64.61 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.414 ' O ' ' OD1' ' A' ' 86' ' ' ASN . . . -73.81 140.34 45.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -1.129 . . . . 0.0 109.418 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 28' ' ' THR . 87.4 m -100.36 -5.27 27.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.633 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.486 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 21.2 tt -146.67 149.3 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.507 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.849 ' CG2' HG12 ' A' ' 75' ' ' VAL . 86.4 m -52.47 150.79 4.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.634 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.622 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -128.03 136.98 51.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.193 -0.942 . . . . 0.0 109.212 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.776 HG13 ' HD2' ' A' ' 33' ' ' PRO . 56.9 t -138.61 147.43 54.75 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 109.172 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.776 ' HD2' HG13 ' A' ' 32' ' ' VAL . 54.8 Cg_endo -77.66 132.21 11.91 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.123 1.882 . . . . 0.0 111.308 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 37' ' ' LEU . 79.9 tt0 -41.87 -27.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.759 . . . . 0.0 109.833 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -48.41 -24.53 1.28 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.14 -0.975 . . . . 0.0 109.308 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.638 ' CE2' HD22 ' A' ' 19' ' ' LEU . 7.6 m-85 -97.03 -9.38 28.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.646 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.95 HD11 HD11 ' A' ' 62' ' ' LEU . 2.8 mm? -107.83 9.26 28.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 109.628 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -59.23 -37.75 78.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 109.265 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -113.84 27.28 9.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.895 . . . . 0.0 109.249 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -117.17 -170.1 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.378 -0.826 . . . . 0.0 109.634 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 -148.01 132.02 8.55 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.177 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.572 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 50.0 Cg_endo -70.87 124.8 10.95 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.654 2.236 . . . . 0.0 111.908 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.742 HD11 ' OE2' ' A' ' 74' ' ' GLU . 41.2 pt -76.61 -32.86 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.274 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.769 ' O ' HG22 ' A' ' 59' ' ' VAL . 97.5 mt-30 -146.16 174.01 11.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 0.0 109.381 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 36.6 p -119.9 159.78 23.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.603 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.3 ttm -134.86 141.76 46.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.908 . . . . 0.0 109.409 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 47' ' ' LEU . 5.0 mp -92.04 132.63 36.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.544 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.5 mt -120.38 132.87 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 109.304 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 75.7 tttt -118.28 129.76 55.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.56 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.12 179.72 4.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.531 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.7 mt -69.92 -49.25 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.362 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -56.92 -42.03 79.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.467 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.53 -169.51 39.37 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 81.8 tt0 -109.32 133.65 52.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.216 -1.167 . . . . 0.0 109.527 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -127.57 150.65 49.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.87 . . . . 0.0 109.337 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -114.17 142.1 46.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.153 -0.967 . . . . 0.0 109.507 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -133.95 168.11 19.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -0.863 . . . . 0.0 109.345 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.501 ' HB3' ' CB ' ' A' ' 42' ' ' PRO . 63.4 m-20 -107.14 150.67 26.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.762 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 44' ' ' GLN . 13.7 m -101.03 152.05 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.272 -0.892 . . . . 0.0 109.193 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.711 ' CD2' HD12 ' A' ' 37' ' ' LEU . 11.1 m-85 -130.93 122.63 27.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -0.994 . . . . 0.0 109.731 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 39.7 t80 -85.26 110.06 18.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 108.885 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.95 HD11 HD11 ' A' ' 37' ' ' LEU . 53.1 mt -125.1 171.01 10.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 110.36 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.702 HG23 ' HG2' ' A' ' 72' ' ' GLU . 89.7 m -116.08 119.35 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CE2' HG22 ' A' ' 66' ' ' VAL . 17.3 p90 -136.07 154.22 51.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.037 . . . . 0.0 109.782 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.46 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 45.3 mttm -90.69 127.04 36.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.341 -0.849 . . . . 0.0 109.411 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.735 HG11 HG11 ' A' ' 90' ' ' VAL . 18.9 t -101.5 101.55 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 109.614 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 92.9 mt-30 62.87 33.13 15.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.297 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.82 24.8 34.21 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 65' ' ' LYS . 67.3 mtt180 -126.72 120.09 28.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -1.165 . . . . 0.0 109.362 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -67.0 117.05 8.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.403 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.75 HG21 ' HH2' ' A' ' 92' ' ' TRP . 86.0 t -141.15 130.85 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.702 ' HG2' HG23 ' A' ' 63' ' ' THR . 58.4 mt-10 -111.78 135.44 52.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.589 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.41 166.27 29.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.835 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.742 ' OE2' HD11 ' A' ' 43' ' ' ILE . 95.4 mt-10 -80.69 136.06 36.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.372 -0.83 . . . . 0.0 109.193 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.849 HG12 ' CG2' ' A' ' 30' ' ' THR . 34.6 m -123.26 145.55 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.227 -0.921 . . . . 0.0 109.696 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.714 ' CD2' HG12 ' A' ' 59' ' ' VAL . 89.0 mt -90.53 143.9 26.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.091 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.34 135.64 36.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.0 . . . . 0.0 109.445 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.522 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 3.8 t -143.89 150.46 49.81 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 109.519 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.49 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 52.0 Cg_endo -72.46 5.99 2.52 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.665 2.244 . . . . 0.0 112.301 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.522 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 84.4 m-85 -71.37 167.51 19.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.056 -1.028 . . . . 0.0 109.527 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -107.79 17.05 22.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.66 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.657 ' OH ' HD21 ' A' ' 84' ' ' LEU . 15.6 p90 -137.19 -163.51 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 109.52 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.441 ' O ' ' CD2' ' A' ' 82' ' ' TYR . 4.0 mt -127.44 154.92 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -0.981 . . . . 0.0 109.744 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.753 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.3 mt -117.21 132.8 56.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.011 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.888 HD11 ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -97.91 122.48 41.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.084 -1.01 . . . . 0.0 109.628 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.731 ' O ' HG22 ' A' ' 90' ' ' VAL . 26.2 t30 -79.54 142.36 57.67 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.435 -0.791 . . . . 0.0 109.098 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.562 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 47.0 Cg_endo -67.31 -23.47 44.66 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.512 2.141 . . . . 0.0 111.677 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.418 ' OG ' ' ND2' ' A' ' 86' ' ' ASN . 51.8 p -80.41 -33.85 36.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.373 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.955 ' OD1' HG13 ' A' ' 90' ' ' VAL . 2.2 p30 -74.78 -28.87 60.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.493 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.955 HG13 ' OD1' ' A' ' 89' ' ' ASP . 4.1 m -122.3 78.62 44.54 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.656 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.565 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.8 Cg_endo -71.68 -23.56 22.73 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.615 2.21 . . . . 0.0 111.822 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.775 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 47.1 p90 -77.32 -33.09 55.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.593 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.749 HD23 ' CD1' ' A' ' 23' ' ' TRP . 21.9 tp -55.16 -31.95 61.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.511 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 71.1 mtm -84.58 122.58 29.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -57.75 -36.91 72.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.478 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 ptpt -66.01 128.56 93.91 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.535 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.66 147.06 62.7 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.769 2.313 . . . . 0.0 111.789 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.505 HD11 ' CB ' ' A' ' 91' ' ' PRO . 46.7 mt . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.505 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.09 157.36 59.99 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.729 2.286 . . . . 0.0 111.709 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.606 HD11 ' HB2' ' A' ' 23' ' ' TRP . 25.2 mt -88.27 -175.11 4.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.505 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.58 141.58 50.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 109.403 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.34 149.29 26.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 51.9 tt0 -118.35 118.14 30.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.858 HG22 ' HG3' ' A' ' 15' ' ' LYS . 41.5 mt -111.11 128.7 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.858 ' HG3' HG22 ' A' ' 14' ' ' ILE . 44.3 mttm 56.71 22.85 7.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 91.63 0.87 71.9 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.496 HG22 ' CD2' ' A' ' 19' ' ' LEU . 24.8 m -102.4 122.25 43.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -1.194 . . . . 0.0 109.457 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.834 ' O ' HD22 ' A' ' 19' ' ' LEU . 26.8 tttt -82.56 123.57 29.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.834 HD22 ' O ' ' A' ' 18' ' ' LYS . 1.5 mm? -132.89 167.08 20.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -85.88 139.65 31.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.801 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -128.28 168.66 15.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.628 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.688 ' O ' HD22 ' A' ' 85' ' ' LEU . 18.4 m80 -129.4 126.85 39.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.403 -0.811 . . . . 0.0 109.648 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.606 ' HB2' HD11 ' A' ' 10' ' ' LEU . 33.3 t90 -79.4 125.86 30.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.456 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -131.39 102.77 6.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.528 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 58.2 p -61.63 -31.68 71.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.629 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.08 -31.53 73.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.49 139.66 49.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -1.166 . . . . 0.0 109.615 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.434 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 35.0 p -106.02 -4.9 19.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.85 . . . . 0.0 109.554 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.511 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 19.7 tt -143.82 141.14 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.405 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.537 ' N ' ' HB2' ' A' ' 86' ' ' ASN . 23.4 m -54.92 137.42 45.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.731 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.715 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.9 OUTLIER -125.94 128.63 47.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.724 HG12 HG23 ' A' ' 83' ' ' ILE . 25.2 m -127.83 163.44 43.26 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.584 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.8 Cg_endo -78.91 134.1 11.65 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.57 2.18 . . . . 0.0 111.688 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 81.1 tt0 -49.03 -22.89 0.98 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.616 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.6 -40.36 52.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.41 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -86.85 -4.23 59.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.275 -0.89 . . . . 0.0 109.605 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.501 ' HA ' HD13 ' A' ' 37' ' ' LEU . 3.8 mm? -89.4 18.7 5.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.234 -0.916 . . . . 0.0 109.844 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 37' ' ' LEU . 76.6 mt-10 -41.58 -57.58 2.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.343 -0.848 . . . . 0.0 108.905 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 p30 -96.22 38.99 1.16 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.602 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 21.2 pt-20 -41.29 132.71 2.55 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.536 0.684 . . . . 0.0 110.624 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.02 89.94 43.99 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.486 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 50.8 Cg_endo -70.01 125.95 12.6 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.703 2.269 . . . . 0.0 112.317 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 61' ' ' TYR . 38.6 pt -109.74 -16.55 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.303 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.528 ' HG2' ' N ' ' A' ' 45' ' ' THR . 43.4 tt0 -143.12 166.55 24.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.212 -0.93 . . . . 0.0 109.457 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.528 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 61.2 p -116.74 151.27 36.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.402 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 46.5 ttm -145.49 144.03 30.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.563 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.743 HD21 ' OE2' ' A' ' 54' ' ' GLU . 8.9 tt -100.19 131.59 46.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.287 -0.883 . . . . 0.0 109.51 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 30.6 mm -115.24 134.9 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.4 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -128.23 119.75 25.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.8 -177.32 3.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.453 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.7 mt -71.23 -50.51 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.347 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -49.88 -39.41 39.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.57 -175.62 47.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.743 ' OE2' HD21 ' A' ' 47' ' ' LEU . 61.7 tt0 -103.72 129.19 51.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -1.127 . . . . 0.0 109.431 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.459 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 22.9 mttm -130.31 137.9 50.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.187 -0.945 . . . . 0.0 109.365 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -108.46 128.62 54.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.89 . . . . 0.0 109.674 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.656 ' OE1' HD21 ' A' ' 76' ' ' LEU . 90.4 mt-30 -125.35 159.9 30.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.262 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -92.5 163.79 13.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.539 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 29.4 t -101.48 139.29 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 108.896 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.602 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 3.1 m-85 -121.4 150.01 42.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.033 -1.042 . . . . 0.0 110.159 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.58 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 46.4 t80 -107.14 113.66 27.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 0.0 108.715 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.654 HD12 HG21 ' A' ' 75' ' ' VAL . 39.2 mt -116.28 162.21 17.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.115 -0.991 . . . . 0.0 110.343 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.701 HG23 ' HG2' ' A' ' 72' ' ' GLU . 20.4 m -120.12 118.24 30.04 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.479 ' HB3' HG12 ' A' ' 14' ' ' ILE . 14.3 p90 -144.07 154.98 43.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.022 -1.049 . . . . 0.0 109.937 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.471 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 47.9 mtmt -92.62 126.99 37.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.364 -0.835 . . . . 0.0 109.167 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 21.3 t -106.37 111.84 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.146 -0.971 . . . . 0.0 109.711 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.476 HE22 HD22 ' A' ' 93' ' ' LEU . 87.2 mt-30 62.98 37.22 11.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.54 25.28 63.44 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' O ' HG23 ' A' ' 71' ' ' VAL . 78.1 mtt-85 -129.59 107.5 9.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 109.511 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 79.0 tttt -58.91 125.33 23.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.679 HG21 ' CH2' ' A' ' 92' ' ' TRP . 97.7 t -146.26 133.09 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 109.231 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.701 ' HG2' HG23 ' A' ' 63' ' ' THR . 80.6 mt-10 -115.27 135.57 54.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 109.633 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.467 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . . . -160.36 173.38 15.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.389 -0.82 . . . . 0.0 109.674 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.539 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 94.4 mt-10 -79.79 143.97 33.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.85 . . . . 0.0 109.172 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.654 HG21 HG21 ' A' ' 32' ' ' VAL . 3.2 m -138.97 162.45 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.78 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.656 HD21 ' OE1' ' A' ' 57' ' ' GLN . 20.5 tp -113.23 145.73 40.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -0.827 . . . . 0.0 109.258 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.99 136.23 36.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.447 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.47 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 5.4 t -141.47 148.43 50.44 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 109.521 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.47 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 48.6 Cg_endo -69.87 -0.8 7.52 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.744 2.296 . . . . 0.0 111.774 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.521 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 31.5 m-85 -59.75 166.63 2.47 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.179 -0.951 . . . . 0.0 109.323 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -107.6 19.35 20.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.952 . . . . 0.0 109.86 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.809 ' OH ' HD21 ' A' ' 84' ' ' LEU . 25.7 p90 -142.48 -154.83 0.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.724 HG23 HG12 ' A' ' 32' ' ' VAL . 4.7 mt -130.15 144.51 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.997 -1.064 . . . . 0.0 109.777 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.809 HD21 ' OH ' ' A' ' 82' ' ' TYR . 1.3 mp -110.36 123.92 50.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.343 -0.848 . . . . 0.0 109.116 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.801 HD11 ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -95.44 134.64 38.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.786 ' O ' HG22 ' A' ' 90' ' ' VAL . 26.5 t30 -89.19 142.31 29.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.288 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.51 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 47.1 Cg_endo -67.41 -26.12 41.27 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.537 2.158 . . . . 0.0 111.79 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.2 m -78.08 -31.2 50.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.312 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.769 ' OD1' HG13 ' A' ' 90' ' ' VAL . 2.1 p30 -77.01 -32.97 57.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.162 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -110.9 73.7 0.89 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.897 . . . . 0.0 109.394 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.583 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.0 Cg_endo -70.29 -24.36 27.34 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.743 2.295 . . . . 0.0 112.016 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.162 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.4 p90 -71.43 -36.89 71.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.092 -1.005 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.497 HD12 ' CG2' ' A' ' 90' ' ' VAL . 72.6 mt -50.23 -42.7 52.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.349 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 88.3 mtp -68.17 134.39 50.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.444 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -103.44 143.31 32.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.476 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -120.93 86.17 41.35 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.1 146.29 57.65 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.668 2.245 . . . . 0.0 111.8 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.5 tp . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 0.0 109.49 179.993 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.05 148.42 63.17 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.748 2.299 . . . . 0.0 111.824 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.761 ' CD1' HD11 ' A' ' 93' ' ' LEU . 29.0 mt -81.06 -173.44 4.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.516 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.465 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 75.1 mm-40 -117.89 137.9 52.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 109.476 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.09 146.12 30.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.541 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -123.96 116.92 23.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.325 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.56 HG22 ' HG3' ' A' ' 15' ' ' LYS . 56.0 mt -112.83 130.41 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.933 . . . . 0.0 109.674 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.56 ' HG3' HG22 ' A' ' 14' ' ' ILE . 95.9 mttt 52.22 23.47 2.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.318 -0.864 . . . . 0.0 109.621 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.31 -13.97 66.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.83 HG22 HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -80.39 114.13 19.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -1.181 . . . . 0.0 109.427 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.884 ' C ' HD12 ' A' ' 19' ' ' LEU . 69.5 tttt -87.64 118.79 27.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 109.558 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.884 HD12 ' C ' ' A' ' 18' ' ' LYS . 9.3 mp -133.64 172.98 12.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.353 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' NZ ' ' OE2' ' A' ' 11' ' ' GLU . 16.0 mmtt -91.24 147.39 23.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.375 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.622 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -133.15 174.3 10.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 109.698 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.506 ' O ' HD22 ' A' ' 85' ' ' LEU . 40.8 m80 -131.07 127.76 38.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.86 . . . . 0.0 109.379 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.813 ' CD1' HD13 ' A' ' 93' ' ' LEU . 35.5 t90 -76.39 117.4 18.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -124.58 100.72 6.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.317 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.564 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 28.5 p -62.81 -30.38 71.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.07 -39.46 80.04 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.15 140.6 58.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.141 . . . . 0.0 109.52 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.6 m -96.11 -13.0 23.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.498 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 29' ' ' ILE . 7.4 tp -143.94 162.85 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.265 -0.897 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 26.4 m -66.27 132.64 48.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.681 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 0.9 OUTLIER -119.22 126.79 52.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.382 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.805 HG13 HG13 ' A' ' 75' ' ' VAL . 3.6 m -127.91 167.21 19.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.406 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.1 Cg_endo -79.58 133.32 10.43 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.459 2.106 . . . . 0.0 111.639 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.5 tt0 -43.05 -27.23 0.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.34 -0.85 . . . . 0.0 109.571 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.3 -38.54 27.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.844 . . . . 0.0 109.576 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.601 ' HE2' HD22 ' A' ' 19' ' ' LEU . 15.5 m-85 -87.91 -7.19 57.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 109.649 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' A' ' 77' ' ' ALA . 12.0 mt -100.46 20.79 14.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.139 -0.976 . . . . 0.0 109.757 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 37' ' ' LEU . 72.0 mt-10 -43.74 -56.87 3.53 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 40' ' ' GLU . 45.1 m-20 -94.61 40.06 1.09 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.611 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 20.2 pt-20 -39.0 135.21 0.93 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.532 0.682 . . . . 0.0 110.394 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.83 81.66 70.33 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.504 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 48.7 Cg_endo -69.46 116.31 4.47 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.727 2.285 . . . . 0.0 112.186 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.8 pt -78.05 -31.64 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.091 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.671 ' O ' HG12 ' A' ' 59' ' ' VAL . 37.4 mt-30 -143.51 163.2 33.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.239 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 82.7 p -119.68 157.56 28.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.931 . . . . 0.0 109.522 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' GLN . 88.0 mtp -144.75 143.76 30.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.331 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -93.46 122.89 36.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.386 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.7 mm -118.09 127.68 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.608 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.416 ' HG2' ' HG2' ' A' ' 54' ' ' GLU . 21.8 mttp -107.01 137.44 45.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.415 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -124.65 179.36 5.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.94 . . . . 0.0 109.379 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.4 mt -64.34 -50.05 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 0.0 109.365 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -51.87 -46.84 64.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.464 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.81 -172.17 45.11 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HG2' ' HG2' ' A' ' 49' ' ' LYS . 96.1 mt-10 -84.94 135.55 34.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -1.139 . . . . 0.0 109.387 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -128.5 148.97 50.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -98.81 121.11 40.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.571 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.965 ' OE1' HD21 ' A' ' 76' ' ' LEU . 1.2 tp60 -118.58 132.86 56.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 69.5 m-20 -109.66 156.41 20.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 0.0 109.596 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.745 HG21 ' CD ' ' A' ' 74' ' ' GLU . 12.5 p -98.51 136.36 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.289 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 3.7 m-85 -121.72 141.53 51.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.619 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.628 ' O ' HD23 ' A' ' 62' ' ' LEU . 33.4 t80 -102.52 114.96 29.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.27 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.628 HD23 ' O ' ' A' ' 61' ' ' TYR . 21.0 mt -119.32 160.93 21.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 110.029 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.719 HG23 ' HG2' ' A' ' 72' ' ' GLU . 11.4 m -121.78 116.88 25.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.478 -0.763 . . . . 0.0 109.137 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 8.2 p90 -142.98 161.72 37.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 109.668 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.485 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 12.5 mtmm -96.68 129.09 44.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.295 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.452 HG11 HG11 ' A' ' 90' ' ' VAL . 60.4 t -107.09 112.64 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.557 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 90.6 mt-30 63.48 33.53 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 109.403 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.37 23.63 58.29 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -127.98 111.45 13.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.319 -1.106 . . . . 0.0 109.408 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 80.5 tttt -61.04 121.23 11.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.612 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.578 HG21 ' HH2' ' A' ' 92' ' ' TRP . 65.6 t -141.66 133.55 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 109.164 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.719 ' HG2' HG23 ' A' ' 63' ' ' THR . 53.8 mt-10 -116.28 137.25 52.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 109.837 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.59 -169.7 2.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.439 -0.788 . . . . 0.0 109.379 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.745 ' CD ' HG21 ' A' ' 59' ' ' VAL . 98.2 mt-10 -79.96 171.36 15.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.094 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.805 HG13 HG13 ' A' ' 32' ' ' VAL . 72.9 t -159.4 151.03 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.143 -0.973 . . . . 0.0 109.808 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.965 HD21 ' OE1' ' A' ' 57' ' ' GLN . 25.9 tp -121.32 143.62 49.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.43 -0.794 . . . . 0.0 109.282 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.649 ' HB2' HD13 ' A' ' 37' ' ' LEU . . . -79.77 133.41 36.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 109.602 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 1.4 t -138.68 150.91 67.53 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.859 . . . . 0.0 109.355 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.6 Cg_endo -72.28 1.97 5.51 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.624 2.216 . . . . 0.0 111.885 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -65.14 168.0 7.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.532 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.8 p30 -108.9 14.07 24.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.233 -0.917 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.585 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 17.7 p90 -136.34 -157.8 0.82 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 109.008 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.548 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.0 mt -129.09 144.7 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.056 -1.027 . . . . 0.0 109.707 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 84' ' ' LEU . 6.2 mp -109.95 136.33 49.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.259 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.802 ' N ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -103.92 145.36 30.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.768 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.684 ' O ' HG22 ' A' ' 90' ' ' VAL . 4.9 t30 -96.87 136.59 21.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.255 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.526 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.0 Cg_endo -63.45 -31.98 71.53 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.847 2.365 . . . . 0.0 111.94 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -75.24 -30.17 60.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.227 -0.921 . . . . 0.0 109.176 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -77.49 -30.83 53.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.326 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.909 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.6 OUTLIER -122.25 75.95 42.18 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 109.468 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.21 -24.95 27.03 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.637 2.225 . . . . 0.0 111.932 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.909 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 32.7 p90 -74.19 -28.47 61.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.137 -0.977 . . . . 0.0 109.481 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.813 HD13 ' CD1' ' A' ' 23' ' ' TRP . 9.6 tt -58.89 -36.91 75.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.485 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 87.5 mtp -78.65 149.56 32.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.496 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.01 154.21 19.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.407 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.455 ' HB3' ' HD2' ' A' ' 97' ' ' PRO . 6.3 mtmt -115.04 159.31 38.22 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.168 -0.957 . . . . 0.0 109.511 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 96' ' ' LYS . 50.6 Cg_endo -70.49 -15.28 34.36 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.631 2.22 . . . . 0.0 111.768 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.4 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.444 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.3 159.98 51.13 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.683 2.255 . . . . 0.0 111.637 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.553 ' CD2' HD11 ' A' ' 93' ' ' LEU . 4.6 mp -80.23 166.35 21.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.96 . . . . 0.0 109.525 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -103.63 148.74 25.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.558 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.38 151.22 20.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 64' ' ' PHE . 65.7 tt0 -119.62 121.71 39.91 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.409 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.548 ' HB ' ' CE2' ' A' ' 36' ' ' PHE . 44.6 mt -113.54 124.21 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 60.8 mttm 61.28 20.38 10.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 109.474 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.65 -12.89 68.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.0 m -88.52 131.11 35.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -1.145 . . . . 0.0 109.446 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.999 ' O ' HD22 ' A' ' 19' ' ' LEU . 18.0 mttp -82.98 133.37 35.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.879 . . . . 0.0 109.492 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.999 HD22 ' O ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -144.64 159.82 42.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.87 . . . . 0.0 109.459 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -81.41 150.93 28.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.352 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.883 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -139.14 169.69 17.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.492 ' HB2' ' CE2' ' A' ' 82' ' ' TYR . 23.7 m80 -130.5 136.89 49.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 109.644 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.957 ' CD1' HD13 ' A' ' 93' ' ' LEU . 64.3 t90 -95.17 118.91 32.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 109.431 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -130.17 104.24 7.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.528 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.582 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 60.4 p -56.22 -27.59 55.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.531 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.37 -36.5 93.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.424 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -64.55 143.58 57.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.458 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.511 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 59.4 m -108.36 -12.08 15.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.501 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.403 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 20.2 tt -142.64 155.35 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.495 ' HB ' HG12 ' A' ' 75' ' ' VAL . 34.4 m -71.38 136.45 47.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.608 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.539 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -120.84 131.9 54.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.423 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.904 HG12 HG23 ' A' ' 83' ' ' ILE . 15.4 m -121.72 161.17 43.33 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 82' ' ' TYR . 55.8 Cg_endo -79.27 129.57 8.73 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.583 2.189 . . . . 0.0 111.717 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.864 ' CG ' ' HB1' ' A' ' 77' ' ' ALA . 79.2 mt-10 -43.77 -26.93 0.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 109.362 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.77 -39.45 77.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.285 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.569 ' HZ ' HD23 ' A' ' 19' ' ' LEU . 1.7 m-85 -83.7 -2.15 55.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.428 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.715 ' CD1' ' HB2' ' A' ' 77' ' ' ALA . 7.2 mt -99.43 23.43 9.36 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.154 -0.966 . . . . 0.0 109.741 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 37' ' ' LEU . 55.2 tt0 -44.27 -55.96 4.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.07 -1.019 . . . . 0.0 108.918 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -97.08 40.21 1.15 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.689 ' HB2' HD22 ' A' ' 37' ' ' LEU . 21.5 pt-20 -43.12 133.68 3.81 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.465 0.65 . . . . 0.0 110.361 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -127.29 87.03 57.34 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 48.3 Cg_endo -69.6 121.38 8.11 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.642 2.228 . . . . 0.0 112.235 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.464 HD11 ' OE2' ' A' ' 74' ' ' GLU . 38.3 pt -94.1 -31.44 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.522 -0.736 . . . . 0.0 109.058 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -135.18 176.95 8.2 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.371 -0.831 . . . . 0.0 109.136 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 69.1 p -127.51 156.54 42.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.21 -0.931 . . . . 0.0 109.595 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.503 ' HG3' ' CG2' ' A' ' 59' ' ' VAL . 84.1 mtp -143.65 144.83 32.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 109.345 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.668 HD22 ' CD ' ' A' ' 56' ' ' GLN . 12.1 mt -98.34 138.43 35.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.178 -0.951 . . . . 0.0 109.476 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 55' ' ' LYS . 74.5 mt -126.64 136.0 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.872 . . . . 0.0 109.43 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 78.6 tttt -124.41 135.37 53.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.541 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.0 p -129.92 158.26 40.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.457 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.54 HG23 ' N ' ' A' ' 52' ' ' HIS . 13.6 tt -53.99 -41.87 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 109.548 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.54 ' N ' HG23 ' A' ' 51' ' ' ILE . 97.1 m-70 -62.36 -37.19 84.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 109.578 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.28 -176.65 48.14 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 73.8 tt0 -107.61 128.81 54.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -1.107 . . . . 0.0 109.484 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 48' ' ' ILE . 76.2 mttt -130.23 143.34 50.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.852 . . . . 0.0 109.221 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.668 ' CD ' HD22 ' A' ' 47' ' ' LEU . 80.7 mt-30 -115.77 141.96 47.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.885 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -137.56 165.25 26.76 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.374 -0.828 . . . . 0.0 108.803 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 76.2 m-20 -103.76 162.1 13.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.029 . . . . 0.0 109.831 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.577 HG12 ' HB3' ' A' ' 74' ' ' GLU . 12.0 t -100.46 139.35 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.62 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 4.0 m-85 -118.37 149.58 40.97 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.103 -0.998 . . . . 0.0 110.08 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 42.4 t80 -108.17 112.4 24.89 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.499 HD12 HG21 ' A' ' 75' ' ' VAL . 34.2 mt -115.98 163.31 16.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.121 -0.987 . . . . 0.0 110.305 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.702 HG23 ' HG2' ' A' ' 72' ' ' GLU . 28.6 m -120.47 116.94 26.42 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 13.6 p90 -138.54 156.94 47.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 109.815 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -93.3 127.24 38.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.332 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.641 HG11 HG11 ' A' ' 90' ' ' VAL . 24.1 t -103.64 106.69 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.927 . . . . 0.0 109.564 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 91.2 mt-30 63.24 36.4 11.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.329 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.46 51.4 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -130.72 109.68 10.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -1.119 . . . . 0.0 109.325 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.464 ' HE2' HG21 ' A' ' 63' ' ' THR . 18.9 tttm -59.65 123.34 16.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 109.697 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.535 HG21 ' CH2' ' A' ' 92' ' ' TRP . 87.6 t -143.49 129.37 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.312 -0.868 . . . . 0.0 109.329 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.702 ' HG2' HG23 ' A' ' 63' ' ' THR . 49.3 mt-10 -111.5 135.36 52.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.96 . . . . 0.0 109.629 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . . . -160.26 170.48 21.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.345 -0.847 . . . . 0.0 109.589 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.577 ' HB3' HG12 ' A' ' 59' ' ' VAL . 95.0 mt-10 -79.76 146.17 32.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.234 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.542 HG21 HG21 ' A' ' 32' ' ' VAL . 3.7 m -138.77 164.36 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.161 -0.962 . . . . 0.0 109.85 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.442 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 21.2 tp -118.04 149.41 41.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.432 -0.793 . . . . 0.0 109.196 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.864 ' HB1' ' CG ' ' A' ' 34' ' ' GLU . . . -79.81 132.27 36.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 0.0 109.5 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.463 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.8 t -135.32 149.97 71.24 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.386 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.463 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.1 Cg_endo -70.73 0.59 6.15 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.808 2.338 . . . . 0.0 111.837 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -64.47 176.75 1.02 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.485 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -114.61 17.55 17.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.429 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.598 ' CZ ' ' HG ' ' A' ' 84' ' ' LEU . 23.6 p90 -142.27 -156.27 0.67 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.066 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.904 HG23 HG12 ' A' ' 32' ' ' VAL . 3.1 mt -128.1 124.21 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.612 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.598 ' HG ' ' CZ ' ' A' ' 82' ' ' TYR . 1.5 mt -80.18 133.14 36.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 108.981 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.883 HD21 ' HB1' ' A' ' 21' ' ' ALA . 6.8 mt -101.41 144.2 30.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 109.934 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.635 ' O ' HG22 ' A' ' 90' ' ' VAL . 9.5 t-20 -101.88 134.26 20.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.398 -0.814 . . . . 0.0 109.118 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.498 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 43.1 Cg_endo -64.48 -31.12 61.6 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.7 2.267 . . . . 0.0 111.903 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 m -75.67 -28.26 58.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.339 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.416 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 83.8 m-20 -77.81 -29.16 50.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 109.361 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.965 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -121.85 76.69 38.89 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.481 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.5 Cg_endo -69.82 -24.88 28.91 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.676 2.251 . . . . 0.0 111.766 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.965 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.2 p90 -75.98 -24.84 55.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.563 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.957 HD13 ' CD1' ' A' ' 23' ' ' TRP . 9.6 tt -62.46 -34.95 77.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 109.451 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.611 ' CG ' ' CZ2' ' A' ' 23' ' ' TRP . 93.8 mmm -103.67 136.11 43.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -80.34 141.94 34.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.596 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 49.47 62.41 12.09 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.678 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.74 149.71 61.06 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.682 2.255 . . . . 0.0 111.751 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 35.7 tp . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 109.486 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.21 154.51 65.88 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.712 2.275 . . . . 0.0 111.811 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 23' ' ' TRP . 28.7 mt -89.22 -171.17 3.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.408 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.08 137.37 54.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.364 -0.835 . . . . 0.0 109.455 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 65' ' ' LYS . . . -148.7 154.02 39.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.905 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 17' ' ' THR . 70.4 tt0 -123.2 115.5 21.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.873 . . . . 0.0 109.269 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 64' ' ' PHE . 74.6 mt -109.6 127.41 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 69.9 mttt 60.22 21.82 11.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.52 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.66 -15.32 62.82 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 68.0 m -80.02 130.47 35.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -1.136 . . . . 0.0 109.316 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.478 ' O ' HD23 ' A' ' 19' ' ' LEU . 41.4 tttp -91.78 125.27 36.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.17 -0.956 . . . . 0.0 109.491 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.532 ' CD1' ' CZ ' ' A' ' 36' ' ' PHE . 97.8 mt -143.47 168.55 19.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.371 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -92.31 154.03 18.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.453 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.64 ' CB ' HD21 ' A' ' 85' ' ' LEU . . . -138.42 172.32 13.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.244 -0.91 . . . . 0.0 109.402 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.42 ' O ' HD22 ' A' ' 85' ' ' LEU . 39.2 m80 -125.63 123.97 40.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 109.458 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.59 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 55.4 t90 -76.92 122.06 24.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.552 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -130.06 103.62 6.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.59 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 52.2 p -61.23 -25.6 67.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.943 . . . . 0.0 109.524 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.1 89.05 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.468 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -72.9 141.17 47.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -1.194 . . . . 0.0 109.552 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.438 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 28.5 p -105.52 -3.17 22.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 0.0 109.559 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' ' 74' ' ' GLU . 19.9 tt -145.51 147.94 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.323 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 38.2 m -61.56 133.13 55.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.905 . . . . 0.0 109.67 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.654 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -116.56 129.19 56.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 109.53 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.757 HG22 ' CG1' ' A' ' 75' ' ' VAL . 4.7 m -131.38 164.52 41.94 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.953 . . . . 0.0 109.358 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.507 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.8 Cg_endo -78.55 131.62 10.55 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.422 2.082 . . . . 0.0 111.483 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.3 tt0 -43.14 -26.7 0.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.945 . . . . 0.0 109.718 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.05 -36.44 18.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.58 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' CZ ' ' CD1' ' A' ' 19' ' ' LEU . 13.9 m-85 -88.82 -7.19 56.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 109.663 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.915 HD13 ' HB2' ' A' ' 77' ' ' ALA . 4.3 mt -94.93 23.35 5.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 110.027 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 37' ' ' LEU . 23.2 tp10 -44.99 -56.43 4.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.0 109.032 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 40' ' ' GLU . 13.8 p30 -97.45 36.89 1.42 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.716 ' HB2' HD22 ' A' ' 37' ' ' LEU . 21.4 pt-20 -39.38 131.07 1.66 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.536 0.684 . . . . 0.0 110.503 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -124.61 87.54 54.43 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 49.1 Cg_endo -69.87 117.73 5.26 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.653 2.236 . . . . 0.0 112.213 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.3 pt -91.37 -24.86 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.29 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -143.24 178.53 7.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.897 . . . . 0.0 109.495 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 71.6 p -120.91 149.72 42.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 109.595 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.949 ' CE ' HD11 ' A' ' 48' ' ' ILE . 61.3 ttp -137.75 145.19 42.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.89 . . . . 0.0 109.398 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.527 HD23 ' C ' ' A' ' 47' ' ' LEU . 9.0 tt -110.39 130.92 55.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.949 HD11 ' CE ' ' A' ' 46' ' ' MET . 32.4 mm -116.31 139.68 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.449 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -130.7 124.01 30.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.433 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.0 p -121.83 168.69 11.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.513 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.506 HG13 ' N ' ' A' ' 52' ' ' HIS . 24.1 pt -65.24 -39.38 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.598 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.506 ' N ' HG13 ' A' ' 51' ' ' ILE . 76.1 m80 -63.46 -33.3 75.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.607 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.66 -179.13 46.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' OE2' HD21 ' A' ' 47' ' ' LEU . 73.9 tt0 -103.14 131.94 49.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -1.139 . . . . 0.0 109.437 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 8.0 mtmt -128.41 130.16 47.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.211 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -114.48 130.28 56.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.684 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -136.51 156.53 48.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.384 -0.822 . . . . 0.0 109.127 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 59.1 m-20 -86.77 165.24 16.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.995 . . . . 0.0 109.777 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.507 HG11 ' CD ' ' A' ' 74' ' ' GLU . 41.3 t -99.5 139.59 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.367 -0.833 . . . . 0.0 108.945 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 3.9 m-85 -122.52 147.73 46.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.046 -1.034 . . . . 0.0 110.119 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.598 ' O ' HD12 ' A' ' 62' ' ' LEU . 39.8 t80 -105.55 112.09 25.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.613 ' HB2' HG21 ' A' ' 75' ' ' VAL . 6.9 mp -116.38 161.28 19.3 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 110.155 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.696 HG23 ' HG2' ' A' ' 72' ' ' GLU . 18.1 m -121.39 117.33 26.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.513 -0.742 . . . . 0.0 109.057 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 6.1 p90 -140.08 156.83 46.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.085 -1.009 . . . . 0.0 109.939 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 80.6 mttt -91.91 127.86 37.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.385 -0.822 . . . . 0.0 109.239 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.574 HG11 HG11 ' A' ' 90' ' ' VAL . 58.1 t -108.27 109.44 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.606 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 85.3 mt-30 62.88 37.98 11.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.321 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.76 29.08 58.02 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -133.26 113.55 12.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -1.14 . . . . 0.0 109.332 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -63.52 121.21 13.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.715 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 ' CH2' ' A' ' 92' ' ' TRP . 94.2 t -140.57 132.06 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.268 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.696 ' HG2' HG23 ' A' ' 63' ' ' THR . 49.7 mt-10 -115.77 136.92 52.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.131 -0.981 . . . . 0.0 109.745 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.37 -169.65 2.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.432 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.514 ' HB3' HD11 ' A' ' 29' ' ' ILE . 95.9 mt-10 -80.02 165.66 22.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 0.0 109.153 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.757 ' CG1' HG22 ' A' ' 32' ' ' VAL . 94.7 t -152.58 156.77 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.92 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.465 ' N ' HG12 ' A' ' 75' ' ' VAL . 14.8 tp -125.43 141.31 52.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.53 -0.731 . . . . 0.0 109.213 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.915 ' HB2' HD13 ' A' ' 37' ' ' LEU . . . -80.42 136.01 36.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -0.97 . . . . 0.0 109.43 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.48 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -143.91 151.67 53.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.48 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.2 Cg_endo -72.75 4.14 3.81 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.689 2.259 . . . . 0.0 111.864 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -65.6 171.72 3.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.157 -0.965 . . . . 0.0 109.392 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -113.72 17.63 18.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.409 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.74 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 12.4 p90 -139.81 -159.38 0.95 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.261 -0.899 . . . . 0.0 109.032 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.674 HG23 HG12 ' A' ' 32' ' ' VAL . 2.5 mt -129.17 147.17 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.183 -0.948 . . . . 0.0 109.633 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.74 HD11 ' CZ ' ' A' ' 82' ' ' TYR . 6.6 mp -111.69 135.95 51.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.344 -0.847 . . . . 0.0 108.952 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.758 ' N ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -102.55 140.73 36.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.984 . . . . 0.0 109.867 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.642 ' O ' HG22 ' A' ' 90' ' ' VAL . 8.9 t-20 -92.32 134.58 28.05 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.487 -0.758 . . . . 0.0 109.096 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.519 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.5 Cg_endo -64.03 -30.74 66.37 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.766 2.311 . . . . 0.0 111.946 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 m -74.68 -29.61 61.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.262 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -79.44 -29.32 41.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.43 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.177 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -122.88 74.82 47.63 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.379 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.7 -24.47 29.89 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.727 2.284 . . . . 0.0 111.812 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.177 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 42.3 p90 -72.78 -29.87 63.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.5 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.591 HD12 ' CG2' ' A' ' 90' ' ' VAL . 73.4 mt -59.77 -38.01 80.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.51 ' O ' ' N ' ' A' ' 96' ' ' LYS . 65.0 mtt -51.95 -40.21 60.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.843 . . . . 0.0 109.605 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.6 mttm 45.12 -94.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.234 -0.916 . . . . 0.0 109.598 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 94' ' ' MET . 10.2 ttpt 64.69 60.89 1.39 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.114 -0.991 . . . . 0.0 109.485 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.6 147.44 57.47 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.667 2.245 . . . . 0.0 111.735 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.6 tp . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.412 179.933 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.77 149.46 66.85 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.778 2.319 . . . . 0.0 111.912 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.53 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 29.4 mt -83.13 -176.24 6.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.467 ' OE2' ' CE ' ' A' ' 18' ' ' LYS . 72.3 tt0 -113.2 137.32 51.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.496 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.12 142.74 27.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 109.609 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -116.16 120.25 38.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.264 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.635 HG22 ' HG3' ' A' ' 15' ' ' LYS . 36.9 mt -111.53 129.14 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.601 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.635 ' HG3' HG22 ' A' ' 14' ' ' ILE . 32.5 mttm 51.84 24.39 2.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -0.878 . . . . 0.0 109.665 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.64 -4.72 79.63 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.873 HG22 HD11 ' A' ' 19' ' ' LEU . 13.1 m -87.98 128.85 35.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -1.196 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.889 ' C ' HD12 ' A' ' 19' ' ' LEU . 19.3 tttt -86.8 121.75 29.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.492 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.889 HD12 ' C ' ' A' ' 18' ' ' LYS . 5.2 mp -140.54 161.89 36.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.89 . . . . 0.0 109.458 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -88.37 155.36 19.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -0.922 . . . . 0.0 109.428 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.071 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -139.23 176.87 8.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -134.56 122.49 22.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.817 ' CE2' HD22 ' A' ' 93' ' ' LEU . 71.4 t90 -79.59 128.08 32.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.303 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -141.58 109.75 5.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.555 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 20.7 t -60.88 -27.18 67.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.77 -27.14 70.68 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.482 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -79.84 127.63 32.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -1.195 . . . . 0.0 109.48 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 m -95.33 -16.84 22.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 0.0 109.438 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 29' ' ' ILE . 21.1 tt -135.56 130.84 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 84' ' ' LEU . 90.5 m -50.92 139.19 17.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.595 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.593 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -119.82 128.95 54.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.27 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.924 HG12 HG23 ' A' ' 83' ' ' ILE . 16.6 m -122.4 162.57 37.23 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 78' ' ' SER . 55.4 Cg_endo -78.67 131.35 10.27 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.466 2.111 . . . . 0.0 111.623 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.964 ' HG2' ' HB1' ' A' ' 77' ' ' ALA . 96.8 mt-10 -42.9 -27.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 109.548 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -47.46 -43.02 23.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.77 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.586 ' CE1' ' CD2' ' A' ' 19' ' ' LEU . 21.4 m-85 -84.98 -6.32 59.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.102 -0.999 . . . . 0.0 109.756 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' A' ' 40' ' ' GLU . 4.3 mm? -92.48 18.09 9.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.168 -0.958 . . . . 0.0 109.678 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 37' ' ' LEU . 68.7 mt-10 -44.25 -54.17 5.97 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 40' ' ' GLU . 18.7 p30 -99.41 37.16 1.62 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 19.0 pt-20 -38.69 134.11 0.98 Allowed 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.53 0.681 . . . . 0.0 110.513 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.5 mtp85 -128.42 83.37 66.35 Favored Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 48.5 Cg_endo -68.59 117.25 4.86 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.842 2.361 . . . . 0.0 112.341 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.1 pt -91.17 -28.95 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.391 -0.818 . . . . 0.0 109.04 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -141.36 157.05 45.7 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.483 -0.76 . . . . 0.0 109.183 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 81.0 p -120.44 154.58 35.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.124 -0.985 . . . . 0.0 109.674 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.47 ' CE ' HG21 ' A' ' 59' ' ' VAL . 63.0 mtt -140.85 142.65 34.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.408 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.4 tp -96.59 127.45 42.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 55' ' ' LYS . 29.4 mm -113.9 132.51 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.555 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -110.57 133.11 53.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.74 179.38 4.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.44 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 54.2 mt -68.75 -49.92 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -54.11 -47.74 71.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.458 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.69 -162.41 25.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -100.51 132.4 45.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -1.119 . . . . 0.0 109.436 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 48' ' ' ILE . 22.8 tptm -120.58 136.92 54.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.357 -0.839 . . . . 0.0 109.452 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -104.42 122.84 46.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.608 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.624 ' HB3' HD11 ' A' ' 76' ' ' LEU . 13.0 mm-40 -119.02 145.24 46.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.256 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.554 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 78.9 m-20 -101.21 155.92 17.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.497 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 44.6 t -99.09 134.19 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.146 -0.971 . . . . 0.0 109.125 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.61 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 3.4 m-85 -122.61 147.41 46.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.161 -0.962 . . . . 0.0 109.61 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.675 ' O ' HD23 ' A' ' 62' ' ' LEU . 32.9 t80 -104.88 115.5 30.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 108.961 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 61' ' ' TYR . 18.9 mt -121.47 156.52 32.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 110.08 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.718 HG23 ' HG2' ' A' ' 72' ' ' GLU . 67.9 m -115.31 125.68 53.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.449 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 18.1 p90 -149.02 151.23 34.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.082 -1.011 . . . . 0.0 109.681 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -85.28 133.32 34.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.323 -0.861 . . . . 0.0 109.198 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.549 HG11 HG11 ' A' ' 90' ' ' VAL . 40.1 t -109.58 112.64 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 93.7 mt-30 61.33 20.96 11.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.86 . . . . 0.0 109.468 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.64 21.77 18.19 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.93 ' HG2' HG23 ' A' ' 71' ' ' VAL . 6.6 ttt85 -126.86 116.82 21.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -1.057 . . . . 0.0 109.068 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -64.55 116.07 5.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 109.367 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.93 HG23 ' HG2' ' A' ' 69' ' ' ARG . 55.4 t -138.12 134.97 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 109.481 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.718 ' HG2' HG23 ' A' ' 63' ' ' THR . 80.6 mt-10 -111.05 140.35 45.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.3 168.99 24.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.624 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.497 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 95.8 mt-10 -79.84 141.06 36.55 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.393 -0.817 . . . . 0.0 109.079 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.624 HG21 HD12 ' A' ' 62' ' ' LEU . 2.8 m -138.18 163.46 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.186 -0.946 . . . . 0.0 109.775 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.624 HD11 ' HB3' ' A' ' 57' ' ' GLN . 21.1 tp -117.39 146.85 43.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.964 ' HB1' ' HG2' ' A' ' 34' ' ' GLU . . . -79.75 126.01 30.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.386 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 1.1 t -133.06 152.18 79.23 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.474 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.487 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 48.9 Cg_endo -69.6 -0.82 7.33 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.605 2.203 . . . . 0.0 111.779 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -58.78 169.86 0.91 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.384 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -111.97 22.32 15.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.695 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 19.2 p90 -148.14 -159.32 1.01 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.417 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.924 HG23 HG12 ' A' ' 32' ' ' VAL . 4.0 mt -125.22 140.64 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.735 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.786 ' O ' HG23 ' A' ' 30' ' ' THR . 6.9 mp -106.35 130.59 54.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.32 -0.863 . . . . 0.0 109.039 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.071 HD21 ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -111.48 135.18 52.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.624 -179.677 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.531 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 6.8 p-10 -97.55 158.17 33.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.243 -0.91 . . . . 0.0 109.737 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 48.8 Cg_endo -69.19 -20.0 38.11 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.663 2.242 . . . . 0.0 111.403 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.5 p -76.36 -36.39 58.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.317 -0.864 . . . . 0.0 109.116 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.459 ' HB2' ' OD1' ' A' ' 86' ' ' ASN . 88.0 m-20 -79.38 -32.07 43.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -0.826 . . . . 0.0 108.905 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.062 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -119.25 71.68 12.45 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.835 . . . . 0.0 109.515 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.565 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.4 Cg_endo -70.31 -20.15 32.59 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.735 2.29 . . . . 0.0 111.784 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.062 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 47.2 p90 -79.85 -32.88 40.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.923 . . . . 0.0 109.562 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.817 HD22 ' CE2' ' A' ' 23' ' ' TRP . 0.7 OUTLIER -43.53 -42.2 4.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.431 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.543 ' SD ' HD11 ' A' ' 98' ' ' LEU . 71.9 mtm -82.16 127.9 33.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.0 109.474 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -61.17 -37.18 81.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.504 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.13 153.76 76.93 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.524 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.75 168.67 20.87 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.727 2.285 . . . . 0.0 111.819 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.691 ' N ' HD12 ' A' ' 98' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 51.1 Cg_endo -69.8 149.3 66.46 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.677 2.251 . . . . 0.0 111.854 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.526 HD13 HD12 ' A' ' 85' ' ' LEU . 4.1 mp -82.59 161.15 22.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.473 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.55 142.64 29.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.502 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.07 151.84 28.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.54 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 18' ' ' LYS . 92.2 mt-10 -130.88 121.53 25.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 109.432 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 75.9 mt -114.7 128.14 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.936 . . . . 0.0 109.43 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 65.5 mttt 61.11 20.26 10.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.44 -12.42 69.76 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.45 HG22 HD12 ' A' ' 19' ' ' LEU . 41.9 m -81.8 134.63 35.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -1.169 . . . . 0.0 109.409 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.747 ' O ' HD12 ' A' ' 19' ' ' LEU . 89.0 mttt -89.75 139.04 30.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -158.8 165.61 33.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.411 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 9' ' ' PRO . 11.8 mmtt -86.5 150.67 24.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.764 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -133.49 171.11 14.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.539 ' HB2' ' CE2' ' A' ' 82' ' ' TYR . 26.2 m80 -131.52 133.83 45.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 109.836 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.605 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 58.5 t90 -90.31 115.13 27.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 109.448 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -127.08 102.53 7.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.386 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.473 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 32.2 t -57.83 -34.03 69.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.613 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.95 -35.59 48.72 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.18 136.11 51.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.2 m -95.29 -16.4 22.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.45 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.5 tt -141.65 149.41 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.316 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 27.9 m -57.69 135.49 56.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.732 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -119.24 119.53 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.9 . . . . 0.0 109.214 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.637 HG12 HG23 ' A' ' 83' ' ' ILE . 29.1 m -113.44 162.2 23.5 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.281 -0.887 . . . . 0.0 109.515 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.6 Cg_endo -79.2 130.6 9.32 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.547 2.164 . . . . 0.0 111.575 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 81.0 tt0 -43.27 -26.87 0.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 0.0 109.51 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -53.08 -41.81 65.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.402 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.636 ' HZ ' HD13 ' A' ' 19' ' ' LEU . 5.9 m-85 -83.15 -3.04 56.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.226 -0.921 . . . . 0.0 109.445 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 40' ' ' GLU . 6.1 mt -95.93 20.72 9.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.946 . . . . 0.0 109.779 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 37' ' ' LEU . 71.5 mt-10 -43.9 -56.51 3.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 0.0 108.942 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 49.2 m-20 -97.05 40.15 1.15 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.742 ' HB2' HD22 ' A' ' 37' ' ' LEU . 21.0 pt-20 -42.94 134.2 3.44 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.522 0.677 . . . . 0.0 110.551 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -127.83 85.97 59.41 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.32 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 49.9 Cg_endo -70.28 118.85 5.92 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.717 2.278 . . . . 0.0 112.242 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.468 HG13 ' N ' ' A' ' 44' ' ' GLN . 36.1 pt -90.5 -35.86 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.023 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.468 ' N ' HG13 ' A' ' 43' ' ' ILE . 94.7 mt-30 -137.99 175.66 9.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.405 -0.809 . . . . 0.0 109.106 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 76.6 p -129.85 151.83 50.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.086 -1.009 . . . . 0.0 109.829 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.481 ' HG3' ' CG2' ' A' ' 59' ' ' VAL . 81.2 mtp -138.38 147.12 43.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.422 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.683 HD12 ' HB2' ' A' ' 56' ' ' GLN . 20.8 tp -98.63 129.43 45.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.506 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.47 134.2 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.43 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -104.21 140.7 37.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 52' ' ' HIS . 91.4 m -131.81 144.42 50.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.92 . . . . 0.0 109.385 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 52' ' ' HIS . 16.4 tt -48.82 -41.71 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.901 . . . . 0.0 109.478 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.521 ' N ' HG23 ' A' ' 51' ' ' ILE . 56.1 t-80 -67.28 -36.52 81.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 109.452 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' ' HB ' ' A' ' 50' ' ' THR . . . -179.25 -173.94 44.91 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -103.79 129.04 51.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -1.193 . . . . 0.0 109.528 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -122.68 134.14 54.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 0.0 109.35 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.683 ' HB2' HD12 ' A' ' 47' ' ' LEU . 62.8 tt0 -109.46 125.37 52.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.596 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.415 ' OE1' ' HB3' ' A' ' 76' ' ' LEU . 7.4 tt0 -123.02 147.16 46.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.258 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.483 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 83.4 m-20 -83.81 159.04 21.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.195 -0.941 . . . . 0.0 109.661 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.683 HG11 ' OE1' ' A' ' 74' ' ' GLU . 43.4 t -98.94 134.69 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.262 -0.898 . . . . 0.0 109.043 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.604 ' CD2' ' HB2' ' A' ' 40' ' ' GLU . 4.0 m-85 -119.06 148.46 43.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.047 -1.033 . . . . 0.0 109.913 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.588 ' O ' HD12 ' A' ' 62' ' ' LEU . 43.3 t80 -107.0 112.49 25.47 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.826 HD22 HG21 ' A' ' 75' ' ' VAL . 6.8 mp -115.66 158.88 22.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.155 -0.965 . . . . 0.0 110.445 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.716 HG23 ' HG2' ' A' ' 72' ' ' GLU . 51.0 m -117.74 116.76 27.67 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.801 ' CE2' HG22 ' A' ' 66' ' ' VAL . 39.9 p90 -137.21 160.02 40.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 109.955 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -93.11 129.08 39.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 109.356 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.801 HG22 ' CE2' ' A' ' 64' ' ' PHE . 1.7 t -105.53 103.55 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 109.656 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 22.0 mt-30 63.61 36.73 10.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.895 . . . . 0.0 109.33 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.72 26.01 51.54 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -129.55 120.88 26.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.333 -1.098 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -66.33 122.82 18.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.582 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.693 HG21 ' CH2' ' A' ' 92' ' ' TRP . 90.2 t -144.17 133.44 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.451 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.716 ' HG2' HG23 ' A' ' 63' ' ' THR . 76.4 mt-10 -117.16 137.18 52.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.641 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.07 172.49 17.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.6 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.683 ' OE1' HG11 ' A' ' 59' ' ' VAL . 96.1 mt-10 -79.9 141.35 36.17 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -0.922 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.826 HG21 HD22 ' A' ' 62' ' ' LEU . 2.9 m -135.14 162.3 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.943 . . . . 0.0 109.752 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.415 ' HB3' ' OE1' ' A' ' 57' ' ' GLN . 72.8 mt -119.34 154.71 33.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.847 . . . . 0.0 109.287 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB2' HD13 ' A' ' 37' ' ' LEU . . . -80.17 138.83 36.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.478 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.572 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 4.6 t -143.11 149.0 47.26 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.475 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.2 Cg_endo -72.65 3.37 4.36 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.701 2.267 . . . . 0.0 112.065 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.572 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 74.3 m-85 -66.81 174.93 2.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 109.587 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -114.06 15.65 18.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 0.0 109.341 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' N ' ' A' ' 83' ' ' ILE . 33.0 p90 -139.22 -157.89 0.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.208 -0.933 . . . . 0.0 109.08 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.637 HG23 HG12 ' A' ' 32' ' ' VAL . 4.5 mt -123.66 126.21 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.669 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.732 HD13 ' HB3' ' A' ' 31' ' ' CYS . 5.7 mp -84.27 142.59 30.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 108.941 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.764 HD21 ' HB1' ' A' ' 21' ' ' ALA . 6.6 mt -112.92 143.26 44.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 110.083 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.74 ' O ' HG22 ' A' ' 90' ' ' VAL . 3.3 t30 -103.61 137.41 19.24 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.53 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.5 Cg_endo -64.0 -35.65 53.33 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.703 2.269 . . . . 0.0 111.998 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.447 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 2.5 m -72.54 -27.01 61.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.141 -0.974 . . . . 0.0 109.411 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -79.55 -28.92 41.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.34 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.094 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -120.26 71.85 18.03 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.841 . . . . 0.0 109.464 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.34 -16.3 35.09 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.632 2.221 . . . . 0.0 111.762 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.094 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 41.6 p90 -82.6 -28.51 30.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.894 . . . . 0.0 109.414 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.605 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 22.0 tp -60.58 -26.28 66.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.4 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 88.0 mtp -67.52 -35.54 79.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.36 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 92' ' ' TRP . 63.7 mttm -117.36 137.66 52.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.402 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -71.66 148.09 92.5 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.902 . . . . 0.0 109.62 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 49.3 Cg_endo -69.5 -16.77 38.84 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.804 2.336 . . . . 0.0 111.833 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 97' ' ' PRO . 44.3 mt . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.215 0.531 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.74 152.05 69.31 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.655 2.237 . . . . 0.0 111.709 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 3.7 mp -84.38 164.47 18.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.439 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -101.79 147.21 26.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.475 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.25 146.31 25.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.521 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 17' ' ' THR . 89.9 mt-10 -123.8 118.68 27.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.71 HG22 ' HG3' ' A' ' 15' ' ' LYS . 61.6 mt -114.15 129.65 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.503 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.71 ' HG3' HG22 ' A' ' 14' ' ' ILE . 93.2 mttt 54.35 22.39 3.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.94 -8.55 76.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 32.7 m -82.58 128.45 34.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -1.13 . . . . 0.0 109.493 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.812 ' O ' HD23 ' A' ' 19' ' ' LEU . 29.6 tttt -92.47 122.79 35.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.403 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.812 HD23 ' O ' ' A' ' 18' ' ' LYS . 63.7 mt -140.88 168.08 20.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.498 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -87.67 155.54 19.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.496 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.696 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -139.85 167.73 21.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -0.859 . . . . 0.0 109.337 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.622 ' O ' HD22 ' A' ' 85' ' ' LEU . 46.1 m80 -130.98 132.47 45.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.498 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.573 ' CZ2' ' HB3' ' A' ' 87' ' ' PRO . 38.9 t90 -85.76 122.98 30.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.587 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -130.15 99.31 5.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.875 . . . . 0.0 109.463 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.516 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 53.4 p -57.16 -26.76 61.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -0.861 . . . . 0.0 109.509 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.22 -36.17 92.0 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -72.17 137.37 46.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -1.15 . . . . 0.0 109.425 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.451 ' O ' HG22 ' A' ' 28' ' ' THR . 93.5 m -99.1 -10.45 22.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 109.385 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.452 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 21.2 tt -139.4 152.77 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 84' ' ' LEU . 32.4 m -61.24 152.11 29.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.477 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.975 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -127.93 113.72 16.23 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.111 179.829 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.782 HG13 ' HD2' ' A' ' 33' ' ' PRO . 60.3 t -113.55 146.91 36.4 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.312 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.782 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.3 Cg_endo -76.75 131.22 12.14 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.125 1.883 . . . . 0.0 111.625 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 33' ' ' PRO . 81.3 tt0 -40.7 -27.48 0.05 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.533 -0.729 . . . . 0.0 110.234 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.14 -27.75 3.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.096 -1.003 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.751 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 21.4 m-85 -101.77 -3.04 28.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 0.0 109.77 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.569 ' CD2' ' CG ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -115.25 15.01 17.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.698 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 70.7 mm-40 -61.48 -24.13 66.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.099 -1.001 . . . . 0.0 109.325 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -128.44 27.07 5.61 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.565 ' CB ' HD23 ' A' ' 37' ' ' LEU . 53.7 mm-40 -96.15 174.4 6.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.506 -0.747 . . . . 0.0 109.805 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.03 128.83 20.78 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 109.223 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.572 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 52.1 Cg_endo -72.27 121.44 7.5 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.578 2.185 . . . . 0.0 111.923 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 61' ' ' TYR . 3.2 pt -84.96 -29.7 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 109.173 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 59' ' ' VAL . 63.2 tt0 -143.68 163.85 32.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.189 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 71.5 p -122.94 149.07 44.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 109.761 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 63.0 mtt -141.92 144.21 33.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.317 -0.864 . . . . 0.0 109.359 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.517 HD23 ' C ' ' A' ' 47' ' ' LEU . 8.7 tt -93.16 131.72 37.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.385 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.473 ' N ' HD23 ' A' ' 47' ' ' LEU . 74.2 mt -119.24 129.21 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.868 . . . . 0.0 109.568 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -108.28 134.73 50.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.399 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.18 -168.72 1.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.492 ' HA ' HD13 ' A' ' 51' ' ' ILE . 16.7 mm -80.08 -47.01 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.371 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -58.01 -38.83 76.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.508 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.41 -169.41 41.05 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.2 mp0 -104.98 136.99 43.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -1.105 . . . . 0.0 109.507 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -137.23 134.01 35.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.363 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -107.18 127.91 53.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.545 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.713 ' OE1' HD21 ' A' ' 76' ' ' LEU . 90.6 mt-30 -123.82 160.73 26.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.306 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 79.6 m-20 -93.23 144.41 25.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 109.689 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.539 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 21.7 t -86.39 153.78 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 109.293 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.572 ' CE2' ' HD3' ' A' ' 42' ' ' PRO . 11.4 m-85 -133.16 139.3 46.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.138 -0.976 . . . . 0.0 109.889 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.493 ' O ' HD23 ' A' ' 62' ' ' LEU . 43.5 t80 -102.15 114.4 28.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.257 -0.902 . . . . 0.0 108.956 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.576 HD12 HG21 ' A' ' 75' ' ' VAL . 44.1 mt -121.01 169.05 10.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.061 -1.024 . . . . 0.0 110.288 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.711 HG23 ' HG2' ' A' ' 72' ' ' GLU . 25.4 m -121.22 118.05 28.62 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.502 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 9.5 p90 -140.34 163.22 33.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.988 -1.07 . . . . 0.0 109.801 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.45 ' NZ ' ' OE1' ' A' ' 13' ' ' GLU . 15.2 mtmt -99.38 126.01 45.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.388 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 78.0 t -104.42 116.19 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.481 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 94.7 mt-30 62.29 30.96 17.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.386 -0.821 . . . . 0.0 109.393 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.65 22.45 59.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -125.64 117.61 23.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -1.164 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -58.91 123.9 18.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.439 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.689 HG21 ' CH2' ' A' ' 92' ' ' TRP . 53.7 t -148.55 127.03 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.335 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.711 ' HG2' HG23 ' A' ' 63' ' ' THR . 79.5 mt-10 -107.66 138.82 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.525 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.32 168.34 25.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.338 -0.851 . . . . 0.0 109.695 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.539 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 95.5 mt-10 -80.04 137.29 36.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.328 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.694 ' HB ' HG23 ' A' ' 32' ' ' VAL . 5.0 m -127.92 151.39 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.713 HD21 ' OE1' ' A' ' 57' ' ' GLN . 24.6 tp -103.75 143.63 32.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.355 -0.84 . . . . 0.0 109.082 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.17 125.9 30.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.243 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.495 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 35.2 t -137.14 150.13 68.3 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.296 -0.878 . . . . 0.0 109.534 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.495 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.8 Cg_endo -71.01 5.07 2.34 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.669 2.246 . . . . 0.0 112.176 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 31.3 m-85 -62.57 178.22 0.45 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 109.362 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -118.22 18.3 13.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.549 ' CD2' ' N ' ' A' ' 83' ' ' ILE . 13.9 p90 -145.08 -153.97 0.51 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.349 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.549 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 2.4 mt -133.22 148.01 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 0.0 109.563 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.975 HD13 ' HB3' ' A' ' 31' ' ' CYS . 6.0 mp -112.27 133.73 54.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 108.886 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.76 ' H ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -100.63 133.09 45.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.067 -1.021 . . . . 0.0 109.851 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.677 ' O ' HG22 ' A' ' 90' ' ' VAL . 3.3 t30 -85.67 136.57 36.84 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.573 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 40.5 Cg_endo -63.06 -25.76 73.45 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.696 2.264 . . . . 0.0 111.849 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.497 ' OG ' ' ND2' ' A' ' 86' ' ' ASN . 1.0 OUTLIER -80.42 -28.92 37.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.27 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -78.06 -28.6 48.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.864 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.179 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -116.06 73.95 5.17 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.202 -0.936 . . . . 0.0 109.505 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.414 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.8 Cg_endo -70.3 -23.73 28.0 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.757 2.305 . . . . 0.0 111.791 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.179 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 43.9 p90 -73.06 -29.63 63.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.492 HD12 ' CG2' ' A' ' 90' ' ' VAL . 76.3 mt -61.3 -33.76 74.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.241 -0.912 . . . . 0.0 109.467 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.48 ' SD ' ' CH2' ' A' ' 23' ' ' TRP . 89.9 mtp -107.44 154.22 21.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.51 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -88.2 139.81 30.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.476 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -125.43 79.55 66.74 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.495 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 98' ' ' LEU . 49.7 Cg_endo -70.04 145.36 55.3 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.656 2.237 . . . . 0.0 111.735 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 97' ' ' PRO . 26.1 tp . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.172 -0.955 . . . . 0.0 109.493 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.508 ' CB ' ' CD ' ' A' ' 9' ' ' PRO . 11.5 mm100 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.595 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 48.3 Cg_endo -69.92 152.48 68.52 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.66 2.24 . . . . 0.0 111.77 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 23' ' ' TRP . 86.3 mt -93.81 154.17 17.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.475 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -88.49 140.24 29.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.548 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.48 155.35 41.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 17' ' ' THR . 67.5 tt0 -128.65 109.56 11.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -0.953 . . . . 0.0 109.412 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.585 ' HB ' ' CE2' ' A' ' 36' ' ' PHE . 90.0 mt -104.92 128.81 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.51 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 52.7 mttp 61.31 18.17 8.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.632 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.08 -10.93 73.39 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 81.8 m -85.5 140.43 30.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -1.136 . . . . 0.0 109.171 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -79.26 117.45 20.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.295 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.907 HD22 ' CE1' ' A' ' 36' ' ' PHE . 11.7 tp -130.14 147.81 51.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.476 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.746 ' O ' HD12 ' A' ' 83' ' ' ILE . 40.6 mttt -81.93 157.82 24.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.6 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.075 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -144.98 160.08 41.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.554 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.727 ' O ' HD22 ' A' ' 85' ' ' LEU . 61.2 m80 -128.72 129.32 45.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.265 -0.897 . . . . 0.0 109.471 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.59 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 21.9 t90 -75.28 125.45 29.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.641 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -132.85 95.9 3.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.394 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.59 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 54.6 p -56.45 -31.8 64.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.657 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.57 -27.58 68.31 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -79.98 139.29 37.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -1.167 . . . . 0.0 109.472 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.503 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 41.8 p -103.57 -4.36 24.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.584 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.791 HG21 HD11 ' A' ' 76' ' ' LEU . 21.2 tt -143.98 149.41 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.932 . . . . 0.0 109.472 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.692 ' HB ' HG22 ' A' ' 75' ' ' VAL . 27.8 m -61.12 139.67 58.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.647 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.803 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -123.48 140.07 53.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.546 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.041 HG12 HG23 ' A' ' 83' ' ' ILE . 34.9 m -141.13 165.8 26.73 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.915 . . . . 0.0 109.411 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.4 Cg_endo -78.29 128.15 8.73 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.29 1.993 . . . . 0.0 111.451 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' PRO . 83.9 tt0 -41.78 -28.19 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.749 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -53.27 -31.48 43.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.557 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.907 ' CE1' HD22 ' A' ' 19' ' ' LEU . 2.2 m-85 -88.75 -10.92 46.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 0.0 109.673 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.659 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -106.56 0.88 24.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.858 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -51.83 -25.78 8.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 109.321 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -120.99 23.57 10.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.39 -0.819 . . . . 0.0 109.234 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.541 ' HB2' HD23 ' A' ' 37' ' ' LEU . 41.7 mm-40 -98.02 157.03 16.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.724 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.24 129.3 25.46 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.08 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.539 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 52.9 Cg_endo -72.93 124.53 9.71 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.53 2.153 . . . . 0.0 111.745 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.45 HD13 ' HB2' ' A' ' 61' ' ' TYR . 26.9 pt -81.8 -28.99 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.26 -0.9 . . . . 0.0 109.356 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.564 ' O ' HG12 ' A' ' 59' ' ' VAL . 94.7 mt-30 -147.51 177.97 8.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.289 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 60.4 p -118.53 148.58 42.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.145 -0.972 . . . . 0.0 109.71 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.435 ' O ' ' HG3' ' A' ' 56' ' ' GLN . 86.2 mtp -129.34 149.28 51.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.908 HD13 ' N ' ' A' ' 48' ' ' ILE . 1.8 tm? -101.86 128.82 48.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.299 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.908 ' N ' HD13 ' A' ' 47' ' ' LEU . 25.2 mm -111.83 138.16 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 109.49 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.419 ' HG3' ' HG3' ' A' ' 54' ' ' GLU . 20.9 tttm -121.38 132.29 54.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.531 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.8 p -126.81 156.15 41.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.352 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 52' ' ' HIS . 17.9 tt -58.26 -36.7 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.435 ' N ' HG23 ' A' ' 51' ' ' ILE . 84.0 t60 -68.6 -46.24 69.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.871 . . . . 0.0 109.352 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.86 -167.65 27.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HG3' ' HG3' ' A' ' 49' ' ' LYS . 50.3 mp0 -113.04 129.88 56.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.187 -1.184 . . . . 0.0 109.552 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 59.2 mttm -124.82 147.54 48.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.348 -0.845 . . . . 0.0 109.121 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.506 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 57.0 tt0 -120.34 132.86 55.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.655 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -128.85 161.23 30.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.289 -0.882 . . . . 0.0 109.293 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 41.4 m-20 -98.22 141.36 31.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.181 -0.949 . . . . 0.0 109.714 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 44' ' ' GLN . 14.4 p -79.99 158.47 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.245 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.659 ' CD2' HD23 ' A' ' 37' ' ' LEU . 25.6 m-85 -139.64 123.66 17.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.185 -0.947 . . . . 0.0 110.053 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.473 ' OH ' ' HB2' ' A' ' 72' ' ' GLU . 45.2 t80 -85.91 110.19 19.25 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.453 HD22 ' CD ' ' A' ' 40' ' ' GLU . 60.1 mt -115.81 161.62 18.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.032 -1.043 . . . . 0.0 110.624 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.7 HG23 ' HG2' ' A' ' 72' ' ' GLU . 29.5 m -121.23 124.24 44.17 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.981 ' CE2' HG22 ' A' ' 66' ' ' VAL . 43.2 p90 -145.92 160.38 41.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.044 -1.035 . . . . 0.0 109.97 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.504 ' HD3' ' HA ' ' A' ' 70' ' ' LYS . 6.8 mmtt -90.1 126.75 35.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.406 -0.809 . . . . 0.0 109.229 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.981 HG22 ' CE2' ' A' ' 64' ' ' PHE . 1.7 t -104.54 103.09 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.688 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.586 ' NE2' ' CD2' ' A' ' 93' ' ' LEU . 24.9 mt-30 62.61 35.06 14.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.317 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.46 30.93 28.88 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -136.28 120.56 17.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -1.169 . . . . 0.0 109.39 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.504 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 15.0 tttp -67.35 120.44 13.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.471 HG21 ' CH2' ' A' ' 92' ' ' TRP . 64.0 t -141.94 131.84 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.475 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.7 ' HG2' HG23 ' A' ' 63' ' ' THR . 27.3 mt-10 -116.01 136.48 52.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.31 -178.11 6.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.845 . . . . 0.0 109.667 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 94.1 mt-10 -79.64 152.81 29.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.02 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.897 ' CG1' HG22 ' A' ' 32' ' ' VAL . 91.6 t -143.51 156.97 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.123 -0.985 . . . . 0.0 109.744 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.791 HD11 HG21 ' A' ' 29' ' ' ILE . 17.2 mt -121.89 147.37 46.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.37 -0.831 . . . . 0.0 109.313 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.94 139.66 36.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.468 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.5 t -143.98 150.81 50.74 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 109.345 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.468 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.9 Cg_endo -71.37 1.75 5.17 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.677 2.251 . . . . 0.0 111.772 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.51 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 70.6 m-85 -69.15 162.53 26.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.278 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -104.32 19.79 19.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.604 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.84 ' OH ' HD21 ' A' ' 84' ' ' LEU . 22.4 p90 -140.57 -162.35 1.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.979 . . . . 0.0 109.552 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.041 HG23 HG12 ' A' ' 32' ' ' VAL . 7.5 mt -125.44 152.16 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.1 -1.0 . . . . 0.0 110.248 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.84 HD21 ' OH ' ' A' ' 82' ' ' TYR . 2.2 mt -118.55 124.59 47.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.298 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.075 HD11 ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -92.47 140.68 29.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 109.82 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.656 ' O ' HG22 ' A' ' 90' ' ' VAL . 8.2 t-20 -90.87 134.79 29.71 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.491 -0.755 . . . . 0.0 109.25 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.5 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.1 Cg_endo -63.95 -30.3 67.07 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.796 2.33 . . . . 0.0 111.78 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.407 ' HB3' HD21 ' A' ' 86' ' ' ASN . 6.4 t -75.73 -29.09 58.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 109.269 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -79.89 -33.21 40.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.897 . . . . 0.0 109.44 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.157 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.8 OUTLIER -119.52 76.39 18.71 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.882 . . . . 0.0 109.424 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.439 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.3 Cg_endo -69.99 -22.05 31.58 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.697 2.264 . . . . 0.0 111.785 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.157 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.2 p90 -76.23 -25.72 55.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.171 -0.955 . . . . 0.0 109.401 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.586 ' CD2' ' NE2' ' A' ' 67' ' ' GLN . 59.9 mt -68.37 -30.17 69.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.478 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 90.0 mtp -53.25 -36.57 61.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.84 . . . . 0.0 109.558 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.92 138.37 48.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.127 -0.983 . . . . 0.0 109.554 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.3 160.49 45.47 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.355 -0.84 . . . . 0.0 109.473 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.428 ' O ' ' HB3' ' A' ' 98' ' ' LEU . 50.1 Cg_endo -69.57 156.03 64.95 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.727 2.285 . . . . 0.0 111.81 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 97' ' ' PRO . 21.6 tp . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.484 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.492 ' CB ' ' CD ' ' A' ' 9' ' ' PRO . 1.3 mm-40 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 8' ' ' GLN . 50.7 Cg_endo -70.14 163.08 39.89 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.729 2.286 . . . . 0.0 111.668 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.779 HD11 ' HB2' ' A' ' 23' ' ' TRP . 65.8 mt -93.63 142.03 27.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.493 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -83.43 134.1 34.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 65' ' ' LYS . . . -145.14 150.75 37.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.527 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.458 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 45.0 tt0 -115.93 121.0 41.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.405 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.633 HG22 ' HG3' ' A' ' 15' ' ' LYS . 27.1 mt -111.06 125.4 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.633 ' HG3' HG22 ' A' ' 14' ' ' ILE . 42.5 mttt 55.02 24.79 6.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.321 -0.862 . . . . 0.0 109.55 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.458 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 90.31 4.52 71.01 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 42.7 m -103.64 126.45 50.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -1.203 . . . . 0.0 109.467 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -82.12 129.15 34.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.73 HD13 ' HZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -141.27 167.76 21.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -87.55 148.61 24.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 0.0 109.569 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.846 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -135.92 163.79 29.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 109.475 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.741 ' O ' HD22 ' A' ' 85' ' ' LEU . 20.6 m80 -130.37 129.42 43.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.563 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.779 ' HB2' HD11 ' A' ' 10' ' ' LEU . 48.4 t90 -77.0 127.74 33.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -137.59 107.41 6.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.499 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 18.2 p -65.69 -33.11 75.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.82 -15.76 55.49 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.12 130.43 34.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -1.155 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.7 m -94.98 -24.02 17.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.986 HD11 ' HB2' ' A' ' 74' ' ' GLU . 11.3 tp -132.72 143.12 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -0.926 . . . . 0.0 109.6 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 84' ' ' LEU . 39.1 m -58.46 136.46 57.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.655 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 9.9 t -124.76 140.04 53.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.834 HG13 HG13 ' A' ' 75' ' ' VAL . 2.6 m -137.72 172.14 7.29 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.32 -0.862 . . . . 0.0 109.14 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.5 Cg_endo -79.82 132.26 9.58 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.22 1.946 . . . . 0.0 111.833 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 33' ' ' PRO . 22.4 pt-20 -44.22 -25.92 0.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.642 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -48.52 -34.34 11.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 109.526 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.73 ' HZ ' HD13 ' A' ' 19' ' ' LEU . 12.8 m-85 -89.42 -9.75 49.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 109.646 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.571 HD12 ' CB ' ' A' ' 40' ' ' GLU . 3.6 mm? -90.45 21.19 4.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.783 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 37' ' ' LEU . 52.9 tt0 -44.15 -57.37 3.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 108.919 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 40' ' ' GLU . 24.4 m-20 -98.52 37.67 1.45 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 20.5 pt-20 -38.7 132.7 1.16 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.519 0.676 . . . . 0.0 110.368 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.04 85.01 61.64 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.504 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 50.2 Cg_endo -68.76 116.24 4.34 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.655 2.237 . . . . 0.0 112.171 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.4 pt -79.28 -27.51 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.294 -0.879 . . . . 0.0 109.148 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.491 ' O ' HG12 ' A' ' 59' ' ' VAL . 94.4 mt-30 -146.91 172.65 13.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 109.322 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 72.7 p -123.74 150.33 44.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.509 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 87.6 mtp -130.33 148.77 52.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.878 . . . . 0.0 109.355 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.675 HD23 ' HG3' ' A' ' 56' ' ' GLN . 49.1 mt -103.83 125.75 50.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.424 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 55' ' ' LYS . 23.4 mm -114.53 130.17 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 109.453 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -106.94 136.7 46.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 52' ' ' HIS . 52.0 m -126.95 139.97 52.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 109.463 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 52' ' ' HIS . 19.1 tt -47.95 -36.22 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.443 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.473 ' H ' HG22 ' A' ' 50' ' ' THR . 84.0 t60 -74.25 -31.77 62.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.952 . . . . 0.0 109.439 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 50' ' ' THR . . . -179.6 -177.52 47.89 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -102.8 128.54 49.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 109.455 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 48' ' ' ILE . 15.6 tptp -121.47 135.7 55.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.285 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.675 ' HG3' HD23 ' A' ' 47' ' ' LEU . 63.3 tt0 -103.61 123.67 47.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.193 -0.942 . . . . 0.0 109.644 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.413 ' HB3' HD11 ' A' ' 76' ' ' LEU . 16.2 mm-40 -116.94 136.51 52.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.168 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 61.9 m-20 -96.01 154.64 17.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 109.431 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.68 HG21 ' CD ' ' A' ' 74' ' ' GLU . 7.2 p -97.81 138.64 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.153 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.61 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 4.6 m-85 -121.91 147.83 45.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.272 -0.892 . . . . 0.0 109.636 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.534 ' O ' HD23 ' A' ' 62' ' ' LEU . 35.9 t80 -108.24 113.12 25.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -0.826 . . . . 0.0 108.957 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 61' ' ' TYR . 28.4 mt -117.25 158.84 23.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.071 -1.018 . . . . 0.0 110.128 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.712 HG23 ' HG2' ' A' ' 72' ' ' GLU . 22.0 m -119.88 115.7 24.36 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 9.4 p90 -138.89 162.02 35.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.067 -1.02 . . . . 0.0 109.945 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 32.2 mttm -92.39 127.37 37.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.395 -0.816 . . . . 0.0 109.278 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 49.8 t -106.98 105.86 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 109.537 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 21.2 mt-30 63.85 36.26 10.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.291 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.09 33.86 39.36 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 71' ' ' VAL . 74.3 mtt180 -139.19 108.81 6.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.225 -1.162 . . . . 0.0 109.405 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -55.72 121.71 9.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.91 . . . . 0.0 109.628 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.614 HG21 ' CH2' ' A' ' 92' ' ' TRP . 80.3 t -141.16 129.98 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 109.429 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.712 ' HG2' HG23 ' A' ' 63' ' ' THR . 54.5 mt-10 -113.7 136.36 52.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.621 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.37 -173.49 4.03 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.368 -0.832 . . . . 0.0 109.353 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.986 ' HB2' HD11 ' A' ' 29' ' ' ILE . 97.2 mt-10 -80.0 164.79 23.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.002 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.834 HG13 HG13 ' A' ' 32' ' ' VAL . 89.8 t -152.76 145.42 15.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.134 -0.979 . . . . 0.0 109.914 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 57' ' ' GLN . 14.9 tp -114.95 143.03 45.79 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.14 143.12 32.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.1 -1.0 . . . . 0.0 109.649 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.488 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -152.25 152.11 28.78 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 0.0 109.304 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.488 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.2 Cg_endo -71.19 2.53 4.25 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.613 2.209 . . . . 0.0 112.019 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 41.1 m-85 -63.34 169.23 3.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.047 -1.033 . . . . 0.0 109.301 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -113.71 23.26 13.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.519 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.887 ' OH ' HD21 ' A' ' 84' ' ' LEU . 16.3 p90 -147.86 -166.81 2.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 109.528 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.625 HG23 HG12 ' A' ' 32' ' ' VAL . 4.9 mt -114.95 151.67 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.94 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.908 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.1 mt -119.14 124.97 48.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 108.949 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.908 HD13 ' C ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -107.45 138.38 43.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.968 . . . . 0.0 109.647 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.769 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -100.76 159.3 29.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 109.518 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 47.6 Cg_endo -69.41 -24.24 31.48 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.71 2.274 . . . . 0.0 111.505 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.9 m -74.27 -34.07 63.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.334 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.92 ' OD1' HG13 ' A' ' 90' ' ' VAL . 1.7 p30 -80.16 -38.34 31.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 0.0 109.263 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.92 HG13 ' OD1' ' A' ' 89' ' ' ASP . 2.3 m -108.18 69.64 0.33 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.584 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.563 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 52.8 Cg_endo -70.72 -25.85 23.72 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.798 2.332 . . . . 0.0 112.045 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.847 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.9 p90 -71.26 -37.65 71.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.955 . . . . 0.0 109.497 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.558 HD23 ' CD1' ' A' ' 23' ' ' TRP . 29.8 tp -51.47 -38.62 54.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 95.4 mmm -59.01 -32.99 70.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.936 . . . . 0.0 109.589 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -62.22 140.95 58.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.497 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.84 79.32 49.59 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.69 -19.35 36.55 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.74 2.293 . . . . 0.0 111.682 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.3 tp . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.88 . . . . 0.0 109.454 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 49.6 Cg_endo . . . . . 0 C--O 1.215 -0.645 0 CA-C-O 121.248 0.437 . . . . 0.0 111.708 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 10' ' ' LEU . 4.1 mp -88.8 167.46 13.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.261 -0.9 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -104.35 139.6 39.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.27 152.81 33.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 17' ' ' THR . 59.8 tt0 -123.8 120.38 32.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.456 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.668 HG22 ' HG3' ' A' ' 15' ' ' LYS . 29.8 mt -111.69 128.47 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.668 ' HG3' HG22 ' A' ' 14' ' ' ILE . 48.3 mttm 50.77 29.58 4.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.564 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.416 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.36 -12.08 67.78 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 28.7 m -80.59 129.95 34.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -1.1 . . . . 0.0 109.455 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.734 ' O ' HD23 ' A' ' 19' ' ' LEU . 62.4 tttm -96.61 125.38 41.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.609 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.734 HD23 ' O ' ' A' ' 18' ' ' LYS . 37.9 mt -147.19 169.85 18.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.284 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 9' ' ' PRO . 44.1 mttt -87.28 153.93 21.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.9 . . . . 0.0 109.487 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.872 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -136.36 168.84 18.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.323 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.793 ' O ' HD22 ' A' ' 85' ' ' LEU . 70.3 m-70 -131.06 131.37 44.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.615 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.463 ' HE1' HG23 ' A' ' 90' ' ' VAL . 53.1 t90 -86.25 126.95 34.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.368 -0.833 . . . . 0.0 109.336 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 23' ' ' TRP . 97.1 m-20 -137.67 103.9 5.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.46 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 22.9 t -59.56 -29.23 67.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.51 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.32 -27.36 65.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.48 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -84.05 131.2 34.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -1.144 . . . . 0.0 109.576 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.8 p -96.66 -11.62 24.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 109.487 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.563 HD13 HD11 ' A' ' 76' ' ' LEU . 10.1 tt -134.23 145.51 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.89 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.645 ' HB ' HG12 ' A' ' 75' ' ' VAL . 86.6 m -63.55 140.97 58.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.442 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.682 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -121.47 128.43 52.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.915 HG13 ' HB ' ' A' ' 75' ' ' VAL . 4.2 m -127.77 163.34 43.82 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.408 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.7 Cg_endo -79.1 138.97 14.75 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.519 2.146 . . . . 0.0 111.943 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.864 ' HG2' ' HB1' ' A' ' 77' ' ' ALA . 74.7 mt-10 -46.88 -24.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.463 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.48 -24.54 3.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.492 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.51 ' C ' HD22 ' A' ' 37' ' ' LEU . 22.8 m-85 -97.85 -8.92 27.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 109.629 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.993 HD11 HD11 ' A' ' 62' ' ' LEU . 2.7 mm? . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 0.0 109.694 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.597 ' CD2' HD12 ' A' ' 37' ' ' LEU . 8.1 m-85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.32 0.581 . . . . 0.0 110.002 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.514 ' CE1' ' HB3' ' A' ' 72' ' ' GLU . 47.0 t80 -95.88 108.98 21.4 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.993 HD11 HD11 ' A' ' 37' ' ' LEU . 50.5 mt -120.6 168.35 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.054 -1.029 . . . . 0.0 110.517 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.724 HG23 ' HG2' ' A' ' 72' ' ' GLU . 88.9 m -118.05 125.94 51.31 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.626 ' CE2' HG22 ' A' ' 66' ' ' VAL . 37.5 p90 -145.16 155.2 43.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 0.0 109.685 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 31.7 mttt -89.03 129.18 35.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.718 HG11 ' CG1' ' A' ' 90' ' ' VAL . 2.0 t -103.33 97.78 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 76.5 mt-30 65.02 41.11 4.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.214 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.22 32.88 41.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.405 ' O ' HG23 ' A' ' 71' ' ' VAL . 89.4 mtt180 -137.63 108.63 6.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -1.146 . . . . 0.0 109.34 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -58.12 122.51 13.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.516 HG21 ' CH2' ' A' ' 92' ' ' TRP . 93.6 t -147.7 134.22 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.285 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.724 ' HG2' HG23 ' A' ' 63' ' ' THR . 88.5 mt-10 -110.61 140.46 44.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.667 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.15 162.84 34.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.351 -0.843 . . . . 0.0 109.569 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 96.7 mt-10 -80.9 136.28 36.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.846 . . . . 0.0 109.175 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.915 ' HB ' HG13 ' A' ' 32' ' ' VAL . 12.4 m -129.54 150.91 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.225 -0.922 . . . . 0.0 109.683 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.761 ' N ' HD12 ' A' ' 76' ' ' LEU . 5.4 mp -100.41 150.17 22.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.277 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.864 ' HB1' ' HG2' ' A' ' 34' ' ' GLU . . . -80.04 135.6 36.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.484 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 2.8 t -142.9 150.19 52.29 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.484 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.0 Cg_endo -70.78 2.27 4.27 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.664 2.243 . . . . 0.0 112.088 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.41 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 67.1 m-85 -66.04 171.17 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.568 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -110.98 20.45 17.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.788 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.827 ' OH ' HD21 ' A' ' 84' ' ' LEU . 12.3 p90 -145.46 -159.91 1.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 109.441 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.703 HG23 HG12 ' A' ' 32' ' ' VAL . 4.3 mt -125.16 154.44 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.62 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.879 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.8 mt -120.03 126.48 50.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.263 -0.898 . . . . 0.0 109.063 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.879 HD13 ' C ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -105.61 142.02 36.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.536 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.723 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -102.26 161.82 22.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.366 -0.834 . . . . 0.0 109.431 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 51.9 Cg_endo -71.64 -21.6 25.27 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.618 2.212 . . . . 0.0 111.677 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.2 m -77.81 -34.1 52.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 0.0 109.403 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.951 ' OD1' HG13 ' A' ' 90' ' ' VAL . 1.6 p30 -80.02 -40.67 27.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.457 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.951 HG13 ' OD1' ' A' ' 89' ' ' ASP . 2.6 m -109.31 70.0 0.44 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.58 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.6 Cg_endo -70.53 -22.18 28.91 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.659 2.239 . . . . 0.0 111.843 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.803 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 47.5 p90 -77.27 -31.71 55.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 93' ' ' LEU . 10.0 tt . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.561 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.6 Cg_endo . . . . . 0 C--O 1.215 -0.642 0 CA-C-O 121.129 0.387 . . . . 0.0 111.766 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.433 ' H ' HD12 ' A' ' 10' ' ' LEU . 4.3 mp -80.51 168.29 19.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 109.336 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -102.03 145.77 28.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.81 152.98 36.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.257 -0.902 . . . . 0.0 109.471 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 65' ' ' LYS . 82.0 tt0 -126.72 119.73 27.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.825 HG22 ' HG3' ' A' ' 15' ' ' LYS . 50.2 mt -115.93 129.61 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 109.374 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.825 ' HG3' HG22 ' A' ' 14' ' ' ILE . 82.8 mttt 58.35 24.03 11.18 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 109.572 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.44 -0.85 85.62 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.0 m -98.83 128.21 44.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -1.223 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.671 ' O ' HD12 ' A' ' 19' ' ' LEU . 34.1 mttp -83.78 138.89 33.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 109.443 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.692 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -150.01 167.21 27.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.555 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -83.53 155.0 23.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.516 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.045 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -147.88 167.14 25.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 109.379 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.561 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 67.1 m-70 -132.45 131.89 42.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.649 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 1.064 ' CZ2' HD11 ' A' ' 93' ' ' LEU . 71.6 t90 -84.7 128.15 34.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.327 -0.858 . . . . 0.0 109.386 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -138.33 104.97 5.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 109.526 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.56 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 6.5 p -60.45 -26.91 67.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.951 . . . . 0.0 109.438 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.05 -28.13 73.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.487 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -85.44 122.15 29.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -1.14 . . . . 0.0 109.232 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.1 p -91.89 -12.76 32.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.39 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.442 HG21 ' CD1' ' A' ' 76' ' ' LEU . 11.1 tp -127.04 142.33 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -0.936 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.718 ' HB ' HG12 ' A' ' 75' ' ' VAL . 44.4 m -63.39 139.56 58.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.893 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -120.78 123.23 42.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.21 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.983 HG12 HG23 ' A' ' 83' ' ' ILE . 17.3 m -121.83 162.87 34.59 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 109.727 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.7 Cg_endo -79.35 133.16 10.58 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.593 2.196 . . . . 0.0 111.554 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -46.72 -24.88 0.63 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.422 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.58 -32.95 53.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.646 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.692 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 5.3 m-85 -93.55 -3.95 51.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 109.67 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.691 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.176 -0.952 . . . . 0.0 109.737 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.691 ' CD2' HD23 ' A' ' 37' ' ' LEU . 38.3 m-85 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.235 0.541 . . . . 0.0 109.838 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.53 ' O ' HD23 ' A' ' 62' ' ' LEU . 36.2 t80 -94.74 111.8 23.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 108.874 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 61' ' ' TYR . 43.9 mt -121.3 167.09 13.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 110.122 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.723 HG23 ' HG2' ' A' ' 72' ' ' GLU . 52.2 m -124.01 113.99 19.16 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.508 ' CE2' HG22 ' A' ' 66' ' ' VAL . 12.7 p90 -134.29 159.27 41.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.815 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 74.5 mttt -90.84 123.74 34.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.307 -0.871 . . . . 0.0 109.291 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.73 HG11 HG11 ' A' ' 90' ' ' VAL . 51.9 t -100.85 106.52 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.762 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 98.0 mt-30 62.3 36.54 14.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.313 -0.867 . . . . 0.0 109.484 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.69 26.25 54.4 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.556 ' O ' HG23 ' A' ' 71' ' ' VAL . 55.0 mtt180 -131.35 115.06 15.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.248 -1.148 . . . . 0.0 109.277 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.53 120.31 9.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 69' ' ' ARG . 36.4 t -141.2 133.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.723 ' HG2' HG23 ' A' ' 63' ' ' THR . 45.6 mt-10 -113.94 136.38 52.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.602 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.36 166.42 29.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.831 . . . . 0.0 109.631 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 98.1 mt-10 -80.87 133.69 35.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.718 HG12 ' HB ' ' A' ' 30' ' ' THR . 3.4 m -127.21 161.9 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.536 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.442 ' CD1' HG21 ' A' ' 29' ' ' ILE . 5.0 mt -116.25 151.52 35.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.362 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.0 134.56 36.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.339 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.479 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.5 t -140.08 150.84 63.36 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.361 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.479 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.4 Cg_endo -70.55 -0.18 7.17 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.652 2.234 . . . . 0.0 111.78 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -64.95 168.52 6.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.493 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -110.99 22.35 15.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.612 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.563 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 15.3 p90 -144.04 -160.78 1.16 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 109.281 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.983 HG23 HG12 ' A' ' 32' ' ' VAL . 5.0 mt -126.64 143.56 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 109.737 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.893 HD13 ' HB3' ' A' ' 31' ' ' CYS . 6.4 mp -107.57 123.15 48.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.814 . . . . 0.0 109.066 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.045 HD21 ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -102.13 137.48 40.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.548 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.786 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -99.63 160.16 28.1 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.86 . . . . 0.0 109.687 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 51.7 Cg_endo -71.21 -27.92 19.28 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.735 2.29 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.0 m -69.19 -38.9 78.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.1 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.98 ' OD1' HG13 ' A' ' 90' ' ' VAL . 1.7 p30 -74.43 -40.15 62.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.87 . . . . 0.0 108.993 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.98 HG13 ' OD1' ' A' ' 89' ' ' ASP . 3.4 m -111.79 79.99 2.77 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.579 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 48.7 Cg_endo -69.18 -31.39 23.19 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.69 2.26 . . . . 0.0 112.085 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.877 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 30.6 p90 -63.89 -21.58 66.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.096 -1.003 . . . . 0.0 109.419 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.064 HD11 ' CZ2' ' A' ' 23' ' ' TRP . 2.2 mm? . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 109.606 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.536 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 48.9 Cg_endo . . . . . 0 C--O 1.215 -0.652 0 CA-C-O 121.213 0.422 . . . . 0.0 111.804 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.536 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 18.3 mt -99.49 178.64 4.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.131 -0.981 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.68 139.85 42.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.354 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.86 149.66 31.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 109.707 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 18' ' ' LYS . 96.2 mt-10 -123.74 116.1 22.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.27 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.843 HG22 ' HG3' ' A' ' 15' ' ' LYS . 49.9 mt -108.95 129.53 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.843 ' HG3' HG22 ' A' ' 14' ' ' ILE . 85.6 mttt 54.91 24.47 5.86 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.253 -0.904 . . . . 0.0 109.62 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.29 -2.61 83.55 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.5 m -89.88 117.37 28.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -1.202 . . . . 0.0 109.491 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.644 ' O ' HD23 ' A' ' 19' ' ' LEU . 84.2 tttt -81.8 125.75 31.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 18' ' ' LYS . 92.5 mt -145.77 161.77 39.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.28 148.6 30.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.785 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -129.92 173.14 10.98 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.172 -0.955 . . . . 0.0 109.532 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.807 ' O ' HD22 ' A' ' 85' ' ' LEU . 41.0 m-70 -127.24 127.99 45.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 0.0 109.657 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.574 ' CH2' ' HB3' ' A' ' 25' ' ' SER . 60.8 t90 -91.94 128.12 37.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.581 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.636 ' CB ' HD21 ' A' ' 84' ' ' LEU . 61.1 t0 -137.82 104.36 5.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.574 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 59.6 p -56.64 -28.0 59.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.895 . . . . 0.0 109.514 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.07 -29.67 74.84 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.77 142.2 58.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -1.176 . . . . 0.0 109.506 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.494 ' O ' HG22 ' A' ' 28' ' ' THR . 86.7 m -108.61 -5.24 16.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.512 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 18.4 tt -152.0 144.54 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.942 ' HB ' HG12 ' A' ' 75' ' ' VAL . 44.8 m -53.94 150.64 7.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.679 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.36 129.59 52.27 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.269 -0.894 . . . . 0.0 109.116 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.764 HG13 ' HD2' ' A' ' 33' ' ' PRO . 77.3 t -134.57 145.83 56.67 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.297 -0.877 . . . . 0.0 109.455 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.764 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.3 Cg_endo -77.95 133.55 12.55 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.291 1.994 . . . . 0.0 111.651 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 40.7 tp10 -42.06 -27.4 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.44 -0.788 . . . . 0.0 109.792 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -47.81 -39.15 17.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.645 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.517 ' CZ ' ' CD1' ' A' ' 19' ' ' LEU . 32.7 m-85 -92.12 -5.48 52.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 109.847 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.7 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.93 . . . . 0.0 109.857 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.7 ' CD2' HD23 ' A' ' 37' ' ' LEU . 34.6 m-85 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.323 0.582 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.47 ' O ' HD23 ' A' ' 62' ' ' LEU . 42.9 t80 -94.47 107.74 19.7 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 61' ' ' TYR . 39.3 mt -118.1 171.29 8.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -0.99 . . . . 0.0 110.334 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.717 HG23 ' HG2' ' A' ' 72' ' ' GLU . 82.8 m -125.93 119.02 26.66 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.575 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 4.1 p90 -140.6 157.73 45.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.791 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 13' ' ' GLU . 20.3 mttm -87.36 132.02 34.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.835 . . . . 0.0 109.383 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.634 HG11 HG11 ' A' ' 90' ' ' VAL . 98.8 t -112.1 107.08 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 83.4 mt-30 63.37 35.46 12.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 109.4 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.74 33.81 32.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -141.24 115.09 9.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -1.116 . . . . 0.0 109.411 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -61.68 123.11 17.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.535 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.654 HG21 ' CH2' ' A' ' 92' ' ' TRP . 92.0 t -144.41 132.58 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.462 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.717 ' HG2' HG23 ' A' ' 63' ' ' THR . 50.4 mt-10 -109.02 138.01 46.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.622 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HB1' ' OD2' ' A' ' 89' ' ' ASP . . . -160.27 165.76 30.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.668 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 96.1 mt-10 -81.42 129.87 34.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.942 HG12 ' HB ' ' A' ' 30' ' ' THR . 3.2 m -124.92 160.88 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.119 -0.988 . . . . 0.0 109.61 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.428 ' CD1' HG21 ' A' ' 29' ' ' ILE . 29.0 mt -109.35 145.11 36.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.95 134.76 36.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.438 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.491 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 3.5 t -142.25 149.64 52.43 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.395 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.474 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.7 Cg_endo -70.16 0.26 6.21 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.635 2.223 . . . . 0.0 111.873 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.491 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 66.6 m-85 -65.82 177.52 1.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.333 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -119.85 22.27 11.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.414 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.951 ' OH ' HD12 ' A' ' 84' ' ' LEU . 15.1 p90 -135.78 -173.72 3.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.863 . . . . 0.0 109.183 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.558 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 1.4 mt -131.54 112.33 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.951 HD12 ' OH ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -79.56 135.25 36.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.208 -0.933 . . . . 0.0 109.176 179.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.807 HD22 ' O ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -98.65 134.62 41.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.669 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.745 ' O ' HG22 ' A' ' 90' ' ' VAL . 29.8 t30 -86.21 140.77 34.58 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.441 -0.787 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HD2' ' OD1' ' A' ' 86' ' ' ASN . 46.5 Cg_endo -67.91 -34.54 23.35 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.69 2.26 . . . . 0.0 111.756 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.7 m -66.37 -36.05 81.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.182 -0.949 . . . . 0.0 109.283 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.583 ' OD2' ' HB1' ' A' ' 73' ' ' ALA . 91.8 m-20 -72.42 -32.1 66.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.493 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.184 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -113.93 72.85 2.22 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.546 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.4 Cg_endo -71.04 -21.98 26.87 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.667 2.245 . . . . 0.0 112.0 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.184 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 47.0 p90 -74.72 -30.43 61.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.462 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 66.9 mt . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.57 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.1 Cg_endo . . . . . 0 C--O 1.216 -0.621 0 CA-C-O 121.271 0.446 . . . . 0.0 111.811 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.476 ' H ' HD12 ' A' ' 10' ' ' LEU . 4.5 mp -81.27 166.47 20.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.46 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -104.65 144.37 31.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.503 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.2 152.78 30.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 109.463 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.451 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 78.3 tt0 -123.14 120.34 32.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.321 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.86 HG22 ' HG2' ' A' ' 15' ' ' LYS . 57.7 mt -114.92 128.03 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.86 ' HG2' HG22 ' A' ' 14' ' ' ILE . 31.7 mmtp 59.43 23.26 11.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.451 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 86.54 10.51 73.32 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.502 HG22 HD23 ' A' ' 19' ' ' LEU . 33.8 m -108.52 125.8 52.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -1.13 . . . . 0.0 109.451 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 1.031 ' O ' HD22 ' A' ' 19' ' ' LEU . 28.7 mttm -80.28 125.32 29.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.453 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.031 HD22 ' O ' ' A' ' 18' ' ' LYS . 1.3 mm? -141.06 158.26 44.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -80.23 155.44 27.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 109.402 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.538 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -146.73 164.29 33.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.563 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.695 ' O ' HD22 ' A' ' 85' ' ' LEU . 73.4 m-70 -124.9 133.19 53.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.616 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 20.0 t90 -83.95 126.25 32.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -132.91 97.71 4.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.311 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.523 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 52.1 p -58.53 -26.83 63.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.578 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.05 -31.31 76.19 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -77.78 138.32 38.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.173 . . . . 0.0 109.693 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.8 p -98.64 -4.71 33.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.592 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.961 HD13 HD11 ' A' ' 76' ' ' LEU . 21.1 tt -142.65 156.64 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.0 109.327 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.79 ' HB ' HG12 ' A' ' 75' ' ' VAL . 33.5 m -71.71 140.48 49.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.952 . . . . 0.0 109.63 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.545 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -124.31 122.08 36.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.423 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.579 HG13 ' HB ' ' A' ' 75' ' ' VAL . 3.4 m -119.62 164.61 20.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.922 . . . . 0.0 109.368 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.2 Cg_endo -79.04 137.85 14.02 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.475 2.117 . . . . 0.0 111.65 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -47.57 -23.59 0.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 0.0 109.592 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.03 -36.66 18.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.55 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.409 ' CE1' ' HB ' ' A' ' 14' ' ' ILE . 31.1 m-85 -89.61 -10.52 45.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.581 ' CD2' ' CG ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.581 ' CG ' ' CD2' ' A' ' 37' ' ' LEU . 9.1 m-85 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.374 0.607 . . . . 0.0 109.968 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.533 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 48.1 t80 -100.02 112.96 25.24 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 61' ' ' TYR . 57.6 mt -123.19 170.5 10.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 110.417 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.692 HG23 ' HG2' ' A' ' 72' ' ' GLU . 89.4 m -118.84 126.68 52.39 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.751 ' CE2' HG22 ' A' ' 66' ' ' VAL . 35.7 p90 -142.99 154.78 44.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.093 -1.004 . . . . 0.0 109.748 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -88.07 128.4 35.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 109.383 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.751 HG22 ' CE2' ' A' ' 64' ' ' PHE . 2.2 t -105.78 103.78 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 90.0 mt-30 62.01 31.57 17.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.926 . . . . 0.0 109.285 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.99 28.66 25.21 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -132.91 126.53 32.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -1.172 . . . . 0.0 109.508 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -68.28 123.52 20.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.563 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.4 t -145.29 129.05 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.448 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.692 ' HG2' HG23 ' A' ' 63' ' ' THR . 67.2 mt-10 -112.45 135.17 53.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.04 166.07 30.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.739 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 91.9 mt-10 -80.24 133.26 35.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.283 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.79 HG12 ' HB ' ' A' ' 30' ' ' THR . 3.8 m -129.04 159.47 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.961 HD11 HD13 ' A' ' 29' ' ' ILE . 4.1 mp -110.83 151.28 28.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -0.885 . . . . 0.0 109.406 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.01 142.08 35.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.416 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.476 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 8.3 t -145.05 148.63 39.21 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 109.361 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.476 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.1 Cg_endo -70.34 0.24 6.37 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.649 2.233 . . . . 0.0 111.873 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -63.63 171.88 2.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 109.458 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -111.74 17.59 19.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.59 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.732 ' OH ' HD21 ' A' ' 84' ' ' LEU . 21.6 p90 -141.03 -156.17 0.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.136 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.6 mt -130.46 147.04 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.019 -1.051 . . . . 0.0 109.988 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.732 HD21 ' OH ' ' A' ' 82' ' ' TYR . 1.1 mt -108.99 130.39 55.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 108.98 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.777 ' H ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -99.73 144.29 28.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 109.853 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.587 ' O ' HG22 ' A' ' 90' ' ' VAL . 4.2 t30 -97.02 136.91 21.32 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.453 -0.78 . . . . 0.0 109.034 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.566 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.1 Cg_endo -63.88 -33.56 63.65 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.85 2.367 . . . . 0.0 112.028 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.407 ' HB2' HD21 ' A' ' 86' ' ' ASN . 6.2 m -75.47 -29.43 59.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.302 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 90.4 m-20 -73.35 -31.13 63.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.273 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.75 HG11 HG11 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -121.49 77.54 36.07 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.888 . . . . 0.0 109.363 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.82 -23.83 30.1 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.802 2.335 . . . . 0.0 111.874 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.686 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 32.8 p90 -80.91 -22.42 39.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.418 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.616 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 25.0 tp . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.403 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.567 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 47.9 Cg_endo . . . . . 0 C--O 1.215 -0.634 0 CA-C-O 121.194 0.414 . . . . 0.0 111.763 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.731 ' CD1' HD11 ' A' ' 93' ' ' LEU . 26.4 mt -80.91 -177.58 6.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.486 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -118.02 139.9 50.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.368 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.75 154.01 38.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 17' ' ' THR . 87.1 tt0 -128.5 120.47 26.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.944 . . . . 0.0 109.357 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 1.01 HG22 ' HG3' ' A' ' 15' ' ' LYS . 59.2 mt -115.63 127.83 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.393 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 1.01 ' HG3' HG22 ' A' ' 14' ' ' ILE . 45.6 mttt 60.77 23.76 13.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 109.449 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.427 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.29 -5.22 84.29 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.685 HG22 ' CD2' ' A' ' 19' ' ' LEU . 35.4 m -93.14 127.59 38.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -1.158 . . . . 0.0 109.459 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.871 ' O ' HD22 ' A' ' 19' ' ' LEU . 18.2 tttm -87.24 120.45 28.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.568 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 18' ' ' LYS . 3.5 mm? -129.59 164.6 23.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 109.313 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -83.0 155.96 23.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.938 . . . . 0.0 109.395 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.792 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -144.85 163.24 34.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 73.6 m-70 -125.92 127.8 46.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.527 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.723 ' CD1' HD13 ' A' ' 93' ' ' LEU . 51.9 t90 -78.67 118.5 20.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.907 . . . . 0.0 109.507 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -128.2 102.93 6.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.953 . . . . 0.0 109.336 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.584 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 60.6 p -60.8 -29.2 69.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.609 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.98 -34.36 78.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.08 136.74 54.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.491 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.448 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 36.9 m -95.51 -14.73 23.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 tt -142.36 155.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.564 ' HB ' HG12 ' A' ' 75' ' ' VAL . 47.5 m -61.1 136.93 58.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -119.22 126.6 51.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.382 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.911 HG12 HG23 ' A' ' 83' ' ' ILE . 15.7 m -124.96 161.37 49.55 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 109.66 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 78' ' ' SER . 54.8 Cg_endo -79.38 132.05 9.92 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.751 2.301 . . . . 0.0 111.834 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.1 tt0 -45.36 -26.81 0.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.63 -36.1 33.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.509 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.07 -2.56 57.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.692 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 0.0 109.916 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.692 ' CD2' HD23 ' A' ' 37' ' ' LEU . 17.5 m-85 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.303 0.573 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 48.6 t80 -95.86 112.0 23.84 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.504 HD12 HG21 ' A' ' 75' ' ' VAL . 37.6 mt -121.79 170.22 9.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.052 -1.03 . . . . 0.0 110.489 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.717 HG23 ' HG2' ' A' ' 72' ' ' GLU . 87.1 m -121.97 119.77 32.47 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.763 ' CE2' HG22 ' A' ' 66' ' ' VAL . 44.6 p90 -140.68 154.46 46.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.026 -1.046 . . . . 0.0 109.739 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.431 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 20.1 mttm -85.87 132.33 34.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.833 . . . . 0.0 109.318 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.763 HG22 ' CE2' ' A' ' 64' ' ' PHE . 1.9 t -109.0 100.86 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.703 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 81.2 mt-30 65.09 35.45 7.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.458 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.33 35.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -134.08 116.73 15.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -1.072 . . . . 0.0 109.424 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.555 ' HE3' HG21 ' A' ' 63' ' ' THR . 15.3 tttp -66.8 119.7 12.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.534 HG21 ' CH2' ' A' ' 92' ' ' TRP . 98.6 t -141.24 134.39 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.867 . . . . 0.0 109.429 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.717 ' HG2' HG23 ' A' ' 63' ' ' THR . 61.1 mt-10 -110.5 136.13 50.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 109.593 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.26 166.34 29.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.672 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 96.3 mt-10 -80.02 136.24 36.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.27 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.718 HG21 HG21 ' A' ' 32' ' ' VAL . 4.1 m -127.96 158.19 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.22 -0.925 . . . . 0.0 109.65 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.4 tp -109.32 146.09 34.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.8 124.5 28.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 109.227 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.483 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 2.0 t -128.09 150.21 73.18 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.483 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.8 Cg_endo -70.58 -0.3 7.39 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.683 2.255 . . . . 0.0 111.628 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 56.0 m-85 -64.13 172.14 2.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 109.444 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -112.14 17.09 19.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.607 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.68 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 19.3 p90 -139.35 -156.82 0.71 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.245 -0.909 . . . . 0.0 109.087 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.911 HG23 HG12 ' A' ' 32' ' ' VAL . 3.0 mt -130.04 140.9 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.72 ' N ' HD12 ' A' ' 84' ' ' LEU . 6.5 mp -105.5 131.77 52.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 108.987 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.792 HD21 ' HB1' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -98.94 146.55 25.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.139 -0.976 . . . . 0.0 109.666 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.676 ' O ' HG22 ' A' ' 90' ' ' VAL . 4.7 t30 -99.74 136.86 20.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 109.189 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.524 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.6 Cg_endo -64.13 -33.26 61.93 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.805 2.336 . . . . 0.0 111.81 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.408 ' HB3' HD21 ' A' ' 86' ' ' ASN . 4.8 t -76.56 -25.95 54.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.18 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.432 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 89.6 m-20 -80.26 -32.69 38.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.376 -0.827 . . . . 0.0 109.306 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.964 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -120.03 76.23 22.45 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.872 . . . . 0.0 109.54 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.27 -24.85 26.87 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.682 2.255 . . . . 0.0 111.796 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.964 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 39.8 p90 -75.27 -27.59 59.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -0.89 . . . . 0.0 109.585 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.731 HD11 ' CD1' ' A' ' 10' ' ' LEU . 9.4 tt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.566 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 48.9 Cg_endo . . . . . 0 C--O 1.215 -0.646 0 CA-C-O 121.239 0.433 . . . . 0.0 111.793 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.494 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 20.9 mt -83.79 -177.36 6.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.92 . . . . 0.0 109.559 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -117.93 136.97 53.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 109.389 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.98 150.13 32.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.207 -0.933 . . . . 0.0 109.653 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.445 ' HG2' ' HA ' ' A' ' 18' ' ' LYS . 95.5 mt-10 -118.58 123.04 44.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.28 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' A' ' 64' ' ' PHE . 56.2 mt -117.37 124.11 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.582 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.7 tptt 64.11 22.13 12.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.524 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.13 -1.03 82.39 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.734 HG22 ' CD2' ' A' ' 19' ' ' LEU . 10.6 m -96.16 129.66 43.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.136 . . . . 0.0 109.384 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.88 ' O ' HD22 ' A' ' 19' ' ' LEU . 71.4 tttt -86.9 117.02 25.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.44 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.88 HD22 ' O ' ' A' ' 18' ' ' LYS . 3.8 mm? -132.17 161.37 33.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.386 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -84.45 153.57 23.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.419 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.789 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -141.58 163.01 34.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 109.56 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.566 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 74.2 m-70 -121.01 127.72 52.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 109.627 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.494 ' HB2' ' CD1' ' A' ' 10' ' ' LEU . 34.1 t90 -80.39 118.89 22.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.587 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -127.67 102.97 7.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.265 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' A' ' 87' ' ' PRO . 23.4 t -59.12 -29.43 67.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 109.625 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.51 -40.16 94.06 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.434 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -65.19 128.27 35.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -1.151 . . . . 0.0 109.487 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.509 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 45.6 p -94.09 -8.07 40.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.217 -0.927 . . . . 0.0 109.447 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 29' ' ' ILE . 11.1 tp -139.09 151.23 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.245 -0.909 . . . . 0.0 109.293 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 34.7 m -68.59 140.06 55.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 9.2 t -129.51 139.24 51.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.256 -0.903 . . . . 0.0 109.14 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.546 ' HB ' ' HD2' ' A' ' 33' ' ' PRO . 4.0 m -136.85 167.05 22.85 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.225 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.546 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.5 Cg_endo -78.93 134.32 11.77 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.202 1.935 . . . . 0.0 111.704 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -45.05 -24.58 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.363 -0.836 . . . . 0.0 109.874 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -47.71 -36.18 10.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 109.723 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -92.38 -7.41 47.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.182 -0.949 . . . . 0.0 109.588 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.58 ' HG ' ' CD2' ' A' ' 60' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 109.527 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.58 ' CD2' ' HG ' ' A' ' 37' ' ' LEU . 26.6 m-85 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.441 0.639 . . . . 0.0 110.316 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.82 ' O ' HD22 ' A' ' 62' ' ' LEU . 4.8 t80 -98.19 110.13 22.77 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.82 HD22 ' O ' ' A' ' 61' ' ' TYR . 3.6 mm? -124.03 156.35 36.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.481 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.548 HG23 ' HB2' ' A' ' 72' ' ' GLU . 5.0 m -110.97 126.09 54.4 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.443 -0.786 . . . . 0.0 108.931 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.624 ' CE2' HG22 ' A' ' 66' ' ' VAL . 28.1 p90 -141.48 153.39 44.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.107 -0.995 . . . . 0.0 109.694 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 6.0 mmtp -83.85 127.95 34.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.28 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.891 HG11 HG11 ' A' ' 90' ' ' VAL . 25.1 t -105.75 98.99 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 82.1 mt-30 64.68 36.5 8.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.51 30.01 31.3 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 65' ' ' LYS . 56.6 mtt180 -136.7 125.17 23.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -1.134 . . . . 0.0 109.449 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -67.33 128.41 36.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.473 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.437 HG21 ' CH2' ' A' ' 92' ' ' TRP . 43.3 t -150.0 128.18 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.56 ' HG2' ' CE2' ' A' ' 61' ' ' TYR . 55.2 tt0 -118.31 134.59 54.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.0 175.23 13.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.268 -0.895 . . . . 0.0 109.434 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.426 ' HG3' ' CD1' ' A' ' 61' ' ' TYR . 95.6 mt-10 -79.71 139.65 37.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 109.261 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' ' 32' ' ' VAL . 10.8 m -133.82 151.86 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.269 -0.894 . . . . 0.0 109.583 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.852 ' N ' HD12 ' A' ' 76' ' ' LEU . 4.3 mp -102.61 145.77 29.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.33 -0.856 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.0 137.94 36.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.298 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.478 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.3 t -144.02 151.17 51.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.0 Cg_endo -71.79 2.53 4.62 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.69 2.26 . . . . 0.0 111.83 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -63.55 167.11 5.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.162 -0.962 . . . . 0.0 109.338 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -109.71 17.71 20.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.762 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 14.5 p90 -139.49 -157.71 0.79 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.136 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.541 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.0 mt -128.98 145.82 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 109.575 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.762 HD11 ' CZ ' ' A' ' 82' ' ' TYR . 5.9 mp -110.76 135.0 52.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -0.882 . . . . 0.0 108.872 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.835 ' N ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -105.64 142.49 35.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.606 ' O ' HG22 ' A' ' 90' ' ' VAL . 6.5 t30 -100.13 134.86 20.56 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 108.949 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.492 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 41.5 Cg_endo -63.86 -22.85 68.88 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.769 2.313 . . . . 0.0 112.234 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.431 ' HB2' HD21 ' A' ' 86' ' ' ASN . 14.2 m -77.05 -31.62 56.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 0.0 109.298 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.914 ' OD1' HG13 ' A' ' 90' ' ' VAL . 1.9 p30 -80.37 -35.63 35.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 109.378 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.035 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 2.4 m -112.1 69.28 0.92 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.391 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.87 -21.94 32.26 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.679 2.252 . . . . 0.0 111.813 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.035 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 38.7 p90 -72.76 -28.8 62.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.431 HD13 HE22 ' A' ' 67' ' ' GLN . 24.2 tp . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.573 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.4 Cg_endo . . . . . 0 C--O 1.215 -0.669 0 CA-C-O 121.205 0.419 . . . . 0.0 111.707 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.71 HD12 HD13 ' A' ' 85' ' ' LEU . 17.2 mt -81.45 179.92 7.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.33 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -110.48 139.13 46.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.89 148.65 32.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.488 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.436 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 79.3 tt0 -129.23 116.08 18.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -0.86 . . . . 0.0 109.37 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.642 HG22 ' HG3' ' A' ' 15' ' ' LYS . 59.4 mt -111.72 127.31 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.14 -0.975 . . . . 0.0 109.592 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.642 ' HG3' HG22 ' A' ' 14' ' ' ILE . 54.4 mttp 57.88 24.76 11.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.288 -0.882 . . . . 0.0 109.599 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.436 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.52 -10.69 72.54 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.426 HG21 ' HZ ' ' A' ' 36' ' ' PHE . 50.0 m -79.72 125.51 29.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -1.105 . . . . 0.0 109.312 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.755 ' O ' HD23 ' A' ' 19' ' ' LEU . 3.3 ttmt -88.81 117.34 27.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.527 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.775 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 73.3 mt -136.54 156.52 48.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.868 . . . . 0.0 109.363 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -84.72 151.75 24.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.865 ' CB ' HD21 ' A' ' 85' ' ' LEU . . . -133.69 -179.76 5.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.936 . . . . 0.0 109.578 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 67.5 m-70 -134.24 131.16 38.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.901 . . . . 0.0 109.599 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.596 ' N ' HD12 ' A' ' 85' ' ' LEU . 64.4 t90 -88.33 119.04 28.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.264 -0.898 . . . . 0.0 109.352 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -128.21 103.02 6.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.297 -0.877 . . . . 0.0 109.427 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.511 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 21.4 t -55.83 -31.84 63.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.646 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.27 -37.51 91.96 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.467 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -68.03 144.94 54.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -1.192 . . . . 0.0 109.517 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.517 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 39.7 p -113.13 -5.6 13.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.459 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.8 tt -141.8 146.28 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 0.0 109.423 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.641 ' HB ' HG22 ' A' ' 75' ' ' VAL . 51.7 m -66.73 141.17 57.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 0.0 109.633 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -126.66 136.41 52.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.995 HG12 HG23 ' A' ' 83' ' ' ILE . 25.0 m -132.38 165.02 39.31 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.831 . . . . 0.0 108.899 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.4 Cg_endo -78.23 129.84 9.81 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.115 1.876 . . . . 0.0 111.419 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 33' ' ' PRO . 81.3 tt0 -40.87 -27.82 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.53 -0.731 . . . . 0.0 109.891 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -50.79 -28.33 9.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.538 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.775 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 15.0 m-85 -96.36 -7.76 34.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 109.528 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.64 ' CD2' ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.797 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.64 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 25.5 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.253 0.549 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.603 ' O ' HD23 ' A' ' 62' ' ' LEU . 34.5 t80 -87.14 114.12 23.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.887 . . . . 0.0 108.776 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 61' ' ' TYR . 32.4 mt -120.89 163.45 18.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.133 -0.979 . . . . 0.0 110.235 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.733 HG23 ' HG2' ' A' ' 72' ' ' GLU . 41.5 m -124.24 121.12 34.17 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.709 ' CE2' HG22 ' A' ' 66' ' ' VAL . 22.0 p90 -145.4 164.17 32.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.951 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -90.87 132.95 35.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.414 -0.804 . . . . 0.0 109.339 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.823 HG11 HG11 ' A' ' 90' ' ' VAL . 38.3 t -111.4 98.3 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.552 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 88.0 mt-30 63.35 36.28 11.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.325 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.45 35.08 18.13 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -141.98 124.59 15.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -1.1 . . . . 0.0 109.39 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -69.68 122.44 19.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.14 134.79 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.887 . . . . 0.0 109.556 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.733 ' HG2' HG23 ' A' ' 63' ' ' THR . 52.1 mt-10 -125.77 132.59 52.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.557 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.29 -176.99 5.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.82 154.03 28.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.273 -0.892 . . . . 0.0 109.091 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.786 ' CG1' HG22 ' A' ' 32' ' ' VAL . 56.0 t -144.83 157.64 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.188 -0.945 . . . . 0.0 109.748 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.468 ' N ' HG12 ' A' ' 75' ' ' VAL . 16.4 tp -117.58 144.4 45.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 109.041 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.97 137.46 36.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 109.529 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.475 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 3.2 t -142.31 150.23 54.35 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.332 -0.855 . . . . 0.0 109.471 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.475 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 52.8 Cg_endo -72.68 5.71 2.76 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.602 2.202 . . . . 0.0 111.905 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -64.73 -178.94 0.45 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -118.87 14.68 13.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.471 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.578 ' CZ ' ' HG ' ' A' ' 84' ' ' LEU . 20.5 p90 -142.28 -156.99 0.73 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 108.972 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.995 HG23 HG12 ' A' ' 32' ' ' VAL . 2.8 mt -128.84 128.28 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.25 -0.906 . . . . 0.0 109.812 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.578 ' HG ' ' CZ ' ' A' ' 82' ' ' TYR . 1.7 mt -83.86 136.91 33.93 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.2 -0.937 . . . . 0.0 108.713 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.865 HD21 ' CB ' ' A' ' 21' ' ' ALA . 5.2 mt -102.13 143.57 31.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 0.0 110.049 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.665 ' O ' HG22 ' A' ' 90' ' ' VAL . 10.3 t-20 -102.54 133.12 20.68 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.472 -0.768 . . . . 0.0 109.133 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 44.2 Cg_endo -66.05 -30.27 47.67 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.759 2.306 . . . . 0.0 111.929 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.409 ' HB2' HD21 ' A' ' 86' ' ' ASN . 14.7 m -76.21 -31.75 58.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.162 -0.961 . . . . 0.0 109.238 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -73.21 -28.3 62.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.382 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.938 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 2.2 m -124.1 77.83 59.45 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.559 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.5 Cg_endo -70.14 -20.45 33.03 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.731 2.287 . . . . 0.0 111.972 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.938 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 48.8 p90 -80.99 -27.45 35.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.812 ' O ' HD13 ' A' ' 93' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 109.391 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.546 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.9 Cg_endo . . . . . 0 C--O 1.216 -0.608 0 CA-C-O 121.233 0.431 . . . . 0.0 111.747 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.471 ' H ' HD12 ' A' ' 10' ' ' LEU . 4.5 mp -81.8 176.36 9.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.428 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -104.76 140.31 38.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.65 152.7 33.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.873 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 17' ' ' THR . 91.9 mt-10 -129.35 116.35 18.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 109.531 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.926 HG22 ' HG3' ' A' ' 15' ' ' LYS . 33.5 mt -109.88 128.76 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 109.401 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.926 ' HG3' HG22 ' A' ' 14' ' ' ILE . 2.8 mtmt 58.71 22.32 9.84 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.178 -0.951 . . . . 0.0 109.55 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.72 -0.88 83.15 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.471 HG22 HD23 ' A' ' 19' ' ' LEU . 31.2 m -93.46 132.7 37.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -1.218 . . . . 0.0 109.479 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.981 ' O ' HD22 ' A' ' 19' ' ' LEU . 25.7 tttt -83.05 121.15 26.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.51 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.981 HD22 ' O ' ' A' ' 18' ' ' LYS . 1.6 mm? -138.34 158.82 43.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.945 . . . . 0.0 109.545 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HD3' ' CG ' ' A' ' 9' ' ' PRO . 46.2 mttt -82.48 147.01 28.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.75 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -134.86 159.78 40.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.373 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.855 ' O ' HD22 ' A' ' 85' ' ' LEU . 53.1 m-70 -123.06 133.97 54.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.42 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.948 ' CD1' HD23 ' A' ' 93' ' ' LEU . 63.5 t90 -95.29 121.81 37.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.598 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.744 ' CB ' HD21 ' A' ' 84' ' ' LEU . 61.1 t0 -131.07 103.79 6.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -0.881 . . . . 0.0 109.306 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.564 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 56.1 p -56.69 -16.84 7.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.58 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.92 -35.51 58.07 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.465 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -69.6 140.79 53.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -1.152 . . . . 0.0 109.594 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.8 p -107.02 -0.89 22.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 0.0 109.495 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.858 HD13 HD11 ' A' ' 76' ' ' LEU . 20.0 tt -144.26 152.52 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.232 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.661 ' HB ' HG12 ' A' ' 75' ' ' VAL . 34.5 m -65.99 149.9 49.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.501 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 84' ' ' LEU . 13.1 t -123.06 141.66 51.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.173 -0.955 . . . . 0.0 109.121 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.771 HG23 ' HB ' ' A' ' 75' ' ' VAL . 74.3 t -143.43 145.9 33.72 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.412 -0.805 . . . . 0.0 109.308 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.738 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.4 Cg_endo -77.76 132.11 11.73 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.245 1.964 . . . . 0.0 111.447 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 33' ' ' PRO . 82.6 tt0 -41.59 -28.1 0.12 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.429 -0.794 . . . . 0.0 109.71 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -51.46 -30.21 18.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.145 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -97.63 0.39 47.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 109.712 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.642 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.013 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.642 ' CD2' HD23 ' A' ' 37' ' ' LEU . 13.8 m-85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.36 0.6 . . . . 0.0 109.99 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.556 ' O ' HD23 ' A' ' 62' ' ' LEU . 46.5 t80 -99.83 113.65 26.31 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 61' ' ' TYR . 40.2 mt -122.46 169.35 11.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.705 HG23 ' HG2' ' A' ' 72' ' ' GLU . 97.8 m -120.7 116.48 25.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.586 ' CE2' HG22 ' A' ' 66' ' ' VAL . 22.6 p90 -136.41 158.19 45.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.057 -1.027 . . . . 0.0 109.773 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 13' ' ' GLU . 40.8 mttm -89.98 129.12 36.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.322 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.796 HG11 HG11 ' A' ' 90' ' ' VAL . 11.7 t -105.99 101.88 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.917 . . . . 0.0 109.515 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 80.4 mt-30 64.32 38.98 7.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.895 . . . . 0.0 109.412 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.62 32.43 41.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.0 mtt-85 -138.33 114.51 10.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.442 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HE2' HG21 ' A' ' 63' ' ' THR . 72.6 tttt -61.49 122.75 15.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.616 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.511 HG21 ' CH2' ' A' ' 92' ' ' TRP . 58.8 t -145.32 130.13 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.224 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.705 ' HG2' HG23 ' A' ' 63' ' ' THR . 82.1 mt-10 -108.3 137.36 46.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 0.0 109.617 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.3 166.56 29.26 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.603 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.484 ' O ' ' HB ' ' A' ' 30' ' ' THR . 93.6 mt-10 -79.86 140.57 36.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.771 ' HB ' HG23 ' A' ' 32' ' ' VAL . 10.2 m -131.16 153.19 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.635 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.858 HD11 HD13 ' A' ' 29' ' ' ILE . 5.2 mp -107.48 148.42 29.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.385 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.78 140.09 37.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 109.425 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.501 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -151.56 152.86 31.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.296 -0.877 . . . . 0.0 109.239 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.501 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.0 Cg_endo -70.57 2.49 3.94 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.528 2.152 . . . . 0.0 112.034 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 34.0 m-85 -65.88 170.38 5.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 109.438 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -114.43 21.19 14.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.365 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.582 ' OH ' HD12 ' A' ' 84' ' ' LEU . 33.3 p90 -142.01 -166.5 2.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 109.143 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 19' ' ' LEU . 1.5 mt -132.02 118.62 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.923 . . . . 0.0 109.64 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.744 HD21 ' CB ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -82.61 134.45 35.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 108.987 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.855 HD22 ' O ' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -97.31 142.26 29.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.065 -1.022 . . . . 0.0 109.763 -179.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.645 ' O ' HG22 ' A' ' 90' ' ' VAL . 6.5 t-20 -90.11 135.57 29.84 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.033 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.56 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 41.5 Cg_endo -64.1 -33.14 62.71 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.805 2.337 . . . . 0.0 111.972 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.409 ' HB2' HD21 ' A' ' 86' ' ' ASN . 13.4 m -71.88 -28.02 63.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.118 -0.989 . . . . 0.0 109.107 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -79.17 -30.79 43.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 109.344 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.127 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -119.67 74.25 17.72 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.917 . . . . 0.0 109.328 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.575 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.9 Cg_endo -69.6 -18.92 37.49 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.749 2.299 . . . . 0.0 111.926 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.127 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 48.9 p90 -81.21 -26.24 36.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.479 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.948 HD23 ' CD1' ' A' ' 23' ' ' TRP . 24.1 tp . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.442 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 48.8 Cg_endo . . . . . 0 C--O 1.215 -0.627 0 CA-C-O 121.203 0.418 . . . . 0.0 111.694 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 23' ' ' TRP . 25.2 mt -90.6 -177.32 5.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.582 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -112.19 134.44 53.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.353 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.0 146.24 28.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -0.948 . . . . 0.0 109.5 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 17' ' ' THR . 65.4 tt0 -121.97 122.21 38.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.883 . . . . 0.0 109.224 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.456 HG12 ' HB3' ' A' ' 64' ' ' PHE . 43.2 mt -114.74 127.12 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.694 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 58.07 25.59 12.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.531 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.44 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 90.66 -13.69 65.0 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 52.8 m -79.78 131.85 36.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -1.21 . . . . 0.0 109.385 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.865 ' O ' HD23 ' A' ' 19' ' ' LEU . 29.7 tttm -96.4 123.9 40.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 109.62 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.865 HD23 ' O ' ' A' ' 18' ' ' LYS . 57.2 mt -143.32 162.67 35.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -89.43 146.93 24.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.928 . . . . 0.0 109.527 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.621 ' CB ' HD11 ' A' ' 85' ' ' LEU . . . -130.01 176.58 7.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.749 ' O ' HD22 ' A' ' 85' ' ' LEU . 59.5 m-70 -127.47 129.97 48.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.455 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.605 ' HB2' HD11 ' A' ' 10' ' ' LEU . 20.6 t90 -83.17 122.54 28.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.683 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -127.52 96.28 4.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.341 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.46 ' HA ' ' HG3' ' A' ' 87' ' ' PRO . 17.3 t -53.68 -33.9 56.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.645 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.62 -35.65 86.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.32 137.22 57.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -1.166 . . . . 0.0 109.631 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.518 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 89.2 m -102.07 -9.43 20.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 109.381 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.435 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 20.1 tt -139.61 160.12 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.335 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.513 ' CG2' HG12 ' A' ' 75' ' ' VAL . 38.5 m -71.51 150.19 45.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.315 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.556 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -126.83 127.17 44.57 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -0.916 . . . . 0.0 108.998 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.78 HG13 ' HD2' ' A' ' 33' ' ' PRO . 53.8 t -126.92 147.37 61.11 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 109.176 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.78 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.5 Cg_endo -77.26 132.99 12.95 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.176 1.917 . . . . 0.0 111.914 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 33' ' ' PRO . 80.5 tt0 -43.01 -26.67 0.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.741 . . . . 0.0 109.701 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.48 -23.09 1.41 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.516 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.611 ' HZ ' HD11 ' A' ' 19' ' ' LEU . 14.1 m-85 -102.44 -6.41 22.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.518 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.031 HD11 HD11 ' A' ' 62' ' ' LEU . 2.7 mm? . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.198 -0.939 . . . . 0.0 109.558 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.261 0.553 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.685 ' O ' HD23 ' A' ' 62' ' ' LEU . 41.3 t80 -91.36 119.4 31.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 108.844 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.031 HD11 HD11 ' A' ' 37' ' ' LEU . 64.4 mt -131.16 170.18 14.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.387 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.705 HG23 ' HG2' ' A' ' 72' ' ' GLU . 87.9 m -119.56 122.92 42.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.517 -0.739 . . . . 0.0 109.084 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.812 ' CE2' HG22 ' A' ' 66' ' ' VAL . 33.2 p90 -141.82 157.2 45.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 0.0 109.781 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 83.7 mttt -87.83 129.69 35.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.23 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.812 HG22 ' CE2' ' A' ' 64' ' ' PHE . 4.3 t -104.24 98.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 90.0 mt-30 62.93 35.34 13.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.898 . . . . 0.0 109.193 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.77 31.81 20.08 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.446 ' O ' HG23 ' A' ' 71' ' ' VAL . 51.6 mtt180 -136.84 111.62 8.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -1.125 . . . . 0.0 109.432 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -61.84 117.72 6.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.575 HG21 ' CH2' ' A' ' 92' ' ' TRP . 44.4 t -142.31 136.91 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 0.0 109.412 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.705 ' HG2' HG23 ' A' ' 63' ' ' THR . 64.0 mt-10 -112.61 137.93 50.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.974 . . . . 0.0 109.388 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.21 166.31 29.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.83 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 96.3 mt-10 -81.43 136.15 35.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.228 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.683 ' HB ' HG23 ' A' ' 32' ' ' VAL . 17.5 m -125.55 148.03 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.181 -0.949 . . . . 0.0 109.731 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 32' ' ' VAL . 28.1 tp -94.05 143.05 26.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.853 . . . . 0.0 109.13 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.27 133.66 36.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.556 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 21.8 t -144.4 148.84 42.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.626 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.48 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.3 Cg_endo -70.36 1.79 4.49 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.728 2.285 . . . . 0.0 112.058 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.556 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 39.6 m-85 -63.34 172.72 1.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 109.432 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -113.36 21.29 15.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 109.579 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.586 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 13.1 p90 -144.87 -161.02 1.21 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.16 -0.963 . . . . 0.0 109.356 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.453 HG13 ' C ' ' A' ' 82' ' ' TYR . 2.2 mt -132.62 149.1 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.881 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.741 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.4 mt -109.21 131.82 54.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.865 . . . . 0.0 108.757 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.807 ' H ' HD22 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -99.95 133.17 44.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.109 -0.994 . . . . 0.0 109.723 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.574 ' O ' HG22 ' A' ' 90' ' ' VAL . 6.2 t-20 -88.18 136.23 32.21 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 0.0 109.146 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.547 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 41.8 Cg_endo -64.34 -32.16 61.6 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.744 2.296 . . . . 0.0 111.881 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.439 ' HB2' HD21 ' A' ' 86' ' ' ASN . 14.2 m -72.32 -33.94 67.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 109.222 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -71.9 -34.11 68.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.313 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.781 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 33.5 m -115.84 76.56 6.07 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 109.55 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.44 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 48.6 Cg_endo -69.15 -21.63 36.04 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.698 2.265 . . . . 0.0 111.678 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.781 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 36.4 p90 -70.66 -26.32 63.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.314 -0.866 . . . . 0.0 109.469 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.441 HD23 ' CD1' ' A' ' 23' ' ' TRP . 28.6 tp . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.474 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.568 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.3 Cg_endo . . . . . 0 C--O 1.215 -0.625 0 CA-C-O 121.233 0.43 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 23' ' ' TRP . 15.3 mt -79.83 -174.63 4.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.443 ' OE2' ' HE3' ' A' ' 18' ' ' LYS . 75.9 tt0 -113.65 137.2 51.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 109.501 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.3 142.25 25.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -120.65 118.02 29.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.888 HG22 ' HG3' ' A' ' 15' ' ' LYS . 36.6 mt -109.49 129.46 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.507 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.888 ' HG3' HG22 ' A' ' 14' ' ' ILE . 72.0 mttt 54.52 24.83 5.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.9 . . . . 0.0 109.5 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.06 -10.81 72.79 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.593 HG22 HD11 ' A' ' 19' ' ' LEU . 4.3 m -80.31 126.94 31.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -1.183 . . . . 0.0 109.422 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HE3' ' OE2' ' A' ' 11' ' ' GLU . 39.1 tttt -85.93 125.16 33.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.347 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.593 HD11 HG22 ' A' ' 17' ' ' THR . 1.9 mp -146.21 156.03 43.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 109.587 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -80.16 152.13 29.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 0.0 109.507 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.702 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -136.92 169.56 17.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 85.1 m-70 -127.41 138.84 53.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 109.463 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.629 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 40.0 t90 -91.08 114.1 26.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.206 -0.934 . . . . 0.0 109.408 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -121.57 100.1 6.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 109.382 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.573 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 59.8 p -60.8 -25.66 66.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.758 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.64 -41.59 95.76 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.442 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -67.77 140.97 56.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.194 -1.18 . . . . 0.0 109.538 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.435 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 68.6 p -99.59 -10.27 22.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.893 . . . . 0.0 109.384 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.453 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 19.7 tt -139.06 159.79 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.272 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.4 m -67.53 153.26 44.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 109.671 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.578 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -131.21 116.81 18.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.072 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.785 HG13 ' HD2' ' A' ' 33' ' ' PRO . 54.0 t -114.07 147.71 38.41 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.785 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.4 Cg_endo -77.4 132.04 12.07 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.094 1.862 . . . . 0.0 111.664 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.1 tt0 -41.77 -27.67 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.467 -0.77 . . . . 0.0 109.801 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -50.56 -31.64 16.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.525 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.43 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 14.3 m-85 -98.47 -3.24 37.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.665 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.675 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.797 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.675 ' CD2' HD23 ' A' ' 37' ' ' LEU . 12.4 m-85 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.271 0.558 . . . . 0.0 109.902 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.501 ' O ' HD23 ' A' ' 62' ' ' LEU . 44.3 t80 -100.67 113.11 25.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.849 . . . . 0.0 108.771 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.666 HD12 HG21 ' A' ' 75' ' ' VAL . 44.6 mt -122.46 173.02 7.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.105 -0.997 . . . . 0.0 110.276 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.673 HG23 ' HG2' ' A' ' 72' ' ' GLU . 86.6 m -124.01 125.48 44.63 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 9.4 p90 -144.68 157.81 44.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.888 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -88.38 130.52 35.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.418 -0.801 . . . . 0.0 109.292 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.469 HG11 HG11 ' A' ' 90' ' ' VAL . 74.4 t -110.77 104.47 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 86.7 mt-30 63.13 35.17 13.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.331 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.77 31.95 34.59 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -137.54 116.53 12.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -1.139 . . . . 0.0 109.477 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -62.13 121.0 11.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.504 HG21 ' CH2' ' A' ' 92' ' ' TRP . 87.3 t -142.69 129.05 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.88 . . . . 0.0 109.498 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.673 ' HG2' HG23 ' A' ' 63' ' ' THR . 35.8 mt-10 -108.59 136.47 48.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.19 169.98 22.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 109.619 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 95.4 mt-10 -80.41 135.89 36.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.74 ' HB ' HG23 ' A' ' 32' ' ' VAL . 5.0 m -126.76 152.22 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 109.631 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 32' ' ' VAL . 20.7 tp -105.42 149.13 26.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.109 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.58 137.3 37.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 109.196 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.571 ' OG ' ' CE2' ' A' ' 80' ' ' TYR . 23.3 t -148.7 149.57 31.14 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.926 . . . . 0.0 109.669 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.488 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 54.5 Cg_endo -72.88 6.88 2.23 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.661 2.241 . . . . 0.0 111.985 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.571 ' CE2' ' OG ' ' A' ' 78' ' ' SER . 30.7 m-85 -60.52 -178.99 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.613 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -119.93 20.73 12.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.927 . . . . 0.0 109.325 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.602 ' OH ' HD21 ' A' ' 84' ' ' LEU . 13.3 p90 -153.61 -152.35 0.41 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.275 -0.89 . . . . 0.0 108.894 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.533 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 1.7 mt -132.35 125.58 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.785 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.602 HD21 ' OH ' ' A' ' 82' ' ' TYR . 1.2 mt -82.94 143.27 30.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.218 -0.926 . . . . 0.0 108.93 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.702 HD21 ' HB1' ' A' ' 21' ' ' ALA . 3.9 mt -109.73 135.3 50.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -0.978 . . . . 0.0 109.929 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.697 ' O ' HG22 ' A' ' 90' ' ' VAL . 4.4 t30 -91.16 136.65 26.99 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 109.125 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.522 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 43.5 Cg_endo -64.6 -36.96 39.75 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.781 2.32 . . . . 0.0 112.034 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.422 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 3.1 m -70.38 -32.47 70.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.121 -0.987 . . . . 0.0 109.303 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.464 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 81.8 m-20 -71.84 -29.2 64.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.352 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.155 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -118.81 74.92 12.98 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.314 -0.866 . . . . 0.0 109.531 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.59 -21.99 28.89 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.747 2.298 . . . . 0.0 111.801 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.155 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 40.8 p90 -76.28 -28.31 56.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 0.0 109.49 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.629 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 38.6 tp . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.461 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 C--O 1.216 -0.616 0 CA-C-O 121.15 0.396 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.595 HD13 HD23 ' A' ' 85' ' ' LEU . 4.3 mp -85.0 165.84 17.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.514 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -103.46 144.13 31.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 109.428 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.7 148.11 22.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 64' ' ' PHE . 78.1 tt0 -121.02 121.08 37.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.868 HG22 ' HG3' ' A' ' 15' ' ' LYS . 42.4 mt -111.93 127.71 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.868 ' HG3' HG22 ' A' ' 14' ' ' ILE . 3.6 mtmt 54.5 25.82 6.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.443 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 93.29 -15.81 62.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.886 HG22 HD11 ' A' ' 19' ' ' LEU . 2.3 m -79.85 126.07 30.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -1.181 . . . . 0.0 109.312 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.967 ' C ' HD12 ' A' ' 19' ' ' LEU . 31.4 tttt -94.26 116.9 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.0 109.63 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.967 HD12 ' C ' ' A' ' 18' ' ' LYS . 9.4 mp -135.09 166.09 23.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.306 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -80.32 155.03 27.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.449 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.888 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -141.27 163.03 34.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 109.482 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.835 ' O ' HD22 ' A' ' 85' ' ' LEU . 70.0 m-70 -125.38 136.84 53.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.749 ' CD1' HD23 ' A' ' 93' ' ' LEU . 26.2 t90 -85.58 126.67 34.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.422 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -133.58 100.63 4.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.519 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 60.4 p -62.39 -29.21 70.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.495 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.2 -33.25 64.61 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.414 ' O ' ' OD1' ' A' ' 86' ' ' ASN . . . -73.81 140.34 45.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -1.129 . . . . 0.0 109.418 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 28' ' ' THR . 87.4 m -100.36 -5.27 27.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.633 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.486 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 21.2 tt -146.67 149.3 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.507 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.849 ' CG2' HG12 ' A' ' 75' ' ' VAL . 86.4 m -52.47 150.79 4.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.634 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.622 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -128.03 136.98 51.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.193 -0.942 . . . . 0.0 109.212 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.776 HG13 ' HD2' ' A' ' 33' ' ' PRO . 56.9 t -138.61 147.43 54.75 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 109.172 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.776 ' HD2' HG13 ' A' ' 32' ' ' VAL . 54.8 Cg_endo -77.66 132.21 11.91 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.123 1.882 . . . . 0.0 111.308 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 37' ' ' LEU . 79.9 tt0 -41.87 -27.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.759 . . . . 0.0 109.833 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -48.41 -24.53 1.28 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.14 -0.975 . . . . 0.0 109.308 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.638 ' CE2' HD22 ' A' ' 19' ' ' LEU . 7.6 m-85 -97.03 -9.38 28.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.646 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.95 HD11 HD11 ' A' ' 62' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 109.628 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.711 ' CD2' HD12 ' A' ' 37' ' ' LEU . 11.1 m-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.147 0.499 . . . . 0.0 109.731 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 39.7 t80 -85.26 110.06 18.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 108.885 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.95 HD11 HD11 ' A' ' 37' ' ' LEU . 53.1 mt -125.1 171.01 10.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 110.36 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.702 HG23 ' HG2' ' A' ' 72' ' ' GLU . 89.7 m -116.08 119.35 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CE2' HG22 ' A' ' 66' ' ' VAL . 17.3 p90 -136.07 154.22 51.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.037 . . . . 0.0 109.782 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.46 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 45.3 mttm -90.69 127.04 36.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.341 -0.849 . . . . 0.0 109.411 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.735 HG11 HG11 ' A' ' 90' ' ' VAL . 18.9 t -101.5 101.55 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 109.614 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 92.9 mt-30 62.87 33.13 15.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.297 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.82 24.8 34.21 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 65' ' ' LYS . 67.3 mtt180 -126.72 120.09 28.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -1.165 . . . . 0.0 109.362 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -67.0 117.05 8.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.403 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.75 HG21 ' HH2' ' A' ' 92' ' ' TRP . 86.0 t -141.15 130.85 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.702 ' HG2' HG23 ' A' ' 63' ' ' THR . 58.4 mt-10 -111.78 135.44 52.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.589 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.41 166.27 29.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.835 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 95.4 mt-10 -80.69 136.06 36.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.372 -0.83 . . . . 0.0 109.193 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.849 HG12 ' CG2' ' A' ' 30' ' ' THR . 34.6 m -123.26 145.55 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.227 -0.921 . . . . 0.0 109.696 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 32' ' ' VAL . 89.0 mt -90.53 143.9 26.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.091 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.34 135.64 36.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.0 . . . . 0.0 109.445 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.522 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 3.8 t -143.89 150.46 49.81 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 109.519 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.49 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 52.0 Cg_endo -72.46 5.99 2.52 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.665 2.244 . . . . 0.0 112.301 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.522 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 84.4 m-85 -71.37 167.51 19.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.056 -1.028 . . . . 0.0 109.527 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -107.79 17.05 22.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.66 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.657 ' OH ' HD21 ' A' ' 84' ' ' LEU . 15.6 p90 -137.19 -163.51 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 109.52 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.441 ' O ' ' CD2' ' A' ' 82' ' ' TYR . 4.0 mt -127.44 154.92 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -0.981 . . . . 0.0 109.744 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.753 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.3 mt -117.21 132.8 56.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.011 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.888 HD11 ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -97.91 122.48 41.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.084 -1.01 . . . . 0.0 109.628 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.731 ' O ' HG22 ' A' ' 90' ' ' VAL . 26.2 t30 -79.54 142.36 57.67 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.435 -0.791 . . . . 0.0 109.098 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.562 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 47.0 Cg_endo -67.31 -23.47 44.66 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.512 2.141 . . . . 0.0 111.677 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.418 ' OG ' ' ND2' ' A' ' 86' ' ' ASN . 51.8 p -80.41 -33.85 36.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.373 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.955 ' OD1' HG13 ' A' ' 90' ' ' VAL . 2.2 p30 -74.78 -28.87 60.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.493 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.955 HG13 ' OD1' ' A' ' 89' ' ' ASP . 4.1 m -122.3 78.62 44.54 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.656 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.565 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.8 Cg_endo -71.68 -23.56 22.73 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.615 2.21 . . . . 0.0 111.822 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.775 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 47.1 p90 -77.32 -33.09 55.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.593 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.749 HD23 ' CD1' ' A' ' 23' ' ' TRP . 21.9 tp . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.511 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.6 Cg_endo . . . . . 0 C--O 1.215 -0.657 0 CA-C-O 121.186 0.411 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.606 HD11 ' HB2' ' A' ' 23' ' ' TRP . 25.2 mt -88.27 -175.11 4.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.505 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.58 141.58 50.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 109.403 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.34 149.29 26.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 51.9 tt0 -118.35 118.14 30.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.858 HG22 ' HG3' ' A' ' 15' ' ' LYS . 41.5 mt -111.11 128.7 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.858 ' HG3' HG22 ' A' ' 14' ' ' ILE . 44.3 mttm 56.71 22.85 7.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 91.63 0.87 71.9 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.496 HG22 ' CD2' ' A' ' 19' ' ' LEU . 24.8 m -102.4 122.25 43.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -1.194 . . . . 0.0 109.457 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.834 ' O ' HD22 ' A' ' 19' ' ' LEU . 26.8 tttt -82.56 123.57 29.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.834 HD22 ' O ' ' A' ' 18' ' ' LYS . 1.5 mm? -132.89 167.08 20.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -85.88 139.65 31.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.801 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -128.28 168.66 15.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.628 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.688 ' O ' HD22 ' A' ' 85' ' ' LEU . 47.6 m-70 -129.4 126.85 39.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.403 -0.811 . . . . 0.0 109.648 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.606 ' HB2' HD11 ' A' ' 10' ' ' LEU . 33.3 t90 -79.4 125.86 30.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.456 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -131.39 102.77 6.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.528 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 58.2 p -61.63 -31.68 71.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.629 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.08 -31.53 73.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.49 139.66 49.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -1.166 . . . . 0.0 109.615 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.434 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 35.0 p -106.02 -4.9 19.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.85 . . . . 0.0 109.554 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.511 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 19.7 tt -143.82 141.14 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.405 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.537 ' N ' ' HB2' ' A' ' 86' ' ' ASN . 23.4 m -54.92 137.42 45.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.731 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.715 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.9 OUTLIER -125.94 128.63 47.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.724 HG12 HG23 ' A' ' 83' ' ' ILE . 25.2 m -127.83 163.44 43.26 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.584 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.8 Cg_endo -78.91 134.1 11.65 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.57 2.18 . . . . 0.0 111.688 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 81.1 tt0 -49.03 -22.89 0.98 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.616 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.6 -40.36 52.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.41 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -86.85 -4.23 59.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.275 -0.89 . . . . 0.0 109.605 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.501 ' HA ' HD13 ' A' ' 37' ' ' LEU . 3.8 mm? . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.234 -0.916 . . . . 0.0 109.844 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 3.1 m-85 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.393 0.616 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.58 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 46.4 t80 -107.14 113.66 27.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 0.0 108.715 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.654 HD12 HG21 ' A' ' 75' ' ' VAL . 39.2 mt -116.28 162.21 17.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.115 -0.991 . . . . 0.0 110.343 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.701 HG23 ' HG2' ' A' ' 72' ' ' GLU . 20.4 m -120.12 118.24 30.04 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.479 ' HB3' HG12 ' A' ' 14' ' ' ILE . 14.3 p90 -144.07 154.98 43.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.022 -1.049 . . . . 0.0 109.937 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.471 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 47.9 mtmt -92.62 126.99 37.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.364 -0.835 . . . . 0.0 109.167 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 21.3 t -106.37 111.84 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.146 -0.971 . . . . 0.0 109.711 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.476 HE22 HD22 ' A' ' 93' ' ' LEU . 87.2 mt-30 62.98 37.22 11.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.54 25.28 63.44 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.417 ' O ' HG23 ' A' ' 71' ' ' VAL . 78.1 mtt-85 -129.59 107.5 9.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 109.511 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 79.0 tttt -58.91 125.33 23.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.679 HG21 ' CH2' ' A' ' 92' ' ' TRP . 97.7 t -146.26 133.09 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 109.231 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.701 ' HG2' HG23 ' A' ' 63' ' ' THR . 80.6 mt-10 -115.27 135.57 54.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 109.633 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.467 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . . . -160.36 173.38 15.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.389 -0.82 . . . . 0.0 109.674 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 94.4 mt-10 -79.79 143.97 33.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.85 . . . . 0.0 109.172 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.654 HG21 HG21 ' A' ' 32' ' ' VAL . 3.2 m -138.97 162.45 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.78 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.5 tp -113.23 145.73 40.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -0.827 . . . . 0.0 109.258 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.99 136.23 36.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.447 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.47 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 5.4 t -141.47 148.43 50.44 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 109.521 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.47 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 48.6 Cg_endo -69.87 -0.8 7.52 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.744 2.296 . . . . 0.0 111.774 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.521 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 31.5 m-85 -59.75 166.63 2.47 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.179 -0.951 . . . . 0.0 109.323 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -107.6 19.35 20.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.952 . . . . 0.0 109.86 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.809 ' OH ' HD21 ' A' ' 84' ' ' LEU . 25.7 p90 -142.48 -154.83 0.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.724 HG23 HG12 ' A' ' 32' ' ' VAL . 4.7 mt -130.15 144.51 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.997 -1.064 . . . . 0.0 109.777 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.809 HD21 ' OH ' ' A' ' 82' ' ' TYR . 1.3 mp -110.36 123.92 50.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.343 -0.848 . . . . 0.0 109.116 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.801 HD11 ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -95.44 134.64 38.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.786 ' O ' HG22 ' A' ' 90' ' ' VAL . 26.5 t30 -89.19 142.31 29.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.288 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.51 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 47.1 Cg_endo -67.41 -26.12 41.27 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.537 2.158 . . . . 0.0 111.79 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.2 m -78.08 -31.2 50.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.312 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.769 ' OD1' HG13 ' A' ' 90' ' ' VAL . 2.1 p30 -77.01 -32.97 57.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.162 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -110.9 73.7 0.89 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.897 . . . . 0.0 109.394 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.583 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.0 Cg_endo -70.29 -24.36 27.34 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.743 2.295 . . . . 0.0 112.016 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.162 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.4 p90 -71.43 -36.89 71.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.092 -1.005 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.497 HD12 ' CG2' ' A' ' 90' ' ' VAL . 72.6 mt . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.349 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.557 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.5 Cg_endo . . . . . 0 C--O 1.215 -0.662 0 CA-C-O 121.233 0.43 . . . . 0.0 111.824 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.761 ' CD1' HD11 ' A' ' 93' ' ' LEU . 29.0 mt -81.06 -173.44 4.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.516 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.465 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 75.1 mm-40 -117.89 137.9 52.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 109.476 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.09 146.12 30.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.541 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -123.96 116.92 23.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.325 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.56 HG22 ' HG3' ' A' ' 15' ' ' LYS . 56.0 mt -112.83 130.41 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.933 . . . . 0.0 109.674 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.56 ' HG3' HG22 ' A' ' 14' ' ' ILE . 95.9 mttt 52.22 23.47 2.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.318 -0.864 . . . . 0.0 109.621 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.31 -13.97 66.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.83 HG22 HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -80.39 114.13 19.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -1.181 . . . . 0.0 109.427 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.884 ' C ' HD12 ' A' ' 19' ' ' LEU . 69.5 tttt -87.64 118.79 27.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 109.558 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.884 HD12 ' C ' ' A' ' 18' ' ' LYS . 9.3 mp -133.64 172.98 12.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.353 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.465 ' NZ ' ' OE2' ' A' ' 11' ' ' GLU . 16.0 mmtt -91.24 147.39 23.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.375 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.622 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -133.15 174.3 10.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 109.698 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 79.7 m-70 -131.07 127.76 38.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.86 . . . . 0.0 109.379 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.813 ' CD1' HD13 ' A' ' 93' ' ' LEU . 35.5 t90 -76.39 117.4 18.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -124.58 100.72 6.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.317 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.564 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 28.5 p -62.81 -30.38 71.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.07 -39.46 80.04 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.15 140.6 58.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.141 . . . . 0.0 109.52 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.6 m -96.11 -13.0 23.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.498 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 29' ' ' ILE . 7.4 tp -143.94 162.85 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.265 -0.897 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 26.4 m -66.27 132.64 48.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.681 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 0.9 OUTLIER -119.22 126.79 52.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.382 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.805 HG13 HG13 ' A' ' 75' ' ' VAL . 3.6 m -127.91 167.21 19.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.406 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.1 Cg_endo -79.58 133.32 10.43 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.459 2.106 . . . . 0.0 111.639 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.5 tt0 -43.05 -27.23 0.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.34 -0.85 . . . . 0.0 109.571 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.3 -38.54 27.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.844 . . . . 0.0 109.576 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.601 ' HE2' HD22 ' A' ' 19' ' ' LEU . 15.5 m-85 -87.91 -7.19 57.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 109.649 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' A' ' 77' ' ' ALA . 12.0 mt . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.139 -0.976 . . . . 0.0 109.757 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 3.7 m-85 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.256 0.551 . . . . 0.0 109.619 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.628 ' O ' HD23 ' A' ' 62' ' ' LEU . 33.4 t80 -102.52 114.96 29.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.27 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.628 HD23 ' O ' ' A' ' 61' ' ' TYR . 21.0 mt -119.32 160.93 21.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 110.029 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.719 HG23 ' HG2' ' A' ' 72' ' ' GLU . 11.4 m -121.78 116.88 25.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.478 -0.763 . . . . 0.0 109.137 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 8.2 p90 -142.98 161.72 37.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 109.668 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.485 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 12.5 mtmm -96.68 129.09 44.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.295 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.452 HG11 HG11 ' A' ' 90' ' ' VAL . 60.4 t -107.09 112.64 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.557 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 90.6 mt-30 63.48 33.53 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 109.403 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.37 23.63 58.29 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -127.98 111.45 13.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.319 -1.106 . . . . 0.0 109.408 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 80.5 tttt -61.04 121.23 11.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.612 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.578 HG21 ' HH2' ' A' ' 92' ' ' TRP . 65.6 t -141.66 133.55 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 109.164 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.719 ' HG2' HG23 ' A' ' 63' ' ' THR . 53.8 mt-10 -116.28 137.25 52.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 109.837 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.59 -169.7 2.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.439 -0.788 . . . . 0.0 109.379 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 75' ' ' VAL . 98.2 mt-10 -79.96 171.36 15.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.094 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.805 HG13 HG13 ' A' ' 32' ' ' VAL . 72.9 t -159.4 151.03 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.143 -0.973 . . . . 0.0 109.808 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.9 tp -121.32 143.62 49.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.43 -0.794 . . . . 0.0 109.282 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.649 ' HB2' HD13 ' A' ' 37' ' ' LEU . . . -79.77 133.41 36.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 109.602 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 1.4 t -138.68 150.91 67.53 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.859 . . . . 0.0 109.355 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.6 Cg_endo -72.28 1.97 5.51 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.624 2.216 . . . . 0.0 111.885 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -65.14 168.0 7.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.532 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.8 p30 -108.9 14.07 24.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.233 -0.917 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.585 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 17.7 p90 -136.34 -157.8 0.82 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 109.008 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.548 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.0 mt -129.09 144.7 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.056 -1.027 . . . . 0.0 109.707 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 84' ' ' LEU . 6.2 mp -109.95 136.33 49.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.259 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.802 ' N ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -103.92 145.36 30.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.768 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.684 ' O ' HG22 ' A' ' 90' ' ' VAL . 4.9 t30 -96.87 136.59 21.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.255 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.526 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.0 Cg_endo -63.45 -31.98 71.53 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.847 2.365 . . . . 0.0 111.94 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -75.24 -30.17 60.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.227 -0.921 . . . . 0.0 109.176 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -77.49 -30.83 53.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.326 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.909 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.6 OUTLIER -122.25 75.95 42.18 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 109.468 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.21 -24.95 27.03 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.637 2.225 . . . . 0.0 111.932 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.909 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 32.7 p90 -74.19 -28.47 61.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.137 -0.977 . . . . 0.0 109.481 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.813 HD13 ' CD1' ' A' ' 23' ' ' TRP . 9.6 tt . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.485 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.569 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.3 Cg_endo . . . . . 0 C--O 1.214 -0.702 0 CA-C-O 121.287 0.453 . . . . 0.0 111.637 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.553 ' CD2' HD11 ' A' ' 93' ' ' LEU . 4.6 mp -80.23 166.35 21.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.96 . . . . 0.0 109.525 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -103.63 148.74 25.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.558 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.38 151.22 20.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 64' ' ' PHE . 65.7 tt0 -119.62 121.71 39.91 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.409 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.548 ' HB ' ' CE2' ' A' ' 36' ' ' PHE . 44.6 mt -113.54 124.21 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 60.8 mttm 61.28 20.38 10.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 109.474 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.65 -12.89 68.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.0 m -88.52 131.11 35.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -1.145 . . . . 0.0 109.446 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.999 ' O ' HD22 ' A' ' 19' ' ' LEU . 18.0 mttp -82.98 133.37 35.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.879 . . . . 0.0 109.492 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.999 HD22 ' O ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -144.64 159.82 42.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.87 . . . . 0.0 109.459 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -81.41 150.93 28.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.352 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.883 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -139.14 169.69 17.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.569 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 60.9 m-70 -130.5 136.89 49.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 109.644 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.957 ' CD1' HD13 ' A' ' 93' ' ' LEU . 64.3 t90 -95.17 118.91 32.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 109.431 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -130.17 104.24 7.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.528 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.582 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 60.4 p -56.22 -27.59 55.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.531 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.37 -36.5 93.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.424 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -64.55 143.58 57.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.458 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.511 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 59.4 m -108.36 -12.08 15.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.501 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.403 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 20.2 tt -142.64 155.35 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.495 ' HB ' HG12 ' A' ' 75' ' ' VAL . 34.4 m -71.38 136.45 47.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.608 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.539 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -120.84 131.9 54.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.423 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.904 HG12 HG23 ' A' ' 83' ' ' ILE . 15.4 m -121.72 161.17 43.33 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 82' ' ' TYR . 55.8 Cg_endo -79.27 129.57 8.73 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.583 2.189 . . . . 0.0 111.717 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.864 ' CG ' ' HB1' ' A' ' 77' ' ' ALA . 79.2 mt-10 -43.77 -26.93 0.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 109.362 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.77 -39.45 77.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.285 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.569 ' HZ ' HD23 ' A' ' 19' ' ' LEU . 1.7 m-85 -83.7 -2.15 55.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.428 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.715 ' CD1' ' HB2' ' A' ' 77' ' ' ALA . 7.2 mt . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.154 -0.966 . . . . 0.0 109.741 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 4.0 m-85 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.467 0.651 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 42.4 t80 -108.17 112.4 24.89 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.499 HD12 HG21 ' A' ' 75' ' ' VAL . 34.2 mt -115.98 163.31 16.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.121 -0.987 . . . . 0.0 110.305 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.702 HG23 ' HG2' ' A' ' 72' ' ' GLU . 28.6 m -120.47 116.94 26.42 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 13.6 p90 -138.54 156.94 47.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 109.815 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -93.3 127.24 38.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.332 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.641 HG11 HG11 ' A' ' 90' ' ' VAL . 24.1 t -103.64 106.69 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.927 . . . . 0.0 109.564 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 91.2 mt-30 63.24 36.4 11.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.329 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.46 51.4 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -130.72 109.68 10.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -1.119 . . . . 0.0 109.325 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.464 ' HE2' HG21 ' A' ' 63' ' ' THR . 18.9 tttm -59.65 123.34 16.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 109.697 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.535 HG21 ' CH2' ' A' ' 92' ' ' TRP . 87.6 t -143.49 129.37 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.312 -0.868 . . . . 0.0 109.329 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.702 ' HG2' HG23 ' A' ' 63' ' ' THR . 49.3 mt-10 -111.5 135.36 52.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.96 . . . . 0.0 109.629 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . . . -160.26 170.48 21.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.345 -0.847 . . . . 0.0 109.589 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 95.0 mt-10 -79.76 146.17 32.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.234 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.542 HG21 HG21 ' A' ' 32' ' ' VAL . 3.7 m -138.77 164.36 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.161 -0.962 . . . . 0.0 109.85 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.442 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 21.2 tp -118.04 149.41 41.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.432 -0.793 . . . . 0.0 109.196 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.864 ' HB1' ' CG ' ' A' ' 34' ' ' GLU . . . -79.81 132.27 36.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 0.0 109.5 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.463 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.8 t -135.32 149.97 71.24 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.386 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.463 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.1 Cg_endo -70.73 0.59 6.15 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.808 2.338 . . . . 0.0 111.837 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -64.47 176.75 1.02 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.485 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -114.61 17.55 17.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.429 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.598 ' CZ ' ' HG ' ' A' ' 84' ' ' LEU . 23.6 p90 -142.27 -156.27 0.67 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.066 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.904 HG23 HG12 ' A' ' 32' ' ' VAL . 3.1 mt -128.1 124.21 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.612 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.598 ' HG ' ' CZ ' ' A' ' 82' ' ' TYR . 1.5 mt -80.18 133.14 36.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 108.981 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.883 HD21 ' HB1' ' A' ' 21' ' ' ALA . 6.8 mt -101.41 144.2 30.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 109.934 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.635 ' O ' HG22 ' A' ' 90' ' ' VAL . 9.5 t-20 -101.88 134.26 20.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.398 -0.814 . . . . 0.0 109.118 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.498 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 43.1 Cg_endo -64.48 -31.12 61.6 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.7 2.267 . . . . 0.0 111.903 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 m -75.67 -28.26 58.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.339 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.416 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 83.8 m-20 -77.81 -29.16 50.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 109.361 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.965 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -121.85 76.69 38.89 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.481 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.5 Cg_endo -69.82 -24.88 28.91 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.676 2.251 . . . . 0.0 111.766 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.965 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.2 p90 -75.98 -24.84 55.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.563 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.957 HD13 ' CD1' ' A' ' 23' ' ' TRP . 9.6 tt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 109.451 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.555 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.0 Cg_endo . . . . . 0 C--O 1.215 -0.64 0 CA-C-O 121.273 0.447 . . . . 0.0 111.811 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 23' ' ' TRP . 28.7 mt -89.22 -171.17 3.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.408 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.08 137.37 54.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.364 -0.835 . . . . 0.0 109.455 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 65' ' ' LYS . . . -148.7 154.02 39.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.905 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 17' ' ' THR . 70.4 tt0 -123.2 115.5 21.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.873 . . . . 0.0 109.269 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 64' ' ' PHE . 74.6 mt -109.6 127.41 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 69.9 mttt 60.22 21.82 11.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.52 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.66 -15.32 62.82 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 68.0 m -80.02 130.47 35.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -1.136 . . . . 0.0 109.316 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.478 ' O ' HD23 ' A' ' 19' ' ' LEU . 41.4 tttp -91.78 125.27 36.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.17 -0.956 . . . . 0.0 109.491 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.532 ' CD1' ' CZ ' ' A' ' 36' ' ' PHE . 97.8 mt -143.47 168.55 19.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.371 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -92.31 154.03 18.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.453 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.64 ' CB ' HD21 ' A' ' 85' ' ' LEU . . . -138.42 172.32 13.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.244 -0.91 . . . . 0.0 109.402 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.555 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 76.4 m-70 -125.63 123.97 40.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 109.458 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.59 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 55.4 t90 -76.92 122.06 24.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.552 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -130.06 103.62 6.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.59 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 52.2 p -61.23 -25.6 67.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.943 . . . . 0.0 109.524 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.1 89.05 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.468 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -72.9 141.17 47.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -1.194 . . . . 0.0 109.552 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.438 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 28.5 p -105.52 -3.17 22.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 0.0 109.559 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' ' 74' ' ' GLU . 19.9 tt -145.51 147.94 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.323 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 38.2 m -61.56 133.13 55.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.905 . . . . 0.0 109.67 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.654 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -116.56 129.19 56.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 109.53 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.757 HG22 ' CG1' ' A' ' 75' ' ' VAL . 4.7 m -131.38 164.52 41.94 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.953 . . . . 0.0 109.358 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.507 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.8 Cg_endo -78.55 131.62 10.55 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.422 2.082 . . . . 0.0 111.483 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.3 tt0 -43.14 -26.7 0.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.945 . . . . 0.0 109.718 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.05 -36.44 18.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.58 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.532 ' CZ ' ' CD1' ' A' ' 19' ' ' LEU . 13.9 m-85 -88.82 -7.19 56.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 109.663 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.915 HD13 ' HB2' ' A' ' 77' ' ' ALA . 4.3 mt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 110.027 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 3.9 m-85 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.408 0.623 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.598 ' O ' HD12 ' A' ' 62' ' ' LEU . 39.8 t80 -105.55 112.09 25.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.613 ' HB2' HG21 ' A' ' 75' ' ' VAL . 6.9 mp -116.38 161.28 19.3 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 110.155 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.696 HG23 ' HG2' ' A' ' 72' ' ' GLU . 18.1 m -121.39 117.33 26.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.513 -0.742 . . . . 0.0 109.057 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 6.1 p90 -140.08 156.83 46.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.085 -1.009 . . . . 0.0 109.939 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 80.6 mttt -91.91 127.86 37.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.385 -0.822 . . . . 0.0 109.239 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.574 HG11 HG11 ' A' ' 90' ' ' VAL . 58.1 t -108.27 109.44 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.606 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 85.3 mt-30 62.88 37.98 11.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.321 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.76 29.08 58.02 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -133.26 113.55 12.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -1.14 . . . . 0.0 109.332 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -63.52 121.21 13.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.715 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 ' CH2' ' A' ' 92' ' ' TRP . 94.2 t -140.57 132.06 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.268 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.696 ' HG2' HG23 ' A' ' 63' ' ' THR . 49.7 mt-10 -115.77 136.92 52.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.131 -0.981 . . . . 0.0 109.745 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.37 -169.65 2.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.432 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.514 ' HB3' HD11 ' A' ' 29' ' ' ILE . 95.9 mt-10 -80.02 165.66 22.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 0.0 109.153 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.757 ' CG1' HG22 ' A' ' 32' ' ' VAL . 94.7 t -152.58 156.77 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.92 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.465 ' N ' HG12 ' A' ' 75' ' ' VAL . 14.8 tp -125.43 141.31 52.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.53 -0.731 . . . . 0.0 109.213 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.915 ' HB2' HD13 ' A' ' 37' ' ' LEU . . . -80.42 136.01 36.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -0.97 . . . . 0.0 109.43 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.48 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -143.91 151.67 53.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.48 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.2 Cg_endo -72.75 4.14 3.81 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.689 2.259 . . . . 0.0 111.864 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -65.6 171.72 3.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.157 -0.965 . . . . 0.0 109.392 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -113.72 17.63 18.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.409 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.74 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 12.4 p90 -139.81 -159.38 0.95 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.261 -0.899 . . . . 0.0 109.032 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.674 HG23 HG12 ' A' ' 32' ' ' VAL . 2.5 mt -129.17 147.17 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.183 -0.948 . . . . 0.0 109.633 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.74 HD11 ' CZ ' ' A' ' 82' ' ' TYR . 6.6 mp -111.69 135.95 51.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.344 -0.847 . . . . 0.0 108.952 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.758 ' N ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -102.55 140.73 36.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.984 . . . . 0.0 109.867 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.642 ' O ' HG22 ' A' ' 90' ' ' VAL . 8.9 t-20 -92.32 134.58 28.05 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.487 -0.758 . . . . 0.0 109.096 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.519 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.5 Cg_endo -64.03 -30.74 66.37 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.766 2.311 . . . . 0.0 111.946 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 m -74.68 -29.61 61.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.262 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -79.44 -29.32 41.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.43 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.177 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -122.88 74.82 47.63 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.379 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.7 -24.47 29.89 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.727 2.284 . . . . 0.0 111.812 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.177 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 42.3 p90 -72.78 -29.87 63.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.5 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.591 HD12 ' CG2' ' A' ' 90' ' ' VAL . 73.4 mt . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.558 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 47.9 Cg_endo . . . . . 0 C--O 1.214 -0.688 0 CA-C-O 121.287 0.453 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.53 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 29.4 mt -83.13 -176.24 6.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.467 ' OE2' ' CE ' ' A' ' 18' ' ' LYS . 72.3 tt0 -113.2 137.32 51.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.496 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.12 142.74 27.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 109.609 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -116.16 120.25 38.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.264 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.635 HG22 ' HG3' ' A' ' 15' ' ' LYS . 36.9 mt -111.53 129.14 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.601 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.635 ' HG3' HG22 ' A' ' 14' ' ' ILE . 32.5 mttm 51.84 24.39 2.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -0.878 . . . . 0.0 109.665 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.64 -4.72 79.63 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.873 HG22 HD11 ' A' ' 19' ' ' LEU . 13.1 m -87.98 128.85 35.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -1.196 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.889 ' C ' HD12 ' A' ' 19' ' ' LEU . 19.3 tttt -86.8 121.75 29.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.492 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.889 HD12 ' C ' ' A' ' 18' ' ' LYS . 5.2 mp -140.54 161.89 36.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.89 . . . . 0.0 109.458 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -88.37 155.36 19.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -0.922 . . . . 0.0 109.428 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.071 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -139.23 176.87 8.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 64.9 m-70 -134.56 122.49 22.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.817 ' CE2' HD22 ' A' ' 93' ' ' LEU . 71.4 t90 -79.59 128.08 32.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.303 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -141.58 109.75 5.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.555 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 20.7 t -60.88 -27.18 67.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.77 -27.14 70.68 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.482 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -79.84 127.63 32.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -1.195 . . . . 0.0 109.48 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 m -95.33 -16.84 22.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 0.0 109.438 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 29' ' ' ILE . 21.1 tt -135.56 130.84 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 84' ' ' LEU . 90.5 m -50.92 139.19 17.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.595 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.593 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -119.82 128.95 54.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.27 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.924 HG12 HG23 ' A' ' 83' ' ' ILE . 16.6 m -122.4 162.57 37.23 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 78' ' ' SER . 55.4 Cg_endo -78.67 131.35 10.27 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.466 2.111 . . . . 0.0 111.623 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.964 ' HG2' ' HB1' ' A' ' 77' ' ' ALA . 96.8 mt-10 -42.9 -27.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 109.548 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -47.46 -43.02 23.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.77 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.586 ' CE1' ' CD2' ' A' ' 19' ' ' LEU . 21.4 m-85 -84.98 -6.32 59.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.102 -0.999 . . . . 0.0 109.756 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.522 HD21 ' CG2' ' A' ' 32' ' ' VAL . 4.3 mm? . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.168 -0.958 . . . . 0.0 109.678 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.56 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 3.4 m-85 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.289 0.566 . . . . 0.0 109.61 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.675 ' O ' HD23 ' A' ' 62' ' ' LEU . 32.9 t80 -104.88 115.5 30.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 108.961 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 61' ' ' TYR . 18.9 mt -121.47 156.52 32.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 110.08 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.718 HG23 ' HG2' ' A' ' 72' ' ' GLU . 67.9 m -115.31 125.68 53.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.449 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 18.1 p90 -149.02 151.23 34.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.082 -1.011 . . . . 0.0 109.681 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -85.28 133.32 34.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.323 -0.861 . . . . 0.0 109.198 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.549 HG11 HG11 ' A' ' 90' ' ' VAL . 40.1 t -109.58 112.64 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 93.7 mt-30 61.33 20.96 11.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.86 . . . . 0.0 109.468 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.64 21.77 18.19 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.93 ' HG2' HG23 ' A' ' 71' ' ' VAL . 6.6 ttt85 -126.86 116.82 21.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -1.057 . . . . 0.0 109.068 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -64.55 116.07 5.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 109.367 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.93 HG23 ' HG2' ' A' ' 69' ' ' ARG . 55.4 t -138.12 134.97 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 109.481 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.718 ' HG2' HG23 ' A' ' 63' ' ' THR . 80.6 mt-10 -111.05 140.35 45.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.3 168.99 24.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.624 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 95.8 mt-10 -79.84 141.06 36.55 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.393 -0.817 . . . . 0.0 109.079 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.624 HG21 HD12 ' A' ' 62' ' ' LEU . 2.8 m -138.18 163.46 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.186 -0.946 . . . . 0.0 109.775 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.1 tp -117.39 146.85 43.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.964 ' HB1' ' HG2' ' A' ' 34' ' ' GLU . . . -79.75 126.01 30.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.386 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 1.1 t -133.06 152.18 79.23 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.474 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.487 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 48.9 Cg_endo -69.6 -0.82 7.33 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.605 2.203 . . . . 0.0 111.779 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -58.78 169.86 0.91 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.384 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -111.97 22.32 15.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.695 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 19.2 p90 -148.14 -159.32 1.01 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.417 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.924 HG23 HG12 ' A' ' 32' ' ' VAL . 4.0 mt -125.22 140.64 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.735 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.786 ' O ' HG23 ' A' ' 30' ' ' THR . 6.9 mp -106.35 130.59 54.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.32 -0.863 . . . . 0.0 109.039 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.071 HD21 ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -111.48 135.18 52.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.624 -179.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.531 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 6.8 p-10 -97.55 158.17 33.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.243 -0.91 . . . . 0.0 109.737 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 48.8 Cg_endo -69.19 -20.0 38.11 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.663 2.242 . . . . 0.0 111.403 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.5 p -76.36 -36.39 58.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.317 -0.864 . . . . 0.0 109.116 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.459 ' HB2' ' OD1' ' A' ' 86' ' ' ASN . 88.0 m-20 -79.38 -32.07 43.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -0.826 . . . . 0.0 108.905 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.062 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -119.25 71.68 12.45 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.835 . . . . 0.0 109.515 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.565 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.4 Cg_endo -70.31 -20.15 32.59 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.735 2.29 . . . . 0.0 111.784 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.062 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 47.2 p90 -79.85 -32.88 40.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.923 . . . . 0.0 109.562 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.817 HD22 ' CE2' ' A' ' 23' ' ' TRP . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.431 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.548 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 51.1 Cg_endo . . . . . 0 C--O 1.214 -0.68 0 CA-C-O 121.29 0.454 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.526 HD13 HD12 ' A' ' 85' ' ' LEU . 4.1 mp -82.59 161.15 22.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.473 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.55 142.64 29.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.502 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.07 151.84 28.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.54 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 18' ' ' LYS . 92.2 mt-10 -130.88 121.53 25.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 109.432 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 75.9 mt -114.7 128.14 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.936 . . . . 0.0 109.43 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 65.5 mttt 61.11 20.26 10.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.44 -12.42 69.76 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.45 HG22 HD12 ' A' ' 19' ' ' LEU . 41.9 m -81.8 134.63 35.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -1.169 . . . . 0.0 109.409 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.747 ' O ' HD12 ' A' ' 19' ' ' LEU . 89.0 mttt -89.75 139.04 30.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -158.8 165.61 33.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.411 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 9' ' ' PRO . 11.8 mmtt -86.5 150.67 24.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.764 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -133.49 171.11 14.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.548 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 68.2 m-70 -131.52 133.83 45.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 109.836 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.605 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 58.5 t90 -90.31 115.13 27.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 109.448 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -127.08 102.53 7.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.386 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.473 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 32.2 t -57.83 -34.03 69.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.613 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.95 -35.59 48.72 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.18 136.11 51.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.2 m -95.29 -16.4 22.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.45 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.5 tt -141.65 149.41 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.316 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 27.9 m -57.69 135.49 56.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.732 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -119.24 119.53 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.9 . . . . 0.0 109.214 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.637 HG12 HG23 ' A' ' 83' ' ' ILE . 29.1 m -113.44 162.2 23.5 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.281 -0.887 . . . . 0.0 109.515 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.6 Cg_endo -79.2 130.6 9.32 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.547 2.164 . . . . 0.0 111.575 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 81.0 tt0 -43.27 -26.87 0.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 0.0 109.51 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -53.08 -41.81 65.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.402 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.636 ' HZ ' HD13 ' A' ' 19' ' ' LEU . 5.9 m-85 -83.15 -3.04 56.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.226 -0.921 . . . . 0.0 109.445 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 77' ' ' ALA . 6.1 mt . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.946 . . . . 0.0 109.779 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 4.0 m-85 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.319 0.581 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.588 ' O ' HD12 ' A' ' 62' ' ' LEU . 43.3 t80 -107.0 112.49 25.47 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.826 HD22 HG21 ' A' ' 75' ' ' VAL . 6.8 mp -115.66 158.88 22.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.155 -0.965 . . . . 0.0 110.445 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.716 HG23 ' HG2' ' A' ' 72' ' ' GLU . 51.0 m -117.74 116.76 27.67 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.801 ' CE2' HG22 ' A' ' 66' ' ' VAL . 39.9 p90 -137.21 160.02 40.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 109.955 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -93.11 129.08 39.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 109.356 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.801 HG22 ' CE2' ' A' ' 64' ' ' PHE . 1.7 t -105.53 103.55 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 109.656 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 84.1 mt-30 63.61 36.73 10.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.895 . . . . 0.0 109.33 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.72 26.01 51.54 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -129.55 120.88 26.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.333 -1.098 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -66.33 122.82 18.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.582 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.693 HG21 ' CH2' ' A' ' 92' ' ' TRP . 90.2 t -144.17 133.44 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.451 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.716 ' HG2' HG23 ' A' ' 63' ' ' THR . 76.4 mt-10 -117.16 137.18 52.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.641 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.07 172.49 17.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.6 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 96.1 mt-10 -79.9 141.35 36.17 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -0.922 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.826 HG21 HD22 ' A' ' 62' ' ' LEU . 2.9 m -135.14 162.3 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.943 . . . . 0.0 109.752 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.8 mt -119.34 154.71 33.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.847 . . . . 0.0 109.287 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB2' HD13 ' A' ' 37' ' ' LEU . . . -80.17 138.83 36.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.478 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.572 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 4.6 t -143.11 149.0 47.26 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.475 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.2 Cg_endo -72.65 3.37 4.36 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.701 2.267 . . . . 0.0 112.065 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.572 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 74.3 m-85 -66.81 174.93 2.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 109.587 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -114.06 15.65 18.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 0.0 109.341 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' N ' ' A' ' 83' ' ' ILE . 33.0 p90 -139.22 -157.89 0.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.208 -0.933 . . . . 0.0 109.08 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.637 HG23 HG12 ' A' ' 32' ' ' VAL . 4.5 mt -123.66 126.21 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.669 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.732 HD13 ' HB3' ' A' ' 31' ' ' CYS . 5.7 mp -84.27 142.59 30.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 108.941 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.764 HD21 ' HB1' ' A' ' 21' ' ' ALA . 6.6 mt -112.92 143.26 44.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 110.083 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.74 ' O ' HG22 ' A' ' 90' ' ' VAL . 3.3 t30 -103.61 137.41 19.24 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.53 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.5 Cg_endo -64.0 -35.65 53.33 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.703 2.269 . . . . 0.0 111.998 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.447 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 2.5 m -72.54 -27.01 61.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.141 -0.974 . . . . 0.0 109.411 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -79.55 -28.92 41.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.34 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.094 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -120.26 71.85 18.03 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.841 . . . . 0.0 109.464 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.34 -16.3 35.09 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.632 2.221 . . . . 0.0 111.762 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.094 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 41.6 p90 -82.6 -28.51 30.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.894 . . . . 0.0 109.414 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.605 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 22.0 tp . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.4 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.528 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.2 Cg_endo . . . . . 0 C--O 1.215 -0.644 0 CA-C-O 121.181 0.409 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 3.7 mp -84.38 164.47 18.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.439 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -101.79 147.21 26.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.475 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.25 146.31 25.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.521 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 17' ' ' THR . 89.9 mt-10 -123.8 118.68 27.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.71 HG22 ' HG3' ' A' ' 15' ' ' LYS . 61.6 mt -114.15 129.65 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.503 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.71 ' HG3' HG22 ' A' ' 14' ' ' ILE . 93.2 mttt 54.35 22.39 3.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.94 -8.55 76.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 32.7 m -82.58 128.45 34.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -1.13 . . . . 0.0 109.493 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.812 ' O ' HD23 ' A' ' 19' ' ' LEU . 29.6 tttt -92.47 122.79 35.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.403 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.812 HD23 ' O ' ' A' ' 18' ' ' LYS . 63.7 mt -140.88 168.08 20.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.498 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -87.67 155.54 19.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.496 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.696 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -139.85 167.73 21.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -0.859 . . . . 0.0 109.337 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.622 ' O ' HD22 ' A' ' 85' ' ' LEU . 80.4 m-70 -130.98 132.47 45.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.498 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.573 ' CZ2' ' HB3' ' A' ' 87' ' ' PRO . 38.9 t90 -85.76 122.98 30.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.587 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -130.15 99.31 5.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.875 . . . . 0.0 109.463 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.516 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 53.4 p -57.16 -26.76 61.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -0.861 . . . . 0.0 109.509 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.22 -36.17 92.0 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -72.17 137.37 46.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -1.15 . . . . 0.0 109.425 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.451 ' O ' HG22 ' A' ' 28' ' ' THR . 93.5 m -99.1 -10.45 22.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 109.385 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.452 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 21.2 tt -139.4 152.77 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 84' ' ' LEU . 32.4 m -61.24 152.11 29.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.477 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.975 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -127.93 113.72 16.23 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.111 179.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.782 HG13 ' HD2' ' A' ' 33' ' ' PRO . 60.3 t -113.55 146.91 36.4 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.312 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.782 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.3 Cg_endo -76.75 131.22 12.14 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.125 1.883 . . . . 0.0 111.625 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 33' ' ' PRO . 81.3 tt0 -40.7 -27.48 0.05 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.533 -0.729 . . . . 0.0 110.234 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.14 -27.75 3.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.096 -1.003 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.751 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 21.4 m-85 -101.77 -3.04 28.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 0.0 109.77 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.569 ' CD2' ' CG ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.698 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.569 ' CG ' ' CD2' ' A' ' 37' ' ' LEU . 11.4 m-85 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.29 0.567 . . . . 0.0 109.889 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.493 ' O ' HD23 ' A' ' 62' ' ' LEU . 43.5 t80 -102.15 114.4 28.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.257 -0.902 . . . . 0.0 108.956 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.576 HD12 HG21 ' A' ' 75' ' ' VAL . 44.1 mt -121.01 169.05 10.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.061 -1.024 . . . . 0.0 110.288 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.711 HG23 ' HG2' ' A' ' 72' ' ' GLU . 25.4 m -121.22 118.05 28.62 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.502 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 9.5 p90 -140.34 163.22 33.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.988 -1.07 . . . . 0.0 109.801 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.45 ' NZ ' ' OE1' ' A' ' 13' ' ' GLU . 15.2 mtmt -99.38 126.01 45.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.388 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 78.0 t -104.42 116.19 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.481 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 94.7 mt-30 62.29 30.96 17.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.386 -0.821 . . . . 0.0 109.393 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.65 22.45 59.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -125.64 117.61 23.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -1.164 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -58.91 123.9 18.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.439 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.689 HG21 ' CH2' ' A' ' 92' ' ' TRP . 53.7 t -148.55 127.03 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.335 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.711 ' HG2' HG23 ' A' ' 63' ' ' THR . 79.5 mt-10 -107.66 138.82 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.525 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.32 168.34 25.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.338 -0.851 . . . . 0.0 109.695 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 95.5 mt-10 -80.04 137.29 36.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.328 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.694 ' HB ' HG23 ' A' ' 32' ' ' VAL . 5.0 m -127.92 151.39 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 32' ' ' VAL . 24.6 tp -103.75 143.63 32.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.355 -0.84 . . . . 0.0 109.082 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.17 125.9 30.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.243 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.495 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 35.2 t -137.14 150.13 68.3 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.296 -0.878 . . . . 0.0 109.534 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.495 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.8 Cg_endo -71.01 5.07 2.34 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.669 2.246 . . . . 0.0 112.176 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 31.3 m-85 -62.57 178.22 0.45 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 109.362 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -118.22 18.3 13.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.549 ' CD2' ' N ' ' A' ' 83' ' ' ILE . 13.9 p90 -145.08 -153.97 0.51 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.349 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.549 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 2.4 mt -133.22 148.01 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 0.0 109.563 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.975 HD13 ' HB3' ' A' ' 31' ' ' CYS . 6.0 mp -112.27 133.73 54.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 108.886 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.76 ' H ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -100.63 133.09 45.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.067 -1.021 . . . . 0.0 109.851 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.677 ' O ' HG22 ' A' ' 90' ' ' VAL . 3.3 t30 -85.67 136.57 36.84 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.573 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 40.5 Cg_endo -63.06 -25.76 73.45 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.696 2.264 . . . . 0.0 111.849 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.497 ' OG ' ' ND2' ' A' ' 86' ' ' ASN . 1.0 OUTLIER -80.42 -28.92 37.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.27 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -78.06 -28.6 48.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.864 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.179 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -116.06 73.95 5.17 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.202 -0.936 . . . . 0.0 109.505 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.414 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.8 Cg_endo -70.3 -23.73 28.0 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.757 2.305 . . . . 0.0 111.791 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.179 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 43.9 p90 -73.06 -29.63 63.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.492 HD12 ' CG2' ' A' ' 90' ' ' VAL . 76.3 mt . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.241 -0.912 . . . . 0.0 109.467 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.506 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 48.3 Cg_endo . . . . . 0 C--O 1.215 -0.637 0 CA-C-O 121.204 0.418 . . . . 0.0 111.77 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.746 HD22 HE21 ' A' ' 67' ' ' GLN . 86.3 mt -93.81 154.17 17.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.475 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -88.49 140.24 29.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.548 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.48 155.35 41.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 17' ' ' THR . 67.5 tt0 -128.65 109.56 11.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -0.953 . . . . 0.0 109.412 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.585 ' HB ' ' CE2' ' A' ' 36' ' ' PHE . 90.0 mt -104.92 128.81 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.51 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 52.7 mttp 61.31 18.17 8.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.632 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.08 -10.93 73.39 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 81.8 m -85.5 140.43 30.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -1.136 . . . . 0.0 109.171 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -79.26 117.45 20.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.295 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.907 HD22 ' CE1' ' A' ' 36' ' ' PHE . 11.7 tp -130.14 147.81 51.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.476 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.746 ' O ' HD12 ' A' ' 83' ' ' ILE . 40.6 mttt -81.93 157.82 24.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.6 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.075 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -144.98 160.08 41.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.554 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.727 ' O ' HD22 ' A' ' 85' ' ' LEU . 65.4 m-70 -128.72 129.32 45.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.265 -0.897 . . . . 0.0 109.471 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.59 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 21.9 t90 -75.28 125.45 29.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.641 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -132.85 95.9 3.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.394 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.59 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 54.6 p -56.45 -31.8 64.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.657 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.57 -27.58 68.31 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -79.98 139.29 37.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -1.167 . . . . 0.0 109.472 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.503 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 41.8 p -103.57 -4.36 24.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.584 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.791 HG21 HD11 ' A' ' 76' ' ' LEU . 21.2 tt -143.98 149.41 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.932 . . . . 0.0 109.472 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.692 ' HB ' HG22 ' A' ' 75' ' ' VAL . 27.8 m -61.12 139.67 58.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.647 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.803 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -123.48 140.07 53.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.546 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.041 HG12 HG23 ' A' ' 83' ' ' ILE . 34.9 m -141.13 165.8 26.73 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.915 . . . . 0.0 109.411 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.4 Cg_endo -78.29 128.15 8.73 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.29 1.993 . . . . 0.0 111.451 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' PRO . 83.9 tt0 -41.78 -28.19 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.749 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -53.27 -31.48 43.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.557 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.907 ' CE1' HD22 ' A' ' 19' ' ' LEU . 2.2 m-85 -88.75 -10.92 46.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 0.0 109.673 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.659 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.858 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.659 ' CD2' HD23 ' A' ' 37' ' ' LEU . 25.6 m-85 . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.335 0.588 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.473 ' OH ' ' HB2' ' A' ' 72' ' ' GLU . 45.2 t80 -85.91 110.19 19.25 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.1 mt -115.81 161.62 18.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.032 -1.043 . . . . 0.0 110.624 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.7 HG23 ' HG2' ' A' ' 72' ' ' GLU . 29.5 m -121.23 124.24 44.17 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.981 ' CE2' HG22 ' A' ' 66' ' ' VAL . 43.2 p90 -145.92 160.38 41.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.044 -1.035 . . . . 0.0 109.97 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.504 ' HD3' ' HA ' ' A' ' 70' ' ' LYS . 6.8 mmtt -90.1 126.75 35.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.406 -0.809 . . . . 0.0 109.229 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.981 HG22 ' CE2' ' A' ' 64' ' ' PHE . 1.7 t -104.54 103.09 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.688 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.746 HE21 HD22 ' A' ' 10' ' ' LEU . 82.9 mt-30 62.61 35.06 14.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.317 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.46 30.93 28.88 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -136.28 120.56 17.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -1.169 . . . . 0.0 109.39 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.504 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 15.0 tttp -67.35 120.44 13.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.471 HG21 ' CH2' ' A' ' 92' ' ' TRP . 64.0 t -141.94 131.84 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.475 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.7 ' HG2' HG23 ' A' ' 63' ' ' THR . 27.3 mt-10 -116.01 136.48 52.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.31 -178.11 6.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.845 . . . . 0.0 109.667 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -79.64 152.81 29.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.02 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.897 ' CG1' HG22 ' A' ' 32' ' ' VAL . 91.6 t -143.51 156.97 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.123 -0.985 . . . . 0.0 109.744 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.791 HD11 HG21 ' A' ' 29' ' ' ILE . 17.2 mt -121.89 147.37 46.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.37 -0.831 . . . . 0.0 109.313 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.94 139.66 36.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.468 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.5 t -143.98 150.81 50.74 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 109.345 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.468 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.9 Cg_endo -71.37 1.75 5.17 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.677 2.251 . . . . 0.0 111.772 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.51 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 70.6 m-85 -69.15 162.53 26.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.278 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -104.32 19.79 19.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.604 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.84 ' OH ' HD21 ' A' ' 84' ' ' LEU . 22.4 p90 -140.57 -162.35 1.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.979 . . . . 0.0 109.552 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.041 HG23 HG12 ' A' ' 32' ' ' VAL . 7.5 mt -125.44 152.16 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.1 -1.0 . . . . 0.0 110.248 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.84 HD21 ' OH ' ' A' ' 82' ' ' TYR . 2.2 mt -118.55 124.59 47.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.298 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.075 HD11 ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -92.47 140.68 29.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 109.82 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.656 ' O ' HG22 ' A' ' 90' ' ' VAL . 8.2 t-20 -90.87 134.79 29.71 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.491 -0.755 . . . . 0.0 109.25 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.5 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.1 Cg_endo -63.95 -30.3 67.07 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.796 2.33 . . . . 0.0 111.78 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.407 ' HB3' HD21 ' A' ' 86' ' ' ASN . 6.4 t -75.73 -29.09 58.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 109.269 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -79.89 -33.21 40.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.897 . . . . 0.0 109.44 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.157 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.8 OUTLIER -119.52 76.39 18.71 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.882 . . . . 0.0 109.424 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.439 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.3 Cg_endo -69.99 -22.05 31.58 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.697 2.264 . . . . 0.0 111.785 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.157 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.2 p90 -76.23 -25.72 55.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.171 -0.955 . . . . 0.0 109.401 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.548 HD12 HG21 ' A' ' 90' ' ' VAL . 59.9 mt . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.478 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.403 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.7 Cg_endo . . . . . 0 C--O 1.214 -0.678 0 CA-C-O 121.218 0.424 . . . . 0.0 111.668 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.781 HD22 HE21 ' A' ' 67' ' ' GLN . 65.8 mt -93.63 142.03 27.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.493 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -83.43 134.1 34.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 65' ' ' LYS . . . -145.14 150.75 37.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.527 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.458 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 45.0 tt0 -115.93 121.0 41.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.405 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.633 HG22 ' HG3' ' A' ' 15' ' ' LYS . 27.1 mt -111.06 125.4 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.633 ' HG3' HG22 ' A' ' 14' ' ' ILE . 42.5 mttt 55.02 24.79 6.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.321 -0.862 . . . . 0.0 109.55 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.458 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 90.31 4.52 71.01 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 42.7 m -103.64 126.45 50.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -1.203 . . . . 0.0 109.467 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -82.12 129.15 34.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.73 HD13 ' HZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -141.27 167.76 21.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -87.55 148.61 24.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 0.0 109.569 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.846 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -135.92 163.79 29.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 109.475 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.741 ' O ' HD22 ' A' ' 85' ' ' LEU . 52.8 m-70 -130.37 129.42 43.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.563 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.779 ' HB2' HD11 ' A' ' 10' ' ' LEU . 48.4 t90 -77.0 127.74 33.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -137.59 107.41 6.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.499 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 18.2 p -65.69 -33.11 75.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.82 -15.76 55.49 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.12 130.43 34.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -1.155 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.7 m -94.98 -24.02 17.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.986 HD11 ' HB2' ' A' ' 74' ' ' GLU . 11.3 tp -132.72 143.12 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -0.926 . . . . 0.0 109.6 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 84' ' ' LEU . 39.1 m -58.46 136.46 57.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.655 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 9.9 t -124.76 140.04 53.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.834 HG13 HG13 ' A' ' 75' ' ' VAL . 2.6 m -137.72 172.14 7.29 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.32 -0.862 . . . . 0.0 109.14 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.5 Cg_endo -79.82 132.26 9.58 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.22 1.946 . . . . 0.0 111.833 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 33' ' ' PRO . 22.4 pt-20 -44.22 -25.92 0.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.642 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -48.52 -34.34 11.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 109.526 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.73 ' HZ ' HD13 ' A' ' 19' ' ' LEU . 12.8 m-85 -89.42 -9.75 49.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 109.646 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.486 ' HA ' HD13 ' A' ' 37' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.783 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 4.6 m-85 . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 121.283 0.563 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.534 ' O ' HD23 ' A' ' 62' ' ' LEU . 35.9 t80 -108.24 113.12 25.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -0.826 . . . . 0.0 108.957 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 61' ' ' TYR . 28.4 mt -117.25 158.84 23.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.071 -1.018 . . . . 0.0 110.128 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.712 HG23 ' HG2' ' A' ' 72' ' ' GLU . 22.0 m -119.88 115.7 24.36 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 9.4 p90 -138.89 162.02 35.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.067 -1.02 . . . . 0.0 109.945 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 32.2 mttm -92.39 127.37 37.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.395 -0.816 . . . . 0.0 109.278 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 49.8 t -106.98 105.86 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 109.537 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.781 HE21 HD22 ' A' ' 10' ' ' LEU . 85.5 mt-30 63.85 36.26 10.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.291 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.09 33.86 39.36 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 71' ' ' VAL . 74.3 mtt180 -139.19 108.81 6.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.225 -1.162 . . . . 0.0 109.405 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -55.72 121.71 9.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.91 . . . . 0.0 109.628 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.614 HG21 ' CH2' ' A' ' 92' ' ' TRP . 80.3 t -141.16 129.98 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 109.429 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.712 ' HG2' HG23 ' A' ' 63' ' ' THR . 54.5 mt-10 -113.7 136.36 52.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.621 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.37 -173.49 4.03 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.368 -0.832 . . . . 0.0 109.353 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.986 ' HB2' HD11 ' A' ' 29' ' ' ILE . 97.2 mt-10 -80.0 164.79 23.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.002 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.834 HG13 HG13 ' A' ' 32' ' ' VAL . 89.8 t -152.76 145.42 15.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.134 -0.979 . . . . 0.0 109.914 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.9 tp -114.95 143.03 45.79 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.14 143.12 32.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.1 -1.0 . . . . 0.0 109.649 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.488 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -152.25 152.11 28.78 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 0.0 109.304 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.488 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.2 Cg_endo -71.19 2.53 4.25 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.613 2.209 . . . . 0.0 112.019 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 41.1 m-85 -63.34 169.23 3.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.047 -1.033 . . . . 0.0 109.301 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -113.71 23.26 13.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.519 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.887 ' OH ' HD21 ' A' ' 84' ' ' LEU . 16.3 p90 -147.86 -166.81 2.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 109.528 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.625 HG23 HG12 ' A' ' 32' ' ' VAL . 4.9 mt -114.95 151.67 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.94 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.908 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.1 mt -119.14 124.97 48.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 108.949 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.908 HD13 ' C ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -107.45 138.38 43.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.968 . . . . 0.0 109.647 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.769 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -100.76 159.3 29.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 109.518 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 47.6 Cg_endo -69.41 -24.24 31.48 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.71 2.274 . . . . 0.0 111.505 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.9 m -74.27 -34.07 63.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.334 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.92 ' OD1' HG13 ' A' ' 90' ' ' VAL . 1.7 p30 -80.16 -38.34 31.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 0.0 109.263 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.92 HG13 ' OD1' ' A' ' 89' ' ' ASP . 2.3 m -108.18 69.64 0.33 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.584 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.563 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 52.8 Cg_endo -70.72 -25.85 23.72 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.798 2.332 . . . . 0.0 112.045 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.847 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.9 p90 -71.26 -37.65 71.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.955 . . . . 0.0 109.497 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.558 HD23 ' CD1' ' A' ' 23' ' ' TRP . 29.8 tp . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 49.6 Cg_endo -70.18 147.62 60.57 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.69 2.26 . . . . 0.0 111.708 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 10' ' ' LEU . 4.1 mp -88.8 167.46 13.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.261 -0.9 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -104.35 139.6 39.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.27 152.81 33.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 17' ' ' THR . 59.8 tt0 -123.8 120.38 32.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.456 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.668 HG22 ' HG3' ' A' ' 15' ' ' LYS . 29.8 mt -111.69 128.47 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.668 ' HG3' HG22 ' A' ' 14' ' ' ILE . 48.3 mttm 50.77 29.58 4.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.564 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.416 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.36 -12.08 67.78 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 28.7 m -80.59 129.95 34.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -1.1 . . . . 0.0 109.455 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.734 ' O ' HD23 ' A' ' 19' ' ' LEU . 62.4 tttm -96.61 125.38 41.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.609 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.734 HD23 ' O ' ' A' ' 18' ' ' LYS . 37.9 mt -147.19 169.85 18.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.284 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 9' ' ' PRO . 44.1 mttt -87.28 153.93 21.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.9 . . . . 0.0 109.487 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.872 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -136.36 168.84 18.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.323 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.793 ' O ' HD22 ' A' ' 85' ' ' LEU . 70.3 m-70 -131.06 131.37 44.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.615 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.463 ' HE1' HG23 ' A' ' 90' ' ' VAL . 53.1 t90 -86.25 126.95 34.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.368 -0.833 . . . . 0.0 109.336 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 23' ' ' TRP . 97.1 m-20 -137.67 103.9 5.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.46 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 22.9 t -59.56 -29.23 67.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.51 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.32 -27.36 65.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.48 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -84.05 131.2 34.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -1.144 . . . . 0.0 109.576 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.8 p -96.66 -11.62 24.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 109.487 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.563 HD13 HD11 ' A' ' 76' ' ' LEU . 10.1 tt -134.23 145.51 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.89 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.645 ' HB ' HG12 ' A' ' 75' ' ' VAL . 86.6 m -63.55 140.97 58.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.442 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.682 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -121.47 128.43 52.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.915 HG13 ' HB ' ' A' ' 75' ' ' VAL . 4.2 m -127.77 163.34 43.82 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.408 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.7 Cg_endo -79.1 138.97 14.75 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.519 2.146 . . . . 0.0 111.943 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.864 ' HG2' ' HB1' ' A' ' 77' ' ' ALA . 74.7 mt-10 -46.88 -24.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.463 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.48 -24.54 3.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.492 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.51 ' C ' HD22 ' A' ' 37' ' ' LEU . 22.8 m-85 -97.85 -8.92 27.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 109.629 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.993 HD11 HD11 ' A' ' 62' ' ' LEU . 2.7 mm? -116.55 2.75 13.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 0.0 109.694 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -53.85 -42.95 69.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 109.295 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -110.81 25.43 11.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.331 -0.855 . . . . 0.0 109.291 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.489 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 70.7 mm-40 -108.78 -169.23 1.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.627 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 ptt85 -149.63 129.29 6.49 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.455 -0.778 . . . . 0.0 109.25 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.579 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 51.0 Cg_endo -70.82 124.4 10.61 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.589 2.193 . . . . 0.0 111.975 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.517 HG13 ' N ' ' A' ' 44' ' ' GLN . 31.9 pt -72.59 -36.11 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.245 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.517 ' N ' HG13 ' A' ' 43' ' ' ILE . 94.8 mt-30 -139.37 164.95 28.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.403 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.5 p -128.77 162.46 27.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 63.8 mtt -128.83 145.06 51.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.425 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.733 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.8 mp -100.58 128.75 46.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.532 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.549 HD12 ' HG3' ' A' ' 57' ' ' GLN . 25.5 mt -125.05 133.28 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.49 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -100.42 130.99 46.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.455 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 p -125.12 163.26 22.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.905 . . . . 0.0 109.517 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.499 HG13 ' N ' ' A' ' 52' ' ' HIS . 20.2 pt -61.61 -38.99 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.51 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.499 ' N ' HG13 ' A' ' 51' ' ' ILE . 86.5 t60 -69.62 -34.26 73.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 0.0 109.458 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.92 -172.06 44.83 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -97.05 129.14 44.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -1.174 . . . . 0.0 109.424 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -121.99 147.0 46.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 109.526 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -113.08 135.89 53.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.915 . . . . 0.0 109.511 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.549 ' HG3' HD12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -106.72 128.87 54.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.378 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 42' ' ' PRO . 88.8 m-20 -81.04 152.39 27.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.63 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 22.0 t -115.35 132.0 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.846 . . . . 0.0 109.269 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.597 ' CD2' HD12 ' A' ' 37' ' ' LEU . 8.1 m-85 -121.39 131.72 54.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.002 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.514 ' CE1' ' HB3' ' A' ' 72' ' ' GLU . 47.0 t80 -95.88 108.98 21.4 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.993 HD11 HD11 ' A' ' 37' ' ' LEU . 50.5 mt -120.6 168.35 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.054 -1.029 . . . . 0.0 110.517 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.724 HG23 ' HG2' ' A' ' 72' ' ' GLU . 88.9 m -118.05 125.94 51.31 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.626 ' CE2' HG22 ' A' ' 66' ' ' VAL . 37.5 p90 -145.16 155.2 43.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 0.0 109.685 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 31.7 mttt -89.03 129.18 35.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.718 HG11 ' CG1' ' A' ' 90' ' ' VAL . 2.0 t -103.33 97.78 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 76.5 mt-30 65.02 41.11 4.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.214 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.22 32.88 41.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.405 ' O ' HG23 ' A' ' 71' ' ' VAL . 89.4 mtt180 -137.63 108.63 6.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -1.146 . . . . 0.0 109.34 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -58.12 122.51 13.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.615 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.516 HG21 ' CH2' ' A' ' 92' ' ' TRP . 93.6 t -147.7 134.22 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.285 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.724 ' HG2' HG23 ' A' ' 63' ' ' THR . 88.5 mt-10 -110.61 140.46 44.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.667 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.15 162.84 34.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.351 -0.843 . . . . 0.0 109.569 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.525 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 96.7 mt-10 -80.9 136.28 36.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.846 . . . . 0.0 109.175 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.915 ' HB ' HG13 ' A' ' 32' ' ' VAL . 12.4 m -129.54 150.91 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.225 -0.922 . . . . 0.0 109.683 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.761 ' N ' HD12 ' A' ' 76' ' ' LEU . 5.4 mp -100.41 150.17 22.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.277 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.864 ' HB1' ' HG2' ' A' ' 34' ' ' GLU . . . -80.04 135.6 36.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.484 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 2.8 t -142.9 150.19 52.29 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.484 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.0 Cg_endo -70.78 2.27 4.27 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.664 2.243 . . . . 0.0 112.088 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 67.1 m-85 -66.04 171.17 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.568 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -110.98 20.45 17.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.788 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.827 ' OH ' HD21 ' A' ' 84' ' ' LEU . 12.3 p90 -145.46 -159.91 1.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 109.441 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.703 HG23 HG12 ' A' ' 32' ' ' VAL . 4.3 mt -125.16 154.44 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.62 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.879 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.8 mt -120.03 126.48 50.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.263 -0.898 . . . . 0.0 109.063 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.879 HD13 ' C ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -105.61 142.02 36.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.536 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.723 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -102.26 161.82 22.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.366 -0.834 . . . . 0.0 109.431 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 51.9 Cg_endo -71.64 -21.6 25.27 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.618 2.212 . . . . 0.0 111.677 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.2 m -77.81 -34.1 52.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 0.0 109.403 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.951 ' OD1' HG13 ' A' ' 90' ' ' VAL . 1.6 p30 -80.02 -40.67 27.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.457 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.951 HG13 ' OD1' ' A' ' 89' ' ' ASP . 2.6 m -109.31 70.0 0.44 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.58 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.6 Cg_endo -70.53 -22.18 28.91 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.659 2.239 . . . . 0.0 111.843 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.803 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 47.5 p90 -77.27 -31.71 55.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 93' ' ' LEU . 10.0 tt -54.2 -40.98 68.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.505 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 90.2 mtp -60.06 -36.57 77.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.242 -0.911 . . . . 0.0 109.505 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -86.9 145.11 26.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.41 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -68.88 144.9 96.35 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.11 145.14 54.28 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.766 2.31 . . . . 0.0 111.775 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 98' ' ' LEU . 7.2 tt . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.95 . . . . 0.0 109.466 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.561 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.6 Cg_endo -70.02 144.59 53.1 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.794 2.329 . . . . 0.0 111.766 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.86 HD21 ' CE ' ' A' ' 94' ' ' MET . 4.3 mp -80.51 168.29 19.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 109.336 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -102.03 145.77 28.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.81 152.98 36.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.257 -0.902 . . . . 0.0 109.471 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 65' ' ' LYS . 82.0 tt0 -126.72 119.73 27.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.825 HG22 ' HG3' ' A' ' 15' ' ' LYS . 50.2 mt -115.93 129.61 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 109.374 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.825 ' HG3' HG22 ' A' ' 14' ' ' ILE . 82.8 mttt 58.35 24.03 11.18 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 109.572 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.44 -0.85 85.62 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.0 m -98.83 128.21 44.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -1.223 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.671 ' O ' HD12 ' A' ' 19' ' ' LEU . 34.1 mttp -83.78 138.89 33.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 109.443 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.692 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -150.01 167.21 27.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.555 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -83.53 155.0 23.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.516 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.045 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -147.88 167.14 25.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 109.379 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.561 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 67.1 m-70 -132.45 131.89 42.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.649 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 1.064 ' CZ2' HD11 ' A' ' 93' ' ' LEU . 71.6 t90 -84.7 128.15 34.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.327 -0.858 . . . . 0.0 109.386 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -138.33 104.97 5.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 109.526 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.56 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 6.5 p -60.45 -26.91 67.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.951 . . . . 0.0 109.438 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.05 -28.13 73.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.487 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -85.44 122.15 29.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -1.14 . . . . 0.0 109.232 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.1 p -91.89 -12.76 32.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.39 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.442 HG21 ' CD1' ' A' ' 76' ' ' LEU . 11.1 tp -127.04 142.33 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -0.936 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.718 ' HB ' HG12 ' A' ' 75' ' ' VAL . 44.4 m -63.39 139.56 58.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.893 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -120.78 123.23 42.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.21 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.983 HG12 HG23 ' A' ' 83' ' ' ILE . 17.3 m -121.83 162.87 34.59 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 109.727 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.7 Cg_endo -79.35 133.16 10.58 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.593 2.196 . . . . 0.0 111.554 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -46.72 -24.88 0.63 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.422 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.58 -32.95 53.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.646 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.692 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 5.3 m-85 -93.55 -3.95 51.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 109.67 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.691 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -112.75 4.72 17.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.176 -0.952 . . . . 0.0 109.737 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -52.49 -25.61 10.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.123 -0.986 . . . . 0.0 109.53 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -123.91 28.09 6.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.268 -0.895 . . . . 0.0 108.956 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 41.7 mm-40 -102.23 152.81 20.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.417 -0.802 . . . . 0.0 109.736 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.1 mtm180 -116.95 127.67 26.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.216 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.568 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 52.6 Cg_endo -72.1 116.09 4.57 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.577 2.185 . . . . 0.0 111.824 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.521 HG13 ' N ' ' A' ' 44' ' ' GLN . 27.9 pt -67.37 -36.5 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 109.325 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.521 ' N ' HG13 ' A' ' 43' ' ' ILE . 91.1 mt-30 -137.1 160.96 37.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.257 -0.902 . . . . 0.0 109.291 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 56.9 p -125.9 151.55 46.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.626 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 69.2 mtm -142.69 147.04 35.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.363 -0.836 . . . . 0.0 109.351 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 56' ' ' GLN . 0.5 OUTLIER -102.09 124.8 48.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.538 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.94 HD12 ' HG3' ' A' ' 57' ' ' GLN . 66.9 mt -118.02 134.42 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.398 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 33.2 mttp -106.3 139.89 40.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.523 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.5 p -128.91 162.48 27.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 109.386 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 52' ' ' HIS . 12.9 tt -52.9 -39.47 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.489 ' N ' HG23 ' A' ' 51' ' ' ILE . 70.6 m80 -63.3 -37.64 88.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.563 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.93 -175.94 43.24 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 93.8 mt-10 -90.74 135.11 33.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.213 -1.169 . . . . 0.0 109.545 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -134.33 139.67 45.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.364 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 47' ' ' LEU . 51.4 tt0 -97.65 119.95 37.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.643 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.94 ' HG3' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -107.22 146.34 31.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.281 -0.887 . . . . 0.0 109.407 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 88.1 m-20 -110.97 152.03 27.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 109.461 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.528 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 25.9 t -95.81 145.27 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.835 . . . . 0.0 109.117 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.691 ' CD2' HD23 ' A' ' 37' ' ' LEU . 38.3 m-85 -132.59 126.97 34.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.53 ' O ' HD23 ' A' ' 62' ' ' LEU . 36.2 t80 -94.74 111.8 23.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 108.874 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 61' ' ' TYR . 43.9 mt -121.3 167.09 13.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 110.122 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.723 HG23 ' HG2' ' A' ' 72' ' ' GLU . 52.2 m -124.01 113.99 19.16 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.508 ' CE2' HG22 ' A' ' 66' ' ' VAL . 12.7 p90 -134.29 159.27 41.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.815 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 74.5 mttt -90.84 123.74 34.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.307 -0.871 . . . . 0.0 109.291 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.73 HG11 HG11 ' A' ' 90' ' ' VAL . 51.9 t -100.85 106.52 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.762 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 98.0 mt-30 62.3 36.54 14.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.313 -0.867 . . . . 0.0 109.484 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.69 26.25 54.4 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.556 ' O ' HG23 ' A' ' 71' ' ' VAL . 55.0 mtt180 -131.35 115.06 15.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.248 -1.148 . . . . 0.0 109.277 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.53 120.31 9.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 69' ' ' ARG . 36.4 t -141.2 133.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.723 ' HG2' HG23 ' A' ' 63' ' ' THR . 45.6 mt-10 -113.94 136.38 52.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.602 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.36 166.42 29.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.831 . . . . 0.0 109.631 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.528 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 98.1 mt-10 -80.87 133.69 35.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.718 HG12 ' HB ' ' A' ' 30' ' ' THR . 3.4 m -127.21 161.9 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.536 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.442 ' CD1' HG21 ' A' ' 29' ' ' ILE . 5.0 mt -116.25 151.52 35.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.362 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.0 134.56 36.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.339 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.479 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.5 t -140.08 150.84 63.36 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.361 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.479 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.4 Cg_endo -70.55 -0.18 7.17 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.652 2.234 . . . . 0.0 111.78 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -64.95 168.52 6.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.493 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -110.99 22.35 15.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.612 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.563 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 15.3 p90 -144.04 -160.78 1.16 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 109.281 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.983 HG23 HG12 ' A' ' 32' ' ' VAL . 5.0 mt -126.64 143.56 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 109.737 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.893 HD13 ' HB3' ' A' ' 31' ' ' CYS . 6.4 mp -107.57 123.15 48.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.814 . . . . 0.0 109.066 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.045 HD21 ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -102.13 137.48 40.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.548 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.786 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -99.63 160.16 28.1 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.86 . . . . 0.0 109.687 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 51.7 Cg_endo -71.21 -27.92 19.28 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.735 2.29 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.0 m -69.19 -38.9 78.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.1 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.98 ' OD1' HG13 ' A' ' 90' ' ' VAL . 1.7 p30 -74.43 -40.15 62.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.87 . . . . 0.0 108.993 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.98 HG13 ' OD1' ' A' ' 89' ' ' ASP . 3.4 m -111.79 79.99 2.77 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.579 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 48.7 Cg_endo -69.18 -31.39 23.19 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.69 2.26 . . . . 0.0 112.085 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.877 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 30.6 p90 -63.89 -21.58 66.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.096 -1.003 . . . . 0.0 109.419 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.064 HD11 ' CZ2' ' A' ' 23' ' ' TRP . 2.2 mm? 58.08 63.14 1.84 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 109.606 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.86 ' CE ' HD21 ' A' ' 10' ' ' LEU . 36.7 mtt 67.75 169.93 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 109.645 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 18.4 tttt -75.58 136.54 40.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.508 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 2.1 tttp 169.76 -56.2 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.472 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 96' ' ' LYS . 49.1 Cg_endo -68.85 143.51 55.6 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.443 2.095 . . . . 0.0 111.723 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.3 mt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.486 179.987 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.536 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 48.9 Cg_endo -70.16 161.06 47.37 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.7 2.267 . . . . 0.0 111.804 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.536 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 18.3 mt -99.49 178.64 4.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.131 -0.981 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.68 139.85 42.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.354 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.86 149.66 31.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 109.707 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 18' ' ' LYS . 96.2 mt-10 -123.74 116.1 22.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.27 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.843 HG22 ' HG3' ' A' ' 15' ' ' LYS . 49.9 mt -108.95 129.53 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.843 ' HG3' HG22 ' A' ' 14' ' ' ILE . 85.6 mttt 54.91 24.47 5.86 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.253 -0.904 . . . . 0.0 109.62 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.29 -2.61 83.55 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.5 m -89.88 117.37 28.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -1.202 . . . . 0.0 109.491 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.644 ' O ' HD23 ' A' ' 19' ' ' LEU . 84.2 tttt -81.8 125.75 31.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 18' ' ' LYS . 92.5 mt -145.77 161.77 39.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.28 148.6 30.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.785 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -129.92 173.14 10.98 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.172 -0.955 . . . . 0.0 109.532 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.807 ' O ' HD22 ' A' ' 85' ' ' LEU . 41.0 m-70 -127.24 127.99 45.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 0.0 109.657 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.574 ' CH2' ' HB3' ' A' ' 25' ' ' SER . 60.8 t90 -91.94 128.12 37.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.581 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.636 ' CB ' HD21 ' A' ' 84' ' ' LEU . 61.1 t0 -137.82 104.36 5.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.574 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 59.6 p -56.64 -28.0 59.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.895 . . . . 0.0 109.514 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.07 -29.67 74.84 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.77 142.2 58.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -1.176 . . . . 0.0 109.506 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.494 ' O ' HG22 ' A' ' 28' ' ' THR . 86.7 m -108.61 -5.24 16.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.512 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 18.4 tt -152.0 144.54 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.942 ' HB ' HG12 ' A' ' 75' ' ' VAL . 44.8 m -53.94 150.64 7.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.679 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.36 129.59 52.27 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.269 -0.894 . . . . 0.0 109.116 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.764 HG13 ' HD2' ' A' ' 33' ' ' PRO . 77.3 t -134.57 145.83 56.67 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.297 -0.877 . . . . 0.0 109.455 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.764 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.3 Cg_endo -77.95 133.55 12.55 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.291 1.994 . . . . 0.0 111.651 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 40.7 tp10 -42.06 -27.4 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.44 -0.788 . . . . 0.0 109.792 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -47.81 -39.15 17.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.645 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.517 ' CZ ' ' CD1' ' A' ' 19' ' ' LEU . 32.7 m-85 -92.12 -5.48 52.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 109.847 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.7 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -107.66 1.71 23.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.93 . . . . 0.0 109.857 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -50.63 -24.71 3.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.975 . . . . 0.0 109.391 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -125.39 30.1 5.88 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 108.955 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.498 ' CD ' HD22 ' A' ' 62' ' ' LEU . 47.8 mm-40 -105.23 154.78 19.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.849 . . . . 0.0 109.836 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -117.7 128.74 25.81 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.823 . . . . 0.0 109.154 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 51.3 Cg_endo -71.19 119.53 6.35 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.65 2.233 . . . . 0.0 112.05 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.8 pt -75.49 -26.36 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.307 -0.871 . . . . 0.0 109.16 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -145.55 151.15 37.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.352 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 51.5 p -121.06 156.09 32.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.918 . . . . 0.0 109.485 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.2 mtp -147.48 141.5 25.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 0.0 109.47 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.1 tp -98.79 130.13 45.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.472 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.837 HD12 ' HG3' ' A' ' 57' ' ' GLN . 66.3 mt -123.33 127.06 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.147 -0.971 . . . . 0.0 109.527 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.449 ' HG3' ' HG2' ' A' ' 54' ' ' GLU . 36.7 tttt -102.29 126.28 49.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.352 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.31 -169.76 1.52 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.932 . . . . 0.0 109.52 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.484 ' HA ' HD13 ' A' ' 51' ' ' ILE . 15.6 mm -78.62 -47.31 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.331 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -57.4 -41.28 80.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.12 -169.28 41.52 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HG2' ' HG3' ' A' ' 49' ' ' LYS . 98.6 mt-10 -84.06 140.16 32.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -1.168 . . . . 0.0 109.449 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -125.99 141.01 52.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -100.66 117.06 34.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.837 ' HG3' HD12 ' A' ' 48' ' ' ILE . 3.2 mm-40 -112.67 125.15 53.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.469 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.559 ' O ' HD23 ' A' ' 76' ' ' LEU . 91.8 m-20 -109.48 156.0 20.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.875 . . . . 0.0 109.476 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.553 HG11 ' OE1' ' A' ' 74' ' ' GLU . 39.9 t -101.85 142.9 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.377 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.7 ' CD2' HD23 ' A' ' 37' ' ' LEU . 34.6 m-85 -131.31 129.38 41.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.146 -0.971 . . . . 0.0 110.037 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.47 ' O ' HD23 ' A' ' 62' ' ' LEU . 42.9 t80 -94.47 107.74 19.7 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.498 HD22 ' CD ' ' A' ' 40' ' ' GLU . 39.3 mt -118.1 171.29 8.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -0.99 . . . . 0.0 110.334 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.717 HG23 ' HG2' ' A' ' 72' ' ' GLU . 82.8 m -125.93 119.02 26.66 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.575 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 4.1 p90 -140.6 157.73 45.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.791 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 13' ' ' GLU . 20.3 mttm -87.36 132.02 34.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.835 . . . . 0.0 109.383 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.634 HG11 HG11 ' A' ' 90' ' ' VAL . 98.8 t -112.1 107.08 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 83.4 mt-30 63.37 35.46 12.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 109.4 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.74 33.81 32.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -141.24 115.09 9.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -1.116 . . . . 0.0 109.411 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -61.68 123.11 17.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.535 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.654 HG21 ' CH2' ' A' ' 92' ' ' TRP . 92.0 t -144.41 132.58 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.462 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.717 ' HG2' HG23 ' A' ' 63' ' ' THR . 50.4 mt-10 -109.02 138.01 46.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.622 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HB1' ' OD2' ' A' ' 89' ' ' ASP . . . -160.27 165.76 30.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.668 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.553 ' OE1' HG11 ' A' ' 59' ' ' VAL . 96.1 mt-10 -81.42 129.87 34.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.942 HG12 ' HB ' ' A' ' 30' ' ' THR . 3.2 m -124.92 160.88 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.119 -0.988 . . . . 0.0 109.61 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 58' ' ' ASP . 29.0 mt -109.35 145.11 36.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.95 134.76 36.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.438 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.491 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 3.5 t -142.25 149.64 52.43 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.395 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.474 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.7 Cg_endo -70.16 0.26 6.21 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.635 2.223 . . . . 0.0 111.873 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.491 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 66.6 m-85 -65.82 177.52 1.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.333 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -119.85 22.27 11.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.414 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.951 ' OH ' HD12 ' A' ' 84' ' ' LEU . 15.1 p90 -135.78 -173.72 3.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.863 . . . . 0.0 109.183 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.558 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 1.4 mt -131.54 112.33 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.951 HD12 ' OH ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -79.56 135.25 36.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.208 -0.933 . . . . 0.0 109.176 179.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.807 HD22 ' O ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -98.65 134.62 41.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.669 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.745 ' O ' HG22 ' A' ' 90' ' ' VAL . 29.8 t30 -86.21 140.77 34.58 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.441 -0.787 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HD2' ' OD1' ' A' ' 86' ' ' ASN . 46.5 Cg_endo -67.91 -34.54 23.35 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.69 2.26 . . . . 0.0 111.756 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.7 m -66.37 -36.05 81.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.182 -0.949 . . . . 0.0 109.283 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.583 ' OD2' ' HB1' ' A' ' 73' ' ' ALA . 91.8 m-20 -72.42 -32.1 66.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.493 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.184 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -113.93 72.85 2.22 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.4 Cg_endo -71.04 -21.98 26.87 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.667 2.245 . . . . 0.0 112.0 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.184 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 47.0 p90 -74.72 -30.43 61.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.462 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 66.9 mt -59.21 -35.34 73.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 66.1 mtt -58.63 -39.16 79.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 109.614 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -80.19 150.61 30.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 109.573 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 6.2 ttpt 52.33 73.42 0.95 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.563 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.92 145.31 55.86 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.759 2.306 . . . . 0.0 111.7 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.2 mt . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.436 179.922 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.57 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.1 Cg_endo -69.85 160.15 50.73 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.72 2.28 . . . . 0.0 111.811 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.476 ' H ' HD12 ' A' ' 10' ' ' LEU . 4.5 mp -81.27 166.47 20.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.46 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -104.65 144.37 31.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.503 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.2 152.78 30.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 109.463 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.451 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 78.3 tt0 -123.14 120.34 32.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.321 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.86 HG22 ' HG2' ' A' ' 15' ' ' LYS . 57.7 mt -114.92 128.03 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.86 ' HG2' HG22 ' A' ' 14' ' ' ILE . 31.7 mmtp 59.43 23.26 11.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.451 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 86.54 10.51 73.32 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.502 HG22 HD23 ' A' ' 19' ' ' LEU . 33.8 m -108.52 125.8 52.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -1.13 . . . . 0.0 109.451 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 1.031 ' O ' HD22 ' A' ' 19' ' ' LEU . 28.7 mttm -80.28 125.32 29.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.453 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.031 HD22 ' O ' ' A' ' 18' ' ' LYS . 1.3 mm? -141.06 158.26 44.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -80.23 155.44 27.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 109.402 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.538 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -146.73 164.29 33.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.563 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.695 ' O ' HD22 ' A' ' 85' ' ' LEU . 73.4 m-70 -124.9 133.19 53.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.616 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 20.0 t90 -83.95 126.25 32.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -132.91 97.71 4.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.311 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.523 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 52.1 p -58.53 -26.83 63.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.578 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.05 -31.31 76.19 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -77.78 138.32 38.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.173 . . . . 0.0 109.693 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.8 p -98.64 -4.71 33.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.592 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.961 HD13 HD11 ' A' ' 76' ' ' LEU . 21.1 tt -142.65 156.64 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.0 109.327 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.79 ' HB ' HG12 ' A' ' 75' ' ' VAL . 33.5 m -71.71 140.48 49.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.952 . . . . 0.0 109.63 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.545 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -124.31 122.08 36.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.423 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.579 HG13 ' HB ' ' A' ' 75' ' ' VAL . 3.4 m -119.62 164.61 20.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.922 . . . . 0.0 109.368 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.2 Cg_endo -79.04 137.85 14.02 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.475 2.117 . . . . 0.0 111.65 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -47.57 -23.59 0.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 0.0 109.592 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.03 -36.66 18.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.55 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.409 ' CE1' ' HB ' ' A' ' 14' ' ' ILE . 31.1 m-85 -89.61 -10.52 45.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.581 ' CD2' ' CG ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -107.87 38.2 2.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 39' ' ' ASP . 42.7 tp10 -56.83 92.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 109.709 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 37' ' ' LEU . 55.8 m-20 61.93 28.59 17.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.326 -0.859 . . . . 0.0 109.657 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 17.9 mm-40 -59.28 -178.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.94 114.28 43.93 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.539 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 53.9 Cg_endo -72.9 128.37 13.15 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.586 2.19 . . . . 0.0 111.753 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.84 HD13 ' HB2' ' A' ' 61' ' ' TYR . 28.4 pt -84.97 -29.61 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.5 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 1.012 ' O ' HG12 ' A' ' 59' ' ' VAL . 93.9 mt-30 -147.34 165.78 29.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.498 HG22 ' OD1' ' A' ' 58' ' ' ASP . 18.4 p -115.45 154.12 29.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 109.723 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.454 ' O ' ' HG3' ' A' ' 56' ' ' GLN . 24.8 mmm -138.8 161.78 36.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.294 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.965 HD23 ' HG3' ' A' ' 56' ' ' GLN . 49.3 mt -108.17 135.95 48.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 109.643 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.21 131.38 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -100.96 134.65 43.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.565 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 m -126.4 159.61 32.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.375 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.517 HG13 ' N ' ' A' ' 52' ' ' HIS . 19.1 pt -61.19 -39.59 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.176 -0.953 . . . . 0.0 109.457 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.517 ' N ' HG13 ' A' ' 51' ' ' ILE . 79.1 m80 -69.49 -35.75 75.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.912 . . . . 0.0 109.565 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.24 -171.62 44.02 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -102.28 128.76 48.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -1.128 . . . . 0.0 109.53 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -123.28 132.22 53.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 109.5 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.965 ' HG3' HD23 ' A' ' 47' ' ' LEU . 56.7 tt0 -103.77 134.03 47.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.499 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -130.36 155.98 45.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 109.542 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.498 ' OD1' HG22 ' A' ' 45' ' ' THR . 33.1 m-20 -87.27 142.13 28.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.428 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.012 HG12 ' O ' ' A' ' 44' ' ' GLN . 9.6 p -92.29 160.25 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.433 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.581 ' CG ' ' CD2' ' A' ' 37' ' ' LEU . 9.1 m-85 -135.51 142.18 45.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.187 -0.945 . . . . 0.0 109.968 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.84 ' HB2' HD13 ' A' ' 43' ' ' ILE . 48.1 t80 -100.02 112.96 25.24 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 61' ' ' TYR . 57.6 mt -123.19 170.5 10.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 110.417 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.692 HG23 ' HG2' ' A' ' 72' ' ' GLU . 89.4 m -118.84 126.68 52.39 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.751 ' CE2' HG22 ' A' ' 66' ' ' VAL . 35.7 p90 -142.99 154.78 44.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.093 -1.004 . . . . 0.0 109.748 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -88.07 128.4 35.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 109.383 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.751 HG22 ' CE2' ' A' ' 64' ' ' PHE . 2.2 t -105.78 103.78 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 90.0 mt-30 62.01 31.57 17.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.926 . . . . 0.0 109.285 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.99 28.66 25.21 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -132.91 126.53 32.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -1.172 . . . . 0.0 109.508 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -68.28 123.52 20.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.563 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.4 t -145.29 129.05 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.448 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.692 ' HG2' HG23 ' A' ' 63' ' ' THR . 67.2 mt-10 -112.45 135.17 53.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.04 166.07 30.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.739 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.548 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 91.9 mt-10 -80.24 133.26 35.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.283 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.79 HG12 ' HB ' ' A' ' 30' ' ' THR . 3.8 m -129.04 159.47 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.961 HD11 HD13 ' A' ' 29' ' ' ILE . 4.1 mp -110.83 151.28 28.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -0.885 . . . . 0.0 109.406 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.01 142.08 35.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.416 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.476 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 8.3 t -145.05 148.63 39.21 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 109.361 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.476 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.1 Cg_endo -70.34 0.24 6.37 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.649 2.233 . . . . 0.0 111.873 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -63.63 171.88 2.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 109.458 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -111.74 17.59 19.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.59 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.732 ' OH ' HD21 ' A' ' 84' ' ' LEU . 21.6 p90 -141.03 -156.17 0.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.136 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.6 mt -130.46 147.04 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.019 -1.051 . . . . 0.0 109.988 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.732 HD21 ' OH ' ' A' ' 82' ' ' TYR . 1.1 mt -108.99 130.39 55.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 108.98 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.777 ' H ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -99.73 144.29 28.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 109.853 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.587 ' O ' HG22 ' A' ' 90' ' ' VAL . 4.2 t30 -97.02 136.91 21.32 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.453 -0.78 . . . . 0.0 109.034 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.566 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.1 Cg_endo -63.88 -33.56 63.65 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.85 2.367 . . . . 0.0 112.028 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.407 ' HB2' HD21 ' A' ' 86' ' ' ASN . 6.2 m -75.47 -29.43 59.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.302 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 90.4 m-20 -73.35 -31.13 63.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.273 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.75 HG11 HG11 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -121.49 77.54 36.07 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.888 . . . . 0.0 109.363 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.82 -23.83 30.1 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.802 2.335 . . . . 0.0 111.874 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.686 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 32.8 p90 -80.91 -22.42 39.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.418 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.616 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 25.0 tp -56.67 -41.16 76.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.403 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 84.5 mtp -85.02 134.13 34.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.306 -0.871 . . . . 0.0 109.5 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -110.0 147.8 32.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 109.42 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -125.6 76.53 69.74 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.518 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.684 ' O ' HD23 ' A' ' 98' ' ' LEU . 50.0 Cg_endo -70.26 -21.16 31.57 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.633 2.222 . . . . 0.0 111.738 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 97' ' ' PRO . 56.8 mt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.45 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.567 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 47.9 Cg_endo -68.86 149.73 72.8 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.759 2.306 . . . . 0.0 111.763 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.731 ' CD1' HD11 ' A' ' 93' ' ' LEU . 26.4 mt -80.91 -177.58 6.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.486 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -118.02 139.9 50.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.368 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.75 154.01 38.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 17' ' ' THR . 87.1 tt0 -128.5 120.47 26.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.944 . . . . 0.0 109.357 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 1.01 HG22 ' HG3' ' A' ' 15' ' ' LYS . 59.2 mt -115.63 127.83 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.393 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 1.01 ' HG3' HG22 ' A' ' 14' ' ' ILE . 45.6 mttt 60.77 23.76 13.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 109.449 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.427 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.29 -5.22 84.29 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.685 HG22 ' CD2' ' A' ' 19' ' ' LEU . 35.4 m -93.14 127.59 38.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -1.158 . . . . 0.0 109.459 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.871 ' O ' HD22 ' A' ' 19' ' ' LEU . 18.2 tttm -87.24 120.45 28.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.568 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 18' ' ' LYS . 3.5 mm? -129.59 164.6 23.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 109.313 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -83.0 155.96 23.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.938 . . . . 0.0 109.395 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.792 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -144.85 163.24 34.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 73.6 m-70 -125.92 127.8 46.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.527 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.723 ' CD1' HD13 ' A' ' 93' ' ' LEU . 51.9 t90 -78.67 118.5 20.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.907 . . . . 0.0 109.507 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -128.2 102.93 6.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.953 . . . . 0.0 109.336 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.584 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 60.6 p -60.8 -29.2 69.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.609 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.98 -34.36 78.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.08 136.74 54.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.491 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.448 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 36.9 m -95.51 -14.73 23.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 tt -142.36 155.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.564 ' HB ' HG12 ' A' ' 75' ' ' VAL . 47.5 m -61.1 136.93 58.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -119.22 126.6 51.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.382 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.911 HG12 HG23 ' A' ' 83' ' ' ILE . 15.7 m -124.96 161.37 49.55 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 109.66 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 78' ' ' SER . 54.8 Cg_endo -79.38 132.05 9.92 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.751 2.301 . . . . 0.0 111.834 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.1 tt0 -45.36 -26.81 0.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.63 -36.1 33.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.509 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.07 -2.56 57.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.692 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -109.35 0.35 19.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 0.0 109.916 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -51.46 -25.76 6.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.0 109.484 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -122.18 25.41 9.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 109.177 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.663 ' CD ' HD22 ' A' ' 62' ' ' LEU . 55.5 mm-40 -100.55 160.93 13.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.734 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.33 128.99 25.07 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.37 -0.831 . . . . 0.0 109.233 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 52.8 Cg_endo -72.89 121.07 7.03 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.54 2.16 . . . . 0.0 112.048 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.541 HD13 ' HB2' ' A' ' 61' ' ' TYR . 36.4 pt -89.91 -23.5 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.245 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.437 ' HG3' HG13 ' A' ' 43' ' ' ILE . 94.6 mt-30 -141.81 175.3 9.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.26 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 40.2 p -126.67 150.35 49.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.164 -0.96 . . . . 0.0 109.811 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 29.1 tpp -132.37 145.74 51.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.324 -0.86 . . . . 0.0 109.462 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.748 ' N ' HD12 ' A' ' 47' ' ' LEU . 5.1 mp -102.18 132.6 48.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.9 . . . . 0.0 109.446 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 66.2 mt -122.4 135.15 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.493 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -111.39 135.95 51.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.166 -0.958 . . . . 0.0 109.57 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.1 p -127.12 157.94 38.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 109.363 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 52' ' ' HIS . 11.1 tp -56.92 -38.02 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.503 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.456 ' N ' HG23 ' A' ' 51' ' ' ILE . 67.2 m80 -67.09 -39.42 86.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.495 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.82 -170.14 41.06 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.32 132.2 44.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -1.193 . . . . 0.0 109.557 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.465 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 54.2 tptt -129.17 131.22 47.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.425 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.421 ' OE1' HD23 ' A' ' 47' ' ' LEU . 25.9 mt-30 -111.54 141.6 44.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.682 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.885 ' NE2' HD21 ' A' ' 76' ' ' LEU . 25.5 mt-30 -132.27 157.54 44.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.267 -0.896 . . . . 0.0 109.296 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 58.2 m-20 -90.88 142.16 28.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.756 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 20.5 t -83.42 154.83 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 108.985 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.692 ' CD2' HD23 ' A' ' 37' ' ' LEU . 17.5 m-85 -135.51 130.21 34.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 110.011 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.541 ' HB2' HD13 ' A' ' 43' ' ' ILE . 48.6 t80 -95.86 112.0 23.84 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.663 HD22 ' CD ' ' A' ' 40' ' ' GLU . 37.6 mt -121.79 170.22 9.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.052 -1.03 . . . . 0.0 110.489 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.717 HG23 ' HG2' ' A' ' 72' ' ' GLU . 87.1 m -121.97 119.77 32.47 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.763 ' CE2' HG22 ' A' ' 66' ' ' VAL . 44.6 p90 -140.68 154.46 46.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.026 -1.046 . . . . 0.0 109.739 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.431 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 20.1 mttm -85.87 132.33 34.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.833 . . . . 0.0 109.318 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.763 HG22 ' CE2' ' A' ' 64' ' ' PHE . 1.9 t -109.0 100.86 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.703 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 81.2 mt-30 65.09 35.45 7.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.458 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.33 35.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -134.08 116.73 15.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -1.072 . . . . 0.0 109.424 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.555 ' HE3' HG21 ' A' ' 63' ' ' THR . 15.3 tttp -66.8 119.7 12.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.534 HG21 ' CH2' ' A' ' 92' ' ' TRP . 98.6 t -141.24 134.39 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.867 . . . . 0.0 109.429 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.717 ' HG2' HG23 ' A' ' 63' ' ' THR . 61.1 mt-10 -110.5 136.13 50.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 109.593 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.26 166.34 29.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.672 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.533 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 96.3 mt-10 -80.02 136.24 36.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.27 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.718 HG21 HG21 ' A' ' 32' ' ' VAL . 4.1 m -127.96 158.19 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.22 -0.925 . . . . 0.0 109.65 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.885 HD21 ' NE2' ' A' ' 57' ' ' GLN . 32.4 tp -109.32 146.09 34.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.8 124.5 28.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 109.227 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.483 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 2.0 t -128.09 150.21 73.18 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.483 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.8 Cg_endo -70.58 -0.3 7.39 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.683 2.255 . . . . 0.0 111.628 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 56.0 m-85 -64.13 172.14 2.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 109.444 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -112.14 17.09 19.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.607 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.68 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 19.3 p90 -139.35 -156.82 0.71 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.245 -0.909 . . . . 0.0 109.087 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.911 HG23 HG12 ' A' ' 32' ' ' VAL . 3.0 mt -130.04 140.9 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.72 ' N ' HD12 ' A' ' 84' ' ' LEU . 6.5 mp -105.5 131.77 52.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 108.987 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.792 HD21 ' HB1' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -98.94 146.55 25.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.139 -0.976 . . . . 0.0 109.666 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.676 ' O ' HG22 ' A' ' 90' ' ' VAL . 4.7 t30 -99.74 136.86 20.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 109.189 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.524 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.6 Cg_endo -64.13 -33.26 61.93 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.805 2.336 . . . . 0.0 111.81 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.408 ' HB3' HD21 ' A' ' 86' ' ' ASN . 4.8 t -76.56 -25.95 54.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.18 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.432 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 89.6 m-20 -80.26 -32.69 38.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.376 -0.827 . . . . 0.0 109.306 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.964 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -120.03 76.23 22.45 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.872 . . . . 0.0 109.54 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.27 -24.85 26.87 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.682 2.255 . . . . 0.0 111.796 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.964 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 39.8 p90 -75.27 -27.59 59.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -0.89 . . . . 0.0 109.585 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.731 HD11 ' CD1' ' A' ' 10' ' ' LEU . 9.4 tt -56.75 -39.4 73.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.3 mmm -100.03 143.09 30.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.425 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -91.41 139.88 30.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.93 . . . . 0.0 109.48 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -73.47 132.66 81.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.541 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.08 145.6 55.75 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.769 2.313 . . . . 0.0 111.839 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.844 ' N ' HD12 ' A' ' 98' ' ' LEU . 4.0 mp . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 109.417 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.566 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 48.9 Cg_endo -69.79 146.85 61.25 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.687 2.258 . . . . 0.0 111.793 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.494 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 20.9 mt -83.79 -177.36 6.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.92 . . . . 0.0 109.559 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -117.93 136.97 53.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 109.389 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.98 150.13 32.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.207 -0.933 . . . . 0.0 109.653 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.445 ' HG2' ' HA ' ' A' ' 18' ' ' LYS . 95.5 mt-10 -118.58 123.04 44.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.28 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' A' ' 64' ' ' PHE . 56.2 mt -117.37 124.11 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.582 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.7 tptt 64.11 22.13 12.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.524 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.13 -1.03 82.39 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.734 HG22 ' CD2' ' A' ' 19' ' ' LEU . 10.6 m -96.16 129.66 43.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.136 . . . . 0.0 109.384 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.88 ' O ' HD22 ' A' ' 19' ' ' LEU . 71.4 tttt -86.9 117.02 25.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.44 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.88 HD22 ' O ' ' A' ' 18' ' ' LYS . 3.8 mm? -132.17 161.37 33.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.386 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -84.45 153.57 23.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.419 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.789 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -141.58 163.01 34.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 109.56 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.566 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 74.2 m-70 -121.01 127.72 52.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 109.627 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.494 ' HB2' ' CD1' ' A' ' 10' ' ' LEU . 34.1 t90 -80.39 118.89 22.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.587 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -127.67 102.97 7.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.265 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' A' ' 87' ' ' PRO . 23.4 t -59.12 -29.43 67.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 109.625 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.51 -40.16 94.06 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.434 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -65.19 128.27 35.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -1.151 . . . . 0.0 109.487 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.509 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 45.6 p -94.09 -8.07 40.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.217 -0.927 . . . . 0.0 109.447 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 29' ' ' ILE . 11.1 tp -139.09 151.23 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.245 -0.909 . . . . 0.0 109.293 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 34.7 m -68.59 140.06 55.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 9.2 t -129.51 139.24 51.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.256 -0.903 . . . . 0.0 109.14 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.546 ' HB ' ' HD2' ' A' ' 33' ' ' PRO . 4.0 m -136.85 167.05 22.85 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.225 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.546 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.5 Cg_endo -78.93 134.32 11.77 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.202 1.935 . . . . 0.0 111.704 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 38' ' ' GLU . 81.3 tt0 -45.05 -24.58 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.363 -0.836 . . . . 0.0 109.874 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -47.71 -36.18 10.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 109.723 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.483 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 38.4 m-85 -92.38 -7.41 47.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.182 -0.949 . . . . 0.0 109.588 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.652 HD12 ' HG3' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -106.0 -12.89 15.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 109.527 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 34' ' ' GLU . 81.2 tt0 -49.81 -22.83 1.58 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.107 -0.995 . . . . 0.0 109.398 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -122.61 14.64 10.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.309 -0.869 . . . . 0.0 109.124 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.724 ' CD ' HD11 ' A' ' 62' ' ' LEU . 61.4 mm-40 -98.69 155.85 17.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.154 -0.966 . . . . 0.0 109.673 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -111.37 129.27 24.24 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.374 -0.829 . . . . 0.0 109.052 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.568 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 50.0 Cg_endo -70.34 120.29 7.02 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.522 2.148 . . . . 0.0 111.939 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.735 HD13 ' HB2' ' A' ' 61' ' ' TYR . 21.2 pt -88.21 -27.82 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.245 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.463 ' O ' ' N ' ' A' ' 59' ' ' VAL . 63.9 tt0 -142.67 164.13 30.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.264 -0.898 . . . . 0.0 109.259 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.436 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 69.9 p -115.59 158.92 21.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.405 ' HE1' ' CD1' ' A' ' 48' ' ' ILE . 4.0 ttp -147.14 145.29 29.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.528 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.833 HD23 ' HG3' ' A' ' 56' ' ' GLN . 42.1 mt -83.67 129.67 34.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 109.615 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 55' ' ' LYS . 30.1 mm -115.78 131.78 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 109.301 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 54.4 tttt -103.94 127.69 51.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 0.0 109.55 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -115.76 -178.31 3.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 109.672 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 55.8 mt -70.77 -50.3 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -56.51 -42.06 77.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -177.41 -159.1 21.91 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 81.8 tt0 -105.42 129.07 53.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -1.111 . . . . 0.0 109.507 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 48' ' ' ILE . 83.2 tttt -129.14 136.48 50.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.833 ' HG3' HD23 ' A' ' 47' ' ' LEU . 62.7 tt0 -94.39 129.85 40.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.699 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.428 ' NE2' HG13 ' A' ' 48' ' ' ILE . 24.8 mt-30 -115.99 159.37 21.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.905 . . . . 0.0 109.388 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.451 ' HB3' ' CB ' ' A' ' 42' ' ' PRO . 62.7 m-20 -86.54 142.27 28.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.0 109.611 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 14.4 t -89.04 151.12 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 109.269 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.58 ' CD2' ' HG ' ' A' ' 37' ' ' LEU . 26.6 m-85 -132.4 137.51 47.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.138 -0.977 . . . . 0.0 110.316 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.82 ' O ' HD22 ' A' ' 62' ' ' LEU . 4.8 t80 -98.19 110.13 22.77 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.82 HD22 ' O ' ' A' ' 61' ' ' TYR . 3.6 mm? -124.03 156.35 36.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.481 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.548 HG23 ' HB2' ' A' ' 72' ' ' GLU . 5.0 m -110.97 126.09 54.4 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.443 -0.786 . . . . 0.0 108.931 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.624 ' CE2' HG22 ' A' ' 66' ' ' VAL . 28.1 p90 -141.48 153.39 44.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.107 -0.995 . . . . 0.0 109.694 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 6.0 mmtp -83.85 127.95 34.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.28 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.891 HG11 HG11 ' A' ' 90' ' ' VAL . 25.1 t -105.75 98.99 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 82.1 mt-30 64.68 36.5 8.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.51 30.01 31.3 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 65' ' ' LYS . 56.6 mtt180 -136.7 125.17 23.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -1.134 . . . . 0.0 109.449 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -67.33 128.41 36.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.473 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.437 HG21 ' CH2' ' A' ' 92' ' ' TRP . 43.3 t -150.0 128.18 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.56 ' HG2' ' CE2' ' A' ' 61' ' ' TYR . 55.2 tt0 -118.31 134.59 54.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.0 175.23 13.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.268 -0.895 . . . . 0.0 109.434 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 95.6 mt-10 -79.71 139.65 37.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 109.261 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' ' 32' ' ' VAL . 10.8 m -133.82 151.86 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.269 -0.894 . . . . 0.0 109.583 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.852 ' N ' HD12 ' A' ' 76' ' ' LEU . 4.3 mp -102.61 145.77 29.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.33 -0.856 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.0 137.94 36.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.298 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.478 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.3 t -144.02 151.17 51.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.0 Cg_endo -71.79 2.53 4.62 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.69 2.26 . . . . 0.0 111.83 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -63.55 167.11 5.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.162 -0.962 . . . . 0.0 109.338 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -109.71 17.71 20.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.762 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 14.5 p90 -139.49 -157.71 0.79 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.136 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.541 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.0 mt -128.98 145.82 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 109.575 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.762 HD11 ' CZ ' ' A' ' 82' ' ' TYR . 5.9 mp -110.76 135.0 52.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -0.882 . . . . 0.0 108.872 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.835 ' N ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -105.64 142.49 35.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.606 ' O ' HG22 ' A' ' 90' ' ' VAL . 6.5 t30 -100.13 134.86 20.56 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 108.949 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.492 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 41.5 Cg_endo -63.86 -22.85 68.88 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.769 2.313 . . . . 0.0 112.234 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.431 ' HB2' HD21 ' A' ' 86' ' ' ASN . 14.2 m -77.05 -31.62 56.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 0.0 109.298 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.914 ' OD1' HG13 ' A' ' 90' ' ' VAL . 1.9 p30 -80.37 -35.63 35.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 109.378 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.035 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 2.4 m -112.1 69.28 0.92 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.391 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.87 -21.94 32.26 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.679 2.252 . . . . 0.0 111.813 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.035 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 38.7 p90 -72.76 -28.8 62.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.431 HD13 HE22 ' A' ' 67' ' ' GLN . 24.2 tp -66.68 -36.27 82.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 90.6 mtp -66.85 -33.07 74.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 109.55 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -94.79 141.15 28.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 109.454 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.8 79.52 68.21 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.14 -0.975 . . . . 0.0 109.612 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.96 143.58 50.31 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.656 2.238 . . . . 0.0 111.782 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.6 tp . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.483 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.573 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.4 Cg_endo -70.15 154.91 65.76 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.745 2.296 . . . . 0.0 111.707 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.71 HD12 HD13 ' A' ' 85' ' ' LEU . 17.2 mt -81.45 179.92 7.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.33 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -110.48 139.13 46.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.89 148.65 32.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.488 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.436 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 79.3 tt0 -129.23 116.08 18.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -0.86 . . . . 0.0 109.37 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.642 HG22 ' HG3' ' A' ' 15' ' ' LYS . 59.4 mt -111.72 127.31 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.14 -0.975 . . . . 0.0 109.592 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.642 ' HG3' HG22 ' A' ' 14' ' ' ILE . 54.4 mttp 57.88 24.76 11.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.288 -0.882 . . . . 0.0 109.599 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.436 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 89.52 -10.69 72.54 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.426 HG21 ' HZ ' ' A' ' 36' ' ' PHE . 50.0 m -79.72 125.51 29.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -1.105 . . . . 0.0 109.312 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.755 ' O ' HD23 ' A' ' 19' ' ' LEU . 3.3 ttmt -88.81 117.34 27.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.527 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.775 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 73.3 mt -136.54 156.52 48.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.868 . . . . 0.0 109.363 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -84.72 151.75 24.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.865 ' CB ' HD21 ' A' ' 85' ' ' LEU . . . -133.69 -179.76 5.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.936 . . . . 0.0 109.578 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 67.5 m-70 -134.24 131.16 38.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.901 . . . . 0.0 109.599 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.596 ' N ' HD12 ' A' ' 85' ' ' LEU . 64.4 t90 -88.33 119.04 28.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.264 -0.898 . . . . 0.0 109.352 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -128.21 103.02 6.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.297 -0.877 . . . . 0.0 109.427 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.511 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 21.4 t -55.83 -31.84 63.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.646 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.27 -37.51 91.96 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.467 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -68.03 144.94 54.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -1.192 . . . . 0.0 109.517 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.517 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 39.7 p -113.13 -5.6 13.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.459 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.8 tt -141.8 146.28 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 0.0 109.423 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.641 ' HB ' HG22 ' A' ' 75' ' ' VAL . 51.7 m -66.73 141.17 57.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 0.0 109.633 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -126.66 136.41 52.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.995 HG12 HG23 ' A' ' 83' ' ' ILE . 25.0 m -132.38 165.02 39.31 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.831 . . . . 0.0 108.899 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.4 Cg_endo -78.23 129.84 9.81 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.115 1.876 . . . . 0.0 111.419 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 81.3 tt0 -40.87 -27.82 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.53 -0.731 . . . . 0.0 109.891 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -50.79 -28.33 9.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.538 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.775 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 15.0 m-85 -96.36 -7.76 34.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 109.528 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.64 ' CD2' ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -108.11 -5.43 16.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.797 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 93.7 mt-10 -48.66 -26.9 2.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.103 -0.998 . . . . 0.0 109.291 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -121.96 26.13 8.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.943 . . . . 0.0 109.189 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.489 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 40.9 mm-40 -101.62 158.94 15.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.594 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.57 130.47 24.84 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.355 -0.84 . . . . 0.0 109.246 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.574 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 52.3 Cg_endo -71.3 119.73 6.48 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 122.626 2.218 . . . . 0.0 111.822 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.658 HD13 ' HB2' ' A' ' 61' ' ' TYR . 37.9 pt -73.77 -34.36 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.89 . . . . 0.0 109.117 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.507 ' N ' HG13 ' A' ' 43' ' ' ILE . 89.7 mt-30 -140.05 157.26 45.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.356 -0.84 . . . . 0.0 109.033 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 33.0 p -125.99 157.36 38.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 109.757 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.3 mtp -132.94 146.7 52.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 0.0 109.328 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 tp -102.93 127.66 50.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.932 . . . . 0.0 109.531 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.3 mt -116.63 137.42 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.352 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.1 tttt -126.29 130.24 50.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.548 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.6 p -128.8 158.12 39.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.44 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.1 tt -56.06 -34.46 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.913 . . . . 0.0 109.458 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -68.43 -40.73 81.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.521 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.52 -170.01 41.84 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -99.15 134.2 42.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -1.141 . . . . 0.0 109.553 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -115.67 145.92 42.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.283 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -114.04 123.09 48.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.73 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.658 ' CD ' HD11 ' A' ' 76' ' ' LEU . 2.2 tp60 -126.56 132.62 51.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.341 -0.849 . . . . 0.0 109.393 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 45.0 m-20 -121.07 153.99 36.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.249 -0.907 . . . . 0.0 109.304 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.9 m -98.61 150.58 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.444 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.64 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 25.5 m-85 -128.6 127.06 41.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.87 . . . . 0.0 109.794 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.658 ' HB2' HD13 ' A' ' 43' ' ' ILE . 34.5 t80 -87.14 114.12 23.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.887 . . . . 0.0 108.776 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 61' ' ' TYR . 32.4 mt -120.89 163.45 18.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.133 -0.979 . . . . 0.0 110.235 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.733 HG23 ' HG2' ' A' ' 72' ' ' GLU . 41.5 m -124.24 121.12 34.17 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.709 ' CE2' HG22 ' A' ' 66' ' ' VAL . 22.0 p90 -145.4 164.17 32.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.951 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -90.87 132.95 35.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.414 -0.804 . . . . 0.0 109.339 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.823 HG11 HG11 ' A' ' 90' ' ' VAL . 38.3 t -111.4 98.3 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.552 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 88.0 mt-30 63.35 36.28 11.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.325 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.45 35.08 18.13 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -141.98 124.59 15.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -1.1 . . . . 0.0 109.39 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -69.68 122.44 19.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.14 134.79 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.887 . . . . 0.0 109.556 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.733 ' HG2' HG23 ' A' ' 63' ' ' THR . 52.1 mt-10 -125.77 132.59 52.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.557 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.29 -176.99 5.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.82 154.03 28.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.273 -0.892 . . . . 0.0 109.091 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.786 ' CG1' HG22 ' A' ' 32' ' ' VAL . 56.0 t -144.83 157.64 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.188 -0.945 . . . . 0.0 109.748 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.658 HD11 ' CD ' ' A' ' 57' ' ' GLN . 16.4 tp -117.58 144.4 45.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 109.041 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.97 137.46 36.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 109.529 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.475 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 3.2 t -142.31 150.23 54.35 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.332 -0.855 . . . . 0.0 109.471 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.475 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 52.8 Cg_endo -72.68 5.71 2.76 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.602 2.202 . . . . 0.0 111.905 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -64.73 -178.94 0.45 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -118.87 14.68 13.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.471 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.578 ' CZ ' ' HG ' ' A' ' 84' ' ' LEU . 20.5 p90 -142.28 -156.99 0.73 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 108.972 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.995 HG23 HG12 ' A' ' 32' ' ' VAL . 2.8 mt -128.84 128.28 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.25 -0.906 . . . . 0.0 109.812 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.578 ' HG ' ' CZ ' ' A' ' 82' ' ' TYR . 1.7 mt -83.86 136.91 33.93 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.2 -0.937 . . . . 0.0 108.713 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.865 HD21 ' CB ' ' A' ' 21' ' ' ALA . 5.2 mt -102.13 143.57 31.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 0.0 110.049 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.665 ' O ' HG22 ' A' ' 90' ' ' VAL . 10.3 t-20 -102.54 133.12 20.68 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.472 -0.768 . . . . 0.0 109.133 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 44.2 Cg_endo -66.05 -30.27 47.67 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.759 2.306 . . . . 0.0 111.929 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.409 ' HB2' HD21 ' A' ' 86' ' ' ASN . 14.7 m -76.21 -31.75 58.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.162 -0.961 . . . . 0.0 109.238 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -73.21 -28.3 62.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.382 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.938 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 2.2 m -124.1 77.83 59.45 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.559 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.5 Cg_endo -70.14 -20.45 33.03 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.731 2.287 . . . . 0.0 111.972 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.938 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 48.8 p90 -80.99 -27.45 35.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.812 ' O ' HD13 ' A' ' 93' ' ' LEU . 3.4 tm? -57.95 -37.91 75.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 109.391 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 71.5 mtm -81.62 131.68 35.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.395 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -58.49 -33.11 69.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.462 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt 55.93 67.78 2.72 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.52 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.48 145.02 51.8 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.713 2.275 . . . . 0.0 111.776 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 24.0 tp . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.159 -0.963 . . . . 0.0 109.484 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.546 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.9 Cg_endo -70.45 160.71 48.57 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.732 2.288 . . . . 0.0 111.747 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.471 ' H ' HD12 ' A' ' 10' ' ' LEU . 4.5 mp -81.8 176.36 9.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.428 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -104.76 140.31 38.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.65 152.7 33.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.873 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 17' ' ' THR . 91.9 mt-10 -129.35 116.35 18.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 109.531 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.926 HG22 ' HG3' ' A' ' 15' ' ' LYS . 33.5 mt -109.88 128.76 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 109.401 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.926 ' HG3' HG22 ' A' ' 14' ' ' ILE . 2.8 mtmt 58.71 22.32 9.84 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.178 -0.951 . . . . 0.0 109.55 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.72 -0.88 83.15 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.471 HG22 HD23 ' A' ' 19' ' ' LEU . 31.2 m -93.46 132.7 37.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -1.218 . . . . 0.0 109.479 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.981 ' O ' HD22 ' A' ' 19' ' ' LEU . 25.7 tttt -83.05 121.15 26.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.51 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.981 HD22 ' O ' ' A' ' 18' ' ' LYS . 1.6 mm? -138.34 158.82 43.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.945 . . . . 0.0 109.545 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HD3' ' CG ' ' A' ' 9' ' ' PRO . 46.2 mttt -82.48 147.01 28.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.75 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -134.86 159.78 40.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.373 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.855 ' O ' HD22 ' A' ' 85' ' ' LEU . 53.1 m-70 -123.06 133.97 54.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.42 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.948 ' CD1' HD23 ' A' ' 93' ' ' LEU . 63.5 t90 -95.29 121.81 37.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.598 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.744 ' CB ' HD21 ' A' ' 84' ' ' LEU . 61.1 t0 -131.07 103.79 6.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -0.881 . . . . 0.0 109.306 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.564 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 56.1 p -56.69 -16.84 7.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.58 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.92 -35.51 58.07 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.465 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -69.6 140.79 53.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -1.152 . . . . 0.0 109.594 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.8 p -107.02 -0.89 22.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 0.0 109.495 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.858 HD13 HD11 ' A' ' 76' ' ' LEU . 20.0 tt -144.26 152.52 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.232 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.661 ' HB ' HG12 ' A' ' 75' ' ' VAL . 34.5 m -65.99 149.9 49.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.501 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 84' ' ' LEU . 13.1 t -123.06 141.66 51.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.173 -0.955 . . . . 0.0 109.121 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.771 HG23 ' HB ' ' A' ' 75' ' ' VAL . 74.3 t -143.43 145.9 33.72 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.412 -0.805 . . . . 0.0 109.308 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.738 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.4 Cg_endo -77.76 132.11 11.73 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.245 1.964 . . . . 0.0 111.447 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 33' ' ' PRO . 82.6 tt0 -41.59 -28.1 0.12 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.429 -0.794 . . . . 0.0 109.71 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -51.46 -30.21 18.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.145 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -97.63 0.39 47.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 109.712 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.642 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -113.01 -3.61 14.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.013 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -52.1 -24.12 6.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.127 -0.983 . . . . 0.0 109.433 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -126.14 27.7 6.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 108.96 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.462 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 52.0 mm-40 -103.23 173.05 6.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 109.945 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -132.76 128.22 20.73 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 109.207 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.571 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 53.7 Cg_endo -73.74 123.82 8.8 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.631 2.221 . . . . 0.0 111.917 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.604 HD13 ' HB2' ' A' ' 61' ' ' TYR . 33.5 pt -85.31 -28.31 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.171 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.416 ' N ' HG13 ' A' ' 43' ' ' ILE . 93.6 mt-30 -143.89 166.57 24.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.879 . . . . 0.0 109.202 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 61.3 p -124.75 151.09 45.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.808 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.504 ' CE ' HG21 ' A' ' 59' ' ' VAL . 64.9 mtt -138.68 142.31 38.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.337 -0.852 . . . . 0.0 109.324 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.552 HD23 ' C ' ' A' ' 47' ' ' LEU . 9.2 tt -96.36 131.91 42.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.602 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.51 ' N ' HD23 ' A' ' 47' ' ' LEU . 69.0 mt -118.59 133.54 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.365 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -113.98 136.22 53.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.56 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.8 p -129.15 158.27 39.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 109.512 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.443 HG23 ' N ' ' A' ' 52' ' ' HIS . 10.8 tp -56.52 -37.04 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.515 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.443 ' N ' HG23 ' A' ' 51' ' ' ILE . 58.8 t-80 -67.41 -37.9 83.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.521 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.67 -175.41 47.35 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -106.46 128.46 54.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -1.1 . . . . 0.0 109.545 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -131.27 137.55 48.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.91 . . . . 0.0 109.387 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 46' ' ' MET . 38.9 tt0 -114.34 130.44 56.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.194 -0.941 . . . . 0.0 109.673 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -120.64 159.62 24.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 109.213 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 52.6 m-20 -98.73 141.12 31.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.135 -0.978 . . . . 0.0 109.628 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.541 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 15.9 t -82.64 150.44 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.082 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.642 ' CD2' HD23 ' A' ' 37' ' ' LEU . 13.8 m-85 -131.43 135.49 47.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.121 -0.987 . . . . 0.0 109.99 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.604 ' HB2' HD13 ' A' ' 43' ' ' ILE . 46.5 t80 -99.83 113.65 26.31 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 61' ' ' TYR . 40.2 mt -122.46 169.35 11.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.705 HG23 ' HG2' ' A' ' 72' ' ' GLU . 97.8 m -120.7 116.48 25.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.586 ' CE2' HG22 ' A' ' 66' ' ' VAL . 22.6 p90 -136.41 158.19 45.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.057 -1.027 . . . . 0.0 109.773 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 13' ' ' GLU . 40.8 mttm -89.98 129.12 36.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.322 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.796 HG11 HG11 ' A' ' 90' ' ' VAL . 11.7 t -105.99 101.88 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.917 . . . . 0.0 109.515 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 80.4 mt-30 64.32 38.98 7.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.895 . . . . 0.0 109.412 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.62 32.43 41.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.0 mtt-85 -138.33 114.51 10.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.442 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HE2' HG21 ' A' ' 63' ' ' THR . 72.6 tttt -61.49 122.75 15.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.616 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.511 HG21 ' CH2' ' A' ' 92' ' ' TRP . 58.8 t -145.32 130.13 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.224 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.705 ' HG2' HG23 ' A' ' 63' ' ' THR . 82.1 mt-10 -108.3 137.36 46.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 0.0 109.617 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.3 166.56 29.26 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.603 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.541 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 93.6 mt-10 -79.86 140.57 36.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.771 ' HB ' HG23 ' A' ' 32' ' ' VAL . 10.2 m -131.16 153.19 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.635 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.858 HD11 HD13 ' A' ' 29' ' ' ILE . 5.2 mp -107.48 148.42 29.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.385 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.78 140.09 37.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 109.425 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.501 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -151.56 152.86 31.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.296 -0.877 . . . . 0.0 109.239 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.501 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.0 Cg_endo -70.57 2.49 3.94 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.528 2.152 . . . . 0.0 112.034 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 34.0 m-85 -65.88 170.38 5.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 109.438 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -114.43 21.19 14.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.365 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.582 ' OH ' HD12 ' A' ' 84' ' ' LEU . 33.3 p90 -142.01 -166.5 2.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 109.143 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 19' ' ' LEU . 1.5 mt -132.02 118.62 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.923 . . . . 0.0 109.64 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.744 HD21 ' CB ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -82.61 134.45 35.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 108.987 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.855 HD22 ' O ' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -97.31 142.26 29.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.065 -1.022 . . . . 0.0 109.763 -179.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.645 ' O ' HG22 ' A' ' 90' ' ' VAL . 6.5 t-20 -90.11 135.57 29.84 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.033 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.56 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 41.5 Cg_endo -64.1 -33.14 62.71 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.805 2.337 . . . . 0.0 111.972 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.409 ' HB2' HD21 ' A' ' 86' ' ' ASN . 13.4 m -71.88 -28.02 63.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.118 -0.989 . . . . 0.0 109.107 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -79.17 -30.79 43.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 109.344 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.127 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -119.67 74.25 17.72 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.917 . . . . 0.0 109.328 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.575 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.9 Cg_endo -69.6 -18.92 37.49 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.749 2.299 . . . . 0.0 111.926 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.127 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 48.9 p90 -81.21 -26.24 36.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.479 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.948 HD23 ' CD1' ' A' ' 23' ' ' TRP . 24.1 tp -60.47 -32.04 71.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.442 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 87.6 mtp -81.29 130.41 35.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.192 -0.943 . . . . 0.0 109.486 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -71.06 138.52 49.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.24 140.63 93.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.287 -0.883 . . . . 0.0 109.453 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.25 -20.73 32.17 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.696 2.264 . . . . 0.0 111.83 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.8 mt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 48.8 Cg_endo -69.89 158.48 56.64 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.568 2.179 . . . . 0.0 111.694 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 23' ' ' TRP . 25.2 mt -90.6 -177.32 5.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.582 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -112.19 134.44 53.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.353 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.0 146.24 28.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -0.948 . . . . 0.0 109.5 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 17' ' ' THR . 65.4 tt0 -121.97 122.21 38.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.883 . . . . 0.0 109.224 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.456 HG12 ' HB3' ' A' ' 64' ' ' PHE . 43.2 mt -114.74 127.12 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.694 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 58.07 25.59 12.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.531 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.44 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 90.66 -13.69 65.0 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 52.8 m -79.78 131.85 36.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -1.21 . . . . 0.0 109.385 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.865 ' O ' HD23 ' A' ' 19' ' ' LEU . 29.7 tttm -96.4 123.9 40.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 109.62 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.865 HD23 ' O ' ' A' ' 18' ' ' LYS . 57.2 mt -143.32 162.67 35.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -89.43 146.93 24.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.928 . . . . 0.0 109.527 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.621 ' CB ' HD11 ' A' ' 85' ' ' LEU . . . -130.01 176.58 7.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.749 ' O ' HD22 ' A' ' 85' ' ' LEU . 59.5 m-70 -127.47 129.97 48.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.455 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.605 ' HB2' HD11 ' A' ' 10' ' ' LEU . 20.6 t90 -83.17 122.54 28.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.683 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -127.52 96.28 4.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.341 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.46 ' HA ' ' HG3' ' A' ' 87' ' ' PRO . 17.3 t -53.68 -33.9 56.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.645 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.62 -35.65 86.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.32 137.22 57.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -1.166 . . . . 0.0 109.631 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.518 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 89.2 m -102.07 -9.43 20.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 109.381 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.435 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 20.1 tt -139.61 160.12 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.335 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.513 ' CG2' HG12 ' A' ' 75' ' ' VAL . 38.5 m -71.51 150.19 45.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.315 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.556 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -126.83 127.17 44.57 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -0.916 . . . . 0.0 108.998 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.78 HG13 ' HD2' ' A' ' 33' ' ' PRO . 53.8 t -126.92 147.37 61.11 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 109.176 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.78 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.5 Cg_endo -77.26 132.99 12.95 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.176 1.917 . . . . 0.0 111.914 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 33' ' ' PRO . 80.5 tt0 -43.01 -26.67 0.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.741 . . . . 0.0 109.701 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.48 -23.09 1.41 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.516 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.611 ' HZ ' HD11 ' A' ' 19' ' ' LEU . 14.1 m-85 -102.44 -6.41 22.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.518 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.031 HD11 HD11 ' A' ' 62' ' ' LEU . 2.7 mm? -109.98 -5.36 15.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.198 -0.939 . . . . 0.0 109.558 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 94.2 mt-10 -45.27 -44.38 11.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.381 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -107.26 24.51 12.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.381 -0.824 . . . . 0.0 109.472 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.546 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 72.2 mm-40 -108.74 -171.35 1.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.796 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -146.54 129.47 8.03 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.455 -0.778 . . . . 0.0 109.144 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.576 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 49.6 Cg_endo -69.38 123.34 10.13 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 122.733 2.289 . . . . 0.0 111.87 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.559 HD13 ' HB2' ' A' ' 61' ' ' TYR . 37.0 pt -78.46 -27.3 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -0.842 . . . . 0.0 109.57 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.931 ' O ' HG12 ' A' ' 59' ' ' VAL . 81.7 mt-30 -146.62 163.45 35.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 109.612 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 34.0 p -112.03 158.4 19.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.299 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 46.0 ttm -142.1 137.19 30.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 109.507 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.922 HD21 ' OE2' ' A' ' 54' ' ' GLU . 27.1 tp -94.47 129.13 41.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.575 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 71.5 mt -117.83 131.3 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.86 . . . . 0.0 109.44 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 15.6 tttp -125.58 119.89 29.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 0.0 109.428 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.49 -170.34 1.65 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 109.556 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 51' ' ' ILE . 19.4 mm -78.22 -46.85 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -58.69 -38.87 79.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.0 -173.06 43.98 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.922 ' OE2' HD21 ' A' ' 47' ' ' LEU . 80.4 tt0 -113.28 131.02 56.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -1.078 . . . . 0.0 109.394 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 23.4 mttm -129.46 131.26 46.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 109.471 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.545 ' HB2' HD12 ' A' ' 47' ' ' LEU . 48.8 tt0 -102.49 128.47 49.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.845 ' NE2' HD21 ' A' ' 76' ' ' LEU . 26.4 mt-30 -128.28 154.27 46.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.483 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.49 ' HB3' ' CB ' ' A' ' 42' ' ' PRO . 67.4 m-20 -90.54 152.56 20.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.73 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.931 HG12 ' O ' ' A' ' 44' ' ' GLN . 9.3 p -95.52 158.49 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.299 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.576 ' CE2' ' HD3' ' A' ' 42' ' ' PRO . 20.5 m-85 -136.83 126.35 25.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.852 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.685 ' O ' HD23 ' A' ' 62' ' ' LEU . 41.3 t80 -91.36 119.4 31.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 108.844 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.031 HD11 HD11 ' A' ' 37' ' ' LEU . 64.4 mt -131.16 170.18 14.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.387 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.705 HG23 ' HG2' ' A' ' 72' ' ' GLU . 87.9 m -119.56 122.92 42.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.517 -0.739 . . . . 0.0 109.084 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.812 ' CE2' HG22 ' A' ' 66' ' ' VAL . 33.2 p90 -141.82 157.2 45.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 0.0 109.781 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 83.7 mttt -87.83 129.69 35.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.23 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.812 HG22 ' CE2' ' A' ' 64' ' ' PHE . 4.3 t -104.24 98.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 90.0 mt-30 62.93 35.34 13.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.898 . . . . 0.0 109.193 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.77 31.81 20.08 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.446 ' O ' HG23 ' A' ' 71' ' ' VAL . 51.6 mtt180 -136.84 111.62 8.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -1.125 . . . . 0.0 109.432 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -61.84 117.72 6.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.575 HG21 ' CH2' ' A' ' 92' ' ' TRP . 44.4 t -142.31 136.91 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 0.0 109.412 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.705 ' HG2' HG23 ' A' ' 63' ' ' THR . 64.0 mt-10 -112.61 137.93 50.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.974 . . . . 0.0 109.388 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.21 166.31 29.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.83 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 96.3 mt-10 -81.43 136.15 35.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.228 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.683 ' HB ' HG23 ' A' ' 32' ' ' VAL . 17.5 m -125.55 148.03 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.181 -0.949 . . . . 0.0 109.731 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.845 HD21 ' NE2' ' A' ' 57' ' ' GLN . 28.1 tp -94.05 143.05 26.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.853 . . . . 0.0 109.13 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.27 133.66 36.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.556 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 21.8 t -144.4 148.84 42.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.626 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.48 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 49.3 Cg_endo -70.36 1.79 4.49 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.728 2.285 . . . . 0.0 112.058 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.556 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 39.6 m-85 -63.34 172.72 1.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 109.432 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -113.36 21.29 15.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 109.579 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.586 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 13.1 p90 -144.87 -161.02 1.21 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.16 -0.963 . . . . 0.0 109.356 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.453 HG13 ' C ' ' A' ' 82' ' ' TYR . 2.2 mt -132.62 149.1 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.881 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.741 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.4 mt -109.21 131.82 54.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.865 . . . . 0.0 108.757 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.807 ' H ' HD22 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -99.95 133.17 44.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.109 -0.994 . . . . 0.0 109.723 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.574 ' O ' HG22 ' A' ' 90' ' ' VAL . 6.2 t-20 -88.18 136.23 32.21 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 0.0 109.146 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.547 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 41.8 Cg_endo -64.34 -32.16 61.6 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.744 2.296 . . . . 0.0 111.881 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.439 ' HB2' HD21 ' A' ' 86' ' ' ASN . 14.2 m -72.32 -33.94 67.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 109.222 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -71.9 -34.11 68.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.313 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.781 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 33.5 m -115.84 76.56 6.07 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 109.55 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.44 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 48.6 Cg_endo -69.15 -21.63 36.04 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.698 2.265 . . . . 0.0 111.678 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.781 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 36.4 p90 -70.66 -26.32 63.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.314 -0.866 . . . . 0.0 109.469 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.441 HD23 ' CD1' ' A' ' 23' ' ' TRP . 28.6 tp -78.05 -34.16 50.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.474 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 95.2 mtp -67.24 -29.46 69.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.508 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -75.67 139.54 42.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.24 -0.913 . . . . 0.0 109.4 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.484 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -128.61 80.89 71.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.748 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.12 -18.18 35.5 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.613 2.208 . . . . 0.0 111.68 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.5 tp . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 109.469 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.568 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.3 Cg_endo -70.25 153.09 66.99 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.674 2.249 . . . . 0.0 111.736 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 23' ' ' TRP . 15.3 mt -79.83 -174.63 4.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.443 ' OE2' ' HE3' ' A' ' 18' ' ' LYS . 75.9 tt0 -113.65 137.2 51.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 109.501 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.3 142.25 25.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -120.65 118.02 29.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.888 HG22 ' HG3' ' A' ' 15' ' ' LYS . 36.6 mt -109.49 129.46 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.507 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.888 ' HG3' HG22 ' A' ' 14' ' ' ILE . 72.0 mttt 54.52 24.83 5.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.9 . . . . 0.0 109.5 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.06 -10.81 72.79 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.593 HG22 HD11 ' A' ' 19' ' ' LEU . 4.3 m -80.31 126.94 31.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -1.183 . . . . 0.0 109.422 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HE3' ' OE2' ' A' ' 11' ' ' GLU . 39.1 tttt -85.93 125.16 33.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.347 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.593 HD11 HG22 ' A' ' 17' ' ' THR . 1.9 mp -146.21 156.03 43.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 109.587 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -80.16 152.13 29.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 0.0 109.507 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.702 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -136.92 169.56 17.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 85.1 m-70 -127.41 138.84 53.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 109.463 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.629 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 40.0 t90 -91.08 114.1 26.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.206 -0.934 . . . . 0.0 109.408 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -121.57 100.1 6.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 109.382 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.573 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 59.8 p -60.8 -25.66 66.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.758 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.64 -41.59 95.76 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.442 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -67.77 140.97 56.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.194 -1.18 . . . . 0.0 109.538 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.435 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 68.6 p -99.59 -10.27 22.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.893 . . . . 0.0 109.384 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.453 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 19.7 tt -139.06 159.79 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.272 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.4 m -67.53 153.26 44.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 109.671 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.578 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -131.21 116.81 18.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.072 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.785 HG13 ' HD2' ' A' ' 33' ' ' PRO . 54.0 t -114.07 147.71 38.41 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.785 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.4 Cg_endo -77.4 132.04 12.07 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.094 1.862 . . . . 0.0 111.664 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.1 tt0 -41.77 -27.67 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.467 -0.77 . . . . 0.0 109.801 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -50.56 -31.64 16.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.525 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.43 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 14.3 m-85 -98.47 -3.24 37.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.665 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.675 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -110.95 13.25 22.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.797 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -60.94 -22.52 64.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.069 -1.019 . . . . 0.0 109.255 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -128.5 27.36 5.56 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.314 -0.866 . . . . 0.0 108.724 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.496 ' CG ' ' HA ' ' A' ' 37' ' ' LEU . 57.3 mm-40 -99.43 162.3 13.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.407 -0.808 . . . . 0.0 109.815 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.88 129.4 24.59 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.458 -0.776 . . . . 0.0 109.216 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.578 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 54.2 Cg_endo -73.42 123.92 9.02 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.556 2.171 . . . . 0.0 112.008 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.441 HG13 ' N ' ' A' ' 44' ' ' GLN . 24.3 pt -83.51 -31.27 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 109.246 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.45 ' CG ' ' HB ' ' A' ' 59' ' ' VAL . 13.3 pt20 -143.07 175.64 9.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.831 . . . . 0.0 109.255 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 77.3 p -128.45 155.48 44.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.703 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.546 ' HE3' HG21 ' A' ' 59' ' ' VAL . 63.5 mtt -142.15 147.37 36.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.345 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.638 HD12 ' HB2' ' A' ' 56' ' ' GLN . 21.5 tp -98.64 126.9 44.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.15 -0.969 . . . . 0.0 109.541 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.41 HD13 ' O ' ' A' ' 47' ' ' LEU . 29.0 mm -116.27 135.26 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.915 . . . . 0.0 109.423 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -109.08 135.42 50.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.2 p -128.53 158.14 39.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.581 HG23 ' CD2' ' A' ' 52' ' ' HIS . 15.3 tt -53.18 -41.01 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.928 . . . . 0.0 109.497 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.581 ' CD2' HG23 ' A' ' 51' ' ' ILE . 48.2 m170 -63.23 -35.55 80.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.554 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.13 -176.42 43.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -93.36 133.65 36.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.132 . . . . 0.0 109.405 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -131.94 133.97 45.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.638 ' HB2' HD12 ' A' ' 47' ' ' LEU . 48.9 tt0 -107.8 128.22 54.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 109.663 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.789 HE21 HD21 ' A' ' 76' ' ' LEU . 26.5 mt-30 -125.35 161.24 27.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.173 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.49 ' HB3' ' CB ' ' A' ' 42' ' ' PRO . 59.8 m-20 -96.71 142.06 29.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.933 . . . . 0.0 109.716 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.546 HG21 ' HE3' ' A' ' 46' ' ' MET . 12.9 t -83.85 151.11 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.046 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.675 ' CD2' HD23 ' A' ' 37' ' ' LEU . 12.4 m-85 -131.72 137.7 48.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.087 -1.008 . . . . 0.0 109.902 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.501 ' O ' HD23 ' A' ' 62' ' ' LEU . 44.3 t80 -100.67 113.11 25.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.849 . . . . 0.0 108.771 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.666 HD12 HG21 ' A' ' 75' ' ' VAL . 44.6 mt -122.46 173.02 7.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.105 -0.997 . . . . 0.0 110.276 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.673 HG23 ' HG2' ' A' ' 72' ' ' GLU . 86.6 m -124.01 125.48 44.63 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 9.4 p90 -144.68 157.81 44.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.888 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -88.38 130.52 35.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.418 -0.801 . . . . 0.0 109.292 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.469 HG11 HG11 ' A' ' 90' ' ' VAL . 74.4 t -110.77 104.47 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 86.7 mt-30 63.13 35.17 13.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.331 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.77 31.95 34.59 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -137.54 116.53 12.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -1.139 . . . . 0.0 109.477 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -62.13 121.0 11.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.504 HG21 ' CH2' ' A' ' 92' ' ' TRP . 87.3 t -142.69 129.05 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.88 . . . . 0.0 109.498 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.673 ' HG2' HG23 ' A' ' 63' ' ' THR . 35.8 mt-10 -108.59 136.47 48.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.19 169.98 22.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 109.619 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.534 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 95.4 mt-10 -80.41 135.89 36.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.74 ' HB ' HG23 ' A' ' 32' ' ' VAL . 5.0 m -126.76 152.22 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 109.631 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.789 HD21 HE21 ' A' ' 57' ' ' GLN . 20.7 tp -105.42 149.13 26.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.109 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.58 137.3 37.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 109.196 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.571 ' OG ' ' CE2' ' A' ' 80' ' ' TYR . 23.3 t -148.7 149.57 31.14 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.926 . . . . 0.0 109.669 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.488 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 54.5 Cg_endo -72.88 6.88 2.23 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.661 2.241 . . . . 0.0 111.985 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.571 ' CE2' ' OG ' ' A' ' 78' ' ' SER . 30.7 m-85 -60.52 -178.99 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.613 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -119.93 20.73 12.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.927 . . . . 0.0 109.325 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.602 ' OH ' HD21 ' A' ' 84' ' ' LEU . 13.3 p90 -153.61 -152.35 0.41 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.275 -0.89 . . . . 0.0 108.894 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.533 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 1.7 mt -132.35 125.58 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.785 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.602 HD21 ' OH ' ' A' ' 82' ' ' TYR . 1.2 mt -82.94 143.27 30.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.218 -0.926 . . . . 0.0 108.93 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.702 HD21 ' HB1' ' A' ' 21' ' ' ALA . 3.9 mt -109.73 135.3 50.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -0.978 . . . . 0.0 109.929 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.697 ' O ' HG22 ' A' ' 90' ' ' VAL . 4.4 t30 -91.16 136.65 26.99 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 109.125 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.522 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 43.5 Cg_endo -64.6 -36.96 39.75 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.781 2.32 . . . . 0.0 112.034 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.422 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 3.1 m -70.38 -32.47 70.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.121 -0.987 . . . . 0.0 109.303 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.464 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 81.8 m-20 -71.84 -29.2 64.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.352 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.155 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -118.81 74.92 12.98 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.314 -0.866 . . . . 0.0 109.531 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.59 -21.99 28.89 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.747 2.298 . . . . 0.0 111.801 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.155 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 40.8 p90 -76.28 -28.31 56.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 0.0 109.49 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.629 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 38.6 tp -56.36 -40.45 74.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.461 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 69.8 mtm -93.3 135.2 34.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 109.48 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -106.46 146.85 30.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.428 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -64.38 153.85 85.25 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.4 143.84 48.9 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.695 2.263 . . . . 0.0 111.735 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.5 tp . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.414 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.09 151.55 67.23 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.668 2.246 . . . . 0.0 111.722 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.595 HD13 HD23 ' A' ' 85' ' ' LEU . 4.3 mp -85.0 165.84 17.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.514 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -103.46 144.13 31.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 109.428 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.7 148.11 22.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 64' ' ' PHE . 78.1 tt0 -121.02 121.08 37.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.868 HG22 ' HG3' ' A' ' 15' ' ' LYS . 42.4 mt -111.93 127.71 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.868 ' HG3' HG22 ' A' ' 14' ' ' ILE . 3.6 mtmt 54.5 25.82 6.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.443 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 93.29 -15.81 62.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.886 HG22 HD11 ' A' ' 19' ' ' LEU . 2.3 m -79.85 126.07 30.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -1.181 . . . . 0.0 109.312 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.967 ' C ' HD12 ' A' ' 19' ' ' LEU . 31.4 tttt -94.26 116.9 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.0 109.63 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.967 HD12 ' C ' ' A' ' 18' ' ' LYS . 9.4 mp -135.09 166.09 23.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.306 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -80.32 155.03 27.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.449 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.888 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -141.27 163.03 34.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 109.482 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.835 ' O ' HD22 ' A' ' 85' ' ' LEU . 70.0 m-70 -125.38 136.84 53.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.749 ' CD1' HD23 ' A' ' 93' ' ' LEU . 26.2 t90 -85.58 126.67 34.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.422 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -133.58 100.63 4.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.519 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 60.4 p -62.39 -29.21 70.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.495 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.2 -33.25 64.61 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.414 ' O ' ' OD1' ' A' ' 86' ' ' ASN . . . -73.81 140.34 45.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -1.129 . . . . 0.0 109.418 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 28' ' ' THR . 87.4 m -100.36 -5.27 27.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.633 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.486 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 21.2 tt -146.67 149.3 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.507 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.849 ' CG2' HG12 ' A' ' 75' ' ' VAL . 86.4 m -52.47 150.79 4.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.634 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.622 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -128.03 136.98 51.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.193 -0.942 . . . . 0.0 109.212 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.776 HG13 ' HD2' ' A' ' 33' ' ' PRO . 56.9 t -138.61 147.43 54.75 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 109.172 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.776 ' HD2' HG13 ' A' ' 32' ' ' VAL . 54.8 Cg_endo -77.66 132.21 11.91 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.123 1.882 . . . . 0.0 111.308 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 37' ' ' LEU . 79.9 tt0 -41.87 -27.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.759 . . . . 0.0 109.833 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -48.41 -24.53 1.28 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.14 -0.975 . . . . 0.0 109.308 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.638 ' CE2' HD22 ' A' ' 19' ' ' LEU . 7.6 m-85 -97.03 -9.38 28.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.646 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.95 HD11 HD11 ' A' ' 62' ' ' LEU . 2.8 mm? -107.83 9.26 28.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 109.628 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -59.23 -37.75 78.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 109.265 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -113.84 27.28 9.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.895 . . . . 0.0 109.249 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -117.17 -170.1 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.378 -0.826 . . . . 0.0 109.634 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 -148.01 132.02 8.55 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.177 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.572 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 50.0 Cg_endo -70.87 124.8 10.95 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.654 2.236 . . . . 0.0 111.908 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.742 HD11 ' OE2' ' A' ' 74' ' ' GLU . 41.2 pt -76.61 -32.86 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.274 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.769 ' O ' HG22 ' A' ' 59' ' ' VAL . 97.5 mt-30 -146.16 174.01 11.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 0.0 109.381 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 36.6 p -119.9 159.78 23.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.603 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.3 ttm -134.86 141.76 46.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.908 . . . . 0.0 109.409 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 47' ' ' LEU . 5.0 mp -92.04 132.63 36.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.544 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.5 mt -120.38 132.87 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 109.304 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 75.7 tttt -118.28 129.76 55.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.56 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.12 179.72 4.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.531 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.7 mt -69.92 -49.25 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.362 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -56.92 -42.03 79.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.467 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.53 -169.51 39.37 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 81.8 tt0 -109.32 133.65 52.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.216 -1.167 . . . . 0.0 109.527 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -127.57 150.65 49.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.87 . . . . 0.0 109.337 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -114.17 142.1 46.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.153 -0.967 . . . . 0.0 109.507 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -133.95 168.11 19.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -0.863 . . . . 0.0 109.345 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.501 ' HB3' ' CB ' ' A' ' 42' ' ' PRO . 63.4 m-20 -107.14 150.67 26.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.762 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 44' ' ' GLN . 13.7 m -101.03 152.05 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.272 -0.892 . . . . 0.0 109.193 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.711 ' CD2' HD12 ' A' ' 37' ' ' LEU . 11.1 m-85 -130.93 122.63 27.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -0.994 . . . . 0.0 109.731 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 39.7 t80 -85.26 110.06 18.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 108.885 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.95 HD11 HD11 ' A' ' 37' ' ' LEU . 53.1 mt -125.1 171.01 10.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 110.36 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.702 HG23 ' HG2' ' A' ' 72' ' ' GLU . 89.7 m -116.08 119.35 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CE2' HG22 ' A' ' 66' ' ' VAL . 17.3 p90 -136.07 154.22 51.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.037 . . . . 0.0 109.782 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.46 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 45.3 mttm -90.69 127.04 36.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.341 -0.849 . . . . 0.0 109.411 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.735 HG11 HG11 ' A' ' 90' ' ' VAL . 18.9 t -101.5 101.55 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 109.614 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 92.9 mt-30 62.87 33.13 15.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.297 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.82 24.8 34.21 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 65' ' ' LYS . 67.3 mtt180 -126.72 120.09 28.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -1.165 . . . . 0.0 109.362 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -67.0 117.05 8.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.403 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.75 HG21 ' HH2' ' A' ' 92' ' ' TRP . 86.0 t -141.15 130.85 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.702 ' HG2' HG23 ' A' ' 63' ' ' THR . 58.4 mt-10 -111.78 135.44 52.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.589 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.41 166.27 29.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.835 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.742 ' OE2' HD11 ' A' ' 43' ' ' ILE . 95.4 mt-10 -80.69 136.06 36.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.372 -0.83 . . . . 0.0 109.193 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.849 HG12 ' CG2' ' A' ' 30' ' ' THR . 34.6 m -123.26 145.55 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.227 -0.921 . . . . 0.0 109.696 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.714 ' CD2' HG12 ' A' ' 59' ' ' VAL . 89.0 mt -90.53 143.9 26.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.091 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.34 135.64 36.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.0 . . . . 0.0 109.445 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.522 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 3.8 t -143.89 150.46 49.81 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 109.519 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.49 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 52.0 Cg_endo -72.46 5.99 2.52 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.665 2.244 . . . . 0.0 112.301 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.522 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 84.4 m-85 -71.37 167.51 19.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.056 -1.028 . . . . 0.0 109.527 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -107.79 17.05 22.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.66 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.657 ' OH ' HD21 ' A' ' 84' ' ' LEU . 15.6 p90 -137.19 -163.51 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 109.52 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.441 ' O ' ' CD2' ' A' ' 82' ' ' TYR . 4.0 mt -127.44 154.92 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -0.981 . . . . 0.0 109.744 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.753 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.3 mt -117.21 132.8 56.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.011 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.888 HD11 ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -97.91 122.48 41.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.084 -1.01 . . . . 0.0 109.628 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.731 ' O ' HG22 ' A' ' 90' ' ' VAL . 26.2 t30 -79.54 142.36 57.67 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.435 -0.791 . . . . 0.0 109.098 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.562 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 47.0 Cg_endo -67.31 -23.47 44.66 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.512 2.141 . . . . 0.0 111.677 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.418 ' OG ' ' ND2' ' A' ' 86' ' ' ASN . 51.8 p -80.41 -33.85 36.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.373 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.955 ' OD1' HG13 ' A' ' 90' ' ' VAL . 2.2 p30 -74.78 -28.87 60.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.493 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.955 HG13 ' OD1' ' A' ' 89' ' ' ASP . 4.1 m -122.3 78.62 44.54 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.656 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.565 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.8 Cg_endo -71.68 -23.56 22.73 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.615 2.21 . . . . 0.0 111.822 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.775 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 47.1 p90 -77.32 -33.09 55.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.593 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.749 HD23 ' CD1' ' A' ' 23' ' ' TRP . 21.9 tp -55.16 -31.95 61.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.511 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 71.1 mtm -84.58 122.58 29.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -57.75 -36.91 72.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.478 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 ptpt -66.01 128.56 93.91 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.535 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.66 147.06 62.7 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.769 2.313 . . . . 0.0 111.789 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.505 HD11 ' CB ' ' A' ' 91' ' ' PRO . 46.7 mt . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.505 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.6 Cg_endo -70.09 157.36 59.99 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.729 2.286 . . . . 0.0 111.709 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.606 HD11 ' HB2' ' A' ' 23' ' ' TRP . 25.2 mt -88.27 -175.11 4.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.505 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.58 141.58 50.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 109.403 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.34 149.29 26.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 51.9 tt0 -118.35 118.14 30.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.858 HG22 ' HG3' ' A' ' 15' ' ' LYS . 41.5 mt -111.11 128.7 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.858 ' HG3' HG22 ' A' ' 14' ' ' ILE . 44.3 mttm 56.71 22.85 7.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 91.63 0.87 71.9 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.496 HG22 ' CD2' ' A' ' 19' ' ' LEU . 24.8 m -102.4 122.25 43.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -1.194 . . . . 0.0 109.457 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.834 ' O ' HD22 ' A' ' 19' ' ' LEU . 26.8 tttt -82.56 123.57 29.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.834 HD22 ' O ' ' A' ' 18' ' ' LYS . 1.5 mm? -132.89 167.08 20.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -85.88 139.65 31.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.801 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -128.28 168.66 15.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.628 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.688 ' O ' HD22 ' A' ' 85' ' ' LEU . 47.6 m-70 -129.4 126.85 39.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.403 -0.811 . . . . 0.0 109.648 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.606 ' HB2' HD11 ' A' ' 10' ' ' LEU . 33.3 t90 -79.4 125.86 30.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.456 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -131.39 102.77 6.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.528 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 58.2 p -61.63 -31.68 71.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.629 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.08 -31.53 73.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.49 139.66 49.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -1.166 . . . . 0.0 109.615 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.434 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 35.0 p -106.02 -4.9 19.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.85 . . . . 0.0 109.554 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.511 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 19.7 tt -143.82 141.14 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.405 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.537 ' N ' ' HB2' ' A' ' 86' ' ' ASN . 23.4 m -54.92 137.42 45.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.731 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.715 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.9 OUTLIER -125.94 128.63 47.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.724 HG12 HG23 ' A' ' 83' ' ' ILE . 25.2 m -127.83 163.44 43.26 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.584 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.8 Cg_endo -78.91 134.1 11.65 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.57 2.18 . . . . 0.0 111.688 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 81.1 tt0 -49.03 -22.89 0.98 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.616 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.6 -40.36 52.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.41 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -86.85 -4.23 59.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.275 -0.89 . . . . 0.0 109.605 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.501 ' HA ' HD13 ' A' ' 37' ' ' LEU . 3.8 mm? -89.4 18.7 5.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.234 -0.916 . . . . 0.0 109.844 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 37' ' ' LEU . 76.6 mt-10 -41.58 -57.58 2.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.343 -0.848 . . . . 0.0 108.905 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 p30 -96.22 38.99 1.16 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.602 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 21.2 pt-20 -41.29 132.71 2.55 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.536 0.684 . . . . 0.0 110.624 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.02 89.94 43.99 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.486 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 50.8 Cg_endo -70.01 125.95 12.6 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.703 2.269 . . . . 0.0 112.317 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 61' ' ' TYR . 38.6 pt -109.74 -16.55 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.303 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.528 ' HG2' ' N ' ' A' ' 45' ' ' THR . 43.4 tt0 -143.12 166.55 24.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.212 -0.93 . . . . 0.0 109.457 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.528 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 61.2 p -116.74 151.27 36.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.402 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 46.5 ttm -145.49 144.03 30.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.563 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.743 HD21 ' OE2' ' A' ' 54' ' ' GLU . 8.9 tt -100.19 131.59 46.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.287 -0.883 . . . . 0.0 109.51 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 30.6 mm -115.24 134.9 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.4 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -128.23 119.75 25.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.8 -177.32 3.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.453 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.7 mt -71.23 -50.51 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.347 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -49.88 -39.41 39.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.57 -175.62 47.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.743 ' OE2' HD21 ' A' ' 47' ' ' LEU . 61.7 tt0 -103.72 129.19 51.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -1.127 . . . . 0.0 109.431 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.459 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 22.9 mttm -130.31 137.9 50.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.187 -0.945 . . . . 0.0 109.365 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -108.46 128.62 54.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.89 . . . . 0.0 109.674 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.806 ' NE2' HD21 ' A' ' 76' ' ' LEU . 25.3 mt-30 -125.35 159.9 30.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.262 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -92.5 163.79 13.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.539 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 29.4 t -101.48 139.29 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 108.896 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.602 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 3.1 m-85 -121.4 150.01 42.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.033 -1.042 . . . . 0.0 110.159 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.58 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 46.4 t80 -107.14 113.66 27.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 0.0 108.715 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.654 HD12 HG21 ' A' ' 75' ' ' VAL . 39.2 mt -116.28 162.21 17.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.115 -0.991 . . . . 0.0 110.343 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.701 HG23 ' HG2' ' A' ' 72' ' ' GLU . 20.4 m -120.12 118.24 30.04 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.479 ' HB3' HG12 ' A' ' 14' ' ' ILE . 14.3 p90 -144.07 154.98 43.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.022 -1.049 . . . . 0.0 109.937 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.471 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 47.9 mtmt -92.62 126.99 37.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.364 -0.835 . . . . 0.0 109.167 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 21.3 t -106.37 111.84 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.146 -0.971 . . . . 0.0 109.711 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.476 HE22 HD22 ' A' ' 93' ' ' LEU . 87.2 mt-30 62.98 37.22 11.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.54 25.28 63.44 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' O ' HG23 ' A' ' 71' ' ' VAL . 78.1 mtt-85 -129.59 107.5 9.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 109.511 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 79.0 tttt -58.91 125.33 23.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.679 HG21 ' CH2' ' A' ' 92' ' ' TRP . 97.7 t -146.26 133.09 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 109.231 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.701 ' HG2' HG23 ' A' ' 63' ' ' THR . 80.6 mt-10 -115.27 135.57 54.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 109.633 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.467 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . . . -160.36 173.38 15.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.389 -0.82 . . . . 0.0 109.674 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.539 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 94.4 mt-10 -79.79 143.97 33.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.85 . . . . 0.0 109.172 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.654 HG21 HG21 ' A' ' 32' ' ' VAL . 3.2 m -138.97 162.45 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.78 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.806 HD21 ' NE2' ' A' ' 57' ' ' GLN . 20.5 tp -113.23 145.73 40.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -0.827 . . . . 0.0 109.258 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.99 136.23 36.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.447 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.47 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 5.4 t -141.47 148.43 50.44 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 109.521 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.47 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 48.6 Cg_endo -69.87 -0.8 7.52 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.744 2.296 . . . . 0.0 111.774 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.521 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 31.5 m-85 -59.75 166.63 2.47 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.179 -0.951 . . . . 0.0 109.323 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -107.6 19.35 20.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.952 . . . . 0.0 109.86 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.809 ' OH ' HD21 ' A' ' 84' ' ' LEU . 25.7 p90 -142.48 -154.83 0.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.724 HG23 HG12 ' A' ' 32' ' ' VAL . 4.7 mt -130.15 144.51 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.997 -1.064 . . . . 0.0 109.777 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.809 HD21 ' OH ' ' A' ' 82' ' ' TYR . 1.3 mp -110.36 123.92 50.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.343 -0.848 . . . . 0.0 109.116 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.801 HD11 ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -95.44 134.64 38.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.786 ' O ' HG22 ' A' ' 90' ' ' VAL . 26.5 t30 -89.19 142.31 29.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.288 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.51 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 47.1 Cg_endo -67.41 -26.12 41.27 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.537 2.158 . . . . 0.0 111.79 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.2 m -78.08 -31.2 50.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.312 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.769 ' OD1' HG13 ' A' ' 90' ' ' VAL . 2.1 p30 -77.01 -32.97 57.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.162 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -110.9 73.7 0.89 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.897 . . . . 0.0 109.394 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.583 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.0 Cg_endo -70.29 -24.36 27.34 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.743 2.295 . . . . 0.0 112.016 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.162 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.4 p90 -71.43 -36.89 71.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.092 -1.005 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.497 HD12 ' CG2' ' A' ' 90' ' ' VAL . 72.6 mt -50.23 -42.7 52.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.349 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 88.3 mtp -68.17 134.39 50.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.444 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -103.44 143.31 32.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.476 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -120.93 86.17 41.35 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.1 146.29 57.65 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.668 2.245 . . . . 0.0 111.8 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.5 tp . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 0.0 109.49 179.993 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.557 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.5 Cg_endo -70.05 148.42 63.17 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.748 2.299 . . . . 0.0 111.824 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.761 ' CD1' HD11 ' A' ' 93' ' ' LEU . 29.0 mt -81.06 -173.44 4.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.516 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.465 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 75.1 mm-40 -117.89 137.9 52.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 109.476 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.09 146.12 30.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.541 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -123.96 116.92 23.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.325 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.56 HG22 ' HG3' ' A' ' 15' ' ' LYS . 56.0 mt -112.83 130.41 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.933 . . . . 0.0 109.674 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.56 ' HG3' HG22 ' A' ' 14' ' ' ILE . 95.9 mttt 52.22 23.47 2.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.318 -0.864 . . . . 0.0 109.621 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.31 -13.97 66.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.83 HG22 HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -80.39 114.13 19.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -1.181 . . . . 0.0 109.427 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.884 ' C ' HD12 ' A' ' 19' ' ' LEU . 69.5 tttt -87.64 118.79 27.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 109.558 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.884 HD12 ' C ' ' A' ' 18' ' ' LYS . 9.3 mp -133.64 172.98 12.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.353 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' NZ ' ' OE2' ' A' ' 11' ' ' GLU . 16.0 mmtt -91.24 147.39 23.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.375 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.622 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -133.15 174.3 10.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 109.698 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 79.7 m-70 -131.07 127.76 38.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.86 . . . . 0.0 109.379 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.813 ' CD1' HD13 ' A' ' 93' ' ' LEU . 35.5 t90 -76.39 117.4 18.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -124.58 100.72 6.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.317 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.564 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 28.5 p -62.81 -30.38 71.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.07 -39.46 80.04 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.15 140.6 58.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.141 . . . . 0.0 109.52 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.6 m -96.11 -13.0 23.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.498 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 29' ' ' ILE . 7.4 tp -143.94 162.85 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.265 -0.897 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 26.4 m -66.27 132.64 48.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.681 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 0.9 OUTLIER -119.22 126.79 52.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.382 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.805 HG13 HG13 ' A' ' 75' ' ' VAL . 3.6 m -127.91 167.21 19.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.406 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.1 Cg_endo -79.58 133.32 10.43 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.459 2.106 . . . . 0.0 111.639 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.5 tt0 -43.05 -27.23 0.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.34 -0.85 . . . . 0.0 109.571 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.3 -38.54 27.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.844 . . . . 0.0 109.576 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.601 ' HE2' HD22 ' A' ' 19' ' ' LEU . 15.5 m-85 -87.91 -7.19 57.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 109.649 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' A' ' 77' ' ' ALA . 12.0 mt -100.46 20.79 14.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.139 -0.976 . . . . 0.0 109.757 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 37' ' ' LEU . 72.0 mt-10 -43.74 -56.87 3.53 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 40' ' ' GLU . 45.1 m-20 -94.61 40.06 1.09 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.611 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 20.2 pt-20 -39.0 135.21 0.93 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.532 0.682 . . . . 0.0 110.394 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.83 81.66 70.33 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.504 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 48.7 Cg_endo -69.46 116.31 4.47 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.727 2.285 . . . . 0.0 112.186 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.8 pt -78.05 -31.64 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.091 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.671 ' O ' HG12 ' A' ' 59' ' ' VAL . 37.4 mt-30 -143.51 163.2 33.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.239 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 82.7 p -119.68 157.56 28.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.931 . . . . 0.0 109.522 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' GLN . 88.0 mtp -144.75 143.76 30.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.331 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -93.46 122.89 36.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.386 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.7 mm -118.09 127.68 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.608 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.416 ' HG2' ' HG2' ' A' ' 54' ' ' GLU . 21.8 mttp -107.01 137.44 45.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.415 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -124.65 179.36 5.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.94 . . . . 0.0 109.379 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.4 mt -64.34 -50.05 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 0.0 109.365 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -51.87 -46.84 64.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.464 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.81 -172.17 45.11 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HG2' ' HG2' ' A' ' 49' ' ' LYS . 96.1 mt-10 -84.94 135.55 34.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -1.139 . . . . 0.0 109.387 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -128.5 148.97 50.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -98.81 121.11 40.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.571 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.965 ' OE1' HD21 ' A' ' 76' ' ' LEU . 1.2 tp60 -118.58 132.86 56.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 69.5 m-20 -109.66 156.41 20.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 0.0 109.596 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.745 HG21 ' CD ' ' A' ' 74' ' ' GLU . 12.5 p -98.51 136.36 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.289 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 3.7 m-85 -121.72 141.53 51.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.619 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.628 ' O ' HD23 ' A' ' 62' ' ' LEU . 33.4 t80 -102.52 114.96 29.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.27 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.628 HD23 ' O ' ' A' ' 61' ' ' TYR . 21.0 mt -119.32 160.93 21.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 110.029 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.719 HG23 ' HG2' ' A' ' 72' ' ' GLU . 11.4 m -121.78 116.88 25.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.478 -0.763 . . . . 0.0 109.137 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 8.2 p90 -142.98 161.72 37.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 109.668 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.485 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 12.5 mtmm -96.68 129.09 44.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.295 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.452 HG11 HG11 ' A' ' 90' ' ' VAL . 60.4 t -107.09 112.64 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.557 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 90.6 mt-30 63.48 33.53 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 109.403 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.37 23.63 58.29 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -127.98 111.45 13.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.319 -1.106 . . . . 0.0 109.408 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 80.5 tttt -61.04 121.23 11.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.612 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.578 HG21 ' HH2' ' A' ' 92' ' ' TRP . 65.6 t -141.66 133.55 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 109.164 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.719 ' HG2' HG23 ' A' ' 63' ' ' THR . 53.8 mt-10 -116.28 137.25 52.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 109.837 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.59 -169.7 2.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.439 -0.788 . . . . 0.0 109.379 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.745 ' CD ' HG21 ' A' ' 59' ' ' VAL . 98.2 mt-10 -79.96 171.36 15.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.094 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.805 HG13 HG13 ' A' ' 32' ' ' VAL . 72.9 t -159.4 151.03 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.143 -0.973 . . . . 0.0 109.808 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.965 HD21 ' OE1' ' A' ' 57' ' ' GLN . 25.9 tp -121.32 143.62 49.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.43 -0.794 . . . . 0.0 109.282 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.649 ' HB2' HD13 ' A' ' 37' ' ' LEU . . . -79.77 133.41 36.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 109.602 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 1.4 t -138.68 150.91 67.53 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.859 . . . . 0.0 109.355 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.6 Cg_endo -72.28 1.97 5.51 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.624 2.216 . . . . 0.0 111.885 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -65.14 168.0 7.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.532 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.8 p30 -108.9 14.07 24.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.233 -0.917 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.585 ' CE2' ' HG ' ' A' ' 84' ' ' LEU . 17.7 p90 -136.34 -157.8 0.82 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 109.008 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.548 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 3.0 mt -129.09 144.7 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.056 -1.027 . . . . 0.0 109.707 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 84' ' ' LEU . 6.2 mp -109.95 136.33 49.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.259 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.802 ' N ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -103.92 145.36 30.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.768 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.684 ' O ' HG22 ' A' ' 90' ' ' VAL . 4.9 t30 -96.87 136.59 21.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.255 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.526 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.0 Cg_endo -63.45 -31.98 71.53 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.847 2.365 . . . . 0.0 111.94 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -75.24 -30.17 60.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.227 -0.921 . . . . 0.0 109.176 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -77.49 -30.83 53.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.326 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.909 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.6 OUTLIER -122.25 75.95 42.18 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 109.468 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.21 -24.95 27.03 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.637 2.225 . . . . 0.0 111.932 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.909 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 32.7 p90 -74.19 -28.47 61.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.137 -0.977 . . . . 0.0 109.481 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.813 HD13 ' CD1' ' A' ' 23' ' ' TRP . 9.6 tt -58.89 -36.91 75.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.485 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 87.5 mtp -78.65 149.56 32.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.496 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.01 154.21 19.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.407 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.455 ' HB3' ' HD2' ' A' ' 97' ' ' PRO . 6.3 mtmt -115.04 159.31 38.22 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.168 -0.957 . . . . 0.0 109.511 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 96' ' ' LYS . 50.6 Cg_endo -70.49 -15.28 34.36 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.631 2.22 . . . . 0.0 111.768 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.4 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.444 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.569 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.3 Cg_endo -70.3 159.98 51.13 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.683 2.255 . . . . 0.0 111.637 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.553 ' CD2' HD11 ' A' ' 93' ' ' LEU . 4.6 mp -80.23 166.35 21.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.96 . . . . 0.0 109.525 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -103.63 148.74 25.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.558 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.38 151.22 20.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 64' ' ' PHE . 65.7 tt0 -119.62 121.71 39.91 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.409 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.548 ' HB ' ' CE2' ' A' ' 36' ' ' PHE . 44.6 mt -113.54 124.21 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 60.8 mttm 61.28 20.38 10.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 109.474 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.65 -12.89 68.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.0 m -88.52 131.11 35.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -1.145 . . . . 0.0 109.446 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.999 ' O ' HD22 ' A' ' 19' ' ' LEU . 18.0 mttp -82.98 133.37 35.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.879 . . . . 0.0 109.492 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.999 HD22 ' O ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -144.64 159.82 42.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.87 . . . . 0.0 109.459 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -81.41 150.93 28.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.352 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.883 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -139.14 169.69 17.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.569 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 60.9 m-70 -130.5 136.89 49.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 109.644 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.957 ' CD1' HD13 ' A' ' 93' ' ' LEU . 64.3 t90 -95.17 118.91 32.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 109.431 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -130.17 104.24 7.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.528 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.582 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 60.4 p -56.22 -27.59 55.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.531 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.37 -36.5 93.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.424 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -64.55 143.58 57.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.458 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.511 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 59.4 m -108.36 -12.08 15.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.501 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.403 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 20.2 tt -142.64 155.35 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.495 ' HB ' HG12 ' A' ' 75' ' ' VAL . 34.4 m -71.38 136.45 47.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.608 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.539 ' CB ' ' HB2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -120.84 131.9 54.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.423 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.904 HG12 HG23 ' A' ' 83' ' ' ILE . 15.4 m -121.72 161.17 43.33 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 82' ' ' TYR . 55.8 Cg_endo -79.27 129.57 8.73 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.583 2.189 . . . . 0.0 111.717 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.864 ' CG ' ' HB1' ' A' ' 77' ' ' ALA . 79.2 mt-10 -43.77 -26.93 0.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 109.362 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.77 -39.45 77.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.285 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.569 ' HZ ' HD23 ' A' ' 19' ' ' LEU . 1.7 m-85 -83.7 -2.15 55.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.428 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.715 ' CD1' ' HB2' ' A' ' 77' ' ' ALA . 7.2 mt -99.43 23.43 9.36 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.154 -0.966 . . . . 0.0 109.741 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 37' ' ' LEU . 55.2 tt0 -44.27 -55.96 4.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.07 -1.019 . . . . 0.0 108.918 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -97.08 40.21 1.15 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.689 ' HB2' HD22 ' A' ' 37' ' ' LEU . 21.5 pt-20 -43.12 133.68 3.81 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.465 0.65 . . . . 0.0 110.361 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -127.29 87.03 57.34 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 48.3 Cg_endo -69.6 121.38 8.11 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.642 2.228 . . . . 0.0 112.235 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.464 HD11 ' OE2' ' A' ' 74' ' ' GLU . 38.3 pt -94.1 -31.44 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.522 -0.736 . . . . 0.0 109.058 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -135.18 176.95 8.2 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.371 -0.831 . . . . 0.0 109.136 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 69.1 p -127.51 156.54 42.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.21 -0.931 . . . . 0.0 109.595 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.503 ' HG3' ' CG2' ' A' ' 59' ' ' VAL . 84.1 mtp -143.65 144.83 32.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 109.345 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.668 HD22 ' CD ' ' A' ' 56' ' ' GLN . 12.1 mt -98.34 138.43 35.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.178 -0.951 . . . . 0.0 109.476 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 55' ' ' LYS . 74.5 mt -126.64 136.0 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.872 . . . . 0.0 109.43 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 78.6 tttt -124.41 135.37 53.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.541 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.0 p -129.92 158.26 40.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.457 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.54 HG23 ' N ' ' A' ' 52' ' ' HIS . 13.6 tt -53.99 -41.87 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 109.548 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.54 ' N ' HG23 ' A' ' 51' ' ' ILE . 97.1 m-70 -62.36 -37.19 84.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 109.578 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.28 -176.65 48.14 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 73.8 tt0 -107.61 128.81 54.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -1.107 . . . . 0.0 109.484 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 48' ' ' ILE . 76.2 mttt -130.23 143.34 50.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.852 . . . . 0.0 109.221 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.668 ' CD ' HD22 ' A' ' 47' ' ' LEU . 28.0 mt-30 -115.77 141.96 47.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.885 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.539 HE21 HD11 ' A' ' 76' ' ' LEU . 20.6 mt-30 -137.56 165.25 26.76 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.374 -0.828 . . . . 0.0 108.803 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 76.2 m-20 -103.76 162.1 13.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.029 . . . . 0.0 109.831 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.577 HG12 ' HB3' ' A' ' 74' ' ' GLU . 12.0 t -100.46 139.35 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.62 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 4.0 m-85 -118.37 149.58 40.97 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.103 -0.998 . . . . 0.0 110.08 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 72' ' ' GLU . 42.4 t80 -108.17 112.4 24.89 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.499 HD12 HG21 ' A' ' 75' ' ' VAL . 34.2 mt -115.98 163.31 16.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.121 -0.987 . . . . 0.0 110.305 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.702 HG23 ' HG2' ' A' ' 72' ' ' GLU . 28.6 m -120.47 116.94 26.42 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 13.6 p90 -138.54 156.94 47.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 109.815 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -93.3 127.24 38.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.332 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.641 HG11 HG11 ' A' ' 90' ' ' VAL . 24.1 t -103.64 106.69 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.927 . . . . 0.0 109.564 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 91.2 mt-30 63.24 36.4 11.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.329 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.46 51.4 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -130.72 109.68 10.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -1.119 . . . . 0.0 109.325 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.464 ' HE2' HG21 ' A' ' 63' ' ' THR . 18.9 tttm -59.65 123.34 16.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 109.697 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.535 HG21 ' CH2' ' A' ' 92' ' ' TRP . 87.6 t -143.49 129.37 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.312 -0.868 . . . . 0.0 109.329 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.702 ' HG2' HG23 ' A' ' 63' ' ' THR . 49.3 mt-10 -111.5 135.36 52.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.96 . . . . 0.0 109.629 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . . . -160.26 170.48 21.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.345 -0.847 . . . . 0.0 109.589 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.577 ' HB3' HG12 ' A' ' 59' ' ' VAL . 95.0 mt-10 -79.76 146.17 32.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.234 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.542 HG21 HG21 ' A' ' 32' ' ' VAL . 3.7 m -138.77 164.36 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.161 -0.962 . . . . 0.0 109.85 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.539 HD11 HE21 ' A' ' 57' ' ' GLN . 21.2 tp -118.04 149.41 41.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.432 -0.793 . . . . 0.0 109.196 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.864 ' HB1' ' CG ' ' A' ' 34' ' ' GLU . . . -79.81 132.27 36.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 0.0 109.5 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.463 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.8 t -135.32 149.97 71.24 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.386 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.463 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.1 Cg_endo -70.73 0.59 6.15 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.808 2.338 . . . . 0.0 111.837 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -64.47 176.75 1.02 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.485 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -114.61 17.55 17.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.429 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.598 ' CZ ' ' HG ' ' A' ' 84' ' ' LEU . 23.6 p90 -142.27 -156.27 0.67 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.066 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.904 HG23 HG12 ' A' ' 32' ' ' VAL . 3.1 mt -128.1 124.21 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.612 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.598 ' HG ' ' CZ ' ' A' ' 82' ' ' TYR . 1.5 mt -80.18 133.14 36.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 108.981 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.883 HD21 ' HB1' ' A' ' 21' ' ' ALA . 6.8 mt -101.41 144.2 30.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 109.934 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.635 ' O ' HG22 ' A' ' 90' ' ' VAL . 9.5 t-20 -101.88 134.26 20.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.398 -0.814 . . . . 0.0 109.118 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.498 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 43.1 Cg_endo -64.48 -31.12 61.6 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.7 2.267 . . . . 0.0 111.903 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 m -75.67 -28.26 58.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.339 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.416 ' OD2' ' HB3' ' A' ' 86' ' ' ASN . 83.8 m-20 -77.81 -29.16 50.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 109.361 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.965 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -121.85 76.69 38.89 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.481 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.5 Cg_endo -69.82 -24.88 28.91 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.676 2.251 . . . . 0.0 111.766 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.965 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.2 p90 -75.98 -24.84 55.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.563 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.957 HD13 ' CD1' ' A' ' 23' ' ' TRP . 9.6 tt -62.46 -34.95 77.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 109.451 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.611 ' CG ' ' CZ2' ' A' ' 23' ' ' TRP . 93.8 mmm -103.67 136.11 43.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -80.34 141.94 34.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.596 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 49.47 62.41 12.09 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.678 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.74 149.71 61.06 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.682 2.255 . . . . 0.0 111.751 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 35.7 tp . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 109.486 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.555 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 50.0 Cg_endo -70.21 154.51 65.88 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.712 2.275 . . . . 0.0 111.811 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 23' ' ' TRP . 28.7 mt -89.22 -171.17 3.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.408 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.08 137.37 54.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.364 -0.835 . . . . 0.0 109.455 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 65' ' ' LYS . . . -148.7 154.02 39.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.905 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 17' ' ' THR . 70.4 tt0 -123.2 115.5 21.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.873 . . . . 0.0 109.269 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 64' ' ' PHE . 74.6 mt -109.6 127.41 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 69.9 mttt 60.22 21.82 11.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.52 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.66 -15.32 62.82 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 68.0 m -80.02 130.47 35.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -1.136 . . . . 0.0 109.316 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.478 ' O ' HD23 ' A' ' 19' ' ' LEU . 41.4 tttp -91.78 125.27 36.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.17 -0.956 . . . . 0.0 109.491 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.532 ' CD1' ' CZ ' ' A' ' 36' ' ' PHE . 97.8 mt -143.47 168.55 19.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.371 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -92.31 154.03 18.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.453 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.64 ' CB ' HD21 ' A' ' 85' ' ' LEU . . . -138.42 172.32 13.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.244 -0.91 . . . . 0.0 109.402 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.555 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 76.4 m-70 -125.63 123.97 40.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 109.458 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.59 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 55.4 t90 -76.92 122.06 24.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.552 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -130.06 103.62 6.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.59 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 52.2 p -61.23 -25.6 67.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.943 . . . . 0.0 109.524 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.1 89.05 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.468 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -72.9 141.17 47.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -1.194 . . . . 0.0 109.552 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.438 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 28.5 p -105.52 -3.17 22.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 0.0 109.559 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' ' 74' ' ' GLU . 19.9 tt -145.51 147.94 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.323 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 38.2 m -61.56 133.13 55.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.905 . . . . 0.0 109.67 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.654 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -116.56 129.19 56.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 109.53 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.757 HG22 ' CG1' ' A' ' 75' ' ' VAL . 4.7 m -131.38 164.52 41.94 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.953 . . . . 0.0 109.358 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.507 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.8 Cg_endo -78.55 131.62 10.55 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.422 2.082 . . . . 0.0 111.483 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 82.3 tt0 -43.14 -26.7 0.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.945 . . . . 0.0 109.718 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.05 -36.44 18.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.58 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' CZ ' ' CD1' ' A' ' 19' ' ' LEU . 13.9 m-85 -88.82 -7.19 56.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 109.663 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.915 HD13 ' HB2' ' A' ' 77' ' ' ALA . 4.3 mt -94.93 23.35 5.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 110.027 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 37' ' ' LEU . 23.2 tp10 -44.99 -56.43 4.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.0 109.032 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 40' ' ' GLU . 13.8 p30 -97.45 36.89 1.42 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.716 ' HB2' HD22 ' A' ' 37' ' ' LEU . 21.4 pt-20 -39.38 131.07 1.66 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.536 0.684 . . . . 0.0 110.503 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -124.61 87.54 54.43 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 49.1 Cg_endo -69.87 117.73 5.26 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.653 2.236 . . . . 0.0 112.213 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.3 pt -91.37 -24.86 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.29 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -143.24 178.53 7.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.897 . . . . 0.0 109.495 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 71.6 p -120.91 149.72 42.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 109.595 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.949 ' CE ' HD11 ' A' ' 48' ' ' ILE . 61.3 ttp -137.75 145.19 42.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.89 . . . . 0.0 109.398 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.527 HD23 ' C ' ' A' ' 47' ' ' LEU . 9.0 tt -110.39 130.92 55.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.949 HD11 ' CE ' ' A' ' 46' ' ' MET . 32.4 mm -116.31 139.68 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.449 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -130.7 124.01 30.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.433 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.0 p -121.83 168.69 11.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.513 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.506 HG13 ' N ' ' A' ' 52' ' ' HIS . 24.1 pt -65.24 -39.38 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.598 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.506 ' N ' HG13 ' A' ' 51' ' ' ILE . 76.1 m80 -63.46 -33.3 75.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.607 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.66 -179.13 46.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' OE2' HD21 ' A' ' 47' ' ' LEU . 73.9 tt0 -103.14 131.94 49.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -1.139 . . . . 0.0 109.437 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 8.0 mtmt -128.41 130.16 47.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.211 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -114.48 130.28 56.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.684 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.46 HE21 HD11 ' A' ' 76' ' ' LEU . 25.0 mt-30 -136.51 156.53 48.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.384 -0.822 . . . . 0.0 109.127 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 59.1 m-20 -86.77 165.24 16.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.995 . . . . 0.0 109.777 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.507 HG11 ' CD ' ' A' ' 74' ' ' GLU . 41.3 t -99.5 139.59 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.367 -0.833 . . . . 0.0 108.945 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 3.9 m-85 -122.52 147.73 46.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.046 -1.034 . . . . 0.0 110.119 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.598 ' O ' HD12 ' A' ' 62' ' ' LEU . 39.8 t80 -105.55 112.09 25.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.613 ' HB2' HG21 ' A' ' 75' ' ' VAL . 6.9 mp -116.38 161.28 19.3 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 110.155 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.696 HG23 ' HG2' ' A' ' 72' ' ' GLU . 18.1 m -121.39 117.33 26.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.513 -0.742 . . . . 0.0 109.057 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 6.1 p90 -140.08 156.83 46.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.085 -1.009 . . . . 0.0 109.939 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 80.6 mttt -91.91 127.86 37.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.385 -0.822 . . . . 0.0 109.239 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.574 HG11 HG11 ' A' ' 90' ' ' VAL . 58.1 t -108.27 109.44 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.606 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 85.3 mt-30 62.88 37.98 11.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.321 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.76 29.08 58.02 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -133.26 113.55 12.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -1.14 . . . . 0.0 109.332 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -63.52 121.21 13.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.715 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 ' CH2' ' A' ' 92' ' ' TRP . 94.2 t -140.57 132.06 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.268 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.696 ' HG2' HG23 ' A' ' 63' ' ' THR . 49.7 mt-10 -115.77 136.92 52.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.131 -0.981 . . . . 0.0 109.745 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.37 -169.65 2.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.432 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.514 ' HB3' HD11 ' A' ' 29' ' ' ILE . 95.9 mt-10 -80.02 165.66 22.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 0.0 109.153 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.757 ' CG1' HG22 ' A' ' 32' ' ' VAL . 94.7 t -152.58 156.77 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.92 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.465 ' N ' HG12 ' A' ' 75' ' ' VAL . 14.8 tp -125.43 141.31 52.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.53 -0.731 . . . . 0.0 109.213 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.915 ' HB2' HD13 ' A' ' 37' ' ' LEU . . . -80.42 136.01 36.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -0.97 . . . . 0.0 109.43 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.48 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -143.91 151.67 53.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.48 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.2 Cg_endo -72.75 4.14 3.81 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.689 2.259 . . . . 0.0 111.864 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -65.6 171.72 3.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.157 -0.965 . . . . 0.0 109.392 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -113.72 17.63 18.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.409 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.74 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 12.4 p90 -139.81 -159.38 0.95 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.261 -0.899 . . . . 0.0 109.032 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.674 HG23 HG12 ' A' ' 32' ' ' VAL . 2.5 mt -129.17 147.17 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.183 -0.948 . . . . 0.0 109.633 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.74 HD11 ' CZ ' ' A' ' 82' ' ' TYR . 6.6 mp -111.69 135.95 51.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.344 -0.847 . . . . 0.0 108.952 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.758 ' N ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -102.55 140.73 36.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.984 . . . . 0.0 109.867 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.642 ' O ' HG22 ' A' ' 90' ' ' VAL . 8.9 t-20 -92.32 134.58 28.05 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.487 -0.758 . . . . 0.0 109.096 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.519 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.5 Cg_endo -64.03 -30.74 66.37 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.766 2.311 . . . . 0.0 111.946 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 m -74.68 -29.61 61.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.262 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -79.44 -29.32 41.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.43 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.177 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -122.88 74.82 47.63 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.379 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.7 -24.47 29.89 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.727 2.284 . . . . 0.0 111.812 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.177 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 42.3 p90 -72.78 -29.87 63.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.5 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.591 HD12 ' CG2' ' A' ' 90' ' ' VAL . 73.4 mt -59.77 -38.01 80.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.51 ' O ' ' N ' ' A' ' 96' ' ' LYS . 65.0 mtt -51.95 -40.21 60.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.843 . . . . 0.0 109.605 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.6 mttm 45.12 -94.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.234 -0.916 . . . . 0.0 109.598 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 94' ' ' MET . 10.2 ttpt 64.69 60.89 1.39 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.114 -0.991 . . . . 0.0 109.485 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.6 147.44 57.47 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.667 2.245 . . . . 0.0 111.735 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.6 tp . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.412 179.933 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.558 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 47.9 Cg_endo -69.77 149.46 66.85 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.778 2.319 . . . . 0.0 111.912 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.53 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 29.4 mt -83.13 -176.24 6.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.467 ' OE2' ' CE ' ' A' ' 18' ' ' LYS . 72.3 tt0 -113.2 137.32 51.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.496 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.12 142.74 27.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 109.609 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -116.16 120.25 38.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.264 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.635 HG22 ' HG3' ' A' ' 15' ' ' LYS . 36.9 mt -111.53 129.14 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.601 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.635 ' HG3' HG22 ' A' ' 14' ' ' ILE . 32.5 mttm 51.84 24.39 2.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -0.878 . . . . 0.0 109.665 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.64 -4.72 79.63 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.873 HG22 HD11 ' A' ' 19' ' ' LEU . 13.1 m -87.98 128.85 35.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -1.196 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.889 ' C ' HD12 ' A' ' 19' ' ' LEU . 19.3 tttt -86.8 121.75 29.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.492 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.889 HD12 ' C ' ' A' ' 18' ' ' LYS . 5.2 mp -140.54 161.89 36.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.89 . . . . 0.0 109.458 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -88.37 155.36 19.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -0.922 . . . . 0.0 109.428 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.071 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -139.23 176.87 8.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 64.9 m-70 -134.56 122.49 22.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.817 ' CE2' HD22 ' A' ' 93' ' ' LEU . 71.4 t90 -79.59 128.08 32.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.303 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -141.58 109.75 5.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.555 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 20.7 t -60.88 -27.18 67.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.77 -27.14 70.68 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.482 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -79.84 127.63 32.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -1.195 . . . . 0.0 109.48 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 m -95.33 -16.84 22.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 0.0 109.438 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 29' ' ' ILE . 21.1 tt -135.56 130.84 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 84' ' ' LEU . 90.5 m -50.92 139.19 17.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.595 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.593 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -119.82 128.95 54.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.27 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.924 HG12 HG23 ' A' ' 83' ' ' ILE . 16.6 m -122.4 162.57 37.23 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 78' ' ' SER . 55.4 Cg_endo -78.67 131.35 10.27 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.466 2.111 . . . . 0.0 111.623 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.964 ' HG2' ' HB1' ' A' ' 77' ' ' ALA . 96.8 mt-10 -42.9 -27.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 109.548 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -47.46 -43.02 23.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.77 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.586 ' CE1' ' CD2' ' A' ' 19' ' ' LEU . 21.4 m-85 -84.98 -6.32 59.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.102 -0.999 . . . . 0.0 109.756 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' A' ' 40' ' ' GLU . 4.3 mm? -92.48 18.09 9.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.168 -0.958 . . . . 0.0 109.678 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 37' ' ' LEU . 68.7 mt-10 -44.25 -54.17 5.97 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 40' ' ' GLU . 18.7 p30 -99.41 37.16 1.62 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 19.0 pt-20 -38.69 134.11 0.98 Allowed 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.53 0.681 . . . . 0.0 110.513 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.5 mtp85 -128.42 83.37 66.35 Favored Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 48.5 Cg_endo -68.59 117.25 4.86 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.842 2.361 . . . . 0.0 112.341 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.1 pt -91.17 -28.95 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.391 -0.818 . . . . 0.0 109.04 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -141.36 157.05 45.7 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.483 -0.76 . . . . 0.0 109.183 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 81.0 p -120.44 154.58 35.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.124 -0.985 . . . . 0.0 109.674 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.47 ' CE ' HG21 ' A' ' 59' ' ' VAL . 63.0 mtt -140.85 142.65 34.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.408 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.4 tp -96.59 127.45 42.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 55' ' ' LYS . 29.4 mm -113.9 132.51 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.555 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -110.57 133.11 53.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.74 179.38 4.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.44 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 54.2 mt -68.75 -49.92 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -54.11 -47.74 71.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.458 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.69 -162.41 25.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -100.51 132.4 45.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -1.119 . . . . 0.0 109.436 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 48' ' ' ILE . 22.8 tptm -120.58 136.92 54.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.357 -0.839 . . . . 0.0 109.452 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -104.42 122.84 46.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.608 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.624 ' HB3' HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -119.02 145.24 46.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.256 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.554 ' HB2' ' CE1' ' A' ' 60' ' ' TYR . 78.9 m-20 -101.21 155.92 17.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.497 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 44.6 t -99.09 134.19 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.146 -0.971 . . . . 0.0 109.125 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.61 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 3.4 m-85 -122.61 147.41 46.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.161 -0.962 . . . . 0.0 109.61 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.675 ' O ' HD23 ' A' ' 62' ' ' LEU . 32.9 t80 -104.88 115.5 30.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 108.961 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 61' ' ' TYR . 18.9 mt -121.47 156.52 32.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 110.08 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.718 HG23 ' HG2' ' A' ' 72' ' ' GLU . 67.9 m -115.31 125.68 53.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.449 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 18.1 p90 -149.02 151.23 34.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.082 -1.011 . . . . 0.0 109.681 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -85.28 133.32 34.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.323 -0.861 . . . . 0.0 109.198 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.549 HG11 HG11 ' A' ' 90' ' ' VAL . 40.1 t -109.58 112.64 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 93.7 mt-30 61.33 20.96 11.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.86 . . . . 0.0 109.468 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.64 21.77 18.19 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.93 ' HG2' HG23 ' A' ' 71' ' ' VAL . 6.6 ttt85 -126.86 116.82 21.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -1.057 . . . . 0.0 109.068 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -64.55 116.07 5.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 109.367 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.93 HG23 ' HG2' ' A' ' 69' ' ' ARG . 55.4 t -138.12 134.97 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 109.481 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.718 ' HG2' HG23 ' A' ' 63' ' ' THR . 80.6 mt-10 -111.05 140.35 45.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.3 168.99 24.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.624 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.497 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 95.8 mt-10 -79.84 141.06 36.55 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.393 -0.817 . . . . 0.0 109.079 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.624 HG21 HD12 ' A' ' 62' ' ' LEU . 2.8 m -138.18 163.46 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.186 -0.946 . . . . 0.0 109.775 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.624 HD11 ' HB3' ' A' ' 57' ' ' GLN . 21.1 tp -117.39 146.85 43.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.964 ' HB1' ' HG2' ' A' ' 34' ' ' GLU . . . -79.75 126.01 30.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.386 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 1.1 t -133.06 152.18 79.23 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.474 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.487 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 48.9 Cg_endo -69.6 -0.82 7.33 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.605 2.203 . . . . 0.0 111.779 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -58.78 169.86 0.91 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.384 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -111.97 22.32 15.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.695 ' CZ ' HD11 ' A' ' 84' ' ' LEU . 19.2 p90 -148.14 -159.32 1.01 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.417 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.924 HG23 HG12 ' A' ' 32' ' ' VAL . 4.0 mt -125.22 140.64 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.735 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.786 ' O ' HG23 ' A' ' 30' ' ' THR . 6.9 mp -106.35 130.59 54.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.32 -0.863 . . . . 0.0 109.039 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.071 HD21 ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -111.48 135.18 52.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.624 -179.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.531 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 6.8 p-10 -97.55 158.17 33.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.243 -0.91 . . . . 0.0 109.737 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 48.8 Cg_endo -69.19 -20.0 38.11 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.663 2.242 . . . . 0.0 111.403 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.5 p -76.36 -36.39 58.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.317 -0.864 . . . . 0.0 109.116 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.459 ' HB2' ' OD1' ' A' ' 86' ' ' ASN . 88.0 m-20 -79.38 -32.07 43.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -0.826 . . . . 0.0 108.905 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.062 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -119.25 71.68 12.45 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.365 -0.835 . . . . 0.0 109.515 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.565 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 50.4 Cg_endo -70.31 -20.15 32.59 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.735 2.29 . . . . 0.0 111.784 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.062 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 47.2 p90 -79.85 -32.88 40.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.923 . . . . 0.0 109.562 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.817 HD22 ' CE2' ' A' ' 23' ' ' TRP . 0.7 OUTLIER -43.53 -42.2 4.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.431 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.543 ' SD ' HD11 ' A' ' 98' ' ' LEU . 71.9 mtm -82.16 127.9 33.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.0 109.474 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -61.17 -37.18 81.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.504 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.13 153.76 76.93 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.524 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.75 168.67 20.87 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.727 2.285 . . . . 0.0 111.819 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.691 ' N ' HD12 ' A' ' 98' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.548 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 51.1 Cg_endo -69.8 149.3 66.46 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.677 2.251 . . . . 0.0 111.854 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.526 HD13 HD12 ' A' ' 85' ' ' LEU . 4.1 mp -82.59 161.15 22.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.473 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.55 142.64 29.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.502 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.07 151.84 28.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.54 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 18' ' ' LYS . 92.2 mt-10 -130.88 121.53 25.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 109.432 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 75.9 mt -114.7 128.14 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.936 . . . . 0.0 109.43 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 65.5 mttt 61.11 20.26 10.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.44 -12.42 69.76 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.45 HG22 HD12 ' A' ' 19' ' ' LEU . 41.9 m -81.8 134.63 35.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -1.169 . . . . 0.0 109.409 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.747 ' O ' HD12 ' A' ' 19' ' ' LEU . 89.0 mttt -89.75 139.04 30.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -158.8 165.61 33.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.411 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 9' ' ' PRO . 11.8 mmtt -86.5 150.67 24.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.764 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -133.49 171.11 14.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.548 ' CE1' ' HB3' ' A' ' 9' ' ' PRO . 68.2 m-70 -131.52 133.83 45.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 109.836 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.605 ' CD1' ' CD2' ' A' ' 93' ' ' LEU . 58.5 t90 -90.31 115.13 27.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 109.448 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -127.08 102.53 7.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.386 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.473 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 32.2 t -57.83 -34.03 69.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.613 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.95 -35.59 48.72 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.18 136.11 51.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.2 m -95.29 -16.4 22.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.45 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.5 tt -141.65 149.41 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.316 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 27.9 m -57.69 135.49 56.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.732 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -119.24 119.53 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.9 . . . . 0.0 109.214 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.637 HG12 HG23 ' A' ' 83' ' ' ILE . 29.1 m -113.44 162.2 23.5 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.281 -0.887 . . . . 0.0 109.515 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.6 Cg_endo -79.2 130.6 9.32 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.547 2.164 . . . . 0.0 111.575 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 81.0 tt0 -43.27 -26.87 0.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 0.0 109.51 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -53.08 -41.81 65.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.402 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.636 ' HZ ' HD13 ' A' ' 19' ' ' LEU . 5.9 m-85 -83.15 -3.04 56.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.226 -0.921 . . . . 0.0 109.445 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 40' ' ' GLU . 6.1 mt -95.93 20.72 9.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.946 . . . . 0.0 109.779 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 37' ' ' LEU . 71.5 mt-10 -43.9 -56.51 3.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 0.0 108.942 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 49.2 m-20 -97.05 40.15 1.15 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.742 ' HB2' HD22 ' A' ' 37' ' ' LEU . 21.0 pt-20 -42.94 134.2 3.44 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.522 0.677 . . . . 0.0 110.551 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -127.83 85.97 59.41 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.32 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 49.9 Cg_endo -70.28 118.85 5.92 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.717 2.278 . . . . 0.0 112.242 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.468 HG13 ' N ' ' A' ' 44' ' ' GLN . 36.1 pt -90.5 -35.86 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.023 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.468 ' N ' HG13 ' A' ' 43' ' ' ILE . 94.7 mt-30 -137.99 175.66 9.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.405 -0.809 . . . . 0.0 109.106 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 76.6 p -129.85 151.83 50.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.086 -1.009 . . . . 0.0 109.829 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.481 ' HG3' ' CG2' ' A' ' 59' ' ' VAL . 81.2 mtp -138.38 147.12 43.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.422 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.683 HD12 ' HB2' ' A' ' 56' ' ' GLN . 20.8 tp -98.63 129.43 45.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.506 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.47 134.2 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.43 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -104.21 140.7 37.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 52' ' ' HIS . 91.4 m -131.81 144.42 50.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.92 . . . . 0.0 109.385 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 52' ' ' HIS . 16.4 tt -48.82 -41.71 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.901 . . . . 0.0 109.478 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.521 ' N ' HG23 ' A' ' 51' ' ' ILE . 56.1 t-80 -67.28 -36.52 81.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 109.452 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' ' HB ' ' A' ' 50' ' ' THR . . . -179.25 -173.94 44.91 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -103.79 129.04 51.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -1.193 . . . . 0.0 109.528 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -122.68 134.14 54.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 0.0 109.35 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.683 ' HB2' HD12 ' A' ' 47' ' ' LEU . 62.8 tt0 -109.46 125.37 52.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.596 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.415 ' OE1' ' HB3' ' A' ' 76' ' ' LEU . 7.4 tt0 -123.02 147.16 46.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.258 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.483 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 83.4 m-20 -83.81 159.04 21.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.195 -0.941 . . . . 0.0 109.661 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.683 HG11 ' OE1' ' A' ' 74' ' ' GLU . 43.4 t -98.94 134.69 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.262 -0.898 . . . . 0.0 109.043 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.604 ' CD2' ' HB2' ' A' ' 40' ' ' GLU . 4.0 m-85 -119.06 148.46 43.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.047 -1.033 . . . . 0.0 109.913 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.588 ' O ' HD12 ' A' ' 62' ' ' LEU . 43.3 t80 -107.0 112.49 25.47 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.826 HD22 HG21 ' A' ' 75' ' ' VAL . 6.8 mp -115.66 158.88 22.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.155 -0.965 . . . . 0.0 110.445 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.716 HG23 ' HG2' ' A' ' 72' ' ' GLU . 51.0 m -117.74 116.76 27.67 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.801 ' CE2' HG22 ' A' ' 66' ' ' VAL . 39.9 p90 -137.21 160.02 40.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 109.955 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -93.11 129.08 39.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 109.356 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.801 HG22 ' CE2' ' A' ' 64' ' ' PHE . 1.7 t -105.53 103.55 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 109.656 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 84.1 mt-30 63.61 36.73 10.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.895 . . . . 0.0 109.33 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.72 26.01 51.54 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -129.55 120.88 26.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.333 -1.098 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -66.33 122.82 18.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.582 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.693 HG21 ' CH2' ' A' ' 92' ' ' TRP . 90.2 t -144.17 133.44 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.451 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.716 ' HG2' HG23 ' A' ' 63' ' ' THR . 76.4 mt-10 -117.16 137.18 52.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.641 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.07 172.49 17.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.6 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.683 ' OE1' HG11 ' A' ' 59' ' ' VAL . 96.1 mt-10 -79.9 141.35 36.17 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -0.922 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.826 HG21 HD22 ' A' ' 62' ' ' LEU . 2.9 m -135.14 162.3 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.943 . . . . 0.0 109.752 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.415 ' HB3' ' OE1' ' A' ' 57' ' ' GLN . 72.8 mt -119.34 154.71 33.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.847 . . . . 0.0 109.287 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB2' HD13 ' A' ' 37' ' ' LEU . . . -80.17 138.83 36.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.478 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.572 ' OG ' ' CD2' ' A' ' 80' ' ' TYR . 4.6 t -143.11 149.0 47.26 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.475 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 53.2 Cg_endo -72.65 3.37 4.36 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.701 2.267 . . . . 0.0 112.065 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.572 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 74.3 m-85 -66.81 174.93 2.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 109.587 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -114.06 15.65 18.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 0.0 109.341 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' N ' ' A' ' 83' ' ' ILE . 33.0 p90 -139.22 -157.89 0.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.208 -0.933 . . . . 0.0 109.08 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.637 HG23 HG12 ' A' ' 32' ' ' VAL . 4.5 mt -123.66 126.21 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.669 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.732 HD13 ' HB3' ' A' ' 31' ' ' CYS . 5.7 mp -84.27 142.59 30.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 108.941 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.764 HD21 ' HB1' ' A' ' 21' ' ' ALA . 6.6 mt -112.92 143.26 44.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 110.083 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.74 ' O ' HG22 ' A' ' 90' ' ' VAL . 3.3 t30 -103.61 137.41 19.24 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.53 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 42.5 Cg_endo -64.0 -35.65 53.33 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.703 2.269 . . . . 0.0 111.998 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.447 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 2.5 m -72.54 -27.01 61.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.141 -0.974 . . . . 0.0 109.411 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -79.55 -28.92 41.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.34 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.094 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -120.26 71.85 18.03 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.841 . . . . 0.0 109.464 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.34 -16.3 35.09 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.632 2.221 . . . . 0.0 111.762 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.094 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 41.6 p90 -82.6 -28.51 30.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.894 . . . . 0.0 109.414 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.605 ' CD2' ' CD1' ' A' ' 23' ' ' TRP . 22.0 tp -60.58 -26.28 66.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.4 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 88.0 mtp -67.52 -35.54 79.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.36 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 92' ' ' TRP . 63.7 mttm -117.36 137.66 52.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.402 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -71.66 148.09 92.5 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.902 . . . . 0.0 109.62 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 49.3 Cg_endo -69.5 -16.77 38.84 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.804 2.336 . . . . 0.0 111.833 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 97' ' ' PRO . 44.3 mt . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.215 0.531 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.528 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 49.2 Cg_endo -69.74 152.05 69.31 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.655 2.237 . . . . 0.0 111.709 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 23' ' ' TRP . 3.7 mp -84.38 164.47 18.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.439 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -101.79 147.21 26.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.475 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.25 146.31 25.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.521 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 17' ' ' THR . 89.9 mt-10 -123.8 118.68 27.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.71 HG22 ' HG3' ' A' ' 15' ' ' LYS . 61.6 mt -114.15 129.65 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.503 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.71 ' HG3' HG22 ' A' ' 14' ' ' ILE . 93.2 mttt 54.35 22.39 3.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.94 -8.55 76.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 32.7 m -82.58 128.45 34.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -1.13 . . . . 0.0 109.493 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.812 ' O ' HD23 ' A' ' 19' ' ' LEU . 29.6 tttt -92.47 122.79 35.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.403 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.812 HD23 ' O ' ' A' ' 18' ' ' LYS . 63.7 mt -140.88 168.08 20.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.498 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -87.67 155.54 19.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.496 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.696 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -139.85 167.73 21.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -0.859 . . . . 0.0 109.337 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.622 ' O ' HD22 ' A' ' 85' ' ' LEU . 80.4 m-70 -130.98 132.47 45.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.498 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.573 ' CZ2' ' HB3' ' A' ' 87' ' ' PRO . 38.9 t90 -85.76 122.98 30.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.587 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -130.15 99.31 5.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.875 . . . . 0.0 109.463 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.516 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 53.4 p -57.16 -26.76 61.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -0.861 . . . . 0.0 109.509 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.22 -36.17 92.0 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -72.17 137.37 46.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -1.15 . . . . 0.0 109.425 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.451 ' O ' HG22 ' A' ' 28' ' ' THR . 93.5 m -99.1 -10.45 22.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 109.385 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.452 ' C ' ' HB2' ' A' ' 86' ' ' ASN . 21.2 tt -139.4 152.77 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 84' ' ' LEU . 32.4 m -61.24 152.11 29.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.477 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.975 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -127.93 113.72 16.23 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.111 179.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.782 HG13 ' HD2' ' A' ' 33' ' ' PRO . 60.3 t -113.55 146.91 36.4 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.312 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.782 ' HD2' HG13 ' A' ' 32' ' ' VAL . 55.3 Cg_endo -76.75 131.22 12.14 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.125 1.883 . . . . 0.0 111.625 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 33' ' ' PRO . 81.3 tt0 -40.7 -27.48 0.05 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.533 -0.729 . . . . 0.0 110.234 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -49.14 -27.75 3.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.096 -1.003 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.751 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 21.4 m-85 -101.77 -3.04 28.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 0.0 109.77 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.569 ' CD2' ' CG ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -115.25 15.01 17.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.698 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 70.7 mm-40 -61.48 -24.13 66.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.099 -1.001 . . . . 0.0 109.325 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -128.44 27.07 5.61 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.565 ' CB ' HD23 ' A' ' 37' ' ' LEU . 53.7 mm-40 -96.15 174.4 6.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.506 -0.747 . . . . 0.0 109.805 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.03 128.83 20.78 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 109.223 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.572 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 52.1 Cg_endo -72.27 121.44 7.5 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.578 2.185 . . . . 0.0 111.923 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 61' ' ' TYR . 3.2 pt -84.96 -29.7 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 109.173 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 59' ' ' VAL . 63.2 tt0 -143.68 163.85 32.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.189 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 71.5 p -122.94 149.07 44.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 109.761 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 63.0 mtt -141.92 144.21 33.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.317 -0.864 . . . . 0.0 109.359 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.517 HD23 ' C ' ' A' ' 47' ' ' LEU . 8.7 tt -93.16 131.72 37.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.385 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.473 ' N ' HD23 ' A' ' 47' ' ' LEU . 74.2 mt -119.24 129.21 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.868 . . . . 0.0 109.568 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -108.28 134.73 50.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.399 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.18 -168.72 1.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.492 ' HA ' HD13 ' A' ' 51' ' ' ILE . 16.7 mm -80.08 -47.01 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.371 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -58.01 -38.83 76.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.508 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.41 -169.41 41.05 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.2 mp0 -104.98 136.99 43.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -1.105 . . . . 0.0 109.507 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -137.23 134.01 35.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.363 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -107.18 127.91 53.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.545 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.865 ' NE2' HD21 ' A' ' 76' ' ' LEU . 26.1 mt-30 -123.82 160.73 26.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.306 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 79.6 m-20 -93.23 144.41 25.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 109.689 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.539 ' CG1' ' HB3' ' A' ' 74' ' ' GLU . 21.7 t -86.39 153.78 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 109.293 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.572 ' CE2' ' HD3' ' A' ' 42' ' ' PRO . 11.4 m-85 -133.16 139.3 46.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.138 -0.976 . . . . 0.0 109.889 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.493 ' O ' HD23 ' A' ' 62' ' ' LEU . 43.5 t80 -102.15 114.4 28.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.257 -0.902 . . . . 0.0 108.956 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.576 HD12 HG21 ' A' ' 75' ' ' VAL . 44.1 mt -121.01 169.05 10.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.061 -1.024 . . . . 0.0 110.288 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.711 HG23 ' HG2' ' A' ' 72' ' ' GLU . 25.4 m -121.22 118.05 28.62 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.502 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 9.5 p90 -140.34 163.22 33.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.988 -1.07 . . . . 0.0 109.801 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.45 ' NZ ' ' OE1' ' A' ' 13' ' ' GLU . 15.2 mtmt -99.38 126.01 45.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.388 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 78.0 t -104.42 116.19 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.481 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 66' ' ' VAL . 94.7 mt-30 62.29 30.96 17.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.386 -0.821 . . . . 0.0 109.393 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.65 22.45 59.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -125.64 117.61 23.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -1.164 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -58.91 123.9 18.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.439 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.689 HG21 ' CH2' ' A' ' 92' ' ' TRP . 53.7 t -148.55 127.03 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.335 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.711 ' HG2' HG23 ' A' ' 63' ' ' THR . 79.5 mt-10 -107.66 138.82 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.525 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.32 168.34 25.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.338 -0.851 . . . . 0.0 109.695 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.539 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 95.5 mt-10 -80.04 137.29 36.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.328 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.694 ' HB ' HG23 ' A' ' 32' ' ' VAL . 5.0 m -127.92 151.39 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.865 HD21 ' NE2' ' A' ' 57' ' ' GLN . 24.6 tp -103.75 143.63 32.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.355 -0.84 . . . . 0.0 109.082 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 32' ' ' VAL . . . -79.17 125.9 30.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.243 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.495 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 35.2 t -137.14 150.13 68.3 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.296 -0.878 . . . . 0.0 109.534 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.495 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.8 Cg_endo -71.01 5.07 2.34 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.669 2.246 . . . . 0.0 112.176 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CD2' ' OG ' ' A' ' 78' ' ' SER . 31.3 m-85 -62.57 178.22 0.45 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 109.362 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -118.22 18.3 13.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.549 ' CD2' ' N ' ' A' ' 83' ' ' ILE . 13.9 p90 -145.08 -153.97 0.51 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.349 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.549 ' N ' ' CD2' ' A' ' 82' ' ' TYR . 2.4 mt -133.22 148.01 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 0.0 109.563 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.975 HD13 ' HB3' ' A' ' 31' ' ' CYS . 6.0 mp -112.27 133.73 54.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 108.886 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.76 ' H ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -100.63 133.09 45.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.067 -1.021 . . . . 0.0 109.851 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.677 ' O ' HG22 ' A' ' 90' ' ' VAL . 3.3 t30 -85.67 136.57 36.84 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.573 ' HB3' ' CZ2' ' A' ' 23' ' ' TRP . 40.5 Cg_endo -63.06 -25.76 73.45 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.696 2.264 . . . . 0.0 111.849 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.497 ' OG ' ' ND2' ' A' ' 86' ' ' ASN . 1.0 OUTLIER -80.42 -28.92 37.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.27 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -78.06 -28.6 48.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.864 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.179 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -116.06 73.95 5.17 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.202 -0.936 . . . . 0.0 109.505 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.414 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.8 Cg_endo -70.3 -23.73 28.0 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.757 2.305 . . . . 0.0 111.791 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.179 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 43.9 p90 -73.06 -29.63 63.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.492 HD12 ' CG2' ' A' ' 90' ' ' VAL . 76.3 mt -61.3 -33.76 74.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.241 -0.912 . . . . 0.0 109.467 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.48 ' SD ' ' CH2' ' A' ' 23' ' ' TRP . 89.9 mtp -107.44 154.22 21.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.51 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -88.2 139.81 30.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.476 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -125.43 79.55 66.74 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.495 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 98' ' ' LEU . 49.7 Cg_endo -70.04 145.36 55.3 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.656 2.237 . . . . 0.0 111.735 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 97' ' ' PRO . 26.1 tp . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.172 -0.955 . . . . 0.0 109.493 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.508 ' CB ' ' CD ' ' A' ' 9' ' ' PRO . 11.5 mm100 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' A' ' 8' ' ' GLN . 48.3 Cg_endo -69.92 152.48 68.52 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.66 2.24 . . . . 0.0 111.77 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.746 HD22 HE21 ' A' ' 67' ' ' GLN . 86.3 mt -93.81 154.17 17.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.475 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -88.49 140.24 29.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.548 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.48 155.35 41.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 17' ' ' THR . 67.5 tt0 -128.65 109.56 11.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -0.953 . . . . 0.0 109.412 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.585 ' HB ' ' CE2' ' A' ' 36' ' ' PHE . 90.0 mt -104.92 128.81 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.51 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 52.7 mttp 61.31 18.17 8.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.632 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.08 -10.93 73.39 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 81.8 m -85.5 140.43 30.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -1.136 . . . . 0.0 109.171 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -79.26 117.45 20.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.295 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.907 HD22 ' CE1' ' A' ' 36' ' ' PHE . 11.7 tp -130.14 147.81 51.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.476 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.746 ' O ' HD12 ' A' ' 83' ' ' ILE . 40.6 mttt -81.93 157.82 24.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.6 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.075 ' HB1' HD11 ' A' ' 85' ' ' LEU . . . -144.98 160.08 41.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.554 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.727 ' O ' HD22 ' A' ' 85' ' ' LEU . 65.4 m-70 -128.72 129.32 45.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.265 -0.897 . . . . 0.0 109.471 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.59 ' CZ3' ' HB3' ' A' ' 25' ' ' SER . 21.9 t90 -75.28 125.45 29.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.641 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -132.85 95.9 3.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.394 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.59 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 54.6 p -56.45 -31.8 64.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.657 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.57 -27.58 68.31 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 87' ' ' PRO . . . -79.98 139.29 37.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -1.167 . . . . 0.0 109.472 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.503 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 41.8 p -103.57 -4.36 24.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.584 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.791 HG21 HD11 ' A' ' 76' ' ' LEU . 21.2 tt -143.98 149.41 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.932 . . . . 0.0 109.472 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.692 ' HB ' HG22 ' A' ' 75' ' ' VAL . 27.8 m -61.12 139.67 58.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.647 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.803 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -123.48 140.07 53.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.546 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.041 HG12 HG23 ' A' ' 83' ' ' ILE . 34.9 m -141.13 165.8 26.73 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.915 . . . . 0.0 109.411 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 55.4 Cg_endo -78.29 128.15 8.73 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.29 1.993 . . . . 0.0 111.451 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' PRO . 83.9 tt0 -41.78 -28.19 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.749 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -53.27 -31.48 43.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.557 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.907 ' CE1' HD22 ' A' ' 19' ' ' LEU . 2.2 m-85 -88.75 -10.92 46.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 0.0 109.673 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.659 HD23 ' CD2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -106.56 0.88 24.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.858 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -51.83 -25.78 8.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 109.321 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -120.99 23.57 10.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.39 -0.819 . . . . 0.0 109.234 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.541 ' HB2' HD23 ' A' ' 37' ' ' LEU . 41.7 mm-40 -98.02 157.03 16.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.724 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.24 129.3 25.46 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.08 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.539 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 52.9 Cg_endo -72.93 124.53 9.71 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.53 2.153 . . . . 0.0 111.745 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.45 HD13 ' HB2' ' A' ' 61' ' ' TYR . 26.9 pt -81.8 -28.99 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.26 -0.9 . . . . 0.0 109.356 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.564 ' O ' HG12 ' A' ' 59' ' ' VAL . 94.7 mt-30 -147.51 177.97 8.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.289 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 60.4 p -118.53 148.58 42.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.145 -0.972 . . . . 0.0 109.71 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.435 ' O ' ' HG3' ' A' ' 56' ' ' GLN . 86.2 mtp -129.34 149.28 51.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.908 HD13 ' N ' ' A' ' 48' ' ' ILE . 1.8 tm? -101.86 128.82 48.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.299 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.908 ' N ' HD13 ' A' ' 47' ' ' LEU . 25.2 mm -111.83 138.16 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 109.49 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.419 ' HG3' ' HG3' ' A' ' 54' ' ' GLU . 20.9 tttm -121.38 132.29 54.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.531 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.8 p -126.81 156.15 41.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.352 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 52' ' ' HIS . 17.9 tt -58.26 -36.7 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.435 ' N ' HG23 ' A' ' 51' ' ' ILE . 84.0 t60 -68.6 -46.24 69.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.871 . . . . 0.0 109.352 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.86 -167.65 27.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HG3' ' HG3' ' A' ' 49' ' ' LYS . 50.3 mp0 -113.04 129.88 56.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.187 -1.184 . . . . 0.0 109.552 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 59.2 mttm -124.82 147.54 48.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.348 -0.845 . . . . 0.0 109.121 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.506 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 57.0 tt0 -120.34 132.86 55.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.655 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -128.85 161.23 30.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.289 -0.882 . . . . 0.0 109.293 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 41.4 m-20 -98.22 141.36 31.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.181 -0.949 . . . . 0.0 109.714 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 44' ' ' GLN . 14.4 p -79.99 158.47 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.245 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.659 ' CD2' HD23 ' A' ' 37' ' ' LEU . 25.6 m-85 -139.64 123.66 17.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.185 -0.947 . . . . 0.0 110.053 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.473 ' OH ' ' HB2' ' A' ' 72' ' ' GLU . 45.2 t80 -85.91 110.19 19.25 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.453 HD22 ' CD ' ' A' ' 40' ' ' GLU . 60.1 mt -115.81 161.62 18.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.032 -1.043 . . . . 0.0 110.624 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.7 HG23 ' HG2' ' A' ' 72' ' ' GLU . 29.5 m -121.23 124.24 44.17 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.981 ' CE2' HG22 ' A' ' 66' ' ' VAL . 43.2 p90 -145.92 160.38 41.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.044 -1.035 . . . . 0.0 109.97 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.504 ' HD3' ' HA ' ' A' ' 70' ' ' LYS . 6.8 mmtt -90.1 126.75 35.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.406 -0.809 . . . . 0.0 109.229 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.981 HG22 ' CE2' ' A' ' 64' ' ' PHE . 1.7 t -104.54 103.09 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.688 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.746 HE21 HD22 ' A' ' 10' ' ' LEU . 82.9 mt-30 62.61 35.06 14.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.317 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.46 30.93 28.88 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -136.28 120.56 17.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -1.169 . . . . 0.0 109.39 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.504 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 15.0 tttp -67.35 120.44 13.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.471 HG21 ' CH2' ' A' ' 92' ' ' TRP . 64.0 t -141.94 131.84 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.475 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.7 ' HG2' HG23 ' A' ' 63' ' ' THR . 27.3 mt-10 -116.01 136.48 52.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.31 -178.11 6.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.845 . . . . 0.0 109.667 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 94.1 mt-10 -79.64 152.81 29.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.02 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.897 ' CG1' HG22 ' A' ' 32' ' ' VAL . 91.6 t -143.51 156.97 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.123 -0.985 . . . . 0.0 109.744 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.791 HD11 HG21 ' A' ' 29' ' ' ILE . 17.2 mt -121.89 147.37 46.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.37 -0.831 . . . . 0.0 109.313 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.94 139.66 36.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.468 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.5 t -143.98 150.81 50.74 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 109.345 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.468 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 50.9 Cg_endo -71.37 1.75 5.17 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.677 2.251 . . . . 0.0 111.772 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.51 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 70.6 m-85 -69.15 162.53 26.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.278 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -104.32 19.79 19.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.604 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.84 ' OH ' HD21 ' A' ' 84' ' ' LEU . 22.4 p90 -140.57 -162.35 1.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.979 . . . . 0.0 109.552 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.041 HG23 HG12 ' A' ' 32' ' ' VAL . 7.5 mt -125.44 152.16 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.1 -1.0 . . . . 0.0 110.248 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.84 HD21 ' OH ' ' A' ' 82' ' ' TYR . 2.2 mt -118.55 124.59 47.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.298 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.075 HD11 ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -92.47 140.68 29.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 109.82 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.656 ' O ' HG22 ' A' ' 90' ' ' VAL . 8.2 t-20 -90.87 134.79 29.71 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.491 -0.755 . . . . 0.0 109.25 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.5 ' CD ' ' OD1' ' A' ' 86' ' ' ASN . 42.1 Cg_endo -63.95 -30.3 67.07 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.796 2.33 . . . . 0.0 111.78 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.407 ' HB3' HD21 ' A' ' 86' ' ' ASN . 6.4 t -75.73 -29.09 58.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 109.269 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -79.89 -33.21 40.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.897 . . . . 0.0 109.44 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.157 HG12 ' CZ2' ' A' ' 92' ' ' TRP . 0.8 OUTLIER -119.52 76.39 18.71 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.882 . . . . 0.0 109.424 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.439 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 49.3 Cg_endo -69.99 -22.05 31.58 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.697 2.264 . . . . 0.0 111.785 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.157 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.2 p90 -76.23 -25.72 55.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.171 -0.955 . . . . 0.0 109.401 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.548 HD12 HG21 ' A' ' 90' ' ' VAL . 59.9 mt -68.37 -30.17 69.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.478 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 90.0 mtp -53.25 -36.57 61.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.84 . . . . 0.0 109.558 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.92 138.37 48.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.127 -0.983 . . . . 0.0 109.554 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.3 160.49 45.47 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.355 -0.84 . . . . 0.0 109.473 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.428 ' O ' ' HB3' ' A' ' 98' ' ' LEU . 50.1 Cg_endo -69.57 156.03 64.95 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.727 2.285 . . . . 0.0 111.81 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 97' ' ' PRO . 21.6 tp . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.484 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.492 ' CB ' ' CD ' ' A' ' 9' ' ' PRO . 1.3 mm-40 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 8' ' ' GLN . 50.7 Cg_endo -70.14 163.08 39.89 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.729 2.286 . . . . 0.0 111.668 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.781 HD22 HE21 ' A' ' 67' ' ' GLN . 65.8 mt -93.63 142.03 27.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.493 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -83.43 134.1 34.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 65' ' ' LYS . . . -145.14 150.75 37.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.527 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.458 ' OE2' ' HA2' ' A' ' 16' ' ' GLY . 45.0 tt0 -115.93 121.0 41.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.405 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.633 HG22 ' HG3' ' A' ' 15' ' ' LYS . 27.1 mt -111.06 125.4 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.633 ' HG3' HG22 ' A' ' 14' ' ' ILE . 42.5 mttt 55.02 24.79 6.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.321 -0.862 . . . . 0.0 109.55 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.458 ' HA2' ' OE2' ' A' ' 13' ' ' GLU . . . 90.31 4.52 71.01 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 42.7 m -103.64 126.45 50.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -1.203 . . . . 0.0 109.467 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -82.12 129.15 34.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.73 HD13 ' HZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -141.27 167.76 21.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -87.55 148.61 24.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 0.0 109.569 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.846 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -135.92 163.79 29.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 109.475 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.741 ' O ' HD22 ' A' ' 85' ' ' LEU . 52.8 m-70 -130.37 129.42 43.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.563 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.779 ' HB2' HD11 ' A' ' 10' ' ' LEU . 48.4 t90 -77.0 127.74 33.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -137.59 107.41 6.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.499 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 18.2 p -65.69 -33.11 75.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.82 -15.76 55.49 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.12 130.43 34.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -1.155 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.7 m -94.98 -24.02 17.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.986 HD11 ' HB2' ' A' ' 74' ' ' GLU . 11.3 tp -132.72 143.12 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -0.926 . . . . 0.0 109.6 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 84' ' ' LEU . 39.1 m -58.46 136.46 57.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.655 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 9.9 t -124.76 140.04 53.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.834 HG13 HG13 ' A' ' 75' ' ' VAL . 2.6 m -137.72 172.14 7.29 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.32 -0.862 . . . . 0.0 109.14 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 32' ' ' VAL . 54.5 Cg_endo -79.82 132.26 9.58 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.22 1.946 . . . . 0.0 111.833 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 33' ' ' PRO . 22.4 pt-20 -44.22 -25.92 0.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.642 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . -48.52 -34.34 11.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 109.526 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.73 ' HZ ' HD13 ' A' ' 19' ' ' LEU . 12.8 m-85 -89.42 -9.75 49.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 109.646 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.571 HD12 ' CB ' ' A' ' 40' ' ' GLU . 3.6 mm? -90.45 21.19 4.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.783 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 37' ' ' LEU . 52.9 tt0 -44.15 -57.37 3.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 108.919 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 40' ' ' GLU . 24.4 m-20 -98.52 37.67 1.45 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 20.5 pt-20 -38.7 132.7 1.16 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.519 0.676 . . . . 0.0 110.368 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.04 85.01 61.64 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.504 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 50.2 Cg_endo -68.76 116.24 4.34 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.655 2.237 . . . . 0.0 112.171 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.4 pt -79.28 -27.51 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.294 -0.879 . . . . 0.0 109.148 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.491 ' O ' HG12 ' A' ' 59' ' ' VAL . 94.4 mt-30 -146.91 172.65 13.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 109.322 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 72.7 p -123.74 150.33 44.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.509 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 87.6 mtp -130.33 148.77 52.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.878 . . . . 0.0 109.355 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.675 HD23 ' HG3' ' A' ' 56' ' ' GLN . 49.1 mt -103.83 125.75 50.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.424 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 55' ' ' LYS . 23.4 mm -114.53 130.17 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 109.453 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -106.94 136.7 46.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 52' ' ' HIS . 52.0 m -126.95 139.97 52.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 109.463 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 52' ' ' HIS . 19.1 tt -47.95 -36.22 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.443 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.473 ' H ' HG22 ' A' ' 50' ' ' THR . 84.0 t60 -74.25 -31.77 62.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.952 . . . . 0.0 109.439 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 50' ' ' THR . . . -179.6 -177.52 47.89 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -102.8 128.54 49.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 109.455 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 48' ' ' ILE . 15.6 tptp -121.47 135.7 55.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.285 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.675 ' HG3' HD23 ' A' ' 47' ' ' LEU . 63.3 tt0 -103.61 123.67 47.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.193 -0.942 . . . . 0.0 109.644 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.413 ' HB3' HD11 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -116.94 136.51 52.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.168 179.86 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 61.9 m-20 -96.01 154.64 17.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 109.431 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.68 HG21 ' CD ' ' A' ' 74' ' ' GLU . 7.2 p -97.81 138.64 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.153 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.61 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 4.6 m-85 -121.91 147.83 45.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.272 -0.892 . . . . 0.0 109.636 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.534 ' O ' HD23 ' A' ' 62' ' ' LEU . 35.9 t80 -108.24 113.12 25.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -0.826 . . . . 0.0 108.957 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 61' ' ' TYR . 28.4 mt -117.25 158.84 23.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.071 -1.018 . . . . 0.0 110.128 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.712 HG23 ' HG2' ' A' ' 72' ' ' GLU . 22.0 m -119.88 115.7 24.36 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 9.4 p90 -138.89 162.02 35.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.067 -1.02 . . . . 0.0 109.945 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 32.2 mttm -92.39 127.37 37.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.395 -0.816 . . . . 0.0 109.278 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 49.8 t -106.98 105.86 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 109.537 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.781 HE21 HD22 ' A' ' 10' ' ' LEU . 85.5 mt-30 63.85 36.26 10.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.291 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.09 33.86 39.36 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 71' ' ' VAL . 74.3 mtt180 -139.19 108.81 6.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.225 -1.162 . . . . 0.0 109.405 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -55.72 121.71 9.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.91 . . . . 0.0 109.628 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.614 HG21 ' CH2' ' A' ' 92' ' ' TRP . 80.3 t -141.16 129.98 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 109.429 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.712 ' HG2' HG23 ' A' ' 63' ' ' THR . 54.5 mt-10 -113.7 136.36 52.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.621 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.37 -173.49 4.03 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.368 -0.832 . . . . 0.0 109.353 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.986 ' HB2' HD11 ' A' ' 29' ' ' ILE . 97.2 mt-10 -80.0 164.79 23.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.002 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.834 HG13 HG13 ' A' ' 32' ' ' VAL . 89.8 t -152.76 145.42 15.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.134 -0.979 . . . . 0.0 109.914 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 57' ' ' GLN . 14.9 tp -114.95 143.03 45.79 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.14 143.12 32.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.1 -1.0 . . . . 0.0 109.649 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.488 ' OG ' ' HD2' ' A' ' 79' ' ' PRO . 1.0 OUTLIER -152.25 152.11 28.78 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 0.0 109.304 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.488 ' HD2' ' OG ' ' A' ' 78' ' ' SER . 51.2 Cg_endo -71.19 2.53 4.25 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.613 2.209 . . . . 0.0 112.019 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 41.1 m-85 -63.34 169.23 3.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.047 -1.033 . . . . 0.0 109.301 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -113.71 23.26 13.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.519 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.887 ' OH ' HD21 ' A' ' 84' ' ' LEU . 16.3 p90 -147.86 -166.81 2.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 109.528 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.625 HG23 HG12 ' A' ' 32' ' ' VAL . 4.9 mt -114.95 151.67 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.94 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.908 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.1 mt -119.14 124.97 48.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 108.949 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.908 HD13 ' C ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -107.45 138.38 43.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.968 . . . . 0.0 109.647 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.769 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -100.76 159.3 29.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 109.518 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 47.6 Cg_endo -69.41 -24.24 31.48 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.71 2.274 . . . . 0.0 111.505 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.9 m -74.27 -34.07 63.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.334 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.92 ' OD1' HG13 ' A' ' 90' ' ' VAL . 1.7 p30 -80.16 -38.34 31.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 0.0 109.263 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.92 HG13 ' OD1' ' A' ' 89' ' ' ASP . 2.3 m -108.18 69.64 0.33 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.584 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.563 ' HD2' ' CZ3' ' A' ' 92' ' ' TRP . 52.8 Cg_endo -70.72 -25.85 23.72 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.798 2.332 . . . . 0.0 112.045 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.847 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 44.9 p90 -71.26 -37.65 71.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.955 . . . . 0.0 109.497 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.558 HD23 ' CD1' ' A' ' 23' ' ' TRP . 29.8 tp -51.47 -38.62 54.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 95.4 mmm -59.01 -32.99 70.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.936 . . . . 0.0 109.589 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -62.22 140.95 58.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.497 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.84 79.32 49.59 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.69 -19.35 36.55 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.74 2.293 . . . . 0.0 111.682 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.3 tp . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.88 . . . . 0.0 109.454 179.948 . . . . . . . . 0 0 . 1 stop_ save_